Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.7727150144960551,1.9662232787850085,0.0,0.035530463587953476,0.03,5/24,7.28%,NCOA4;NEDD4;SORL1;RAB7A;LAPTM5
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.919564140683298,1.8383759512982247,0.0,0.27832196477230225,0.35,3/8,2.14%,ATRAID;HPSE;TMEM119
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.8307419276649731,1.8323260563026884,0.037037037037037035,0.2092349522401705,0.39,1/11,0.08%,PLA2G4C
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.7996270652256051,1.8163658129216433,0.0,0.19245667776808134,0.43,5/20,7.28%,NCOA4;NEDD4;SORL1;RAB7A;LAPTM5
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.7123252211360451,1.7667586551527776,0.0,0.3932037970400185,0.76,8/19,13.08%,ZNF703;BCL9;SMAD7;TGFB1;LATS2;TRIM33;TWSG1;SMAD2
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.9430280392304308,1.712006918956217,0.0,0.8053571746602789,0.99,1/6,1.53%,BCL2L1
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),0.9130629835255991,1.7119907977935405,0.0,0.6903061497088105,0.99,3/6,2.81%,ZNF385A;TAL1;SH2B3
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.801840122195893,-1.7113249955818421,0.0,0.009447802359016492,0.01,60/84,16.01%,RPL23;RPL37A;RPL38;RPS4X;RPS27A;RPL23A;RPS11;RPS25;RPS27;RPS20;RPS6;RPS18;RPL37;RPS24;RPL3;RPL32;RPL12;RPL11;RPL14;RPL35;FTSJ1;RPS13;RPS12;RPS21;RPL36;RPS8;RPS3A;RPL9;RPL4;RPL28;RPS23;RPL24;RPL31;RPLP1;RPS9;RPL30;RPL10A;RPL13A;RPS14;RPL27A;RPL41;RPL21;RPL19;UBA52;RPS15;RPL18A;RPL15;RPL39;RPL6;RPL5;RPS7;RPS16;RPLP0;RPL34;RPL7A;RPS3;RPS2;RPL8;TMA7;RPL27
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.8102265824130371,-1.7109419163181778,0.0,0.004723901179508246,0.01,59/84,14.65%,RPL23;RPL37A;RPL38;RPS4X;RPS27A;RPL23A;RPS11;RPS25;RPS27;RPS20;RPLP2;RPS6;RPS18;RPL37;RPS24;RPL3;RPL32;RPL12;RPL11;RPL14;RPL35;RPS13;RPS12;RPS21;RPL36;RPS8;RPS3A;RPL9;RPL4;RPL28;SRP14;RPS23;RPL24;RPL31;RPLP1;RPS9;RPL30;RPL10A;SEC61B;RPL13A;RPS14;RPL27A;RPL41;RPL21;RPL19;UBA52;RPS15;RPL18A;RPL15;RPL39;RPL6;RPL5;RPS7;RPS16;RPLP0;RPL34;RPL7A;RPS3;RPS2
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.6456237817211096,1.696408634079205,0.0,0.7653854031238312,1.0,1/28,0.02%,PHLDB2
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.8103799604313431,-1.6962679089448303,0.0,0.006298534906010993,0.02,61/87,16.01%,RPL23;RPL37A;RPL38;RPS4X;RPS27A;RPL23A;RPS11;RPS25;RPS27;RPS20;RPLP2;RPS6;RPS18;RPL37;RPS24;RPL3;RPL32;RPL12;RPL11;RPL14;RPL35;RPS13;RPS12;RPS21;RPL36;RPS8;RPS3A;RPL9;RPL4;RPL28;SRP14;RPS23;RPL24;RPL31;RPLP1;RPS9;RPL30;RPL10A;RPL13A;RPS14;RPL27A;RPL41;RPL21;RPL19;UBA52;RPS15;RPL18A;RPL15;RPL39;RPL6;RPL5;RPS7;RPS16;RPLP0;RPL34;RPL7A;RPS3;RPS2;SRPRA;RPL8;RPL27
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.7952358334001746,-1.6877636930619162,0.0,0.009447802359016492,0.04,61/95,16.01%,RPL23;RPL37A;RPL38;RPS4X;RPS27A;RPL23A;RPS11;RPS25;RPS27;RPS20;RPLP2;RPS6;RPS18;RPL37;RPS24;RPL3;RPL32;RPL12;RPL11;RPL14;RPL35;RPS13;RPS12;RPS21;RPL36;RPS8;RPS3A;RPL9;RPL4;RPL28;SRP14;RPS23;RPL24;RPL31;RPLP1;RPS9;RPL30;RPL10A;RPL13A;RPS14;RPL27A;RPL41;RPL21;RPL19;UBA52;RPS15;RPL18A;RPL15;RPL39;RPL6;RPL5;RPS7;RPS16;RPLP0;RPL34;RPL7A;RPS3;RPS2;SRPRA;RPL8;RPL27
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.7981509542539628,-1.6790836144515684,0.0,0.00944780235901649,0.05,58/102,14.65%,RPL23;RPL37A;RPL38;RPS4X;RPS27A;EIF4A3;RPL23A;RPS11;RPS25;RPS27;RPS20;RPLP2;RPS6;RPS18;RPL37;RPS24;RPL3;RPL32;RPL12;RPL11;RPL14;RPL35;RPS13;RPS12;RPS21;RPL36;RPS8;RPS3A;RPL9;RPL4;RPL28;RPS23;RPL24;RPL31;RPLP1;RPS9;RPL30;RPL10A;RPL13A;RPS14;RPL27A;RPL41;RPL21;RPL19;UBA52;RPS15;RPL18A;RPL15;RPL39;RPL6;RPL5;RPS7;RPS16;RPLP0;RPL34;RPL7A;RPS3;RPS2
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.7220043653157002,1.6753565280955731,0.0,0.9040529068490386,1.0,6/16,9.26%,ZNF703;BCL9;SMAD7;TGFB1;LATS2;TRIM33
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.9491720545519007,1.6749911640194652,0.0,0.8195693600954603,1.0,1/8,0.08%,NUFIP1
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.5628384127975945,1.6742094729677135,0.0,0.7482930967765961,1.0,23/56,19.50%,NRP1;AVIL;ARAP1;P2RY12;ARHGAP35;WASF2;FSCN1;TAPT1;CDC42EP3;DEF8;EPS8;P2RX7;CDC42;PLEKHM1;CROCC;ARPC2;FNBP1L;PFN1;KCTD17;CYFIP1;FMR1;ACTR2;AUTS2
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.7629096474969087,-1.6708438050030205,0.0,0.014171703538524734,0.09,64/128,14.65%,PCSK1;RPL23;RPL37A;RPL38;RPS4X;RPS27A;RPL23A;RPS11;RPS25;RPS27;RPS20;RPLP2;RPS6;RPS18;RPL37;RPS24;RPL3;RPL32;RPL12;RPL11;RPL14;RPL35;RPS13;RPS12;RPS21;RPL36;RPS8;RPS3A;RPL9;RPL4;RPL28;RPS23;RPL24;RPL31;RPLP1;RPS9;RPL30;COPS5;RPL10A;MRPL43;RPL13A;RPS14;RPL27A;RPL41;RPL21;RPL19;EEF1A2;DMD;RPS15;RPL18A;RPL15;RPL39;MRPS7;RPL6;RPL5;RPS7;RPS16;RPLP0;RPL34;RPL7A;MRPL51;DARS1;RPS3;RPS2
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.8476801755875792,1.661792154756641,0.0,0.7895658575100774,1.0,2/8,6.95%,ACTA2;TMEM79
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.7911214184326721,1.6563076743513099,0.043478260869565216,0.7816701989349766,1.0,2/15,2.35%,PHLDB2;CRK
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.8734333389135733,1.6504215264795663,0.0,0.784208089191259,1.0,5/8,11.15%,LGALS9;CD274;CBFB;RUNX1;TWSG1
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.8095029236752451,1.6496341008781705,0.08333333333333333,0.6906233859908458,1.0,6/13,14.03%,RAP1A;MAP4K4;RAPGEF6;STK26;RAP2A;RAP2C
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.8095029236752451,1.6496341008781705,0.08333333333333333,0.6906233859908458,1.0,6/13,14.03%,RAP1A;MAP4K4;RAPGEF6;STK26;RAP2A;RAP2C
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),0.6430067967506009,1.6493310966788943,0.04,0.6506951566891872,1.0,7/27,19.08%,LCP1;TGFB1;CEP290;PLK3;ATP13A2;TPR;RAB29
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.9266832308341986,1.6468238247504579,0.0,0.6323106575559869,1.0,3/7,3.12%,NEDD4;DAB2IP;HHEX
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.8130304085260276,-1.645316716054928,0.0,0.026993721025761398,0.19,8/32,8.09%,CCL4;MYLK;PKP2;CACNB2;CCL3;FHL1;ANK3;ANK2
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.705432111453556,1.6446306771290504,0.0,0.6090046127268518,1.0,4/20,10.74%,ZNF703;TGFB1;NRIP1;CYP19A1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.6827319855944727,1.644270318800857,0.0,0.581515254056172,1.0,7/36,8.18%,TNFAIP8L3;PIK3C2B;PTAFR;PI4KB;CSF1R;GAB2;PLCB4
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.9685211605981505,-1.6411867685467323,0.0,0.033067308256557716,0.24,1/8,0.08%,DDIT4
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.7063793799714888,1.6375082550612532,0.0,0.6023259541576876,1.0,2/27,2.29%,ATRAID;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.8511681873193634,1.6348235954601589,0.09090909090909091,0.5970194563490971,1.0,4/7,12.08%,TGFB1;TP53;MAP2K1;MAP2K2
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.8731377296883494,1.6330052980387872,0.05555555555555555,0.5829055765443962,1.0,1/6,5.43%,ABL1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.9111109041576455,1.6310472897803303,0.0,0.5714482893729185,1.0,3/9,4.98%,CBFB;RUNX1;TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.9058335643585897,1.6298399048930614,0.09090909090909091,0.5599601061461469,1.0,2/6,0.28%,ACER2;NEXMIF
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.6986513798259792,1.6285257968128446,0.0,0.5443449229180052,1.0,2/18,6.29%,ARL2BP;TAF3
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.9551602974388235,1.627730415021637,0.0,0.5303250676276019,1.0,1/7,0.02%,PHLDB2
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)",0.9052245110069849,1.6190370826136133,0.05714285714285714,0.5731402162104401,1.0,2/5,4.94%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.7225586530589401,1.6188204593741318,0.0,0.5541935527454352,1.0,5/25,4.17%,AVIL;FER;ABI3;WASF2;FSCN1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.76363335057412,1.611548085819297,0.125,0.5850683004149674,1.0,4/11,12.08%,TGFB1;TP53;MAP2K1;MAP2K2
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.6318798779197754,1.6103329608311756,0.0,0.572689945358519,1.0,5/19,8.89%,LGALS9;TRIM38;KPNA6;CHMP2B;TRIM11
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.7743979574566459,1.6089571581281792,0.0,0.5640461094587615,1.0,5/10,20.36%,SUPT16H;BRD4;CDK13;CDC73;LEO1
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.922234517543137,1.6060658149838354,0.0,0.5656162688344918,1.0,1/6,0.86%,PUS1
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.8452407912877999,1.5988334155387294,0.034482758620689655,0.5953094340373775,1.0,4/9,11.98%,GSN;ARFIP1;WHAMM;WASHC5
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.6529256797908122,1.5921993718271965,0.0,0.618568451797895,1.0,9/20,20.36%,SUPT16H;BRD4;THOC5;SCAF8;KAT7;CDK13;CDC73;SUPT5H;LEO1
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.551261529705785,1.5903170925004837,0.0,0.6138874542140852,1.0,19/84,17.05%,ARHGAP31;RALB;RIN2;KRAS;RGL2;RAPGEF6;MAPK11;TP53;RASGRP2;SHTN1;ABR;CRKL;RIT2;FGF2;USP28;ARHGAP1;SHOC2;MRAS;G3BP1
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.6194229503619391,1.5885956232114635,0.0,0.6072188236607905,1.0,5/29,10.86%,NEDD4;SORL1;CEP290;PGAP1;PLK3
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.6526721410216532,1.5874050612740414,0.0,0.5971611248642006,1.0,4/24,4.88%,PHLDB2;RPS6KA6;RBM19;DAG1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.8027649619912088,1.5873531489069244,0.0,0.5821529803256994,1.0,2/10,3.64%,PKD2;NFKBIE
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.7200249245366974,-1.586047212748426,0.0,0.1826575122743188,0.73,72/175,16.01%,RPL23;RPL37A;RPL38;RPS4X;RPS27A;RPL23A;RPS11;RPS25;RPS27;RPS20;RPLP2;RPS6;RPS18;RPL37;RPS24;RPL3;RPL32;RPL12;RPL11;RPL14;RPL35;FTSJ1;RPS13;RPS12;RPS21;RPL36;RPS8;RPS3A;RPL9;RPL4;RPL28;EEF1B2;RPS23;RPL24;RPL31;RPLP1;RPS9;RPL30;COPS5;RPL10A;MRPL43;RPL13A;RPS14;RPL27A;RPL41;RPL21;RPL19;EEF1A2;UBA52;RPS15;RPL18A;PPA1;RPL15;RPL39;MRPS7;RPL6;RPL5;RPS7;RPS16;RPLP0;RPL34;RPL7A;MRPL51;DARS1;LARS1;RPS3;RPS2;EEF1A1;RPL8;TMA7;NARS1;RPL27
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),0.9468933196573025,1.5796800043143595,0.034482758620689655,0.606978752960872,1.0,2/5,1.99%,RAP1A;RIN2
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.7766220327987712,1.5706592273771907,0.1111111111111111,0.6528361602339421,1.0,2/8,10.14%,SORL1;PGAP1
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.8872656308048219,1.5704303187602433,0.0,0.6384203933581483,1.0,2/8,4.88%,PHLDB2;DAG1
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),0.9885937259647609,1.5650286781105018,0.0,0.6613073106564054,1.0,1/6,0.08%,NUFIP1
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),0.9087403107427388,1.5638578442774098,0.0,0.6546218745901733,1.0,3/7,4.17%,GSN;LCP1;FSCN1
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.8906241245412022,-1.563373313057616,0.0,0.3278387418578722,0.93,2/15,0.29%,NUDT12;NAMPT
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.7341491794831441,-1.5621182490941024,0.0,0.3057652399827155,0.93,64/153,16.18%,RPL23;RPL37A;RPL38;RPS4X;RPS27A;EIF4A3;RPL23A;RPS11;RPS25;RPS27;RPS20;RPLP2;RPS6;RPS18;RPL37;RPS24;RPL3;RPL32;RPL12;RPL11;RPL14;RPL35;RPS13;RPS12;RPS21;RPL36;RPS8;RPS3A;RPL9;RPL4;RPL28;RPS23;RPL24;RPL31;RPLP1;RPS9;RPL30;POLR2G;RPL10A;TENT4B;RPL13A;RPS14;RPL27A;RPL41;RPL21;RPL19;UBA52;RPS15;RPL18A;RPL15;RPL39;RPL6;RPL5;RPS7;RPS16;RPLP0;RPL34;RPL7A;RPS3;RPS2;RPL8;CNOT8;RPL27;EIF3E
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.8064536207705917,1.5608680260428798,0.0,0.6648144520234852,1.0,5/10,10.06%,GSN;HPN;MYH9;KLKB1;PLGRKT
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.7733594513474333,1.559945312142791,0.037037037037037035,0.6573135763771395,1.0,3/12,12.97%,ARV1;TECR;MGST2
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.7248522186033475,1.558011219891126,0.0,0.6534077452734991,1.0,4/17,11.13%,RAP1A;CBFB;RUNX1;PDLIM5
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.6220397655150857,1.556539426395182,0.0,0.6506516144543981,1.0,3/24,4.43%,NUP42;SMURF1;TGFB1
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),-0.9100329539804694,-1.5555602510039426,0.01282051282051282,0.33382235001858257,0.94,3/12,5.14%,CCL4;GPR183;CCL3
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.6294500615715758,1.5552710068661653,0.05,0.6460743480993174,1.0,1/29,0.02%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.7656671607862378,1.5527098022177925,0.05,0.6516287022030669,1.0,4/11,7.39%,GSN;WASF2;WHAMM;WASF3
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.8153885679146423,1.550401364810444,0.041666666666666664,0.6546429859767376,1.0,6/10,14.38%,FSCN1;SCRIB;MSN;RAP2A;CDC42;OPHN1
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.7253165582608694,-1.5501741641675324,0.0,0.35320245742169337,0.95,38/133,10.57%,NR4A3;NAMPT;SOCS3;SLC2A3;CCL4;GADD45B;FOSL2;CEBPD;TNC;NFIL3;PPP1R15A;PLPP3;GPR183;BHLHE40;NR4A1;FOS;VEGFA;RHOB;BCL2A1;IL7R;CD69;DUSP1;IFIT2;NR4A2;MAP3K8;LITAF;SAT1;TRIP10;JUNB;TNFAIP8;IL18;KDM6B;ETS2;TGIF1;ID2;MXD1;ATF3;PDE4B
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.8370297644423896,1.5492169553358546,0.08333333333333333,0.6507085542998916,1.0,2/10,3.30%,PLEKHM2;LYST
prerank,GO_Biological_Process_2021__positive regulation of podosome assembly (GO:0071803),0.9543829968773975,1.548189435029506,0.0,0.6451348954617717,1.0,2/5,4.17%,LCP1;FSCN1
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.9442801669691614,1.5433281327993769,0.03571428571428571,0.6579715479250644,1.0,2/6,1.99%,RAP1A;RIN2
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.9640133620636374,1.542947003782413,0.025,0.6475157818725825,1.0,1/5,2.63%,SMAD7
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),0.8546353258201858,1.5411742865071696,0.0,0.6496999056082923,1.0,2/8,3.40%,CX3CR1;ITGAM
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)",0.9027726584912674,1.539589161753548,0.0,0.6482751251135371,1.0,2/6,4.94%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.7936751825015693,-1.531403383528493,0.0125,0.5338008332844317,1.0,5/22,8.09%,CCL4;MYLK;CACNB2;CCL3;ANK2
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.8909123330279062,1.5310806880478611,0.030303030303030304,0.6920272476987032,1.0,1/6,0.08%,PLA2G4C
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.8708022655482681,1.5233850228786836,0.058823529411764705,0.7399168857920708,1.0,3/7,3.51%,SPRED2;ZNF385A;SPRED1
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),0.8890741765084504,1.522213129631323,0.0,0.733506681626862,1.0,3/8,3.91%,SIRPA;CX3CR1;TMEM106A
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.6393429949900689,1.5216547361618855,0.0,0.7259475593188967,1.0,5/17,14.09%,LGALS9;PLA2G7;CXCL12;JAM2;SERPINE1
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.7731457989560231,1.5187489848261548,0.04,0.7321949835087402,1.0,2/9,18.07%,LAPTM5;RBSN
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.8676763745174982,1.518096751555012,0.0,0.7243326783300781,1.0,2/8,7.92%,PLA2G4C;PLA2G12A
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.8471971077122834,-1.5150245684895822,0.0,0.7495256538153082,1.0,5/17,10.79%,KCNE1;FHL1;ANK3;ANK2;CD63
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.6956048714166382,-1.5148906789126761,0.0,0.7056327386890441,1.0,54/137,13.76%,RPL23;RPL37A;RPL38;RPL23A;RPS25;RPS27;RPLP2;RPS6;WDR12;RPL37;RPS24;RPL3;RPL32;RPL12;RPL11;RPL14;RPL35;RPL36;IMP3;RPL9;RPL4;RPL28;RPL24;RPL31;RPLP1;RPS9;RPL30;RPL10A;MAPT;RPL13A;RPS14;RPL27A;NOB1;RPL41;RPL21;RPL19;NOP53;UBA52;UTP3;RRP1B;RPS15;MPHOSPH6;RPL18A;RRP36;RPL15;RPL39;RPL6;SBDS;RPL5;RPS7;RPS16;RPLP0;RPL34;RPL7A
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.8808861112945506,1.5113294251223302,0.0,0.7594636591925056,1.0,3/6,7.07%,SMAD7;HHEX;DACH1
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.9284209297116597,1.5107842124878197,0.038461538461538464,0.7510593379976629,1.0,2/7,2.46%,PLA2G4C;PLA2G7
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),0.9506388696190176,1.5104256421783318,0.0,0.7421919060594728,1.0,1/6,1.77%,ITGA5
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.6639769331307197,1.5093200669522961,0.0,0.7394225332756686,1.0,4/16,7.09%,RING1;DDB2;RYBP;RNF2
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.8596212074682332,1.5081145657916053,0.03571428571428571,0.7369087815717215,1.0,2/7,6.63%,LGALS9;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.8235519537768743,1.5078087542569203,0.06896551724137931,0.7289752601837605,1.0,2/8,4.06%,RALB;PIP4K2B
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.8131741836287085,1.5072013504330963,0.03333333333333333,0.7227911449892251,1.0,2/7,1.73%,NRP1;HPN
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6843991925612478,-1.5055979925527823,0.0,0.8169570275149554,1.0,61/162,16.01%,RPL23;RPL37A;RPL38;RPL23A;RPS25;RPS27;RPLP2;GLUL;RPS6;WDR12;RPL37;RPS24;RPL3;RPL32;RPL12;RPL11;RPL14;RPL35;RPL36;IMP3;RPL9;RPL4;RPL28;RPL24;RPL31;RPLP1;RPS9;RPL30;HEATR3;RPL10A;RPL13A;RPS14;RPL27A;NOB1;RIOK2;RPL41;RPL21;RPL19;NOP53;UBA52;UTP3;RRP1B;RPS15;MPHOSPH6;RPL18A;RRP36;RPL15;RPL39;RPL6;SBDS;RPL5;RPS7;RPS16;RPLP0;RPL34;RPL7A;METTL17;RPS2;WDR46;RPL8;RPL27
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.7979532605874862,1.5051835594613507,0.03125,0.7246212855684034,1.0,3/9,5.63%,ZNF703;SMAD7;VCL
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.8231950010655777,-1.504972905740156,0.0125,0.7841675957983687,1.0,3/22,6.12%,KCNE1;CEMIP;ANK3
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.901599739465914,1.504712122953863,0.02857142857142857,0.7178469587862454,1.0,2/5,4.94%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.8812365841081502,1.5023933327160615,0.0625,0.7234261969802949,1.0,3/6,11.15%,LGALS9;CD274;TWSG1
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.7537461384052209,1.4994594791350624,0.06060606060606061,0.7318955404851859,1.0,2/7,4.36%,NUAK1;NEK6
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.8808614790380825,1.4984166164096964,0.02702702702702703,0.7298746786823156,1.0,2/5,6.37%,TP53;SIRT1
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.6897489476794003,-1.4968587025939715,0.0,0.912458806778698,1.0,85/233,17.17%,BRIP1;RPL23;RPL37A;RPL38;RPS4X;RPS27A;RPL23A;RPS11;RPS25;RPS27;RPS20;GCNT1;RPLP2;RPS6;RPS18;RPL37;RPS24;RPL3;RPL32;RPL12;RPL11;RPL14;RPL35;RPS13;NR4A2;RPS12;RPS21;RPL36;RPS8;RPS3A;RPL9;RPL4;RPA2;RPL28;BRCA1;EEF1B2;RPS23;RPL24;RPL31;RPLP1;RPS9;RPL30;POLR2G;COPS5;RPL10A;MRPL43;DONSON;RPL13A;RPS14;RPL27A;RPL41;RPL21;RPL19;EEF1A2;CLSPN;PAX8;RPS15;RPL18A;RPL15;RPL39;MRPS7;RPL6;RPL5;RPA3;RPS7;PTMA;RPS16;RPLP0;ING4;RPL34;RPL7A;MRPL51;DARS1;ING5;RPS3;RPS2;RFC4;EEF1A1;RPL8;RPL27;TIMELESS;POLL;RPL7;DNA2;ORC6
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),-0.9176941127880477,-1.4948371670546838,0.014705882352941176,0.8624493867730767,1.0,1/8,0.99%,INSIG1
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),-0.9176941127880477,-1.4948371670546838,0.014705882352941176,0.8624493867730767,1.0,1/8,0.99%,INSIG1
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),0.8756764601938611,1.4941453063541916,0.034482758620689655,0.7494122780459135,1.0,2/7,2.71%,CX3CR1;P2RY12
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.6061286015883446,1.493360526818139,0.045454545454545456,0.7453706776936042,1.0,4/21,4.43%,ZNRF3;NEDD4;SMURF1;TGFB1
prerank,GO_Biological_Process_2021__cell junction disassembly (GO:0150146),0.8987709856074876,1.4927098154574685,0.02631578947368421,0.7393069538878012,1.0,1/5,2.17%,CX3CR1
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.7753636795785028,1.4923633630612692,0.0625,0.7324972366697919,1.0,2/8,6.16%,BCL2L1;TP53
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.912775048707678,-1.4914193492084509,0.0273972602739726,0.8807928471974009,1.0,1/10,0.14%,TOP2A
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.8598485129414899,1.4909190674569317,0.0,0.7325197243049743,1.0,2/6,11.36%,LPL;TIRAP
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.8304369169700544,-1.490507398496371,0.0,0.8581069186080628,1.0,3/19,6.63%,KCNE1;INSIG1;MDFIC
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.7186671227958051,-1.4898428899980458,0.023529411764705882,0.8341622166148308,1.0,7/41,7.98%,NR4A3;THBS1;HMGB2;RAB7B;WDR5;FAXDC2;PRKCQ
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.7752303120401094,1.4889944471598138,0.08695652173913043,0.7367819177765333,1.0,1/12,0.19%,ACER2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.8017413441620562,1.4889763047160438,0.10344827586206896,0.7280856379954207,1.0,4/9,15.16%,TRAF6;NFAT5;ALOX5;IRAK1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.8476712667271126,1.4881476253876325,0.041666666666666664,0.7243077637447867,1.0,3/8,4.88%,PHLDB2;TGFB1;DAG1
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.8725387494367915,1.485783494772115,0.03333333333333333,0.721198743259793,1.0,1/7,0.22%,GCLC
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.8725387494367915,1.485783494772115,0.03333333333333333,0.721198743259793,1.0,1/7,0.22%,GCLC
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.894382722055942,1.484426411470609,0.0,0.7219018997211324,1.0,1/5,5.87%,CAP1
prerank,GO_Biological_Process_2021__regulation of hippocampal neuron apoptotic process (GO:0110089),0.9054635122723986,1.4829195499798054,0.10714285714285714,0.7219082314441276,1.0,2/5,3.40%,CX3CR1;ITGAM
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.8287328965584093,-1.4822493461514186,0.0125,0.9304195763159439,1.0,2/16,2.45%,MT2A;FOS
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.8470484184553468,1.4814326397607342,0.09375,0.7232602701578107,1.0,2/6,5.65%,GALNT1;POGLUT3
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.8638858502051189,1.4790075225185837,0.09090909090909091,0.7280418213097134,1.0,2/6,2.29%,GSN;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.8660395490753061,-1.4777110216197353,0.02702702702702703,0.9854784614481815,1.0,2/12,3.30%,HTR2B;HIF1A
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),0.7287230225402237,1.4772109725995044,0.08695652173913043,0.7287692864818014,1.0,5/13,16.55%,NSUN2;METTL16;METTL8;TRMT6;ZC3H13
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.755954385371712,1.477204932349015,0.05263157894736842,0.7207608327841991,1.0,5/13,12.38%,DESI2;UBA7;SENP6;UBA1;UBA2
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.661492442223775,-1.4769352668875941,0.0,0.9661252708609084,1.0,94/275,17.96%,RPL23;RPL37A;RPL38;ARAF;RPS4X;RPS27A;TNC;RPL23A;PAPPA2;RPS11;RPS25;RPS27;VCAN;RPS20;RPLP2;RPS6;RPS18;RPL37;RPS24;RPL3;RPL32;RPL12;RPL11;RPL14;RPL35;ERO1A;RPS13;RPS12;RPS21;RPL36;RPS8;RPS3A;RPL9;RPL4;RPL28;RPS23;FBXL2;RPL24;RPL31;RPLP1;RPS9;RPL30;COPS5;RPL10A;MRPL43;SERP1;RPL13A;RPS14;RPL27A;LTBP1;RPL41;GPC3;RPL21;RPL19;EEF1A2;LAMB1;UBA52;SPARCL1;RPS15;GGCX;RPL18A;RPL15;RPL39;MRPS7;RPL6;RPL5;USP6;VGF;RPS7;CDH2;FN1;RPS16;RPLP0;RPL34;RPL7A;MRPL51;DARS1;SLC35A1;RPS3;RPS2;CHGB;EEF1A1;RPL8;TMEM132A;UBE2M;RPL27;CPE;LGALS1;RPL7;DUSP12;CKAP4;MRPL27;PIGH;RPL10
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)",0.9094925743222839,1.4767878873628384,0.0,0.7162735485629462,1.0,2/5,4.94%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.7635434213795159,1.4760387493242852,0.0625,0.7135383063917683,1.0,2/10,4.54%,ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.887157278067923,-1.4747130367323749,0.0,0.9721113784402325,1.0,3/11,1.24%,GLRA1;NLRP12;HHIP
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.8295253096566526,1.4744224528019745,0.0,0.7171609884490469,1.0,4/8,4.29%,SIRPA;CX3CR1;CD274;MAPKAPK2
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.5237436139267638,1.4734153532119323,0.0,0.7154713351974211,1.0,6/44,11.42%,RALB;LPL;SIRT1;STK26;RRAGD;CLEC16A
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.7503441865569149,-1.473135225101039,0.011627906976744186,0.9711689252492466,1.0,4/32,3.30%,HTR2B;TGFB2;RBPJ;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.8189921711149692,-1.472602441772963,0.04,0.9507638440623595,1.0,2/15,3.30%,HTR2B;HIF1A
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.71279731008215,-1.4723581213196457,0.0,0.9252750955475504,1.0,16/50,14.20%,RPL38;RPS25;GLUL;RPS6;WDR12;RPS24;RPL11;RPL14;HEATR3;RIOK2;RPS15;RRP36;RPL5;RPS7;RPS16;METTL17
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.6759398990496432,-1.4723572000568137,0.0,0.8963602488116895,1.0,31/112,18.11%,TOP2A;PRLR;GLA;PRKAR2B;ALDH3B1;FOS;ETFB;OVOL2;TSPAN13;LSR;XRCC3;SLC7A5;BLVRB;PAPSS2;MAPT;SNX10;ID2;COX6C;STIL;OLFM1;RAPGEFL1;SLC16A1;CD44;ST14;SORD;FKBP5;CPE;PDCD4;KLF4;ATP2B4;CALCR
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.8110587803197253,1.471292245575751,0.10344827586206896,0.7152489886537164,1.0,1/9,0.19%,ACER2
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.8110587803197253,1.471292245575751,0.10344827586206896,0.7152489886537164,1.0,1/9,0.19%,ACER2
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.8358387075146778,-1.4711904661818147,0.01282051282051282,0.8938193625711963,1.0,2/15,2.45%,MT2A;FOS
prerank,GO_Biological_Process_2021__p38MAPK cascade (GO:0038066),0.8075164417862087,1.4709957319799432,0.16216216216216217,0.709642456423343,1.0,1/5,1.01%,LGALS9
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.6613708906393356,-1.470590369979447,0.0,0.876422607068765,1.0,55/170,13.76%,RPL23;RPL37A;RPL38;RPL23A;RPS25;RPS27;RPLP2;RPS6;WDR12;RPL37;RPS24;RPL3;RPL32;RPL12;RPL11;INTS12;RPL14;RPL35;RPL36;IMP3;RPL9;RPL4;RPL28;RPL24;RPL31;RPLP1;RPS9;RPL30;RPL10A;RPL13A;RPS14;RPL27A;NOB1;RPL41;RPL21;RPL19;NOP53;SSB;UBA52;UTP3;RRP1B;RPS15;MPHOSPH6;RPL18A;RRP36;RPL15;RPL39;RPL6;SBDS;RPL5;RPS7;RPS16;RPLP0;RPL34;RPL7A
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.6367436719905518,1.470384738794154,0.0,0.705465130566201,1.0,2/15,2.29%,ATRAID;DAB2IP
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.7625253987515604,1.47012997729345,0.06060606060606061,0.7001870024399366,1.0,3/9,10.28%,ARHGAP35;CNTN4;EPHB3
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.7475451003858976,-1.4699261975149533,0.011363636363636364,0.8619095123525614,1.0,10/39,8.67%,ENPP2;GLIPR2;GLUL;TGFB2;HIF1A;PTN;DOCK1;RAB11A;DOCK5;PRKCE
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.7890722323191108,1.469385316644817,0.07407407407407407,0.6975931613357599,1.0,4/10,15.17%,TRAF6;NFAT5;IRAK1;ZDHHC21
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.7580648826795144,-1.4680089096556095,0.0379746835443038,0.8718222065736884,1.0,12/25,14.09%,SLC51A;SLC16A4;ATP8B1;SLC16A3;SLCO3A1;SLCO1A2;ABCC3;ABCB4;CD36;SLC10A1;SLC16A7;SLC16A1
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.8329961295015028,-1.467612495638785,0.027777777777777776,0.8523449803891093,1.0,3/16,5.45%,TOP2A;HMGB2;H1-0
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.8141542849673034,1.4673681508885288,0.08823529411764706,0.7036425141928042,1.0,5/8,16.50%,P2RY12;DEF8;EPS8;PLEKHM1;PFN1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),0.8571480433155196,1.4648203865065126,0.038461538461538464,0.7095744038875758,1.0,4/9,5.55%,PDPN;FSCN1;TGFB1;DDR1
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),0.8510742648824858,1.4632446534427797,0.10714285714285714,0.7130007452697973,1.0,3/5,9.42%,PGM5;FLII;TMOD2
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.9291388631405876,-1.4626707209181993,0.0,0.9186744662254193,1.0,1/9,0.02%,KCNE1
prerank,GO_Biological_Process_2021__lactation (GO:0007595),-0.9702277456580913,-1.4625214043243806,0.0,0.8755750836218532,1.0,2/5,2.56%,PRLR;VEGFA
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),-0.9702277456580913,-1.4625214043243806,0.0,0.8755750836218532,1.0,2/5,2.56%,PRLR;VEGFA
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.6773608402594942,-1.461996866745001,0.0,0.8627456593209204,1.0,36/129,11.47%,DDIT4;SLC2A3;FOSL2;PLIN2;SAP30;NFIL3;PPP1R15A;BHLHE40;MT2A;FOS;VEGFA;PHKG1;RBPJ;AKAP12;RORA;DUSP1;MXI1;ERO1A;NDRG1;FBP1;NOCT;FAM162A;PLAC8;ANKZF1;GAPDH;CXCR4;GPC3;PDK3;PPFIA4;PGK1;BNIP3L;TPD52;ATF3;ENO2;HSPA5;TGFBI
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.9423420866510234,-1.4613356894769824,0.014705882352941176,0.8516518983627721,1.0,1/8,1.11%,RGS2
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),-0.9465727356260323,-1.4604859781582176,0.0,0.8452487366310798,1.0,2/6,3.14%,KCNE1;KCNT2
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.7480550167230519,-1.4601647386380687,0.02127659574468085,0.8311918848125645,1.0,13/41,14.20%,KCNE1;CEMIP;NDUFB9;LRP2;SLC26A5;COL11A1;TIMM13;SOD1;USP53;LHFPL5;CDH23;MYO3B;PIEZO2
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.8507759395206297,-1.4592526632331133,0.02531645569620253,0.8278374378133782,1.0,7/14,11.46%,PRLR;SLC5A9;CYP3A5;TG;TSHR;FMO5;SLC10A1
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),0.8289400461849042,1.4579050687376407,0.11428571428571428,0.7376801011594152,1.0,1/6,2.80%,NLRP1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.6721325416032932,-1.4575138723717043,0.0,0.8361305087729592,1.0,56/148,13.93%,RPL23;RPL37A;RPL38;RPL23A;RPS25;RPS27;RPLP2;RPS6;WDR12;RPL37;RPS24;RPL3;RPL32;RPL12;RPL11;RPL14;RPL35;RPL36;IMP3;RPL9;RPL4;RPL28;NHP2;RPL24;RPL31;RPLP1;RPS9;RPL30;RPL10A;RPL13A;RPS14;RPL27A;NOB1;RIOK2;RPL41;RPL21;RPL19;NOP53;UBA52;UTP3;RRP1B;RPS15;MPHOSPH6;RPL18A;RRP36;RPL15;RPL39;RPL6;SBDS;RPL5;RPS7;RPS16;RPLP0;RPL34;RPL7A;MAK16
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.811909201432173,1.4571380573249504,0.17142857142857143,0.736195674783099,1.0,2/6,4.72%,PGM5;PTCH1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.546244938787201,1.456869005702948,0.0,0.7308649566082768,1.0,5/45,6.30%,DCP1B;PDE12;LSM6;NT5C3B;EDC3
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.7227585532655865,1.4567574545958173,0.10714285714285714,0.724426674265496,1.0,2/13,4.94%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.6952651368452185,1.4562685242574807,0.043478260869565216,0.7209315776944077,1.0,3/12,12.32%,LGALS9;TGFBR2;BATF3
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.9177441550679752,-1.4556121501519026,0.0,0.8480910245253314,1.0,2/8,0.29%,NUDT12;NAMPT
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.8843389331180038,-1.4551935922718726,0.015384615384615385,0.8363273379887721,1.0,3/6,5.65%,NAMPT;GSTP1;NOD2
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.8287161236183119,-1.4539586363558925,0.028985507246376812,0.8396975361942206,1.0,1/13,0.08%,DDIT4
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.6936911523960834,1.4537772223978778,0.125,0.7289128439104396,1.0,5/13,16.14%,NRP1;SORL1;PDGFA;SERPINE1;TRIB1
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.928023020745981,-1.4526243417168536,0.03125,0.8431218825186314,1.0,1/6,3.11%,RSAD2
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.7873834046561228,-1.4523825026569517,0.08,0.8293688463003298,1.0,2/11,5.14%,CCL4;CCL3
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.8372548670074783,-1.4522028273522491,0.029411764705882353,0.8161447730135013,1.0,4/10,5.46%,ALOX12;ACSL1;ALOX15B;GSTP1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.7128610473295414,-1.4519905071663428,0.0125,0.8044892838913476,1.0,7/25,11.59%,CYP3A5;PLPP3;ALOX12;ALOX15B;DGKG;DGKI;MBOAT2
prerank,GO_Biological_Process_2021__eosinophil chemotaxis (GO:0048245),-0.9388483388457282,-1.4508909015221794,0.014925373134328358,0.7918976159102913,1.0,2/5,5.14%,CCL4;CCL3
prerank,GO_Biological_Process_2021__eosinophil migration (GO:0072677),-0.9388483388457282,-1.4508909015221794,0.014925373134328358,0.7918976159102913,1.0,2/5,5.14%,CCL4;CCL3
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.7219699127021366,-1.449795549921718,0.0,0.7920970013496861,1.0,17/51,16.36%,NDUFA2;NDUFB9;CYCS;COX7C;NDUFS8;NDUFA3;COX4I1;NDUFA1;UQCRC1;COX6C;NDUFS5;UQCR10;UQCRB;NDUFB6;COA6;NDUFS7;COX5B
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),0.6612983581522238,1.449484797252847,0.058823529411764705,0.7494473761014572,1.0,5/18,13.22%,PUS1;NSUN2;METTL16;METTL8;TRMT6
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.857178955227071,-1.449242454938542,0.013513513513513514,0.7849963503912648,1.0,2/11,1.99%,THBS1;FGF1
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.639799218668206,1.449014506292613,0.0625,0.7451880265009172,1.0,5/18,7.83%,ACER2;NEXMIF;P2RY12;SYK;CIB1
prerank,GO_Biological_Process_2021__regulation of prostaglandin biosynthetic process (GO:0031392),0.9154097164763497,1.4488875557604732,0.030303030303030304,0.7391174903311148,1.0,2/5,7.41%,SIRT1;IL1B
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.620303992135119,1.4481987749984553,0.09523809523809523,0.735750710906101,1.0,5/17,9.82%,MCU;MICU3;MAIP1;SMDT1;C19ORF12
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.8634350014240693,1.4477970575808976,0.034482758620689655,0.731618589358903,1.0,2/7,2.29%,ATRAID;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.8648542234971924,-1.4476928667477476,0.0,0.7983392993368933,1.0,2/10,5.14%,CCL4;CCL3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),-0.8800668843814707,-1.4472256220230215,0.014492753623188406,0.7916938112369072,1.0,1/7,0.73%,THBS1
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.5762769647059872,1.447092647684678,0.058823529411764705,0.7294975929193321,1.0,5/21,7.09%,RING1;DDB2;RNF20;RYBP;RNF2
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.6865377580943992,-1.4461038674611013,0.033707865168539325,0.7947176417659371,1.0,10/57,9.53%,KCNE1;JPH1;NEFL;CACNB2;ANK3;DAPK1;ANK2;DMD;FGF13;AHNAK
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.9584417752080756,-1.4438870522564065,0.0,0.8123561208695326,1.0,1/6,0.33%,SLC2A3
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.8631329331849357,1.4437221357117327,0.12195121951219512,0.7419894532754958,1.0,2/6,3.39%,PSAT1;PSPH
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.7569291983603195,1.441743070656876,0.1,0.7452364184761429,1.0,2/11,4.54%,ST6GALNAC3;ST8SIA4
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.8088081082140527,-1.4415488110556425,0.025,0.8384162674082052,1.0,8/19,15.60%,RPS27A;RPA2;UBA52;RFC1;UBC;RPA3;RFC4;UBB
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.7907996410025868,-1.4414520293745026,0.02531645569620253,0.8266077238555378,1.0,8/23,9.59%,CENPF;AGT;VEGFA;TGFB2;GREB1L;SULF2;STAT1;PAX8
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.7412851153496558,1.441264187802416,0.09375,0.7422582561315324,1.0,3/10,6.87%,CX3CR1;SYK;NMI
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.7765157595598737,-1.4406376878222058,0.04819277108433735,0.8271255721495219,1.0,2/21,1.81%,TOP2A;KNSTRN
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.8938245962361837,-1.4405160415266314,0.013157894736842105,0.8167261762355947,1.0,1/11,0.02%,KCNE1
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),-0.9016446827670013,-1.4403527165834293,0.027777777777777776,0.807071359092954,1.0,3/6,5.14%,CCL4;MYO1G;CCL3
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.911082324043278,1.440078606749226,0.0,0.7414023402019626,1.0,2/5,6.25%,UBE2E2;UBA7
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.7207192365907974,-1.4389906924927136,0.0,0.8191385657242805,1.0,14/50,12.97%,NDUFA2;NDUFB9;CYCS;COX7C;NDUFS8;NDUFA3;COX4I1;NDUFA1;UQCRC1;COX6C;NDUFS5;UQCR10;UQCRB;NDUFB6
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.6669787378286193,-1.4389819900855965,0.01098901098901099,0.8070924103459822,1.0,40/72,25.34%,PCSK1;ENPP2;VEGFA;SULT4A1;CCK;CALY;SST;PAK5;PTPRT;RAB3C;NRXN1;GRIA4;GDAP1L1;PCSK2;KCNC1;PHYHIPL;CTNND2;CHGB;SCG5;SH3GL2;TAGLN3;SNAP25;UNC13A;CPE;SYT4;CLVS2;SYP;STMN2;GAD2;ASXL3;ST8SIA3;LY6H;CADPS;CSRNP3;TMEM59L;CA10;UNC5D;GRIA2;CACNA1B;SCG3
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.6537050805609226,1.438185263727422,0.1,0.746139735347023,1.0,6/25,10.68%,ATRAID;TMEM119;FFAR4;ACVR1;IL6ST;IL6R
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.8702679067631973,-1.4381655845856725,0.014285714285714285,0.8075817146881051,1.0,3/10,7.80%,NR4A3;HIF1A;PINK1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.8140388547057686,-1.438030119917138,0.023529411764705882,0.7975294877061205,1.0,3/20,2.46%,NR4A3;RGS2;AGT
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.8711925281256739,1.4379479941514168,0.04878048780487805,0.7410916913399915,1.0,3/6,12.01%,ARHGAP35;CXCL12;EPS8
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.8076553890286595,-1.4379415755388438,0.013513513513513514,0.7876273544087126,1.0,10/17,13.23%,RPL23A;RPL3;RPL11;RPL24;NOP53;RPL6;RPL5;TRAF7;RPLP0;MRPL20
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),0.8753801974869585,1.4378811330763193,0.0,0.7354517097148744,1.0,2/5,11.43%,GSN;LIMA1
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.8174380465944553,-1.4369550177832182,0.043478260869565216,0.7907285696587968,1.0,3/11,5.46%,ALOX12;ALOX15B;GSTP1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.7785571704619944,-1.4361821451906236,0.025,0.7916740689055325,1.0,4/20,8.92%,KCNE1;PKP2;ANK2;DMD
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.896665563101335,-1.4360404418601669,0.0,0.7836569037789624,1.0,3/9,1.24%,GLRA1;NLRP12;HHIP
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.8022373320194703,-1.435848024491007,0.04054054054054054,0.7753496469299532,1.0,6/16,16.44%,SH3PXD2B;ALOX12;DUOX1;SOD1;NCF4;NCF2
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.8956518456516478,-1.4355567331025538,0.04838709677419355,0.7696229526930407,1.0,1/6,0.33%,SLC2A3
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.7735045092201348,-1.4352436034654246,0.024691358024691357,0.7639223050290476,1.0,8/28,6.90%,IL7R;H1-3;H1-4;H1-2;H1-0;RPA2;ZCWPW1;FIGNL1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.7216885516208223,-1.4340731891714307,0.024390243902439025,0.7715705259863466,1.0,3/36,1.97%,TFRC;FTH1;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.6980353004529297,-1.4339936225436485,0.02127659574468085,0.762282180207229,1.0,15/63,8.67%,THBS1;ENPP2;GLIPR2;FGF1;SPARC;AGT;VEGFA;RHOB;TGFB2;HIF1A;DOCK1;RAB11A;IQSEC1;DOCK5;PRKCE
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,-0.6698306801802758,-1.4333817029251463,0.010526315789473684,0.7607842849598029,1.0,48/91,26.20%,PCSK1;FAM13C;SULT4A1;AKAP12;FAIM2;BRINP1;PCDH17;MAP1B;ANK2;ITSN1;KIF1B;ERC2;MAPK4;RAB3C;LIFR;NRXN1;GRIA4;PTPRD;PHYHIPL;CHGB;LRP4;TAGLN3;SNAP25;UNC13A;CNTN1;CPE;KCTD16;SYT4;CLVS2;MAPK10;TTLL7;STMN2;ASXL3;ST8SIA3;PLPPR4;MAP2;RGS4;CADPS;CDC42BPA;CSRNP3;UNC5D;GRIA2;PLD1;FAM171B;CACNA1B;CRMP1;CADM3;NDRG4
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.7912733965557175,-1.4333148831021942,0.04054054054054054,0.7520917235918312,1.0,4/15,8.67%,MYLK;PTN;DUOX1;PRKCE
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.7458577586042305,-1.4330064905932165,0.022988505747126436,0.747528557381695,1.0,6/30,3.89%,CENPF;AGT;VEGFA;TGFB2;GREB1L;SULF2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.6434559076201646,1.4328714223051802,0.05555555555555555,0.7561684952307197,1.0,4/23,10.04%,ZDHHC3;DAB2IP;BID;TNFRSF10A
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.8262269511320359,-1.4316194992579863,0.030303030303030304,0.7568486492180799,1.0,3/12,5.49%,CCL4;CCL3;FLT1
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.7015094917809648,-1.4312456421158275,0.022727272727272728,0.7517751305674549,1.0,8/44,2.46%,PCSK1;ENPP2;PLPP3;FAM13C;FGF1;DENND2A;MYLK;AGT
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.7715142605731464,1.4306991642773563,0.13333333333333333,0.7629101141605372,1.0,2/7,4.77%,SORL1;BIN1
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.7370710043894362,-1.4305715800928736,0.012658227848101266,0.7529342727056201,1.0,6/38,7.60%,DDIT4;FOS;TGFB2;CCL3;FCGR2B;MAPT
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.8544829230849755,-1.4301097256180144,0.029850746268656716,0.7514298620427069,1.0,4/12,8.37%,SOCS3;CDC37;STAT1;PARP9
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.5580730042505673,1.429589240047059,0.041666666666666664,0.7642809508826712,1.0,6/27,5.81%,CPA1;PLA2G4C;MAPKAPK2;DAGLB;CYP2S1;ALOX5AP
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.7309277668238432,1.4294178201305603,0.16666666666666666,0.759195548738922,1.0,2/9,3.64%,PKD2;NFKBIE
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.6681459694078583,-1.4293827183968817,0.0,0.7508287989682759,1.0,35/69,22.57%,PLPP3;FAM13C;VCAN;TGFB2;KCNT2;PTN;BRINP1;MAP1B;ANK2;COL11A1;CCDC3;RGCC;ADGRL2;COL23A1;ADGRL3;MAPK4;LIFR;STOX2;PTPRD;LRP4;RCAN2;CPE;FBXL7;THY1;MAPK10;STMN2;ASXL3;GPRC5B;TMEM178A;PLPPR4;MPDZ;RUNX1T1;DIO2;MAP2;CRYAB
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.6697462444900687,-1.4267618270221754,0.02127659574468085,0.7749345162202389,1.0,17/85,14.87%,PRLR;TOM1L1;PRKAR2B;CHI3L1;SLC11A1;FGF1;VEGFA;TGFB2;ADCY3;PINK1;IL18;CLSPN;PAK5;GHR;INSR;PRR5;TRAF2
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),0.8169198055979092,1.4264195813352862,0.05555555555555555,0.7701968200680332,1.0,3/6,13.79%,TMEM79;KRT10;MAFG
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),-0.8942793186820088,-1.4251845637552896,0.0,0.7838491305503119,1.0,1/10,0.02%,KCNE1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.8182568944295046,1.4249326462442788,0.029411764705882353,0.7736827303764444,1.0,3/8,11.50%,PLXNA2;PLXNA4;PLXNB2
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.7913391004319698,-1.4246854411814698,0.0547945205479452,0.7814382306724305,1.0,2/15,3.44%,PRKAR2B;ADCY3
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.7995972095766659,-1.4238708687654174,0.028169014084507043,0.7835446637746972,1.0,2/13,3.44%,PRKAR2B;ADCY3
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.8210754539403017,1.423736750868176,0.03571428571428571,0.7741085874534378,1.0,2/8,3.40%,TICAM1;ITGAM
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),0.7137090103891528,1.4237246347525214,0.045454545454545456,0.7681993615950146,1.0,4/13,5.55%,LCP1;ARHGAP35;PDPN;DDR1
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.8632235465729089,-1.423187321269747,0.029411764705882353,0.7587082547045979,1.0,1/11,0.34%,CENPF
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.8632235465729089,-1.423187321269747,0.029411764705882353,0.7587082547045979,1.0,1/11,0.34%,CENPF
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.8632235465729089,-1.423187321269747,0.029411764705882353,0.7587082547045979,1.0,1/11,0.34%,CENPF
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.8632235465729089,-1.423187321269747,0.029411764705882353,0.7587082547045979,1.0,1/11,0.34%,CENPF
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.8161463748976949,-1.4220517670430723,0.045454545454545456,0.765370405688242,1.0,3/12,7.89%,NR4A3;ACSL1;CLIP3
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.7152064225667963,1.422011159293142,0.03333333333333333,0.7726081362521905,1.0,4/9,9.72%,MCU;MICU3;MAIP1;SMDT1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.9329668930506707,-1.4216670155717306,0.0,0.7611811900589058,1.0,2/7,3.27%,RHOB;RBPJ
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.9265036953642524,-1.42061999109995,0.045454545454545456,0.7598323472978716,1.0,1/5,0.27%,NR4A3
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.9265036953642524,-1.42061999109995,0.045454545454545456,0.7598323472978716,1.0,1/5,0.27%,NR4A3
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.8613010705231143,-1.420581472585811,0.014492753623188406,0.7377622136231994,1.0,1/10,0.19%,UAP1L1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.8613010705231143,-1.420581472585811,0.014492753623188406,0.7377622136231994,1.0,1/10,0.19%,UAP1L1
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),-0.8613010705231143,-1.420581472585811,0.014492753623188406,0.7377622136231994,1.0,1/10,0.19%,UAP1L1
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.7900718695563754,1.420558913785724,0.09375,0.7748134428039679,1.0,1/8,1.87%,NAA20
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.6091932652336524,1.420395887720998,0.0,0.7700918637856684,1.0,7/24,15.42%,WDR33;CPSF4;SNRPB;LSM11;PAPOLA;SCAF8;CSTF1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.4935444109392816,1.419640991920183,0.125,0.7674580134997953,1.0,8/33,9.86%,LYL1;TAL1;HHEX;RHOG;FAM110A;CNPY3;FAM78A;EPOR
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.8160870737111072,1.4195227363853307,0.037037037037037035,0.7625987000973251,1.0,6/10,14.38%,SCRIB;MSN;RAB10;RAP2A;CDC42;OPHN1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.8077036511738818,1.419468517651175,0.0967741935483871,0.7574645303105801,1.0,3/7,10.40%,NEDD4;COMMD1;WNK3
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.7351869954226251,-1.4193410844995855,0.024096385542168676,0.7455508502338449,1.0,15/37,13.23%,RPL23A;RPS27;RPL3;RPL11;RPL24;RPS14;NOP53;RPS15;MRPS7;RPL6;SBDS;RPL5;TRAF7;RPLP0;MRPL20
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.8461994950723989,1.4174290133604635,0.08571428571428572,0.7619310524972246,1.0,2/5,10.04%,ZDHHC3;TNFRSF10A
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.5397749332872157,1.4167105833912732,0.0,0.7603689617719349,1.0,13/54,10.23%,PHLDB2;NRP1;SERPINF2;ARAP1;LPAR1;WASF2;ALMS1;ABL1;PPM1F;SORBS3;NF2;INPP5K;FHOD1
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.8877247136094397,1.416498930780847,0.06976744186046512,0.7556991219790201,1.0,2/5,3.39%,PSAT1;PSPH
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.6525647626124252,-1.4164969504490064,0.010869565217391304,0.7710860233012689,1.0,32/69,23.32%,PCSK1;FAM13C;DEPP1;AGT;KCNT2;PCDH17;CAMK2N1;SST;PTPRT;RAB3C;PTPRD;PCSK2;ALDH1A1;PHYHIPL;CHGB;SCG5;RCAN2;SH3GL2;SNAP25;CPE;MAFB;SYT4;MAPK10;TSPAN7;STMN2;ASXL3;ST8SIA3;PLPPR4;RUNX1T1;RGS4;CADPS;CSRNP3
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.9287301839330525,1.4156109383208602,0.03333333333333333,0.7494759291111502,1.0,2/5,4.88%,PHLDB2;DAG1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.9287301839330525,1.4156109383208602,0.03333333333333333,0.7494759291111502,1.0,2/5,4.88%,PHLDB2;DAG1
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.7312292732124516,1.4151819460319222,0.13333333333333333,0.7465538433142487,1.0,1/6,0.97%,SLC7A8
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.805420325691521,-1.4145466241484241,0.0125,0.7870469260411165,1.0,7/20,9.83%,NAMPT;CHI3L1;SH3PXD2B;SULF2;DDRGK1;ARID5B;ITGB8
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.8283135373362667,-1.413986520952191,0.023809523809523808,0.786663241704524,1.0,2/13,2.46%,NR4A3;AGT
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.7701543418507257,-1.4133710356918932,0.02666666666666667,0.7869931067842427,1.0,3/17,6.82%,PRKAR2B;ADCY3;RAB11A
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.8999856508315178,-1.4131225423396476,0.014285714285714285,0.7833802789351173,1.0,1/7,2.56%,VEGFA
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.574363156555782,1.413003666233253,0.0,0.752883943713255,1.0,7/32,15.20%,KHDRBS3;CPSF4;METTL16;RBM23;PAPOLA;SAFB2;SON
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),-0.9663255574189888,-1.4125926390796424,0.0,0.7832141478538808,1.0,1/5,0.82%,ENPP2
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.4600488533491012,1.4125413896309391,0.0,0.7499786589990549,1.0,12/80,12.83%,NUP42;NUP188;VCPKMT;LOXL3;SIRT1;HDAC10;SENP6;NUP214;NSMCE2;RAE1;UBA2;EP300
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.7890146829971073,-1.4110916268140263,0.0375,0.7932718417079663,1.0,1/19,0.02%,KCNE1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.6677516509844859,1.4110394165328854,0.06666666666666667,0.7511691616996558,1.0,10/15,28.87%,TMEM119;MAML1;PIEZO1;NOTCH1;HDAC5;BHLHE41;HDAC1;HDAC9;MMP14;FBXO22
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.8425206676164839,1.4106591245619202,0.07142857142857142,0.7487179095756274,1.0,2/7,2.09%,PDE12;TICAM1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.6947393296147937,-1.4096317425859008,0.011111111111111112,0.8043399305649174,1.0,5/41,3.30%,HTR2B;NR4A1;VEGFA;HMGB2;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.7409138990581652,-1.408886314932454,0.08,0.8073653248048824,1.0,5/21,17.03%,NR4A3;CLIP3;APPL1;INSR;IRS2
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.8111042011860524,-1.4086030548951303,0.0379746835443038,0.8039828980911731,1.0,5/18,10.19%,TFRC;GPR183;VAV3;IL7;TNFSF13B
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.670771256867821,-1.4078229413465588,0.0449438202247191,0.8005164016196233,1.0,15/41,16.20%,MX2;IFITM3;RSAD2;MX1;IFIT2;HLA-B;IFIT3;GBP2;STAT1;HLA-F;IRF1;OAS3;IFIT1;IFIT5;STAT2
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.670771256867821,-1.4078229413465588,0.0449438202247191,0.8005164016196233,1.0,15/41,16.20%,MX2;IFITM3;RSAD2;MX1;IFIT2;HLA-B;IFIT3;GBP2;STAT1;HLA-F;IRF1;OAS3;IFIT1;IFIT5;STAT2
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.7665023858039542,-1.4077878924389917,0.01098901098901099,0.7940226310176876,1.0,4/25,6.86%,TOP2A;CENPF;HMGB2;SPON2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.689336898896696,1.4073819747572105,0.0,0.7610241187419766,1.0,8/18,19.50%,AVIL;WASF2;FSCN1;CDC42;ARPC2;CYFIP1;ACTR2;AUTS2
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.8457018926423399,-1.407031029019472,0.0,0.7962801629253129,1.0,4/16,7.31%,KCNE1;SLC11A1;KCNT2;ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.917751466968372,-1.4070054192928831,0.0,0.7896921581947426,1.0,1/6,2.56%,VEGFA
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),-0.8779107473649033,-1.4070050016612763,0.047619047619047616,0.7830560896384844,1.0,2/6,3.23%,THBS1;ACSL1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.6361527609266652,1.4066629500380152,0.0,0.7602883315856265,1.0,7/19,11.36%,LGALS9;IRF5;MAPK11;SYK;LAPTM5;SCIMP;TIRAP
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.8193142199721186,1.4060788629585248,0.13513513513513514,0.7581411363811763,1.0,1/5,1.93%,COPRS
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.9393135434717998,-1.4059438023947224,0.014705882352941176,0.7889702286642021,1.0,1/5,0.02%,KCNE1
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),0.8003350183395881,1.4057383383473427,0.09375,0.755394911292671,1.0,4/7,16.86%,P2RY12;SRC;PIEZO1;FERMT2
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.8375146513006633,1.405586424082287,0.11428571428571428,0.7510485493953588,1.0,3/6,5.99%,GSN;MCU;WHAMM
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.7489359599863292,-1.4054364147502827,0.0125,0.7890086184947241,1.0,6/25,10.94%,PCSK1;FA2H;DEGS2;NMRAL1;DMD;AANAT
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",0.7956469773953606,1.4044293284550926,0.13333333333333333,0.7507068319737971,1.0,2/8,4.94%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.7435674282378223,-1.4037110755564284,0.03333333333333333,0.8041473745576002,1.0,4/24,5.14%,CCL4;JAML;TGFB2;CCL3
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.696291539163162,-1.4036271141371113,0.011111111111111112,0.7922439429762375,1.0,18/48,21.86%,NDUFA2;NDUFB9;DMAC1;NDUFS8;NDUFA3;NDUFA1;TMEM126B;NDUFS5;NDUFB6;TMEM126A;TIMM21;BCS1L;NDUFS7;TIMMDC1;ACAD9;NDUFA10;NDUFS6;NDUFB4
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.696291539163162,-1.4036271141371113,0.011111111111111112,0.7922439429762375,1.0,18/48,21.86%,NDUFA2;NDUFB9;DMAC1;NDUFS8;NDUFA3;NDUFA1;TMEM126B;NDUFS5;NDUFB6;TMEM126A;TIMM21;BCS1L;NDUFS7;TIMMDC1;ACAD9;NDUFA10;NDUFS6;NDUFB4
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),0.7298811374313613,1.4032729784126978,0.16,0.7469802409372758,1.0,3/8,8.89%,LGALS9;TRIM38;TRIM11
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),0.7298811374313613,1.4032729784126978,0.16,0.7469802409372758,1.0,3/8,8.89%,LGALS9;TRIM38;TRIM11
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.7380383113699618,-1.4030165406587967,0.024096385542168676,0.7931619036441523,1.0,7/30,8.83%,ACVR1B;HMGB2;RAB7B;HIF1A;FAXDC2;STAT1;HSPA1B
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.8074941802834036,-1.402736856907208,0.028985507246376812,0.7900162353539503,1.0,3/11,6.75%,IHO1;SYCE2;ZCWPW1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.6526413545322644,1.402372233642176,0.125,0.7468230134929453,1.0,7/15,29.27%,MED24;MITF;MED4;PAXIP1;SUB1;MED13;MED12
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.713862430931569,-1.401967061869613,0.02127659574468085,0.7916068102542871,1.0,12/41,13.32%,KCNE1;CEMIP;NDUFB9;LRP2;SLC26A5;COL11A1;TIMM13;SOD1;USP53;LHFPL5;CDH23;MYO3B
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.8806457045446512,-1.4017015317084502,0.043478260869565216,0.7894819846253155,1.0,2/7,5.51%,ENPP2;PDXDC1
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.6429106054336435,-1.40157433887621,0.02197802197802198,0.7846802672442067,1.0,48/90,25.49%,PCSK1;RIMS1;HAMP;SULT4A1;PCDH17;TCEAL2;LRRC4C;UBE2QL1;SST;PAK5;MAPK4;PTPRT;RAB3C;NRXN1;GRIA4;PCSK2;KCNC1;PHYHIPL;CTNND2;CHGB;SH3GL2;SNAP25;CNTN1;MAFB;SYT4;CLVS2;MAPK10;SCN3B;GABRB3;SYP;ROBO2;ERO1B;STMN2;GAD2;ASXL3;ST8SIA3;CADM2;LY6H;CADPS;CSRNP3;CA10;CAMK2B;UNC5D;GRIA2;CACNA1B;NOVA1;SCG3;EZH1
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.7919498474024377,1.4013305067491215,0.08823529411764706,0.747120406316542,1.0,1/5,0.58%,PEX13
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.7586163881788885,-1.40100370353355,0.03529411764705882,0.784967025228747,1.0,5/24,12.95%,KCNE1;FHL1;ANK2;KCNMA1;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.757361251273724,-1.400577106242636,0.03529411764705882,0.7835185101401158,1.0,5/23,12.95%,KCNE1;ANK3;ANK2;KCNMA1;AKAP6
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.7363019494098589,1.400430245293061,0.16129032258064516,0.7461397353470232,1.0,3/7,12.95%,FER;SYK;UNC13D
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.703900505686578,1.4002591723493933,0.14285714285714285,0.7424153680946171,1.0,1/7,1.01%,LGALS9
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.6984580406243412,-1.3998397922532841,0.036585365853658534,0.7854559324836891,1.0,13/34,14.41%,NR4A3;ME1;SLC16A3;GAPDH;PGK1;ENO4;ENO2;PGAM1;PKM;LDHA;PDHB;SLC16A1;PGM1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.6506470577514037,-1.399438335154315,0.011111111111111112,0.7838834513665186,1.0,6/66,2.56%,DDIT4;TFRC;ARAF;PAQR3;MTCP1;VEGFA
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.7398909750771918,1.398221262152962,0.10714285714285714,0.7469539751375803,1.0,2/7,7.71%,GSN;MAGED2
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.7290902004753121,1.397914201168066,0.10256410256410256,0.7436386261089477,1.0,1/9,0.08%,PLA2G4C
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.7360227073670381,1.3967328949010545,0.12,0.7457010876484064,1.0,2/9,7.18%,SIRT1;TFE3
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.8896773889347488,1.3966725364030297,0.0625,0.7413442126541704,1.0,1/5,1.87%,NAA20
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.8030248811290324,-1.3966412697719877,0.07692307692307693,0.8096907633652639,1.0,1/15,0.27%,NR4A3
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.6919447059706467,1.3952051913547374,0.14285714285714285,0.74418989283305,1.0,3/8,12.95%,FER;SYK;UNC13D
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.7833970556610521,-1.3947725613370168,0.013513513513513514,0.827347551765133,1.0,8/18,15.60%,RPS27A;RPA2;UBA52;RFC1;UBC;RPA3;RFC4;UBB
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.7552235903361875,1.3945025539811717,0.08695652173913043,0.7429814719169828,1.0,1/7,1.38%,PDE12
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),-0.898518195930968,-1.3944985590004506,0.07936507936507936,0.8180279677565956,1.0,1/5,1.97%,SLC11A1
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),-0.898518195930968,-1.3944985590004506,0.07936507936507936,0.8180279677565956,1.0,1/5,1.97%,SLC11A1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.8169948826979905,-1.39419806916894,0.06578947368421052,0.8146333352894001,1.0,1/10,0.47%,PRLR
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.7388272549440851,1.3937489866381374,0.18421052631578946,0.7417162639766354,1.0,4/8,9.79%,TAL1;SH2B3;TGFBR2;THOC5
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5858617751895405,1.3933113732175901,0.1111111111111111,0.7392605837142258,1.0,4/24,6.30%,DCP1B;LSM6;NT5C3B;EDC3
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.7356357929664755,-1.3932849484585492,0.04938271604938271,0.8189001641829543,1.0,12/16,22.94%,GAPDH;PGK1;ENO4;ENO2;PGAM1;PKM;LDHA;PGM1;HK2;PFKL;GPI;ENO1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.758278211690733,-1.3927948517054696,0.03896103896103896,0.8191244645267297,1.0,8/21,17.18%,H2BC11;HMGB2;GBP2;FGR;RPL39;GSDMD;TLR2;PPP1R11
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.8030722807966275,1.3925431374129158,0.18181818181818182,0.7346466465335628,1.0,2/5,9.78%,NPR2;PDE1B
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.8030722807966275,1.3925431374129158,0.18181818181818182,0.7346466465335628,1.0,2/5,9.78%,NPR2;PDE1B
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.7336166533801062,-1.3920724671863516,0.06741573033707865,0.8208867141866029,1.0,7/23,9.77%,HTR2B;FGF1;CENPV;SVIL;RACGAP1;PRKCE;CIT
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),-0.8886114884448046,-1.3914794670482378,0.013157894736842105,0.8214930684984267,1.0,2/8,2.59%,TOP2A;HMGB2
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.8119677926835307,-1.3912764912170665,0.06756756756756757,0.8187214463841422,1.0,4/16,2.56%,GLRA1;TACR1;ACVR1B;VEGFA
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.8079307795229794,-1.3912686462401154,0.08536585365853659,0.8131671002614609,1.0,3/16,7.60%,CCL4;CCL3;MAPT
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.5347079428071115,1.3910000927493167,0.0,0.7367346126325648,1.0,7/46,5.99%,GSN;NRP1;FER;ATP2C1;MCU;MYH9;WHAMM
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.6326669550122452,1.390949171266998,0.038461538461538464,0.7324954832479456,1.0,3/19,4.13%,PHLDB2;ARAP1;WASF2
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.9162987955745201,-1.3908595882426291,0.014084507042253521,0.8126413173907149,1.0,1/6,0.82%,ENPP2
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),-0.8664647878692475,-1.3896107059060396,0.08333333333333333,0.8209881406085083,1.0,3/7,6.12%,THBS1;FBP1;ANK3
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.46493933101540497,1.389371986358282,0.0,0.7356045397482694,1.0,13/49,9.28%,ACER2;NEXMIF;PLXNA2;DSCAM;ARHGDIB;SEMA4D;TGFB1;SIPA1;JAG1;GCNT2;PLXNA4;NF2;ADAM10
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.7304265416914344,-1.3887954564449367,0.047619047619047616,0.8233727620500697,1.0,8/26,11.27%,CD55;TRIM5;FCGR2B;FGR;DHX58;APPL1;CD36;IRF1
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.8655309773273951,1.3885687986981061,0.14285714285714285,0.7360077341697262,1.0,3/5,10.47%,ERCC4;TP53;SRC
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.6266653843185703,1.38844666643818,0.041666666666666664,0.7322542668183976,1.0,5/18,5.55%,LCP1;ITGA5;ARHGAP35;PDPN;DDR1
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.9336411115379167,-1.3882678840386107,0.015873015873015872,0.8256613223751302,1.0,1/5,0.27%,NR4A3
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.6622624016492483,-1.3878975777243978,0.0,0.8233537827639538,1.0,31/78,18.02%,TMEM140;TRIM5;IFITM3;RSAD2;MX1;SELL;IFIT2;IL7;IFIT3;IFI44L;GBP2;OGFR;IL15;DHX58;PARP9;PROCR;TRIM25;PSMA3;CMPK2;IFI44;HERC6;IRF1;B2M;TXNIP;PARP14;TAP1;PLSCR1;STAT2;SP110;SLC25A28;HLA-C
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),0.7396541936801939,1.3876081648393455,0.038461538461538464,0.7316568416178383,1.0,3/8,10.74%,SRD5A1;DHRS9;CYP19A1
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.7734786707822208,1.3854389921094485,0.06060606060606061,0.7367860716373157,1.0,2/8,0.51%,CPA1;MEP1A
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.8946503665426536,-1.3850915508063828,0.02631578947368421,0.8512469925473856,1.0,3/7,4.58%,VIM;PKP2;NEFL
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.5814244003571775,1.384995679697231,0.058823529411764705,0.7347646340100135,1.0,3/26,0.28%,PHLDB2;ACER2;NEXMIF
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.8361881248416021,-1.3838833696985873,0.0547945205479452,0.8600002875806732,1.0,2/8,2.56%,PRLR;VEGFA
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.8132415607066452,-1.383237288450398,0.0958904109589041,0.8627335312049268,1.0,1/10,2.10%,IHO1
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.657367262251742,-1.3827657919276903,0.0,0.8620347773324849,1.0,40/96,24.83%,TMEM163;PIANP;CDK14;SULT4A1;NEFL;BRINP1;ABLIM3;TCEAL2;NARF;CALY;SRRM3;ERC2;APLP1;PAK5;MAPK4;LHFPL5;GDAP1L1;NEFM;BSN;KCNC1;SH3GL2;TAGLN3;SNAP25;SYT16;SYT4;GALNTL6;CLVS2;STMN2;ST8SIA3;KIF5A;LY6H;DCTN1;TMEM59L;CA10;MTUS2;KCTD8;LINGO1;GRIA2;VSTM2B;CACNA1B
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,-0.6629892495516926,-1.3826288109978595,0.021505376344086023,0.857970883057439,1.0,50/79,28.32%,DENND2A;SULT4A1;NEFL;BRINP1;PCDH17;MAP1B;ANK2;PLP1;GPM6B;EFR3B;TRPM3;ADGRL3;MAPK4;RAB3C;NRXN1;GRIA4;GDAP1L1;NEFM;PTPRD;SH3GL2;SNAP25;UNC13A;CNTN1;CLVS2;FMN2;SCN3B;GABRB3;ATP1B2;ROBO2;STMN2;ASXL3;ST8SIA3;NTRK3;RUNX1T1;CADPS;CSRNP3;UNC5D;GRIA2;CACNA1B;NOVA1;B3GAT1;CRMP1;MAGI2;CADM3;NDRG4;SRRM4;PNMA2;ABI2;NCAN;TMEM132B
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.5063952195409895,1.3824515030277262,0.0,0.7457405166550236,1.0,11/57,11.30%,ACER2;RPS6KA6;SESN2;ZNF385A;PLAGL1;NBN;TP53;PIDD1;TFAP4;PLK3;USP10
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.8858386536337405,-1.3824008886856485,0.030303030303030304,0.8498782724620411,1.0,1/6,8.00%,STAT1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.8858386536337405,-1.3824008886856485,0.030303030303030304,0.8498782724620411,1.0,1/6,8.00%,STAT1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.7294283661671566,-1.3819097232766027,0.022988505747126436,0.8498809727158592,1.0,3/27,3.30%,HTR2B;GLA;HIF1A
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.6676365481243609,1.3814922232293783,0.09523809523809523,0.7468013827136517,1.0,3/18,5.12%,UCP2;HVCN1;SLC46A1
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.7241656471233289,-1.3814220607033614,0.09090909090909091,0.8496444539194006,1.0,9/21,10.33%,PRLR;OVOL2;LSR;RARRES1;BAIAP2L1;BTN2A2;PADI2;PPP1R13L;BTN3A1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.635114456716073,-1.3809102248683558,0.020833333333333332,0.8498862713271249,1.0,8/74,5.03%,NR4A3;INSIG1;PRKAR2B;NR4A1;TSHR;ADCY3;SYAP1;NR4A2
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.8874085742632194,-1.380448385235532,0.013513513513513514,0.8488850419576316,1.0,1/6,4.63%,RBX1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.6817404149732722,-1.380439821371872,0.0,0.8437298280617335,1.0,8/60,3.30%,THBS1;PLPP3;FGF1;SPARC;AGT;VEGFA;RHOB;HIF1A
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.8000806534481315,-1.3780151768819682,0.13333333333333333,0.8669816658588836,1.0,2/8,10.57%,H2BC11;RPL39
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.7455230138764575,1.3779304762161113,0.14814814814814814,0.7602203264726195,1.0,2/9,3.30%,PLEKHM2;LYST
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),-0.8613044670291881,-1.3762041949925565,0.07142857142857142,0.882876843757909,1.0,2/7,3.82%,TGFB2;PTN
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.6631150363769234,-1.3759314258907207,0.010309278350515464,0.880373875917622,1.0,22/89,17.47%,NAMPT;NLRP12;THBS1;RPS4X;EIF4A3;VIM;TGFB2;PRR16;NOD2;RBM3;NMD3;NLRC5;RPL5;RGCC;ATAD5;INSR;TLR2;EIF3E;EIF3D;DNA2;IRS2;KLF4
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.7566244097887421,-1.3752771927595986,0.04938271604938271,0.8822529621074308,1.0,7/28,10.19%,TFRC;GPR183;VAV3;IL7;FCGR2B;MNDA;TNFSF13B
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.8167864707169227,1.374938483905101,0.125,0.7668983761612304,1.0,1/6,6.73%,SYK
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.8167864707169227,1.374938483905101,0.125,0.7668983761612304,1.0,1/6,6.73%,SYK
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.9469001688893715,-1.374886972536349,0.045454545454545456,0.8808083693261397,1.0,1/5,0.02%,KCNE1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.8018664427226327,-1.3747263862948857,0.02702702702702703,0.8775141460521244,1.0,3/14,4.41%,NLRP12;AIM2;BEX3
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.5373872209211333,1.374495623288874,0.06666666666666667,0.7644550745007405,1.0,12/25,21.03%,GSN;SIRT1;BTRC;CTSH;FBXW11;EP300;FBXL3;PEX2;PRKN;MDM2;CDC73;GGA3
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.7652371131740925,1.3744820730685596,0.12903225806451613,0.7603647941385769,1.0,2/6,0.95%,PTPRM;NRP1
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),-0.8902509454423286,-1.3740428074975037,0.0,0.881288754572306,1.0,3/7,8.14%,NAMPT;SH3PXD2B;ARID5B
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.838162104007545,-1.3736987892015518,0.07692307692307693,0.8801550315997374,1.0,3/6,9.51%,TGFB2;ANK2;NOTCH2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.9396486636592092,-1.3728694655284466,0.015625,0.8855369575798162,1.0,2/5,3.30%,TGFB2;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.51987354908656,1.3726092600426087,0.07692307692307693,0.7661776364335626,1.0,12/38,18.96%,NEDD4;TGFB1;ZPR1;TP53;IL1B;EFCAB7;ANP32B;YWHAE;BAG3;TCF7L2;SMAD3;TPR
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.8809292961103345,-1.372469406991068,0.046153846153846156,0.8849994046007376,1.0,1/6,0.52%,KMO
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.600257586571638,1.37182981324421,0.07692307692307693,0.7617832727912734,1.0,5/18,13.90%,BID;TP53;YWHAG;PPP1R13B;YWHAE
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.600257586571638,1.37182981324421,0.07692307692307693,0.7617832727912734,1.0,5/18,13.90%,BID;TP53;YWHAG;PPP1R13B;YWHAE
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.8816104115349388,-1.3704859879003835,0.043478260869565216,0.9023200543695574,1.0,2/8,3.72%,MX2;MX1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.6096996115994772,1.3701338267856669,0.09090909090909091,0.7664878554514716,1.0,7/24,15.74%,LCP1;ARFIP1;PPM1F;P3H1;STXBP5;RHBDF2;ATP13A2
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.7789365690321111,1.369637722221988,0.10714285714285714,0.7648135945167058,1.0,2/7,6.15%,IPPK;ISYNA1
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.695131687446532,-1.369194422294147,0.022727272727272728,0.9123409607498815,1.0,10/43,9.44%,SLC51A;CD55;PLIN2;ASPN;CBR1;DEGS2;AQP11;SPON2;GSTM3;CD36
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.7280188528711415,-1.3682499061022928,0.0379746835443038,0.9183915465540512,1.0,6/28,12.59%,NAPA;MX2;RIMS1;MX1;UBXN2B;NSF
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.760581924539061,-1.3682384807718027,0.08450704225352113,0.9133055571856112,1.0,2/14,3.44%,PRKAR2B;ADCY3
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.9188429268096698,1.3681822819595297,0.027777777777777776,0.7675203476464408,1.0,2/5,3.73%,PLEKHJ1;SORL1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.7918150874343958,-1.3680324109964679,0.0410958904109589,0.911068759302431,1.0,2/15,3.72%,MX2;MX1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.7179463882303295,-1.3675431220700294,0.05333333333333334,0.9116862389378623,1.0,4/20,12.22%,RPL23;RPL11;RPL5;RPS7
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.8817289736196152,-1.3673315918750857,0.0547945205479452,0.9089528954952661,1.0,2/7,3.72%,MX2;MX1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.859648039690804,-1.36711146943807,0.06451612903225806,0.9061445301653357,1.0,2/6,2.56%,THBS1;VEGFA
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.8372164097394871,-1.3666432244559723,0.05555555555555555,0.906726587511166,1.0,1/12,0.02%,KCNE1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.7837848348119889,-1.3664991822211183,0.0684931506849315,0.902708806612327,1.0,3/13,5.39%,OMD;OGN;B4GAT1
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),0.842113954571923,1.3659396447171883,0.14705882352941177,0.7737952096231615,1.0,3/5,13.30%,RPAP2;RPRD1B;RPRD1A
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.8502444106927837,-1.3652961343094887,0.04477611940298507,0.9122320376648173,1.0,2/8,1.54%,THBS1;F13A1
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7411643437227051,-1.3652715059752516,0.1038961038961039,0.9074020451479444,1.0,4/14,11.17%,RPS27;RPS14;RPS15;MRPS7
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.583206697320507,1.3650749508291944,0.10526315789473684,0.7749465521796173,1.0,6/22,6.37%,CGAS;NUAK1;ABI3;HMGA1;NEK6;SIRT1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.7870538480986375,-1.3642604169608543,0.10526315789473684,0.9146910392582593,1.0,1/13,0.47%,PRLR
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),-0.7620805060057197,-1.3641161125038384,0.05333333333333334,0.9117895314480022,1.0,2/16,1.29%,NR4A3;CYCS
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.7866220053883917,-1.3637819800014346,0.07317073170731707,0.9114081598270585,1.0,2/13,8.12%,GDPD1;RDH11
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.767994049637832,1.363722214940824,0.14814814814814814,0.7770678072785059,1.0,2/8,6.37%,SORL1;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.8320827116135526,-1.363528249941186,0.05084745762711865,0.9097172688580262,1.0,1/10,0.74%,CD55
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),-0.8892154914429762,-1.3632653032680062,0.058823529411764705,0.9075418234121212,1.0,1/7,2.56%,VEGFA
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.8422603760546737,-1.3628391852681754,0.07894736842105263,0.9072389683269326,1.0,4/9,5.45%,H1-3;H1-4;H1-2;H1-0
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.7965030411560537,-1.3627114186508014,0.06493506493506493,0.9043535868601731,1.0,3/12,13.90%,PRLR;IL10RA;GHR
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.8800206795503235,-1.3624589605784156,0.0125,0.9029329018926021,1.0,3/9,5.14%,GPR183;MYO1G;CCL3
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.6403884354940287,-1.361294027115223,0.010309278350515464,0.9111224399976527,1.0,40/83,26.42%,VCAN;PTN;FAIM2;BRINP1;CLIP3;ANK2;PLP1;LRRC4C;APLP1;ADGRL3;MAPK4;PHYHIPL;CTNND2;TAGLN3;SNAP25;ADCY8;LHFPL3;CLVS2;NRXN2;ATP1B2;ATP2B2;STMN2;ST8SIA3;GPRC5B;TMEM178A;PLPPR4;GFAP;LY6H;MAP2;TMEM59L;CA10;LINGO1;OLIG1;GRIA2;VSTM2B;CRMP1;CADM3;NDRG4;AQP4;NKX6-2
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.75905012173719,-1.3610009060055897,0.06172839506172839,0.9092897866255507,1.0,2/19,2.56%,THBS1;VEGFA
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.8942808658345435,-1.3607053196168097,0.07936507936507936,0.9074760265871818,1.0,1/6,0.27%,NR4A3
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.6664918746162927,-1.360698594814749,0.021052631578947368,0.9029192039109297,1.0,14/59,12.88%,GADD45B;SCRG1;TNC;PLPP3;SPARC;VEGFA;ADAMTS2;LAMA2;STAT1;COL11A1;IL10RA;COL10A1;FN1;DAAM2
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.8912484083198253,-1.3604918057312274,0.05,0.9004334085021838,1.0,1/8,0.40%,HTR2B
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.5459092598154991,1.3601029980956183,0.07142857142857142,0.7880803341183703,1.0,10/22,19.48%,RAP1A;ICAM1;RAPGEF6;PPP1R16B;MSN;RAP2C;AFDN;RAB1B;MYADM;PDE4D
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.6211408953704033,1.359704701372214,0.09090909090909091,0.7858002357281063,1.0,4/16,1.60%,HPSE;B4GALT7;GAL3ST4;HS3ST4
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.8398504344789322,-1.359515744535688,0.06756756756756757,0.907852277442549,1.0,3/10,4.68%,THBS1;SULF2;SPRY1
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.6811948284908143,1.3593607631972742,0.11764705882352941,0.7829995700216008,1.0,1/8,5.97%,ZPR1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.7176111699379317,-1.3593433590467114,0.08536585365853659,0.9051280956978979,1.0,6/19,14.87%,CD55;NOD2;SLC7A5;HLA-F;B2M;TRAF2
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.7606758201564733,-1.3591263068596537,0.038461538461538464,0.9031909149644709,1.0,2/19,3.72%,MX2;MX1
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.6917760580874721,-1.3587247828798947,0.07407407407407407,0.9032099055219763,1.0,14/39,14.28%,VEGFA;HIF1A;RORA;NDRG1;FAM162A;EGLN3;PINK1;NOP53;PGK1;BNIP3L;BNIP3;RGCC;CARD16;SUV39H2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.7592924413228186,-1.3584444843238346,0.09090909090909091,0.9014895594207823,1.0,2/20,3.22%,TFRC;DNAJB9
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.873324387984552,-1.3578684977400186,0.015625,0.9035747216526712,1.0,1/7,0.40%,HTR2B
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.69575414572444,1.3577993115154388,0.08823529411764706,0.7856380679651033,1.0,3/8,12.51%,SLC25A18;LRRC8D;SLC25A14
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.8035830327875019,-1.357443872663471,0.0,0.9040104089730852,1.0,4/16,4.62%,DNAH11;DNHD1;DNAH17;CCDC39
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.6526297722225352,-1.3571058340278706,0.010638297872340425,0.903376631445959,1.0,21/68,22.31%,NDUFA2;NDUFB9;DMAC1;NDUFS8;NDUFA3;NDUFA1;SCO2;TMEM126B;NDUFS5;NDUFB6;COX20;TMEM126A;TIMM21;BCS1L;NDUFS7;TIMMDC1;ACAD9;NDUFA10;NDUFS6;NDUFB4;SCO1
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.907886555359336,-1.3570409907818641,0.056338028169014086,0.8997533924637997,1.0,2/5,2.56%,THBS1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.6926429111101294,-1.3567067059836975,0.06097560975609756,0.8990088438904914,1.0,7/25,11.53%,ARIH2;TOMM7;VPS11;ABLIM3;RHOU;PINK1;USP36
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.7260827939544403,1.356307080576406,0.20512820512820512,0.7893864107242796,1.0,5/7,24.34%,SETD1B;KMT2B;KMT2A;KMT2D;SETD4
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.8650007377651268,-1.3562253701267681,0.030303030303030304,0.9004166422158324,1.0,2/7,6.41%,VPS11;BRCA1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.8695192965785158,-1.356127972369036,0.06944444444444445,0.8929303349169987,1.0,2/7,3.72%,MX2;MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.8695192965785158,-1.356127972369036,0.06944444444444445,0.8929303349169987,1.0,2/7,3.72%,MX2;MX1
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.6374794895018632,1.35571775784339,0.18181818181818182,0.7892286057618947,1.0,5/14,14.38%,MSN;CYTH3;RAP2A;CDC42;OPHN1
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.7612406772873491,1.3547437085950034,0.21875,0.7897237706815794,1.0,4/5,23.79%,ANKRD11;EDA;LRP6;HDAC1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.8244664763260245,-1.354357154596506,0.036585365853658534,0.90770885902627,1.0,2/11,2.32%,GLRA1;MT2A
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.6967389726392952,-1.3542526517569964,0.05747126436781609,0.9044367765392136,1.0,2/30,2.72%,DDIT4;HINT1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.6663864293791075,-1.3539591186052662,0.05813953488372093,0.9027999065516794,1.0,13/53,9.51%,NR4A3;HTR2B;JAML;FGF1;NR4A1;VEGFA;HMGB2;HIF1A;C5AR1;PTN;NOD2;LAMB1;NOTCH2
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.7634157639724228,-1.3536699115979673,0.05333333333333334,0.9014001856334888,1.0,2/16,2.56%,GADD45B;VEGFA
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.6433276386251896,1.3534204455953642,0.0625,0.7918638476923827,1.0,4/15,7.09%,RING1;DDB2;RYBP;RNF2
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.7070578552560779,-1.3533661730159794,0.022727272727272728,0.9007640725748292,1.0,5/29,4.39%,JAML;IL7R;CD69;RORA;SELL
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.7982929752361676,1.353244535131049,0.0625,0.7882955164026972,1.0,2/6,6.37%,SORL1;SIRT1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),-0.8203489972142398,-1.3530030954696144,0.06666666666666667,0.9006611960483812,1.0,3/11,8.09%,KCNE1;PKP2;ANK2
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.5382776054617618,1.3528923714217547,0.07692307692307693,0.7858125025716673,1.0,6/36,7.40%,RALB;LCP1;ARHGAP35;PIP4K2B;FSCN1;TAPT1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.6795101135307597,-1.3526744664051078,0.08433734939759036,0.9006030119080995,1.0,4/41,3.27%,THBS1;ACVR1B;TGFB2;RBPJ
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.7683497371118272,1.3523809346550038,0.16,0.7845730145875872,1.0,5/6,23.17%,GTF2H2;ARRB2;ARRB1;GRK2;ADRB2
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),-0.9064303046792264,-1.3523380061435242,0.08064516129032258,0.9000664431702667,1.0,2/5,3.82%,LRP2;PTN
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.7044869129478326,-1.3515598219246934,0.03488372093023256,0.9037819742886692,1.0,4/31,8.83%,THBS1;FGF1;MAPT;HSPA1B
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.8686823975971196,-1.350817331445071,0.1044776119402985,0.9071184484157065,1.0,2/6,11.73%,ATF5;RGCC
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.8448990382033338,-1.3504437647328646,0.012987012987012988,0.906731359128519,1.0,2/11,7.31%,KCNE1;ATP1B3
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.8821753990745455,-1.3503794421367326,0.046875,0.9033980065644184,1.0,3/6,8.78%,CLDN18;ATP8B1;ABCC3
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.7440233151433466,-1.3502327261644895,0.08108108108108109,0.900690491559572,1.0,4/23,8.09%,KCNE1;PKP2;CACNB2;ANK2
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),-0.9124556468630197,-1.3502311519996146,0.0625,0.8966515207454036,1.0,2/5,4.62%,KMO;AFMID
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.8413398297369163,1.3501196443607801,0.11764705882352941,0.789989526994595,1.0,3/5,13.78%,SMAD7;PMEPA1;SNX25
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.715009948143975,-1.3500819833509579,0.07228915662650602,0.8941670089783464,1.0,8/30,15.82%,NDUFA2;NDUFB9;NDUFS8;NDUFA3;NDUFA1;NDUFS5;NDUFB6;NDUFS7
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.6721189058079104,1.3499620347430477,0.16666666666666666,0.7867295529733905,1.0,3/9,14.03%,RAP1A;RAP2A;RAP2C
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.8051823998538272,-1.3498026268499295,0.1111111111111111,0.889180337063189,1.0,2/7,7.39%,SEPSECS;TRNAU1AP
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.8051823998538272,-1.3498026268499295,0.1111111111111111,0.889180337063189,1.0,2/7,7.39%,SEPSECS;TRNAU1AP
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.6697654898019398,1.3498022184442637,0.2413793103448276,0.7836155061201463,1.0,3/10,23.30%,RUNX1;NLRC4;RHBDD1
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.6361065285798416,-1.3493395787603322,0.08791208791208792,0.8899247138347604,1.0,5/48,7.98%,NR4A3;THBS1;MEIS2;WDR5;PRKCQ
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.787189097840008,1.3490703094865075,0.1891891891891892,0.7826951161538599,1.0,2/5,10.47%,CBL;SRC
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.851357799849894,-1.3479691750153648,0.08571428571428572,0.900483302911348,1.0,1/9,0.27%,NR4A3
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.7219054007774041,1.3479208621976866,0.11764705882352941,0.7839368951766323,1.0,5/8,24.20%,ADRA1A;ZDHHC21;PDE4D;ADRB2;ADCY9
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.6355293512637739,-1.3471159981321938,0.08045977011494253,0.9059163502152142,1.0,14/42,13.60%,NR4A3;FGF1;NR4A1;VEGFA;TGFB2;C5AR1;AQP11;NOD2;LAMB1;B2M;EPB41L4B;UHRF1;NR1D1;DEAF1
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.6951803944255133,-1.3470841604859007,0.03409090909090909,0.9022651252860749,1.0,20/45,18.12%,RPL23A;WDR12;RPL3;RPL11;RPL14;NHP2;RPL24;HEATR3;RPL10A;NOP53;RPL6;RPL5;TRAF7;RPLP0;MRPL20;RPL7A;MAK16;RPL7;RPL10;PES1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.9337395298738813,-1.346797791001566,0.0,0.9015084831058072,1.0,3/5,3.30%,VEGFA;RBPJ;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.742359522333281,1.3463551540716123,0.17857142857142858,0.786238401396285,1.0,2/9,13.38%,TGFB1;TGFBR1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.4845211249404122,1.3462966153123905,0.07142857142857142,0.7826805438711268,1.0,10/50,10.68%,ATRAID;TMEM119;PPARG;SEMA4D;PTCH1;FFAR4;ACVR1;IL6ST;SKI;IL6R
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.7395011473790315,1.3457039668671558,0.1891891891891892,0.78133500588226,1.0,1/6,4.43%,TGFB1
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.7791138357369276,1.3456560573550664,0.12903225806451613,0.7778891793356325,1.0,1/5,6.37%,SIRT1
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.7093033439286672,1.3455308682683502,0.1875,0.7749736473864682,1.0,5/11,18.85%,TAL1;CEBPA;EP300;CBFA2T3;SPI1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.6770094875091912,1.3454707253624771,0.14285714285714285,0.7680721202778585,1.0,3/8,9.74%,RPS6KA6;TP53;TFAP4
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.6770094875091912,1.3454707253624771,0.14285714285714285,0.7680721202778585,1.0,3/8,9.74%,RPS6KA6;TP53;TFAP4
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.7901640664264409,1.345010005473576,0.11764705882352941,0.7662791225420382,1.0,4/7,15.73%,WHAMM;BIN3;BIN2;FNBP1L
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),-0.8738679300408971,-1.3448723591926663,0.08450704225352113,0.9187987794143536,1.0,1/7,0.14%,TOP2A
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.5551079990339879,1.344697001776307,0.08333333333333333,0.7641222788449017,1.0,7/31,13.53%,TGFA;NCK2;TGFB1;CBL;SRC;GAREM1;SLC30A10
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.8000562842545447,-1.3446859479809572,0.10126582278481013,0.915950246728856,1.0,3/15,7.45%,DNAJB9;CR1;FCGR2B
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.8238247091558731,1.3438741366506919,0.06451612903225806,0.7645809653066763,1.0,4/5,17.43%,SPRED2;SPRED1;EP300;DYRK1A
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,-0.6313382724172483,-1.3437720698763318,0.020618556701030927,0.9214433565704032,1.0,40/87,24.79%,SPOCK1;SULT4A1;CCDC85C;FAIM2;BRINP1;AMER2;CCK;TCEAL2;PLP1;LRRC4C;SST;PAK5;RAB3C;NRXN1;GRIA4;GABRB1;KCNC1;PHYHIPL;PDE10A;SH3GL2;TAGLN3;SNAP25;GABRG2;GRM3;SYT4;CLVS2;SCN3B;SERPINI1;STMN2;GAD2;ST8SIA3;PLPPR4;GFAP;CADM2;LY6H;CSRNP3;NRGN;CA10;GRIA2;VSTM2B
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.6817963670657565,1.343447219050298,0.05555555555555555,0.7627206183547347,1.0,1/14,0.22%,GCLC
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.752775810800419,-1.3432931602472944,0.05747126436781609,0.9230301887687642,1.0,5/24,8.70%,CENPF;OIP5;CENPV;ITGB3BP;CENPE
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.6753808335764026,1.3429822557138278,0.2222222222222222,0.7610914688930849,1.0,4/11,9.50%,DGUOK;ADK;POLD3;AMPD3
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.7827364713430824,1.3426388858692466,0.19230769230769232,0.7591569021870541,1.0,2/7,11.49%,BCL2L1;SERPINB9
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.7804018796377536,1.342355811919072,0.13157894736842105,0.7569741367998519,1.0,2/6,6.00%,NBN;ERCC4
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.6811078836722513,1.3418216094167177,0.17857142857142858,0.75602693280379,1.0,3/11,6.61%,PPARG;PRKAB2;ADIPOR2
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.6848378234337951,-1.341312509643789,0.058823529411764705,0.9404566653305736,1.0,8/31,11.53%,ARIH2;TOMM7;VPS11;ABLIM3;RHOU;PINK1;ATP5IF1;USP36
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.6971201984182648,-1.3411017467374255,0.04395604395604396,0.9391593914602088,1.0,6/34,10.19%,TFRC;GPR183;VAV3;IL7;NOD2;TNFSF13B
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.7093444294134577,1.340938718139884,0.125,0.756035627427816,1.0,2/11,9.35%,ZNF703;NRIP1
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.842263527251237,-1.3408800124054223,0.1,0.9375951425109683,1.0,3/8,7.63%,HMGB2;RAB7B;FAXDC2
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.7217641984568385,1.3402945204435839,0.13793103448275862,0.7524527839434142,1.0,2/7,17.48%,ABL1;PRKN
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.7217641984568385,1.3402945204435839,0.13793103448275862,0.7524527839434142,1.0,2/7,17.48%,ABL1;PRKN
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.6512714872996603,-1.3401036755057658,0.03333333333333333,0.9424479332272474,1.0,8/54,9.26%,SLC51A;SLC38A4;SLC16A10;ACSL1;ATP8B1;SLCO1A2;ABCC3;SLC6A15
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.6814881296512275,1.3400516214076292,0.15789473684210525,0.7505031256122103,1.0,2/11,5.21%,SPIN1;RPAP2
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.7045627055103465,1.3395753336666827,0.2413793103448276,0.7428071521822078,1.0,2/10,7.49%,PANK1;PANK3
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.7045627055103465,1.3395753336666827,0.2413793103448276,0.7428071521822078,1.0,2/10,7.49%,PANK1;PANK3
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.7045627055103465,1.3395753336666827,0.2413793103448276,0.7428071521822078,1.0,2/10,7.49%,PANK1;PANK3
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.7906803330952958,-1.3394543007864572,0.09090909090909091,0.9458824795102009,1.0,2/10,9.99%,VEGFA;CTBP1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.740657891949795,-1.339279565898745,0.07407407407407407,0.9444274134069139,1.0,6/16,17.75%,SH3BP5;SH3BP5L;CBLB;SNX6;ERRFI1;THY1
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),-0.8465569212638357,-1.3390257845797566,0.08695652173913043,0.9442727093286439,1.0,2/9,2.54%,CD55;MYO1G
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.7016572524725191,1.3390070649433319,0.17857142857142858,0.7415963283652303,1.0,2/12,7.49%,PANK1;PANK3
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.7524438125848614,-1.3389718098446461,0.09090909090909091,0.9410866506172598,1.0,1/16,0.19%,UAP1L1
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.7259584912112598,-1.3389118868493293,0.125,0.937849266138272,1.0,5/23,8.83%,ACVR1B;HMGB2;HIF1A;STAT1;HSPA1B
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.6229870301655731,-1.3387876703745958,0.07777777777777778,0.9353709960012406,1.0,2/57,0.44%,PCSK1;SRGN
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.8781604273186193,-1.3383145191654642,0.07936507936507936,0.9360621418549143,1.0,4/5,12.22%,RPL23;RPL11;RPL5;RPS7
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.8916472856785642,-1.3379586415936935,0.057971014492753624,0.9359826871462895,1.0,2/7,8.70%,CENPF;CENPE
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.8928126775042933,-1.3378765471725587,0.09333333333333334,0.9330466749073866,1.0,2/6,8.70%,CENPF;CENPE
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.7346329331468555,-1.3377744532172686,0.08823529411764706,0.9302480740401898,1.0,5/18,16.66%,PCSK1;SRP14;SST;PCSK2;MAFB
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.6984093793222966,-1.337748428575538,0.075,0.9267160377912095,1.0,3/26,2.81%,FA2H;SLC5A9;OVOL2
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.7002907092127275,-1.3361248797110685,0.03571428571428571,0.9417313435069066,1.0,11/33,15.60%,RPS27A;DTL;RPA2;UBA52;TRIM25;RFC1;UBC;RPA3;USP43;RFC4;UBB
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.7952706321054991,1.335983645191098,0.10810810810810811,0.7508161339880699,1.0,1/6,4.73%,GCNA
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.687738021066314,-1.3353110518671631,0.056179775280898875,0.9468797475369859,1.0,6/37,17.47%,THBS1;VEGFA;BEX3;CARD16;CD44;KLF4
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.6608284312880379,1.3344280751870585,0.125,0.7547439786660433,1.0,2/10,4.54%,ST6GALNAC3;ST8SIA4
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.621480254919907,-1.3342698221369977,0.04081632653061224,0.9535558625987592,1.0,30/103,14.27%,GADD45B;THBS1;TNFRSF11B;VIM;TNC;SPOCK1;SPARC;MYLK;VCAN;VEGFA;RHOB;ECM2;LAMA2;BASP1;FBN2;SNTB1;SAT1;IL15;COL11A1;ID2;NOTCH2;ENO2;TGFBI;APLP1;CDH2;FN1;EMP3;ITGA2;CTHRC1;CD44
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.7613606202072098,1.3340944888924111,0.20512820512820512,0.7531954302439218,1.0,3/5,21.61%,RAB10;LIN7B;LIN7A
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.6646251420682123,-1.3337773818749636,0.056818181818181816,0.9545999989834614,1.0,3/36,3.30%,THBS1;VEGFA;HIF1A
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.7450333204103947,-1.3333930862035457,0.034482758620689655,0.9548208415459369,1.0,4/21,5.14%,CCL4;JAML;TGFB2;CCL3
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),-0.8672747061790103,-1.3332232595261237,0.06578947368421052,0.9533054013115427,1.0,1/7,0.14%,TOP2A
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),0.6456382178702634,1.3330197079896124,0.09375,0.7542695871849445,1.0,2/10,5.80%,PEX13;PEX16
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.6883991887188099,1.332583464208931,0.14285714285714285,0.7498719269003795,1.0,2/8,13.43%,NFATC3;NFAT5
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.6883991887188099,1.332583464208931,0.14285714285714285,0.7498719269003795,1.0,2/8,13.43%,NFATC3;NFAT5
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.8428127214340523,-1.3324575068953584,0.05555555555555555,0.9579777497027654,1.0,1/10,0.02%,KCNE1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.625313433853729,-1.332352447561495,0.09782608695652174,0.9552533811523416,1.0,11/49,18.21%,TFRC;ARAF;MTCP1;VEGFA;PINK1;HCLS1;CD44;TERF2IP;ATP2B4;CALCR;TXN
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.7337020014374779,-1.3323197582424477,0.04938271604938271,0.9517475341664065,1.0,7/29,11.77%,TOP2A;H1-3;H1-4;H1-2;H1-0;TTN;INCENP
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.7230268524474195,-1.3320074885454907,0.10843373493975904,0.951502710657103,1.0,1/19,0.08%,DDIT4
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.7327853448897286,-1.3317732114966419,0.04597701149425287,0.9502824043252908,1.0,4/23,5.14%,CCL4;JAML;TGFB2;CCL3
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.6264943251756637,-1.3315129043684786,0.031578947368421054,0.9495041370811573,1.0,38/80,26.37%,FAM13C;PTN;SPRY1;FAIM2;BRINP1;PCDH17;MAP1B;ANK2;PLP1;LRRC4C;GPM6B;ADGRL3;MAPK4;PTPRZ1;PTPRD;PHYHIPL;LRP4;RCAN2;CPE;FBXL7;CLVS2;MAPK10;STMN2;ASXL3;GPRC5B;TMEM178A;PLPPR4;GFAP;RUNX1T1;LY6H;MAP2;CSRNP3;GRIA2;NOVA1;CRMP1;CADM3;NDRG4;AQP4
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.7636893106693255,-1.3314809010994906,0.05128205128205128,0.9462171640170888,1.0,1/14,0.28%,GLRA1
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),-0.8425948430713052,-1.330930859756799,0.07936507936507936,0.9478937162245067,1.0,2/9,8.68%,GLRA1;SOD1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.805517100312727,-1.330383273194621,0.06451612903225806,0.949521963123344,1.0,4/8,15.60%,RPS27A;UBA52;UBC;UBB
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.696739944569629,1.3302968105748267,0.20689655172413793,0.7568930276742001,1.0,4/7,21.01%,ABHD10;LYPLA1;PPT1;ABHD17A
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",0.5313644637577536,1.330223010232094,0.0,0.7539860460560296,1.0,6/22,15.87%,ZMYND11;SUPT16H;WDR43;THOC5;SCAF8;KAT7
prerank,GO_Biological_Process_2021__T cell chemotaxis (GO:0010818),-0.9253311056747011,-1.329850579416567,0.014925373134328358,0.9513155578342017,1.0,2/6,5.14%,GPR183;CCL3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.6350916547153936,-1.3296435316420825,0.08695652173913043,0.9498402948429949,1.0,17/62,19.66%,RPS27A;VEGFA;RBPJ;HIF1A;RBX1;EGLN3;LIMD1;UBA52;PSMA3;UBC;PSMA5;PSMD8;UBB;PSMB4;ELOB;CITED2;PSMD7
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.6277425949468487,1.3295457056620001,0.17857142857142858,0.7533637715122087,1.0,5/9,27.28%,IL1B;RPS6KA4;FMR1;AKAP8L;RPS6KA5
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.6153905041996249,-1.3287547202074887,0.010101010101010102,0.9557439169973733,1.0,35/150,13.30%,GPR18;NAMPT;SOCS3;MX2;MT2A;IFITM3;RSAD2;HIF1A;MX1;CD69;IFIT2;IL7;HLA-B;IFIT3;IFI44L;OGFR;IL15;STAT1;ARID5B;DHX58;IL10RA;TRIM25;PSMA3;CMPK2;PDE4B;IFI44;HERC6;IRF1;B2M;TXNIP;NLRC5;OAS3;FPR1;IFIT1;PARP14
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.7126424120464872,-1.328264502134971,0.10344827586206896,0.9574241349694779,1.0,8/26,13.30%,HIF1A;TXK;IL7;PARP9;CXCR4;HSPA1B;NLRC5;PARP14
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.4456478063040076,1.328212693591967,0.0,0.7559766818775722,1.0,17/91,9.65%,PHLDB2;NEXMIF;DAB2IP;SMAD7;SRGAP2;ARHGDIB;RECK;DAG1;RNF20;VCL;STK26;DACH1;JAG1;SRGAP2C;SRGAP2B;NF2;DUSP3
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.8726738154644271,-1.3277669974520074,0.0410958904109589,0.9590569150219406,1.0,3/7,4.68%,THBS1;SULF2;SPRY1
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.5162370250085413,1.3277346958917748,0.07142857142857142,0.7515275515468358,1.0,2/32,1.70%,NUP42;NUP188
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),0.5162370250085413,1.3277346958917748,0.07142857142857142,0.7515275515468358,1.0,2/32,1.70%,NUP42;NUP188
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.8981106333254041,-1.3277336820099954,0.07936507936507936,0.9560757634452701,1.0,1/5,1.99%,FGF1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",-0.8550183079711011,-1.32742657885208,0.07352941176470588,0.9559647666354847,1.0,1/6,0.74%,CD55
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.7870632166799254,1.3269177269613215,0.2222222222222222,0.7517472642942375,1.0,2/6,6.30%,DCP1B;EDC3
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.5107444621584725,1.3268578967924143,0.09090909090909091,0.7489321024040708,1.0,14/49,18.88%,PEX13;ECI1;ACADS;MTLN;ACOX1;EHHADH;AIG1;ECHDC1;PEX2;NUDT19;MMAA;ACAT2;PECR;ABCD3
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.5567860550101966,1.3268418453601398,0.07692307692307693,0.7459958873163027,1.0,5/20,18.43%,UBE2E2;ANAPC4;UBE2E3;PRKN;UBE2D4
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.705770402871035,-1.3265278922122807,0.07865168539325842,0.9618762592179646,1.0,5/30,12.95%,KCNE1;ATP1B3;ANK2;KCNMA1;AKAP6
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.9206854316325707,-1.3259812478131667,0.028985507246376812,0.9640206509247555,1.0,1/5,0.65%,RPL23
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.6010111519159561,-1.3259279117474723,0.0,0.9609617446692736,1.0,28/119,16.63%,SRGN;CCL4;GCNT1;TGFB2;HIF1A;IL7;RPS3A;RPL9;GBP2;BRCA1;RPS9;FCGR2B;FGR;IL15;STAT1;IL18;TPD52;RPL39;B2M;NCF4;HCLS1;DARS1;TRAF2;HLA-DMB;TAP1;TLR2;EIF3D;GPR65
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.8659266642232266,-1.3258328298569235,0.04285714285714286,0.9586438589284666,1.0,2/8,5.20%,DUSP1;XRCC3
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.7569507772603415,-1.3258202847925333,0.07246376811594203,0.9553194811324652,1.0,3/12,5.97%,TNFRSF1B;NOD2;SLC7A5
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.6142429683226479,-1.3251267335584982,0.030927835051546393,0.9583402112298774,1.0,23/116,14.27%,SH3BP5;RHOBTB3;GLA;BHLHE40;ALDH3B1;FOS;OVOL2;THSD4;MINDY1;SVIL;SLC7A5;BLVRB;GREB1;ENDOD1;PAPSS2;MAPT;UGCG;SYBU;OLFM1;RAPGEFL1;KAZN;SLC16A1;CD44
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.8615506888345346,-1.3248608606476642,0.029411764705882353,0.9582577460768769,1.0,3/8,7.35%,SLC2A3;SLC5A9;SLC2A9
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.6747362601278293,1.3247766787352038,0.1935483870967742,0.7515839192838869,1.0,2/10,4.06%,RALB;PIP4K2B
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.7150331965520859,-1.3247171377965177,0.125,0.9562863094888798,1.0,8/23,21.27%,FGF1;PINK1;IL18;INSR;PRR5;TXN;NRG1;NTRK3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.7310241731397353,-1.324421382276291,0.16216216216216217,0.9561108743179783,1.0,2/15,1.48%,DDIT4;PAQR3
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.82836405505213,-1.324355888711154,0.1095890410958904,0.9531894500580785,1.0,4/7,16.44%,ALOX12;DUOX1;NCF4;NCF2
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.8485911918779772,-1.3242154291140065,0.07692307692307693,0.9513235901856321,1.0,2/7,5.65%,HLA-B;NOD2
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.6446173278577161,-1.3238844881227199,0.031914893617021274,0.9513005502057589,1.0,19/72,15.77%,KCNE1;ANKUB1;OMG;CCDC170;CD163;FMO5;MS4A6A;SMIM14;HSPA2;FAM20A;DNAH12;ABCA1;CCPG1;CD14;RASSF4;ALDH1A1;HLA-DMB;CHL1;MGLL
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.6243481904498991,-1.3233393245713458,0.02040816326530612,0.9534987342189167,1.0,24/103,20.42%,RPL38;RPL23A;RPS27;RPL3;RPL11;SNRPD2;RPL24;RPS14;NOP53;DDX1;RPS15;MRPS7;RPL6;RPL5;TRAF7;RPLP0;MRPL20;SRSF5;PRPF6;DICER1;RPL10;EIF2D;GCFC2;SRSF9
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.7785164863332732,-1.323140588486305,0.10666666666666667,0.9522790160956935,1.0,6/11,18.11%,CEMIP;CACNB2;ANK2;AKAP6;THY1;CALCR
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.882944334026417,-1.3227155002269946,0.04477611940298507,0.952549160489551,1.0,1/5,7.76%,DAPK1
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.6579972879846873,-1.321918084916559,0.043010752688172046,0.9576397446680881,1.0,8/54,6.41%,THBS1;CHI3L1;FGF1;VEGFA;RHOB;HIF1A;FLT1;BRCA1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.8244721650098894,-1.3218352118424188,0.11940298507462686,0.9519475342429717,1.0,2/10,5.10%,IL7R;IL7
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.8244721650098894,-1.3218352118424188,0.11940298507462686,0.9519475342429717,1.0,2/10,5.10%,IL7R;IL7
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,-0.6373670531520356,-1.321773769132284,0.02197802197802198,0.9491307703212648,1.0,30/60,24.83%,SULT4A1;CASKIN1;MAP1B;ANK2;LRRC4C;SRRM3;EFR3B;ERC2;APLP1;PAK5;ADGRL3;MAPK4;PTPRZ1;STOX2;KCNC1;PHYHIPL;CTNND2;LRP4;TAGLN3;UNC13A;CPE;CLVS2;ATP1B2;CADM2;CSRNP3;TMEM59L;LINGO1;UNC5D;GRIA2;CACNA1B
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.8345749050455709,-1.3213241313179793,0.11594202898550725,0.9502806687818983,1.0,2/9,4.07%,NUDT16;ENTPD3
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.7658632987647328,-1.3212374058125964,0.0945945945945946,0.9479080066484905,1.0,6/17,15.00%,H2BC11;SLC11A1;HMGB2;RPL30;PYCARD;GSDMD
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.7177662231663078,-1.3211100628221495,0.1375,0.9459692450420694,1.0,4/19,8.09%,KCNE1;FHL1;ATP1B3;ANK2
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,-0.628262312608531,-1.3203278544281192,0.08602150537634409,0.9512495785339247,1.0,35/86,21.98%,PCSK1;GNRHR;FAM13C;KCNT2;COL11A1;NREP;SST;TRPM3;RAB3C;TMEM130;NRXN1;GRIA4;NEFM;PTPRD;PCSK2;CHGB;KCTD16;SYT4;SEZ6L2;AMPH;THY1;CACNA1C;CLVS2;MAPK10;FMN2;ROBO2;STMN2;GAD2;ASXL3;ST8SIA3;PLPPR4;CADM2;RUNX1T1;JAM3;MAP1A
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.6721062713535814,1.3198041128898692,0.1,0.7680192711575433,1.0,3/14,5.81%,CPA1;MAPKAPK2;ALOX5AP
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.8280515104163642,-1.319666160274318,0.10144927536231885,0.9546429755264331,1.0,3/7,10.26%,DUOX1;CLCA4;CFTR
prerank,MSigDB_Hallmark_2020__Apical Surface,-0.6761663707126099,-1.3195090348449856,0.11904761904761904,0.9529874177488753,1.0,6/24,8.64%,SULF2;ATP8B1;CRYBG1;MAL;BRCA1;GSTM3
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.7932630166950428,-1.319471195517587,0.05128205128205128,0.9501382177763933,1.0,4/11,5.45%,H1-3;H1-4;H1-2;H1-0
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.7510745249856912,-1.3193013480995595,0.058823529411764705,0.9483824080385316,1.0,8/24,18.66%,KCNE1;ANK3;SCN9A;DMD;AKAP6;GNA11;SCN1A;SCN3B
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),-0.8343520552136008,-1.319273751168404,0.15873015873015872,0.9456620307884905,1.0,3/7,13.36%,TFRC;BNIP3;PID1
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.5702676783314439,1.319248851866229,0.15789473684210525,0.7672685176939928,1.0,6/22,6.61%,SIRPA;AVIL;CX3CR1;PRKAB2;SIRT1;ADIPOR2
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.7083639701873417,-1.3190592665593328,0.10588235294117647,0.9448430119970578,1.0,7/26,10.84%,CD55;FOSL2;BHLHE40;IL18;ABCC3;PPP1R13L;MLANA
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.7172534303999706,-1.318322793904861,0.10256410256410256,0.949379000626071,1.0,6/22,5.80%,THBS1;FGF1;SEMA6A;VEGFA;GLUL;EPN1
prerank,GO_Biological_Process_2021__regulation of dendritic cell antigen processing and presentation (GO:0002604),-0.9258647440481231,-1.318035374979266,0.046875,0.949176737989508,1.0,4/5,7.45%,THBS1;SLC11A1;NOD2;FCGR2B
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),-0.9278042304054608,-1.3178140841416124,0.014084507042253521,0.9485096315696818,1.0,1/5,2.46%,AGT
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.8139583125285936,-1.3177700099628291,0.10606060606060606,0.9458644099428476,1.0,2/9,2.89%,CD55;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.721230223199952,-1.3174958610984435,0.07058823529411765,0.9451507379549436,1.0,2/23,0.35%,SOCS3;SH3BP5
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.7437574615883955,-1.3173321258074768,0.06329113924050633,0.9438569978861099,1.0,3/20,8.09%,KCNE1;PKP2;ANK2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.5803829294076167,1.3173222562996771,0.23529411764705882,0.772185971602734,1.0,4/14,9.74%,CEBPA;HHEX;LATS2;TFAP4
prerank,GO_Biological_Process_2021__positive regulation of calcium-mediated signaling (GO:0050850),-0.8832786898270566,-1.3171703328343194,0.08571428571428572,0.9421728878480243,1.0,2/7,5.14%,CCL4;CCL3
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.6421214298314815,-1.3171418971856947,0.1111111111111111,0.9394295387727561,1.0,10/48,12.41%,CYCS;CD93;NAPSB;H2AC8;MS4A4A;FCGR2B;FGR;CXCR4;NCF4;PRDM1
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),-0.8667861770631522,-1.3168838114231989,0.15492957746478872,0.9389286937954193,1.0,3/5,13.26%,GLA;GALC;GBA3
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),-0.8802562269599085,-1.3168801660179952,0.014925373134328358,0.9329402015350609,1.0,1/6,8.00%,STAT1
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),-0.8802562269599085,-1.3168801660179952,0.014925373134328358,0.9329402015350609,1.0,1/6,8.00%,STAT1
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.6472776561744906,-1.3168411488928458,0.0425531914893617,0.9303217779784256,1.0,33/71,24.83%,SULT4A1;NR4A2;CASKIN1;MAPT;CALY;ERC2;APLP1;PAK5;MAPK4;NRXN1;GDAP1L1;BSN;KCNC1;PHYHIPL;CTNND2;SNAP25;UNC13A;GABRG2;SYT4;CLVS2;SYP;STMN2;GAD2;ST8SIA3;KIF5A;LY6H;HS6ST3;CSRNP3;TMEM59L;LINGO1;LONRF2;GRIA2;CACNA1B
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.6670728784362407,-1.3165709179045055,0.08695652173913043,0.9303979125653118,1.0,13/39,13.49%,DDIT4;SPOCK1;VEGFA;SEMA3A;NR4A2;CCK;CEP85L;MAP1B;FGF13;ASTN2;ADGRL3;GPM6A;TUBGCP2
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.7051671442353642,-1.316484270131069,0.0975609756097561,0.9281341079357627,1.0,7/22,20.62%,CLDN18;LSR;CLDN20;MPP7;PDCD6IP;MICALL2;ACTG1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.6807150737589841,-1.316438494020929,0.06818181818181818,0.9257351406399607,1.0,12/31,18.45%,GRIK1;GRM8;SHANK3;DGKI;TSHZ3;CDH2;NLGN3;NRXN1;UNC13A;SYT1;GRM3;RELN
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.6119159016565774,1.3162574109453027,0.1111111111111111,0.7733515586504953,1.0,6/11,20.75%,SLC25A18;LRRC8D;ARL6IP5;SLC1A3;GIPC1;SLC25A13
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.6064807674558128,1.3159359476424737,0.17391304347826086,0.7715119504519913,1.0,5/15,7.41%,NEDD4;ITGA5;DAB2IP;HHEX;IL1B
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.7250968573667901,1.3151838213254547,0.1724137931034483,0.7701064785021519,1.0,3/8,9.50%,DGUOK;ADK;AMPD3
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.5675035416795546,1.3150527260985903,0.14285714285714285,0.7679224640042129,1.0,4/20,4.43%,NEDD4;IDE;SMURF1;TGFB1
prerank,GO_Biological_Process_2021__regulation of dendritic cell chemotaxis (GO:2000508),0.787156480933884,1.315046197829504,0.08823529411764706,0.7649227668791964,1.0,1/5,1.01%,LGALS9
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),-0.8543113701779397,-1.315009874001926,0.11290322580645161,0.9366736042245118,1.0,1/5,0.27%,NR4A3
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.7560460922513587,-1.314359638328598,0.057971014492753624,0.9396701038080929,1.0,6/12,18.45%,TGFB2;MMP24;METRN;CDH2;NFIB;RELN
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.8549497272435868,-1.3141981584762668,0.05263157894736842,0.9382941270721048,1.0,3/9,3.35%,TGFB2;RBPJ;ADGRG6
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.7394004684520182,1.313854036208038,0.22857142857142856,0.7664165239056476,1.0,1/8,0.05%,STPG1
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.8177176974944222,-1.31344980714091,0.07246376811594203,0.9424773340766388,1.0,3/9,8.66%,RSAD2;NOD2;IL18
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.8461533831115704,-1.3132175845077547,0.136986301369863,0.9387946716741975,1.0,2/6,13.26%,GLA;GBA3
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.8461533831115704,-1.3132175845077547,0.136986301369863,0.9387946716741975,1.0,2/6,13.26%,GLA;GBA3
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8084993608547038,-1.312709746591474,0.10294117647058823,0.941036215152565,1.0,7/10,15.74%,RPS27A;UBA52;PGK1;UBC;B2M;UBB;TLR2
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.757075593003683,-1.3126653265755195,0.0641025641025641,0.938744139950055,1.0,8/18,13.30%,SOCS3;CDC37;TXK;STAT1;PARP9;NR1H2;NLRC5;PARP14
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.6847298889495178,-1.3124334979797028,0.14942528735632185,0.9380068883642618,1.0,5/26,7.35%,KCNE1;FA2H;OVOL2;COBL;SLC2A9
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.6692250977969776,1.3120263624323059,0.14285714285714285,0.7715251957658065,1.0,4/11,19.09%,OCRL;INPP5K;INPP1;SYNJ1
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.8217744334541116,-1.3118442258293135,0.12121212121212122,0.9404041065881167,1.0,2/7,3.82%,IHO1;PTN
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.6537421818028449,-1.3117069515292115,0.09523809523809523,0.9387417322532257,1.0,8/33,12.22%,RPL23;RPL11;DDRGK1;NOP53;CAMLG;SDCBP;RPL5;RPS7
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.7336551364433526,-1.3116253162162685,0.06578947368421052,0.9365998216639639,1.0,6/21,8.67%,THBS1;PLPP3;ENPP4;MYLK;DUOX1;PRKCE
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.7808376179909546,-1.3116036147290047,0.1,0.9338391638688669,1.0,3/10,15.09%,BNIP3L;BNIP3;BMF
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.7361815566449298,-1.3114546646715968,0.09876543209876543,0.9320400175690358,1.0,7/21,17.39%,CD55;C5AR1;CR1;FCGR2B;C5AR2;SERPING1;CLU
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),-0.8547060980019885,-1.311432079027002,0.1,0.9295667052147735,1.0,2/6,9.33%,SSB;DDX1
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.8858471718586345,-1.310966879905125,0.06896551724137931,0.9314907066797794,1.0,3/7,8.68%,VEGFA;EIF2B2;SOD1
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.8094898613891404,-1.3107635005114155,0.14705882352941177,0.9304524875794168,1.0,4/9,9.44%,AGT;ALOX15B;IL18;CD36
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.7157530394348031,-1.3106004494719243,0.08536585365853659,0.9295336326935356,1.0,6/23,14.34%,HTR2B;VEGFA;TGFB2;TTN;OLFM1;INSR
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.8081648640126096,-1.309800329493413,0.1044776119402985,0.9346555760601953,1.0,4/7,18.02%,HLA-B;HLA-F;B2M;HLA-C
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.61975620495025,-1.309734464361782,0.0898876404494382,0.9322956399272344,1.0,24/90,15.78%,RPS27A;VEGFA;HIF1A;RORA;RBX1;NDRG1;FAM162A;EGLN3;PINK1;NOP53;LIMD1;UBA52;PGK1;BNIP3L;PSMA3;UBC;BNIP3;PSMA5;RGCC;CARD16;SUV39H2;PSMD8;UBB;PSMB4
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.7537055640746063,1.3091587546273713,0.17857142857142858,0.7790179892977805,1.0,1/5,0.86%,PUS1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.7789026107193119,-1.3089094662217196,0.07058823529411765,0.9371547099620274,1.0,2/14,2.46%,NR4A3;AGT
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.8382379607186248,-1.3088491608865758,0.058823529411764705,0.934969056528824,1.0,2/7,8.89%,PRELID1;ABCB4
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.5859145027264537,1.308644633899772,0.09523809523809523,0.7778893931942072,1.0,3/21,4.13%,PHLDB2;ARAP1;WASF2
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.6845946146672701,-1.3079811220633704,0.14864864864864866,0.9394850074408432,1.0,6/20,11.06%,TFRC;PRELID1;MAPT;PINK1;TMEM14A;BNIP3
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.7049035118417605,-1.3078946939002927,0.0963855421686747,0.9375832335163983,1.0,6/28,8.74%,HTR2B;SEMA6A;SEMA3A;CENPV;PDXDC1;GPC3
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),-0.8943296587871381,-1.3076826902618404,0.12307692307692308,0.9367454479716936,1.0,3/5,7.45%,CD55;CR1;FCGR2B
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.6576348955444714,1.3075126698885946,0.13636363636363635,0.7795828409208695,1.0,1/15,0.19%,ACER2
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.854757716150433,-1.3064831311233924,0.1746031746031746,0.9448078610547453,1.0,2/6,8.93%,HTR2B;TTN
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.6697524194690732,1.30647157457222,0.15384615384615385,0.7800428494576658,1.0,4/10,17.43%,IDE;APH1A;APEH;DYRK1A
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.8505125283486165,-1.3063354399862455,0.11594202898550725,0.9435131836902357,1.0,1/6,1.72%,CYP3A5
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.8095618245708592,1.3063152694477538,0.1891891891891892,0.7779325202558889,1.0,3/5,18.33%,TGFB1;SMAD2;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.8665464447725355,-1.3061727903306215,0.125,0.94252814347886,1.0,1/5,1.11%,RGS2
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.6153533117566388,-1.3060533806451073,0.07291666666666667,0.9406451108111809,1.0,29/132,19.20%,TOP2A;DIAPH3;TFRC;CKS2;NAA38;HMGB2;RPA2;RACGAP1;BRCA1;DONSON;PRDX4;CENPE;CIT;RFC1;PAICS;RPA3;PNN;CDKN1B;PRPS1;LMNB1;TIMELESS;CBX5;ORC6;SRSF2;BRCA2;ILF3;MCM3;MCM6;STMN1
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),-0.8273587855206065,-1.304840115398179,0.13432835820895522,0.9481115419357531,1.0,2/7,1.51%,NR4A3;LRP2
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",-0.8854029064383702,-1.3048219877026297,0.11290322580645161,0.9454609133050363,1.0,2/5,6.34%,CD55;CR1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.7819286109120034,-1.3047041804601094,0.08974358974358974,0.9441558121825185,1.0,4/11,10.42%,CYCS;COX7C;COX4I1;COX6C
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.8110393418716983,-1.304468199789407,0.11940298507462686,0.9438598196259855,1.0,7/10,16.04%,OPALIN;PTN;TNFRSF1B;CXCR4;DAAM2;PTPRZ1;TNFRSF21
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.8283167471053947,-1.3043217236053313,0.06349206349206349,0.94216184496215,1.0,3/9,8.68%,VEGFA;EIF2B2;SOD1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.7031244250495146,-1.3040989883425538,0.075,0.9414963843694553,1.0,10/22,24.33%,OMG;FGF13;DCC;MAG;LRP4;THY1;MAP2;GDI1;LINGO1;ARHGDIA
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),-0.8580074561793506,-1.3037148835640218,0.11594202898550725,0.9417472766216239,1.0,1/5,1.70%,PPP1R15A
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.8133161605494672,-1.3036403716847387,0.171875,0.9395076663131894,1.0,3/6,14.78%,SYAP1;PINK1;PRR5
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.7072173197567823,-1.3035033194391894,0.08433734939759036,0.9378678607293742,1.0,3/24,4.39%,CCL4;JAML;SELL
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.8576537885213547,-1.3034321708924217,0.1044776119402985,0.9359977717369293,1.0,1/7,1.66%,NUDT16
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.7757833475809014,1.3029268255737607,0.16129032258064516,0.7875470811698527,1.0,1/6,3.11%,EYS
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.804914256863527,-1.3028407199036505,0.1791044776119403,0.9363645464053821,1.0,3/5,18.02%,HLA-B;HLA-F;HLA-C
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.804914256863527,-1.3028407199036505,0.1791044776119403,0.9363645464053821,1.0,3/5,18.02%,HLA-B;HLA-F;HLA-C
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.8550529604790886,-1.3028083769246859,0.07692307692307693,0.9340656890922614,1.0,2/7,6.01%,KNSTRN;RACGAP1
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.6192492270042049,-1.3023876926703353,0.031914893617021274,0.9348850445729855,1.0,30/79,21.30%,PLPP3;FAM13C;SPARC;AGT;VEGFA;GLUL;PTN;BRINP1;PCDH17;ANK2;COL11A1;PLP1;SPARCL1;ADGRL2;LIFR;PTPRD;CD44;LRP4;RCAN2;TLR2;CPE;FBXL7;CLU;THY1;MAPK10;COL5A1;GPRC5B;TMEM178A;PLPPR4;MPDZ
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.7197913957873127,-1.3023317296810928,0.10126582278481013,0.9326293123121361,1.0,8/23,17.75%,CEMIP;JPH1;ANK2;CALM3;DMD;AKAP6;CALM1;THY1
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.7900969434850794,-1.3015057047652359,0.16216216216216217,0.9371382461818903,1.0,2/11,2.54%,CD55;MYO1G
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.7402360021144231,1.3014442990315775,0.125,0.791368451260242,1.0,2/8,9.24%,ZDHHC3;ADRA1A
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),-0.6129270383670891,-1.3013132411244401,0.08333333333333333,0.9360893016874157,1.0,13/73,14.51%,DDIT4;SPOCK1;VEGFA;TGFB2;NR4A2;UGCG;RORB;ID2;ERCC2;MANF;ALK;PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.7452369466227242,-1.3009468176271601,0.09333333333333334,0.9366598107335686,1.0,4/15,5.45%,H1-3;H1-4;H1-2;H1-0
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.8420793387140033,-1.3008991681663842,0.08333333333333333,0.9344239910081116,1.0,2/6,2.83%,OMD;OGN
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.9070615289217185,-1.300499151675823,0.04225352112676056,0.9351771272024842,1.0,2/5,2.56%,ACVR1B;VEGFA
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.5879084400181174,-1.3003578435256444,0.0,0.9338352408190724,1.0,74/199,24.83%,TMEM163;TACR1;PIANP;PDE4A;SULT4A1;RORA;BRINP1;AMER2;CCK;TCEAL2;CHN1;PDE1A;RORB;HSPA12A;SLC17A7;ERC2;SST;ADGRL2;KCNMA1;VGF;PAK5;MAPK4;RAB3C;NRXN1;GRIA4;GDAP1L1;NEFM;BSN;SLC16A1;FRRS1L;PCSK2;RAB15;KCNC1;PHYHIPL;CTNND2;CPLX1;SH3GL2;TIMELESS;TAGLN3;SNAP25;UNC13A;SYT1;GABRG2;ADCY8;GRM3;SYT4;GAD1;CLVS2;RELN;SYP;SRGAP3;HPCAL4;STMN2;FAM81A;GAD2;ST8SIA3;ETV1;KIF5A;CADM2;NTNG1;LY6H;SV2B;MAP2;LMO3;CSRNP3;NRGN;TMEM59L;CA10;AGAP1;OPRM1;LINGO1;GRIA2;VSTM2B;CACNA1B
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.49050266814971816,1.3003545145069784,0.08,0.7940034550926998,1.0,8/27,10.47%,SMAD7;TGFB1;ZDHHC2;JAG1;TENM3;NF2;EPHB3;SRC
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.6884802666988417,1.3003220312002504,0.18181818181818182,0.7911627322780752,1.0,2/9,6.30%,DCP1B;EDC3
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.7114353355399282,-1.2999420236510417,0.12987012987012986,0.9353324335426324,1.0,3/19,5.97%,DNAJB9;NOD2;SLC7A5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.7149060872977601,-1.2993857213511608,0.11842105263157894,0.9379511178921425,1.0,8/19,15.60%,RPS27A;RPA2;UBA52;RFC1;UBC;RPA3;RFC4;UBB
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.6621701604665473,-1.2991275943941418,0.09411764705882353,0.9380464363883121,1.0,6/29,9.24%,NR4A3;THBS1;OGN;STAT1;IL18;ID2
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.6240078351234352,-1.2990687470945401,0.08602150537634409,0.9359963331678607,1.0,14/72,10.66%,TNFRSF11B;HHIP;CHI3L1;SH3PXD2B;VCAN;TGFB2;SULF2;DDRGK1;PAPSS2;ETS2;ITGB8;TRPS1;EIF2AK3;COL10A1
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.49042350949095875,1.298782782736255,0.0,0.7950604109587949,1.0,10/65,7.50%,GCLC;FKBP9;MYO1D;DAB2IP;HID1;TSPAN15;LGR4;DAG1;DDR1;UNC5B
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.7977984024817981,1.2978293427619279,0.13333333333333333,0.7958911899373421,1.0,4/7,14.38%,MSN;RAP2A;CDC42;OPHN1
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.8664881563206368,-1.2977687544267604,0.09836065573770492,0.945034893647175,1.0,1/5,8.64%,GSTM3
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.5125200757842258,1.297691141906264,0.15,0.7932943629483195,1.0,4/22,6.63%,ACTA2;MRC2;TPM2;CXCL12
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.778511882088298,-1.2968125646494046,0.08333333333333333,0.9518406903527419,1.0,3/13,5.14%,SRGN;ASPN;CCL3
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.8077371377482672,-1.2967190803915576,0.11428571428571428,0.9499473985859368,1.0,2/9,4.49%,PLPP3;DEGS2
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.8064305224902188,-1.295186893418687,0.0759493670886076,0.9617307048398844,1.0,1/10,0.52%,KMO
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.6552784476326862,-1.2949082980210582,0.14814814814814814,0.961912250845999,1.0,3/27,1.62%,DDIT4;CEMIP;CHI3L1
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.760957273350575,-1.2946669793380063,0.1267605633802817,0.9614646528335292,1.0,2/8,5.18%,ALOX12;ALOX15B
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.78663090488725,-1.2945080519486434,0.1527777777777778,0.9603427962861297,1.0,2/10,8.90%,TGFB2;LAMB1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.7913704676692302,-1.2939814474884095,0.09333333333333334,0.9627010673604184,1.0,2/8,5.65%,VIM;NOD2
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.7903878193791771,-1.2936320438109106,0.09090909090909091,0.9633019170434676,1.0,4/12,18.11%,PRKAR2B;AKAP12;AKAP6;CALCR
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.8227073295636813,1.2932047236031643,0.25,0.8080667549092987,1.0,3/5,11.16%,DNMT3A;CTCF;MECP2
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),0.7531611335882306,1.2930164287611141,0.16666666666666666,0.8057925970081705,1.0,5/6,24.34%,SETD1B;KMT2B;KMT2A;KMT2D;SETD4
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.8665998553352955,-1.2929873445378943,0.046153846153846156,0.9670571593586984,1.0,2/7,7.35%,SLC2A3;SLC2A9
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.6073695161828685,-1.292610280544831,0.030612244897959183,0.9678665980965161,1.0,33/127,14.27%,CLEC12A;CCL4;ADGRE1;RGS1;RGS2;JAML;SIRPB2;VCAN;IFITM3;C5AR1;MX1;TNFRSF1B;SELL;CD163;CCL3;IFIT3;FCGR2B;FGR;CXCR4;IL10RA;CD36;MS4A6A;MNDA;TYMP;NCF4;FN1;FPR1;IFIT1;LSP1;VNN2;CD14;PYCARD;CD44
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.49695094579139765,1.2922315255296306,0.07692307692307693,0.8055740883573971,1.0,17/45,8.06%,PHLDB2;ZNF703;BCL9L;IL17RD;HPN;SPRED2;DAB2IP;SMAD7;SPRED1;PDPN;TGFB1;DAG1;TGFBR2;SPRY2;IL1B;GCNT2;USF3
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.6258257714926558,1.2921521605595088,0.18518518518518517,0.8028069345730657,1.0,3/12,10.47%,PPP1R16B;INPP5K;SRC
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.8463017043762044,1.2920236569296633,0.15151515151515152,0.8002321744578953,1.0,2/5,4.17%,PDPN;FSCN1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.699014940638837,1.2919797730501716,0.23333333333333334,0.7973756937093618,1.0,1/7,1.11%,PIK3C2B
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),-0.8107613313825976,-1.2915937107867625,0.18309859154929578,0.9742860689233942,1.0,1/7,2.39%,VCAN
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.6378573514382565,1.2914147173033967,0.19230769230769232,0.7965066259686947,1.0,1/10,4.33%,ITPA
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.7829893599532062,-1.2911802970777775,0.1875,0.9753684210848876,1.0,5/11,16.40%,H2BC11;RPL30;GAPDH;RPL39;GNLY
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.6328548598303737,-1.2909029607976859,0.0989010989010989,0.9752641607006631,1.0,12/61,7.83%,HTR2B;RGS2;PAQR3;FGF1;AGT;VEGFA;DUSP1;SPRY1;GSTP1;FLT1;NOD2;DIRAS2
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),-0.689949410290974,-1.2904841372198748,0.1282051282051282,0.9767800651903698,1.0,5/24,9.59%,SH3PXD2B;TGFB2;MEIS2;SCO2;PAX8
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.8000517238457158,1.289954251704891,0.14705882352941177,0.8005004925871054,1.0,1/6,3.17%,BAP1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.6291355404951108,-1.2894384525793496,0.06521739130434782,0.9845295390908789,1.0,32/69,25.58%,SULT4A1;PTN;RBM3;PLP1;GPM6B;IFI44;SRRM3;APLP1;PAK5;ADGRL3;MAPK4;IFIT1;PTPRZ1;STOX2;INAFM2;PHYHIPL;CTNND2;RND3;TAGLN3;S100A6;CLVS2;STMN2;GFAP;LY6H;MAP2;S100B;PARP12;CSRNP3;TMEM59L;LINGO1;GRIA2;CRMP1
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte mediated immunity (GO:0002887),0.7939277252255136,1.2891848755910496,0.19444444444444445,0.8011970964863011,1.0,2/5,2.17%,LGALS9;CX3CR1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,-0.6032684270455269,-1.28902677535338,0.010101010101010102,0.9857207127907203,1.0,56/119,28.06%,TMEM163;SULT4A1;NEFL;BRINP1;CHN1;MAP1B;ANK2;GPM6B;KIF1B;LNPK;ERC2;APLP1;PAK5;ADGRL3;MAPK4;GDAP1L1;NEFM;KCNC1;LINGO2;SH3GL2;TAGLN3;SNAP25;SYT1;SYT4;CLVS2;RELN;KCNH7;SRGAP3;EPHA7;SLC25A36;STMN2;MAP9;ST8SIA3;KIF5A;NRG1;CADM2;DYNC1I1;KIF5C;MAP2;INSYN2A;CSRNP3;TMEM59L;RIPOR2;LINGO1;GRIA2;FAM171B;CACNA1B;NOVA1;CRMP1;NDRG4;CNTNAP2;REEP2;PNMA2;EDIL3;ABI2;NCAN
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),-0.77865214976049,-1.288887816385254,0.15625,0.9840567957085913,1.0,2/7,8.95%,NR4A3;UGCG
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.6387099480594824,-1.2886866480631243,0.06666666666666667,0.9834457920855931,1.0,33/65,26.37%,PTN;FAIM2;PCDH17;ANK2;PLP1;SPARCL1;GPM6B;CCDC3;ADGRL3;MAPK4;DAAM2;PTPRT;NRXN1;APOD;PTPRZ1;PTPRD;ALDH1A1;PHYHIPL;RCAN2;CHL1;CNTN1;THY1;TSPAN7;STMN2;GPRC5B;PLPPR4;GFAP;CRYAB;S100B;LINGO1;SORBS1;CADM3;AQP4
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),-0.8501938795531598,-1.2884372525353056,0.078125,0.9836615763791399,1.0,1/6,2.56%,VEGFA
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.827725139994298,-1.2879214131046732,0.1388888888888889,0.9861475955912558,1.0,2/6,16.64%,RBX1;FBXL7
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.8547464076711282,1.287739833637367,0.15384615384615385,0.8037075459936953,1.0,2/7,3.83%,GSN;PDPN
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.790505814927613,-1.2872660276117232,0.13333333333333333,0.989102961764484,1.0,3/8,12.31%,RAB7B;RSAD2;GRAMD4
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.7758531026358174,-1.2867928440516418,0.09333333333333334,0.9909855186854396,1.0,5/16,8.01%,HTR2B;CHRM5;AGT;TSHR;HTR7
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.629370037736255,-1.2867227472885867,0.031914893617021274,0.9892136820215921,1.0,19/75,22.47%,THBS1;RPS4X;EIF4A3;VIM;PRR16;RBM3;RPS9;POLR2G;RPL5;PKM;EIF3E;EIF3D;EEF2;RPS6KB2;C1QBP;UPF3A;YBX3;SOX4;RCC1L
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.8021211661609642,1.2861992299383167,0.1935483870967742,0.8074645568422453,1.0,5/7,17.39%,RUBCNL;PIP4K2B;PLEKHM1;ATP13A2;ARL8B
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.7093290880871433,-1.285947302080597,0.15789473684210525,0.9938609711945651,1.0,7/15,22.79%,MAPT;HDGFL3;FGF13;STMN3;STMN1;STMN2;CKAP5
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.8434104620112735,-1.2858414627016306,0.09090909090909091,0.9921385381305574,1.0,2/7,3.27%,MYLK;RBPJ
prerank,GO_Biological_Process_2021__gamma-delta T cell activation (GO:0046629),-0.8508021151654064,-1.2856140400932392,0.14516129032258066,0.9919002577425877,1.0,2/5,11.38%,JAML;TCF7
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),-0.858849180383452,-1.2854499270943804,0.2153846153846154,0.9904525267025227,1.0,1/6,1.66%,NUDT16
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.6478030182046097,1.285403817290134,0.0625,0.807667074775335,1.0,8/16,11.85%,MAP3K10;DAB2IP;MAP3K5;MAP3K4;MAP3K11;DVL2;TRAF6;DVL3
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.6843084580767224,1.2853269222032528,0.29545454545454547,0.8050223764168117,1.0,5/7,31.55%,LIG4;RNF168;RNF8;EXOSC6;MSH2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.7144125335483722,-1.2852553547322147,0.14102564102564102,0.9897460922419304,1.0,8/16,17.27%,JPH1;CACNB2;PLN;ANK2;DMD;AHNAK;CAV3;CALM1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.3944314532842067,1.2844428285480893,0.0,0.8048150431736082,1.0,13/60,7.59%,SELPLG;LYL1;TAL1;SH2B3;CEBPA;CSF1R;TGFB1;RUNX1;TGFBR2;WNT2B;PLD4;TP53;JAG1
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.6798521517104655,-1.2838080031385697,0.075,1.0,1.0,11/32,15.60%,RPS27A;DTL;RPA2;UBA52;TRIM25;RFC1;UBC;RPA3;USP43;RFC4;UBB
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.6097658010601417,1.2836936957408467,0.19230769230769232,0.8045260527050052,1.0,3/15,5.53%,ARV1;PRKAB2;NPC2
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.5978138804906468,-1.2836056774200089,0.07,0.9988282623644515,1.0,23/105,15.28%,TFRC;NR4A1;FOS;RHOB;RXRB;TUBA4A;CCK;HTR7;JUNB;HLA-F;ATF3;ENO2;HSPA2;IRF1;OLFM1;MGAT1;DGAT1;GRINA;AP2S1;PTPRD;ABCB1;RFC4;TAP1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),-0.8866945858302888,-1.2828005471581692,0.07462686567164178,1.0,1.0,1/5,1.99%,FGF1
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.6212728769745379,-1.282403326679662,0.052083333333333336,1.0,1.0,45/81,30.47%,MEIS2;AMER2;DIRAS2;SLC17A7;TRPM3;PAK5;TMEM130;NRXN1;GRIA4;BSN;FRRS1L;KCNC1;PHYHIPL;SNAP25;UNC13A;GABRG2;KCTD16;GRM3;SCN1A;CLVS2;SCN3B;STMN2;GAD2;ST8SIA3;GRIN2A;NTRK3;GABRA2;SLC1A2;CADPS;CSRNP3;CA10;GRIA2;CACNA1B;MAGI2;NDRG4;SRRM4;NCAN;TMEM132B;SCN2A;SLC6A1;ASIC2;PPFIA2;ATCAY;GABRA1;LSAMP
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.7606531939736267,-1.282169974366584,0.16176470588235295,1.0,1.0,5/13,11.46%,SLC51A;ATP8B1;SLCO1A2;ABCC3;SLC10A1
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),0.4827226198053227,1.2819493505812427,0.07692307692307693,0.8085458060079157,1.0,2/36,1.70%,NUP42;NUP188
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.7192081371724923,-1.2816708714394112,0.1,1.0,1.0,7/22,17.39%,CD55;C5AR1;CR1;FCGR2B;C5AR2;SERPING1;CLU
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.5879617788870031,1.281390832728834,0.14814814814814814,0.8078744316624452,1.0,4/17,8.00%,ICAM1;SEMA4D;SYK;MSN
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.7049954810172064,1.2813848951698408,0.25,0.805110435329807,1.0,3/6,15.28%,STIM1;HOMER1;CD84
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.7526329821873659,1.2813092831637587,0.11764705882352941,0.8023655669994708,1.0,2/8,5.06%,SESN2;SESN3
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.6292257088286289,-1.281209161991473,0.0898876404494382,1.0,1.0,11/52,14.34%,TFRC;MACC1;CYP3A5;ATP5MK;COBL;TRHDE;ITGB8;CFTR;PDZD2;SLC16A7;INSR
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.7394050132525017,-1.2811184699973985,0.2222222222222222,1.0,1.0,1/12,1.34%,NEK11
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.7695606475798737,-1.281103627888584,0.13157894736842105,1.0,1.0,3/13,5.14%,SRGN;RBPJ;CCL3
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),-0.8466345762976147,-1.2805122753587994,0.16666666666666666,1.0,1.0,1/5,7.87%,IL15
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.7975843401534609,-1.2805030439311615,0.12,0.9980043846280501,1.0,4/9,5.45%,H1-3;H1-4;H1-2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.7975843401534609,-1.2805030439311615,0.12,0.9980043846280501,1.0,4/9,5.45%,H1-3;H1-4;H1-2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.7975843401534609,-1.2805030439311615,0.12,0.9980043846280501,1.0,4/9,5.45%,H1-3;H1-4;H1-2;H1-0
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.6056939514236437,1.2802320209111893,0.15789473684210525,0.8038052693541384,1.0,3/15,12.08%,RAB33B;MAP2K1;MAP2K2
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.6213596818683408,-1.2801834270772718,0.020618556701030927,0.997967016736306,1.0,30/120,12.74%,NAMPT;ADGRE1;CD55;TACR1;RGS1;OSMR;ACVR1B;RNF144B;GPR183;HIF1A;C5AR1;IL7R;TNFRSF1B;CD69;SELL;NOD2;MARCO;IL15;SLC31A2;IL10RA;IL18;GPC3;ITGB8;MXD1;KIF1B;PDE4B;IRF1;FPR1;EMP3;ABCA1
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.7197653305162819,-1.2800313910497771,0.15384615384615385,0.9967659696548846,1.0,4/19,5.63%,CGNL1;TGFB2;SPRY1;FBP1
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.8175597328709464,-1.2799750288888367,0.12698412698412698,0.9947511423547603,1.0,3/7,11.77%,NEK11;MAP3K12;INCENP
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.6309731498312978,-1.2793380604372795,0.1,0.9975153250305824,1.0,11/46,12.39%,HTR2B;THBS1;NR4A1;SPARC;VEGFA;HMGB2;HIF1A;STAT1;ATP5IF1;RGCC;ATP5F1A
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.8271817337133014,-1.2792501167333616,0.14084507042253522,0.9958935263619396,1.0,3/7,8.42%,MAPT;PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.8420000660422933,-1.2789902197501872,0.2222222222222222,0.9959294625486688,1.0,3/6,12.07%,VEGFA;NR4A2;MANF
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.65571685706229,-1.2784412405680756,0.1111111111111111,0.998152427271081,1.0,6/35,8.88%,THBS1;CBR1;AGT;BRCA1;PINK1;PDK3
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.6746145010671439,-1.2781960471451135,0.07058823529411765,0.9980478453924848,1.0,5/29,9.24%,NR4A3;THBS1;STAT1;IL18;ID2
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.8082119153715113,-1.2781821378970806,0.18571428571428572,0.9958118334417998,1.0,2/6,3.53%,MDH1;ME1
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),-0.8382351058975251,-1.2781543944509783,0.09210526315789473,0.9936535831758978,1.0,2/8,8.53%,GPR183;CXCR4
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.87966249616397,-1.2775164477570642,0.125,0.9964192880388739,1.0,2/5,7.80%,HIF1A;PINK1
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),-0.8416772863068935,-1.277048192508188,0.15254237288135594,0.9981915148039191,1.0,1/5,5.03%,NR4A2
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.8849716261316782,-1.2769878353819486,0.109375,0.9962429711042916,1.0,2/5,8.26%,CLDN18;CLDN20
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),-0.8225940773958658,-1.2769618280469037,0.06060606060606061,0.9940817960990519,1.0,2/8,5.18%,APOLD1;ALOX15B
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.6327845868236451,-1.276653568427428,0.033707865168539325,0.994674367797626,1.0,16/66,21.60%,THBS1;RPS4X;EIF4A3;VIM;PRR16;RBM3;RPL5;EIF3E;SIRT3;EIF3D;NSMAF;CLU;EEF2;UPF3A;SOX4;RACK1
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.6300929481583204,-1.2765444286097947,0.047058823529411764,0.9934761517988226,1.0,15/55,16.42%,SOCS3;OSMR;ACVR1B;TNFRSF1B;IL7;MAP3K8;STAT1;CD36;IRF1;CD14;CD44;TLR2;TNFRSF21;STAT2;IL3RA
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.7515976990701535,-1.2764803918097969,0.21739130434782608,0.9916889049569055,1.0,2/12,5.45%,HMGB2;H1-0
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.7062410775387628,-1.2764215368703287,0.10810810810810811,0.9898879992576045,1.0,7/26,16.82%,RPS27A;VIM;UBA52;CFTR;UBC;UBB;ATG5
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),-0.7744570229853501,-1.2763693600591917,0.14285714285714285,0.9879639264985457,1.0,2/8,8.47%,PRKAR2B;PKIA
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.895283029042234,-1.2763616178664245,0.10144927536231885,0.9856988428778523,1.0,1/5,0.27%,NR4A3
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.6939342593349686,-1.2756265230238422,0.11392405063291139,0.9900118624380028,1.0,2/17,2.89%,THBS1;TGFB2
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.6632530317435762,1.2754658156470942,0.2857142857142857,0.8174855574199698,1.0,4/9,18.70%,RAPGEF6;RAP2C;AFDN;RAB1B
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.7423512998828136,-1.2753211020572461,0.16417910447761194,0.9903430246975511,1.0,2/9,6.75%,IHO1;ZCWPW1
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),-0.6995461223230314,-1.2750361173011129,0.13253012048192772,0.9905423498567012,1.0,3/22,2.70%,HTR2B;SEMA6A;SEMA3A
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.6275343488699983,-1.2736357112179242,0.053763440860215055,1.0,1.0,17/76,18.07%,THBS1;RPS4X;EIF4A3;VIM;AGT;PRR16;VPS11;RBM3;NR1H2;RPL5;UHRF1;RDX;EIF3E;EIF3D;ASPSCR1;KLF4;ASPH
prerank,GO_Biological_Process_2021__negative regulation of mast cell activation involved in immune response (GO:0033007),0.8218046332580902,1.2735366577611797,0.2962962962962963,0.8212566515169887,1.0,2/5,1.27%,LGALS9;FER
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.7029226507151982,-1.2726508171810074,0.16666666666666666,1.0,1.0,1/18,0.33%,SLC2A3
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.8420208189781071,-1.2717913551078328,0.10294117647058823,1.0,1.0,6/7,15.74%,RPS27A;UBA52;UBC;B2M;UBB;TLR2
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.8420208189781071,-1.2717913551078328,0.10294117647058823,1.0,1.0,6/7,15.74%,RPS27A;UBA52;UBC;B2M;UBB;TLR2
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.5815708997332154,-1.271625049254284,0.0,1.0,1.0,76/291,16.01%,RPL23;RPL37A;RPL38;RPS4X;RPS27A;EIF4A3;RPL23A;RPS11;RPS25;RPS27;RPS20;RPLP2;RPS6;RPS18;RPL37;RPS24;RPL3;RPL32;RPL12;RPL11;RPL14;RPL35;RPS13;NR4A2;RPS12;RPS21;RPL36;RPS8;RPS3A;RPL9;RPL4;RPL28;RBM3;RPS23;RPL24;RPL31;RPLP1;RPS9;RPL30;POLR2G;COPS5;RPL10A;MRPL43;RPL13A;RPS14;RPL27A;RPL41;RPL21;RPL19;EEF1A2;PAX8;RPS15;RPL18A;RPL15;RPL39;MRPS7;RPL6;RPL5;RPS7;PTMA;RPS16;RPLP0;ANGPT2;RPL34;RPL7A;MRPL51;DARS1;TFIP11;RPS3;RPS2;SRSF5;AGFG1;EEF1A1;RPL8;TSPAN32;RPL27
prerank,GO_Biological_Process_2021__toll-like receptor 2 signaling pathway (GO:0034134),0.7552610322802162,1.2714869738533372,0.20588235294117646,0.8262550696261174,1.0,1/5,1.01%,LGALS9
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.7343184329717158,-1.2714319569709387,0.13846153846153847,1.0,1.0,1/11,0.27%,NR4A3
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.8752435394658282,-1.2699396301531078,0.14925373134328357,1.0,1.0,2/6,2.32%,GLRA1;MT2A
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),-0.8818030662472451,-1.2698482973583163,0.14285714285714285,1.0,1.0,1/5,0.47%,PRLR
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.6163519757629902,1.2695103815533044,0.14814814814814814,0.8315014726972197,1.0,9/14,20.75%,SLC25A18;PDPN;SLC46A1;ARL6IP5;FOLR2;SLC19A1;SLC1A3;GIPC1;SLC25A13
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.788124003773198,-1.2673130933601218,0.17142857142857143,1.0,1.0,2/8,5.14%,THBS1;CCL3
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.7291053720794333,-1.2673086038689068,0.14666666666666667,1.0,1.0,2/16,8.68%,FGF1;SOD1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.7329484004485539,-1.2673012917222048,0.07792207792207792,1.0,1.0,4/17,14.87%,THBS1;AGT;PYCARD;TRAF2
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.7726363408865456,-1.2672775803976137,0.15584415584415584,1.0,1.0,2/10,2.89%,RGS2;TGFB2
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.6439037509987926,1.2670443182097586,0.22727272727272727,0.8381977613438337,1.0,3/11,13.93%,HMGA1;BANF1;NUTF2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.6499964776515763,1.266591824549171,0.21212121212121213,0.8366864009996569,1.0,2/8,6.51%,CDC14B;BTRC
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),-0.834811211930511,-1.2665556291070479,0.17142857142857143,1.0,1.0,4/7,12.47%,C5AR1;CR1;C5AR2;FPR1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.719522821293016,1.266019120154809,0.2413793103448276,0.8355441117378106,1.0,2/7,11.49%,RAB7A;SERPINB9
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),-0.8430625219169738,-1.2659299008929514,0.13846153846153847,1.0,1.0,3/6,9.93%,HS3ST5;PROCR;THBD
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.7250876892280602,-1.265718100485554,0.1038961038961039,1.0,1.0,3/17,2.83%,OMD;VCAN;OGN
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.8541468378466701,-1.2656973804278313,0.14285714285714285,1.0,1.0,2/5,11.06%,TFRC;BNIP3
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.8234695424512786,-1.2654031788555575,0.11594202898550725,1.0,1.0,1/9,0.73%,THBS1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.5973503570703845,-1.265262616984894,0.04,1.0,1.0,56/118,26.42%,TMEM163;ENPP2;FA2H;ST18;OMG;OPALIN;CREB5;NFE2L3;FAIM2;AMER2;GALC;PLP1;MOBP;SPARCL1;GPM6B;KIF1B;ANLN;MOG;ERMN;MAPK4;PTPRT;NRXN1;EPHB1;MAG;ZDHHC9;PHYHIPL;ASPA;ADCY8;GRM3;ATP1B2;ATP2B2;SLC25A19;ST8SIA3;GPRC5B;TMEM178A;NINJ2;GFAP;TTYH1;LY6H;PEX5L;TF;ARSG;SLC1A2;SEC14L5;CA10;OLIG1;GRIA2;SORBS1;PDE8A;VSTM2B;ARRDC2;MYRF;MPPED1;CADM3;AQP4;NKX6-2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),-0.8625462167650407,-1.2649942049008085,0.09722222222222222,1.0,1.0,1/5,1.29%,CYCS
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.710157275527782,-1.2649759183865033,0.15942028985507245,1.0,1.0,7/18,16.23%,SLC51A;ATP8B1;SLCO1A2;ABCC3;SLC10A1;SLC16A1;STARD5
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.5929571016981208,-1.2649589966093584,0.061224489795918366,1.0,1.0,39/100,22.80%,SOCS3;VIM;FGF1;AGT;OPALIN;PTN;FAIM2;BRINP1;AMER2;TCEAL2;PLP1;SPARCL1;GPM6B;AANAT;HSPA2;MAPK4;DAAM2;NRXN1;PTPRZ1;PHYHIPL;RCAN2;SNAP25;ADCY8;SLC25A28;BAALC;ATP1B2;ATP2B2;STMN2;GPRC5B;TMEM178A;PLPPR4;GRIN2A;GFAP;CADM2;DIO2;LY6H;CRYAB;SLC1A2;S100B
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.7992986841579519,1.2649247729149262,0.2926829268292683,0.8367145972228016,1.0,2/5,10.14%,PIGT;PGAP1
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.7487404743402294,-1.264800791047242,0.11842105263157894,1.0,1.0,2/14,4.53%,KCNE1;PKP2
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.6125609384739984,-1.2645572346352951,0.1111111111111111,1.0,1.0,17/65,12.74%,SLC51A;OSBPL5;PRELID1;PLTP;ACSL1;ATP8B1;SLCO3A1;SLCO1A2;ABCA5;ABCC3;UGCG;CD36;ABCA9;PCTP;ABCA6;SLC10A1;ABCA1
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),0.6807286131303215,1.264511064398863,0.18518518518518517,0.835659075044654,1.0,1/8,1.00%,DR1
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.5352443234008228,1.2639287073864602,0.10344827586206896,0.8353211989527864,1.0,7/15,25.75%,LYST;PIKFYVE;RAB29;AP1M1;HPS4;DTNBP1;RAB32
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.726232540257781,1.263901285229232,0.3333333333333333,0.8327034340109186,1.0,3/7,14.02%,STK10;MSN;JAM2
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.6647967982874586,-1.2638992645632405,0.23170731707317074,1.0,1.0,6/26,10.22%,LRP2;CYP3A5;AKR1B1;RDH11;GPC3;GPC5
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.8743702562671988,-1.2638349699197131,0.07936507936507936,1.0,1.0,1/5,6.41%,BRCA1
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.6850671036653774,-1.2637779590938223,0.125,1.0,1.0,4/20,9.23%,SH3PXD2B;TGFB2;MEIS2;SCO2
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.6418555366100903,-1.2630182005596036,0.16455696202531644,1.0,1.0,1/26,0.28%,GLRA1
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.6298992261907616,-1.2629093189738336,0.14606741573033707,1.0,1.0,12/32,22.80%,PLTP;CATIP;ENKUR;TMEM232;NME9;HSPA2;DNAH12;PTPRT;DNAH7;RFX2;GFAP;S100B
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.5986067812969406,-1.2627829111882136,0.11458333333333333,1.0,1.0,24/91,13.06%,THBS1;TNC;MMP21;SPARC;VCAN;THSD4;ADAMTS2;ECM2;LAMA2;ADAMTS19;FBN2;ADAM15;COL11A1;MMP24;LAMB1;ITGB8;ITGAE;COL10A1;TGFBI;APLP1;COL4A5;FN1;COL23A1;ITGA2
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.6807506336144742,1.262456398198813,0.3103448275862069,0.8356717975669986,1.0,1/7,2.14%,TMEM119
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.7047260022953519,-1.2624464716987895,0.1875,1.0,1.0,6/22,14.70%,LRP2;AKR1B1;RDH11;GPC3;GPC5;ALDH1A1
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.7095274719545819,-1.2623350053588391,0.1267605633802817,1.0,1.0,3/17,5.39%,OMD;OGN;B4GAT1
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.7284628139544418,1.2616257220412963,0.25,0.8361580605869097,1.0,3/5,23.36%,SETD3;SETD2;SETD5
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,-0.592158250510078,-1.2611857933400608,0.0625,1.0,1.0,48/104,26.87%,PDE5A;SULT4A1;FAIM2;BRINP1;AMER2;TCEAL2;PDE1A;PLP1;CALY;KCNMA1;PAK5;RAB3C;NRXN1;GRIA4;GDAP1L1;BSN;KCNC1;CTNND2;CPLX1;SNAP25;GABRG2;GRM3;SYT4;GAD1;CLVS2;NRXN2;SYP;ATP1B2;SLC24A2;ATP2B2;STMN2;GAD2;ST8SIA3;KIF5A;CADM2;LY6H;TSHZ1;CADPS;CA10;HCN1;SHANK2;GRIA2;VSTM2B;CACNA1B;SLC24A3;CNTNAP2;SRRM4;CACNG2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.6715883965939065,-1.2611026381764152,0.16455696202531644,1.0,1.0,11/26,22.54%,TUBB4A;CLIP3;HDGFL3;FGF13;APC2;MID1IP1;TTBK2;STMN1;STMN2;EML2;MAP2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.5968141291903793,-1.2609653603481839,0.1276595744680851,1.0,1.0,19/70,21.25%,RPS27A;VEGFA;HIF1A;RBX1;EGLN3;LIMD1;UBA52;ATF3;PSMA3;UBC;PSMA5;PSMD8;UBB;PSMB4;IMPACT;ELOB;PSMD7;KLF2;PSMD5
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.6432098686567639,-1.260951759394271,0.18823529411764706,1.0,1.0,5/32,8.83%,ACVR1B;HMGB2;HIF1A;STAT1;HSPA1B
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.6646448730888856,-1.2606589106832575,0.15789473684210525,1.0,1.0,6/30,12.42%,GLRA1;ADCY3;ADAM15;BRCA1;CFTR;GRAMD1C
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.7163570451467535,1.2606275722178475,0.24242424242424243,0.8369917540828867,1.0,3/9,4.71%,ZNF703;CSF1R;SCRIB
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.7253918571053647,-1.2605636609360267,0.13333333333333333,1.0,1.0,2/15,4.93%,NUDT16;RPS13
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.7318859165098178,1.2604519978252455,0.20588235294117646,0.8349076476552874,1.0,2/5,13.17%,RAP1A;KIDINS220
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.5749244460987576,1.2604147767015774,0.125,0.832372712333908,1.0,2/17,7.22%,NDE1;SLAIN2
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.49453837852525545,1.260386359524554,0.0,0.8297385568400689,1.0,5/38,6.03%,SESN2;FER;SPRED2;SPRED1;PPP1R16B
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),-0.619446675552766,-1.2599358413268598,0.16091954022988506,1.0,1.0,17/39,24.27%,STXBP6;CFTR;RAB3A;NSF;RAB2B;RAB3C;IL1RAPL1;RAB15;CPLX1;STXBP5L;SYT1;RAB5A;RAB21;SEPTIN4;CADPS;RAB3D;RIMS2
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.8277940911121286,-1.2597154718741934,0.2028985507246377,1.0,1.0,2/5,8.17%,FBN2;LTBP1
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.6397884664451455,-1.2597000001479808,0.12941176470588237,1.0,1.0,13/35,17.09%,RPS27A;FANCB;XRCC3;FANCI;RPA2;FANCM;UBA52;UBC;FAN1;RPA3;WDR48;UBB;SLX4
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.5712909077372512,-1.2596220696036038,0.050505050505050504,1.0,1.0,65/166,27.18%,GLRA1;HTR2B;CHRM5;NAPA;PRKAR2B;GRIK1;RIMS1;CACNB2;HTR7;PLP1;SDCBP;KIF1B;SLC17A7;ERC2;SST;RAB3A;NLGN3;NRXN1;GRIA4;GABRA3;BSN;HTR1F;GABRB1;CDH8;CPLX1;SPG11;SNAP25;UNC13A;SYT1;GABRG2;GRM3;CALM1;GAD1;AMPH;NRXN2;GABRB3;PMP22;RPS6KA2;CBLN2;GAD2;GRIN2A;DVL1;KIF5A;GABRA2;UNC13C;KCNMB1;SLC1A2;CHRM2;NRGN;PRKACB;AKAP9;GRIA2;CACNA1B;NOVA1;NLGN2;NAAA;CHRM3;CRHBP;GABBR2;GRIK2;SLC12A7;GRIK4;CAMK4;GABRB2;HRH2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),-0.7837785081852939,-1.259520109543128,0.2112676056338028,1.0,1.0,1/7,0.27%,NR4A3
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.4656548865532305,1.2595078255154886,0.08333333333333333,0.8310052474017995,1.0,12/49,17.15%,CSF1R;CBFB;MED24;AGO1;TP53;MED27;MECP2;MITF;MOV10;CCND1;TCF7L2;MED4
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.6361426630878686,-1.2592277753478411,0.0963855421686747,1.0,1.0,8/41,11.57%,DIAPH3;CATIP;COBL;MAPT;HDGFL3;FGF13;MID1IP1;PSTPIP2
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.6892449229645772,1.2591760813519162,0.2222222222222222,0.8265608384143802,1.0,4/10,19.09%,OCRL;INPP5K;INPP1;SYNJ1
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.6892449229645772,1.2591760813519162,0.2222222222222222,0.8265608384143802,1.0,4/10,19.09%,OCRL;INPP5K;INPP1;SYNJ1
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.46246316645127794,1.2586266017550962,0.1111111111111111,0.8226668876903075,1.0,6/47,12.23%,NUP42;NUP188;AGO1;POLR2C;NUP214;RAE1
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.46246316645127794,1.2586266017550962,0.1111111111111111,0.8226668876903075,1.0,6/47,12.23%,NUP42;NUP188;AGO1;POLR2C;NUP214;RAE1
prerank,PanglaoDB_Augmented_2021__Platelets,-0.5942307768829658,-1.2581407189850353,0.04040404040404041,1.0,1.0,31/143,13.81%,CLEC12A;SLC2A3;SRGN;THBS1;PRKAR2B;F13A1;JAML;SIRPB2;SPARC;VEGFA;ALOX12;CD93;THEMIS2;TNFRSF1B;CD69;SELL;ERO1A;NOD2;FHL1;FGR;CXCR4;CD36;MNDA;CARD16;NCF4;FPR1;LSP1;ITGA2;PALLD;HCLS1;VNN2
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.8437792976082824,-1.2581054950531176,0.14084507042253522,1.0,1.0,2/6,4.99%,ATP8B1;MAL
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),0.4776353448661759,1.257926063442402,0.07142857142857142,0.8226115850927674,1.0,2/34,1.70%,NUP42;NUP188
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.7502184913657165,-1.257778032056944,0.21794871794871795,1.0,1.0,2/10,8.53%,GPR183;CXCR4
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.6000640947296465,-1.2577565030898443,0.14444444444444443,1.0,1.0,9/53,10.22%,HS3ST2;CEMIP;OMD;VCAN;OGN;HS3ST5;B4GAT1;GPC3;GPC5
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.7819713620969888,-1.257592634946768,0.2077922077922078,1.0,1.0,1/7,5.00%,CFL1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.651116754152322,-1.257286643152728,0.1724137931034483,1.0,1.0,6/35,17.47%,THBS1;VEGFA;BEX3;CARD16;CD44;KLF4
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.671527019721496,-1.2570386008150116,0.10126582278481013,1.0,1.0,3/25,12.74%,OSBPL5;ABCA5;ABCA1
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.45819790896977314,1.2568603141685453,0.08333333333333333,0.8235750238248029,1.0,11/49,17.15%,CSF1R;CBFB;MED24;AGO1;TP53;MED27;MECP2;MOV10;CCND1;TCF7L2;MED4
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.7312894908180592,-1.2565230029117769,0.17567567567567569,1.0,1.0,5/12,10.57%,CACNB2;GNB5;DMD;AHNAK;PDE4B
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.6894684647783165,-1.2562105373379422,0.17721518987341772,1.0,1.0,11/17,27.24%,IFITM3;AIM2;STAT1;MNDA;IRF1;PLSCR1;XAF1;PYHIN1;PNPT1;HTRA2;OAS1
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.6625539214238835,1.256080440903778,0.21739130434782608,0.8238179763763479,1.0,5/11,25.16%,PKD2;KRT10;FARSA;CPSF7;FARSB
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.7627655721445323,1.2560265860415092,0.2571428571428571,0.8215107925995278,1.0,3/5,15.64%,PHACTR4;ARHGAP12;NOTCH1
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.582022419200601,-1.2554256574648075,0.1368421052631579,1.0,1.0,32/98,25.18%,RPS27A;H2BC11;HMGB2;CENPV;RBX1;RPA2;UBA52;PSMA3;UBC;PSMA5;RPA3;ERCC2;H2BC9;PSMD8;UBB;PSMB4;ORC6;H2BC5;MCM3;DDB1;MCM6;PSMD7;MCM7;PSMD5;SART3;PSMC2;NAP1L2;TCF4;XPA;MCM5;PSMB9;PSMB2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.8011107901318386,-1.2551132311935622,0.1232876712328767,1.0,1.0,2/8,8.63%,NR4A3;DOCK5
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.7177109983756793,1.2549801739400206,0.2972972972972973,0.8220576133814305,1.0,5/8,23.79%,TMEM119;NOTCH1;HDAC5;BHLHE41;HDAC1
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.7656424878357662,-1.2544763870741502,0.1282051282051282,1.0,1.0,1/12,0.73%,THBS1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.5962557605920445,-1.2544563513553812,0.09574468085106383,1.0,1.0,39/82,26.37%,FAM13C;FGF1;AGT;PTN;NDRG1;FAIM2;CLIP3;ANK2;PLP1;SPARCL1;HSPA12A;MAPK4;DAAM2;APOD;CTHRC1;MAG;PHYHIPL;LRP4;RCAN2;ASPA;CPE;THY1;SEPTIN9;STMN1;PMP22;GPRC5B;TMEM178A;PLPPR4;GFAP;MATN2;CRYAB;S100B;OLIG1;GRIA2;SORBS1;SEMA3B;CADM3;NDRG4;AQP4
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.7683841190470411,-1.2538961954818915,0.15942028985507245,1.0,1.0,2/8,12.89%,IL7R;PTPRT
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.6409963428477652,1.253837545565991,0.1935483870967742,0.8236065741970684,1.0,3/12,9.65%,FGL1;LAPTM5;DUSP3
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),-0.7551925265398467,-1.2538318270595556,0.18571428571428572,1.0,1.0,3/7,14.59%,DPYD;PAICS;PRPS1
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.8189518048039224,-1.2531309667516919,0.11842105263157894,1.0,1.0,1/6,8.53%,CXCR4
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.8189518048039224,-1.2531309667516919,0.11842105263157894,1.0,1.0,1/6,8.53%,CXCR4
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.6524884798832513,-1.252915173628834,0.12658227848101267,1.0,1.0,10/35,16.51%,NR4A3;CYCS;ETFB;NDUFS8;UQCRC1;ATP5F1D;UQCR10;UQCRB;NDUFS7;SIRT3
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.5893962034363102,-1.2528620231009684,0.08045977011494253,1.0,1.0,38/81,25.55%,FAM13C;AGT;UNC5C;PCDH17;PPP1R9A;ANK2;SPARCL1;SYBU;SST;ADGRL2;PXK;PAK5;MAPK4;PTPRT;LIFR;NRXN1;STOX2;PTPRD;PHYHIPL;RCAN2;SNAP25;CNTN1;CPE;SYT4;NFIB;MAPK10;STMN2;ASXL3;ST8SIA3;ETV1;PLPPR4;MAP2;LMO3;CSRNP3;LONRF2;GRIA2;NOVA1;FGF14
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.6691272748581141,1.252667526366077,0.22580645161290322,0.8246631736840363,1.0,4/10,18.33%,PUS10;SMAD2;SRRT;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8276341165869777,-1.2521978093712218,0.1206896551724138,1.0,1.0,3/7,5.80%,THBS1;SEMA6A;EPN1
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.8486240496840441,1.252169371968984,0.08695652173913043,0.8209640138063893,1.0,1/6,0.22%,GCLC
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.8486240496840441,1.252169371968984,0.08695652173913043,0.8209640138063893,1.0,1/6,0.22%,GCLC
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.665611306912481,1.2518180634965452,0.25806451612903225,0.8202902680523173,1.0,2/7,12.42%,USP30;PEX5
prerank,GO_Biological_Process_2021__positive regulation of gliogenesis (GO:0014015),-0.8466365074249649,-1.2516745386983654,0.13793103448275862,1.0,1.0,1/5,1.51%,LRP2
prerank,PanglaoDB_Augmented_2021__Immature Neurons,-0.5720984291902638,-1.2516353479134412,0.08080808080808081,1.0,1.0,35/96,21.27%,SULT4A1;AMER2;ANK2;LRRC4C;GPM6B;KIF1B;EPHA3;EFR3B;ERC2;PAK5;ADGRL3;MAPK4;RAB3C;NRXN1;GRIA4;GDAP1L1;BSN;KCNC1;PHYHIPL;CTNND2;SNAP25;UNC13A;GRM3;SYT4;CLVS2;SCN3B;ATP1B2;ROBO2;EPHA7;STMN2;GAD2;ST8SIA3;KIF5A;CADM2;NTRK3
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.8222118601947519,-1.2515723894036879,0.13157894736842105,1.0,1.0,1/7,0.77%,GLA
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.7318217261966445,-1.251330911168714,0.18421052631578946,1.0,1.0,4/10,12.27%,H2BC11;GSTP1;CCDC3;CARD16
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor internalization (GO:0098884),-0.8818210723794595,-1.251164976475064,0.07462686567164178,1.0,1.0,2/5,3.72%,MX2;MX1
prerank,GO_Biological_Process_2021__postsynaptic endocytosis (GO:0140239),-0.8818210723794595,-1.251164976475064,0.07462686567164178,1.0,1.0,2/5,3.72%,MX2;MX1
prerank,GO_Biological_Process_2021__folic acid transport (GO:0015884),0.8077507598784194,1.2508960118180052,0.1951219512195122,0.8212707156274325,1.0,5/5,19.26%,PDPN;SLC46A1;FOLR2;SLC19A1;ABCC5
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.6894847183506554,-1.2508200518704373,0.1951219512195122,1.0,1.0,5/20,19.86%,CLDN18;CLDN20;MPP7;PDCD6IP;MICALL2
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.47627215434401715,1.2507314346939251,0.1111111111111111,0.8194670089657832,1.0,6/47,12.38%,NUP42;NUP188;NUP214;NSMCE2;RAE1;UBA2
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.6299418890932175,-1.2507013080594716,0.1686746987951807,1.0,1.0,10/47,3.75%,PDE5A;VIM;PLPP3;ASPN;SPARC;VEGFA;ADAMTS2;TNS1;ECM2;LAMA2
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.7834354164837829,-1.2506023501548393,0.16666666666666666,1.0,1.0,2/7,9.51%,TGFB2;NOTCH2
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.6915069250784842,-1.2506008261375592,0.24242424242424243,1.0,1.0,1/13,0.27%,NR4A3
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.5727486909811571,-1.2505273007253084,0.05102040816326531,1.0,1.0,37/149,20.90%,ENPP2;ARAF;PLIN2;OMD;TALDO1;MYLK;ETFB;DNAJB9;ME1;ATP1B3;ITSN1;SOD1;UQCRC1;CD36;SPARCL1;LIPE;UBC;PIM3;UQCR10;DGAT1;ABCA1;LIFR;PFKFB3;PGM1;MGLL;GPD2;GHITM;BCL6;PDCD4;VEGFB;CMPK1;REEP5;NKIRAS1;SLC66A3;FAH;PFKL;NABP1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.6014441269224209,-1.250224107714606,0.11956521739130435,1.0,1.0,10/58,14.27%,NLRP12;THBS1;CYCS;VEGFA;BEX3;DAPK1;CARD16;GRAMD4;PYCARD;CD44
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.6675833101270159,-1.2501970996132319,0.13924050632911392,1.0,1.0,5/26,9.23%,SH3PXD2B;TGFB2;MEIS2;FBN2;SCO2
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),-0.7820407712786148,-1.2499479787733778,0.16666666666666666,1.0,1.0,4/8,20.49%,FCGR2B;MNDA;TNFRSF21;CD300A
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.6533386381241765,-1.249776828266423,0.13333333333333333,1.0,1.0,7/29,9.44%,THBS1;CBR1;AGT;GSTP1;MAPT;SOD1;CD36
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 7 signaling pathway (GO:0034155),-0.8308233691187104,-1.2497050387058837,0.18840579710144928,1.0,1.0,1/5,3.11%,RSAD2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),-0.8308233691187104,-1.2497050387058837,0.18840579710144928,1.0,1.0,1/5,3.11%,RSAD2
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.688031389025813,1.249524992311559,0.2647058823529412,0.8216829671601796,1.0,3/6,18.73%,IL1B;RPS6KA4;FMR1
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.6245675715499678,-1.2494556636799747,0.13333333333333333,1.0,1.0,2/51,0.94%,DDIT4;ARAF
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),-0.7385100348307325,-1.2491034392008138,0.1891891891891892,1.0,1.0,2/9,12.14%,GK;DGAT1
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.6455139398196519,-1.2489795029794575,0.1686746987951807,1.0,1.0,12/36,15.60%,RPS27A;DTL;RPA2;BRCA1;UBA52;TRIM25;RFC1;UBC;RPA3;USP43;RFC4;UBB
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.7010672334543674,-1.2487118544678233,0.18292682926829268,1.0,1.0,7/14,25.45%,RIMS1;SHANK3;NLGN3;NRXN1;RELN;RIMS2;NLGN2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),-0.7412605926680392,-1.24833426811374,0.16216216216216217,1.0,1.0,5/12,8.66%,NOD2;SLC7A5;IL15;PRKCQ;IL18
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.8306539045310932,-1.2483241918710957,0.203125,1.0,1.0,2/5,11.86%,TRIM25;OAS3
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.73620025978572,-1.248302753146126,0.1527777777777778,1.0,1.0,6/12,17.39%,AQP11;FCGR2B;NR1H2;EIF2AK3;MANF;CLU
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.628182118561196,-1.2471041498825663,0.13978494623655913,1.0,1.0,8/52,3.82%,THBS1;FGF1;SPARC;AGT;VEGFA;RHOB;GLUL;PTN
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.7381539180660065,-1.2470471536929186,0.14285714285714285,1.0,1.0,1/15,0.24%,GPR18
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.6661716015314039,-1.2470442728708164,0.175,1.0,1.0,5/20,14.87%,CD55;HLA-B;HLA-F;B2M;TRAF2
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.6850088173367269,-1.2465998753632037,0.18518518518518517,1.0,1.0,2/22,2.89%,HTR2B;TGFB2
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),-0.811395563347749,-1.2463418439795855,0.1917808219178082,1.0,1.0,2/7,3.27%,TGFB2;RBPJ
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.6904769201246133,-1.2462697743198248,0.22058823529411764,1.0,1.0,3/14,9.25%,NR4A3;CLIP3;APPL1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.5661490491675952,-1.2462232369630775,0.1134020618556701,1.0,1.0,53/124,27.18%,GLRA1;HTR2B;CHRM5;PRKAR2B;GRIK1;CACNB2;HTR7;PLP1;SDCBP;SST;NLGN3;NRXN1;GRIA4;GABRA3;BSN;HTR1F;GABRB1;CPLX1;SPG11;SNAP25;SYT1;GABRG2;GRM3;CALM1;GAD1;AMPH;NRXN2;GABRB3;PMP22;RPS6KA2;GAD2;GRIN2A;KIF5A;GABRA2;UNC13C;KCNMB1;SLC1A2;CHRM2;NRGN;PRKACB;AKAP9;GRIA2;CACNA1B;NOVA1;NLGN2;CHRM3;GABBR2;GRIK2;SLC12A7;GRIK4;CAMK4;GABRB2;HRH2
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.5739582566671004,1.2461111855849765,0.2,0.8317688791883384,1.0,2/14,8.90%,GSN;SHTN1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.6376383894071688,-1.2460146782177566,0.16666666666666666,1.0,1.0,6/30,6.06%,RGS1;CHRM5;ADCY3;AKAP12;GRM8;MARCO
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.8416791366236631,-1.2451754309531786,0.10294117647058823,1.0,1.0,3/5,10.94%,SAT1;SAT2;AANAT
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.8498613278474689,-1.2451151962675975,0.14492753623188406,1.0,1.0,1/6,2.32%,MT2A
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.793542758392042,-1.244999508532128,0.17391304347826086,1.0,1.0,1/7,1.11%,RGS2
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.5919246124187328,-1.2448179524363074,0.11458333333333333,1.0,1.0,24/93,13.06%,THBS1;TNC;MMP21;SPARC;VCAN;THSD4;ADAMTS2;ECM2;LAMA2;ADAMTS19;FBN2;ADAM15;COL11A1;MMP24;LAMB1;ITGB8;ITGAE;COL10A1;TGFBI;APLP1;COL4A5;FN1;COL23A1;ITGA2
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.7947541420951516,-1.2447611751198588,0.2,1.0,1.0,1/10,0.99%,INSIG1
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.6288872432361111,-1.2445991772086695,0.14606741573033707,1.0,1.0,8/39,18.93%,NUDT12;NUDT16;SIDT2;HSPA1B;RIDA;RNASET2;DNA2;LSM5
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.6221546602537487,1.2445701741147557,0.23809523809523808,0.8346580360697125,1.0,1/9,2.11%,CD180
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.6902979655130859,-1.2441911827990233,0.20253164556962025,1.0,1.0,2/18,6.12%,CEMIP;ANK3
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.689353693681782,-1.244103286469261,0.15294117647058825,1.0,1.0,7/25,12.95%,KCNE1;DUOX1;STAT1;CFTR;AANAT;VGF;AKAP6
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.6170902509916516,-1.2438101300629052,0.12790697674418605,1.0,1.0,30/61,29.74%,PIANP;SULT4A1;FAIM2;BRINP1;CASKIN1;CLIP3;SRRM3;APLP1;BSN;KCNC1;NCDN;TAGLN3;GAD1;CLVS2;STMN2;CKB;KIF5A;LY6H;TMEM59L;LINGO1;GRIA2;VSTM2B;NLGN2;NDRG4;NCAN;B4GALNT4;ASIC2;CELSR2;STXBP1;SCAMP5
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.6541618103921729,-1.2437594881128702,0.175,1.0,1.0,3/25,4.69%,KMO;GLUL;MTHFD1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.6725003855967668,-1.2436449049552332,0.16049382716049382,1.0,1.0,3/31,1.72%,PRLR;LRP2;CYP3A5
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.6597262714064162,-1.2435680352740093,0.1518987341772152,1.0,1.0,3/25,2.56%,THBS1;NR4A1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of production of molecular mediator of immune response (GO:0002701),-0.8238204495165176,-1.2431008900039109,0.18461538461538463,1.0,1.0,2/5,7.45%,CR1;FCGR2B
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.800318557569869,-1.2430145594692765,0.13513513513513514,1.0,1.0,2/9,2.56%,ACVR1B;VEGFA
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),-0.8825869079984018,-1.243005991497523,0.11764705882352941,1.0,1.0,2/6,6.12%,KCNE1;ANK3
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",-0.691826731024026,-1.2428139578499888,0.16216216216216217,1.0,1.0,5/16,16.30%,NAPA;GRIK1;SLC17A7;CDH8;UNC13A
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.6342216693956662,-1.2426336183555615,0.19101123595505617,1.0,1.0,8/24,15.39%,RPS21;RPS8;NGDN;RPS14;UTP3;RRP36;RPS16;WDR46
prerank,PanglaoDB_Augmented_2021__Neurons,-0.5754037116683977,-1.242450925400681,0.04,1.0,1.0,79/199,24.86%,SCRG1;SLC11A1;MAP7D2;SULT4A1;AIM2;RORA;BEX1;PQBP1;IFIT3;FAIM2;BRINP1;AMER2;CCK;TCEAL2;PPP1R9A;CHN1;NWD2;CAMK2N1;PDE1A;CALY;BEX2;ENO2;SLC17A7;ERC2;KCNMA1;VGF;PAK5;B3GAT2;RAB3C;TMEM130;NRXN1;GRIA4;GDAP1L1;NEFM;BSN;FRRS1L;PCSK2;ZNF445;KCNC1;GPR162;PHYHIPL;CPLX1;SH3GL2;TAGLN3;SNAP25;UNC13A;GABRG2;GRM3;SYT4;GAD1;SCN1A;CLVS2;DYNC2I1;SCN3B;RNPC3;SYP;ATP1B2;STMN2;GAD2;ST8SIA3;KIF5A;CADM2;PNMA8A;DGKB;DYNC1I1;LY6H;MATN2;RYR2;GNAI1;CADPS;CSRNP3;NRGN;VSNL1;TMEM59L;CA10;GRIA2;VSTM2B;CACNA1B;RIMS3
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.7034209530122784,-1.2424456851705514,0.1951219512195122,1.0,1.0,1/18,0.82%,ENPP2
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.7436598208190994,1.2423892683257478,0.16666666666666666,0.8392627694865881,1.0,1/7,0.73%,DCP1B
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),0.7705162637410565,1.2423351052861473,0.23333333333333334,0.8368198141495102,1.0,1/8,2.81%,SH2B3
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.6456163169767122,-1.2423216609148284,0.1744186046511628,1.0,1.0,5/34,3.42%,GPR18;HTR2B;TACR1;AGT;C5AR1
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.6367150558012771,-1.2421222727812564,0.21518987341772153,1.0,1.0,1/27,0.53%,TFRC
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.7175119333377928,-1.242041743377958,0.18840579710144928,1.0,1.0,5/15,14.87%,CD55;RSAD2;IL18;B2M;TRAF2
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.6470433520301224,-1.241986757102773,0.1927710843373494,1.0,1.0,11/26,22.90%,HIF1A;NEFL;MAPT;SOD1;KIF1B;SYBU;AP3M2;KIF3A;RAB21;SPAST;DCTN1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.7824560537200193,-1.2415397061099605,0.13157894736842105,1.0,1.0,3/8,16.74%,THBS1;RGCC;PDCD4
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.7851129373316668,-1.2412015438488415,0.19444444444444445,1.0,1.0,2/7,4.69%,EIF4A3;MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.6484832469637141,-1.2406951212184805,0.24,1.0,1.0,3/15,8.65%,CEMIP;CHI3L1;CALM3
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.659852023114273,-1.2406911446624382,0.13580246913580246,1.0,1.0,4/23,8.23%,TFRC;FTH1;SLC11A1;SLC31A2
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.7238448176149198,1.2402654771138741,0.19230769230769232,0.8389554680229055,1.0,4/6,24.45%,NSUN2;TPR;SETD2;AKAP8L
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.7238448176149198,1.2402654771138741,0.19230769230769232,0.8389554680229055,1.0,4/6,24.45%,NSUN2;TPR;SETD2;AKAP8L
prerank,GO_Biological_Process_2021__positive regulation of osteoclast differentiation (GO:0045672),0.75266070190831,1.2402545351233358,0.2903225806451613,0.8364641668778445,1.0,3/5,23.53%,TRAF6;CCR1;ATP6AP1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.7675140316151935,-1.239905369664388,0.14666666666666667,1.0,1.0,4/9,12.67%,CYCS;UQCRC1;UQCR10;UQCRB
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.7374345949313044,-1.239602270006636,0.1527777777777778,1.0,1.0,3/10,17.26%,NUDT16;NYNRIN;DICER1
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),-0.8298212162803668,-1.2387330720011938,0.17391304347826086,1.0,1.0,2/7,5.14%,SRGN;CCL3
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.5922745173452519,-1.2380188587512506,0.125,1.0,1.0,14/61,15.60%,RPS27A;UVSSA;RBX1;RPA2;POLR2G;COPS5;UBA52;PPIE;RFC1;UBC;RPA3;ERCC2;RFC4;UBB
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.7241776080353641,-1.2379335812028631,0.20512820512820512,1.0,1.0,2/11,11.49%,VEGFA;DGKG
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.6593396017607012,1.237706146892155,0.2962962962962963,0.8431994301733745,1.0,2/6,17.91%,SENP6;SENP5
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.7683691697439108,-1.2376000403391896,0.21052631578947367,1.0,1.0,5/9,16.74%,TGFB2;RBPJ;SPRY1;OLFM1;PDCD4
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.6178775841566825,-1.2371608082112944,0.16666666666666666,1.0,1.0,13/36,14.20%,RPS25;RPS27;RPS6;RPS24;RPS14;NOB1;RIOK2;RPS15;RRP36;MRPS7;RPS7;RPS16;METTL17
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.8153346499725656,-1.2370761236946592,0.17391304347826086,1.0,1.0,3/5,17.91%,CFL1;IGF2R;PPIB
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.6447818335595416,-1.237002312510997,0.18823529411764706,1.0,1.0,9/30,18.28%,SLF1;RPA2;DDX11;ZCWPW1;FIGNL1;KDM1A;TERF2IP;TIMELESS;FMN2
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.7195201832469791,-1.2367663539098654,0.13513513513513514,1.0,1.0,1/16,1.61%,NFIL3
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.5105166911472878,1.2365507602142958,0.1111111111111111,0.8447527285986185,1.0,4/17,9.72%,MCU;MICU3;MAIP1;SMDT1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.6956988214534395,1.2362726214167699,0.21212121212121213,0.8435391653816617,1.0,2/5,12.19%,PPM1F;ADARB1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.6919229894172751,1.2362665091814415,0.17857142857142858,0.8410638806271408,1.0,2/9,4.94%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.5886421758515492,1.2361420201994713,0.21212121212121213,0.839271019726921,1.0,2/12,3.06%,NAA20;NAA35
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),0.7019109072380791,1.2359328313337106,0.22580645161290322,0.8372785280415664,1.0,1/7,7.75%,GTF2H2
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.5866837957375507,-1.2359195960514837,0.125,1.0,1.0,15/93,12.62%,DDIT4;EIF4A3;VEGFA;DNAJB9;ERO1A;IMP3;SLC7A5;NHP2;HERPUD1;SERP1;RPS14;ATF3;EIF2AK3;HSPA5;IFIT1
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),-0.8121398902205946,-1.2358558108613344,0.15625,1.0,1.0,2/5,11.31%,FGF13;DCC
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.7311147413188501,-1.2356499470210462,0.1780821917808219,1.0,1.0,1/14,0.47%,PRLR
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.7057230597781703,-1.2354591901790457,0.25925925925925924,1.0,1.0,4/12,18.11%,CEMIP;AKAP6;THY1;CALCR
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,-0.5730622013351396,-1.2351948515542135,0.09375,1.0,1.0,53/104,26.37%,FAM13C;SULT4A1;FAIM2;BRINP1;AMER2;TCEAL2;SCN9A;MAP1B;ANK2;PLP1;FGF13;KIF1B;ERC2;PAK5;MAPK4;RAB3C;NRXN1;GRIA4;GDAP1L1;NEFM;PTPRD;PIEZO2;CREBRF;KCNC1;PHYHIPL;SH3GL2;TAGLN3;SNAP25;KCTD16;ADCY8;SYT4;CLVS2;MAPK10;SCN3B;STMN2;ASXL3;ST8SIA3;PLPPR4;KIF5A;CADM2;KCNAB2;LY6H;MAP2;CSRNP3;CA10;GRIA2;CACNA1B;NOVA1;CRMP1;MAGI2;CADM3;NDRG4;AQP4
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.7472299496978817,-1.2350837452319814,0.19718309859154928,1.0,1.0,4/7,19.57%,STAT1;IFIT1;DDB1;DYNLT1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.6646115497029628,1.2349291202555337,0.23809523809523808,0.838581826451964,1.0,2/9,6.37%,LGALS9;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.8360503328552097,-1.2345135904272475,0.2112676056338028,1.0,1.0,2/5,12.95%,ALG10B;AKAP6
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.714403928398561,-1.2342214467653174,0.14473684210526316,1.0,1.0,5/18,5.26%,CHI3L1;FGF1;VEGFA;CCDC39;BASP1
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.8125487444085542,-1.2341986882632534,0.21428571428571427,1.0,1.0,2/6,10.84%,SAT1;SAT2
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.6456580608546585,-1.2338684834523115,0.10714285714285714,1.0,1.0,20/36,26.70%,SULT4A1;GRM8;BRCA1;CASKIN1;APLP1;VGF;GDAP1L1;NEFM;KLHL23;UNC13A;SYT4;CLVS2;STMN1;STMN2;KIF5A;TMEM59L;LINGO1;CACNA1B;CRMP1;REEP2
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.6790294236315086,-1.2332727468434161,0.18666666666666668,1.0,1.0,5/26,11.03%,GLRA1;SLC11A1;RACGAP1;SLC13A4;SLC4A10
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.5770835158839093,-1.2331162394178734,0.14893617021276595,1.0,1.0,23/82,16.20%,DDIT4;MX2;TRIM5;IFITM3;RSAD2;MX1;IFIT2;PQBP1;IFIT3;IFI44L;STAT1;BNIP3L;BNIP3;IRF1;NLRC5;OAS3;IFIT1;PYCARD;IFIT5;TLR2;PLSCR1;ATAD3A;STAT2
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.7526559052679631,-1.233044795791932,0.16417910447761194,1.0,1.0,5/7,22.29%,ALOX12;ALOX15B;SCD;FADS3;SCD5
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.7174215698913198,-1.2326555348664316,0.20253164556962025,1.0,1.0,5/16,8.66%,NOD2;SLC7A5;IL15;PRKCQ;IL18
prerank,GO_Biological_Process_2021__regulation of interleukin-18 production (GO:0032661),-0.8419079458995148,-1.2323843321650536,0.12307692307692308,1.0,1.0,1/5,0.57%,NLRP12
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),-0.8135093186265396,-1.2323575932531934,0.21212121212121213,1.0,1.0,1/5,7.60%,MAPT
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.5661297059715283,-1.232222026940377,0.06,1.0,1.0,55/236,20.33%,NUDT12;SRGN;NLRP12;EIF4A3;NUDT16;SLC11A1;RBMS3;VEGFA;OVOL2;TGFB2;HIF1A;CENPV;ZNF540;RPS13;CCL3;NOCT;DDRGK1;SLC7A5;FCGR2B;MAPT;DAPK1;RPL13A;PINK1;GAPDH;PARP9;BTN2A2;HSPA1B;ID2;NOTCH2;ITGB8;EIF2AK3;CCDC3;OLFM1;RIDA;RGCC;ENC1;BMI1;PARP14;RPS3;CNOT8;SH3GL2;PTRH2;PPP1R11;DICER1;KLF4;ILF3;ATP2B4;LSM5;PARP15;CITED2;GPNMB;FOXP1;PATL2;PUS7;EIF2AK2
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.6030957211976394,-1.2319211157674845,0.10526315789473684,1.0,1.0,13/66,15.60%,DDIT4;FOS;TNFRSF1B;FAIM2;EGLN3;FCGR2B;MAPT;HLA-F;DCC;EPHB1;NSMF;TRAF2;UBB
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.7668722347921255,-1.2313635904875373,0.20588235294117646,1.0,1.0,3/10,14.79%,PLTP;ABCB4;ABCB1
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,-0.5855082505622418,-1.2312259881937773,0.07291666666666667,1.0,1.0,42/100,26.64%,VIM;OPALIN;RFTN2;FAIM2;AMER2;PLP1;LRRC4C;SPARCL1;GPM6B;KIF1B;METRN;TRPM3;AKAP6;NRXN1;GRIA4;PTPRZ1;PHYHIPL;CHL1;ADCY8;GRM3;SCN1A;CLVS2;MAPK10;BAALC;ATP1B2;ATP2B2;NRXN3;SEPTIN4;ST8SIA3;PLPPR4;GRIN2A;GFAP;CADM2;NTRK3;SLC1A2;S100B;CA10;GRIA2;MAGI2;CADM3;AQP4;UFL1
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.6204848199721116,-1.2308629640250779,0.13829787234042554,1.0,1.0,6/40,5.45%,H2BC11;HMGB2;H1-3;H1-4;H1-2;H1-0
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.7288346002826047,-1.2305728118937407,0.2028985507246377,1.0,1.0,5/11,25.09%,WDR5;BRCA1;KDM1A;DNMT1;JARID2
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.629003855981778,-1.229837438104092,0.1797752808988764,1.0,1.0,13/25,22.94%,ENOSF1;GAPDH;PGK1;ENO4;ENO2;PGAM1;PKM;LDHA;PGM1;HK2;PFKL;GPI;ENO1
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.7791007974111308,-1.2297815723421133,0.24,1.0,1.0,1/5,8.68%,SOD1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.7791007974111308,-1.2297815723421133,0.24,1.0,1.0,1/5,8.68%,SOD1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.7791007974111308,-1.2297815723421133,0.24,1.0,1.0,1/5,8.68%,SOD1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.6814824310966942,-1.229415428756993,0.23076923076923078,1.0,1.0,9/18,24.14%,PKP2;ANK2;CALM3;FGF13;CAV3;CALM1;CACNA1C;RYR2;AKAP9
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.847354913839855,-1.2291385540583315,0.2318840579710145,1.0,1.0,2/5,6.26%,P4HA3;EGLN3
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.6503308514310119,-1.2291167211170568,0.2375,1.0,1.0,3/19,8.83%,HIF1A;PINK1;HSPA1B
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.5587853072608738,1.2290316474769587,0.21428571428571427,0.8577123577707633,1.0,2/12,5.92%,GCLC;MSRA
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.6381737125426578,-1.228871117550317,0.18421052631578946,1.0,1.0,9/25,18.42%,RPS27A;RBX1;RPA2;UBA52;UBC;RPA3;ERCC2;UBB;DDB1
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.8104527320968418,-1.2288405929615656,0.1506849315068493,1.0,1.0,3/9,9.59%,AGT;VEGFA;PAX8
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.5953284877469875,-1.2282600504026848,0.17582417582417584,1.0,1.0,16/56,22.57%,TUBB4A;VBP1;CLIP3;HDGFL3;FGF13;SHANK3;APC2;MID1IP1;TTBK2;CAV3;CLU;STMN1;STMN2;EML2;MAP2;CRYAB
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5463459926711315,1.2281247859177693,0.25,0.8588786256759547,1.0,8/30,10.47%,NCOA4;NEDD4;ARID1A;PMEPA1;ZMIZ1;NR3C1;PLPP1;SRC
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.7890123811828905,-1.2281207837885821,0.2191780821917808,1.0,1.0,2/7,7.80%,PRELID1;PINK1
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.6943501208050713,-1.2277554742963244,0.14285714285714285,1.0,1.0,3/28,5.92%,NUDT16;ENTPD3;SIDT2
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.7269951645138005,-1.2277420516085769,0.25675675675675674,1.0,1.0,1/8,8.95%,UGCG
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.6001431147023337,-1.2274304622990322,0.17045454545454544,1.0,1.0,18/51,25.18%,RPS27A;UBA52;PSMA3;UBC;PSMA5;PSMD8;UBB;PSMB4;ORC6;MCM3;MCM6;PSMD7;MCM7;PSMD5;PSMC2;MCM5;PSMB9;PSMB2
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.8321649969558381,-1.2271618204294097,0.1323529411764706,1.0,1.0,1/6,2.89%,TGFB2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),-0.7577696751242962,-1.2271019646595147,0.18666666666666668,1.0,1.0,4/8,19.33%,MAPT;SHANK3;ADCY8;LILRB2
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.7483530443869046,-1.2270792326315292,0.17333333333333334,1.0,1.0,3/9,5.14%,INSIG1;RORA;CCL3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.7452933934752519,1.2269510369245122,0.3548387096774194,0.8608691952562725,1.0,2/5,17.88%,PPP1R10;ENG
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.6613384763801444,-1.2269043246790279,0.13924050632911392,1.0,1.0,7/21,18.73%,EYA2;MROH9;CFTR;KCNMA1;DNAH12;ARFGEF3;DNAH7
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.7642347932972,-1.2267563070907626,0.1935483870967742,1.0,1.0,1/6,7.80%,PINK1
prerank,GO_Biological_Process_2021__membrane raft distribution (GO:0031580),-0.8196396827525648,-1.2265144534037447,0.20588235294117646,1.0,1.0,1/5,4.99%,MAL
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.49000451408279416,1.2264338577527278,0.08333333333333333,0.8600167702479663,1.0,13/32,16.86%,NRP1;SERPINF2;LPAR1;ABL1;PPM1F;SORBS3;NF2;FHOD1;TGFBR1;CDC42;EVL;PFN1;FERMT2
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.6599612099374539,-1.226214231986644,0.175,1.0,1.0,7/20,23.30%,GLRA1;NLGN3;GABRA3;GABRG2;GRIN2A;GABRA2;INSYN2A
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.6804819023993495,-1.2262059210758456,0.19230769230769232,1.0,1.0,4/17,14.34%,HIF1A;PFKFB4;PFKFB3;INSR
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.6804819023993495,-1.2262059210758456,0.19230769230769232,1.0,1.0,4/17,14.34%,HIF1A;PFKFB4;PFKFB3;INSR
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.7972176113320941,-1.226109379190755,0.19444444444444445,1.0,1.0,4/9,17.27%,CACNB2;CALM3;PDE4B;CALM1
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),-0.8043896157319457,-1.2257611105221868,0.16923076923076924,1.0,1.0,2/5,8.66%,IL15;IL18
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.6130259181089885,-1.2256909344612255,0.1,1.0,1.0,17/47,22.78%,GLUL;RIMS1;SLC6A15;PPFIA4;SLC17A7;RAB3A;NRXN1;CPLX1;SNAP25;UNC13A;SYT1;GAD1;NRXN2;GAD2;DVL1;GABRA2;SLC1A2
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.6803053800568559,1.2251431167059421,0.3333333333333333,0.8622334593960339,1.0,2/6,6.76%,PKD2;SALL1
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.5653226063891312,-1.225025886013924,0.11956521739130435,1.0,1.0,30/77,20.84%,PCSK1;FAM13C;AGT;KCNT2;PCDH17;SPARCL1;SST;MAPK4;PTPRT;RAB3C;NRXN1;PTPRD;PCSK2;PHYHIPL;CHGB;RCAN2;SNAP25;CNTN1;CPE;GABRG2;SYT4;MAPK10;GABRB3;TSPAN7;STMN2;GAD2;ASXL3;ST8SIA3;ETV1;PLPPR4
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.7025651499092458,-1.225008860479846,0.19480519480519481,1.0,1.0,3/12,10.64%,NR4A3;NR1H2;MID1IP1
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.8041467884967112,-1.2247443809123117,0.22388059701492538,1.0,1.0,2/6,6.18%,TG;DUOX1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.7432906070956862,-1.2245417242659984,0.24358974358974358,1.0,1.0,1/12,0.30%,SOCS3
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.6719163060994265,-1.2244746631885963,0.19540229885057472,1.0,1.0,7/24,15.46%,H1-3;H1-4;H1-2;H1-0;ZNF93;RPS3;TERF2IP
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.6046708485795268,-1.2243599750493446,0.17777777777777778,1.0,1.0,9/42,18.79%,DNAJB9;DDX11;PPP2R5B;SERP1;HSPA5;SRPRA;FKBP14;ARFGAP1;TPP1
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.8413215438270587,-1.2240419125019562,0.13432835820895522,1.0,1.0,1/6,0.34%,CENPF
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-0.8315862591579837,-1.223759219110751,0.13432835820895522,1.0,1.0,1/5,3.11%,RSAD2
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.7083165069516535,1.2234270687534718,0.3448275862068966,0.8639584787668072,1.0,4/6,21.01%,ABHD10;LYPLA1;PPT1;ABHD17A
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.7083165069516535,1.2234270687534718,0.3448275862068966,0.8639584787668072,1.0,4/6,21.01%,ABHD10;LYPLA1;PPT1;ABHD17A
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.6933619862557223,-1.2233361794817696,0.18292682926829268,1.0,1.0,3/20,12.17%,NR4A3;PDE4B;APLP1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.576113287824271,-1.2231566309409947,0.18478260869565216,1.0,1.0,22/77,16.20%,DDIT4;MX2;TRIM5;IFITM3;RSAD2;MX1;IFIT2;PQBP1;IFIT3;IFI44L;STAT1;BNIP3L;BNIP3;IRF1;NLRC5;OAS3;IFIT1;PYCARD;IFIT5;TLR2;PLSCR1;STAT2
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.6679497460932604,-1.2222811481935725,0.2125,1.0,1.0,2/21,7.55%,NUDT16;TENT4B
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),-0.7997448178820958,-1.222269287603814,0.19444444444444445,1.0,1.0,2/6,9.44%,ACSL1;CD36
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.6501254739565189,-1.2220400557863513,0.16455696202531644,1.0,1.0,14/26,30.37%,NEFL;DAPK1;GRIA4;RELN;LRRC7;GRIN2A;CAMK2B;OPRM1;GRIA2;APP;CRHBP;ACTN2;MAPK8IP2;DLG4
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.5500633693674364,1.2213211568447833,0.25,0.8676716179835957,1.0,2/16,1.16%,GSN;AVIL
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.5500633693674364,1.2213211568447833,0.25,0.8676716179835957,1.0,2/16,1.16%,GSN;AVIL
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.5612557159333373,-1.2211159878685016,0.0707070707070707,1.0,1.0,39/238,12.34%,HTR2B;PRLR;TFRC;THBS1;ARAF;RPS27A;NAA38;RNF144B;LRP2;VEGFA;PRELID1;BCL2A1;CFL1;IL7;GSTP1;IFIT3;RPS3A;DDRGK1;FAIM2;FIGNL1;COPS5;ATF5;TNFAIP8;HSPA1B;NUAK2;UBA52;NOTCH2;TPT1;TMEM14A;BNIP3L;BNIP1;BCL2L2;STIL;UBC;BNIP3;PIM3;HSPA5;APIP;PTMA
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.8385405313806157,-1.2206423881292452,0.14925373134328357,1.0,1.0,3/6,11.51%,AGBL3;AGTPBP1;FOLH1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.5947211846059627,-1.2206027985107202,0.15306122448979592,1.0,1.0,17/64,14.34%,SOCS3;OSMR;TNC;PLPP3;SPARC;ADAMTS2;HIF1A;C5AR1;LAMA2;NOD2;COL11A1;FN1;SVEP1;ITGA2;PALLD;CD44;INSR
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.7090008073360896,-1.2203141892413085,0.16216216216216217,1.0,1.0,2/19,5.16%,KCNE1;PPP2R5A
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.6778500130143933,-1.2200284305585944,0.20238095238095238,1.0,1.0,3/17,5.14%,CCL4;DUSP1;CCL3
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.7062232849826806,-1.2200030278584924,0.2564102564102564,1.0,1.0,2/13,5.14%,CCL4;CCL3
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.7497371592349444,-1.2197058797205254,0.23076923076923078,1.0,1.0,3/9,18.00%,RGS2;CAV3;ATP2B4
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.6946702386775903,-1.2196974810474637,0.19230769230769232,1.0,1.0,7/20,20.44%,CD55;C5AR1;CR1;C5AR2;SERPING1;CLU;C1QBP
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.7654816699615177,-1.2196689767133553,0.19718309859154928,1.0,1.0,1/8,1.40%,TRIM5
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),-0.790286582257682,-1.2195912810842557,0.15492957746478872,1.0,1.0,3/6,17.17%,TXNIP;E2F7;ORC6
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.7023638785787247,1.219416255054128,0.2413793103448276,0.8720743584367036,1.0,3/9,15.87%,SIRT1;EP300;KAT7
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.7760705369777751,-1.2192628656379567,0.22535211267605634,1.0,1.0,3/8,14.61%,MT2A;SLC31A2;ATOX1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.6719608667339771,-1.2191185213182751,0.16666666666666666,1.0,1.0,4/21,7.76%,CEBPD;OVOL2;HIF1A;UXT
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.700968729949756,-1.2189946535961587,0.22857142857142856,1.0,1.0,4/13,12.22%,RPL23;RPL11;RPL5;RPS7
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.7383970613405381,-1.2185852559463461,0.1518987341772152,1.0,1.0,4/14,19.20%,RGS2;APLP1;RPGRIP1L;STMN1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.6490372401454145,1.2184993420331531,0.24242424242424243,0.8733387949918966,1.0,4/11,4.94%,PDPN;FSCN1;TGFB1;RUNX1
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.8283271557338912,-1.218437611094607,0.2153846153846154,1.0,1.0,2/6,8.93%,MYLK;TTN
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.735293621201353,-1.2180968785369162,0.25,1.0,1.0,2/10,6.25%,AQP11;HERPUD1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.7231782458249321,1.2177890855159839,0.2571428571428571,0.8732800836845434,1.0,1/6,3.00%,CSF1R
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.6791496482676388,-1.2176584317689172,0.225,1.0,1.0,5/18,9.77%,CENPV;SVIL;RACGAP1;PRKCE;CIT
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.7666032350790324,-1.2172257591871547,0.2328767123287671,1.0,1.0,1/6,6.41%,BRCA1
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.781538109930255,-1.2172225834898807,0.21518987341772153,1.0,1.0,2/9,7.19%,RPS21;ERI2
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.6560910831348234,-1.2168587260796104,0.23529411764705882,1.0,1.0,9/20,26.58%,RIMS1;SHANK3;NLGN3;NRXN1;RELN;RIMS2;NLGN2;APP;TMEM108
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.5839045818253202,-1.2168538387875083,0.16853932584269662,1.0,1.0,16/81,12.38%,SRGN;THBS1;F13A1;SPARC;VEGFA;TGFB2;F8;TUBA4A;SELENOP;ENDOD1;SOD1;TTN;CD36;CD63;MANF;FN1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.72798799358992,-1.2168182138812091,0.11940298507462686,1.0,1.0,2/16,10.30%,THBS1;SDCBP
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.72798799358992,-1.2168182138812091,0.11940298507462686,1.0,1.0,2/16,10.30%,THBS1;SDCBP
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.8412658402477995,-1.2167826414261578,0.13636363636363635,1.0,1.0,4/5,15.91%,ADGRG6;BAIAP2L1;PPP1R13L;TRIM16
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.8212466489898831,-1.2167323125357532,0.19718309859154928,1.0,1.0,4/7,8.95%,FA2H;ALOX12;LSR;UGCG
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.8212466489898831,-1.2167323125357532,0.19718309859154928,1.0,1.0,4/7,8.95%,FA2H;ALOX12;LSR;UGCG
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.8163516383490507,-1.2163183844127654,0.20967741935483872,1.0,1.0,1/5,7.66%,SFXN3
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,-0.580427703739465,-1.216245464766111,0.15053763440860216,1.0,1.0,33/89,24.83%,NR4A2;FAIM2;BRINP1;AMER2;CCK;TCEAL2;CALY;PAK5;RAB3C;NRXN1;GRIA4;KCNC1;TAGLN3;SNAP25;GABRG2;ADCY8;GRM3;SYT4;CLVS2;STMN2;GAD2;ST8SIA3;GRIN2A;PDE2A;GFAP;CADM2;LY6H;MAP2;NRGN;CA10;GRIA2;VSTM2B;CACNA1B
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.7652170672555298,-1.2161897718742445,0.2054794520547945,1.0,1.0,2/8,8.89%,PRELID1;ABCB4
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.7090923740456331,-1.2160844180877677,0.24285714285714285,1.0,1.0,4/12,17.27%,PLPP3;DEGS2;PTS;CALM1
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.835019023188971,-1.2158582747464466,0.22058823529411764,1.0,1.0,2/5,15.68%,CRYL1;SORD
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.835019023188971,-1.2158582747464466,0.22058823529411764,1.0,1.0,2/5,15.68%,CRYL1;SORD
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.835019023188971,-1.2158582747464466,0.22058823529411764,1.0,1.0,2/5,15.68%,CRYL1;SORD
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.7691478371425567,-1.215783337646643,0.24285714285714285,1.0,1.0,2/9,8.02%,PLTP;ABCA5
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.6141126208206231,-1.2157119583132154,0.19318181818181818,1.0,1.0,9/42,8.00%,CCL4;SLC11A1;IFITM3;CCL3;GBP2;DAPK1;RPL13A;GAPDH;STAT1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.8149518009206544,-1.2153411010246475,0.15714285714285714,1.0,1.0,1/5,0.67%,CYREN
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.6418566764469363,-1.2152586013438857,0.25316455696202533,1.0,1.0,2/15,7.52%,HERPUD1;SEC61B
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.836998014154723,-1.2147010978504038,0.15625,1.0,1.0,2/5,6.47%,SLC11A1;RPS23
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.6922284320530231,-1.2146189124254791,0.18072289156626506,1.0,1.0,4/19,4.53%,LRP2;TGFB2;RBPJ;PKP2
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.8112888334339705,-1.2142697035336814,0.16666666666666666,1.0,1.0,2/7,7.80%,TOMM7;PINK1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.6766583627480759,-1.2142649917220223,0.2222222222222222,1.0,1.0,9/18,24.14%,PKP2;PLN;ANK2;FGF13;PDE4B;CAV3;CACNA1C;RYR2;AKAP9
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.6049712121074896,-1.2141854572408664,0.18518518518518517,1.0,1.0,11/30,15.60%,RPS27A;RBX1;RPA2;UBA52;RFC1;UBC;FAN1;RPA3;ERCC2;RFC4;UBB
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),-0.7240789505844002,-1.2139491481766271,0.2,1.0,1.0,8/14,21.58%,ADGRG6;MMP24;METRN;CDH2;PTPRZ1;NFIB;RELN;SOX4
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.6441526636476664,-1.2138406171938183,0.2125,1.0,1.0,7/26,15.74%,RPS27A;UBA52;CD36;UBC;CD14;UBB;TLR2
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.7698209003575494,-1.2138155069624887,0.26865671641791045,1.0,1.0,4/8,16.93%,STEAP2;SLC31A2;ATOX1;CUTC
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.6276830269147178,-1.2134337792387548,0.14606741573033707,1.0,1.0,12/42,15.05%,LAMA2;DOCK1;IQSEC1;PRKCQ;CXCR4;DOCK5;LAMB1;DMD;TTN;CKMT2;LDB3;CAV3
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.7540360055468487,-1.213347366991172,0.2191780821917808,1.0,1.0,3/10,13.90%,IL7R;IL10RA;GHR
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.675357902318626,-1.213027059218271,0.2702702702702703,1.0,1.0,3/15,14.59%,ME1;MTHFD1;PRPS1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.6609039151090247,1.2129911458503513,0.3225806451612903,0.8873531403457361,1.0,4/6,27.42%,RFX3;GSK3B;RHEB;AKT1
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.695911400386717,-1.2128897360162938,0.19480519480519481,1.0,1.0,4/18,4.73%,DNAH11;MMP21;CCDC39;ENKUR
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.7322865919828996,-1.2127597996581447,0.3235294117647059,1.0,1.0,1/8,0.73%,THBS1
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.5900129231757093,-1.2124720387362005,0.12643678160919541,1.0,1.0,14/57,20.47%,TGFB2;CCL3;FAIM2;EGLN3;PINK1;SOD1;PTPRZ1;NSMF;MAG;SNX6;CRLF1;NRBP2;EPHA7;RETREG1
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),-0.8190690585844285,-1.2123147436019674,0.25,1.0,1.0,2/5,8.09%,ANK3;EPB41L3
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.697087887773036,-1.2121489493286184,0.208955223880597,1.0,1.0,2/15,3.56%,PPP1R15A;SH2D4A
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.7424351807933431,-1.2117220404327327,0.2465753424657534,1.0,1.0,1/9,6.41%,BRCA1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.47977400756708344,1.2116893581306443,0.1111111111111111,0.8896371789406746,1.0,3/28,3.90%,NDE1;MYO1D;TRAK2
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.7134217145577515,-1.2115685438315664,0.22077922077922077,1.0,1.0,5/10,25.59%,BRCA1;CTBP1;TAF7;JARID2;SET
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,-0.5721648891723141,-1.2112404595753143,0.11458333333333333,1.0,1.0,50/114,26.20%,FAM13C;TUB;SULT4A1;FAIM2;BRINP1;PPP2R5B;CCK;PCDH17;ATF5;MAP1B;ANK2;LRRC4C;KIF1B;PAK5;ADGRL3;MAPK4;AKAP6;NRXN1;TTBK2;GDAP1L1;NEFM;MFSD6;KCNC1;PHYHIPL;TOX;TAGLN3;SNAP25;CNTN1;CPE;KCTD16;SYT4;CLVS2;MAPK10;STMN2;ASXL3;ST8SIA3;PLPPR4;CADM2;LY6H;TSHZ1;MAP2;CSRNP3;TMEM59L;CA10;GRIA2;CACNA1B;NOVA1;CRMP1;CADM3;NDRG4
prerank,PanglaoDB_Augmented_2021__Neuroblasts,-0.5722708554102116,-1.2112095074734717,0.20212765957446807,1.0,1.0,34/71,29.02%,SULT4A1;CASKIN1;MAP1B;ERC2;APLP1;PAK5;ADGRL3;MAPK4;GDAP1L1;NEFM;KCNC1;TAGLN3;UNC13A;ITGA6;SYT4;CLVS2;EPHA7;STMN2;KIF5A;NTNG1;KIF5C;TSHZ1;CSRNP3;TMEM59L;LINGO1;UNC5D;CACNA1B;CRMP1;EPHA4;REEP2;NCAM1;NCAN;B4GALNT4;PPM1E
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.7574008123025013,1.210727815195676,0.27586206896551724,0.89043624142503,1.0,2/6,10.47%,NEDD4;SRC
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.7546257983343316,-1.2106392857667323,0.2631578947368421,1.0,1.0,1/8,0.77%,GLA
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.7453418456666917,-1.2106269891283703,0.2676056338028169,1.0,1.0,4/8,23.34%,EMC7;EMC10;EMC2;EMC3
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.7575892563086881,-1.2102384018022794,0.23376623376623376,1.0,1.0,1/11,0.53%,TFRC
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.6752408232554009,-1.2102327157129331,0.23076923076923078,1.0,1.0,3/18,8.68%,GLRA1;CCL3;SOD1
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.5984392781624125,-1.2099883133372622,0.15053763440860216,1.0,1.0,8/62,6.41%,THBS1;CHI3L1;FGF1;VEGFA;RHOB;HIF1A;FLT1;BRCA1
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),-0.763537093801268,-1.2093858887857905,0.22727272727272727,1.0,1.0,2/8,7.99%,RACGAP1;SLC13A4
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.7090677185471846,-1.2093450718369325,0.19230769230769232,1.0,1.0,7/15,18.37%,ATP5ME;ATP5F1E;ATP5F1D;ATP5PD;ATP5F1A;VPS9D1;ATP5MC1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.7049528204592062,-1.2093339164081345,0.21052631578947367,1.0,1.0,4/11,11.27%,AIM2;STAT1;MNDA;IRF1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.525851275081987,1.209192529391018,0.18181818181818182,0.8935994997214404,1.0,5/23,13.90%,BID;TP53;YWHAG;PPP1R13B;YWHAE
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.5719190726332314,-1.208922886287726,0.10869565217391304,1.0,1.0,30/114,17.39%,TOP2A;GADD45B;IFITM3;HMGB2;RHOB;TGFB2;DPYD;CD69;H1-0;BRCA1;PPP2R5B;SAT1;IL18;SOD1;BNIP3L;ATF3;BCL2L2;ENO2;IRF1;TXNIP;FEZ1;IGF2R;CDKN1B;CD14;CD44;BMF;TAP1;PDCD4;MCL1;CLU
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.7843776236791788,-1.2086811520906993,0.19718309859154928,1.0,1.0,1/8,0.73%,THBS1
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.6206831804595835,1.2085615712293083,0.2777777777777778,0.8930189457784975,1.0,7/15,19.76%,PEX13;PEX16;PEX5;GDAP1;PEX2;ABCD3;ATAD1
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.7194233454664244,1.2084785882442217,0.2619047619047619,0.8909487676172537,1.0,1/5,1.01%,LGALS9
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.672785226242795,-1.2084579756215839,0.2564102564102564,1.0,1.0,4/19,15.79%,OSBPL5;ABHD12B;MBOAT2;PLSCR1
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.8082374027831669,-1.2078175153343105,0.20967741935483872,1.0,1.0,1/5,4.53%,PKP2
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.6634795429116167,-1.2076760486444376,0.2597402597402597,1.0,1.0,5/16,13.34%,HDGFL3;FGF13;APC2;MID1IP1;TTBK2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.5843293901340443,-1.2076708555154112,0.0989010989010989,1.0,1.0,9/64,6.61%,MYOT;TG;TGFB2;RSAD2;MX1;NR4A2;IFI44L;SELENOP;PLAG1
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),0.7449088450314144,1.2074042382983157,0.34285714285714286,0.892198391530277,1.0,1/6,8.97%,FBL
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.7553505448458047,-1.2067530896746514,0.273972602739726,1.0,1.0,2/8,8.74%,NR4A3;GPC3
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.5072025018875053,1.206520199206139,0.19047619047619047,0.8929132102799898,1.0,4/24,4.46%,SIRPA;LGALS9;CD274;ILRUN
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),-0.7582760378933037,-1.20634779829573,0.3333333333333333,1.0,1.0,2/5,23.83%,HSPA1B;HSBP1L1
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),-0.7582760378933037,-1.20634779829573,0.3333333333333333,1.0,1.0,2/5,23.83%,HSPA1B;HSBP1L1
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.7023555593637516,-1.2063043466534906,0.2898550724637681,1.0,1.0,3/10,17.33%,GLUL;ASPA;GAD1
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.650719967462792,-1.206225831529192,0.1927710843373494,1.0,1.0,4/19,5.60%,PPP1R15A;TGFB2;SH2D4A;MASTL
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.8166412375812983,-1.2054366363193856,0.171875,1.0,1.0,2/5,11.63%,NLRP12;NLRC5
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.5689691866618658,-1.2050731693007948,0.12222222222222222,1.0,1.0,7/73,7.87%,OSBPL5;NAPA;FTH1;STEAP2;STXBP6;SCAMP3;CLVS1
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.5696029354458089,-1.2050120266515367,0.1827956989247312,1.0,1.0,17/70,21.60%,EIF4A3;RTN1;ZNF540;DAPK1;RPL13A;GAPDH;EIF2AK3;RIDA;ENC1;RPS3;CNOT8;CLU;ILF3;PATL2;PUS7;EIF2AK2;RACK1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.6697206835503898,-1.2048852612182552,0.2328767123287671,1.0,1.0,4/17,15.60%,RPS27A;UBA52;UBC;UBB
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),-0.8172952039157076,-1.204727494168955,0.23529411764705882,1.0,1.0,2/5,15.45%,LNPK;TMEM33
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.5653360149159663,-1.2046913907251466,0.12371134020618557,1.0,1.0,34/151,21.60%,THBS1;RPS4X;EIF4A3;VIM;MIF4GD;PRR16;ZNF540;RBM4B;RBM3;DAPK1;RPL13A;GAPDH;EIF2B2;DDX1;EIF2AK3;RIDA;RPL5;ENC1;RPS3;CNOT8;EIF3E;IMPACT;EIF3D;ILF3;EIF4A2;RPL10;EEF2;TRAP1;PATL2;PUS7;EIF2AK2;UPF3A;SOX4;RACK1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.7185571549924987,-1.204449817515364,0.2876712328767123,1.0,1.0,3/13,8.66%,CD55;MYO1G;IL18
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.615417309019125,1.2044456673805415,0.24,0.8976705828341655,1.0,7/11,29.72%,NFATC3;NFAT5;HRH1;NFATC1;PPP3CA;PPP3CC;NFATC2
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.6015485160473587,-1.2043874838890827,0.20224719101123595,1.0,1.0,9/62,12.13%,PRLR;CGNL1;PLPP3;AGT;COBL;SLC13A4;SLC4A10;ADGRL2;EPB41L4B
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),-0.6988738497250706,-1.2041246352291428,0.2345679012345679,1.0,1.0,2/15,5.17%,PTN;TAF6L
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.6887165452913938,-1.203315927886106,0.25675675675675674,1.0,1.0,4/16,12.14%,LIPE;DGKG;DGKI;DGAT1
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.5799780619512096,-1.2032554156721929,0.10526315789473684,1.0,1.0,18/81,14.02%,CLEC12A;ADGRE1;JAML;SLC11A1;SIRPB2;C5AR1;CASP5;CD163;MS4A4A;MARCO;FCGR2B;FGR;MS4A6A;MNDA;NCF4;FPR1;SIGLEC1;CD14
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),-0.7377190007295673,-1.2029667207040282,0.16216216216216217,1.0,1.0,1/10,1.22%,PLIN2
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.5143748826792609,1.202757334055625,0.13636363636363635,0.9001378850070911,1.0,1/22,0.02%,PHLDB2
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.7052836709241954,-1.2025332506530342,0.29333333333333333,1.0,1.0,7/14,15.32%,TOM1L1;OVOL2;SH2D4A;BAIAP2L1;USP43;ENAH;RND3
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),-0.7471591987935675,-1.2020479118959528,0.24242424242424243,1.0,1.0,1/10,0.40%,HTR2B
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.5428904436534775,-1.201995035974041,0.03,1.0,1.0,81/368,17.17%,SOCS3;CCL4;PRLR;RPS27A;CEBPD;TNFRSF11B;VIM;MX2;OSMR;TRIM5;F13A1;TALDO1;ST18;MT2A;FOS;IFITM3;VEGFA;RSAD2;HIF1A;IL7R;MX1;AIM2;TNFRSF1B;RORA;RBX1;IFIT2;CFL1;IL7;CCL3;HLA-B;IFIT3;NOD2;MAP3K8;GBP2;DUOX1;RHOU;IL15;STAT1;JUNB;IL10RA;IL18;SOD1;UGCG;APPL1;UBA52;CD36;TRIM25;HLA-F;TNFSF13B;PSMA3;UBC;PSMA5;IRF1;B2M;TEC;OAS3;FN1;FPR1;IFIT1;RPLP0;LIFR;CDKN1B;PTPRZ1;GHR;PYCARD;CD44;IFIT5;TRAF2;PIK3CB;PSMD8;UBB;LMNB1;PSMB4;STAT2;IL3RA;ANXA2;BCL6;PDCD4;CRLF1;IRS2;MCL1
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.5792228719911345,-1.2017452832980475,0.1702127659574468,1.0,1.0,7/58,8.68%,TFRC;FTH1;SLC11A1;MT2A;HAMP;SLC31A2;SOD1
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.6594154201528593,-1.2017159415520036,0.25316455696202533,1.0,1.0,2/16,7.45%,THBS1;FCGR2B
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.5960757539987734,-1.2014101531915913,0.13333333333333333,1.0,1.0,17/42,26.87%,BEGAIN;NEFL;DAPK1;GRIA4;RELN;LRRC7;PRRT1;GRIN2A;CAMK2B;OPRM1;AKAP9;GRIA2;NLGN2;APP;CRHBP;ACTN2;CACNG2
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.6055260088321491,-1.2009685139082495,0.23529411764705882,1.0,1.0,7/37,3.75%,ASPN;SPARC;MYLK;RBMS3;ADAMTS2;ECM2;LAMA2
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.6818491801733847,-1.2007016801274855,0.19718309859154928,1.0,1.0,5/13,15.69%,LRP2;VEGFA;SMARCD3;KDM1A;TOX
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.7258521613777124,1.2002852819114742,0.30303030303030304,0.9072373437329191,1.0,2/5,16.28%,MTLN;AKT2
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),-0.7652859072366294,-1.2002148094982101,0.18309859154929578,1.0,1.0,2/7,11.82%,COBL;CLMP
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.7245226084311258,-1.2000512218020107,0.26229508196721313,1.0,1.0,4/7,22.58%,ADCY3;CFTR;ADCY8;GNAI1
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.7245226084311258,-1.2000512218020107,0.26229508196721313,1.0,1.0,4/7,22.58%,ADCY3;CFTR;ADCY8;GNAI1
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.5363464974528339,1.1999093790327109,0.18181818181818182,0.9061410149019578,1.0,1/12,3.49%,NSUN2
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.773626081937794,-1.1994904364126167,0.2638888888888889,1.0,1.0,1/5,3.44%,ADCY3
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),0.7091914681608377,1.1990794795937056,0.3333333333333333,0.9067751737478714,1.0,3/6,23.45%,TREM2;PRKCA;PRKCI
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),-0.7894522355974797,-1.1989577701696574,0.29508196721311475,1.0,1.0,1/5,1.33%,OSMR
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.6009778460202261,-1.1988708839241566,0.15294117647058825,1.0,1.0,18/50,17.47%,CLDN18;CEBPD;ALOX15B;MS4A4A;FBP1;MARCO;SAT1;LPCAT1;CD36;THBD;TYMP;SIGLEC1;CD14;ALDH1A1;SCD;ST14;CRLF1;KLF4
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.47866910510974664,1.1988397165377032,0.15789473684210525,0.9053291913858356,1.0,11/23,20.74%,BCL9L;BCL9;TLE3;EP300;TLE2;RBBP5;TCF7L2;KMT2D;CDC73;LEO1;PYGO2
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.6209405867303803,-1.198663261901806,0.19101123595505617,1.0,1.0,15/43,15.32%,OSMR;PLPP3;FGF1;ME1;DOCK1;GBP2;NTN4;THBD;ADGRD1;FN1;FRAS1;SVEP1;PALLD;SH3D19;RND3
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.7279182263860834,1.1982816529561393,0.3235294117647059,0.9042794216442259,1.0,2/5,16.06%,RPIA;FGGY
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.7719311981923569,-1.1980624934866153,0.2,1.0,1.0,1/11,0.53%,TFRC
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.7385594206752237,-1.198030901931816,0.2647058823529412,1.0,1.0,3/9,11.34%,HAMP;HIF1A;B2M
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.7052336107725153,-1.197928168317529,0.2361111111111111,1.0,1.0,2/11,10.00%,HLA-B;HLA-F
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.6464623819025812,-1.1974037806180113,0.27380952380952384,1.0,1.0,5/23,15.60%,RPS27A;NOD2;UBA52;UBC;UBB
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.6648744616616659,1.1973499935581693,0.29411764705882354,0.9054298064370669,1.0,2/7,2.22%,MAP1S;TAL1
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.646136488062155,-1.1970306158273099,0.23809523809523808,1.0,1.0,5/24,15.60%,RPS27A;NOD2;UBA52;UBC;UBB
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),0.5434199116678978,1.1967611190215648,0.15,0.9046107522918446,1.0,7/20,19.76%,PEX13;PEX16;PEX5;GDAP1;PEX2;ABCD3;ATAD1
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.7780279113088382,-1.196680912776006,0.29850746268656714,1.0,1.0,3/5,14.59%,CARMIL1;SLC2A9;PRPS1
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.7243382328108008,-1.1964990730040337,0.21428571428571427,1.0,1.0,3/11,11.40%,CGNL1;LSR;MPP7
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.5547565496085941,-1.196448257520143,0.12371134020618557,1.0,1.0,29/140,19.68%,TOP2A;CENPF;CKS2;SAP30;MT2A;HIF1A;MEIS2;RPA2;SLC7A5;RACGAP1;ATF5;CENPE;DMD;POLQ;NOTCH2;STIL;INCENP;CDKN1B;HIRA;LMNB1;ORC6;SRSF2;BRCA2;ILF3;KIF15;MCM3;MCM6;STMN1;KIF11
prerank,PanglaoDB_Augmented_2021__Basophils,-0.5629365794540487,-1.1963829418119374,0.08247422680412371,1.0,1.0,25/109,14.27%,CLEC12A;CCL4;OSBPL5;F13A1;NFIL3;JAML;GPR183;SIRPB2;CD93;H1-3;CD69;CCL3;MS4A4A;FCGR2B;FGR;INF2;PDK3;MS4A6A;MNDA;TEC;NCF4;FPR1;SIGLEC1;CD14;CD44
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.5649153894005738,-1.196367419227856,0.13829787234042554,1.0,1.0,20/95,14.51%,DDIT4;SPOCK1;BHLHE40;HMGB2;SEMA3A;TGFB2;NR4A2;RACGAP1;CCK;CEP85L;MAP1B;MAPT;FGF13;CIT;ASTN2;ADGRL3;GPM6A;TUBGCP2;PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.8356688230683058,-1.1962055963195024,0.2923076923076923,1.0,1.0,2/5,8.03%,GLUL;NMD3
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),-0.7748075590346493,-1.1961368129873253,0.25,1.0,1.0,1/6,6.41%,BRCA1
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.8570953073783129,-1.1958657695743922,0.15384615384615385,1.0,1.0,2/5,7.35%,SLC5A9;SLC2A9
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),-0.5844280765099221,-1.1957739809097738,0.19318181818181818,1.0,1.0,8/47,19.07%,HTR2B;PINK1;IL10RA;USP36;TBC1D14;BMF;MCL1;NRBP2
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5849231775544487,-1.195761883059259,0.1827956989247312,1.0,1.0,11/51,14.79%,SLC2A3;TFRC;LRP2;SLCO3A1;SLC7A5;ABCC3;CD36;SLC16A7;SLC16A1;INSR;ABCB1
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.7015155314986452,-1.1956809493522862,0.24705882352941178,1.0,1.0,3/17,7.19%,WDR12;RPS21;ERI2
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.7459155274033676,1.1956709276858073,0.275,0.9054972346371667,1.0,1/6,1.90%,PGM2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.47587040035526684,1.1956538528151117,0.125,0.9031779825204465,1.0,4/22,4.43%,TNFAIP8L3;DAB2IP;P2RY12;TGFB1
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.7836133858617642,-1.1954813255628933,0.27848101265822783,1.0,1.0,1/8,5.68%,VPS11
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.8439514249670834,-1.1948331804922028,0.24193548387096775,1.0,1.0,2/5,11.06%,BNIP3L;BNIP3
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),0.72525729889537,1.1942173093502535,0.3684210526315789,0.9062343219540194,1.0,3/5,23.45%,TREM2;PRKCA;PRKCI
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.7341642687663013,-1.1941042385357352,0.23076923076923078,1.0,1.0,2/13,2.59%,TOP2A;HMGB2
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.6284749999426675,-1.1940241504366207,0.20238095238095238,1.0,1.0,6/31,8.59%,ADGRG6;MAL;EPB41L3;EIF2B2;CXCR4;PLP1
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),-0.7479449797542832,-1.1939063948501938,0.26229508196721313,1.0,1.0,1/6,3.42%,C5AR1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.696252728346572,-1.1935983981876284,0.24675324675324675,1.0,1.0,2/12,8.47%,PRKAR2B;PKIA
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.5768894108503431,1.1928360501210216,0.2608695652173913,0.9085738081299432,1.0,3/18,4.17%,NRP1;ARAP1;FSCN1
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.6545157481971136,-1.1926571054977897,0.2261904761904762,1.0,1.0,7/22,16.81%,TFRC;FANCB;ZCWPW1;ERCC2;WDR48;TIMELESS;KMT5C
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.7656568334897054,-1.1925923097729032,0.2153846153846154,1.0,1.0,2/8,8.67%,THBS1;PRKCE
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.5403889430742919,-1.1923604315409764,0.14,1.0,1.0,24/167,13.22%,NDUFA2;MDH1;CYCS;COX7C;ETFB;COX7A2;NDUFS8;ATP5ME;NDUFA3;ATP5F1E;COX4I1;NDUFA1;TIMM13;UQCRC1;ATP5F1D;ATP5PD;COX6C;UQCR10;ATP5F1A;UQCRB;ALDH6A1;NDUFB6;LDHA;PDHB
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.6280072167767108,-1.1921159838340998,0.25,1.0,1.0,7/19,18.42%,RPS27A;RBX1;UBA52;UBC;ERCC2;UBB;DDB1
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.7360162879405355,-1.1915259154474829,0.2727272727272727,1.0,1.0,4/10,15.91%,DUOX1;STAT1;VGF;TRIM16
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.6805130941123161,-1.191447755169677,0.23684210526315788,1.0,1.0,1/20,0.73%,THBS1
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.7922667903127255,-1.1914169129160095,0.19117647058823528,1.0,1.0,3/8,11.26%,OMG;PTN;NREP
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.638294562294368,1.1913431276860216,0.21739130434782608,0.9113452778386423,1.0,1/10,1.00%,DR1
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.7656733713703525,-1.1910093025963342,0.25,1.0,1.0,4/6,22.15%,NOP53;WDR48;TNIP1;SART3
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.43016201725942005,1.190960207282851,0.1111111111111111,0.9102068760325729,1.0,6/45,5.63%,PHLDB2;NRP1;MAP4K4;ABL1;PPM1F;VCL
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),-0.8015863141174653,-1.190917574924226,0.2318840579710145,1.0,1.0,1/6,1.95%,GPR183
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.5566332286903359,-1.1907511269851452,0.14583333333333334,1.0,1.0,32/128,17.50%,SLC2A3;GADD45B;GLIPR2;PLIN2;NFIL3;BHLHE40;IFITM3;RHOB;TNFRSF1B;RORA;SELL;NDRG1;MAP3K8;COCH;SCN9A;IL10RA;AHNAK;MXD1;ITGAE;APLP1;IGF2R;CD44;ABCB1;P4HA1;PLSCR1;TNFRSF21;ITGA6;IL3RA;GPR65;PLEC;PTRH2;CKAP4
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.5599472500272183,-1.190617625072852,0.15625,1.0,1.0,20/76,20.89%,BRIP1;RPA2;BRCA1;WDHD1;DONSON;CLSPN;RFC1;RPA3;ING4;ING5;RFC4;TIMELESS;POLL;DNA2;ORC6;MCM3;MCM6;POLG2;MCM7;POLE2
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.6377778763208785,-1.1904534423656308,0.2125,1.0,1.0,9/24,24.40%,RPA2;RPA3;ORC6;MCM3;MCM6;MCM7;POLE2;DBF4;MCM5
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.6428270089554039,1.1904037791218893,0.2727272727272727,0.9100851900004155,1.0,6/12,24.74%,LPL;SIRT1;FBXW7;MEST;NFKBIA;C3
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.7023375533261831,-1.1900786743352674,0.2602739726027397,1.0,1.0,2/12,12.14%,GK;DGAT1
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),-0.7857321555876264,-1.190048932639426,0.25,1.0,1.0,2/5,10.57%,H2BC11;RPL39
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.6530899878438688,-1.1898435192358916,0.225,1.0,1.0,4/19,14.34%,HIF1A;PFKFB4;PFKFB3;INSR
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",0.609307030985021,1.1896849268679006,0.3235294117647059,0.9099641512343867,1.0,4/8,17.41%,UBE2J1;YOD1;OS9;SVIP
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.6072168062945137,-1.189663366032509,0.17391304347826086,1.0,1.0,6/43,9.44%,RPL23;VIM;NOD2;DDX11;FCGR2B;CD36
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.717943325555673,-1.1895604347995288,0.2676056338028169,1.0,1.0,1/10,2.56%,VEGFA
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.6403867793404014,1.1893694292753572,0.2647058823529412,0.9087128114457493,1.0,2/10,5.66%,BCL2L1;BID
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.5434407469286063,-1.1892839350161701,0.09,1.0,1.0,34/190,11.73%,CENPF;GADD45B;RPL23;THBS1;CKS2;MX2;PPP1R15A;NR4A1;RHOB;TGFB2;DTL;WDR12;DUSP1;ALOX15B;MASTL;BRINP1;BRCA1;PPP2R3B;FIGNL1;CAMK2N1;JUNB;NOP53;HCFC1;ID2;NOTCH2;BEX2;CTBP1;SDCBP;PRR11;MED25;PIM3;IQGAP1;IRF1;RGCC
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.5641647839582511,-1.1892106098752377,0.16494845360824742,1.0,1.0,25/100,16.44%,CLEC12A;ADGRE1;CLEC4E;JAML;SLC11A1;SIRPB2;PLTP;C5AR1;TNFRSF1B;CD163;MS4A4A;MARCO;FCGR2B;FGR;IL10RA;MS4A6A;MNDA;TYMP;NCF4;FPR1;SIGLEC1;CD14;TLR2;STARD5;NCF2
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.6647906151353489,-1.1891108196127758,0.2727272727272727,1.0,1.0,7/18,12.74%,AGT;ALOX15B;ABCA5;IL18;NR1H2;CD36;ABCA1
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.7596801711314272,-1.1889863403556107,0.3108108108108108,1.0,1.0,2/9,4.62%,DNAH17;CCDC39
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),-0.7351962185768384,-1.1888899157570159,0.2647058823529412,1.0,1.0,3/6,13.73%,ERC2;RAB3A;BSN
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.6161839282393609,-1.188726791246138,0.24444444444444444,1.0,1.0,7/39,9.02%,FANCB;H1-3;H1-4;H1-2;H1-0;POLR2G;POLQ
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.6887750254838634,-1.1885544251326157,0.29411764705882354,1.0,1.0,1/9,0.99%,INSIG1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.7603603898556215,-1.188506444332261,0.24285714285714285,1.0,1.0,2/7,9.44%,DUSP1;PADI2
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.6763550442241322,-1.1883875008772404,0.23076923076923078,1.0,1.0,5/13,14.87%,CD55;TNFRSF1B;HLA-F;B2M;TRAF2
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.723812404572534,-1.1883566347957848,0.22388059701492538,1.0,1.0,2/11,2.89%,THBS1;TGFB2
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.7336480807172234,-1.1881453237574922,0.3076923076923077,1.0,1.0,4/9,18.65%,SULF2;DEAF1;DYNC2I1;PCSK5
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.5914341652480636,-1.188108472948597,0.22727272727272727,1.0,1.0,4/39,3.16%,TFRC;FTH1;SLC11A1;HAMP
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),-0.7004194032156146,-1.1880811340947834,0.23376623376623376,1.0,1.0,3/12,9.51%,TGFB2;TNFRSF1B;NOTCH2
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.634113913908016,1.188000249015369,0.22857142857142856,0.9117605735533036,1.0,2/7,9.28%,APH1A;ADAM10
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.5798922062680121,-1.1879265810202246,0.18681318681318682,1.0,1.0,16/54,17.18%,H2BC11;SLC11A1;HMGB2;HAMP;NOD2;GBP2;RPL30;FGR;COLEC12;RPL39;OAS3;PYCARD;GSDMD;TLR2;GNLY;PPP1R11
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.5950167582497503,-1.18785768258591,0.18681318681318682,1.0,1.0,6/37,15.05%,KCNE1;FHL1;CD63;KCNMA1;AKAP6;CAV3
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.7403231192009183,-1.187568087268643,0.2153846153846154,1.0,1.0,1/8,5.63%,FBP1
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.6027511530697365,1.1875605554983097,0.30303030303030304,0.9105110972402819,1.0,2/9,10.47%,NR3C1;SRC
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.596749317111658,-1.1873340989536396,0.17647058823529413,1.0,1.0,8/45,10.86%,PCSK1;GLRX2;GSTP1;TRHDE;GSTM3;SOD1;DMD;GSTK1
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.5649789246192974,-1.187098085884247,0.12121212121212122,1.0,1.0,18/118,15.95%,CENPF;PRLR;RPL38;COX7A2;CCDC39;VBP1;STXBP6;MAPT;CENPE;DMD;CALY;FCHO2;MID1IP1;ANLN;HIGD1C;AP2S1;TRAF2;NSG2
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.7692170251274274,-1.1870965887037255,0.24242424242424243,1.0,1.0,4/7,17.39%,EPB41L3;CXCR4;SOD1;CLU
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.5711038151452326,-1.186681653101616,0.10309278350515463,1.0,1.0,24/119,17.47%,THBS1;RPS4X;EIF4A3;VIM;HIF1A;PRR16;CNEP1R1;RBM3;NMD3;NR1H2;APPL1;CD36;MID1IP1;RPL5;RGCC;NR1D1;ATAD5;INSR;EIF3E;EIF3D;DNA2;IRS2;CLU;KLF4
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.7425330097982257,-1.1865763028212466,0.32857142857142857,1.0,1.0,3/7,17.27%,ANK3;CALM3;CALM1
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5626045709497685,1.1865060538155838,0.17391304347826086,0.9112628898110385,1.0,3/15,7.39%,ARFIP1;WASF2;WASF3
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.7959759442157703,-1.1862178963659737,0.2876712328767123,1.0,1.0,2/5,8.42%,PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),-0.6339261203178848,-1.1861247377189268,0.22093023255813954,1.0,1.0,1/25,0.14%,TOP2A
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.6238920413731788,1.1859314020072995,0.30434782608695654,0.9107673251648725,1.0,3/11,13.06%,ALG1;MPDU1;ALG3
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.7590944149801567,-1.185656972517358,0.3088235294117647,1.0,1.0,1/10,0.73%,THBS1
prerank,PanglaoDB_Augmented_2021__T Cells,-0.5625904359722873,-1.1855692618040197,0.1702127659574468,1.0,1.0,24/85,19.93%,CCL4;JAML;MYO1G;IL7R;CD69;RORA;SELL;TXK;CCL3;IFIT3;JUNB;CXCR4;IL10RA;TGIF1;TCF7;LSP1;CREM;GNLY;GPR65;S100A4;THY1;ARHGAP9;PARVG;CD163L1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.6003078610419562,-1.1854928223853778,0.2564102564102564,1.0,1.0,10/28,15.60%,RPS27A;RBX1;RPA2;UBA52;RFC1;UBC;RPA3;ERCC2;RFC4;UBB
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.675779645955048,1.1853872029485784,0.2608695652173913,0.9078667367090741,1.0,1/8,6.92%,MPDU1
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.675779645955048,1.1853872029485784,0.2608695652173913,0.9078667367090741,1.0,1/8,6.92%,MPDU1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.6331649224264928,-1.1849229415120726,0.22535211267605634,1.0,1.0,3/17,12.27%,NLRP12;GSTP1;CARD16
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.6047411105268924,1.1848462214142863,0.37142857142857144,0.9073838878104092,1.0,4/10,11.39%,SESN2;SESN3;EIF2AK4;RRAGD
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.663041454777796,-1.1847362828572465,0.27631578947368424,1.0,1.0,4/18,19.77%,HMGB2;H1-0;DICER1;MUS81
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.7224891310495787,-1.184589104935043,0.29333333333333333,1.0,1.0,2/10,24.52%,IL15;PLCB1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.7224891310495787,-1.184589104935043,0.29333333333333333,1.0,1.0,2/10,24.52%,IL15;PLCB1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.6498530977143149,1.184517177848453,0.35,0.9061960141765659,1.0,4/10,12.90%,SRC;MAP2K1;MAP2K2;DNAJC13
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.6581384630719526,1.1844837003442794,0.2571428571428571,0.9039097213308372,1.0,1/9,2.88%,CEBPA
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.74653012113591,-1.1844319333094855,0.2835820895522388,1.0,1.0,2/6,14.41%,SOD1;ADPRS
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.6710380164345928,-1.1842226609071782,0.20253164556962025,1.0,1.0,3/18,2.70%,HTR2B;SEMA6A;SEMA3A
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),-0.750177793917847,-1.1837724692075022,0.1746031746031746,1.0,1.0,3/8,16.90%,ADCY3;ADCY10;ADCY8
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.5856235219389511,-1.1833390544248692,0.22340425531914893,1.0,1.0,24/83,19.38%,CLEC12A;CLEC4E;JAML;SLC11A1;SIRPB2;MYLK;C5AR1;SELL;CCL3;CR1;FGR;MNDA;RASGRP4;OAS3;NCF4;FPR1;VNN2;CD14;TLR2;NCF2;S100A4;ARG2;LILRB2;AIF1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.7278739921622206,-1.1833085331097861,0.26666666666666666,1.0,1.0,2/15,7.55%,POLR2G;TENT4B
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.6142536783479692,-1.18322736484648,0.23255813953488372,1.0,1.0,14/32,25.91%,RIMS1;RAB3A;NRXN1;CPLX1;SNAP25;UNC13A;SYT1;GAD1;NRXN2;GAD2;DVL1;PIP5K1C;RIMS2;NAAA
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.6517939253869078,-1.18321480339274,0.24050632911392406,1.0,1.0,14/24,30.97%,ATP5ME;ATP5F1E;ATP5F1D;ATP5PD;ATP5F1A;ATP5MC1;MICOS13;ATP5F1C;APOO;ATP5MC3;SPG7;IMMT;AFG3L2;ATP5MC2
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),-0.7520610326044717,-1.1827603342827422,0.2,1.0,1.0,2/8,13.89%,CHST7;OGA
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.5056731246914528,1.1826850595164144,0.23076923076923078,0.9075110828916214,1.0,5/22,8.40%,ATRAID;TMEM119;TGFB1;ACVR1;PKDCC
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.6778322405633339,1.1822914151211712,0.2631578947368421,0.9063015415721021,1.0,4/12,15.64%,ENPP1;TGFB1;ANKH;NOTCH1
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.6109755432503805,-1.1821077772024593,0.23255813953488372,1.0,1.0,12/31,23.55%,RIMS1;RAB3A;NRXN1;CPLX1;SNAP25;UNC13A;SYT1;GAD1;NRXN2;GAD2;DVL1;PIP5K1C
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.7188098298595013,-1.1817359597599841,0.26666666666666666,1.0,1.0,4/14,12.47%,C5AR1;CR1;C5AR2;FPR1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.6345137321993518,-1.1816990535937713,0.24691358024691357,1.0,1.0,1/25,0.27%,NR4A3
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.5983104011123022,-1.1816821201259293,0.27586206896551724,1.0,1.0,5/28,13.92%,SEMA3A;MAPT;OLFM1;GOLGA4;MAG
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.5555900658225744,-1.1813675683610705,0.18681318681318682,1.0,1.0,10/75,10.76%,TOP2A;RPS27A;HMGB2;FAM50A;CENPV;RBX1;COPS5;UBA52;PADI2;UBC
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.6585592173200833,1.180911364930414,0.26666666666666666,0.9084168312543001,1.0,1/7,4.91%,AGO1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.7080731693708231,-1.180212101050285,0.29333333333333333,1.0,1.0,4/11,16.93%,MT2A;SLC31A2;ATOX1;CUTC
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.6895943844047473,1.1800010775988166,0.22727272727272727,0.9093369245108368,1.0,3/7,5.97%,PKD2;LOXL3;ZPR1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.7692667228528356,-1.179599756833726,0.26865671641791045,1.0,1.0,4/6,19.97%,PRKCQ;BCL6;IRS2;FOXP1
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),-0.5985135502340019,-1.1791015551273722,0.24210526315789474,1.0,1.0,22/42,30.69%,GLRA1;CFTR;SLC4A10;SLC12A8;GABRA3;GABRB1;GABRG2;ANO4;CLIC4;GABRB3;TTYH1;GABRA2;BEST1;SLC12A7;GABRB2;CLIC1;GABRA4;GLRB;SLC6A1;GABRA1;LRRC8A;ANO5
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.6571697721502412,-1.1789789816214857,0.25,1.0,1.0,3/15,12.14%,ACSL1;HSD17B12;DGAT1
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.6722626525439752,-1.1783571352992783,0.2875,1.0,1.0,13/20,24.48%,FGF1;HSPA12A;SRRM3;APLP1;VGF;ENAH;TMEM132A;SEZ6L2;CKB;RBFOX2;TMEM59L;LINGO1;NR2F1
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.5712397021959992,-1.1779370613037126,0.2087912087912088,1.0,1.0,15/52,20.11%,CENPF;FANCI;WDHD1;ZGRF1;PAICS;ATAD5;SUV39H2;KDM1A;RFC4;DNA2;POU5F1;MCM3;HK2;KIF11;KNTC1
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.5486514006351033,1.1778837710318582,0.1875,0.9139477219431548,1.0,4/20,8.11%,NDE1;TRAK2;KIF1C;KIF3B
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.7398575277242972,-1.1778216263997248,0.27941176470588236,1.0,1.0,1/8,2.81%,OVOL2
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.6849240589875822,-1.177637290073944,0.2375,1.0,1.0,4/15,19.21%,AGT;PLN;CAV3;PER2
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),-0.803156060864596,-1.177594851467348,0.24242424242424243,1.0,1.0,2/5,8.71%,TGFB2;KDM6B
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.8242373882993864,-1.1770884722135808,0.234375,1.0,1.0,1/5,2.33%,SYCE2
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.8242373882993864,-1.1770884722135808,0.234375,1.0,1.0,1/5,2.33%,SYCE2
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),-0.7433735533198884,-1.1768502880070515,0.3055555555555556,1.0,1.0,2/7,9.08%,VEGFA;RORB
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.7841302222781363,-1.1767457426594234,0.2542372881355932,1.0,1.0,1/5,15.20%,ATG2A
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.5339947787059015,-1.1766341596822716,0.1,1.0,1.0,51/294,14.50%,HTR2B;PRLR;TFRC;THBS1;ARAF;RPS27A;NAA38;RNF144B;LRP2;VEGFA;ALOX12;PRELID1;BCL2A1;BEX3;CFL1;NR4A2;IL7;GSTP1;IFIT3;RPS3A;DDRGK1;FAIM2;FIGNL1;COPS5;ATF5;PINK1;TNFAIP8;SOD1;HSPA1B;NUAK2;UBA52;NOTCH2;TPT1;TLE1;TMEM14A;BNIP3L;BNIP1;BCL2L2;STIL;UBC;BNIP3;PIM3;HSPA5;APIP;CARD16;PTMA;HCLS1;PTPRZ1;MAG;CD44;SNX6
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),-0.7735970891231196,-1.1765607473859534,0.2647058823529412,1.0,1.0,1/5,0.44%,SRGN
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.7133583900873849,-1.1765508285132429,0.3611111111111111,1.0,1.0,1/10,0.24%,GPR18
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.614560102083767,1.1762960760304806,0.25,0.9144498618429688,1.0,3/10,11.39%,SESN2;SESN3;RRAGD
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.614560102083767,1.1762960760304806,0.25,0.9144498618429688,1.0,3/10,11.39%,SESN2;SESN3;RRAGD
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.6608873338651167,1.1760705900546704,0.3333333333333333,0.9127000557707542,1.0,4/10,12.52%,HP1BP3;BAHD1;SIRT1;SETD7
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.7918986391368753,-1.1759500797633444,0.2903225806451613,1.0,1.0,1/5,3.11%,RSAD2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.7918986391368753,-1.1759500797633444,0.2903225806451613,1.0,1.0,1/5,3.11%,RSAD2
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.699964459796992,1.1758759964857706,0.3333333333333333,0.9109591094761205,1.0,1/5,1.95%,TEX264
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.5845941663054223,1.1756582944470135,0.25925925925925924,0.9095858494111357,1.0,4/18,10.23%,LCP1;FMNL3;STRIP1;FHOD1
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.5781851984490455,1.1756549959280018,0.1875,0.9072947011758432,1.0,4/13,7.16%,LGALS9;FER;SYK;GAB2
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.6854452530482281,-1.1755484870693027,0.26582278481012656,1.0,1.0,1/15,0.57%,NLRP12
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.5858566097533745,1.1754587323194168,0.36363636363636365,0.9056697314065028,1.0,3/10,14.09%,PLA2G7;CXCL12;SERPINE1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.6982786677981699,-1.1754058312088835,0.25,1.0,1.0,6/14,18.37%,ATP5ME;ATP5F1E;ATP5F1D;ATP5PD;ATP5F1A;ATP5MC1
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.6885141132168042,-1.175405801000509,0.34285714285714286,1.0,1.0,2/11,6.41%,WDR5;BRCA1
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.7930762799020838,-1.1750838625434716,0.2647058823529412,1.0,1.0,3/5,16.14%,CCDC39;SPATA6;BBOF1
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),-0.8476227647258705,-1.175026703951263,0.23076923076923078,1.0,1.0,4/5,13.77%,PTN;TNFRSF1B;CXCR4;PTPRZ1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.7409780859640722,-1.174578154599799,0.22058823529411764,1.0,1.0,2/8,11.86%,TRIM25;OAS3
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.7584905817498865,1.1740096046355633,0.27586206896551724,0.9050497337441451,1.0,2/5,9.69%,ENPP1;INPP5K
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.7584905817498865,1.1740096046355633,0.27586206896551724,0.9050497337441451,1.0,2/5,9.69%,ENPP1;INPP5K
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.6822723777719616,-1.173666148431831,0.18181818181818182,1.0,1.0,3/21,2.70%,THBS1;SEMA6A;SEMA3A
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.6779267231035451,1.1735434149330475,0.41935483870967744,0.9044762401641625,1.0,1/7,3.34%,NUAK1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.5355681610552818,-1.1728491765613789,0.09,1.0,1.0,32/236,9.24%,NR4A3;NAMPT;HTR2B;PRLR;RPL23;THBS1;RPS4X;OSMR;TBC1D8;FGF1;AGT;VEGFA;TSHR;TGFB2;RPS6;RBPJ;C5AR1;IL7R;PTN;AQP11;MEIS2;IL7;FLT1;NOD2;DDRGK1;CR1;RPS9;IL15;STAT1;IL18;LAMB1;ID2
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.5321428048201235,-1.172673855169297,0.16,1.0,1.0,25/162,12.24%,DDIT4;NAMPT;SLC2A3;TFRC;GLA;INSIG1;NFIL3;PPP1R15A;BHLHE40;ME1;TUBA4A;ERO1A;SLC7A5;EGLN3;COPS5;SERP1;GAPDH;RDH11;CXCR4;PGK1;PSMA3;PPA1;HSPA5;TOMM40;TM7SF2
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.6885257436885688,1.172556672598734,0.2962962962962963,0.9050840562898166,1.0,3/6,12.63%,LYST;CHMP2B;UBXN6
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),-0.7178181083794659,-1.1725372984908036,0.28378378378378377,1.0,1.0,2/11,2.70%,SEMA6A;SEMA3A
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.6684868261477352,1.1723075675188257,0.3333333333333333,0.9038373925951276,1.0,4/7,22.85%,ACADS;PCK2;MMAA;PCCB
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.6622025599630135,-1.1714446535369232,0.23684210526315788,1.0,1.0,4/13,14.47%,VEGFA;PTN;SMARCD3;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.7883640844678745,-1.1704606639319708,0.29411764705882354,1.0,1.0,3/6,8.42%,TOMM7;PINK1;ATP5IF1
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),-0.7916121654454336,-1.1703434298993323,0.24193548387096775,1.0,1.0,2/5,9.59%,ALOX15B;PAX8
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.6719238120775062,-1.1699171611606183,0.3466666666666667,1.0,1.0,7/14,17.77%,RPL23;RPS20;RPL37;RPS15;RPS7;UBB;HEXIM1
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),-0.6757827174598418,-1.1699057868716425,0.3013698630136986,1.0,1.0,2/14,15.06%,SLC11A1;DMXL2
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.7950058516573149,-1.1697219936222358,0.3559322033898305,1.0,1.0,1/5,15.28%,TAP1
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.6103267542839583,-1.1695300695556472,0.25609756097560976,1.0,1.0,9/30,15.68%,MDH1;FBP1;AKR1B1;GAPDH;PGK1;ENO2;PGAM1;PGM1;SORD
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.5861434102302426,-1.1694763346926198,0.26136363636363635,1.0,1.0,15/44,17.91%,P4HA3;TGFB2;ADAMTS2;COL21A1;COLGALT2;COL26A1;COL11A1;COL10A1;COL4A5;COL23A1;P4HA1;COL19A1;ITGA6;PLEC;PPIB
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.5702244988354225,-1.1693391858021307,0.20652173913043478,1.0,1.0,55/97,31.25%,AMER2;KIF1B;HSPA12A;KCNMA1;TRPM3;PAK5;RAB3C;TMEM130;NRXN1;GRIA4;GDAP1L1;NEFM;FRRS1L;PCSK2;KCNC1;SNAP25;GABRG2;SYT4;SCN1A;AMPH;CLVS2;SCN3B;RNPC3;SYP;ATP1B2;SLC24A2;STMN2;GAD2;ST8SIA3;CACNA2D3;CADM2;NTRK3;NTNG1;FRMD3;SV2B;SLC1A2;CADPS;CA10;HCN1;GRIA2;VSTM2B;CACNA1B;SCG3;MAGI2;CNTNAP2;SRRM4;NCAM1;SCN2A;PPFIA2;ATCAY;GABRA1;LSAMP;NAPB;SGIP1;OLFM3
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.5762494678637317,-1.1691585176456007,0.1956521739130435,1.0,1.0,10/50,14.79%,SLC2A3;TFRC;LRP2;SLCO3A1;SLC7A5;ABCC3;SLC16A7;SLC16A1;INSR;ABCB1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.6054306198082094,1.168688954190314,0.3333333333333333,0.9144110728015221,1.0,8/14,19.00%,P2RY12;ABI3;DEF8;EPS8;EVL;PLEKHM1;PFN1;P2RX4
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.7493135826816703,1.1686350416842577,0.3684210526315789,0.9123872131227561,1.0,3/5,23.45%,IL1B;NOTCH1;PRKCI
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.7428311104781591,-1.168313053256328,0.30303030303030304,1.0,1.0,2/6,5.46%,OSMR;GSTP1
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.5971822383050522,-1.1682393313386163,0.24691358024691357,1.0,1.0,6/33,7.63%,CGNL1;PLPP3;AGT;THSD4;ACSL1;FAXDC2
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),-0.7553580589470646,-1.1680585644296257,0.25,1.0,1.0,1/8,1.61%,NFIL3
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.639597997503574,-1.1680501850507612,0.2682926829268293,1.0,1.0,9/34,20.29%,CASP5;BASP1;PLP1;CALM3;PADI2;HSPA5;CALM1;SUDS3;CKB
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.694329728666358,-1.1680437289730423,0.2702702702702703,1.0,1.0,1/9,8.68%,SOD1
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.7172941153324115,-1.1678790853255592,0.2702702702702703,1.0,1.0,4/7,22.04%,ACSS3;HMGCL;ACAT1;SLC27A5
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.4983242107741345,1.1669713533764172,0.18181818181818182,0.916032526756088,1.0,11/29,14.47%,NRP1;SERPINF2;LPAR1;ABL1;PPM1F;SORBS3;NF2;FHOD1;TGFBR1;CDC42;EVL
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.6535919113512307,-1.1667363829230177,0.2894736842105263,1.0,1.0,5/23,12.95%,HTR2B;ADGRG6;CD36;NUDT4;AKAP6
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.6049569392659527,-1.1664304307430882,0.2558139534883721,1.0,1.0,6/39,8.09%,CCL4;MYLK;CACNB2;CCL3;PLN;ANK2
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.6266756683184111,-1.1661917298267526,0.3058823529411765,1.0,1.0,2/17,5.75%,SLC11A1;NOCT
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.5846037202755494,-1.1661176766003858,0.2235294117647059,1.0,1.0,10/36,18.97%,EYA2;SLF1;DDX11;BRCA1;ZCWPW1;TMEM161A;RPS3;TIMELESS;FMN2;ABRAXAS1
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),-0.8011308681670779,-1.1661072278925069,0.2608695652173913,1.0,1.0,3/6,18.00%,GLA;CAV3;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.7639848471348658,1.166036504744695,0.3157894736842105,0.9166044820286214,1.0,2/5,6.37%,TMEM106A;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.7844718675596636,-1.165616669451443,0.265625,1.0,1.0,1/5,9.44%,CD36
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.7123587638835953,1.1655869805669625,0.35,0.9160995918073725,1.0,3/6,10.19%,NPR2;GUCY1A1;PDE9A
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.6955377527532716,-1.165193464903928,0.28,1.0,1.0,2/13,0.82%,GDPD1;ENPP2
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.6445760378845163,-1.165087765933835,0.26506024096385544,1.0,1.0,6/22,15.69%,SPOCK1;NR4A2;FAIM2;MAPT;AGTPBP1;TOX
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.4805014030926611,1.1647408068097507,0.2222222222222222,0.9174214730183718,1.0,10/21,23.46%,TP53;IL1B;ANP32B;YWHAE;BAG3;TCF7L2;TPR;GSK3B;SP100;RANGAP1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.6584982364080156,-1.1643681084800275,0.2804878048780488,1.0,1.0,3/21,6.34%,PRELID1;AIM2;CR1
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.6150731415541429,-1.1642548909423476,0.25,1.0,1.0,10/43,12.10%,THBS1;MT2A;HAMP;HIF1A;NDRG1;MAPT;CALM3;TTN;ATP5F1D;KCNMA1
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.6190834114842364,1.1642017885415992,0.37142857142857144,0.916945939571063,1.0,4/9,9.69%,ENPP1;APPL2;IL1B;INPP5K
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.6959762758380604,-1.1639906831555678,0.3291139240506329,1.0,1.0,7/11,26.87%,SHANK3;TSHZ3;NLGN3;NRXN1;RELN;NLGN2;CACNG2
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.5989589476853282,-1.163737497855986,0.2413793103448276,1.0,1.0,13/34,26.77%,RHOB;RACGAP1;ANK3;CIT;ANLN;INCENP;STMN1;PDCD6IP;MYH10;SPAST;TTC19;EFHC1;ROCK1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.557451791064748,1.1636787626135894,0.2962962962962963,0.9161269248890651,1.0,8/17,20.67%,LATS2;AMOTL1;DVL2;YWHAE;WWTR1;MOB1B;STK3;MOB1A
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),-0.6703449366458047,-1.16365683004342,0.2441860465116279,1.0,1.0,4/19,10.31%,HTR2B;C5AR1;TXK;RASGRP4
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.6028886070547497,-1.1632429791254864,0.24390243902439024,1.0,1.0,16/34,25.54%,MPG;RPA2;NEIL1;POLQ;RFC1;RPA3;ADPRS;RFC4;POLL;DNA2;LIG3;ERCC6;XPA;TDG;PARG;WRN
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.6285910735449535,-1.1631984464354408,0.25333333333333335,1.0,1.0,6/19,15.05%,VEGFA;ANK2;DMD;TTN;KDM1A;CAV3
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.5133781364019219,1.1628095750165144,0.2857142857142857,0.9169791731327895,1.0,5/19,12.63%,LYST;VTA1;LAPTM4B;CHMP2B;UBXN6
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),-0.8291815688115137,-1.1622302214134492,0.1935483870967742,1.0,1.0,3/5,11.86%,HMGB2;NEIL1;OAS3
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),-0.7261864336706134,-1.1621164619140123,0.2676056338028169,1.0,1.0,1/9,2.59%,HMGB2
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.7556573951049383,-1.1618760685651177,0.25757575757575757,1.0,1.0,1/8,0.30%,SOCS3
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.7105146192653431,-1.1618410416091287,0.27692307692307694,1.0,1.0,4/9,25.10%,BRCA1;LRIF1;SMCHD1;MACROH2A2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.6796010996915112,-1.1613745222380842,0.27848101265822783,1.0,1.0,3/17,3.30%,VEGFA;RBPJ;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.6869255180242819,-1.1612668922552432,0.30434782608695654,1.0,1.0,6/10,26.69%,CR1;BCL6;LILRB2;IL4I1;HLA-DRA;DUSP10
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.8121131661423846,-1.1612484560931702,0.2638888888888889,1.0,1.0,2/5,8.63%,NR4A3;DOCK5
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.5715426963645709,-1.1603894816580356,0.22340425531914893,1.0,1.0,15/56,18.11%,GPR18;CD55;TACR1;C5AR1;JPH1;ACKR4;CXCR4;CD36;C5AR2;FPR1;CAV3;GPR65;ADCY8;CACNA1C;CALCR
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),-0.7269800065983738,-1.160294958813738,0.3333333333333333,1.0,1.0,3/6,15.61%,DPYD;ALDH6A1;DPYS
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),-0.7216883705170786,-1.160233432698658,0.3472222222222222,1.0,1.0,4/7,19.24%,DDX11;PARP9;MED25;DTX3L
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.6210153435307744,-1.1600362313958898,0.25316455696202533,1.0,1.0,3/24,5.41%,DIAPH3;CATIP;COBL
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.33327445362059527,1.159827256010653,0.0,0.925111182685536,1.0,39/189,13.50%,GSN;BBS9;EHD4;NRP1;AVIL;KIF27;RAP1A;P2RY12;EXOC8;MAP4K4;SRGAP2;CDC14B;STK36;FSCN1;WDR35;MKKS;RAPGEF6;RAB3IP;VCL;WHAMM;TCTN3;STK26;CEP41;OCRL;KIF3B;ABCC4;SHTN1;INPP5K;CEP290;RAP2A;CCDC66;DYNLL2;CFAP70;FGD2;PTPRO;P2RX7;CILK1;IQCB1;POC1B
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.70048168550861,-1.1596318300909185,0.3380281690140845,1.0,1.0,4/9,10.99%,HIF1A;NEFL;MAPT;SYBU
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.6757614680476574,1.1595308989134807,0.3333333333333333,0.9240781278728448,1.0,2/5,11.76%,SIRT1;DIPK2A
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.7341995394873034,-1.159442052243713,0.30303030303030304,1.0,1.0,6/8,24.40%,DONSON;MCMDC2;MCM3;MCM6;MCM7;MCM5
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.7324143242928729,-1.1593068330791891,0.29411764705882354,1.0,1.0,6/11,22.54%,TUBB4A;CLIP3;STMN1;STMN2;EML2;MAP2
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),-0.6097888257295329,-1.1592393705019952,0.32967032967032966,1.0,1.0,8/30,18.69%,GLRA1;CFTR;SLC12A8;GABRA3;GABRB1;GABRG2;ANO4;GABRB3
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),0.563321778948586,1.1591698740117813,0.32,0.9232212827873856,1.0,6/15,13.03%,METTL16;FBL;TFB1M;BUD23;NSUN4;MTERF4
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.7361210819625743,-1.159001855235608,0.3333333333333333,1.0,1.0,2/8,18.84%,RAB11A;LIMK2
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.37769637112168764,1.1588519712282688,0.14285714285714285,0.9219699782309979,1.0,6/105,3.54%,TNFAIP8L3;NFYC;RUBCNL;SC5D;PPARG;PRKAB2
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.5340718707746672,-1.1586999011734476,0.2,1.0,1.0,16/89,13.81%,GPR18;JAML;MYO1G;AIM2;CD69;NAPSB;SELL;IL7;FCGR2B;FGR;IL10RA;MNDA;ACAP1;NCF4;LSP1;VNN2
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.6698327559381906,-1.1585970014501143,0.24324324324324326,1.0,1.0,3/16,4.62%,ANKUB1;ATP5MK;CCDC39
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.7866414000937232,-1.1585675637066934,0.22033898305084745,1.0,1.0,3/5,15.05%,TTN;CDH2;CAV3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.686870979466006,-1.1585494441587345,0.3333333333333333,1.0,1.0,1/11,0.73%,THBS1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.5781640609903612,-1.1582468683726708,0.2558139534883721,1.0,1.0,4/41,6.41%,DDIT4;BCL2A1;TNFRSF1B;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),-0.6187724353339067,-1.1581060303344475,0.33766233766233766,1.0,1.0,1/24,0.08%,DDIT4
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.6396131301976312,-1.157956944358318,0.2804878048780488,1.0,1.0,3/21,13.90%,SOCS3;IL10RA;GHR
prerank,GO_Biological_Process_2021__lipoxin biosynthetic process (GO:2001301),-0.7747564677393324,-1.157763010570121,0.25925925925925924,1.0,1.0,2/5,5.18%,ALOX12;ALOX15B
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.5798175998869917,-1.15766571040318,0.24468085106382978,1.0,1.0,7/55,8.14%,H2BC11;HMGB2;H1-3;H1-4;H1-2;H1-0;SMARCD3
prerank,GO_Biological_Process_2021__granulocyte migration (GO:0097530),-0.7255310743402964,-1.1576441779530473,0.3088235294117647,1.0,1.0,1/6,5.14%,CCL3
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.5480019745424314,-1.1575496092365902,0.2717391304347826,1.0,1.0,2/63,0.44%,PCSK1;SRGN
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.6516615687506537,1.1570093856908854,0.3333333333333333,0.9249281192688193,1.0,1/6,3.15%,ARFIP1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.5306082974636902,1.1567429590835,0.2962962962962963,0.923565383662625,1.0,2/16,0.97%,SLC25A18;SLC7A8
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.6894621232434627,1.1563128099419362,0.325,0.9229440708622572,1.0,2/6,27.42%,FAS;AKT1
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.7011229670441583,-1.1560509358575808,0.3116883116883117,1.0,1.0,5/13,22.31%,SCO2;COX20;TIMM21;BCS1L;SCO1
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.6064049221883636,-1.1557661715911132,0.3,1.0,1.0,2/17,7.52%,HERPUD1;SEC61B
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),-0.7893694781978996,-1.1556481627794257,0.3870967741935484,1.0,1.0,1/5,3.97%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),-0.7893694781978996,-1.1556481627794257,0.3870967741935484,1.0,1.0,1/5,3.97%,SLF1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),-0.7893694781978996,-1.1556481627794257,0.3870967741935484,1.0,1.0,1/5,3.97%,SLF1
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.7558027575135842,-1.1555318459514703,0.32857142857142857,1.0,1.0,1/8,0.30%,SOCS3
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.7075194754426372,-1.1554136682158769,0.3287671232876712,1.0,1.0,1/10,3.23%,ACSL1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.7193887916022692,-1.1553660725562085,0.3717948717948718,1.0,1.0,2/9,9.87%,MT2A;ATP5F1D
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.4263180794511138,1.1551760284881523,0.06666666666666667,0.924384227679923,1.0,8/47,10.96%,MATK;TGFA;NCK2;TGFB1;PTPN12;CBL;SRC;GAREM1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.715745254303533,-1.1550804335745217,0.2602739726027397,1.0,1.0,3/10,18.79%,TERF2IP;BRCA2;TPP1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.6423300181111511,-1.1549222274348452,0.2875,1.0,1.0,3/20,3.82%,TGFB2;RBPJ;PTN
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.5600493340756751,-1.1548878387839145,0.2696629213483146,1.0,1.0,10/56,16.04%,CCL4;CHI3L1;CCL3;GBP2;BRCA1;PID1;NR1D1;PYCARD;RPS3;TNFRSF21
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.6886755726162229,-1.1547844058235082,0.30666666666666664,1.0,1.0,3/13,16.45%,FA2H;CAV3;ANXA2
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.48780524206552706,1.1547600612350422,0.3888888888888889,0.9235107352853025,1.0,8/22,19.76%,PEX13;PEX16;PEX5;GDAP1;PEX2;ZFAND6;ABCD3;ATAD1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.49524749412222824,1.1546209297185968,0.2777777777777778,0.9217713634144897,1.0,6/23,8.83%,NEXMIF;ZNF703;TGFB1;PPM1F;JAG1;NF2
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),-0.7065919818040445,-1.1545193094694048,0.29333333333333333,1.0,1.0,3/10,13.44%,TNFRSF1B;IL18;NR1D1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.5823002815148564,-1.1544309203171694,0.26666666666666666,1.0,1.0,19/50,22.57%,PLPP3;FAM13C;PTN;MAP1B;ANK2;LAMB1;ADGRL2;SVEP1;LIFR;LRP4;CPE;FBXL7;THY1;GPRC5B;ALDH1A2;CALD1;MPDZ;RUNX1T1;CRYAB
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.594554635989994,-1.1543658395319119,0.22988505747126436,1.0,1.0,4/31,12.24%,PRLR;INSIG1;FAXDC2;TM7SF2
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),-0.7211781466706465,-1.1540288315710994,0.208955223880597,1.0,1.0,3/9,16.90%,ADCY3;ADCY10;ADCY8
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.6652971961403679,-1.153842380431894,0.323943661971831,1.0,1.0,2/15,2.72%,NUDT16;HINT1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),-0.6457397176046398,-1.153761171631544,0.27586206896551724,1.0,1.0,5/25,10.31%,HTR2B;C5AR1;TXK;FLT1;RASGRP4
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.7858771016355992,-1.1536217868284795,0.3,1.0,1.0,1/5,5.79%,DDRGK1
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),0.7153429858878554,1.1535259659139423,0.41935483870967744,0.9231480811335021,1.0,1/6,6.73%,SYK
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.7914266600134621,-1.153493756123165,0.22950819672131148,1.0,1.0,1/5,10.52%,CMPK2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7105264940842327,1.1533598541060257,0.22580645161290322,0.9213898364089886,1.0,3/5,24.20%,ADRA1A;ADRB2;ADCY9
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),-0.7404596949085742,-1.1529005969288268,0.2753623188405797,1.0,1.0,2/8,5.89%,SLC11A1;GBP2
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.5336089825734017,-1.1528661180612403,0.1875,1.0,1.0,26/140,14.02%,NR4A3;CLEC12A;CCL4;ADGRE1;KMO;JAML;SLC11A1;VCAN;RAB7B;TNFRSF1B;CD163;HLA-B;PLAC8;FCGR2B;FGR;CXCR4;IL10RA;MS4A6A;MNDA;PDCD1LG2;ITGAE;NCF4;LSP1;HCLS1;VNN2;CD14
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.7072229174489446,-1.1526841695351095,0.3380281690140845,1.0,1.0,2/11,8.92%,ANK3;DMD
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.6957639515511758,-1.1524273640775096,0.38235294117647056,1.0,1.0,2/10,6.75%,MEI1;ZCWPW1
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.688531772112633,-1.1519868687145147,0.22666666666666666,1.0,1.0,4/15,4.62%,CHI3L1;FGF1;VEGFA;CCDC39
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.6428619405468935,-1.151957141207823,0.19540229885057472,1.0,1.0,8/24,13.90%,SOCS3;VEGFA;IL15;PARP9;IL18;HCLS1;PARP14;GHR
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.5501948174339065,1.15184633352918,0.29411764705882354,0.9214845192666026,1.0,3/11,5.83%,SUPT16H;HMGA1;ARID1A
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.5501948174339065,1.15184633352918,0.29411764705882354,0.9214845192666026,1.0,3/11,5.83%,SUPT16H;HMGA1;ARID1A
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),0.6351545761036872,1.1517187061044687,0.41379310344827586,0.9198812060066177,1.0,3/8,18.96%,INPP5K;TASOR;SETDB1
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.7081978736080617,-1.151625986686726,0.3088235294117647,1.0,1.0,3/8,10.39%,LRP2;CBR1;PIAS4
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.587344616571818,-1.151583871727535,0.23595505617977527,1.0,1.0,6/31,10.30%,RPL11;AQP11;DDRGK1;NOP53;CAMLG;SDCBP
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.6738599447482236,-1.1515346283516796,0.3048780487804878,1.0,1.0,2/13,2.48%,MX2;IFITM3
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.69453852083811,-1.1512170340737018,0.3466666666666667,1.0,1.0,1/10,2.39%,VCAN
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),-0.7728417666166499,-1.1504808042153203,0.2777777777777778,1.0,1.0,1/7,2.46%,AGT
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.8063800262148763,-1.150396390720438,0.25806451612903225,1.0,1.0,1/5,2.73%,ALOX12
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.6303662801438478,-1.150378411910913,0.3048780487804878,1.0,1.0,1/21,0.40%,HTR2B
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.5510415940327507,-1.15009668604195,0.2,1.0,1.0,14/69,9.60%,PRLR;CD55;PLPP3;AGT;VASN;TNS1;RXRB;SLC16A3;ABLIM3;NTN4;NR1H2;PADI2;NOTCH2;MRO
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.5508457587569586,-1.1493162034717348,0.16666666666666666,1.0,1.0,31/90,19.66%,CLEC12A;CCL4;SLC11A1;SIRPB2;C5AR1;TNFRSF1B;CCL3;MS4A4A;MARCO;FCGR2B;FGR;KLHDC4;CD36;MS4A6A;TRIM25;MNDA;TYMP;PLET1;NCF4;FPR1;NR1D1;SIGLEC1;CD14;MPP1;TLR2;NCF2;S100A4;FCGR2C;LILRB2;AIF1;GPNMB
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.6356794786504797,-1.1490408744905682,0.28205128205128205,1.0,1.0,7/24,19.80%,BRCA1;PINK1;BTN2A2;SDCBP;LRPAP1;SIRT5;TRAP1
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6240896422380384,1.1489486950215586,0.30434782608695654,0.9263655214438619,1.0,2/9,4.94%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.5834814564542974,-1.1489269058668945,0.25882352941176473,1.0,1.0,14/40,22.94%,MDH1;FBP1;GAPDH;PGK1;ENO2;PGAM1;APOD;PGM1;SORD;IRS2;PER2;GAA;GPI;ENO1
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.6249158261532348,-1.1487863647909347,0.2676056338028169,1.0,1.0,5/19,13.34%,HDGFL3;FGF13;APC2;MID1IP1;TTBK2
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),-0.8162012361559231,-1.1480603424431204,0.3384615384615385,1.0,1.0,2/5,10.57%,PLN;PDE4B
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.6657113618840365,-1.1478860362290855,0.3291139240506329,1.0,1.0,3/13,8.93%,VIM;DMD;TTN
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.6657113618840365,-1.1478860362290855,0.3291139240506329,1.0,1.0,3/13,8.93%,VIM;DMD;TTN
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.5906785858276894,-1.1477184628952972,0.2247191011235955,1.0,1.0,11/38,14.70%,RBPJ;GSTP1;IL15;BTN2A2;NR1H2;PCTP;CCDC3;ACOT13;ARRDC3;NR1D1;ALDH1A1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.630518281910339,1.1475538190474053,0.34375,0.9287613488934974,1.0,2/10,14.09%,ICAM1;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.5643690244228173,-1.1475143769260758,0.25,1.0,1.0,7/42,11.53%,ARIH2;TOMM7;VPS11;ABLIM3;RHOU;PINK1;USP36
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.6554792476163828,1.1475067333176288,0.4,0.926628981774821,1.0,3/6,11.77%,NRP1;ABL1;RIT2
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.49239570219266093,1.1474830715579347,0.30434782608695654,0.9245614678115103,1.0,2/18,6.16%,MED24;TP53
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.5492148578262595,-1.1474819111515402,0.2891566265060241,1.0,1.0,7/45,9.39%,NEK11;DTL;RPA2;BRCA1;DONSON;NOP53;CLSPN
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.5763766592240769,-1.1472182102028907,0.26666666666666666,1.0,1.0,8/43,10.19%,TFRC;GPR183;VAV3;IL7;IL15;IL18;PDCD1LG2;TNFSF13B
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.7136990741768907,-1.1471637198242781,0.3108108108108108,1.0,1.0,2/10,10.32%,NMD3;RPS15
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.6081956418420669,-1.1470241477078065,0.29069767441860467,1.0,1.0,6/31,8.65%,NLRP12;TOM1L1;VEGFA;PPP2R5A;PPP2R5B;CALM3
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.6334260029724303,1.1470018722882538,0.36,0.924066208098426,1.0,1/10,3.73%,SORL1
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.7007365864177239,-1.1464595677401885,0.2676056338028169,1.0,1.0,3/10,16.61%,INSIG1;HSPA5;KDELR1
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.7500547174578809,-1.1463914342822699,0.35384615384615387,1.0,1.0,2/6,16.17%,GLUL;SNAP25
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.551243039495214,-1.1460313075718913,0.23711340206185566,1.0,1.0,10/76,11.80%,SLC38A4;CENPF;LRP2;SLC11A1;SLC16A10;SLC7A5;SCAMP3;SLC6A15;TXNIP;ARRDC3
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.6472552764885569,-1.1459140445705966,0.3291139240506329,1.0,1.0,2/13,8.29%,THBS1;EIF2B2
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.3858474365466672,1.1458899590403084,0.16666666666666666,0.9253784789127345,1.0,10/99,4.94%,PHLDB2;SERPINF2;SMAD7;CBFB;MOSMO;NSUN2;TGFB1;BIN1;DAG1;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.7465543064471398,-1.1457717437594988,0.30434782608695654,1.0,1.0,2/6,13.71%,MDFIC;APOD
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.7465543064471398,-1.1457717437594988,0.30434782608695654,1.0,1.0,2/6,13.71%,MDFIC;APOD
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.6492661556472726,-1.1456802946624052,0.34177215189873417,1.0,1.0,5/15,24.15%,WDR5;BRCA1;KDM1A;DNMT1;CTR9
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.4381232830407288,1.145474577971014,0.08333333333333333,0.9243651252801446,1.0,3/37,1.75%,NUP42;NUP188;RUBCNL
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.6052665917111888,-1.145443268587523,0.32051282051282054,1.0,1.0,3/23,9.39%,BRIP1;DONSON;CLSPN
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.5518365086642993,-1.1452672467088125,0.25,1.0,1.0,17/92,8.90%,CD55;FOSL2;VIM;HHIP;ASPN;NR4A1;SPARC;VEGFA;ADAMTS2;TNS1;HIF1A;LAMA2;TNFRSF1B;NR4A2;SPON2;FGR;LAMB1
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.50720188159174,1.1451159446958834,0.25,0.9232475251091973,1.0,5/21,8.40%,ATRAID;TMEM119;TGFB1;ACVR1;PKDCC
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.4410062329612098,1.144905090158864,0.1875,0.9218362479516738,1.0,6/25,6.92%,ST6GALNAC3;GAL3ST4;MAN2B2;ST8SIA4;IDUA;MPDU1
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.7476805983027673,-1.1447397958844785,0.3333333333333333,1.0,1.0,1/5,2.76%,GLUL
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.6661758948259742,-1.1446974389160471,0.2948717948717949,1.0,1.0,4/13,11.44%,PPP1R15A;DNAJB9;DDRGK1;HSPA5
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.648027943030798,1.1446598408321635,0.37037037037037035,0.9204314297285097,1.0,3/5,19.14%,CSF1R;FERMT2;MYADM
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.7140638149287275,-1.1446507712925744,0.39436619718309857,1.0,1.0,4/10,9.44%,OR3A2;C5AR1;ADCY3;CD36
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.38084787289456584,1.1442417490351822,0.16666666666666666,0.9197901441459861,1.0,13/67,14.85%,PEX13;NUP188;IPO13;PEX16;E2F3;SYK;APPL2;NUP214;PPP1R10;PEX5;GDAP1;NUTF2;RANBP6
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),0.650262764670773,1.1441919067616815,0.358974358974359,0.9178568201893343,1.0,2/7,6.37%,TMEM106A;SIRT1
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.6746821707876066,-1.1440845226324876,0.2894736842105263,1.0,1.0,4/16,4.62%,CHI3L1;FGF1;VEGFA;CCDC39
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.6915307493366982,1.1440456881576555,0.2903225806451613,0.9163091223190246,1.0,3/5,14.26%,NCK2;SRC;NCK1
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.6666128939609129,-1.1438991247436274,0.2682926829268293,1.0,1.0,3/15,15.46%,CENPV;MAPT;TERF2IP
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.7294377071392162,-1.1435014555385412,0.3333333333333333,1.0,1.0,1/6,10.79%,CD63
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.7294377071392162,-1.1435014555385412,0.3333333333333333,1.0,1.0,1/6,10.79%,CD63
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.5957399275499626,-1.1434660350503127,0.2777777777777778,1.0,1.0,6/21,17.81%,OVOL2;UGCG;TXNIP;ERCC2;ST14;CLIC4
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.6084845130044316,-1.143288327802173,0.3125,1.0,1.0,7/27,14.41%,MDH1;FBP1;GAPDH;PGK1;ENO2;PGAM1;PGM1
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.5273548013092033,-1.1431859438151077,0.19148936170212766,1.0,1.0,25/127,12.01%,DDIT4;MDH1;SAP30;TALDO1;VCAN;VEGFA;ME1;PKP2;SLC16A3;MXI1;ERO1A;FAM162A;EGLN3;ANKZF1;CXCR4;SOD1;GPC3;PDK3;PPFIA4;PGK1;ENO2;PGAM1;HSPA5;TGFBI;PKM
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.5717786862662371,-1.143103464501,0.30864197530864196,1.0,1.0,17/48,23.17%,TRIM5;IFITM3;RSAD2;MX1;STAT1;OAS3;IFIT1;IFIT5;PLSCR1;ILF3;ZC3HAV1;HEXIM1;TRIM14;EIF2AK2;TNIP1;TRIM13;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.6877635806925598,-1.1427002819340477,0.273972602739726,1.0,1.0,1/10,2.56%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.5293785547011287,-1.1426080228930542,0.11,1.0,1.0,58/291,16.69%,HTR2B;TFRC;RPL23;THBS1;RPS4X;EIF4A3;VIM;SLC11A1;FGF1;AGT;RBMS3;VEGFA;OVOL2;RIMS1;RBPJ;HIF1A;RPL11;PRR16;TXK;CCL3;DDRGK1;ANK3;BRCA1;RBM3;TENT4B;FGR;IL15;CAMK2N1;GAPDH;ANK2;POLR1C;SOD1;HSPA1B;TTN;HCFC1;ID2;CD36;TLE1;ITGB8;BTN3A1;EIF2AK3;OLFM1;RPL5;RGCC;EPB41L4B;RPS7;FN1;PID1;SNF8;RDX;RPS3;PIK3CB;TLR2;PLSCR1;EIF3E;HMGN5;EIF3D;TAF1D
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.5477986616841385,-1.1424838438183325,0.26881720430107525,1.0,1.0,5/52,10.39%,CYREN;HMGB2;BRCA1;POLQ;PIAS4
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.6735347763792336,-1.142460953032757,0.3157894736842105,1.0,1.0,1/20,0.02%,KCNE1
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.4783656021720068,1.1423523750117104,0.2,0.9196562321284044,1.0,4/25,9.17%,ZMYND11;SUPT16H;WDR43;BRD4
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.6864607943520507,1.1422301380754092,0.3333333333333333,0.9178435141340561,1.0,4/7,20.21%,IPPK;POMK;FGGY;ITPK1
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.6726035020538516,-1.142190233531344,0.34328358208955223,1.0,1.0,3/13,8.89%,THBS1;TGFB2;ABCB4
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.5396710858120991,-1.142149127089936,0.24210526315789474,1.0,1.0,16/106,9.33%,PAQR3;PPP1R15A;TUB;FSIP2;RPL11;CNEP1R1;DDRGK1;GBP2;RPA2;RAB11A;SEC61B;SERP1;ANK2;SNX10;SSB;DDX1
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.5946980031208582,-1.1421482465396664,0.2345679012345679,1.0,1.0,8/26,16.60%,MPG;RPA2;NEIL1;RFC1;RPA3;ADPRS;RFC4;POLL
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.5772098317409101,1.1417363724875627,0.2857142857142857,0.9156829985339843,1.0,1/14,0.02%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.5772098317409101,1.1417363724875627,0.2857142857142857,0.9156829985339843,1.0,1/14,0.02%,PHLDB2
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.6277122112875765,1.1417241441075383,0.2702702702702703,0.9136785130894703,1.0,1/8,6.76%,SALL1
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.5267582971045603,-1.1413495155074285,0.2708333333333333,1.0,1.0,18/102,15.78%,CCL4;RPS27A;ST18;HIF1A;RBX1;CCL3;NOD2;MAP3K8;GBP2;UBA52;PSMA3;UBC;PSMA5;NR1D1;PYCARD;PSMD8;UBB;PSMB4
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.5261233664710893,-1.1413428015158344,0.22,1.0,1.0,31/139,13.06%,P4HA3;THBS1;TNC;SH3PXD2B;MMP21;SPARC;VCAN;TGFB2;THSD4;ADAMTS2;ECM2;LAMA2;ADAMTS19;COL21A1;FBN2;ADAM15;COLGALT2;COL26A1;COL11A1;MMP24;LAMB1;GPM6B;ITGB8;ITGAE;COL10A1;TGFBI;APLP1;COL4A5;FN1;COL23A1;ITGA2
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.5766223850954442,-1.1412104021876384,0.2619047619047619,1.0,1.0,4/36,2.89%,JAML;SLC11A1;FGF1;TGFB2
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.5080121944088996,1.141132944009604,0.23076923076923078,0.9135949695664809,1.0,3/13,6.79%,GCLC;ALDH5A1;ALDH18A1
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.3743362254147218,1.1408217333952166,0.16666666666666666,0.912690439384216,1.0,9/92,5.38%,PHLDB2;BCL9L;NEDD4;ARHGAP35;ABI3;SEMA4D;TGFB1;DAG1;ZRANB1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.742168409770883,-1.1408042859773706,0.3466666666666667,1.0,1.0,1/7,5.65%,NOD2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.5706011920935055,-1.140735610355086,0.29411764705882354,1.0,1.0,6/39,13.13%,OSBPL5;STEAP2;STXBP6;ANK3;NSF;GOLGA4
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.68456738872975,-1.1406491996893655,0.36619718309859156,1.0,1.0,3/8,18.18%,NPRL2;ATG5;GABARAPL1
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.68456738872975,-1.1406491996893655,0.36619718309859156,1.0,1.0,3/8,18.18%,NPRL2;ATG5;GABARAPL1
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.7846759480958323,-1.1405185199293015,0.29850746268656714,1.0,1.0,2/7,3.96%,GLUL;GLYATL1
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.5620168691128649,-1.140360342953896,0.25,1.0,1.0,8/58,8.55%,CCL4;JAML;MYO1G;CD69;RORA;SELL;CXCR4;IL10RA
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),-0.7072840723558977,-1.1402908401536749,0.34285714285714286,1.0,1.0,2/9,19.46%,BNIP1;VCPIP1
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),-0.7320153684357681,-1.1402013463188654,0.352112676056338,1.0,1.0,3/8,15.45%,PPP1R15A;HSPA5;TMEM33
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.7365411756316219,-1.140153065710429,0.36923076923076925,1.0,1.0,3/6,19.65%,MYLK;EMP3;PMP22
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.6334725084510725,1.1401259782347521,0.3170731707317073,0.9132968196227893,1.0,4/6,6.37%,CTBP2;PPARG;FFAR4;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.7117897989278682,-1.1398036674369787,0.4057971014492754,1.0,1.0,3/9,8.92%,ANK3;ATP1B3;DMD
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.6727784760041662,-1.1397117314667005,0.3424657534246575,1.0,1.0,4/12,7.87%,VEGFA;TGFB2;RSAD2;IL15
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.7683930120164859,-1.1395965607531433,0.36363636363636365,1.0,1.0,2/5,9.78%,PDK3;PDPR
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.7683930120164859,-1.1395965607531433,0.36363636363636365,1.0,1.0,2/5,9.78%,PDK3;PDPR
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.717766262553805,-1.139403703585105,0.35714285714285715,1.0,1.0,3/9,17.42%,ANK3;SCN9A;SCN1A
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),0.610989573902678,1.1392312927648485,0.3783783783783784,0.9139004988358013,1.0,3/6,24.74%,APPL2;TREM2;C3
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.7315946212672085,-1.1388883001136993,0.35714285714285715,1.0,1.0,1/6,3.82%,PTN
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.6648264490391208,-1.1387929834376938,0.4125,1.0,1.0,2/13,5.14%,THBS1;CCL3
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.6163307516033737,-1.138725576573482,0.3132530120481928,1.0,1.0,5/25,19.86%,CLDN18;CLDN20;MPP7;PDCD6IP;MICALL2
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.5620328457154462,-1.138284887094684,0.27472527472527475,1.0,1.0,19/73,21.21%,CLEC12A;ADGRE1;JAML;SIRPB2;C5AR1;TNFRSF1B;FGR;MNDA;NCF4;FPR1;VNN2;NCF2;GPR65;S100A4;LILRB2;AIF1;PARVG;CD300A;FCER1G
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.5902396574764208,-1.1381680610551597,0.32558139534883723,1.0,1.0,7/30,17.49%,OSBPL5;ABCA5;CD36;ABCA1;STARD5;CLU;ABCA8
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.6419918472969097,-1.138089467273889,0.3116883116883117,1.0,1.0,4/17,11.82%,TGFB2;CCDC39;COBL;CLMP
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.5639800226912008,-1.1380077523005132,0.25842696629213485,1.0,1.0,11/64,10.49%,CCL4;JAML;GPR183;TNFRSF1B;CD69;SELL;GBP2;IL10RA;ITGB8;HLA-F;ITGAE
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.5357878908711894,-1.1380005606642922,0.21739130434782608,1.0,1.0,27/119,17.88%,SRGN;THBS1;F13A1;SPARC;VEGFA;TGFB2;RIMS1;STEAP2;F8;TUBA4A;SELENOP;ENDOD1;SOD1;TTN;CD36;CD63;RAB3A;MANF;FN1;CPLX1;SNAP25;SYT1;SERPING1;SYT4;CALM1;CLU;VEGFB
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.557937303789659,-1.1379799034620024,0.23595505617977527,1.0,1.0,13/47,25.18%,RBX1;FHL1;ATF5;PSMA3;PSMA5;PSMD8;PSMB4;FBXL7;PSMD7;PSMD5;PSMC2;PSMB9;PSMB2
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.5331901091525109,-1.1379537632832946,0.2631578947368421,1.0,1.0,20/88,18.42%,BRIP1;RPS27A;UVSSA;RBX1;RPA2;POLR2G;COPS5;UBA52;PPIE;RFC1;UBC;FAN1;RPA3;ERCC2;RFC4;UBB;POLL;SLX4;BRCA2;DDB1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.5953162714518501,-1.1376964832997136,0.325,1.0,1.0,2/26,2.46%,SH3BP5;AGT
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.7224740002981449,-1.1376460634170873,0.2222222222222222,1.0,1.0,1/9,3.82%,PTN
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),-0.7105157828194932,-1.1374791796753598,0.38666666666666666,1.0,1.0,3/7,22.97%,DGAT1;ACSL3;MFSD2A
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),-0.7381509023206471,-1.1374703798147727,0.3333333333333333,1.0,1.0,3/9,12.47%,AGT;CD36;FPR1
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.6125405823016192,1.137292576100155,0.34375,0.9175544830124609,1.0,2/10,2.84%,CASP7;RYR1
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.6090992917361271,-1.1372085866346622,0.2804878048780488,1.0,1.0,2/23,2.56%,GLRA1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.5423233032646346,-1.1370525489040384,0.28125,1.0,1.0,22/78,18.45%,TFRC;PPP1R15A;VEGFA;TGFB2;SLF1;ATP10A;CLIP3;GPC3;ABCB4;SHANK3;CALY;BNIP3;MPP7;NRXN1;FRMPD4;INSR;RPS3;BMF;LRP4;CLU;NEURL1;RELN
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.6781463451335545,1.136875219608831,0.34285714285714286,0.9168330193985365,1.0,4/5,19.26%,ABCC4;LRRC8D;SLC19A1;ABCC5
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),-0.6581588103182903,-1.1368003191816303,0.27941176470588236,1.0,1.0,3/16,7.45%,THEMIS2;NOD2;FCGR2B
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),-0.6979692119043233,-1.1365744695131181,0.3287671232876712,1.0,1.0,1/8,3.54%,THEMIS2
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.7099813794599545,-1.1362892660808523,0.325,1.0,1.0,4/9,19.11%,PARP9;PARP14;ZC3HAV1;PARP15
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.5982302120169511,-1.1361076890052233,0.30434782608695654,1.0,1.0,10/44,12.79%,HTR2B;AGT;CCL3;ACKR4;PPP1R9A;CXCR4;CD36;EIF2AK3;FPR1;NUDT4
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.549873348438248,-1.1358652081678349,0.23404255319148937,1.0,1.0,16/71,13.25%,PLPP3;FGF1;SPARC;MYLK;FILIP1L;TNS1;LAMA2;PTN;AKAP12;NR4A2;NOCT;ARID5B;FN1;SVEP1;PALLD;ANGPT2
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.6299094901460766,1.1352349167279534,0.35294117647058826,0.9198878946771997,1.0,1/7,2.17%,CX3CR1
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.5367689462042948,-1.1351167217933604,0.20202020202020202,1.0,1.0,25/152,9.88%,NR4A3;CLEC12A;CCL4;ADGRE1;RGS1;F13A1;JAML;SLC11A1;MYO1G;RAB7B;PLTP;RBPJ;C5AR1;TNFRSF1B;CD163;CCL3;MS4A4A;EGLN3;SELENOP;FCGR2B;FGR;IL10RA;CD36;MS4A6A;MNDA
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.48995701285223475,1.135009815723927,0.35,0.9185892848879658,1.0,4/24,6.93%,GSN;P2RY12;RHOG;PDGFA
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.7144950153747471,-1.1348776242945986,0.32051282051282054,1.0,1.0,5/11,22.98%,PARP9;PARP14;PARP11;PARP15;PARP12
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.7384775890129303,-1.134663812973165,0.36065573770491804,1.0,1.0,1/5,1.72%,CYP3A5
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),-0.8162236863308403,-1.1346008486295331,0.2698412698412698,1.0,1.0,1/5,5.20%,XRCC3
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-0.8162236863308403,-1.1346008486295331,0.2698412698412698,1.0,1.0,1/5,5.20%,XRCC3
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.6198309972815099,1.1341814457731219,0.325,0.9168941977184333,1.0,4/8,6.37%,CGAS;ABI3;HMGA1;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.6198309972815099,1.1341814457731219,0.325,0.9168941977184333,1.0,4/8,6.37%,CGAS;ABI3;HMGA1;SIRT1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.7773225159760064,-1.134045996475314,0.3484848484848485,1.0,1.0,2/5,11.73%,TNFRSF1B;RGCC
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.7234172530083609,-1.1338051241962137,0.35384615384615387,1.0,1.0,3/5,22.36%,PAICS;PRPS1;GART
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.5675678917516193,-1.133749157731956,0.29545454545454547,1.0,1.0,5/42,12.74%,INSIG1;OSBPL5;ABCA5;TM7SF2;ABCA1
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.5542604755471845,-1.1334309230853634,0.23157894736842105,1.0,1.0,19/86,12.03%,HTR2B;SRGN;NLRP12;SLC11A1;AGT;TNFRSF1B;TXK;HLA-B;FCGR2B;FGR;IL15;GAPDH;BTN2A2;SOD1;BTN3A1;PLD3;MOG;RGCC;C5AR2
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.5197223001126495,-1.1334006516412332,0.17346938775510204,1.0,1.0,38/160,16.74%,DDIT4;PPP1R15A;SEMA6A;RHOB;GLRX2;MX1;IFIT2;CASP5;TCHP;MAL;ALOX15B;FAM162A;ADAM15;EGLN3;DAPK1;GAPDH;DAPK2;CXCR4;PRKCE;NOTCH2;CIT;BNIP1;BNIP3;IRF1;DCC;ERCC2;TRAF7;PAK5;ING4;CD14;PYCARD;BCL2L14;BMF;TLR2;PLSCR1;TNFRSF21;CIDEB;PDCD4
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.5504183186507156,-1.1332614811675572,0.31521739130434784,1.0,1.0,16/70,16.63%,CCL4;JAML;NR4A1;MYO1G;CD69;RORA;SELL;MAP3K8;FGR;CXCR4;IL10RA;TCF7;LSP1;CD44;GNLY;GPR65
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.670412011256735,1.132829778952724,0.34615384615384615,0.9185975410663295,1.0,2/8,11.43%,MTPN;LIMA1
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.5924274692706744,-1.1325465212940595,0.3170731707317073,1.0,1.0,4/27,9.92%,CCL4;SAP30;CCL3;RRP1B
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.7980986085069848,-1.1325153655834852,0.3333333333333333,1.0,1.0,2/5,14.49%,SHANK3;FRRS1L
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),-0.7353884362846638,-1.1324261999517482,0.23943661971830985,1.0,1.0,1/7,1.35%,ACVR1B
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.6222404366723919,1.1323577421568514,0.30434782608695654,0.9161636058643405,1.0,2/9,7.73%,VTA1;CHMP2B
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.6222404366723919,1.1323577421568514,0.30434782608695654,0.9161636058643405,1.0,2/9,7.73%,VTA1;CHMP2B
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.5671924168808514,1.1316997835226261,0.275,0.9160254087406947,1.0,5/8,31.55%,LIG4;RNF168;RNF8;EXOSC6;MSH2
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.68671933605401,-1.1316647997551377,0.3582089552238806,1.0,1.0,3/8,11.44%,HERPUD1;EIF2AK3;HSPA5
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.5900950724141147,-1.1316142963424394,0.3023255813953488,1.0,1.0,4/27,9.26%,SLC38A4;SLC16A10;SLC7A5;SLC6A15
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.5271449732312561,-1.1313073586376288,0.25,1.0,1.0,13/93,8.83%,CYCS;ERMP1;ALDH3B1;FOS;HIF1A;ERO1A;GSTP1;MAPT;DAPK1;PINK1;TMEM161A;SOD1;HSPA1B
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.7269386755725762,-1.1312903521838176,0.38095238095238093,1.0,1.0,2/6,12.62%,MX1;IFIT1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.5791287793790107,-1.1308319886947038,0.29069767441860467,1.0,1.0,6/41,13.25%,THBS1;VEGFA;HIF1A;RGCC;ATP5F1A;ANGPT2
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),-0.7442726156521902,-1.1307689506495142,0.3548387096774194,1.0,1.0,2/5,22.84%,PRPS1;TKT
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.6669005862066346,-1.1307666927727946,0.3246753246753247,1.0,1.0,7/20,22.69%,OIP5;CENPV;ITGB3BP;CENPP;CENPI;CENPU;CENPK
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.5340093453287785,-1.1305163513533194,0.1717171717171717,1.0,1.0,29/166,14.34%,THBS1;ENPP2;GLIPR2;CEMIP;ACVR1B;FGF1;SEMA6A;MYLK;VEGFA;SEMA3A;TGFB2;HIF1A;DOCK1;CCL3;FLT1;DDRGK1;CARMIL1;RAB11A;FGR;DOCK5;PRKCE;LAMB1;SDCBP;PLET1;HSPA5;FN1;NSMF;RDX;INSR
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),-0.736320679815282,-1.1299519033023715,0.3972602739726027,1.0,1.0,3/6,18.79%,CDH23;NRXN1;TPP1
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.6338681098854101,-1.12983741773768,0.35064935064935066,1.0,1.0,4/22,15.60%,RPS27A;UBA52;UBC;UBB
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.526666395600167,-1.1296246468773752,0.26373626373626374,1.0,1.0,25/65,21.42%,FAM13C;DENND2A;PTN;DZIP1;MAP1B;ANK2;ITSN1;PLP1;HSPA12A;ADGRL2;ADGRL3;LIFR;TUSC3;ENAH;LRP4;CPE;FBXL7;THY1;PTPRG;FIGN;RBFOX2;GPRC5B;GULP1;MPDZ;RUNX1T1
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.7508844202368818,-1.1296043472154436,0.30303030303030304,1.0,1.0,1/5,8.68%,SOD1
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.5233240916690545,-1.1295044226547577,0.19,1.0,1.0,45/187,23.61%,TFRC;RPS27A;NAPA;MX2;LRP2;RIMS1;IL7R;MX1;MTCH1;EPN1;ANK3;CR1;SERP1;TRIP10;ANK2;ITSN1;UBA52;CFTR;FCHO2;UBC;UBXN2B;IGF2R;AP2S1;CAV3;AGFG1;TMEM33;UBB;SH3GL2;SYT1;AMPH;RAB5A;SYP;CHMP5;PDCD6IP;DNM1;ACTG1;EMD;TF;AP2A2;SPAST;REPS2;VAPA;CHRM2;PIP5K1C;ATP10B
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.7187454557479401,-1.1294864376513991,0.35294117647058826,1.0,1.0,4/9,22.36%,MTHFD1;PRPS1;AMPD2;GART
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.6276096589684363,-1.1294497984454628,0.35365853658536583,1.0,1.0,4/19,13.54%,BRINP1;RORB;EPHA3;PTK7
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.5763998099327869,-1.1293558019005598,0.3670886075949367,1.0,1.0,7/23,13.28%,SPOCK1;TGFB2;BTBD2;MAPT;CXCR4;CIT;EPHB1
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.6710711246222333,-1.1293321455910776,0.35714285714285715,1.0,1.0,2/11,2.19%,DNAH11;MMP21
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.7282779979046083,-1.129293089493276,0.3125,1.0,1.0,2/8,16.03%,DDX11;TIMELESS
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.6982276824366326,1.1292622968732258,0.3888888888888889,0.921268875437791,1.0,1/5,6.52%,PGGT1B
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.6464640801449038,-1.1291302126921374,0.3246753246753247,1.0,1.0,2/16,3.27%,AGT;RBPJ
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),-0.7322175602340888,-1.1284749739207303,0.3114754098360656,1.0,1.0,2/7,11.22%,FAIM2;AGTPBP1
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),-0.7438987036335863,-1.1281612190357027,0.36363636363636365,1.0,1.0,2/5,15.05%,RDX;CAV3
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),0.6071777454494005,1.1281564578367937,0.5,0.9228158004911707,1.0,1/10,0.46%,NCOA4
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.6671858530981176,-1.1279032458434135,0.3466666666666667,1.0,1.0,2/12,5.53%,BASP1;SVIL
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.5689611071613137,-1.1274877056794481,0.2558139534883721,1.0,1.0,10/38,19.47%,NLRP12;HHIP;AQP11;FCGR2B;NR1H2;PIM3;CLU;KLF4;THY1;MCTP1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.6400319311641608,-1.127165220269257,0.2857142857142857,1.0,1.0,5/20,15.05%,VAV3;PRR16;LARS1;RDX;CAV3
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.4282406917532205,1.1271575509621898,0.16666666666666666,0.9236382417561066,1.0,5/56,4.91%,NUP42;NUP188;PPARG;TGFB1;AGO1
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.6365690703014977,1.126970864322285,0.4,0.922231680155858,1.0,3/5,24.43%,NUTF2;TOR1AIP2;NUP155
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.5939778955864994,-1.1268397340697534,0.3,1.0,1.0,6/25,14.34%,HIF1A;PFKFB4;PINK1;PID1;PFKFB3;INSR
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.5957012664410496,-1.1267096966995196,0.30952380952380953,1.0,1.0,8/30,21.60%,THBS1;EIF2B2;PDK3;ADCY8;IRS2;PFKL;SOX4;RACK1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4669046431383462,1.1265538177309182,0.3333333333333333,0.9216224488291929,1.0,3/16,4.43%,TNFAIP8L3;P2RY12;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.5625806882702669,-1.1265359425863994,0.29069767441860467,1.0,1.0,16/45,25.77%,PAQR3;SPOCK1;OMG;SEMA3A;DCC;MAG;LRP4;NGEF;THY1;STMN2;RTN4RL1;GDI1;LINGO1;ARHGDIA;CRMP1;EPHA4
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.6622648904080984,-1.126491317626215,0.3380281690140845,1.0,1.0,7/18,19.23%,ANK3;ATP1B3;ANK2;DMD;CFTR;ABCB1;ATP1B2
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.6933607389705947,-1.126320333437035,0.2777777777777778,1.0,1.0,1/9,2.56%,VEGFA
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.6456910847974502,-1.126273819281197,0.4,1.0,1.0,2/13,8.95%,TENT4B;SSB
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.5772647068886897,-1.126058769666704,0.36470588235294116,1.0,1.0,9/37,16.45%,MYLK;SLC16A3;RARRES1;TMEM14A;PPP1R13L;TYMP;BNIP3;ITGA2;ANXA2
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),-0.753585091481755,-1.1254783923605207,0.3064516129032258,1.0,1.0,1/5,2.38%,MYLK
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.7765379801681119,-1.1252489615655517,0.34285714285714286,1.0,1.0,1/6,4.69%,MTHFD1
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.6898990731904067,-1.1251222432680243,0.323943661971831,1.0,1.0,4/9,22.93%,CFL1;IGF2R;PPIB;VAPA
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),-0.7338436220687683,-1.1250543214172934,0.3026315789473684,1.0,1.0,5/8,24.92%,ACSL1;CD36;ACSL3;SLC27A5;SLC2A1
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.7146832338783049,-1.1249717456580821,0.34285714285714286,1.0,1.0,2/5,7.98%,PRELID1;PRKCQ
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.6044276575663542,-1.1244605729661956,0.2898550724637681,1.0,1.0,4/16,18.45%,VEGFA;CRTC3;ADCY8;RELN
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.7062808976270932,-1.1243608872779,0.2948717948717949,1.0,1.0,1/11,0.53%,TFRC
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.6021968053667313,1.1241463988948592,0.4,0.9264918591221475,1.0,2/8,4.43%,PPARG;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.646098642849719,-1.124132914169043,0.38271604938271603,1.0,1.0,3/13,9.25%,CD55;CR1;APPL1
prerank,GO_Biological_Process_2021__positive regulation of neuroinflammatory response (GO:0150078),-0.7411955691245216,-1.1237880895181047,0.40298507462686567,1.0,1.0,2/5,8.66%,CCL3;IL18
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.34585444789470793,1.123373830389936,0.0,0.9264098199173766,1.0,15/138,8.02%,STK32B;RPS6KA6;MAP3K10;GALNT1;CSNK1G1;MAPKAPK2;NEK6;CAB39;TGFBR2;LATS2;MAPK13;MAST2;POGLUT3;MKNK1;MAST3
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.6784411228669389,-1.1232336765655997,0.352112676056338,1.0,1.0,7/15,22.39%,ANK2;CALM3;DMD;AKAP6;CALM1;CACNA1C;RYR2
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.6669013248846887,-1.1231778138015986,0.43283582089552236,1.0,1.0,1/11,2.56%,VEGFA
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.5842206818392546,1.1231670505900784,0.3333333333333333,0.9251615358233712,1.0,4/10,10.26%,ARID1A;PMEPA1;ZMIZ1;PLPP1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.569354041990046,-1.1230275745289395,0.2976190476190476,1.0,1.0,4/41,3.16%,TFRC;FTH1;SLC11A1;HAMP
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.6487348064815355,1.1229209917763265,0.3125,0.9239438928747732,1.0,5/9,13.84%,SUPT16H;MTA2;TP53;CDAN1;RBBP4
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.5774158291278814,-1.1228906242422265,0.2391304347826087,1.0,1.0,11/49,9.44%,HMGB2;HAMP;LAMA2;COL21A1;PLN;PDE1A;CXCR4;DMD;TTN;CKMT2;CD36
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.5216662168518381,-1.1228747859822086,0.2708333333333333,1.0,1.0,30/99,25.54%,RPS27A;RPA2;WDHD1;UBA52;PSMA3;RFC1;UBC;PSMA5;RPA3;MCMDC2;RFC4;PSMD8;UBB;PSMB4;DNA2;ORC6;MCM3;MCM6;PSMD7;TEFM;POLG2;MCM7;POLE2;PSMD5;PSMC2;DBF4;MCM5;PSMB9;PSMB2;WRN
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.6643714415653528,-1.1228464658809,0.3380281690140845,1.0,1.0,1/14,2.32%,MT2A
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.7320185760709741,-1.1227912990003923,0.38333333333333336,1.0,1.0,3/5,20.50%,SOD1;KCNMA1;KLF2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.45204078227893485,1.122750616962761,0.2,0.9224031581216608,1.0,6/20,11.29%,TAL1;KLHL18;EIF4EBP1;DUSP3;PPP1R10;EIF4E
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.7398534841524882,-1.122661060673093,0.38571428571428573,1.0,1.0,3/5,22.60%,BRCA1;KDM1A;DNMT1
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.6763348080939662,-1.122655917108439,0.391304347826087,1.0,1.0,3/9,15.61%,DPYD;TYMP;DPYS
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.5907135805962589,-1.122620125178289,0.35294117647058826,1.0,1.0,8/35,19.80%,TFRC;WDR5;PRDX4;BAIAP2L1;RPL8;KDELR1;PES1;TRAP1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),-0.7756266016594189,-1.1225120668229032,0.3492063492063492,1.0,1.0,2/5,8.66%,SLC11A1;IL18
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.6964532602867006,-1.1224502678663153,0.38461538461538464,1.0,1.0,4/6,25.50%,MAPT;SPG11;DCTN1;APP
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),-0.6768823461410842,-1.1223875810975095,0.3424657534246575,1.0,1.0,3/9,12.42%,INSIG1;RORA;GRAMD1C
prerank,GO_Biological_Process_2021__alpha-beta T cell differentiation (GO:0046632),-0.7413606145375465,-1.1223054963279584,0.36764705882352944,1.0,1.0,1/5,3.11%,RSAD2
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),-0.6144298033326248,-1.1222610997742766,0.2804878048780488,1.0,1.0,2/19,2.70%,SEMA6A;SEMA3A
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.6427916444620785,-1.121452203761447,0.3424657534246575,1.0,1.0,1/14,2.45%,FOS
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.6427916444620785,-1.121452203761447,0.3424657534246575,1.0,1.0,1/14,2.45%,FOS
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.5403813556667436,1.1208684596373908,0.25,0.926211148680013,1.0,2/12,0.51%,FCGBP;MEP1A
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),-0.6709638969845884,-1.120621789875383,0.35714285714285715,1.0,1.0,2/9,5.65%,AGT;NOD2
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.6772665789619307,-1.1205275899050182,0.3116883116883117,1.0,1.0,3/12,8.68%,DUOX1;PRDX4;SOD1
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.6993987461752744,-1.1203227711921646,0.3150684931506849,1.0,1.0,1/8,4.42%,DUSP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.69479131348982,-1.1200089644406557,0.34782608695652173,1.0,1.0,6/12,22.39%,ANK2;CALM3;DMD;CALM1;CACNA1C;RYR2
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.5422213218958086,1.1197928491787073,0.3181818181818182,0.9277398825743409,1.0,4/19,5.84%,MSH4;POLD3;ABL1;MCM9
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.6132296641115437,-1.1196532394270895,0.3707865168539326,1.0,1.0,8/21,26.06%,CYREN;PARP9;TFIP11;KMT5C;DTX3L;ERCC6;SMCHD1;RIF1
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.67134480918613,-1.119450079687951,0.3333333333333333,1.0,1.0,2/10,11.59%,OSBPL5;MBOAT2
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.7262677298484148,-1.119343784757608,0.36507936507936506,1.0,1.0,3/7,11.06%,PRELID1;MAPT;BNIP3
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.635799634464191,1.119269728181432,0.3333333333333333,0.9256699847660692,1.0,4/5,33.79%,EXOSC9;EXOSC6;EXOSC2;EXOSC7
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.635799634464191,1.119269728181432,0.3333333333333333,0.9256699847660692,1.0,4/5,33.79%,EXOSC9;EXOSC6;EXOSC2;EXOSC7
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.7405032266446161,-1.1192558150103558,0.3050847457627119,1.0,1.0,3/9,13.78%,TGFB2;BRCA1;STOX2
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.7383374545440489,-1.119209501810312,0.2608695652173913,1.0,1.0,2/6,19.21%,SUV39H2;PER2
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.6179107240571071,-1.1191919638450905,0.3333333333333333,1.0,1.0,4/19,13.40%,WDR5;MSL3;HCFC1;ING4
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.5838941259848771,-1.1187822117421335,0.3493975903614458,1.0,1.0,3/28,3.30%,TGFB2;RBPJ;HIF1A
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.6176961450633995,1.1187737085111327,0.38235294117647056,0.9248164900006486,1.0,2/8,3.27%,ZDHHC3;PPARG
prerank,GO_Biological_Process_2021__depurination (GO:0045007),-0.7454815568973386,-1.1184191301114377,0.3888888888888889,1.0,1.0,2/6,15.46%,MPG;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.7369983714183317,1.1181096843161942,0.42857142857142855,0.9247145986571443,1.0,2/5,13.87%,MAML1;PIEZO1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.537635783630324,-1.1178634390316642,0.27710843373493976,1.0,1.0,15/47,25.50%,MYOT;TGFB2;MAPT;PPFIA4;NLGN3;VMP1;CTNND2;LRP4;CBLN2;APBB2;ACTG1;DVL1;PPFIBP1;NLGN2;APP
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.6387788052823936,1.1178580016813031,0.35294117647058826,0.923767172009768,1.0,3/6,10.47%,ZNF385A;SH2B3;SRC
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.6193507148504542,-1.1177334445125449,0.3717948717948718,1.0,1.0,5/14,25.45%,CGNL1;BSN;KIF3A;JAM3;NLGN2
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.6851902348114068,-1.1176663499177584,0.3815789473684211,1.0,1.0,2/8,6.26%,P4HA3;EGLN3
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),0.6668152869575072,1.1175824880961112,0.4444444444444444,0.9227988886861488,1.0,3/5,27.47%,APEH;VPS4B;PEX14
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.6614914976620573,-1.116617350905505,0.45714285714285713,1.0,1.0,4/12,23.28%,PRPF6;SART3;PRPF3;SRSF12
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),-0.7152026450457292,-1.1163678463549886,0.3283582089552239,1.0,1.0,1/8,9.07%,SNAPC1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.6749986674551887,-1.1162656154625266,0.3924050632911392,1.0,1.0,4/14,11.44%,PPP1R15A;DDRGK1;ANK2;HSPA5
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.5701920511343317,1.1159576592887095,0.3793103448275862,0.9258733356726957,1.0,5/11,20.14%,TRAPPC10;SNX1;RAB6A;RBSN;LMAN1
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.6459619752283834,-1.1154977219566686,0.3466666666666667,1.0,1.0,2/13,3.82%,IHO1;PTN
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),-0.7447624677402449,-1.1154375286846403,0.3387096774193548,1.0,1.0,3/5,19.97%,BCL6;IRS2;FOXP1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.5541709275957889,1.1151905526729826,0.2727272727272727,0.9264129503920955,1.0,2/16,0.97%,SLC25A18;SLC7A8
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.5688023295501542,-1.115162680174509,0.2926829268292683,1.0,1.0,8/29,19.55%,MX2;MX1;ITSN1;FCHO2;NLGN3;SYT1;AMPH;DNM1
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.4196061394780164,1.1150350098940227,0.23076923076923078,0.9249270542069612,1.0,3/32,6.32%,PDE12;KHSRP;METTL16
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.7278094842215247,1.1149830562288041,0.4375,0.9230533742101179,1.0,3/6,12.82%,CD180;SCIMP;LY86
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.612460790592608,-1.1147467681336933,0.2857142857142857,1.0,1.0,7/22,18.42%,RPS27A;RBX1;COPS5;UBA52;UBC;UBB;DDB1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.5670091452472877,-1.1147077504581895,0.34523809523809523,1.0,1.0,6/20,12.41%,PRELID1;IL7;CR1;SOD1;TCF7;PRDM1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.47001810574794056,1.1146681052109704,0.35294117647058826,0.9222194739855255,1.0,5/27,2.89%,GSN;LCP1;HPN;HTRA1;EXOC8
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.5863287959870629,-1.1145975979173335,0.3448275862068966,1.0,1.0,11/22,26.10%,PTN;NRXN1;LRP4;THY1;NRXN2;LRRC7;SAV1;DVL1;MUSK;ITGA4;MAGI2
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.6546862054559774,-1.1144992228962975,0.2972972972972973,1.0,1.0,5/15,15.22%,CD55;TRIM5;CD36;CARD16;SIGIRR
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),-0.6853312810771252,-1.1143016487246153,0.3783783783783784,1.0,1.0,5/9,22.92%,DDX11;PARP9;MED25;DTX3L;BTAF1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.5531781949221154,-1.1141562173021637,0.27586206896551724,1.0,1.0,21/65,23.24%,ZPBP;TALDO1;GRM8;MEP1B;PEBP1;CLVS1;GSTM3;CFTR;HSPA2;DCC;SPATA6;RFC4;AGFG1;SCG5;GAD1;CCT6B;SEPTIN4;ZC2HC1C;JAM3;IL12RB2;DBF4
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.7879814367697807,-1.1141069588716148,0.35384615384615387,1.0,1.0,3/5,20.16%,RFC4;CHTF18;POLG2
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.7879814367697807,-1.1141069588716148,0.35384615384615387,1.0,1.0,3/5,20.16%,RFC4;CHTF18;POLG2
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.6317036409595823,-1.1138691052533711,0.39473684210526316,1.0,1.0,3/17,4.01%,GDPD1;ENPP2;ABHD12B
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.708664670346395,-1.1137718307086542,0.3561643835616438,1.0,1.0,4/9,17.75%,VEGFA;RORB;RPGRIP1L;THY1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.5381516672581624,-1.1137474492173396,0.2903225806451613,1.0,1.0,26/77,17.86%,SRGN;CD55;SPARC;MYLK;CD93;TNS1;APOLD1;F8;FLT1;SLC7A5;PLAC8;CD36;SPARCL1;PROCR;THBD;RGCC;GPM6A;LIFR;SHROOM4;MGLL;USHBP1;PLEC;ABCA8;HEXIM1;CLIC4;PTPRB
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),-0.5497304695361782,-1.1134100990747289,0.31521739130434784,1.0,1.0,18/63,21.66%,KCNE1;KCNJ13;KCNT2;ATP1B3;KCNH8;SLC12A8;TMEM175;SLC24A1;KCNC1;KCNK10;SLC9A6;NALCN;ATP1B2;SLC24A2;KCNH7;KCNJ3;SLC24A4;KCNAB2
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.7152583989397057,-1.1133971815421857,0.3333333333333333,1.0,1.0,3/9,16.82%,AGTPBP1;FOLH1;ATG5
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.6784730626858763,-1.1132318238216412,0.3424657534246575,1.0,1.0,3/10,16.20%,NLRC5;OAS3;STAT2
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.6699136195365553,-1.112918282847767,0.35064935064935066,1.0,1.0,1/11,0.73%,THBS1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.685643164665151,-1.1128846423378873,0.3333333333333333,1.0,1.0,1/8,0.57%,NLRP12
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.6758044872462257,-1.1122582252937365,0.3382352941176471,1.0,1.0,3/14,16.20%,DDX11;TIMELESS;ADCY10
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.7004943563289017,1.1122197013268451,0.45714285714285713,0.927666320537927,1.0,1/5,4.43%,TGFB1
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.7480095442725321,-1.1120361849344509,0.3333333333333333,1.0,1.0,3/7,9.51%,GPR183;FCGR2B;NOTCH2
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.6673495007566211,-1.111981388303266,0.3188405797101449,1.0,1.0,4/13,18.12%,WDR12;RPL35;RPL7;PES1
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.6872620021269045,-1.1118752888792027,0.37142857142857144,1.0,1.0,2/9,7.22%,SEMA3A;CHN1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.5618546308515306,-1.1118332416908523,0.3076923076923077,1.0,1.0,6/54,9.80%,HTR2B;SLC11A1;MT2A;CCL3;ANK2;TPT1
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.6796462534065635,-1.1118227064567974,0.3472222222222222,1.0,1.0,5/12,19.08%,TRIM5;HS3ST5;TRIM25;TRIM22;TRIM14
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.6593506480321154,-1.1117835163866296,0.38271604938271603,1.0,1.0,3/12,16.98%,MX1;STAT1;CRLF1
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.6817775131377902,-1.1117817498659164,0.36363636363636365,1.0,1.0,4/12,19.65%,ADGRG6;GSTM3;SERPINI1;PMP22
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.5102778400117556,-1.1117337630801547,0.25773195876288657,1.0,1.0,11/91,11.44%,THBS1;PPP1R15A;DNAJB9;ERO1A;DDRGK1;HERPUD1;RASGRF2;ATF3;CFTR;EIF2AK3;HSPA5
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.6601245183734552,1.111669808813542,0.30434782608695654,0.9276093758210334,1.0,1/11,0.08%,PLA2G4C
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),0.6877195888258383,1.1115029998789157,0.42857142857142855,0.9262584291097344,1.0,2/5,15.50%,TIRAP;MFHAS1
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.7179341586861075,-1.1110058298784258,0.3974358974358974,1.0,1.0,1/9,0.73%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.41986373459832355,1.1110030808111526,0.23529411764705882,0.9256197520310268,1.0,6/26,7.83%,NRP1;RIN2;MAP4K4;ABL1;PPM1F;CIB1
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.6068767050765458,-1.1109953768930725,0.3411764705882353,1.0,1.0,2/26,1.51%,ACVR1B;LRP2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.5269313222939476,-1.1109305378592649,0.3146067415730337,1.0,1.0,19/65,25.18%,HLA-B;CD36;HLA-F;PSMA3;PSMA5;B2M;NCF4;MFSD6;TAP1;PSMD8;PSMB4;NCF2;HLA-C;PSMD7;FCER1G;PSMD5;PSMC2;PSMB9;PSMB2
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.5288373776315844,-1.1107720961518843,0.25,1.0,1.0,14/88,13.66%,GLA;TOM1L1;NAPA;GALC;SCAMP3;SOD1;TPD52;KIF1B;CD63;BNIP3;ABCA1;IGF2R;GOLGA4;AP2S1
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.5985674456552244,1.1106594075293854,0.4,0.9247161858099542,1.0,2/11,5.53%,ARV1;NPC2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.520561057867574,-1.110516894267421,0.24742268041237114,1.0,1.0,23/144,15.22%,DDIT4;NLRP12;THBS1;RGS2;HHIP;SEMA6A;AGT;SULF2;SPRY1;NR4A2;PRKCQ;GPC3;APPL1;TLE1;DCC;CARD16;RPGRIP1L;PTPRT;PID1;APOD;LRPAP1;PIK3CB;SIGIRR
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.5481768152584312,-1.1105022160769449,0.3409090909090909,1.0,1.0,16/56,21.66%,KCNE1;KCNJ13;ATP1B3;KCNH8;KCNMA1;TMEM175;SLC24A1;KCNC1;KCNK10;SLC9A6;NALCN;SLC24A2;KCNH7;KCNJ3;SLC24A4;KCNAB2
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.39681694206183954,1.1104189661682784,0.3076923076923077,0.9237920532867906,1.0,11/45,10.74%,FKBP9;CD276;HTRA1;DAB2IP;NXN;NUAK1;DAG1;TENM3;RAI14;AMOTL1;CYP19A1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.6519786710761444,-1.1104101583816526,0.4246575342465753,1.0,1.0,4/10,19.09%,CEMIP;CD44;GUSB;CEMIP2
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.6693642037754539,-1.1100015720584304,0.38235294117647056,1.0,1.0,2/9,2.56%,NR4A1;VEGFA
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),-0.7315942084074737,-1.1099002728882175,0.4057971014492754,1.0,1.0,2/8,9.44%,HTR2B;CD36
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.48691237254040737,1.1098438377130109,0.22727272727272727,0.9239373721562709,1.0,5/18,10.92%,TGFA;ANAPC4;IL1B;IL1A;NSMCE2
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),-0.705978736984559,-1.109734152266058,0.4117647058823529,1.0,1.0,3/5,25.57%,MAFB;ZFP36;HSPA9
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.5558842349287647,-1.1096357420852565,0.26881720430107525,1.0,1.0,14/55,16.31%,NUDT16;CENPV;XRCC3;SVIL;RACGAP1;DDX11;PRKCE;CIT;RGCC;UBXN2B;INSR;GPSM2;PLSCR1;E2F7
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.5285163308174696,-1.1096163322268018,0.2604166666666667,1.0,1.0,15/103,9.83%,THBS1;CHI3L1;FGF1;SEMA6A;SPARC;VEGFA;RHOB;GLUL;TGFB2;HIF1A;FLT1;BRCA1;STAT1;PGK1;ITGB8
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.6005918155189554,1.1095073215979556,0.3333333333333333,0.9231152825517819,1.0,5/10,18.31%,PDPN;SLC46A1;ABCG2;FOLR2;SLC19A1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.5685511455374566,-1.1094425069480034,0.32941176470588235,1.0,1.0,6/36,12.74%,INSIG1;OSBPL5;FAXDC2;ABCA5;TM7SF2;ABCA1
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.6770516948972853,-1.1094240094548384,0.34782608695652173,1.0,1.0,4/8,13.61%,PTN;COBL;ZDHHC15;ALK
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.5162078200291388,-1.1090855414402978,0.2978723404255319,1.0,1.0,11/88,9.33%,DIAPH3;RHOBTB3;SEMA6A;RHOB;ARHGAP4;CFL1;CCL3;RHOU;EPB41L3;FGD6;LIMD1
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.6795311630669116,-1.1090425343792785,0.38571428571428573,1.0,1.0,3/9,21.61%,DGKG;DGKI;DGKB
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.6522979830607751,-1.1084904191983334,0.3013698630136986,1.0,1.0,2/13,16.82%,ATG2A;ATG5
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.5349152789802905,-1.1084415003431682,0.31521739130434784,1.0,1.0,6/64,7.28%,CENPF;PRKAR2B;HAUS6;TUBB4A;TUBA4A;ATF5
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.5866977583097572,-1.1083837292022805,0.27058823529411763,1.0,1.0,3/30,4.39%,JAML;CD69;SELL
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3666534479916625,1.1080837089210376,0.3333333333333333,0.9253840496186337,1.0,11/81,12.23%,NUP42;NUP188;WDR33;CPSF4;HHEX;FYTTD1;U2AF1;THOC5;NUP214;EIF4E;RAE1
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),-0.7443267501677668,-1.1080717284602306,0.36923076923076925,1.0,1.0,1/5,7.55%,TENT4B
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.5258976991464623,-1.1080504768120907,0.2978723404255319,1.0,1.0,21/80,21.71%,FA2H;CYP3A5;ALOX12;ME1;SLC16A3;GNPAT;CKMT2;CD36;LDHA;PDHB;VNN2;SLC16A1;PNPLA8;BTD;ECHDC3;HACL1;PER2;CKB;GATM;ALDH1A2;ACSL3
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.42254788948876637,1.1080026498780495,0.2,0.923695764767582,1.0,5/39,4.54%,ST6GALNAC3;HPSE;B4GALT7;GAL3ST4;ST8SIA4
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.562444415734743,-1.1079979679804426,0.3595505617977528,1.0,1.0,4/42,4.49%,FA2H;PLPP3;ALDH3B1;DEGS2
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.560488021779039,-1.1076271324363571,0.34210526315789475,1.0,1.0,7/37,17.39%,RPL23;ARAF;RPL11;RPL5;RPS7;CAV3;CLU
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.5220930295500591,-1.1075281733977846,0.2967032967032967,1.0,1.0,20/83,19.39%,HTR2B;SH3PXD2B;MMP21;VEGFA;TGFB2;PKP2;MTHFD1;KDM6B;GPC3;ID2;FN1;CDKN1B;LDB3;INSR;POU6F1;MICAL2;CACNA1C;ZFPM2;PCSK5;CITED2
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.5742503511833679,-1.1075110835791613,0.3855421686746988,1.0,1.0,6/25,14.51%,CFL1;FCGR2B;SIPA1L1;ZDHHC15;SHANK3;IL1RAPL1
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.6654027190319276,1.1074894163275286,0.38636363636363635,0.9232395173418797,1.0,1/6,0.46%,ZNF703
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.6561461217242577,-1.1072630210203507,0.36363636363636365,1.0,1.0,1/14,0.40%,HTR2B
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.6565699968421133,1.1068802922826593,0.40540540540540543,0.9233365345228423,1.0,1/6,3.27%,PPARG
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),0.6514397094804731,1.1068023879670839,0.4666666666666667,0.921734396809643,1.0,3/5,33.20%,SVIP;RAB3GAP1;RAB3GAP2
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.7234859099348483,-1.1067507957356018,0.3333333333333333,1.0,1.0,2/5,5.14%,TGFB2;CCL3
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.7054516244289175,1.106666499605415,0.3448275862068966,0.9203297433269428,1.0,1/6,0.77%,SLC25A18
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.5978150922066366,-1.106437023270457,0.36231884057971014,1.0,1.0,6/18,16.29%,FAM162A;PINK1;BNIP3;PYCARD;BMF;CIDEB
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.5929063294959662,1.106326497495389,0.3235294117647059,0.919312021660677,1.0,3/8,6.77%,SERTAD2;ARID1A;ZMIZ1
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),-0.7039921462631017,-1.106315422814344,0.36363636363636365,1.0,1.0,5/8,26.58%,SHANK3;NRXN1;NRXN2;NLGN2;TMEM108
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),0.5943538099262721,1.1061943919395494,0.3125,0.9179416556678905,1.0,2/8,5.12%,PDPN;SLC46A1
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.5737792412074421,1.1061203874045655,0.28,0.9163157032332132,1.0,2/9,10.85%,SYK;DVL2
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.7118424806604391,-1.1059182949152313,0.4126984126984127,1.0,1.0,3/7,20.16%,DNA2;TEFM;POLG2
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),-0.7634525792028046,-1.1058900589999554,0.37681159420289856,1.0,1.0,3/5,21.95%,FCGR2B;FCER1G;CARD9
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),0.511892441776404,1.1057929965037487,0.3548387096774194,0.9153831769043083,1.0,5/13,11.36%,LGALS9;ITGAM;NMI;SCIMP;TIRAP
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.6390825523438289,-1.105783218837408,0.352112676056338,1.0,1.0,2/12,2.70%,SEMA6A;SEMA3A
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.5254431141038499,-1.1057535175956683,0.23157894736842105,1.0,1.0,12/74,11.77%,HTR2B;CEMIP;FGF1;MTCP1;VEGFA;SYAP1;FLT1;NOD2;DIRAS2;CALM3;RGCC;INCENP
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.6907621330483624,-1.105652279116215,0.3972602739726027,1.0,1.0,2/5,20.77%,MAPT;BEX4
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.5552406701146106,1.1054976258086053,0.3448275862068966,0.9146907701987252,1.0,3/9,7.41%,DAGLB;MTLN;IL1B
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.5388497788160419,-1.1054934067358606,0.2967032967032967,1.0,1.0,14/66,15.50%,CD55;CTDSP1;NOD2;LITAF;JUNB;UBALD2;HLA-F;TYMP;PIM3;IRF1;TC2N;SIGIRR;TAP1;ST14
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.6823772871207169,-1.105491714374963,0.3684210526315789,1.0,1.0,4/10,24.96%,PAICS;IMPDH1;GART;PFAS
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.5252424990196038,-1.1054673202433554,0.2916666666666667,1.0,1.0,35/113,24.16%,SPOCK1;PDE4A;B4GAT1;OSCP1;FLRT1;ENDOD1;CASKIN1;ATF5;SCN9A;HSPA12A;SYBU;SRRM3;METRN;EPB41L4B;APLP1;GRAMD1C;KCTD1;IFT74;IMPDH1;ARFGEF3;CPE;SEZ6L2;FAM81A;CKB;RETREG1;TMEM178A;NRG1;EML2;TTC5;MAP2;CNPPD1;TMEM59L;GNAL;AGAP1;LINGO1
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.5390093856558814,1.105303558537175,0.2857142857142857,0.9115953799013963,1.0,3/11,12.51%,SLC37A4;SLC37A2;SLC25A14
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.5390093856558814,1.105303558537175,0.2857142857142857,0.9115953799013963,1.0,3/11,12.51%,SLC37A4;SLC37A2;SLC25A14
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.6600447779747192,-1.1052303578683815,0.3561643835616438,1.0,1.0,6/15,22.39%,ANK2;CALM3;DMD;CALM1;CACNA1C;RYR2
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.6648363653489882,-1.1047449459270318,0.4027777777777778,1.0,1.0,4/10,15.69%,ID2;PTPRZ1;KDM1A;TOX
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),0.6356907046172356,1.1046906140024868,0.38461538461538464,0.9115960806663224,1.0,1/5,1.46%,SERPINF2
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.5623913850450922,-1.1044443522148841,0.4166666666666667,1.0,1.0,12/36,15.79%,FA2H;ANK3;CR1;SERP1;ANK2;EPB41L3;CXCR4;UGCG;RAB3A;NSF;CAV3;PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.5342235264193221,-1.104442181854667,0.32608695652173914,1.0,1.0,16/73,21.60%,EIF4A3;ZNF540;DAPK1;RPL13A;GAPDH;EIF2AK3;RIDA;ENC1;RPS3;CNOT8;EIF3E;ILF3;PATL2;PUS7;EIF2AK2;RACK1
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.783226155318866,-1.1042077317983492,0.37037037037037035,1.0,1.0,1/5,8.95%,SSB
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.6469338282597163,1.1039646015262201,0.4642857142857143,0.9116905884607944,1.0,5/7,23.53%,SYK;DEF8;PLEKHM1;PRKCA;ATP6AP1
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.7205715008895514,-1.1034574518602778,0.32857142857142857,1.0,1.0,6/7,24.40%,MCMDC2;MCM3;MCM6;MUS81;MCM7;MCM5
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.705135236111621,-1.1032664492005977,0.3815789473684211,1.0,1.0,2/8,10.64%,ANTKMT;MID1IP1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.5278125904692768,1.1031752449691612,0.28,0.9123932813715511,1.0,10/14,27.60%,TSPAN15;EGFL7;FBXW7;ARRB1;YTHDF2;WWP2;ZBTB7A;AKT1;MMP14;EGFR
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.6940106423869087,-1.1030136541186308,0.39705882352941174,1.0,1.0,4/6,25.50%,INSR;MAP1A;DCTN1;APP
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.5074789741102005,-1.1029932556571582,0.29591836734693877,1.0,1.0,12/115,11.22%,CENPF;PRKAR2B;DTL;HAUS6;TUBB4A;TUBA4A;RBX1;FHL1;RAB11A;PSMA3;PSMA5;TUBA1A
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.6123231704613125,-1.1027562443655405,0.36486486486486486,1.0,1.0,11/18,33.99%,CDC37;SDCBP;PDCD6IP;YBX3;OGT;CYLD;CFLAR;FLOT2;SLC25A4;PELI1;FLOT1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.58302622736753,-1.1026388069295083,0.3875,1.0,1.0,5/27,9.17%,SLC11A1;CD93;C5AR1;MAPT;CRTC3
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),-0.7446401980149389,-1.1025883875959488,0.32786885245901637,1.0,1.0,4/5,25.45%,SHANK3;NRXN1;NRXN2;NLGN2
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.6141019403291336,1.1025217635145366,0.38235294117647056,0.9121821647902666,1.0,3/7,6.77%,SERTAD2;ARID1A;ZMIZ1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),-0.6860751579943203,-1.1024799717241185,0.4142857142857143,1.0,1.0,3/8,15.61%,DPYD;TYMP;DPYS
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.6928457040286855,-1.1024455901952275,0.4342105263157895,1.0,1.0,3/10,19.65%,EPB41L3;DICER1;PMP22
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.6849975309948141,-1.1020719249111874,0.375,1.0,1.0,2/11,12.53%,PINK1;FEZ1
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",0.673562516793519,1.1020369615441679,0.4358974358974359,0.9119019375191683,1.0,2/5,9.28%,APH1A;ADAM10
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.7020050297714185,-1.1019152995017811,0.40625,1.0,1.0,4/6,26.76%,GK;GK5;COQ2;GOT1
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.6055631575617326,-1.101796308600838,0.39759036144578314,1.0,1.0,6/25,22.69%,OIP5;ITGB3BP;CENPP;CENPI;CENPU;CENPK
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),-0.7223984813353893,-1.1016446719256323,0.359375,1.0,1.0,3/6,19.97%,BCL6;IRS2;FOXP1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.6191622949531441,-1.1014981659306136,0.3375,1.0,1.0,2/18,11.73%,TOM1L1;RGCC
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),-0.6913804914598463,-1.1014824503747158,0.42424242424242425,1.0,1.0,2/5,12.10%,SHANK3;KCNMA1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),0.7303440466795612,1.1013690699914804,0.4,0.9118787609770118,1.0,1/5,4.43%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.6247086445731287,-1.1011856754970413,0.4050632911392405,1.0,1.0,7/19,12.39%,THBS1;SPARC;FLT1;STAT1;ATP5IF1;RGCC;ATP5F1A
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),-0.6907539594673993,-1.1011155823534253,0.42424242424242425,1.0,1.0,1/7,15.20%,ATG2A
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),-0.6907539594673993,-1.1011155823534253,0.42424242424242425,1.0,1.0,1/7,15.20%,ATG2A
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.599572610851689,-1.100933928883105,0.2804878048780488,1.0,1.0,4/23,5.49%,SEMA6A;NR4A1;VEGFA;FLT1
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.5628822325572488,-1.100667689919709,0.375,1.0,1.0,3/29,4.42%,GADD45B;VEGFA;DUSP1
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.5617912262856551,-1.100283666249782,0.3793103448275862,1.0,1.0,6/22,19.12%,RSAD2;TNFRSF1B;STXBP6;IL1RAPL1;SYT4;PNKD
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.7662363596718386,-1.1001710941518625,0.43636363636363634,1.0,1.0,1/6,8.95%,SSB
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.6642308152564309,-1.1000036031933376,0.4444444444444444,1.0,1.0,5/12,20.07%,PPP2R5A;CCDC3;ALK;APOD;ASXL3
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.69349196572,-1.0999456157512884,0.37142857142857144,1.0,1.0,1/7,2.72%,HINT1
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.5633908397885512,-1.099500202886147,0.2716049382716049,1.0,1.0,6/34,5.46%,RGS2;PAQR3;AGT;DUSP1;SPRY1;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.7094263434451198,-1.0994169051321492,0.3770491803278688,1.0,1.0,2/7,6.12%,PKP2;ANK3
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.5444727800992798,-1.0993280407295993,0.3409090909090909,1.0,1.0,10/46,12.95%,SEMA6A;COBL;ANK3;PPP1R9A;LRRN1;SPARCL1;CFTR;SPON1;PTPRT;BMI1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.5664372237575469,-1.0989962342666093,0.35294117647058826,1.0,1.0,6/31,10.22%,CEMIP;OMD;VCAN;OGN;GPC3;GPC5
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.5851230953247216,-1.0987682461567274,0.34210526315789475,1.0,1.0,3/23,3.30%,FOS;TGFB2;HIF1A
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),-0.6009353791955347,-1.0984381865689175,0.43023255813953487,1.0,1.0,7/16,29.44%,SHANK3;NLGN3;RELN;PRRT1;NLGN2;CACNG2;MAPK8IP2
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.5784318854216878,-1.0983246774987736,0.3723404255319149,1.0,1.0,8/31,19.24%,DTL;RNF126;RBX1;TRIM25;UHRF1;ATXN7L3;NEURL1;DTX3L
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.6473126923355847,-1.098217767714291,0.38271604938271603,1.0,1.0,6/15,22.31%,SCO2;COA6;COX20;TIMM21;BCS1L;SCO1
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.6935533743076463,-1.0981646779433842,0.3333333333333333,1.0,1.0,3/11,15.46%,MPG;NEIL1;TERF2IP
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),-0.6828883121205093,-1.0981401188350217,0.37681159420289856,1.0,1.0,1/8,2.39%,VCAN
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.5119121155745651,-1.0980825492985689,0.27,1.0,1.0,33/188,14.60%,KCNE1;NR4A3;GLRA1;INSIG1;VIM;FOS;TSHR;HMGB2;TNFRSF1B;RORA;GSTP1;NOD2;BRINP1;MAPT;DAPK1;PDK3;ABCB4;RORB;PDCD1LG2;CFTR;PDE4B;AANAT;EPHA3;CARD16;AKAP6;PID1;NR1D1;PTK7;NSMF;CD14;LARS1;PYCARD;RPS3
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.686443545373812,-1.0979529660718295,0.35384615384615387,1.0,1.0,7/9,27.09%,ATP5F1D;ATP5PD;ATP5F1A;VPS9D1;ATP5MC1;ATP5F1C;ATP5MC3
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.5429087743702375,-1.0979254129774119,0.3218390804597701,1.0,1.0,14/50,25.18%,RBX1;FHL1;PSMA3;PSMA5;PSMD8;PSMB4;FBXL7;PSMD7;NABP1;PSMD5;PSMC2;INTS3;PSMB9;PSMB2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.6274983990557832,-1.0978072171628337,0.37333333333333335,1.0,1.0,1/14,0.08%,DDIT4
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.6093697126662072,-1.097727624808089,0.3684210526315789,1.0,1.0,3/19,16.74%,THBS1;RGCC;PDCD4
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.5730615199223071,1.0976635787484137,0.3448275862068966,0.9201228943018909,1.0,1/7,2.20%,GALNT1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),-0.5902862425990425,-1.097438800942522,0.35135135135135137,1.0,1.0,5/20,16.20%,MAPT;PINK1;INF2;BNIP3;STAT2
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.7251618842182075,-1.0974359954425483,0.3050847457627119,1.0,1.0,1/6,4.62%,CCDC39
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotactic protein-1 production (GO:0071639),0.6368282872303019,1.0970979931026081,0.4411764705882353,0.9199678350923924,1.0,3/6,7.41%,LGALS9;SYK;IL1B
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.7255967094893467,-1.097018521438301,0.3333333333333333,1.0,1.0,5/6,24.40%,MCMDC2;MCM3;MCM6;MCM7;MCM5
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.6374861918659096,-1.0969743975760209,0.3815789473684211,1.0,1.0,1/16,2.32%,MT2A
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.5222503288280322,-1.096876003990252,0.2553191489361702,1.0,1.0,21/114,16.04%,CCL4;TNFRSF11B;CHI3L1;ST18;AIM2;TNFRSF1B;CCL3;GBP2;BRCA1;STAT1;TNFSF13B;PSMA3;PSMA5;PID1;NR1D1;PYCARD;RPS3;TRAF2;PSMD8;PSMB4;TNFRSF21
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.6891970684371281,-1.0968205274443812,0.43661971830985913,1.0,1.0,1/9,0.82%,ENPP2
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.5061718170949615,-1.0966993145480173,0.2755102040816326,1.0,1.0,27/137,23.04%,RPL23;PLPP3;CDC37;RPL11;ATP1B3;PINK1;GAPDH;ANK2;NOP53;HSPA1B;HCFC1;CAMLG;USP36;RPL5;RPS7;GBA3;CLU;PPIB;ATP1B2;RAB21;DVL1;IFT46;SOX4;WIZ;C10ORF90;CRYAB;PYHIN1
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.6307619484475185,-1.0966383786828167,0.4024390243902439,1.0,1.0,2/12,6.82%,DTL;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),-0.747643370769392,-1.0962423075133425,0.35714285714285715,1.0,1.0,1/5,4.84%,CACNB2
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.7056468860306091,-1.0962213892682464,0.421875,1.0,1.0,4/6,22.90%,ERC2;RAB3A;CBLN2;DCTN1
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.6445126961360121,-1.0958755391969968,0.3698630136986301,1.0,1.0,4/12,20.49%,PPP1R15A;CALM3;CALM1;CD300A
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.5834686553724359,1.0956430707593123,0.3333333333333333,0.9224735399895813,1.0,1/9,4.88%,DAG1
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.7133889332790901,-1.0956128191431382,0.38571428571428573,1.0,1.0,1/7,1.15%,EIF4A3
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.5209255784713256,-1.0954897368809438,0.32989690721649484,1.0,1.0,37/80,26.72%,GADD45B;SULT4A1;FAIM2;BRINP1;ANK2;UBE2QL1;SST;PAK5;MAPK4;PTPRT;KCNC1;PHYHIPL;CTNND2;SH3GL2;SNAP25;GABRG2;KCTD16;GAD1;CLVS2;STMN2;GAD2;ST8SIA3;PLPPR4;GFAP;CADM2;LY6H;HS6ST3;MAP2;TMEM59L;CA10;CAMK2B;GRIA2;VSTM2B;CADM3;NDRG4;AQP4;GABBR2
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),-0.5810394620653523,-1.0954896633924494,0.35802469135802467,1.0,1.0,4/23,19.48%,TAF6L;MSL3;MORF4L2;ATAT1
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.5379945389962899,-1.095438492028494,0.34065934065934067,1.0,1.0,5/43,5.53%,DIAPH3;CATIP;CFL1;COBL;SVIL
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6588246146034935,-1.0952294512875187,0.4025974025974026,1.0,1.0,3/10,5.51%,GLA;ENPP2;PDXDC1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.6754530638780543,-1.0951149915664076,0.4146341463414634,1.0,1.0,4/10,25.11%,HLA-F;CADM1;KLRD1;SLAMF6
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.6754530638780543,-1.0951149915664076,0.4146341463414634,1.0,1.0,4/10,25.11%,HLA-F;CADM1;KLRD1;SLAMF6
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.7267088316057214,-1.0948010034442353,0.391304347826087,1.0,1.0,3/8,20.33%,HMGB2;KDM1A;EIF2AK2
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.5075697177502335,-1.0943031864113255,0.31313131313131315,1.0,1.0,25/142,15.89%,DDIT4;NLRP12;THBS1;CGNL1;RORA;DUSP1;GSTP1;PEBP1;HERPUD1;PPP2R5B;PINK1;STAT1;NOP53;LIMD1;PRDM15;CIT;TLE1;BCL2L2;DGKG;NPRL2;NR1D1;PYCARD;CAV3;PIK3CB;PDE10A
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.7424802066602095,-1.0941394208511888,0.4307692307692308,1.0,1.0,1/6,4.07%,ENTPD3
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.6541011205848306,1.094129484041685,0.43333333333333335,0.9249002158938221,1.0,3/7,3.40%,EDA2R;SMURF1;ITGAM
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.6539951942496086,-1.0936705662193784,0.3783783783783784,1.0,1.0,3/14,15.46%,MPG;NEIL1;TERF2IP
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.630673629271657,-1.0935345423248892,0.4266666666666667,1.0,1.0,3/13,15.50%,OVOL2;CFTR;ST14
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),-0.6925011570706231,-1.0930549278645878,0.42424242424242425,1.0,1.0,1/7,4.42%,DUSP1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.5277648380907346,-1.0926893206372619,0.30612244897959184,1.0,1.0,25/106,21.26%,MDH1;CBR1;GLUL;ACSL1;ME1;RDH11;CD36;ENO2;UROS;LDHA;PDHB;ALDH1A1;MGLL;GPD2;PTS;CBR3;LGALS1;HMGCL;GABARAPL1;PTPRG;BMPR1B;GAD2;ACSM3;IDI1;ECI2
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.5177574564728378,-1.0923518411535917,0.2857142857142857,1.0,1.0,30/134,20.63%,CYCS;MX2;MX1;TOMM7;COX7A2;IFIT2;SLIRP;PINK1;TIMM13;HCFC1;MTERF1;ATP5F1D;BNIP3L;TYMP;BNIP3;AGTPBP1;TOMM40;HIGD1C;PID1;TOMM20;BCS1L;ATAD3A;SIRT3;SIRT5;CHCHD2;DNM1;HK2;SLC25A36;POLG2;WASF1
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.732201825074015,1.0918774351937486,0.4166666666666667,0.929898131659558,1.0,3/5,13.36%,ENPP1;LRMDA;MITF
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.7164929965226391,-1.091836763620406,0.4307692307692308,1.0,1.0,3/8,23.98%,SIDT2;CKAP5;RTRAF
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.5467684302041247,-1.0917744463386867,0.3170731707317073,1.0,1.0,9/28,17.39%,PRELID1;FAM162A;PINK1;BNIP3;PYCARD;BMF;CIDEB;GHITM;CLU
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),-0.5851745924799729,-1.0915347547104217,0.3076923076923077,1.0,1.0,5/17,18.11%,TSHR;ADCY3;RXFP1;ADCY8;CALCR
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),-0.5043293086653828,-1.0914680695975512,0.3157894736842105,1.0,1.0,11/86,16.58%,NEK11;EYA2;TAF6L;MSL3;PADI2;MAP3K12;USP36;INCENP;UHRF1;MORF4L2;ATXN7L3
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.7208784187111713,-1.0912430466492817,0.4050632911392405,1.0,1.0,2/5,15.79%,MAPT;PLSCR1
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.34805415576844195,1.091135062565129,0.0,0.93016223996243,1.0,10/74,3.67%,EDA2R;SIRPA;SERPINF2;ZMYND11;MAP3K10;DAB2IP;MAP4K2;MAP3K5;ZNF675;MAP4K4
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.6377641435276739,1.0910730960262403,0.32432432432432434,0.9285891249210814,1.0,2/7,2.17%,SIRPA;CX3CR1
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.5262476498424679,-1.0909338627132028,0.3645833333333333,1.0,1.0,15/86,13.81%,CLEC12A;JAML;MYO1G;C5AR1;TNFRSF1B;CD69;FGR;IL10RA;MNDA;RASGRP4;NCF4;FPR1;HCLS1;NR1D1;VNN2
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.7513861811184279,-1.0908963105151535,0.41379310344827586,1.0,1.0,1/5,9.44%,PADI2
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.5707764565449474,-1.0907345790525764,0.3246753246753247,1.0,1.0,7/23,18.42%,RPS27A;RBX1;UBA52;UBC;ERCC2;UBB;DDB1
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.4888967907925022,-1.0905710999793257,0.3157894736842105,1.0,1.0,20/120,17.77%,BRIP1;RPL23;RPS20;RPL37;RPL11;RPA2;BRCA1;CHD3;NOP53;PPP1R13L;RPS15;RPL5;RPA3;PRDM1;ING5;PRR5;RFC4;DNA2;TP53INP1;HEXIM1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.7311124630868672,-1.0903846120358243,0.373134328358209,1.0,1.0,2/6,7.60%,PRELID1;MAPT
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.6218381669405761,-1.0903754586925083,0.40789473684210525,1.0,1.0,5/13,20.49%,FCGR2B;ID2;MNDA;TNFRSF21;CD300A
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.49901530581213127,-1.0902299559443995,0.2222222222222222,1.0,1.0,64/277,17.17%,SOCS3;CCL4;PRLR;NLRP12;RPS27A;CEBPD;VIM;OSMR;F13A1;CHI3L1;MT2A;FOS;VEGFA;HIF1A;AIM2;TNFRSF1B;RORA;DUSP1;IL7;CCL3;GBP2;DUOX1;BRCA1;RHOU;DAPK1;RPL13A;GAPDH;STAT1;JUNB;CXCR4;IL10RA;IL18;UBA52;CD36;MNDA;UBC;IRF1;TCF7;TEC;FN1;FPR1;IFIT1;PTPRT;AKAP6;LIFR;HCLS1;PID1;NR1D1;CDKN1B;PTPRZ1;GHR;PYCARD;IL1RAPL1;RPS3;PIK3CB;SIGIRR;UBB;TLR2;TNFRSF21;STAT2;IL3RA;BCL6;CRLF1;MCL1
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.7010505382912344,-1.09018265226511,0.42424242424242425,1.0,1.0,1/7,2.66%,BEGAIN
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.5557594914785797,1.0901071467354864,0.32142857142857145,0.9293816297635542,1.0,3/10,13.84%,SUPT16H;UBN1;RBBP4
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.4963120359083778,1.0898936942037203,0.3333333333333333,0.9282962368947872,1.0,3/13,19.35%,IKBIP;BRCC3;LIG4
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.5936225370317781,-1.0895111338944359,0.33766233766233766,1.0,1.0,5/24,9.39%,DTL;BRCA1;DONSON;NOP53;CLSPN
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.6125894558630188,1.089503938583953,0.3939393939393939,0.927922441154112,1.0,5/9,23.08%,VCL;IL1B;ZDHHC21;IKBKB;ROCK2
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.7601044459428468,-1.0895007739444065,0.45588235294117646,1.0,1.0,2/5,15.79%,UHRF1;PLSCR1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.7601044459428468,-1.0895007739444065,0.45588235294117646,1.0,1.0,2/5,15.79%,UHRF1;PLSCR1
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.5623281438127689,-1.08938792864408,0.4125,1.0,1.0,10/31,18.58%,ANK3;UGCG;UBXN2B;NLGN3;NRXN1;PTPRD;IL1RAPL1;LRP4;ANXA2;NRXN2
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.6630250671436172,1.0892844476749846,0.4146341463414634,0.9268668049434404,1.0,1/7,0.46%,ZNF703
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.6110333613811366,-1.0892026233708436,0.42857142857142855,1.0,1.0,10/16,33.99%,CDC37;SDCBP;PDCD6IP;ASAH1;OGT;CYLD;CFLAR;FLOT2;PELI1;FLOT1
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.6409934787204279,-1.0891117593399449,0.37209302325581395,1.0,1.0,4/14,15.95%,CALY;FCHO2;AP2S1;NSG2
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.5850137577712285,-1.0888836996597548,0.345679012345679,1.0,1.0,5/32,8.78%,ANKRD22;CEBPD;FBP1;IL18;ABCC3
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),0.6346126328399553,1.0882944659483749,0.375,0.9282021044295051,1.0,2/6,14.09%,TP53;SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.694471618312407,-1.0881244942443977,0.41935483870967744,1.0,1.0,2/6,19.33%,FCGR2B;LILRB2
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.5071915967704653,-1.0879351413829421,0.3723404255319149,1.0,1.0,12/82,15.78%,RPS27A;ST18;RBX1;NOD2;MAP3K8;UBA52;PSMA3;UBC;PSMA5;PSMD8;UBB;PSMB4
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.7182398081260497,-1.0879308380767718,0.3939393939393939,1.0,1.0,1/7,0.57%,NLRP12
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),-0.7050949854814794,-1.0877075207584868,0.4225352112676056,1.0,1.0,3/6,22.60%,UHRF1;ZNF445;DNMT1
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),-0.7133974365667757,-1.0876559944419757,0.3898305084745763,1.0,1.0,1/5,8.66%,IL18
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.5000084219284661,-1.0871832296258028,0.25,1.0,1.0,20/125,19.24%,BRIP1;CYREN;HMGB2;XRCC3;RPA2;BRCA1;PARP9;POLQ;DDX1;PIAS4;FAN1;RPA3;POLL;DNA2;SLX4;BRCA2;ACTR5;KDM4B;ABRAXAS1;DTX3L
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.7066499084200752,-1.0870733546265148,0.42857142857142855,1.0,1.0,2/5,8.78%,SLCO3A1;ABCC3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.6184495520724482,-1.0869601180363988,0.3563218390804598,1.0,1.0,7/22,17.27%,RGS2;PLN;ANK2;CALM3;PDE4B;CAV3;CALM1
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.6572567553924636,-1.086937895945337,0.4393939393939394,1.0,1.0,2/11,7.45%,GPR183;FCGR2B
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.7034746778499487,-1.0868952525996374,0.4444444444444444,1.0,1.0,3/7,25.54%,DDX11;DNA2;WRN
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.6738416013796118,-1.0867498756315535,0.4931506849315068,1.0,1.0,3/9,9.93%,THBS1;ENPP4;THBD
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.631875810215071,-1.0863589752001155,0.375,1.0,1.0,3/16,8.00%,SOCS3;ST18;STAT1
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.6437420085914224,-1.0861962989192435,0.4025974025974026,1.0,1.0,6/18,22.69%,OIP5;ITGB3BP;CENPP;CENPI;CENPU;CENPK
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.6437420085914224,-1.0861962989192435,0.4025974025974026,1.0,1.0,6/18,22.69%,OIP5;ITGB3BP;CENPP;CENPI;CENPU;CENPK
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.5564461642704142,1.0861439909971669,0.3235294117647059,0.933275919046538,1.0,3/11,6.37%,DDB2;POLD3;SIRT1
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),-0.7008387406205784,-1.0854882747339334,0.4153846153846154,1.0,1.0,2/5,15.61%,DPYD;DPYS
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.5252301148210639,-1.0853856274212046,0.35294117647058826,1.0,1.0,4/45,9.15%,PRLR;ACSL1;LPCAT1;GNPAT
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.40229840459994004,1.0853406451386391,0.25,0.9341183065666546,1.0,6/31,5.99%,GSN;FER;NCK2;BIN1;VASP;WHAMM
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.6490492460128419,-1.0851332603596902,0.3287671232876712,1.0,1.0,1/9,3.82%,PTN
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.6309371665562151,-1.0850515418978697,0.3698630136986301,1.0,1.0,1/14,0.73%,THBS1
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),-0.5293792175331958,-1.0848036479818364,0.358695652173913,1.0,1.0,12/50,20.43%,FAM50A;TNFRSF1B;PQBP1;AHNAK;RRP1B;USP36;OAS3;CLK1;CLK2;METTL4;MBNL2;AKAP17A
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.3102729925016295,1.084410936507116,0.0,0.935138295475819,1.0,10/151,6.54%,NUFIP1;RP9;RNASEL;SNRNP35;SCNM1;ELAVL4;LSM6;SNRPB;KHSRP;PPARGC1A
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.6539082121737229,-1.0844077171675763,0.3783783783783784,1.0,1.0,4/11,23.18%,SLIRP;PID1;WASF1;PNPT1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.7161199234496223,-1.0843038959271716,0.53125,1.0,1.0,2/5,17.27%,CALM3;CALM1
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.6444651600183033,-1.0841442897136329,0.4027777777777778,1.0,1.0,3/13,11.22%,VEGFA;FBN2;AGTPBP1
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.6023681709145192,-1.0839071859107732,0.4024390243902439,1.0,1.0,4/16,28.45%,MSL3;MORF4L2;MEAF6;BRD8
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.6666744822820505,-1.083831934991827,0.453125,1.0,1.0,4/9,11.93%,HIF1A;RPL11;RPL5;COPS9
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.4889988347463366,-1.083534734053135,0.16,1.0,1.0,93/482,17.63%,TOP2A;HTR2B;PRLR;TFRC;GADD45B;THBS1;ARAF;RPS27A;NAA38;RNF144B;LRP2;PNMA1;AGT;VEGFA;RHOB;PRELID1;BCL2A1;RPS6;VAV3;IFIT2;CFL1;IL7;NDRG1;GSTP1;MTCH1;IFIT3;RPS3A;DDRGK1;FAIM2;FAM162A;EGLN3;RASGRF2;FIGNL1;COPS5;ATF5;DAPK1;PINK1;CLIP3;STAT1;DAPK2;ITGB3BP;ITSN1;TNFAIP8;SOD1;NOP53;HSPA1B;NUAK2;UBA52;NOTCH2;PAX8;TPT1;MNDA;BEX2;RRP1B;TMEM14A;BNIP3L;BNIP1;BCL2L2;STIL;UBC;BNIP3;PIM3;OLFM1;HSPA5;USP36;KCNMA1;APIP;PTMA;CTSB;ING4;ALK;NSMF;PYCARD;CD44;STK17B;ING5;RPS3;BCL2L14;TRAF2;BMF;GNA13;UBB;ATAD3A;CIDEB;ITGA6;HMGN5;LGALS1;BCL6;NGEF;MCL1;CLU;TP53INP1;NEURL1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.5076714584547692,1.0833755603866106,0.4090909090909091,0.9362220757864491,1.0,8/14,21.06%,TP53;IL1B;ANP32B;YWHAE;BAG3;TCF7L2;TPR;GSK3B
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),-0.7547939273799529,-1.0830280754364334,0.3484848484848485,1.0,1.0,2/5,12.79%,RORB;RPGRIP1L
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),-0.7547939273799529,-1.0830280754364334,0.3484848484848485,1.0,1.0,2/5,12.79%,RORB;RPGRIP1L
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.6406386276867931,-1.0828035026400264,0.3950617283950617,1.0,1.0,3/17,12.28%,ATP5IF1;UROS;PPOX
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.47932321421338575,-1.0826762197396074,0.32,1.0,1.0,55/217,21.60%,TOP2A;GADD45B;RPS27A;PNMA1;RHOB;TGFB2;RPS6;VAV3;IFIT2;CCL3;MTCH1;FAM162A;RASGRF2;DAPK1;CLIP3;DAPK2;ITGB3BP;ITSN1;TNFAIP8;SOD1;UBA52;MNDA;RRP1B;BNIP3L;UBC;BNIP3;OLFM1;KCNMA1;TRAF7;ING4;PYCARD;STK17B;ING5;RPS3;BMF;GNA13;UBB;ITGA6;BCL6;NGEF;PTRH2;CLU;NEURL1;ARHGEF4;FGD3;ADAMTSL4;RPS6KA2;SUDS3;EPHA7;SEPTIN4;C1QBP;PLEKHG5;OBSCN;SOX4;RACK1
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.5525523184842074,-1.0826648462750148,0.40476190476190477,1.0,1.0,11/30,19.96%,FA2H;ALOX12;LSR;UGCG;TXNIP;ST14;ERRFI1;ITGA6;CLIC4;STMN1;COL5A1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.5430538024440016,-1.082334657648986,0.3333333333333333,1.0,1.0,16/49,26.77%,RHOB;RACGAP1;ANK3;CIT;ANLN;INCENP;SEPTIN9;STMN1;PDCD6IP;SEPTIN4;SEPTIN8;MYH10;SPAST;TTC19;EFHC1;ROCK1
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.6257568812140697,-1.082070082202063,0.43661971830985913,1.0,1.0,2/12,13.71%,MDFIC;APOD
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),-0.702153952619877,-1.0817474517741135,0.4714285714285714,1.0,1.0,1/7,5.50%,MTCH1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.4968345062847987,-1.0815950432307866,0.32323232323232326,1.0,1.0,19/144,11.73%,CENPF;RPS27A;NEK11;PRKAR2B;HAUS6;TUBB4A;TUBA4A;RIOK2;CENPE;ID2;APPL1;UBA52;PSMA3;UBC;PSMA5;ANLN;TUBA1A;ERCC2;RGCC
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.5073850971023359,1.0815628676244198,0.2413793103448276,0.9400036716539175,1.0,4/12,18.71%,TLR7;TRAF6;IRAK1;IRAK4
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.6061875531933508,-1.0814850682919412,0.4025974025974026,1.0,1.0,8/18,26.78%,SOD1;DMD;TTN;SCN3B;GAA;RYR2;SGCZ;SGCD
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.5741853844157244,-1.0814578845301404,0.37662337662337664,1.0,1.0,1/19,0.57%,NLRP12
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.5436765904761256,-1.0811677990503048,0.3763440860215054,1.0,1.0,15/39,23.93%,ZNF382;SV2C;TVP23A;AANAT;MCF2L2;FRRS1L;CREM;PDE10A;SCN3B;SLC24A2;UNC13C;SV2B;XKR4;HCN1;OPRM1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.7064062108848819,-1.0810700615131312,0.4098360655737705,1.0,1.0,3/7,21.60%,COPS5;HSPA5;RACK1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.531763328771861,-1.080879526331707,0.36363636363636365,1.0,1.0,5/40,5.89%,CCL4;CHI3L1;HIF1A;CCL3;GBP2
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.5886911412760159,1.0808289714217836,0.42857142857142855,0.940377430976803,1.0,2/8,5.85%,PTCH1;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.6756644327360314,-1.0807649300187219,0.4383561643835616,1.0,1.0,3/12,18.41%,RBPJ;AKAP6;ZFPM2
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.7282228686328805,-1.080402496554769,0.39344262295081966,1.0,1.0,2/7,6.34%,CD55;CR1
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.6025162784544216,-1.0802485077712505,0.32051282051282054,1.0,1.0,3/15,13.40%,WDR5;HCFC1;ING4
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.6025162784544216,-1.0802485077712505,0.32051282051282054,1.0,1.0,3/15,13.40%,WDR5;HCFC1;ING4
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.6592658782360672,-1.080013386190287,0.39436619718309857,1.0,1.0,2/10,8.93%,VEGFA;TTN
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.5654464253827629,1.0797374081063003,0.42857142857142855,0.9416021467772167,1.0,1/9,0.95%,NRP1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.6499119637152988,-1.0797324964978208,0.4533333333333333,1.0,1.0,2/11,11.09%,ACSL1;HSD17B12
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.6001793637941738,-1.07969405439939,0.35064935064935066,1.0,1.0,8/25,15.77%,GLRX2;MTCH1;ANK2;UGCG;TYMP;GRK4;SCG5;MGLL
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.5634582439000123,-1.0796437842251947,0.40963855421686746,1.0,1.0,4/24,8.68%,DALRD3;FTSJ1;METTL2A;GTPBP3
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.5841014858784052,-1.0796236599421607,0.3146067415730337,1.0,1.0,8/30,13.90%,SOCS3;VEGFA;IL15;PARP9;IL18;HCLS1;PARP14;GHR
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.6617926242157712,-1.079490818503282,0.4473684210526316,1.0,1.0,1/8,9.39%,CLSPN
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.4981026233031401,-1.0794787029056578,0.3854166666666667,1.0,1.0,19/62,22.04%,NUDT12;ACSL1;SLCO1A2;ABCA5;SOD1;GNPAT;ABCA9;LIPE;GSTK1;ABCA6;ABCA1;ALDH1A1;PNPLA8;ABCA8;PIPOX;HACL1;IDI1;DIO2;SLC27A5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.591350977970839,-1.0794674119084495,0.4230769230769231,1.0,1.0,4/21,14.27%,NR4A3;PRKCQ;PYCARD;CD44
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.5480033808978818,-1.0794265869154824,0.38202247191011235,1.0,1.0,3/26,3.82%,THBS1;VEGFA;PTN
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.6617071538587933,-1.0791002859831518,0.38461538461538464,1.0,1.0,2/9,23.42%,BNIP3;VPS35
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),0.6082067098967822,1.0790923404786912,0.4230769230769231,0.9414117601826439,1.0,1/5,6.16%,TP53
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.6995754510413235,1.0790526635261377,0.45714285714285713,0.939747242596098,1.0,2/6,9.30%,TICAM1;SCIMP
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.5075612694580297,-1.0786570791997874,0.34444444444444444,1.0,1.0,15/79,17.81%,GLRA1;MT2A;FOS;FBP1;ANK3;BNIP3;IQGAP1;B2M;CDKN1B;CPNE8;SYT1;ADCY8;SYT4;RYR3;CLIC4
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.7053494918614036,-1.0782511567712307,0.3888888888888889,1.0,1.0,6/7,24.86%,RIMS1;UNC13A;SYT1;UNC13C;RIMS2;RIMS3
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.47162898010501364,1.0780172794508964,0.3076923076923077,0.9410554423747228,1.0,4/26,6.30%,DCP1B;LSM6;NT5C3B;EDC3
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.6974645808146291,-1.0778343042736587,0.42424242424242425,1.0,1.0,3/7,19.02%,MCMDC2;MCM3;MCM6
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),-0.5416618178928552,-1.0778241693831871,0.37362637362637363,1.0,1.0,11/43,25.61%,WDR5;MSL3;HCFC1;ING4;ING5;MORF4L2;TRIM16;BRCA2;PER1;MEAF6;OGT
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),-0.7307093906606787,-1.0777981299698016,0.4262295081967213,1.0,1.0,2/5,2.26%,THBS1;ENPP4
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),-0.7307093906606787,-1.0777981299698016,0.4262295081967213,1.0,1.0,2/5,2.26%,THBS1;ENPP4
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.566123436442252,-1.0776307850732205,0.40476190476190477,1.0,1.0,8/36,26.31%,SNRPD2;DDX1;SRSF5;PRPF6;GCFC2;SRSF9;CELF2;RBM5
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.6915082433942357,1.0774301388110263,0.4,0.9408226326381591,1.0,1/5,6.08%,LPL
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.6113522654944257,1.077291396018041,0.43243243243243246,0.9393907933985749,1.0,2/7,8.73%,SCRIB;RAB10
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.7665408577430867,-1.0771835572567412,0.39344262295081966,1.0,1.0,1/5,3.05%,RAB7B
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),-0.7190660681932851,-1.0771578810451847,0.3888888888888889,1.0,1.0,3/5,18.95%,CCL3;MGLL;ACP3
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.5560994212335221,-1.077098034014386,0.35294117647058826,1.0,1.0,11/33,16.20%,H2BC11;GSTP1;NR1H2;PADI2;CCDC3;NLRC5;OAS3;CARD16;PARP14;SIGIRR;STAT2
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),-0.6828580426871431,-1.0767970237852158,0.4057971014492754,1.0,1.0,1/6,9.48%,PRDM15
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.4872623598538155,-1.0765923335145622,0.31958762886597936,1.0,1.0,33/179,15.74%,TFRC;RPS27A;TRIM5;PLPP3;AGT;VEGFA;RAB7B;AIM2;BEX1;SLCO3A1;NOD2;DDRGK1;COPS5;PRKCQ;ARID5B;IL18;HSPA1B;CRTC3;UBA52;CD36;TRIM25;UBC;RGCC;CARD16;HCLS1;ALK;PYCARD;KDM1A;RPS3;TRAF2;TERF2IP;UBB;TLR2
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.6322785593557934,-1.0759759538716698,0.37662337662337664,1.0,1.0,5/16,19.08%,TRIM5;HS3ST5;TRIM25;TRIM22;TRIM14
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.5790467857497178,-1.075871838146477,0.3563218390804598,1.0,1.0,5/30,17.32%,H2BC11;HMGB2;H2BC9;HIRA;H2BC5
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.5104355522731323,-1.0758484122145315,0.336734693877551,1.0,1.0,25/109,14.04%,CEBPD;TNFRSF11B;F13A1;CHI3L1;CD93;TNS1;HIF1A;GRM8;CD163;CCL3;MS4A4A;MARCO;SNX10;LTB4R;THBD;TGFBI;KCNMA1;ABCA1;ITGA2;CTSB;EPHB1;PID1;SIGLEC1;CD14;RASSF4
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.6245497595280814,-1.0757210872136111,0.35443037974683544,1.0,1.0,5/18,12.90%,OR3A2;C5AR1;SCN9A;NIPSNAP1;CDH23
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),-0.6788233932325178,-1.0754968476718791,0.373134328358209,1.0,1.0,2/7,9.59%,TG;PAX8
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.5692804500560674,-1.075443138649498,0.43529411764705883,1.0,1.0,8/25,20.49%,PPP1R15A;PPP2R5A;CNEP1R1;CALM3;NSMF;CALM1;LILRB2;CD300A
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.7179176611187819,-1.0754205431227921,0.4666666666666667,1.0,1.0,1/5,14.50%,SNX6
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.6491053241434486,-1.075326245668729,0.39473684210526316,1.0,1.0,1/14,3.27%,RBPJ
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.6380784108091072,-1.0753245289974824,0.4782608695652174,1.0,1.0,3/12,8.93%,VEGFA;KDM6B;TTN
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),-0.7191375015716798,-1.075308921600742,0.4696969696969697,1.0,1.0,1/6,5.63%,FBP1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),-0.7191375015716798,-1.075308921600742,0.4696969696969697,1.0,1.0,1/6,5.63%,FBP1
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.5330781431533563,-1.0752892694687526,0.39080459770114945,1.0,1.0,5/35,10.38%,SPOCK1;AGT;PRELID1;GAPDH;PSMA3
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.5620056463599807,-1.0752384678454674,0.4044943820224719,1.0,1.0,5/23,14.34%,VEGFA;SDCBP;CD63;LRPAP1;INSR
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.5508208560781859,-1.0751419836282823,0.3855421686746988,1.0,1.0,5/29,18.18%,PINK1;BNIP3;ATG2A;ATG5;GABARAPL1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.5334368621001397,1.074299027219873,0.375,0.9462591941198722,1.0,2/11,6.37%,POLD3;SIRT1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),-0.6563322253537188,-1.0741453841702262,0.45588235294117646,1.0,1.0,2/7,25.10%,BRCA2;MACROH2A2
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.6999818014527238,-1.07409205178911,0.4838709677419355,1.0,1.0,1/5,0.73%,THBS1
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.7348652503038109,-1.0735262686887634,0.423728813559322,1.0,1.0,1/5,2.38%,MYLK
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.5644318862075646,-1.0733852955181722,0.4166666666666667,1.0,1.0,1/25,0.28%,GLRA1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),-0.6127559469673638,-1.073362032676843,0.4027777777777778,1.0,1.0,1/13,2.64%,ETFB
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.6946402299181409,-1.0733474856454432,0.45714285714285713,1.0,1.0,4/5,29.24%,FGF13;CAV3;AKAP9;ATP2A2
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.5081162842157095,-1.0733371135942216,0.39361702127659576,1.0,1.0,16/75,16.74%,CCL4;JAML;MYO1G;TSHR;CD69;SELL;FGR;CXCR4;IL10RA;NCF4;LSP1;HCLS1;VNN2;GNLY;GPR65;BCL6
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.5142722971389942,1.073220960142453,0.4,0.948098875105839,1.0,5/13,8.72%,HPGDS;DAGLB;CYP2S1;ACOX1;PTGS1
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.6131887752240861,-1.073056637834919,0.425,1.0,1.0,5/21,14.79%,ATP8B1;ATP10A;ABCB4;ABCA1;ABCB1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.7014673577367425,-1.0729681981494652,0.4411764705882353,1.0,1.0,1/5,5.79%,DDRGK1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.7014673577367425,-1.0729681981494652,0.4411764705882353,1.0,1.0,1/5,5.79%,DDRGK1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.7014673577367425,-1.0729681981494652,0.4411764705882353,1.0,1.0,1/5,5.79%,DDRGK1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.39351630993712594,1.072890658346141,0.4444444444444444,0.9473022605365309,1.0,7/39,8.00%,CD276;LCP1;NCK2;SCRIB;LEPR;EIF2AK4;MSN
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),-0.7342775195872904,-1.0727617388495891,0.4411764705882353,1.0,1.0,4/5,26.51%,SHANK3;NRXN1;NRXN2;CNTNAP2
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),-0.7342775195872904,-1.0727617388495891,0.4411764705882353,1.0,1.0,4/5,26.51%,SHANK3;NRXN1;NRXN2;CNTNAP2
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.5006606349009523,-1.0725099282781525,0.32989690721649484,1.0,1.0,13/101,10.86%,PCSK1;FA2H;PLPP3;ALDH3B1;GCNT1;DEGS2;GSTP1;LPCAT1;NMRAL1;GSTM3;DMD;PCTP;GSTK1
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),-0.717000439166243,-1.0724140217213096,0.4852941176470588,1.0,1.0,3/5,15.74%,CD36;CD14;TLR2
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.568313781518138,-1.0723347220067403,0.425,1.0,1.0,5/20,22.29%,ACSL1;HSD17B12;SCD;ACSL3;SCD5
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.7060722351986357,-1.0722901846308617,0.4507042253521127,1.0,1.0,5/7,26.74%,ATP1B3;ANK2;ATP1B2;AKAP9;ACTN2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.6397601919713172,-1.0720417137329101,0.41025641025641024,1.0,1.0,2/10,7.41%,SULT4A1;PAPSS2
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.43089073883578405,1.0720311565898006,0.4,0.9480083469053957,1.0,8/28,12.90%,PLEKHJ1;EXOC8;RAB22A;LAPTM4B;CHMP2B;LAMTOR1;WASHC5;DNAJC13
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.5349157877102797,-1.0718699047550833,0.38144329896907214,1.0,1.0,14/72,17.63%,KCNE1;GLRA1;TSHR;BRCA1;CFTR;AANAT;AKAP6;NSMF;LARS1;GABRB1;IMPACT;GABRG2;RYR3;NEURL1
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.5286968364053835,-1.0717752252456545,0.36666666666666664,1.0,1.0,9/55,16.82%,RPS27A;VIM;DDRGK1;UBA52;CFTR;UBC;ATG2A;UBB;ATG5
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.515902568854932,1.0715774644306622,0.37037037037037035,0.9475230568480135,1.0,4/17,11.58%,TGFB1;APH1A;ADAM10;TRAF6
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),-0.7087443724995177,-1.0713919798119733,0.36619718309859156,1.0,1.0,3/7,25.54%,XRCC3;SLX4;WRN
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),-0.6989396794579066,-1.0713252535877316,0.5076923076923077,1.0,1.0,5/8,28.29%,KIF5A;KIF5C;MAP1A;RAB27B;HSPB1
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),-0.6989396794579066,-1.0713252535877316,0.5076923076923077,1.0,1.0,5/8,28.29%,KIF5A;KIF5C;MAP1A;RAB27B;HSPB1
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),-0.6989396794579066,-1.0713252535877316,0.5076923076923077,1.0,1.0,5/8,28.29%,KIF5A;KIF5C;MAP1A;RAB27B;HSPB1
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.5125478740553522,-1.0713002759825478,0.336734693877551,1.0,1.0,22/127,15.79%,NLRP12;CD55;RGS2;HHIP;TRIM5;OVOL2;GLRX2;RGS20;RORA;MTCH1;MDFIC;UGCG;CD36;RASGRP4;CD63;IFT81;LIFR;FRRS1L;GRK4;CAV3;MGLL;PLSCR1
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.5713220800046455,-1.0706420298984292,0.38271604938271603,1.0,1.0,8/25,21.61%,GK;DGKG;DGKI;DGAT1;CAV3;MGLL;GK5;DGKB
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.5003785013669512,-1.0704328042238158,0.4,1.0,1.0,9/76,8.83%,CYCS;ERMP1;ALDH3B1;ERO1A;GSTP1;PINK1;TMEM161A;SOD1;HSPA1B
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.4736744313321843,1.0702260782690332,0.23076923076923078,0.9491489827738024,1.0,5/23,10.94%,B4GALT7;GAL3ST4;GLCE;UGDH;FAM20B
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.6416052141227809,-1.070195968834834,0.4657534246575342,1.0,1.0,4/12,20.49%,PPP1R15A;CALM3;CALM1;CD300A
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.669672627023502,1.0701808372708888,0.42105263157894735,0.9475667585518162,1.0,2/5,29.53%,SERBP1;HABP4
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.6708775445618305,-1.0695429658038411,0.39436619718309857,1.0,1.0,4/8,22.04%,ACSS3;HMGCL;ACAT1;SLC27A5
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.6526260431612378,-1.0694868206175434,0.4375,1.0,1.0,3/8,20.21%,IL18;NFKBIZ;NFKBID
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.6344507996903765,-1.0694119825138184,0.4025974025974026,1.0,1.0,4/11,18.66%,CACNB2;ANK2;CACNA1C;SCN3B
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),-0.6510326986922129,-1.06913877546972,0.4794520547945205,1.0,1.0,5/9,25.58%,DPYD;ALDH6A1;DPYS;CTPS1;CRMP1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.4239029968443507,1.0688942695859982,0.3333333333333333,0.9494274031706434,1.0,5/26,5.43%,NRP1;CSF1R;ABI3;ARHGDIB;ABL1
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.5671440361137482,-1.0688664817460198,0.4268292682926829,1.0,1.0,7/28,17.29%,SLC38A4;SLC7A5;SLC16A7;SLC16A1;ABCB1;SLC38A6;SLC13A3
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.49475704088902434,1.068766767866086,0.32142857142857145,0.9479816124453787,1.0,4/13,17.09%,ILRUN;ELMOD2;ZMPSTE24;IFNLR1
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.6350578557032935,-1.0684927370503923,0.42168674698795183,1.0,1.0,2/12,4.62%,DNAH17;CCDC39
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.6618442820847937,-1.0682660756257638,0.49295774647887325,1.0,1.0,2/10,2.48%,TRIM5;IFITM3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.6153505599904596,1.0679841208463636,0.4375,0.9490930586655664,1.0,1/6,3.06%,MCU
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.5227396823264246,-1.0674987194000096,0.3695652173913043,1.0,1.0,11/85,10.30%,ARAF;RNF144B;ARIH2;RPL11;RBX1;DDRGK1;HERPUD1;NOP53;HSPA1B;CAMLG;SDCBP
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),-0.7147057706317785,-1.0674342633823943,0.39344262295081966,1.0,1.0,3/5,23.71%,SHANK3;FRMPD4;CAMK2B
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.5530406357525535,1.067259668793608,0.35714285714285715,0.949438429577605,1.0,3/9,15.78%,SIRT1;SLC30A10;CDK6
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.5530800047444403,-1.0670841526874413,0.3875,1.0,1.0,7/31,19.61%,TOMM7;PINK1;TIMM13;TOMM40;TOMM20;TIMM21;HK2
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.6909373014607827,-1.0668316873447123,0.4126984126984127,1.0,1.0,1/5,3.80%,PPP1R3B
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),-0.6647853440782361,-1.0665734707264678,0.4225352112676056,1.0,1.0,6/8,30.07%,FGF13;GABRG2;GABRB3;GABRA2;GABRB2;GABRA1
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.6345072497090277,-1.066402370553282,0.3698630136986301,1.0,1.0,4/11,17.49%,SLC7A5;ABCC3;ABCB1;ABCA8
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.6076907490911719,-1.066318848827318,0.39759036144578314,1.0,1.0,4/17,16.90%,CFTR;PIM3;NR1D1;ADCY8
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.46992198817811986,1.0662551637517448,0.42105263157894735,0.9504127370147679,1.0,1/18,0.57%,NDE1
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.5547833248074209,1.0662527818293772,0.4,0.9486720543462427,1.0,3/7,24.74%,APPL2;TREM2;C3
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.6556275941548131,-1.0662256078996097,0.44871794871794873,1.0,1.0,3/15,12.28%,ATP5IF1;UROS;PPOX
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),-0.6920665991151929,-1.066125375210075,0.45161290322580644,1.0,1.0,4/5,26.58%,MAPT;SH3GL2;WASF1;TMEM108
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.41820720608046746,1.066073219644488,0.4,0.947414073868422,1.0,8/39,9.29%,PEX13;ECI1;ACADS;PPARGC1A;ADIPOR2;MTLN;ACOX1;EHHADH
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.6863744799248378,-1.0657298745136439,0.45588235294117646,1.0,1.0,3/7,23.50%,POLQ;POLL;MLH1
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.667485029136921,-1.0657063340070432,0.42105263157894735,1.0,1.0,1/13,7.03%,POLR2G
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.5195428232970797,-1.0656851817526014,0.36363636363636365,1.0,1.0,8/45,14.60%,FOS;HIF1A;GLRX2;GSTP1;MAPT;SOD1;APOD;RPS3
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.5496360168491403,-1.0656058197878697,0.43529411764705883,1.0,1.0,10/28,26.98%,GRIK1;GRM8;GRIA4;GRM3;GRIN2A;PLCB1;GRIA2;APP;GRIK2;GRIK4
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),-0.6993299691608208,-1.0654940499572547,0.4358974358974359,1.0,1.0,3/7,21.95%,FCGR2B;FCER1G;CARD9
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.4605458153351033,1.0653518174561323,0.4,0.9476087022368663,1.0,3/23,4.46%,SIRPA;LGALS9;ILRUN
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.6626568541502629,-1.065029433348597,0.43283582089552236,1.0,1.0,2/9,16.03%,DDX11;TIMELESS
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.660743395512722,1.0647131257708273,0.42424242424242425,0.9476516117131879,1.0,1/6,2.50%,NBDY
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.6614205240114381,-1.0646482546770806,0.3918918918918919,1.0,1.0,5/9,20.94%,CACNB2;ANK2;CACNA1C;SCN3B;KCNJ3
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.6647112581633843,-1.0641477548542877,0.5,1.0,1.0,2/8,15.19%,TNFRSF1B;SH3D19
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.5016483450647642,1.0636094223444406,0.3870967741935484,0.949696991284553,1.0,5/13,15.51%,CRK;FGF2;SERPINE1;ALOX5;CASK
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.5687300187270147,-1.0634599770044182,0.4358974358974359,1.0,1.0,3/21,9.51%,BHLHE40;HMGB2;NOTCH2
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.5140555904410768,-1.06280754608327,0.3829787234042553,1.0,1.0,16/72,18.63%,CD55;TRIM5;CASP5;NOD2;FCGR2B;FGR;DHX58;CXCR4;APPL1;CD36;IRF1;GRK4;MGLL;BCL6;CALM1;ERAP1
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.6766089716062903,-1.0627969045906618,0.3968253968253968,1.0,1.0,1/7,0.82%,ENPP2
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.6177100098288179,-1.0627680550019547,0.4,1.0,1.0,3/18,9.25%,THBS1;PRKCE;APPL1
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.5650164351977756,-1.0627628787969559,0.43209876543209874,1.0,1.0,2/21,6.41%,VPS11;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.6739212363388722,-1.0626774795481473,0.4461538461538462,1.0,1.0,2/8,2.48%,TRIM5;IFITM3
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),0.5816185711270572,1.0624165205076876,0.4074074074074074,0.9514985067440632,1.0,1/9,1.27%,FER
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.5882664949986133,1.061948292544083,0.5,0.9513839471117349,1.0,1/6,4.46%,ILRUN
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.6647548876951643,-1.0617426831719246,0.47761194029850745,1.0,1.0,2/5,20.83%,WDR48;TNIP1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.5643201212441811,-1.061358032675145,0.4305555555555556,1.0,1.0,4/21,14.78%,RPS6;SYAP1;PINK1;PRR5
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.5877288481485934,-1.0613043188419966,0.43373493975903615,1.0,1.0,8/22,19.21%,BHLHE40;HMGB2;PTN;TNFRSF1B;TYMP;PTPRZ1;PRUNE1;PER2
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.3451168091667293,1.061217357661615,0.3333333333333333,0.9518480552760725,1.0,10/58,11.01%,NUP188;IPO13;BACH2;SNRPB;E2F3;SYK;APPL2;SNUPN;NUP214;PPP1R10
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.5076115356657128,-1.0612108368311979,0.42857142857142855,1.0,1.0,8/64,9.09%,NUDT16;KNSTRN;IHO1;RACGAP1;RAB11A;ATF5;CALM3;KLHL13
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.4839515678819374,1.0611381354879204,0.3333333333333333,0.9503009430876703,1.0,2/14,2.81%,ZNF385A;SH2B3
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.6235076971786044,-1.0610946490418898,0.48,1.0,1.0,6/14,28.15%,WBP4;WBP11;SRSF12;PRPF39;RBM22;NCBP2
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.5352762219679694,-1.0610760953425145,0.3780487804878049,1.0,1.0,7/30,9.59%,TG;LSR;ALOX15B;COBL;ARID5B;SOD1;PAX8
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.6849359137381416,-1.060691562076139,0.5,1.0,1.0,4/7,29.38%,KIF3A;DCTN1;BBS4;HOOK3
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.48970073139440556,-1.0606888890504933,0.3854166666666667,1.0,1.0,14/99,10.34%,GPR18;JAML;MYO1G;LINC00926;CD69;NAPSB;SELL;CR1;FCGR2B;FGR;IL10RA;ABCB4;MNDA;ACAP1
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),-0.5328911235251989,-1.0606401867277566,0.40860215053763443,1.0,1.0,2/39,1.66%,NUDT12;NUDT16
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.48496376550319553,-1.0604175614511488,0.3854166666666667,1.0,1.0,21/117,17.47%,SRGN;NLRP12;THBS1;SLC11A1;CR1;FCGR2B;DHX58;BTN2A2;TRIM25;PDCD1LG2;NLRC5;RGCC;C5AR2;FN1;APOD;PYCARD;SIGIRR;TNFRSF21;PDCD4;PPP1R11;KLF4
prerank,GO_Biological_Process_2021__regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188),0.6751409545335696,1.0600963043032094,0.475,0.9518323110372835,1.0,1/5,1.01%,LGALS9
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.5301502302767716,-1.0600141344245406,0.36470588235294116,1.0,1.0,11/39,15.50%,FZD6;EMILIN2;OVOL2;BRCA1;FMO5;BAIAP2L1;ANLN;INCENP;BMI1;ITGA2;ST14
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.5589909799719831,-1.059665527225977,0.4675324675324675,1.0,1.0,6/24,13.60%,LRP2;TGFB2;MTHFD1;COBL;STIL;DEAF1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.5589909799719831,-1.059665527225977,0.4675324675324675,1.0,1.0,6/24,13.60%,LRP2;TGFB2;MTHFD1;COBL;STIL;DEAF1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.5830044076505801,-1.0592345923240158,0.4642857142857143,1.0,1.0,4/21,9.79%,HMGB2;DDX11;DDX1;MTERF1
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.6385894074751456,1.0591498847429697,0.4838709677419355,0.9532090618089509,1.0,3/5,26.54%,ATP13A2;PRKN;D2HGDH
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.4191173479066816,1.0591083681088396,0.4,0.9516465759081066,1.0,4/17,4.71%,LGALS9;CD274;TMIGD2;SCRIB
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.5084570784130151,-1.059045669494614,0.4105263157894737,1.0,1.0,23/100,17.12%,CCL4;THBS1;TACR1;CHI3L1;SLC11A1;FOS;C5AR1;CCL3;FCGR2B;CXCR4;IL18;LTB4R;HNRNPA0;PXK;C5AR2;FPR1;SIGLEC1;CD14;CD44;TLR2;MGLL;ADCY8;APOL3
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.6206588568005786,-1.058973361847804,0.4264705882352941,1.0,1.0,2/11,2.56%,NR4A1;VEGFA
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.3390167035973931,1.0587965684502454,0.3333333333333333,0.9508325614176464,1.0,6/90,1.84%,NUP42;SESN2;NRP1;FER;NUP188;DSCAM
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.36619249921932356,1.058649227490613,0.5,0.949597720937433,1.0,11/83,12.23%,NUP42;NUP188;WDR33;CPSF4;HHEX;FYTTD1;U2AF1;THOC5;NUP214;EIF4E;RAE1
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.5836654195430819,-1.0580877487375266,0.4074074074074074,1.0,1.0,8/23,18.12%,WDR12;RPL35;NHP2;RPL10A;RPL7A;MAK16;RPL7;PES1
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.5650226519976196,-1.058077078847853,0.43037974683544306,1.0,1.0,7/24,26.65%,LPCAT1;GNPAT;DHDDS;ABCA8;IDI1;MVD;PIP5K1A
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.4755474068440365,1.0579810250513544,0.4,0.9498265774991541,1.0,1/15,0.57%,NDE1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.6590843712983504,-1.0578555562752376,0.4507042253521127,1.0,1.0,1/7,2.89%,TGFB2
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),-0.6299924582376548,-1.057740309604923,0.42857142857142855,1.0,1.0,1/8,5.65%,NOD2
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.5392897102105711,-1.0577393106459998,0.45,1.0,1.0,11/37,20.83%,IFITM3;RSAD2;MX1;OAS3;IFIT1;IFIT5;PLSCR1;ILF3;ZC3HAV1;EIF2AK2;TNIP1
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.6225610268725539,-1.0576287971099887,0.42105263157894735,1.0,1.0,6/14,23.62%,JPH1;CACNA1C;ATP2B4;GRIN2A;RYR2;JPH4
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.5263735923353962,-1.0576014277357288,0.3870967741935484,1.0,1.0,16/64,18.33%,THBS1;CBR1;AGT;VEGFA;PRELID1;NR1H2;PAX8;CD63;UHRF1;NSF;PID1;INSR;ANXA2;GHITM;KLF4;CHCHD2
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.6791173912616909,-1.0573677581712462,0.46875,1.0,1.0,2/6,9.51%,TGFB2;NOTCH2
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.5418996183202885,-1.0572440560745446,0.39285714285714285,1.0,1.0,5/32,18.18%,PINK1;BNIP3;ATG2A;ATG5;GABARAPL1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.537877591158662,-1.0571552615979685,0.4125,1.0,1.0,4/27,16.67%,CDC37;CAMK2N1;CDKN1B;CCNB3
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.6672546224882072,-1.0571310883788176,0.5072463768115942,1.0,1.0,5/9,31.36%,KIF3A;DCTN1;BBS4;HOOK3;BICD1
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.6402182856369939,-1.0571064321812502,0.4305555555555556,1.0,1.0,6/11,17.26%,PTN;TNFRSF1B;CXCR4;ID2;PTPRZ1;DICER1
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.6351308540910431,1.056909193408008,0.4074074074074074,0.9511524102743055,1.0,3/6,17.32%,RPS6KA1;DDIT3;INO80
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.5233742752009044,-1.0567340002254775,0.4606741573033708,1.0,1.0,8/46,14.87%,H2BC11;GSTP1;CLIP3;HSPA1B;CCDC3;CARD16;PYCARD;TRAF2
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.5993935776319309,-1.0565715393217479,0.46987951807228917,1.0,1.0,2/16,9.72%,TRIM5;TRIM25
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),-0.696987401744392,-1.0564829996293017,0.4027777777777778,1.0,1.0,2/8,8.82%,PPP2R5A;EEF1A2
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.7163159944463735,-1.0562089271188486,0.47692307692307695,1.0,1.0,1/5,11.84%,RAB3A
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.669229882049239,-1.055776844318122,0.4090909090909091,1.0,1.0,4/8,26.74%,CARMIL1;CRACD;WASHC2C;ACTN2
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.5283922841853521,-1.0557354446350107,0.40229885057471265,1.0,1.0,11/41,17.33%,RPL23A;JPH1;COBL;CXCR4;EPB41L4B;MAPK4;ENAH;LRP4;ARFGEF3;CPE;SEZ6L2
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.676260565691164,1.0555316050956234,0.4358974358974359,0.9534429205870577,1.0,3/5,32.37%,ALKBH5;ALKBH3;FTO
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5205859308489931,1.055502065870732,0.38461538461538464,0.9518966710212522,1.0,2/10,3.27%,NFATC3;PPARG
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.6408094521773872,-1.0552320359854686,0.39705882352941174,1.0,1.0,4/12,21.75%,DONSON;TIMELESS;ZRANB3;LIG3
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),-0.713005858193509,-1.055070689159488,0.47368421052631576,1.0,1.0,2/5,7.89%,ANK3;CLIP3
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),-0.5609584434955481,-1.0550054794405825,0.4074074074074074,1.0,1.0,5/24,10.22%,HS3ST2;HS3ST5;B4GAT1;GPC3;GPC5
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.6156387871146366,-1.0549071500493648,0.38961038961038963,1.0,1.0,3/13,11.53%,NUDT16;RIOK2;USP36
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.5440379747347368,-1.0547203747443572,0.41975308641975306,1.0,1.0,5/26,16.96%,BRIP1;DONSON;CLSPN;TIMELESS;DNA2
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.5571416972221311,-1.0545848946149214,0.4430379746835443,1.0,1.0,4/23,19.07%,PINK1;USP36;FEZ1;NRBP2
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.5020899094253121,-1.054302297106047,0.40425531914893614,1.0,1.0,11/83,8.55%,CCL4;JAML;MYO1G;CD69;SELL;TXK;CCL3;SPON2;FGR;CXCR4;IL10RA
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.7278619943112782,-1.0542247482874234,0.4925373134328358,1.0,1.0,1/5,0.73%,THBS1
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.6140383772274327,-1.0541028698350479,0.4358974358974359,1.0,1.0,6/16,18.69%,RIMS1;SLC17A7;RAB3A;CPLX1;SNAP25;RAB5A
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.6831181084525124,-1.0540190342443017,0.4714285714285714,1.0,1.0,4/8,22.90%,AGTPBP1;NRXN1;TPP1;DCTN1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.5832818250761771,-1.053677917201359,0.4050632911392405,1.0,1.0,5/20,11.44%,VEGFA;RBPJ;HIF1A;ATF3;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.7042052470928348,-1.0536377566424542,0.509090909090909,1.0,1.0,2/5,17.03%,PRKCE;IRS2
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.5531355764478523,-1.0533738931598553,0.38636363636363635,1.0,1.0,6/39,6.53%,CLDN18;OSMR;VEGFA;THSD4;DOCK1;NTN4
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.36240731139003607,1.0532611829823297,0.0,0.9563826440010362,1.0,11/85,12.23%,NUP42;NUP188;WDR33;CPSF4;HHEX;FYTTD1;U2AF1;THOC5;NUP214;EIF4E;RAE1
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.539302735382216,-1.0529883253576149,0.39759036144578314,1.0,1.0,5/31,9.39%,DTL;BRCA1;DONSON;NOP53;CLSPN
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),-0.6714647305120144,-1.0529520898518947,0.44594594594594594,1.0,1.0,6/11,26.11%,CHRM5;GNA11;LY6H;CHRM2;PLCB1;CHRM3
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.5634994063942014,-1.0528882860210356,0.48148148148148145,1.0,1.0,5/28,3.75%,ASPN;MYLK;ADAMTS2;TNS1;LAMA2
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),-0.626232754351199,-1.052782884006947,0.4117647058823529,1.0,1.0,3/11,6.35%,TOP2A;SHOC1;FANCM
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.42890257604516036,1.0527810482691096,0.2857142857142857,0.955884761105762,1.0,6/21,18.96%,TGFB1;ZPR1;EFCAB7;BAG3;SMAD3;TPR
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.5323282670217735,-1.0527668116093374,0.3977272727272727,1.0,1.0,11/42,17.20%,SMC1B;CREB5;AQP11;WDR5;BRCA1;GGNBP1;BCL2L14;CREM;OSBP2;SORD;POU5F1
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.7057351501617157,-1.0526887074080473,0.48333333333333334,1.0,1.0,1/5,2.89%,TGFB2
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.7379819160796154,-1.052671753984833,0.4927536231884058,1.0,1.0,1/5,14.79%,ABCB1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.5863754827294512,-1.0524738482742584,0.4155844155844156,1.0,1.0,3/25,12.57%,NR4A3;RAB3A;KXD1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.598713454412144,1.0524679645508028,0.41379310344827586,0.954949214819454,1.0,5/10,23.79%,TMEM119;NOTCH1;HDAC5;BHLHE41;HDAC1
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6954091848366741,-1.0523692786956769,0.4714285714285714,1.0,1.0,2/7,19.33%,FGR;LILRB2
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.6341612933166286,-1.0522090090598082,0.4246575342465753,1.0,1.0,1/10,2.46%,AGT
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.5734121310077179,-1.052003954959201,0.4146341463414634,1.0,1.0,6/26,15.05%,LAMA2;SGCE;FHL1;DMD;POU6F1;CAV3
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.5121369682621458,-1.0514204631021147,0.38823529411764707,1.0,1.0,17/62,25.18%,HLA-B;CD36;HLA-F;PSMA3;PSMA5;B2M;NCF4;TAP1;PSMD8;PSMB4;NCF2;HLA-C;PSMD7;PSMD5;PSMC2;PSMB9;PSMB2
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.5080349303262028,-1.051176208183439,0.43010752688172044,1.0,1.0,20/67,17.01%,ADGRE1;RGS1;TSHR;ADGRG6;ADCY3;AKAP12;GRM8;MARCO;ADGRD1;ADGRL2;FPR1;ADGRL3;GNAO1;ABCA1;HTR1F;GNA13;RXFP1;GPR65;ADCY8;GNA11
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.5954191929913908,1.0509046705094045,0.4482758620689655,0.957609702051574,1.0,1/5,10.47%,SRC
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.5932584753030348,-1.050796758397954,0.4125,1.0,1.0,6/18,26.85%,RIMS1;ANK3;SYT1;RIMS2;RIMS3;GRIK2
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.6151554385421719,-1.0507568905951512,0.42857142857142855,1.0,1.0,4/13,23.18%,SLIRP;PID1;WASF1;PNPT1
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.6124517381175362,1.0505404844406945,0.4444444444444444,0.9572582469831904,1.0,1/7,7.18%,TFE3
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),-0.7339279736599766,-1.0502106378549387,0.5147058823529411,1.0,1.0,2/5,9.51%,RBPJ;NOTCH2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.6835494399677454,-1.0501862662543469,0.4492753623188406,1.0,1.0,2/7,8.31%,CACNB2;SESTD1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),-0.6569503687405628,-1.05002703429412,0.4861111111111111,1.0,1.0,5/12,22.43%,DPYD;TYMP;DPYS;CAD;UPP2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.6635679851708223,-1.0499196164398623,0.4782608695652174,1.0,1.0,1/10,3.27%,RBPJ
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.49992573033374754,-1.049883803119071,0.3894736842105263,1.0,1.0,16/80,14.04%,ENPP2;CHI3L1;GLUL;RTN1;TNS1;OPALIN;CD163;FAIM2;EPB41L3;PLP1;SPARCL1;PTPRT;NRXN1;PID1;CD14;RASSF4
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.5790926642516804,1.0495923095973654,0.4375,0.9582401594602311,1.0,3/6,22.02%,SMC6;SMC5;SIRT2
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.3877396485994159,1.0495213882065224,0.3333333333333333,0.9568914851555682,1.0,9/35,12.30%,TGFB1;RIOK1;ZPR1;TP53;IL1B;WDR43;MAP2K1;MAP2K2;BUD23
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.4160278904840905,1.049500638968334,0.4117647058823529,0.9553193764938478,1.0,3/18,4.43%,TNFAIP8L3;P2RY12;TGFB1
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.6614823110562357,-1.0493357456830412,0.4931506849315068,1.0,1.0,1/8,5.16%,RPS21
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.662568443782666,-1.0493326829180134,0.5,1.0,1.0,1/7,0.79%,ALG10B
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.5096504781703375,-1.0492227557673008,0.39361702127659576,1.0,1.0,9/78,8.95%,GLA;ENPP2;FA2H;PLPP3;ALDH3B1;DEGS2;PDXDC1;GALC;UGCG
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.46381363238270656,1.0488271732187178,0.3,0.9556162505680751,1.0,8/18,12.32%,CSF1R;PPARG;PIR;MYH9;PDE1B;THOC5;IKZF1;BATF3
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.5732505386142643,-1.0486982751639617,0.42168674698795183,1.0,1.0,3/23,8.53%,THBS1;GPR183;CXCR4
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.6196227055929392,-1.0486317918653285,0.4657534246575342,1.0,1.0,4/10,25.92%,BNIP3;INSR;FYCO1;CALCOCO2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.5037803391048001,-1.0484594257894868,0.48314606741573035,1.0,1.0,9/42,12.39%,THBS1;SPARC;TGFB2;AQP11;STAT1;ATP5IF1;B2M;RGCC;ATP5F1A
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),-0.7076455368390426,-1.0484457710789112,0.47058823529411764,1.0,1.0,1/6,7.11%,AKR1B1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.5127233490385443,-1.04834194433422,0.4044943820224719,1.0,1.0,12/59,14.87%,NLRP12;CYCS;BEX3;CASP5;MTCH1;FAM162A;EGLN3;MAPT;EIF2AK3;KHDC1;PYCARD;TRAF2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.5581750544705709,-1.0481994794123266,0.38823529411764707,1.0,1.0,13/34,24.14%,TUBB4A;MAPT;CLIP3;RPS3;CAV3;PRUNE1;STMN1;STMN2;EML2;MAP2;DCTN1;FES;AKAP9
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),-0.6654769819726614,-1.0477960503753017,0.4714285714285714,1.0,1.0,1/7,3.35%,ADGRG6
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),-0.6654769819726614,-1.0477960503753017,0.4714285714285714,1.0,1.0,1/7,3.35%,ADGRG6
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.5044173705971353,-1.0476256926649576,0.4725274725274725,1.0,1.0,15/72,16.74%,CCL4;JAML;GPR183;MYO1G;TNFRSF1B;SELL;FGR;IL10RA;NCF4;LSP1;HCLS1;VNN2;GNLY;GPR65;BCL6
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.6764420784646428,-1.0475667207722912,0.4098360655737705,1.0,1.0,3/8,19.71%,DONSON;TIMELESS;ZRANB3
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.6571490557709678,-1.0473507106886724,0.46153846153846156,1.0,1.0,1/8,2.64%,ETFB
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.5006305757305339,-1.046992077412322,0.44086021505376344,1.0,1.0,19/80,18.02%,ANKRD22;FOSL2;CEBPD;BHLHE40;FBP1;SAT1;JUNB;MARCKSL1;ABCC3;TYMP;MGAT1;OAS3;CTSB;CD14;ST14;RAB20;KLF4;NFIB;HLA-C
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.5689334584577963,1.0469169060703811,0.4482758620689655,0.9591571627684591,1.0,1/5,3.73%,SORL1
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.6017517662551544,-1.0468049127627286,0.4266666666666667,1.0,1.0,5/14,17.75%,CEMIP;CALM3;AKAP6;CALM1;THY1
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.5205235084048767,-1.046590450104934,0.3804347826086957,1.0,1.0,9/54,9.57%,GLRA1;VIM;MYOT;MYLK;SNTB1;DMD;TTN;CKMT2;LTB4R
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),-0.7122779021401087,-1.046578843105502,0.5362318840579711,1.0,1.0,2/6,13.06%,KDM6B;ITGA2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.4343722621571823,1.0462634167939255,0.3333333333333333,0.9593225168747439,1.0,4/16,9.74%,CEBPA;HHEX;LATS2;TFAP4
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.5347169151278051,-1.046205009546303,0.32941176470588235,1.0,1.0,9/34,25.34%,EYA2;BRCA1;TMEM161A;RPS3;ABRAXAS1;ERCC6;SMCHD1;NPAS2;PARG
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.402113993806606,1.045973878869366,0.3076923076923077,0.958354440475536,1.0,4/31,3.27%,FKBP9;DAB2IP;CEBPA;PPARG
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.6710421948488048,1.0449857804530487,0.5666666666666667,0.9594253249291073,1.0,2/5,14.56%,AGO1;MOV10
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.5293927788189547,-1.0449310175645723,0.43023255813953487,1.0,1.0,3/39,2.70%,PAQR3;SPOCK1;SEMA3A
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.6299995656290764,-1.044875219451654,0.44594594594594594,1.0,1.0,3/9,17.39%,ABCA5;ABCA1;CLU
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.33222564833118046,1.0448570446427012,0.2,0.9581320102958294,1.0,24/107,14.90%,RALB;RAP1A;KRAS;RGL2;PDPN;ARHGDIB;RAPGEF6;RHOG;MAPK11;PHACTR4;TP53;GNA12;RASGRP2;CDC42EP3;SHTN1;RAP2A;CRKL;RIT2;EPS8;FGF2;RAP2C;USP28;ARHGAP1;ADGRG1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.541878544980522,-1.0446708259322073,0.47191011235955055,1.0,1.0,10/31,19.24%,FANCB;SLF1;DDX11;ZCWPW1;PARP9;WDR48;TIMELESS;KMT5C;FMN2;DTX3L
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.6827089578126657,-1.0446448640144352,0.4411764705882353,1.0,1.0,1/6,9.39%,CLSPN
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.6339792261647235,-1.0446352282084297,0.4857142857142857,1.0,1.0,6/12,15.60%,HIF1A;NEFL;MAPT;UXT;SYBU;UBB
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.5996466565307659,-1.0446246753435535,0.4305555555555556,1.0,1.0,6/22,22.54%,TUBB4A;CLIP3;STMN1;STMN2;EML2;MAP2
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.6751968199574855,-1.0446062963176204,0.4788732394366197,1.0,1.0,4/7,19.04%,ABHD12B;DGAT1;MGLL;FAAH
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),-0.6754823428174113,-1.0445093842263886,0.5070422535211268,1.0,1.0,1/7,2.39%,VCAN
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.5979056342456448,-1.043777372907479,0.4722222222222222,1.0,1.0,5/11,23.82%,BRCA1;LRIF1;PCGF5;RLIM;SMCHD1
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.6090820193040835,-1.0437188096435475,0.375,1.0,1.0,2/11,15.19%,TNFRSF1B;SH3D19
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.5225780536198754,-1.0433788790931862,0.3953488372093023,1.0,1.0,8/38,21.50%,GRM8;COL11A1;SLC4A10;CDH23;SLC24A1;OAT;KIFC3;EML2
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.6465456821023945,-1.0431446150032275,0.46153846153846156,1.0,1.0,3/6,26.78%,SOD1;SGCZ;SGCD
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.6269693948132838,1.0429245606125694,0.4857142857142857,0.9618838248035181,1.0,3/6,18.61%,VEZF1;FGF2;RFX3
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.652483929960058,-1.0429088145607983,0.4583333333333333,1.0,1.0,1/12,1.05%,CHRM5
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.4215058583936808,1.0427987069138633,0.4,0.960590731464527,1.0,15/37,18.73%,NEDD4;MAPK13;ERCC4;TP53;SDE2;EIF2AK4;EIF2S1;ZBTB1;EP300;CASP9;USP28;OPN3;INO80;PARP1;FMR1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.6255745167420952,-1.042678429585093,0.41333333333333333,1.0,1.0,4/11,12.22%,RPL23;RPL11;RPL5;RPS7
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.5053308184373149,-1.0426337820551097,0.40425531914893614,1.0,1.0,15/91,12.47%,CLEC12A;F13A1;JAML;SLC11A1;VEGFA;ALOX12;C5AR1;TNFRSF1B;SPON2;FGR;CXCR4;MNDA;RASGRP4;NCF4;FPR1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.4619615352146327,1.0424328126278442,0.46153846153846156,0.9598942714612169,1.0,4/16,8.40%,BCL2L1;ABI3;TGFB1;PKDCC
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),-0.6397516875660693,-1.0422529831976213,0.4166666666666667,1.0,1.0,1/7,9.37%,SHANK3
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.49147071934368786,-1.0422294248493384,0.40217391304347827,1.0,1.0,16/106,15.79%,NLRP12;MX2;OSMR;CHI3L1;SLC11A1;IFITM3;MX1;STAT1;CXCR4;AKAP6;LIFR;HCLS1;PID1;IL1RAPL1;SIGIRR;PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.6042117283824991,-1.042211216484856,0.44594594594594594,1.0,1.0,4/17,12.62%,PLN;PARP9;ATP5IF1;IFIT1
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.6206975591233634,-1.0422065517028538,0.44,1.0,1.0,2/10,9.44%,ACSL1;CD36
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.5221334713506347,-1.0421243771717257,0.4090909090909091,1.0,1.0,7/48,16.41%,THBS1;AGT;GSTP1;PYCARD;BCL2L14;TRAF2;ITGA6
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.48693273194634323,-1.0420740360881848,0.4489795918367347,1.0,1.0,14/93,14.53%,DDIT4;CENPF;MEIS2;CXCR4;SHANK3;UTP3;ADGRL2;CDH2;ADGRL3;VPS51;TUBGCP2;APOD;SHROOM4;POU6F1
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.6460570001727896,-1.0418830273403212,0.4852941176470588,1.0,1.0,3/9,17.97%,ME1;CMPK2;CMPK1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.49839046922200764,-1.0415297276898687,0.3645833333333333,1.0,1.0,34/127,22.60%,RBMS3;VEGFA;OVOL2;TGFB2;HIF1A;CCL3;NOCT;DDRGK1;SLC7A5;MAPT;PINK1;PARP9;ID2;NOTCH2;ITGB8;SDCBP;CCDC3;OLFM1;PARP14;LRPAP1;SH3GL2;PTRH2;DICER1;KLF4;ATP2B4;TET1;PARP15;LILRB2;CITED2;FOXP1;TARDBP;RACK1;REL;DNMT1
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),-0.644513939338806,-1.0409057691288912,0.4868421052631579,1.0,1.0,3/9,18.84%,TCHP;ODF2L;LIMK2
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.6542943203970734,1.0408809865053938,0.4411764705882353,0.9624209853000846,1.0,1/5,7.25%,SNX18
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.5004675579685978,-1.0404826456190743,0.5108695652173914,1.0,1.0,15/75,11.86%,CCL4;TRIM5;MT2A;CCL3;HLA-B;GBP2;DAPK1;RPL13A;GAPDH;STAT1;TRIM25;HLA-F;IRF1;B2M;OAS3
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.5672793269036778,-1.0404711468486931,0.4523809523809524,1.0,1.0,8/27,17.29%,SLC16A4;SLC16A3;SLC7A5;SLC6A15;SLC16A7;SLC16A1;SLC38A6;SLC13A3
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.6493819430027385,1.0394736771136959,0.5806451612903226,0.9648169184605099,1.0,1/5,5.19%,LOXL3
prerank,GO_Biological_Process_2021__negative regulation of B cell receptor signaling pathway (GO:0050859),-0.6842622390191804,-1.0393264133630264,0.5303030303030303,1.0,1.0,4/5,30.11%,FCGR2B;CD300A;CD22;GPS2
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.401199667491107,1.0393111835631401,0.4444444444444444,0.9634260924292132,1.0,2/19,3.95%,P3H2;PPIL1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.6292013988633923,-1.0389409683669886,0.5070422535211268,1.0,1.0,4/10,28.85%,NEIL1;UPP2;TDG;OGG1
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.5234828168363366,-1.0388029654578637,0.43333333333333335,1.0,1.0,6/43,7.83%,HTR2B;FGF1;VEGFA;FLT1;NOD2;DIRAS2
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.6633737107614287,-1.0387797551103792,0.4925373134328358,1.0,1.0,1/7,2.89%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),-0.53284732664282,-1.0384243416547227,0.4044943820224719,1.0,1.0,4/32,7.87%,SLC11A1;TUB;FCGR2B;IL15
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.4743481234035726,-1.038196069997034,0.41414141414141414,1.0,1.0,17/145,10.25%,DDIT4;ACVR1B;PPP1R15A;FOS;HINT1;PVT1;H1-2;RPS12;ALOX15B;NDRG1;RPL36;FAM162A;SAT1;FGF13;PROCR;MXD1;ATF3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.7081402720647623,-1.0381796750421837,0.4918032786885246,1.0,1.0,1/5,5.46%,GSTP1
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.4797430655045515,-1.03799667351583,0.4387755102040816,1.0,1.0,29/171,21.60%,RPS6;RPL14;SNRPD2;VBP1;NHP2;EEF1B2;COPS5;PRDX4;SSB;PGK1;RPL6;LDHA;RPLP0;RPL34;RPS3;RPS2;RFC4;PSMD8;GNL3;EIF3D;SRSF2;SNRPA;CAD;MCM6;PSMD7;MCM7;C1QBP;TARDBP;RACK1
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.5980059482488833,-1.0379800648612831,0.5,1.0,1.0,2/12,10.17%,BEGAIN;TYMP
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.5184288883320716,-1.0379147238705497,0.4444444444444444,1.0,1.0,4/50,4.49%,FA2H;PLPP3;ALDH3B1;DEGS2
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.6269572799376625,1.0377448644471314,0.43243243243243246,0.9657512594303269,1.0,1/6,1.86%,RAP1A
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.500977157841758,-1.0368517900659262,0.4666666666666667,1.0,1.0,22/64,23.12%,DENND2A;RBMS3;AKAP12;DZIP1;MAP1B;ANK2;ITSN1;LAMB1;ADGRL2;LIFR;ENAH;PDE10A;FBXL7;THY1;PTPRG;FIGN;APBB2;CALD1;MPDZ;RUNX1T1;MYH10;PPFIBP1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.479454289999202,-1.0367679042125872,0.3838383838383838,1.0,1.0,35/190,15.91%,HTR2B;PRLR;TFRC;GLIPR2;ACVR1B;SLC11A1;AGT;VEGFA;TSHR;TGFB2;ACSL1;PTN;TXK;CFL1;PLAC8;FGR;IL15;GAPDH;CXCR4;IL18;SOD1;KDM6B;CD36;PAX8;SDCBP;BTN3A1;OLFM1;RGCC;ABCA1;GHR;LRPAP1;KDM1A;SCD;KDM3A;TRIM16
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.47633200499064215,-1.0366520087417572,0.46153846153846156,1.0,1.0,20/84,19.27%,INSIG1;DNAJB9;AKAP12;NDRG1;H1-0;SELENOP;SAT1;ARID5B;TNFAIP8;TPD52;B2M;LIFR;MAK;SCD;SORD;FKBP5;TMEM50A;INPP4B;SGK1;BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.6755193202332915,-1.036626908741809,0.5,1.0,1.0,2/7,7.98%,SLC11A1;PRKCQ
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.47740612034460317,-1.0366190909013584,0.42,1.0,1.0,38/201,15.83%,P4HA3;RHOBTB3;RPS27A;VIM;CGNL1;MYO1G;RHOB;TGFB2;ADAMTS2;COL21A1;NEFL;CARMIL1;FIGNL1;PPP1R9A;MAPT;CLIP3;COLGALT2;HDGFL3;COL26A1;COL11A1;MARCKSL1;FGF13;UBA52;CD36;COL10A1;UBC;B2M;TGFBI;ERMN;COL4A5;COL23A1;TUBGCP2;KATNAL2;SHROOM4;P4HA1;RND3;UBB;COL19A1
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.5487068040496326,-1.0363676931437462,0.45348837209302323,1.0,1.0,8/31,14.70%,RBPJ;IL15;NR1H2;PCTP;ACOT13;ARRDC3;NR1D1;ALDH1A1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),-0.5980325252380462,-1.0358191154651437,0.417910447761194,1.0,1.0,2/9,9.24%,TGFB2;ID2
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.5426142486236039,-1.035554206830648,0.39759036144578314,1.0,1.0,6/25,17.57%,CHI3L1;SULF2;DDRGK1;ITGB8;CD44;NFIB
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.5273482321063064,-1.0354864380903186,0.5176470588235295,1.0,1.0,6/35,3.82%,SPARC;MYLK;ADAMTS2;TNS1;LAMA2;PTN
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.6007423830852574,-1.0353483884833532,0.45454545454545453,1.0,1.0,3/19,6.29%,SEMA6A;SEMA3A;UNC5C
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.6004583536044205,-1.0352870719477398,0.48,1.0,1.0,2/12,8.59%,EIF2B2;PLP1
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.5398223566479963,-1.0352785352252185,0.4470588235294118,1.0,1.0,7/29,18.84%,TCHP;BRCA1;PINK1;ODF2L;FEZ1;CAV3;LIMK2
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.5168438435393219,-1.0349619125745855,0.391304347826087,1.0,1.0,14/47,17.49%,PRLR;PLPP3;LAMA2;COL21A1;SPARCL1;MLANA;SVEP1;LIFR;ALDH1A1;SH3D19;CPE;MAFB;SERPING1;ABCA8
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.579543686012029,-1.034868016611234,0.475,1.0,1.0,6/17,25.22%,EIF3D;EIF4A2;EIF2D;EIF3I;EIF3A;DHX29
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),-0.6411593572101563,-1.0348048439267648,0.4722222222222222,1.0,1.0,4/8,18.58%,ZDHHC15;NRXN1;BSN;NRXN2
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.5130550573306067,-1.0347907480259226,0.3953488372093023,1.0,1.0,9/36,18.79%,ENPP2;CYP3A5;PDXDC1;TRHDE;RIDA;PNPLA8;AMDHD2;ERAP1;TPP1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.5824166323084584,-1.0346918904279336,0.5,1.0,1.0,2/13,3.82%,VEGFA;PTN
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.6511207197835183,-1.0346162015161742,0.45454545454545453,1.0,1.0,1/6,18.52%,ACAD9
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.5656916400239271,-1.0345130606984345,0.49333333333333335,1.0,1.0,3/18,17.97%,ME1;CMPK2;CMPK1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.7230889219950934,-1.034137990148738,0.421875,1.0,1.0,2/5,21.57%,PKM;YBX3
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.5342886233257896,1.0325085845422177,0.48,0.9792438708180752,1.0,3/10,15.78%,SIRT1;SLC30A10;CDK6
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.5311968964300909,-1.0323470064601996,0.4588235294117647,1.0,1.0,10/42,15.74%,RPS27A;CLEC4E;NOD2;UBA52;CD36;UBC;CTSB;CD14;UBB;TLR2
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),-0.6446077682696312,-1.0321440916490117,0.5263157894736842,1.0,1.0,3/10,24.52%,EIF2AK3;GHR;PLCB1
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.5244325471748218,-1.0320468920266148,0.40860215053763443,1.0,1.0,8/54,12.79%,HTR2B;CCL3;ACKR4;PPP1R9A;ANK2;CXCR4;EIF2AK3;NUDT4
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.7285374277619335,-1.0319632727420973,0.4603174603174603,1.0,1.0,1/5,1.51%,LRP2
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.5001238308795325,-1.0319215012675942,0.44329896907216493,1.0,1.0,16/101,14.73%,TFRC;MX2;LRP2;SPARC;MX1;CD163;MARCO;FCGR2B;CD36;COLEC12;FCHO2;IGF2R;NLGN3;AP2S1;INSR;GRK4
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),0.605060384654727,1.0315029361606387,0.4473684210526316,0.9800991474597361,1.0,1/6,6.37%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.39306412564659654,1.0313426869511246,0.38461538461538464,0.9788531748833408,1.0,13/47,12.53%,LGALS9;TLR7;TMEM106A;IL17RA;MAPK13;LPL;SYK;IL1B;IL1A;SCIMP;IL6R;TIRAP;LILRA2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),-0.7220477322219756,-1.0313394609629154,0.4696969696969697,1.0,1.0,2/6,10.64%,NR1H2;MID1IP1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.5016971297606649,-1.0312268240924958,0.4772727272727273,1.0,1.0,9/60,15.22%,SOCS3;CDC37;IL7;CLIP3;STAT1;LIFR;PYCARD;TRAF2;SIGIRR
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.4987455555004297,-1.0311139242571747,0.47959183673469385,1.0,1.0,26/92,20.74%,JAML;PIANP;TGFB2;RSAD2;SELL;CLEC2B;HLA-B;FCGR2B;FGR;IL15;DHX58;APPL1;HLA-F;COLEC12;IRF1;B2M;PLSCR1;BCL6;HLA-C;FCGR2C;KLRF1;ERAP1;LILRB2;FOXP1;CD300A;OSCAR
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.48198300615255074,-1.031089070832461,0.45,1.0,1.0,48/198,25.54%,TOP2A;RPS27A;HMGB2;GLRX2;MPG;XRCC3;RPA2;BRCA1;WDHD1;NEIL1;NOP53;POLQ;UBA52;RFC1;UBC;FAN1;RPA3;UHRF1;ADPRS;ZNF445;RFC4;TERF2IP;UBB;TIMELESS;POLL;KMT5C;DNA2;SLX4;ORC6;MCM3;DDB1;MCM6;ZRANB3;MUS81;MCM7;POLE2;NABP1;LIG3;DNMT1;ENDOV;INTS3;DBF4;XPA;MCM5;TDG;FANCL;PARG;WRN
prerank,GO_Biological_Process_2021__delamination (GO:0060232),0.5701118887359862,1.0307238594050103,0.3888888888888889,0.9786789655754374,1.0,3/5,28.76%,SPI1;YTHDF2;AKNA
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.5116760507429231,-1.030399129971451,0.4939759036144578,1.0,1.0,15/41,25.84%,RIMS1;RAB3A;NSF;RAB3C;RAB15;CPLX1;SCG5;STXBP5L;SYT1;MCTP1;RAB21;SEPTIN4;RAB3D;RIMS2;MCTP2
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.659840640660126,-1.0302098928668917,0.5362318840579711,1.0,1.0,2/6,13.53%,NDUFB6;COA6
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),0.6584261581119614,1.0301877856966375,0.5454545454545454,0.9785656711778972,1.0,1/5,6.08%,STIM1
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.6634757904195495,-1.0300304038368162,0.5606060606060606,1.0,1.0,1/7,2.73%,ALOX12
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.49783969369566056,-1.0299911759584282,0.5106382978723404,1.0,1.0,20/86,14.76%,CLDN18;MYOT;JAML;TGFB2;SELL;EMB;CDH9;CLDN20;MMP24;LRRC4C;CDH12;CDH2;ADGRL3;PTPRT;CDH23;PALLD;MAG;PTPRD;IL1RAPL1;CDH8
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.5357073439065076,1.0299332283569702,0.4838709677419355,0.9775895913747653,1.0,2/10,13.70%,HHEX;POLDIP3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.5115430185704131,-1.0296099917843182,0.45977011494252873,1.0,1.0,9/38,15.91%,NLRP12;AIM2;CCL3;NOD2;CD36;MNDA;PYCARD;GSDMD;TRIM16
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),-0.6940426793947969,-1.0296092034903563,0.5416666666666666,1.0,1.0,3/7,20.22%,NREP;APOD;RTN4RL1
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,0.6545720320357555,1.0295585129581206,0.5277777777777778,0.9769775300845505,1.0,1/6,0.29%,FGL1
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),-0.7157711604057901,-1.0295004533268353,0.43137254901960786,1.0,1.0,1/5,2.73%,ALOX12
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),-0.6635738830291888,-1.029252831922134,0.5540540540540541,1.0,1.0,4/6,27.15%,GABRB1;GABRG2;GABRB3;GABRB2
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),-0.6635738830291888,-1.029252831922134,0.5540540540540541,1.0,1.0,4/6,27.15%,GABRB1;GABRG2;GABRB3;GABRB2
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.6401093895058968,-1.0289431049990752,0.5072463768115942,1.0,1.0,2/11,2.56%,FGF1;VEGFA
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.6330800591391353,-1.0286525078293614,0.47540983606557374,1.0,1.0,2/7,10.64%,GSTP1;MID1IP1
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.6607505090042989,-1.0283744289801005,0.5217391304347826,1.0,1.0,2/10,14.34%,LNPK;INSR
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.6909198211227046,-1.0282326079947668,0.4925373134328358,1.0,1.0,2/5,2.56%,NR4A1;VEGFA
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.6643584744017543,-1.028000217530659,0.4927536231884058,1.0,1.0,1/6,14.36%,TFIP11
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.6032237618065146,-1.0277419888031514,0.4805194805194805,1.0,1.0,3/14,2.89%,LRP2;VEGFA;TGFB2
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.6007921671118692,-1.0276593606657844,0.5256410256410257,1.0,1.0,4/13,11.55%,TXK;PRKCQ;THBD;TEC
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.6157676369283017,-1.0276290283043532,0.5454545454545454,1.0,1.0,2/10,10.84%,SAT1;SAT2
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.6614108958118534,-1.0275981381941652,0.5135135135135135,1.0,1.0,4/8,26.55%,ABCB1;ADCY8;OPRM1;CRHBP
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.5664392186140007,-1.0269842330012293,0.475,1.0,1.0,3/19,9.51%,SAP30;RBX1;NOTCH2
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.4740178280444046,-1.0269723484346498,0.43617021276595747,1.0,1.0,12/98,8.93%,RHOBTB3;CGNL1;GAS2L3;MYO1G;RHOB;COBL;SVIL;CARMIL1;PPP1R9A;BAIAP2L1;MARCKSL1;TTN
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.6790253393402481,-1.0266864179634114,0.5555555555555556,1.0,1.0,2/5,26.72%,GRM3;GABBR2
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.6790253393402481,-1.0266864179634114,0.5555555555555556,1.0,1.0,2/5,26.72%,GRM3;GABBR2
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.6637655015522235,-1.0264675489901807,0.4788732394366197,1.0,1.0,3/8,17.97%,ENTPD3;CMPK2;CMPK1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.5536143912524573,-1.0263172501706548,0.4642857142857143,1.0,1.0,3/24,9.02%,CYREN;FANCB;POLQ
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),-0.6377609584488668,-1.0261626510566133,0.5125,1.0,1.0,2/11,8.88%,RORA;PDK3
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.6488638191306899,-1.0259846015130387,0.4861111111111111,1.0,1.0,1/8,6.05%,PLN
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.6449042992720571,-1.0258024660883232,0.47058823529411764,1.0,1.0,4/7,27.07%,SOD1;TOX;TESPA1;CAMK4
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.5072566325971029,-1.0255944896086664,0.4148936170212766,1.0,1.0,13/52,22.39%,HTR2B;CCL3;ATP1B3;ANK2;TPT1;KCNMA1;SLC24A1;ATP2B4;ATP1B2;SLC24A2;ATP2B2;SLC24A4;RYR2
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.5180868119622709,-1.0253452342766334,0.4444444444444444,1.0,1.0,12/40,20.20%,RPS27A;RBX1;DDX11;DDX1;UBA52;UBC;MCMDC2;ERCC2;UBB;DDB1;MCM6;MCM7
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.5431489335004426,-1.0250256626065382,0.46153846153846156,1.0,1.0,11/27,24.33%,OMG;PTN;B2M;MAG;LRP4;THY1;DYNLT1;GORASP1;GDI1;LINGO1;ARHGDIA
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.5305440554451708,-1.0248749598629054,0.4666666666666667,1.0,1.0,12/37,19.26%,SLC5A9;SCN9A;ATP1B3;FGF13;SLC6A15;SLC9B2;SLC24A1;NALCN;SCN1A;SCN3B;SGK1;SLC24A2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.4705556921114534,1.024844053123322,0.48,0.9890912836646509,1.0,3/14,4.43%,BCL2L1;ABI3;TGFB1
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),-0.5936639494750888,-1.0245228410635445,0.48717948717948717,1.0,1.0,3/15,2.70%,SEMA6A;VEGFA;SEMA3A
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.5306118206637278,-1.0242982216313996,0.4945054945054945,1.0,1.0,6/38,17.03%,GPR18;NOTCH2;RASGRP4;PIK3CB;GPR65;IRS2
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.5241984579196359,-1.0242727492261117,0.43902439024390244,1.0,1.0,14/51,19.59%,TRIM5;MT2A;HLA-B;GBP2;STAT1;TRIM25;HLA-F;IRF1;B2M;OAS3;CD44;HLA-C;TRIM22;IFNGR2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5057413266361119,1.0241093982989684,0.4444444444444444,0.9893406657070623,1.0,2/9,11.95%,MAP3K5;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.4891281038727715,-1.023980699222381,0.4186046511627907,1.0,1.0,8/48,11.27%,CDC37;POLR3F;FCGR2B;FGR;DHX58;PARP9;APPL1;IRF1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.5062466016282242,-1.0239426704901933,0.449438202247191,1.0,1.0,7/52,8.01%,PRKAR2B;TSHR;ADCY3;CD163;FCGR2B;FGR;HTR7
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.5276188522982609,-1.0239278918236256,0.45,1.0,1.0,3/23,6.41%,VPS11;DDRGK1;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.6125903327696658,-1.023833958574766,0.5135135135135135,1.0,1.0,3/16,7.80%,PRELID1;DDRGK1;PINK1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.5875762906556053,-1.0235549823083343,0.5189873417721519,1.0,1.0,3/14,13.67%,DTL;RAB11A;ATAD5
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.5546695241435102,-1.023520062997591,0.4868421052631579,1.0,1.0,4/19,8.14%,CCDC39;LSR;COBL;ARID5B
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.5376651233333251,-1.0234304944249513,0.5054945054945055,1.0,1.0,16/38,28.51%,ATP5ME;ATP5F1E;TIMM13;ATP5F1D;ATP5PD;ATP5F1A;GHITM;ATP5MC1;MICOS13;TIMM29;ATP5F1C;HSPA9;APOO;ATP5MC3;SPG7;IMMT
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.45409130243586604,-1.0232938595102246,0.42424242424242425,1.0,1.0,49/204,21.60%,TOP2A;GADD45B;RPS27A;PNMA1;RHOB;RPS6;VAV3;IFIT2;MTCH1;FAM162A;RASGRF2;DAPK1;CLIP3;DAPK2;ITGB3BP;ITSN1;TNFAIP8;SOD1;UBA52;MNDA;RRP1B;BNIP3L;UBC;BNIP3;OLFM1;KCNMA1;ING4;PYCARD;STK17B;ING5;BMF;GNA13;UBB;ITGA6;BCL6;NGEF;CLU;NEURL1;ARHGEF4;FGD3;ADAMTSL4;RPS6KA2;SUDS3;SEPTIN4;C1QBP;PLEKHG5;OBSCN;SOX4;RACK1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.4985589704323625,-1.0232615772132514,0.4421052631578947,1.0,1.0,12/56,17.39%,THBS1;PRELID1;NR4A2;GSTP1;HERPUD1;PINK1;TMEM14A;BCL2L2;ITGA6;GHITM;MCL1;CLU
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.5080049204530757,-1.0230632752013566,0.47368421052631576,1.0,1.0,13/71,13.12%,OSMR;TNC;PLPP3;SH3PXD2B;FILIP1L;PTN;SYNC;DOCK1;LAMB1;MLANA;FN1;BMI1;PALLD
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.4829820986825696,-1.023031199668645,0.4421052631578947,1.0,1.0,24/117,15.74%,TFRC;RPS27A;TRIM5;AGT;RAB7B;AIM2;SLCO3A1;NOD2;DDRGK1;PRKCQ;IL18;HSPA1B;UBA52;CD36;TRIM25;UBC;CARD16;ALK;PYCARD;RPS3;TRAF2;TERF2IP;UBB;TLR2
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.509750237765918,-1.0230263069335443,0.4659090909090909,1.0,1.0,17/57,24.99%,VEGFA;CARMIL1;NOP53;HSPA1B;EPHA3;HSPA2;HSPA5;RDX;TFIP11;IMPACT;CLU;CRACD;MCTP1;CRYAB;WASHC2C;RIOK3;RAPGEF3
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.6922883085347937,-1.0230003666318528,0.5,1.0,1.0,4/5,24.30%,ALDH1A1;GAD1;GAD2;BCAT1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.5083789053126433,-1.022785822703934,0.4418604651162791,1.0,1.0,9/41,15.91%,NLRP12;AIM2;CCL3;NOD2;CD36;MNDA;PYCARD;GSDMD;TRIM16
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.5028144874474895,-1.0226348402974834,0.43478260869565216,1.0,1.0,12/56,15.14%,RGS2;PRKAR2B;PAQR3;AGT;DUSP1;SPRY1;GSTP1;PKIA;CDKN1B;PYCARD;CAV3;PIK3CB
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.5837984320847159,-1.0226304170308906,0.49333333333333335,1.0,1.0,4/12,19.09%,CEMIP;CD44;GUSB;CEMIP2
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),-0.6297552762960243,-1.0223006557468892,0.5,1.0,1.0,2/9,15.09%,DAPK2;BMF
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.6341042209772131,-1.0219720236336594,0.5072463768115942,1.0,1.0,2/10,5.38%,VEGFA;FBN2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.6691611906470071,-1.0214322984549182,0.5217391304347826,1.0,1.0,2/7,15.60%,RPS7;UBB
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.6502629047766877,-1.0209498835964117,0.4383561643835616,1.0,1.0,2/6,30.32%,STK17B;BTG1
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-0.7280813092344902,-1.0208274551799086,0.4745762711864407,1.0,1.0,4/5,25.36%,DMD;ATP2B4;TXN;SNTA1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.6473216737676928,-1.0206548288293713,0.5142857142857142,1.0,1.0,2/7,23.97%,ABCA1;PRKACB
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.5322968110159373,-1.0206457670154938,0.550561797752809,1.0,1.0,1/36,0.65%,RPL23
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",-0.6899817690341311,-1.0201640977347604,0.4626865671641791,1.0,1.0,6/7,30.07%,GABRA3;GABRG2;GABRA2;GABRB2;GABRA4;GABRA1
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.5351601277694458,-1.0199864522738016,0.46511627906976744,1.0,1.0,6/27,19.71%,FANCM;DDX11;ZGRF1;DNA2;BRCA2;ZRANB3
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.5526049023812561,1.0194405645784899,0.4666666666666667,1.0,1.0,2/9,6.37%,SORL1;SIRT1
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.5043937157337275,-1.0193634968313128,0.5212765957446809,1.0,1.0,10/72,4.28%,PLPP3;ASPN;MT2A;AGT;ADAMTS2;ACSL1;TNS1;ECM2;LAMA2;SYAP1
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),0.561569210423807,1.0190166386370612,0.4074074074074074,0.9996102806293758,1.0,3/7,12.25%,DNAJB14;DNAJC18;DNAJB12
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.4919605135385083,-1.0185286041159571,0.5,1.0,1.0,6/53,8.66%,NLRP12;OSMR;AGT;CCL3;IL15;IL18
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.3679150913245848,1.018338312537849,0.36363636363636365,0.9997016567017695,1.0,6/46,4.51%,NEDD4;IDE;DAB2IP;SMURF1;SORL1;RAB7A
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.6806490581956428,-1.0182869687720026,0.5846153846153846,1.0,1.0,2/6,10.84%,SAT1;SAT2
prerank,PanglaoDB_Augmented_2021__Glomus Cells,-0.4914284141328136,-1.0180244349672871,0.5393258426966292,1.0,1.0,20/70,21.30%,VIM;PLPP3;FAM13C;PTN;MAP1B;ANK2;HSPA12A;SRRM3;ADGRL2;LIFR;LRP4;CPE;FBXL7;THY1;FIGN;RBFOX2;GPRC5B;PLPPR4;CALD1;MPDZ
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.5583423371455327,1.0179853630573994,0.4375,0.9987611330739912,1.0,2/9,8.41%,GNPDA1;ST6GAL1
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.5111958142405253,1.0179346538744036,0.4482758620689655,0.9971701846097379,1.0,2/13,5.83%,NCOA4;ARID1A
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.42137988624910827,1.0177711136968253,0.5238095238095238,0.9960393064589564,1.0,6/26,9.28%,GSN;LCP1;HTRA1;EXOC8;KLKB1;ADAM10
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.4584984153582528,1.0177313778133572,0.4782608695652174,0.994418719241067,1.0,5/26,11.42%,SESN2;SESN3;TELO2;RRAGD;CLEC16A
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.5685837751705669,-1.0175653356525722,0.5189873417721519,1.0,1.0,8/18,26.06%,WDR5;BRCA1;TET1;DNMT1;CTR9;JARID2;OGT;RIF1
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.6355779898004501,-1.0175517606167563,0.5,1.0,1.0,4/9,22.90%,HSPA1B;EML2;CKAP5;DCTN1
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.5854149521483694,-1.0172228234184064,0.4861111111111111,1.0,1.0,7/18,16.51%,NDUFS8;UQCRC1;ATP5F1D;UQCR10;UQCRB;NDUFS7;SIRT3
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.6171282407269546,-1.0169212998560153,0.49333333333333335,1.0,1.0,5/8,33.03%,CR1;SLC25A5;SLC17A9;SLC25A24;SLC25A4
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),-0.6479139889502696,-1.016832111641315,0.5,1.0,1.0,2/5,3.82%,SEMA3A;PTN
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.5327243902044408,-1.0164441735742424,0.5063291139240507,1.0,1.0,6/27,13.60%,LRP2;TGFB2;MTHFD1;COBL;STIL;DEAF1
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.687391285483999,-1.0163005125748803,0.5,1.0,1.0,2/5,18.73%,CCDC39;DNAH7
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.4853264788617818,-1.0161759802986747,0.5368421052631579,1.0,1.0,15/78,23.18%,NUDT12;NUDT16;HSPA1B;SSB;RIDA;HNRNPA0;SRSF5;SRSF2;LSM5;SRSF9;TBRG4;U2AF2;PRPF3;ZFP36;PNPT1
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.47577919181300704,1.0161183094796304,0.4166666666666667,0.9977892195501101,1.0,8/14,8.06%,IL17RD;HPN;SPRED2;DAB2IP;SMAD7;SPRED1;SPRY2;USF3
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4979526173151936,-1.0160326735288863,0.4791666666666667,1.0,1.0,8/66,8.73%,NR4A3;MYO1G;VAV3;DOCK1;FCGR2B;FGR;PRKCE;MYO10
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.5540616429013381,-1.0159574520186,0.4230769230769231,1.0,1.0,9/21,27.90%,MAPT;RPS3;CAV3;STMN2;DCTN1;FES;AKAP9;PSRC1;DRG1
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.5249506156714455,-1.0158522898519897,0.5164835164835165,1.0,1.0,10/45,18.11%,DDIT4;FOS;FCGR2B;MAPT;CD36;BNIP3;CDKN1B;CIDEB;CLU;CALCR
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),-0.6471960051342804,-1.0158141149735593,0.5454545454545454,1.0,1.0,4/9,15.16%,PDK3;CD36;PID1;SCD
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.49587773201135604,1.0156678131317682,0.48,0.9974695649904924,1.0,3/13,6.73%,LGALS9;CD274;SYK
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),-0.641992619240892,-1.0153882927757845,0.5142857142857142,1.0,1.0,2/8,7.97%,CLEC4E;GAPDH
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.6555857175690465,-1.0151732855307387,0.5072463768115942,1.0,1.0,1/7,3.38%,DPYD
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),-0.6301019293095188,-1.0150267897868435,0.5373134328358209,1.0,1.0,2/7,16.45%,RAB3A;ANXA2
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.6471749715032687,-1.0149376187970636,0.515625,1.0,1.0,3/6,31.00%,ZWILCH;NABP1;PLK2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-0.6682418657106126,-1.0149244785819125,0.5507246376811594,1.0,1.0,2/7,17.17%,HIF1A;MCL1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.498877183212891,-1.014870029997186,0.5164835164835165,1.0,1.0,9/62,9.44%,PRLR;VEGFA;TSHR;ACSL1;PLAC8;CXCR4;IL18;KDM6B;CD36
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.46425778384785604,-1.0148381782734128,0.44,1.0,1.0,45/215,17.47%,TFRC;RPL23;SLC11A1;FGF1;RBMS3;VEGFA;OVOL2;RIMS1;RBPJ;HIF1A;RPL11;CCL3;DDRGK1;ANK3;BRCA1;CAMK2N1;ANK2;HSPA1B;TTN;HCFC1;ID2;CD36;TLE1;ITGB8;EIF2AK3;CD63;OLFM1;RPL5;RGCC;EPB41L4B;RPS7;FN1;NSF;PID1;SNF8;RDX;INSR;RPS3;PIK3CB;TLR2;PLSCR1;ANXA2;HMGN5;CLU;KLF4
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.5694948278093108,-1.0148000715515215,0.44155844155844154,1.0,1.0,3/16,14.47%,RORA;DMD;KDM1A
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.47665511623405604,-1.0147155434713124,0.44,1.0,1.0,30/256,14.34%,DDIT4;NR4A3;NAMPT;PRLR;FGF1;VEGFA;VAV3;SULF2;DOCK1;FLT1;FLRT1;POLR2G;CHN1;FGR;SIPA1L1;ITSN1;APPL1;SDCBP;RASGRP4;EIF2AK3;EPHA3;ANGPTL1;NCF4;PTPRT;ANGPT2;EPHB1;ALK;AP2S1;GHR;INSR
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.49218372251978804,1.01465004094809,0.3870967741935484,0.998840091633706,1.0,3/10,5.44%,NEXMIF;SERPINF2;PPM1F
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.475405305049259,-1.0143497433242084,0.5425531914893617,1.0,1.0,26/82,23.12%,MYOT;C5AR1;CACNB2;ANK3;MAPT;LRRC4C;SHANK3;PPFIA4;CDH2;ADGRL3;GPM6A;NLGN3;NRXN1;PTPRD;CTNND2;LRP4;UNC13A;NRXN2;CBLN2;APBB2;DVL1;NTNG1;UNC13C;MUSK;DCTN1;PPFIBP1
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.5880316650382655,-1.0142696139510166,0.527027027027027,1.0,1.0,2/15,4.76%,HTR2B;ERO1A
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),-0.6622791060984625,-1.014140621629755,0.5263157894736842,1.0,1.0,1/7,4.14%,TNFRSF1B
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.6116542096656847,-1.0136624885535936,0.5522388059701493,1.0,1.0,2/7,25.10%,TRIM16;MACROH2A2
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.6116542096656847,-1.0136624885535936,0.5522388059701493,1.0,1.0,2/7,25.10%,TRIM16;MACROH2A2
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.3986661442947798,1.0131148126023228,0.375,1.0,1.0,8/31,9.84%,SMAD7;SMURF1;PPARG;SORL1;UBE2D1;SKIL;TRIM33;SKI
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.6845464668379837,-1.0129670653647125,0.6268656716417911,1.0,1.0,1/7,2.56%,VEGFA
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.6446166780104742,-1.012770432623077,0.5,1.0,1.0,2/5,11.34%,ADAM15;B2M
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),-0.6446166780104742,-1.012770432623077,0.5,1.0,1.0,2/5,11.34%,ADAM15;B2M
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.563025393298716,1.0122680281945744,0.38461538461538464,1.0,1.0,3/9,4.71%,LGALS9;CD274;SCRIB
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),-0.6280371480066547,-1.012083346424997,0.5342465753424658,1.0,1.0,2/9,9.51%,TGFB2;NOTCH2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),-0.4673365338928103,-1.0120249056415869,0.45454545454545453,1.0,1.0,10/97,9.51%,NR4A3;NR4A1;RBPJ;RXRB;RORA;NR4A2;POLR2G;NR1H2;RORB;NOTCH2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.6072257890973402,1.0120157041188527,0.5,1.0,1.0,3/5,28.65%,PIEZO1;WNK1;CCL5
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.6237233387989095,-1.0117985599108212,0.5066666666666667,1.0,1.0,3/12,19.47%,RIMS1;CPLX1;MCTP1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.5703290653389065,-1.0116955767878166,0.5308641975308642,1.0,1.0,6/24,15.79%,ATP8B1;ATP10A;ABCB4;ABCA1;ABCB1;PLSCR1
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),-0.5920728803986492,-1.0115542121163499,0.5189873417721519,1.0,1.0,5/12,24.59%,TSHZ3;SLC24A1;SLC24A2;GRIN2A;SHANK2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.5771225676494005,-1.0113788249317797,0.48148148148148145,1.0,1.0,3/20,6.89%,TOM1L1;RNF126;VPS37C
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.5465060601763174,-1.0113034471191371,0.47058823529411764,1.0,1.0,6/26,15.60%,RPS27A;UBA52;UBC;ANLN;RGCC;UBB
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),-0.66731871172411,-1.0112097004417206,0.53125,1.0,1.0,1/6,1.33%,CLEC4E
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),-0.6841638209170473,-1.010570520575412,0.5373134328358209,1.0,1.0,1/5,7.60%,MAPT
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.4620264405407172,-1.0105360975560809,0.4895833333333333,1.0,1.0,27/107,22.79%,CENPF;RPS27;RAB11A;ITGB3BP;CENPE;STIL;SBDS;INCENP;ZWILCH;GPSM2;CENPP;DSN1;CENPI;ABRAXAS1;STMN1;KIF11;CENPU;KNTC1;MAP9;DCTN2;NUP133;SEH1L;DYNC1I1;SEC13;SPAST;CENPK;CKAP5
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.5072966010383798,1.0104555259081724,0.48,1.0,1.0,3/14,13.68%,SLC30A5;SLC30A10;SLC30A1
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.588607180228758,-1.010019970517743,0.5428571428571428,1.0,1.0,2/14,10.00%,HLA-B;HLA-F
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.6064089684431953,-1.0098560850062628,0.5230769230769231,1.0,1.0,2/7,26.72%,GRM3;GABBR2
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.6194831785534898,-1.0096051965826933,0.4861111111111111,1.0,1.0,1/12,2.81%,OVOL2
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),0.4830652068577565,1.0094622845990613,0.4482758620689655,1.0,1.0,3/14,2.59%,RALB;PDE12;CGAS
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5543315444758586,1.0092526246510698,0.5,1.0,1.0,3/16,6.37%,SPRED2;SPRED1;SIRT1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.5845330642488091,-1.0091706214516634,0.5,1.0,1.0,2/19,7.60%,RPS23;MAPT
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.4740858856075892,1.00910172183167,0.375,1.0,1.0,9/25,11.85%,MAP3K10;DAB2IP;MAP3K5;ZNF675;MAP3K4;MAP3K11;DVL2;TRAF6;DVL3
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.6056156470109704,1.0088736526384599,0.4864864864864865,1.0,1.0,2/5,15.64%,TGFB1;NOTCH1
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.6516697750253982,-1.0088419826478665,0.47297297297297297,1.0,1.0,1/6,8.03%,NMD3
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),-0.5461742690005525,-1.008805813154602,0.5,1.0,1.0,9/27,16.53%,SEMA3A;FLRT1;MAP1B;IQGAP1;NLGN3;SPG11;SLC9A6;SH3GL2;IMPACT
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.47712122480729363,-1.008759240609356,0.47368421052631576,1.0,1.0,18/111,13.81%,CCL4;JAML;GPR183;MYO1G;GRM8;NAPSB;SELL;MAP3K8;FCGR2B;FGR;CXCR4;IL10RA;MNDA;TNFSF13B;NCF4;LSP1;HCLS1;VNN2
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.49562026413403953,-1.0087047084446021,0.47058823529411764,1.0,1.0,10/49,13.06%,PLPP3;PTN;DOCK1;TXK;ADAM15;FGR;ITGB8;TEC;FN1;ITGA2
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.48417459231233234,-1.0086916286009786,0.45161290322580644,1.0,1.0,14/72,16.39%,PRLR;VEGFA;TSHR;ACSL1;PLAC8;CXCR4;IL18;KDM6B;CD36;INSR;KDM1A;SCD;KDM3A;PIGA
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.5928593737921781,-1.0084692641700528,0.4857142857142857,1.0,1.0,2/9,2.89%,LRP2;TGFB2
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.5288108710276641,-1.0083436745936576,0.48314606741573035,1.0,1.0,8/32,23.17%,IFITM3;MDFIC;POLR2G;HEXIM1;TRIM14;NELFB;TRIM13;ZFP36
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.4127455767273412,1.0083135084684274,0.4444444444444444,1.0,1.0,9/69,10.26%,TNFAIP8L3;NFYC;RUBCNL;SC5D;PPARG;NPC2;IL1B;SQLE;PLPP1
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.47167947446422087,1.008291567422973,0.41379310344827586,1.0,1.0,2/12,4.94%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.48047110294024503,-1.0081713763305034,0.5425531914893617,1.0,1.0,26/81,26.98%,GRIK1;BEGAIN;RIMS1;GRM8;LRRC4C;DGKI;PXK;CDH2;NLGN3;CPLX1;UNC13A;SYT1;GRM3;RELN;MCTP1;IQSEC2;AKAP9;RIMS2;CACNA1B;RIMS3;NLGN2;APP;MCTP2;TMEM108;GRIK2;GRIK4
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.6441750023443311,-1.007671415278554,0.532258064516129,1.0,1.0,4/7,29.24%,VMP1;CALM1;SNAP29;ATP2A2
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.4856608357713547,-1.0076616929147368,0.5353535353535354,1.0,1.0,17/124,11.44%,THBS1;CEMIP;FGF1;SEMA6A;MYLK;VEGFA;SEMA3A;CCL3;FLT1;DDRGK1;CARMIL1;DUOX1;FGR;LAMB1;SDCBP;PLET1;HSPA5
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.5233239163748677,-1.0076548552296247,0.5,1.0,1.0,3/33,8.09%,RHOBTB3;RHOB;EPB41L3
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.37375995069169404,1.007553840542032,0.4,1.0,1.0,14/65,14.72%,NUP42;NUP188;SMURF1;TGFB1;U2AF1;PHAX;THOC5;NUP214;EIF4E;RAE1;POLDIP3;NUTF2;THOC7;CCHCR1
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.5913576132400795,-1.0072777034373908,0.5,1.0,1.0,2/14,11.56%,ANK3;FAM20A
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.31884453467706797,1.0072537150655334,0.5,1.0,1.0,20/133,13.38%,STK32B;RPS6KA6;MAP3K10;CSNK1G1;MAPKAPK2;NEK6;CAB39;TGFBR2;LATS2;MAPK13;MAST2;MKNK1;MAST3;CHUK;RPS6KA4;CAMKV;RPS6KA1;MAP2K2;NLK;TGFBR1
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.5202956804167145,-1.0070055267758504,0.47058823529411764,1.0,1.0,5/31,12.24%,INSIG1;ALOX12;ALOX15B;FAXDC2;TM7SF2
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),-0.6393943386773181,-1.0068603939145901,0.5384615384615384,1.0,1.0,3/8,26.65%,DGKG;DGKB;PIP5K1A
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.593841644282497,1.0068358525749628,0.45714285714285713,0.9985576695348072,1.0,2/6,6.74%,NRP1;APPL2
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.593841644282497,1.0068358525749628,0.45714285714285713,0.9985576695348072,1.0,2/6,6.74%,NRP1;APPL2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.5143142060034132,1.006629132734576,0.4,0.9975168070208018,1.0,3/14,16.95%,ICAM1;SERPINE1;TCF7L2
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.6462743558469414,-1.0062954693361144,0.5384615384615384,1.0,1.0,1/8,0.79%,ALG10B
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.5472968097125732,-1.0062428017170606,0.5227272727272727,1.0,1.0,6/24,17.93%,ERO1A;HSPA1B;HSPA2;HSPA5;DNAJC7;SDF2L1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.43753923464298944,1.0061755594493234,0.4444444444444444,0.9972637712069529,1.0,6/30,9.69%,ENPP1;SORL1;PIP4K2B;SIRT1;IL1B;INPP5K
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.578370077129335,-1.0060061445788002,0.5405405405405406,1.0,1.0,6/14,15.05%,TTN;PKD2L2;CDH2;LHFPL5;PIEZO2;CAV3
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.4941956521865907,1.0056810094315098,0.41379310344827586,0.9969542444383291,1.0,3/9,6.37%,MKKS;LEPR;SIRT1
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.6611414995121643,-1.005472308316843,0.5,1.0,1.0,3/6,20.17%,UBXN2B;KIF11;MAP9
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.5903396723439384,-1.0054125605035271,0.5,1.0,1.0,2/12,8.14%,RPL23;SMARCD3
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.5671709626809919,-1.0051199101631045,0.48148148148148145,1.0,1.0,2/15,4.14%,RIMS1;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.6186213602042183,-1.0051006549303985,0.5394736842105263,1.0,1.0,2/9,17.27%,GRK4;CALM1
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.5671745241507068,-1.005071380883796,0.5,1.0,1.0,9/21,18.45%,ANTKMT;ANK3;ANK2;CALM3;SHANK3;AKAP6;NLGN3;CALM1;RELN
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.636938763302733,-1.004763757278636,0.5466666666666666,1.0,1.0,2/10,8.63%,NR4A3;DOCK5
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.6392827078516495,-1.004701387833746,0.49230769230769234,1.0,1.0,1/7,2.89%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.5726519912075655,-1.0045282877424693,0.5357142857142857,1.0,1.0,6/18,23.28%,RPS13;SRSF9;C1QBP;RPS26;U2AF2;SRSF12
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.4758838837636545,-1.0044507627977912,0.4946236559139785,1.0,1.0,10/94,8.01%,NLRP12;PRKAR2B;TSHR;ADCY3;TNFRSF1B;RORA;CD163;GSTP1;FGR;HTR7
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.5740250137197709,-1.004346337196893,0.475,1.0,1.0,5/14,14.76%,SELL;CDH9;CDH12;CDH23;CDH8
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.6364402610523434,-1.0043393437496646,0.5230769230769231,1.0,1.0,4/9,27.77%,PLP1;CLU;MYRF;B4GALT5
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.5420205666073625,-1.0042391916042188,0.43373493975903615,1.0,1.0,4/21,17.26%,NUDT16;NHP2;NYNRIN;DICER1
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),-0.6492878881605426,-1.003437554928741,0.5797101449275363,1.0,1.0,2/8,16.63%,IMPACT;GPR65
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.483012472490484,-1.0033498963368703,0.49473684210526314,1.0,1.0,11/99,10.94%,KCNE1;NR4A3;INSIG1;ADCY3;RORA;CCL3;BRCA1;IL18;ABCB4;CFTR;AANAT
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.5997835447019375,1.0032876053965916,0.38235294117647056,1.0,1.0,2/5,6.34%,PPARG;E2F3
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.5240436527909668,-1.0029448250256592,0.4939759036144578,1.0,1.0,2/22,7.52%,HERPUD1;SEC61B
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.6118901848355727,-1.0023000097707802,0.5,1.0,1.0,5/11,23.34%,EMC7;CAMLG;EMC10;EMC2;EMC3
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.5227104890824601,-1.0021753467586043,0.45348837209302323,1.0,1.0,1/28,0.28%,GLRA1
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.6696344816805719,-1.0018089684974836,0.5384615384615384,1.0,1.0,2/6,15.96%,PIAS4;GNL3
prerank,"GO_Biological_Process_2021__negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",0.6529047354337636,1.001599734852322,0.5151515151515151,1.0,1.0,1/5,3.11%,CD274
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),-0.5405962421842901,-1.0013992974433736,0.5,1.0,1.0,10/24,27.90%,MAPT;HSPA1B;RPS3;CAV3;CKAP5;DCTN1;FES;AKAP9;PSRC1;DRG1
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.3761328140380353,1.0012702537966962,0.46153846153846156,1.0,1.0,4/31,5.07%,NRP1;FER;SRGAP2;NTNG2
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.46790982665182385,-1.0012286625673055,0.5,1.0,1.0,16/93,12.36%,SRGN;CCL4;GPR183;BCL2A1;C5AR1;TNFRSF1B;CCL3;MS4A4A;GBP2;FCGR2B;FGR;MS4A6A;MNDA;TYMP;IRF1;NCF4
prerank,PanglaoDB_Augmented_2021__B Cells,-0.4707495460542628,-1.0011936174614586,0.5257731958762887,1.0,1.0,24/106,20.49%,CD55;JAML;MYO1G;CD69;NAPSB;SELL;IFIT3;FGR;CXCR4;IL10RA;ACAP1;PXK;NCF4;LSP1;HCLS1;VNN2;CD14;SCD;GPR65;ARHGAP9;LILRB2;CRELD2;PARVG;CD300A
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.5808083818224108,-1.0011554500320992,0.4878048780487805,1.0,1.0,2/13,12.41%,PRELID1;PRDM1
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.47091346524382605,-1.0011164077150851,0.5208333333333334,1.0,1.0,14/77,14.56%,ACVR1B;TP53TG5;MT2A;TGFB2;TCHP;ALOX15B;FBP1;FHL1;ADAM15;HSPA1B;NOTCH2;ING4;CDKN1B;ING5
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),-0.6137641686603328,-1.00096403679984,0.5454545454545454,1.0,1.0,2/9,11.76%,KIF1B;ERC2
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),0.5678641041990697,1.0006933667819418,0.5757575757575758,1.0,1.0,2/6,6.74%,ENPP1;APPL2
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.5353514443311648,1.000497172012532,0.4583333333333333,1.0,1.0,2/9,9.28%,SLC9C2;SLC9A9
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),-0.6441878851919273,-1.0004346903082393,0.5694444444444444,1.0,1.0,6/7,35.02%,SLC24A1;SLC24A2;PRRT1;SHANK2;PLK2;PICK1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.5948428805839542,1.0002938577458356,0.5428571428571428,1.0,1.0,1/5,4.43%,TGFB1
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.459832861458194,-1.0002367319178156,0.53,1.0,1.0,69/400,17.63%,NR4A3;NAMPT;HTR2B;PRLR;TFRC;RPL23;THBS1;RPS4X;OSMR;FTH1;TBC1D8;FGF1;ST18;AGT;VEGFA;TSHR;HMGB2;TGFB2;RPS6;IL7R;PTN;RNF126;AQP11;MEIS2;IL7;ALOX15B;FLT1;IFIT3;DDRGK1;EGLN3;CR1;RPS9;ATF5;IL15;CAMK2N1;STAT1;JUNB;HSPA1B;ID2;CTBP1;SDCBP;IRF1;RGCC;SST;COPS9;FN1;UHRF1;LIFR;HCLS1;ING4;ALK;CCPG1;CDKN1B;INSR;ING5;CNOT8;GNL3;TIMELESS;STAT2;E2F7;HMGN5;BCL6;CRLF1;IRS2;CLU;KLF4;MNT;TP53INP1;NEURL1
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.5238977489421621,1.0002366622711707,0.4482758620689655,0.9979835839423156,1.0,1/8,4.91%,AGO1
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.5238977489421621,1.0002366622711707,0.4482758620689655,0.9979835839423156,1.0,1/8,4.91%,AGO1
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.6987417308931536,-1.0002033234326893,0.5797101449275363,1.0,1.0,1/5,7.60%,MAPT
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),0.6113607534077053,1.0001145131819305,0.53125,0.9967923751365497,1.0,2/5,13.85%,PRCP;PLCB3
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.5764295646838539,-1.0000757483222327,0.5217391304347826,1.0,1.0,2/14,5.26%,BHLHE40;BASP1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.3227445754763285,1.0,1.0,0.9915600043745038,1.0,14/132,11.02%,PLA2G4C;PIK3C2B;PI4KB;PIP4K2B;ABHD8;AGPAT2;OCRL;PLA2G12A;SLC44A2;VAC14;INPP5K;PTPN13;MTMR14;PITPNM2
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.3236821816000482,1.0,1.0,0.9915600043745038,1.0,18/144,8.62%,GSN;BBS9;EHD4;AVIL;KIF27;PKD2;EXOC8;CDC14B;STK36;WDR35;MKKS;RAB3IP;TCTN3;CEP41;OCRL;KIF3B;RTTN;ABCC4
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.501182083091744,1.0,1.0,0.9915600043745038,1.0,19/86,14.58%,PLA2G4C;PIK3C2B;PI4KB;CSF1R;PIP4K2B;OCRL;PLA2G12A;VAC14;INPP5K;PTPN13;PGAP1;PIP4P2;MTMR14;PITPNM2;FGF2;PLCB3;PIK3R5;PIK3R6;MTMR10
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.2911016032235968,1.0,1.0,0.9915600043745038,1.0,34/257,11.01%,NUP42;SGSM1;TBC1D22B;RAB5B;NUP188;IPO13;SMURF1;ARFIP1;RAB22A;SORL1;TRAK2;TGFB1;RAB7A;ARL11;AP4E1;SYNDIG1;ARL5A;TMED4;TBC1D10B;TBC1D8B;E2F3;SYK;APPL2;SGSM2;LAPTM5;MAIP1;EVI5;TBC1D25;TBC1D5;ARCN1;TBC1D16;TMED3;NUP214;PPP1R10
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.569896790627344,-0.9999173872611661,0.4861111111111111,1.0,1.0,1/16,2.45%,FOS
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.6208021839181281,-0.9997992409802771,0.4782608695652174,1.0,1.0,2/9,13.29%,NOD2;HCLS1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.6171290432939636,-0.9996630501036168,0.4714285714285714,1.0,1.0,3/10,17.26%,ADGRG6;SOD1;DICER1
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),-0.650119395909882,-0.9994914980146958,0.5857142857142857,1.0,1.0,2/6,13.05%,TSHZ3;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.48000596439390264,-0.9994378654164818,0.4842105263157895,1.0,1.0,7/59,9.40%,SLC11A1;TUB;FCGR2B;IL15;CLIP3;GPC3;CALY
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.596151416210321,-0.9992605822077865,0.527027027027027,1.0,1.0,4/11,21.96%,INTS12;SSB;TRNT1;INTS8
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.45806006151603706,0.9991950207047888,0.5,0.9920882545893972,1.0,3/12,9.69%,TP53;SIRT1;INPP5K
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.4587096489564973,-0.9988876248692332,0.53,1.0,1.0,69/346,19.66%,CLEC12A;SLC2A3;CD55;GLA;FTH1;CHI3L1;SLC11A1;ENPP4;ALDH3B1;CD93;C5AR1;TNFRSF1B;CRISPLD2;SELL;GSTP1;HLA-B;CR1;SRP14;PLAC8;LPCAT1;FGR;PRDX4;HSPA1B;PADI2;CD36;PPIE;MNDA;SDCBP;CD63;PGAM1;PSMA5;IQGAP1;B2M;CYSTM1;PTGES2;RAB3A;PKM;DGAT1;FPR1;IGF2R;CTSB;RAB37;CD14;PYCARD;CD44;PGM1;GSDMD;EEF1A1;FCAR;TLR2;IMPDH1;RNASET2;SNAP25;ANXA2;DSN1;CKAP4;PTPRB;HLA-C;GNS;ARHGAP9;ACP3;GUSB;EEF2;ACTR1B;LILRB2;ATP6V1D;DYNLT1;GAA;PSMD7
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.35006683179791265,0.9988410615352711,0.5,0.9914398178188153,1.0,11/85,12.23%,NUP42;NUP188;WDR33;CPSF4;HHEX;FYTTD1;U2AF1;THOC5;NUP214;EIF4E;RAE1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.5052925215260173,0.9987163326280225,0.41935483870967744,0.9901788995609279,1.0,3/11,10.28%,ARHGAP35;CNTN4;EPHB3
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.4659541145591195,-0.9980823456059916,0.44329896907216493,1.0,1.0,27/116,18.58%,SRGN;NLRP12;RGS2;SLC11A1;OVOL2;VASN;RBPJ;SPRY1;HS3ST5;FCGR2B;IL15;BTN2A2;NR1H2;PROCR;PCTP;ACOT13;RGCC;ARRDC3;NR1D1;LRPAP1;ALDH1A1;LRP4;PPP1R11;BRCA2;NFIB;ATP2B4;PTPRG
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.5492229609153462,-0.9980213528081712,0.5058823529411764,1.0,1.0,8/24,22.98%,PARP9;PARP14;SIRT3;SIRT5;PARP11;ZC3HAV1;PARP15;PARP12
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.5699325516711519,0.9980121994112598,0.5151515151515151,0.9904837188493175,1.0,1/5,3.29%,DPH5
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.5630312752358171,-0.997717089226886,0.5063291139240507,1.0,1.0,2/19,5.14%,TGFB2;CCL3
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.5926739503693519,-0.9975897592372799,0.515625,1.0,1.0,5/10,23.17%,IFITM3;HEXIM1;TRIM14;TRIM13;ZFP36
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.4769220161171187,0.9974436991844337,0.5,0.9904534403005527,1.0,3/27,3.90%,NDE1;MAP1S;TRAK2
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.6151644111956479,-0.9965027696600867,0.527027027027027,1.0,1.0,6/9,36.89%,EPHB1;NFIB;EPHA4;SZT2;SPTBN4;EPHB6
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.5989731112660024,-0.9964448991946756,0.5151515151515151,1.0,1.0,3/9,14.47%,VEGFA;SMARCD3;KDM1A
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),-0.5898717385595902,-0.9962845152460624,0.5641025641025641,1.0,1.0,2/15,5.38%,HHIP;FBN2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.569981838764462,-0.9960799117857362,0.5487804878048781,1.0,1.0,7/25,22.69%,OIP5;ITGB3BP;HIRA;CENPP;CENPI;CENPU;CENPK
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.44837429471000473,-0.9957662828702214,0.53,1.0,1.0,24/226,11.56%,TFRC;ENPP2;CEMIP;ARAF;TOM1L1;CHI3L1;FGF1;MTCP1;AGT;VEGFA;TGFB2;SLCO3A1;DDRGK1;MARCO;FAXDC2;PINK1;IL15;CLIP3;CALM3;CENPE;SDCBP;IQGAP1;TEC;FAM20A
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.6518174616912364,-0.9956704950776541,0.5483870967741935,1.0,1.0,1/7,4.69%,MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.6554312023575394,-0.9952303145788587,0.5072463768115942,1.0,1.0,2/5,30.32%,STK17B;BTG1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.5203200274806592,-0.9950656930342866,0.4875,1.0,1.0,14/45,25.54%,EYA2;BRCA1;ZCWPW1;TMEM161A;RGCC;RPS3;TOX;GNL3;ABRAXAS1;STPG4;ERCC6;SMCHD1;NPAS2;WRN
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.45618210756186955,-0.994696634043046,0.55,1.0,1.0,69/350,19.66%,CLEC12A;SLC2A3;CD55;GLA;FTH1;CHI3L1;SLC11A1;ENPP4;ALDH3B1;CD93;C5AR1;TNFRSF1B;CRISPLD2;SELL;GSTP1;HLA-B;CR1;SRP14;PLAC8;LPCAT1;FGR;PRDX4;HSPA1B;PADI2;CD36;PPIE;MNDA;SDCBP;CD63;PGAM1;PSMA5;IQGAP1;B2M;CYSTM1;PTGES2;RAB3A;PKM;DGAT1;FPR1;IGF2R;CTSB;RAB37;CD14;PYCARD;CD44;PGM1;GSDMD;EEF1A1;FCAR;TLR2;IMPDH1;RNASET2;SNAP25;ANXA2;DSN1;CKAP4;PTPRB;HLA-C;GNS;ARHGAP9;ACP3;GUSB;EEF2;ACTR1B;LILRB2;ATP6V1D;DYNLT1;GAA;PSMD7
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.4750453420701785,0.9946691918811181,0.46875,0.9965025429349603,1.0,3/18,11.13%,NEDD4;ABL1;PDLIM5
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),-0.5723121534017097,-0.9945955986828074,0.4925373134328358,1.0,1.0,5/10,27.69%,PTPRD;IL1RAPL1;VPS35;APP;IL1RAPL2
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),-0.5723121534017097,-0.9945955986828074,0.4925373134328358,1.0,1.0,5/10,27.69%,PTPRD;IL1RAPL1;VPS35;APP;IL1RAPL2
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.46950651144779054,-0.9943737224333989,0.5625,1.0,1.0,20/98,19.24%,TRIM5;HIF1A;TNFRSF1B;PFKFB4;VPS11;DAPK1;BNIP3;NPRL2;PFKFB3;RDX;INSR;PIK3CB;SH3D19;CNOT8;IRS2;TP53INP1;ZC3HAV1;TRIM22;TRIM14;DTX3L
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.5532180394554834,-0.9943407738149652,0.5316455696202531,1.0,1.0,5/15,10.45%,HIF1A;SULF2;RORA;BRCA1;EIF2AK3
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.5707047065067428,-0.9942376691716548,0.4634146341463415,1.0,1.0,3/17,8.65%,TOM1L1;VEGFA;CALM3
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.5954354147479228,0.9940326526871192,0.5161290322580645,0.9966480090918806,1.0,3/6,25.99%,ST6GAL1;CSGALNACT1;EXTL2
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.6563795215470867,-0.9933518845539074,0.5571428571428572,1.0,1.0,3/5,11.44%,DNAJB9;DDRGK1;HSPA5
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.5745345912963606,-0.9931907096326255,0.5714285714285714,1.0,1.0,3/17,8.92%,LAMA2;LSR;DMD
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.473288149773124,-0.9930922058963061,0.5,1.0,1.0,15/56,18.58%,PKP2;CDH9;SHANK3;CDH12;CDH2;FN1;ADGRL3;GPM6A;NLGN3;NRXN1;CDH8;VMP1;CTNND2;ITGA6;NRXN2
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.49479551890389334,0.9930767085135908,0.45454545454545453,0.9976244674820385,1.0,2/9,6.37%,TP53;SIRT1
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.5178092340661438,-0.9929972931339016,0.5662650602409639,1.0,1.0,3/31,2.59%,LRP2;BHLHE40;HMGB2
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.5337570546992779,-0.9929117083096204,0.5555555555555556,1.0,1.0,5/25,15.60%,RPS27A;UBA52;UBC;CD14;UBB
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.5337570546992779,-0.9929117083096204,0.5555555555555556,1.0,1.0,5/25,15.60%,RPS27A;UBA52;UBC;CD14;UBB
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.5289178461787821,-0.9928660544353283,0.6125,1.0,1.0,12/28,22.96%,HLA-B;HLA-F;B2M;SEC24C;MFSD6;TAP1;HLA-C;ERAP1;TAPBPL;FCER1G;SEC13;HFE
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.5853801431711463,-0.992381272002247,0.4931506849315068,1.0,1.0,5/11,28.19%,NOTCH2;EPB41L4B;PTPRK;ZFP36;KLF9
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.47526821741706177,-0.9922896375851763,0.5425531914893617,1.0,1.0,22/104,25.59%,RPS27A;VIM;CARHSP1;UBA52;PSMA3;UBC;PSMA5;PSMD8;UBB;PSMB4;CNOT8;ZC3HAV1;PSMD7;GTPBP1;PSMD5;PSMC2;ZFP36;PNPT1;EXOSC1;PSMB9;PSMB2;SET
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),-0.62114124713538,-0.9921343087117687,0.5217391304347826,1.0,1.0,1/7,2.89%,TGFB2
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.6411051587581823,-0.9918386730123439,0.49295774647887325,1.0,1.0,2/7,2.56%,LRP2;VEGFA
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.6668336138718123,-0.9916840829328508,0.5135135135135135,1.0,1.0,1/6,9.59%,PAX8
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),-0.6275299521464394,-0.9915485412610506,0.5373134328358209,1.0,1.0,2/8,8.72%,CNEP1R1;NR1H2
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.6383236876194176,-0.9915383409061352,0.5362318840579711,1.0,1.0,4/10,22.39%,PKP2;CACNA1C;ATP1B2;RYR2
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.4822529669676409,-0.9914122409916402,0.59375,1.0,1.0,20/97,15.16%,GADD45B;BHLHE40;SPARC;MYLK;ACSL1;LAMA2;SVIL;FHL1;DAPK2;PKIA;DMD;CKMT2;CD36;PPFIA4;GNAO1;LSP1;APOD;LDB3;CAV3;SCD
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.5597378147300036,-0.991140162701581,0.5063291139240507,1.0,1.0,4/18,16.37%,AGT;FN1;BMI1;S100A6
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.5824631083943231,-0.990928541362604,0.5733333333333334,1.0,1.0,2/10,5.79%,H1-0;DDRGK1
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.5553571507250803,0.9909055779249277,0.5517241379310345,1.0,1.0,2/8,7.39%,WASF2;WASF3
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.4282395504918201,0.9907535790218103,0.30434782608695654,1.0,1.0,4/26,6.16%,ACER2;SESN2;NBN;TP53
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.5087140908310717,-0.9906338246401519,0.4482758620689655,1.0,1.0,11/45,22.39%,HTR2B;CCL3;ANK2;TPT1;FAM20A;SLC24A1;ATP2B4;SLC24A2;ATP2B2;SLC24A4;RYR2
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.46091553264551605,-0.9905937278731904,0.5714285714285714,1.0,1.0,31/114,19.38%,CLEC12A;F13A1;CD93;TGFB2;TNS1;CD163;MS4A4A;CXCR4;CD36;NOTCH2;PROCR;MS4A6A;MNDA;THBD;TXNIP;CDH2;BMI1;SIGLEC1;CD14;CD44;ALDH1A1;ABCB1;TLR2;GNL3;ITGA6;IL3RA;SERPING1;THY1;BAALC;LILRB2;AIF1
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.3261832575144716,0.9905651838027588,0.5,0.9989356734836735,1.0,4/67,3.06%,TIFA;EHD4;PKD2;MCU
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.5265815582948215,-0.9903899702914724,0.5465116279069767,1.0,1.0,8/33,15.05%,INSIG1;RORA;ABCA5;IL18;NR1H2;ABCA1;NR1D1;CAV3
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.5265815582948215,-0.9903899702914724,0.5465116279069767,1.0,1.0,8/33,15.05%,INSIG1;RORA;ABCA5;IL18;NR1H2;ABCA1;NR1D1;CAV3
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.5283417027077072,-0.9902725924359186,0.48863636363636365,1.0,1.0,2/34,3.43%,TOM1L1;IL7R
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5250638017216217,0.9902345986519789,0.5833333333333334,0.9981581398662279,1.0,2/9,1.01%,GSN;LGALS9
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),-0.6092753778637656,-0.9900977632077697,0.5333333333333333,1.0,1.0,7/10,34.46%,EIF2B2;PTPRZ1;MYRF;SOX6;EIF2B1;NSUN5;EIF2B5
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.4695295095361139,0.9899676900436493,0.5217391304347826,0.9973463463285188,1.0,5/16,16.52%,IL1B;IL1A;ZDHHC21;LYPLA1;DDAH2
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),-0.6678261660732163,-0.9899134781232956,0.5846153846153846,1.0,1.0,2/5,9.93%,THBS1;THBD
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.6025415805208166,0.9897361501771653,0.4444444444444444,0.9962990941275344,1.0,2/5,6.54%,SIRT1;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.45278328962277486,-0.989711382833792,0.53,1.0,1.0,52/336,17.26%,NAMPT;HTR2B;PRLR;RPL23;THBS1;RPS4X;OSMR;TBC1D8;SLC11A1;FGF1;VEGFA;TSHR;TUB;TGFB2;RPS6;IL7R;PTN;TNFRSF1B;AQP11;MEIS2;IL7;FLT1;DDRGK1;CR1;RPS9;FCGR2B;MAPT;IL15;HCFC1;CD36;PPP1R13L;SDCBP;COLEC12;COPS9;EPB41L4B;FN1;AKAP6;LIFR;HCLS1;CCPG1;CDKN1B;PYCARD;INSR;ECHDC3;TLR2;CNOT8;FRMD5;CIDEB;HMGN5;CRLF1;IRS2;DICER1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.4829063629666124,-0.9894946103087813,0.5425531914893617,1.0,1.0,12/70,14.27%,SOCS3;ENPP2;AGT;VEGFA;IL15;PARP9;IL18;TEC;HCLS1;PARP14;GHR;CD44
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.454357308689864,-0.9894177620596052,0.58,1.0,1.0,69/349,19.66%,CLEC12A;SLC2A3;CD55;GLA;FTH1;CHI3L1;SLC11A1;ENPP4;ALDH3B1;CD93;C5AR1;TNFRSF1B;CRISPLD2;SELL;GSTP1;HLA-B;CR1;SRP14;PLAC8;LPCAT1;FGR;PRDX4;HSPA1B;PADI2;CD36;PPIE;MNDA;SDCBP;CD63;PGAM1;PSMA5;IQGAP1;B2M;CYSTM1;PTGES2;RAB3A;PKM;DGAT1;FPR1;IGF2R;CTSB;RAB37;CD14;PYCARD;CD44;PGM1;GSDMD;EEF1A1;FCAR;TLR2;IMPDH1;RNASET2;SNAP25;ANXA2;DSN1;CKAP4;PTPRB;HLA-C;GNS;ARHGAP9;ACP3;GUSB;EEF2;ACTR1B;LILRB2;ATP6V1D;DYNLT1;GAA;PSMD7
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.6732806553531696,-0.9893418362904455,0.5588235294117647,1.0,1.0,1/5,0.79%,ALG10B
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.35897397324587105,0.9892961388391235,0.4,0.9960227076590087,1.0,8/77,7.53%,PHLDB2;CRK;ARHGAP35;FSCN1;RHOG;ABL1;PDGFA;SORBS3
prerank,GO_Biological_Process_2021__negative regulation of mast cell activation (GO:0033004),0.6564380564396123,0.9892532539327796,0.6,0.9946339945546053,1.0,4/6,17.33%,FER;MILR1;CD84;CD300LF
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.5509871882663894,-0.9892526183333207,0.5128205128205128,1.0,1.0,7/17,29.38%,SNX10;STIL;GOLGB1;DCTN2;CSNK1D;BBS4;HOOK3
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.49625667250542105,-0.9891384809564127,0.4819277108433735,1.0,1.0,2/45,4.69%,SLC2A3;MTHFD1
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.6441323664401811,-0.9890320403742765,0.5737704918032787,1.0,1.0,3/6,28.85%,NEIL1;TDG;OGG1
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.5996586863057841,-0.9884024112917865,0.589041095890411,1.0,1.0,1/12,1.62%,CHI3L1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.5526415090761394,-0.9882999306297597,0.5301204819277109,1.0,1.0,6/20,17.93%,ERO1A;HSPA1B;HSPA2;HSPA5;DNAJC7;SDF2L1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.5890373719457994,-0.9881663793461832,0.5507246376811594,1.0,1.0,2/14,4.76%,HTR2B;ERO1A
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),-0.6911718803349309,-0.9881470458781699,0.5625,1.0,1.0,3/5,25.45%,NRXN1;NRXN2;NLGN2
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.514615278602221,-0.9880565278481346,0.4883720930232558,1.0,1.0,8/24,29.17%,WDR83;BCAS2;PRPF6;PRPF3;MPHOSPH10;DBR1;GEMIN2;PRPF4
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.6000715849563603,-0.9879789214169405,0.5405405405405406,1.0,1.0,2/11,10.28%,CCDC39;LRGUK
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.49808726860601854,-0.9877523118292109,0.532608695652174,1.0,1.0,11/47,17.27%,HTR2B;FGF1;RAB11A;CALM3;KLHL13;PRDM15;TXNIP;PIK3R4;ORC6;POU5F1;CALM1
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.470981340028637,-0.9875036623744491,0.5851063829787234,1.0,1.0,16/69,22.04%,FA2H;ALOX12;ACSL1;ALOX15B;GNPAT;CD36;PNPLA8;ECHDC3;ACAD9;HACL1;FAAH;PER2;ELOVL4;ACSM3;ACSL3;SLC27A5
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.6101284635428919,-0.9874062634950408,0.5652173913043478,1.0,1.0,1/10,6.41%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.5698731147302558,-0.9873664545615571,0.5769230769230769,1.0,1.0,3/10,22.57%,VBP1;CLU;CRYAB
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.6890923168344838,-0.9871641208368235,0.5846153846153846,1.0,1.0,1/5,2.56%,VEGFA
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.509613495890791,-0.9871604230051998,0.4927536231884058,1.0,1.0,1/12,8.95%,SSB
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4991064667599122,0.9868728013883986,0.5833333333333334,0.9993899473516209,1.0,4/12,17.41%,UBE2J1;YOD1;OS9;SVIP
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),0.6556494748008296,0.9866141052845667,0.5714285714285714,0.9985824966099224,1.0,1/5,2.71%,P2RY12
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.47396646487453575,-0.9865658096215841,0.5217391304347826,1.0,1.0,16/71,18.20%,CENPF;LRP2;PLTP;SLCO1A2;SCAMP3;ABCA5;ABCA9;PCTP;ABCA6;TXNIP;ARRDC3;ABCA1;TAP1;PEX3;ABCA8;KIF3A
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.5034800462843884,-0.9864140555659855,0.5487804878048781,1.0,1.0,7/31,14.16%,NLRP12;RORA;GSTP1;STAT1;TLE1;NR1D1;PYCARD
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.6419218157524655,-0.9861542871149351,0.5538461538461539,1.0,1.0,1/6,6.37%,DDX11
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.43086284691687776,0.9859716671883829,0.4583333333333333,0.9988129196560378,1.0,6/19,14.88%,ERCC4;TP53;DACH1;SRC;HNRNPC;GNL3L
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.5199591195254287,0.985666350758427,0.4375,0.9980269626617234,1.0,2/7,6.34%,PPARG;E2F3
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.5831753773792157,-0.985601616623443,0.5432098765432098,1.0,1.0,2/12,15.05%,ANK2;CAV3
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.5336957354719175,0.985575902773454,0.4411764705882353,0.9968087857978142,1.0,2/8,6.39%,SIRT1;HDAC10
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.4873328103036439,-0.9852514398027237,0.5,1.0,1.0,16/66,15.87%,CLEC12A;THBS1;CD55;RSAD2;CR1;CD36;MNDA;RASGRP4;UROS;NCF4;FPR1;VNN2;CD44;MPP1;UBB;TSPAN32
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.5820281103678079,0.9850775537379511,0.4444444444444444,0.9965345749225853,1.0,4/7,8.72%,HPGDS;CYP2S1;ACOX1;PTGS1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.6566991444368906,-0.9849671630271645,0.5616438356164384,1.0,1.0,2/5,11.73%,AGT;RGCC
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.40779838742298735,0.9847826143110154,0.38095238095238093,0.9956112525514648,1.0,8/33,11.66%,CEBPA;PPARG;RCN3;SIRT1;ABHD8;ACOX1;NR1H3;FBXW7
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.5047760482732232,-0.9846615086845167,0.5542168674698795,1.0,1.0,13/42,18.11%,ADGRE1;TSHR;ADGRG6;ADCY3;ADGRD1;ADGRL2;ADGRL3;ABCA1;GNA13;RXFP1;GPR65;ADCY8;CALCR
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.6277508096594636,-0.9845895734204723,0.5714285714285714,1.0,1.0,2/10,9.77%,LIMD1;CIT
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.47693393326975586,-0.9844448159315268,0.5054945054945055,1.0,1.0,9/63,7.92%,HHIP;MYLK;OGN;VASN;TNS1;LAMA2;PLN;SPON2;OTUD1
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),-0.6755169369288541,-0.9843111260479552,0.6101694915254238,1.0,1.0,3/5,25.88%,HLA-DMB;TAPBPL;HLA-DRA
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),-0.6434596347271437,-0.9842162562968585,0.6164383561643836,1.0,1.0,3/8,22.39%,PDE4B;ATP2B4;RYR2
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),-0.6434596347271437,-0.9842162562968585,0.6164383561643836,1.0,1.0,3/8,22.39%,PDE4B;ATP2B4;RYR2
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),0.6254866421829962,0.9841438161305864,0.5294117647058824,0.9940970131523155,1.0,3/6,13.57%,TMEM119;P2RX7;UBASH3B
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),0.6254866421829962,0.9841438161305864,0.5294117647058824,0.9940970131523155,1.0,3/6,13.57%,TMEM119;P2RX7;UBASH3B
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.48762883789334777,-0.9840911031264993,0.5862068965517241,1.0,1.0,10/52,17.17%,ACVR1B;TGFB2;BCL2A1;TNFRSF1B;APPL1;BCL2L2;DCC;TRAF2;DEDD;MCL1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",-0.4673337812530094,-0.983996587264562,0.5151515151515151,1.0,1.0,14/119,14.38%,NR4A3;NR4A1;RBPJ;RXRB;RORA;NR4A2;POLR2G;POLR1C;NR1H2;RORB;NOTCH2;ERCC2;NR1D1;POLR3H
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.6910321022243355,-0.9834144235182589,0.6078431372549019,1.0,1.0,3/5,26.76%,CALCR;PDCD7;GOT1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.5244726419843552,-0.9827462588014959,0.5375,1.0,1.0,3/23,14.38%,GTF3C6;SNAPC1;POLR3H
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.4713785326619207,-0.9826401767252163,0.532608695652174,1.0,1.0,18/67,21.75%,FANCB;XRCC3;RPA2;FANCM;BRCA1;POLQ;FAN1;RPA3;MCMDC2;POLL;SLX4;BRCA2;MCM3;MCM6;MUS81;MCM7;NABP1;LIG3
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.45494811610576646,-0.982445519241971,0.53,1.0,1.0,23/146,14.34%,HTR2B;CCL4;GLIPR2;TRIM5;CHI3L1;GPR183;FGF1;VEGFA;TGFB2;C5AR1;CCL3;FLT1;NOD2;MARCO;DIRAS2;CD36;NOTCH2;MAP3K12;IQGAP1;TRAF7;PYCARD;CD44;INSR
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.49180338179824745,-0.982374702569299,0.5681818181818182,1.0,1.0,15/48,15.79%,RHOB;GLUL;HAMP;GPC3;ABCC3;SAT2;BNIP3;SLC10A1;EPB41L4B;TM7SF2;ALDH6A1;GHR;SCD;RND3;PLSCR1
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.5068823753653419,-0.982273301909795,0.6046511627906976,1.0,1.0,3/31,8.33%,SRGN;VPS11;SNX10
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.491148661551259,-0.9817666626123148,0.5121951219512195,1.0,1.0,3/31,3.30%,FOS;TGFB2;HIF1A
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.4604487994033057,-0.9817524836858632,0.5,1.0,1.0,13/77,17.36%,PPP1R15A;HINT1;BCL2A1;TNFRSF1B;ERO1A;BRCA1;BCL2L2;BNIP3;PYCARD;TRAF2;CIDEB;MCL1;GSKIP
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.6266133911584493,-0.9814224331603205,0.59375,1.0,1.0,2/5,14.97%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.6266133911584493,-0.9814224331603205,0.59375,1.0,1.0,2/5,14.97%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.540422494054729,-0.9810811680346153,0.5365853658536586,1.0,1.0,6/15,29.38%,SNX10;STIL;DCTN2;CSNK1D;BBS4;HOOK3
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.5309981162030915,-0.9809100712088242,0.5882352941176471,1.0,1.0,10/27,25.50%,SEC61B;SERP1;EMC7;CAMLG;EMC10;EMC2;EMD;VAPA;EMC3;APP
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.5997934281964072,-0.9808628540019729,0.6111111111111112,1.0,1.0,3/10,16.96%,CLSPN;TIMELESS;DNA2
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.6651866138553202,-0.9807622999101016,0.5294117647058824,1.0,1.0,2/5,25.10%,NOP53;MACROH2A2
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.586722485808423,-0.9802900768746406,0.5256410256410257,1.0,1.0,5/13,17.27%,JPH1;CALM3;DMD;AKAP6;CALM1
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.6137759864971193,-0.9802053177266055,0.573170731707317,1.0,1.0,2/11,10.33%,SLC11A1;BTN3A1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.49950552561762623,-0.9801736948694436,0.5697674418604651,1.0,1.0,5/32,11.12%,HHIP;RORA;PDCL;GPC3;IFT81
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.514601124617034,-0.9795623596895981,0.5517241379310345,1.0,1.0,8/37,15.79%,SLC11A1;TUB;FCGR2B;FGR;IL15;PYCARD;TLR2;PLSCR1
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.5046331676503562,-0.979253907340509,0.5060240963855421,1.0,1.0,7/35,17.96%,AGT;RBM4B;RBM3;NR1H2;UHRF1;KLF4;RPL10
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.6168739961118673,-0.9792193793355809,0.5428571428571428,1.0,1.0,3/7,22.90%,HSPA1B;CKAP5;DCTN1
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.6369218418693028,-0.9789748412087045,0.5151515151515151,1.0,1.0,1/5,4.13%,ASRGL1
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),-0.6462201124810272,-0.9788672112694051,0.5606060606060606,1.0,1.0,2/8,8.93%,VEGFA;TTN
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),-0.5925978628005566,-0.9787325211559635,0.5735294117647058,1.0,1.0,1/10,3.42%,C5AR1
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.4882250579429933,-0.9786797563406608,0.5543478260869565,1.0,1.0,8/55,11.38%,RPS27A;PLPP3;FZD6;RBX1;NR4A2;UBA52;UBC;TCF7
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.4509666843019436,-0.9786673631643477,0.5416666666666666,1.0,1.0,13/107,12.40%,TOM1L1;SLC11A1;MTCP1;AGT;VEGFA;TGFB2;SYAP1;CALM3;CENPE;CLSPN;IQGAP1;INCENP;PAK5
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.4828666198923154,-0.9784950544821364,0.5714285714285714,1.0,1.0,10/58,12.04%,THBS1;CGNL1;PLPP3;TNS1;LAMA2;DOCK1;SMARCD3;SPARCL1;ENC1;SPSB1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.5165632225814776,-0.9783334463067694,0.573170731707317,1.0,1.0,6/30,16.74%,TOM1L1;BRINP1;RGCC;CDKN1B;ZWILCH;BCL6
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.5946357670737271,-0.9781883805258442,0.5068493150684932,1.0,1.0,2/11,5.65%,VIM;NOD2
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.5020513818481211,-0.9781052322937324,0.4827586206896552,1.0,1.0,7/33,19.33%,PPP1R15A;PPP2R5A;CNEP1R1;CALM3;NSMF;CALM1;LILRB2
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.4607783332744943,-0.9778390629490223,0.5520833333333334,1.0,1.0,11/101,9.25%,ACVR1B;LRP2;KNSTRN;SEMA6A;NR4A1;VEGFA;OVOL2;SYAP1;FLT1;MAPT;APPL1
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.47039806091293673,-0.9776136953723508,0.5172413793103449,1.0,1.0,16/53,18.42%,RPS27A;IHO1;RBX1;RPA2;DDX1;UBA52;RFC1;UBC;FAN1;RPA3;ERCC2;RFC4;UBB;DNA2;DICER1;DDB1
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.6131000358207154,-0.9775464843805795,0.5147058823529411,1.0,1.0,6/7,37.85%,TTN;OBSCN;ACTN2;FHOD3;CSRP1;WDR1
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.472375556534356,0.9775297621766874,0.44,1.0,1.0,3/17,6.93%,GSN;RHOG;PDGFA
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.4991518245552555,-0.9771057634578534,0.5957446808510638,1.0,1.0,20/43,30.69%,GLRA1;CFTR;SLC12A8;GABRA3;GABRB1;GABRG2;ANO4;GABRB3;GABRA2;SLC20A2;SLC12A7;GABRB2;GABRA4;GLRB;SLC6A1;SLC25A3;SLC37A3;GABRA1;LRRC8A;ANO5
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.5573237031588777,-0.9770441865405829,0.5921052631578947,1.0,1.0,5/14,10.45%,HIF1A;SULF2;RORA;BRCA1;EIF2AK3
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),-0.543199348280172,-0.9770176420734,0.569620253164557,1.0,1.0,1/15,0.28%,GLRA1
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.4891146258477232,-0.9769706694827331,0.5494505494505495,1.0,1.0,5/45,9.24%,THBS1;PPP1R15A;JUNB;TGIF1;ID2
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.5033671523344341,-0.9769456623721767,0.6071428571428571,1.0,1.0,10/41,13.12%,PLPP3;SPARC;MYLK;TNS1;LAMA2;PTN;FN1;SVEP1;DAAM2;PALLD
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated cytotoxicity (GO:0001915),-0.6396371090447932,-0.9766886167225193,0.5373134328358209,1.0,1.0,4/6,32.53%,FCGR2B;KLRD1;LILRB1;PTPRC
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.540500507435836,-0.9763205426422893,0.5,1.0,1.0,7/21,17.26%,PTN;TNFRSF1B;TYMP;EIF2AK3;PTPRZ1;TNFRSF21;DICER1
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.5187914316780353,0.9754980394923658,0.5,1.0,1.0,5/8,29.62%,FAS;ATP6V1G1;ATP6AP1;ATP6V0D1;ATG7
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.4717629000857768,-0.9754956142835776,0.5813953488372093,1.0,1.0,9/50,20.15%,KMO;GLUL;ALDH6A1;ASPA;GAD1;HMGCL;PIPOX;ACAT1;FAH
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.47265775447971486,-0.9754365967470675,0.5568181818181818,1.0,1.0,14/59,25.67%,RPS27A;UBA52;PSMA3;UBC;PSMA5;PSMD8;UBB;PSMB4;PSMD7;PSMD5;PSMC2;PSMB9;PSMB2;ANAPC7
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.5160751397131627,0.9753862031022654,0.3888888888888889,1.0,1.0,1/8,11.42%,CLEC16A
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.5029232415375989,-0.9752929671833191,0.46153846153846156,1.0,1.0,4/20,16.20%,CDC37;NLRC5;OAS3;STAT2
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.7024968393981045,-0.9752517028043179,0.6060606060606061,1.0,1.0,1/5,2.89%,TGFB2
prerank,GO_Biological_Process_2021__regulation of interleukin-23 production (GO:0032667),0.6423593094087717,0.9752319593141486,0.5454545454545454,1.0,1.0,1/5,4.62%,IL17RA
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.511142780973893,-0.975076029324727,0.5555555555555556,1.0,1.0,7/34,16.74%,TALDO1;CFL1;SOD1;RPLP0;LMNB1;ANXA2;PDCD4
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.5344036112724082,-0.9747630050231822,0.4875,1.0,1.0,3/21,8.00%,NR4A1;VEGFA;STAT1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.4555691299397263,0.9747331548244657,0.4583333333333333,1.0,1.0,2/12,6.37%,ZNF385A;SIRT1
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.5800409117407643,-0.9745909868438775,0.5342465753424658,1.0,1.0,1/7,18.96%,EIF2D
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.509704776426157,-0.9743782473228176,0.5061728395061729,1.0,1.0,7/25,22.29%,ALOX12;ACSS3;SCD;HMGCL;ACAT1;SLC27A5;SCD5
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.48280478950135763,-0.9743780015235817,0.5842696629213483,1.0,1.0,15/61,18.11%,CD55;TACR1;C5AR1;ACKR4;PLN;CXCR4;CD36;C5AR2;FPR1;CDH23;CAV3;ADCY8;CACNA1C;ATP2B4;CALCR
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.631253761908658,0.9743730833252514,0.6363636363636364,1.0,1.0,3/6,8.90%,NRP1;P2RY12;SHTN1
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.6458465481979144,-0.9743673287881717,0.56,1.0,1.0,1/8,7.19%,ERI2
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.6458465481979144,-0.9743673287881717,0.56,1.0,1.0,1/8,7.19%,ERI2
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),-0.6386556470148003,-0.9743648758841387,0.5645161290322581,1.0,1.0,4/7,21.95%,PRKCQ;NFKBIZ;NFKBID;CARD9
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.47236926087205383,-0.9740277226377643,0.5531914893617021,1.0,1.0,13/71,19.16%,KCNJ13;SLC5A9;LRP2;SCN9A;FGF13;SLC9B2;KCNMA1;TRPM3;PIEZO2;KCNC1;SCN1A;SCN3B;SGK1
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),-0.6080415142845421,-0.9738289659035486,0.5571428571428572,1.0,1.0,1/10,1.22%,PLIN2
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.4262945701497234,0.9736557134418597,0.44,1.0,1.0,2/15,13.52%,MCM9;TASOR
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.43312077279899674,0.9735134177836925,0.5,1.0,1.0,4/20,11.01%,NBN;ERCC4;YLPM1;PPP1R10
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.5095072528306619,-0.9734602235058246,0.5862068965517241,1.0,1.0,6/27,8.53%,NR4A1;VEGFA;HMGB2;ACKR4;PRKCQ;CXCR4
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.41692190843351407,0.9729297819935323,0.44,1.0,1.0,4/26,3.56%,SIRPA;ZMYND11;QARS1;ZNF675
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.4470714067595807,-0.9726086188158579,0.4842105263157895,1.0,1.0,15/97,21.25%,NR4A3;FOS;VAV3;PRKCQ;PSMA3;PSMA5;TEC;PIK3CB;PSMD8;PSMB4;CALM1;MAPK10;PSMD7;FCER1G;PSMD5
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.5331176223851988,-0.9722670911826736,0.5584415584415584,1.0,1.0,4/16,24.69%,APPL1;INSR;IRS2;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.5450932916080412,-0.9721401054917901,0.5540540540540541,1.0,1.0,4/19,8.37%,AIM2;PQBP1;STAT1;PARP9
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.6803140034019614,-0.9718866522070799,0.6461538461538462,1.0,1.0,2/5,20.44%,DHX58;C1QBP
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.5590031930218115,-0.9717607431303994,0.5714285714285714,1.0,1.0,3/18,4.53%,TGFB2;RBPJ;PKP2
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.44178975208020443,0.9717276088672343,0.5217391304347826,1.0,1.0,5/18,11.66%,TGFA;ARAP1;CBL;BCAR3;FBXW7
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.6276449001705179,-0.9716123582677055,0.576271186440678,1.0,1.0,1/7,2.49%,ARIH2
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),-0.6067804744580062,-0.9712178051008872,0.5967741935483871,1.0,1.0,3/8,21.38%,LRRC4C;PTPRD;NTNG1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5180268514593479,-0.9711823300575698,0.5595238095238095,1.0,1.0,3/31,6.41%,THBS1;FAIM2;BRCA1
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),-0.589401048685822,-0.971100832263973,0.5384615384615384,1.0,1.0,1/10,1.97%,SLC11A1
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.4645926301308386,-0.9710495952102098,0.6063829787234043,1.0,1.0,21/77,25.40%,TOP2A;ACSL1;RDH11;SOD1;ABCB4;GNPAT;CTBP1;GSTK1;ALDH1A1;ABCB1;HMGCL;CADM1;SLC25A19;IDI1;ECI2;ESR2;STS;DIO1;SIAH1;CACNA1B;CTPS1
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,-0.5342010864902276,-0.9708459822577805,0.6,1.0,1.0,5/26,9.82%,VEGFA;RTN1;UNC5C;ETS2;TLE1
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5483218042938691,0.970778417911606,0.5,1.0,1.0,5/10,21.17%,EFL1;AK3;MFN1;GIMAP7;RHOQ
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.4931375832145002,-0.9707706712053594,0.52,1.0,1.0,5/29,20.17%,RACGAP1;RAB11A;ABRAXAS1;KIF11;MAP9
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.5645910328408615,0.9707636672092823,0.46875,1.0,1.0,3/7,30.60%,CLEC16A;CARD11;LARP1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.40348786185454105,0.9704786611852528,0.5454545454545454,1.0,1.0,5/44,6.37%,SESN2;RALB;PIP4K2B;SESN3;SIRT1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.643993838217825,-0.9701914766738219,0.5970149253731343,1.0,1.0,2/5,20.50%,KLF4;KLF2
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.52487496731264,-0.9697504925870178,0.5540540540540541,1.0,1.0,1/15,6.19%,NHP2
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),-0.6675251142402058,-0.9696036553305889,0.6290322580645161,1.0,1.0,2/5,23.43%,LMO3;PER1
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.5249657504926561,-0.9695487096401513,0.5324675324675324,1.0,1.0,9/23,26.69%,IL7;CR1;BCL6;LILRB2;TESPA1;SOX4;IL4I1;HLA-DRA;DUSP10
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.600408970428107,-0.9694570224000875,0.5882352941176471,1.0,1.0,1/7,6.12%,ANK3
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.6721922606053133,-0.9693978260350878,0.6379310344827587,1.0,1.0,3/5,27.77%,PLP1;MYRF;B4GALT5
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.5385826042346401,-0.9692804110253297,0.524390243902439,1.0,1.0,4/16,19.53%,XRCC3;ATF5;CHMP5;PDCD6IP
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.4882973238130963,-0.9691591150667654,0.5777777777777777,1.0,1.0,7/63,8.83%,RNF144B;ARIH2;RBX1;DDRGK1;HERPUD1;NOP53;HSPA1B
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.43861519025527235,0.9689736955443479,0.5652173913043478,1.0,1.0,1/15,1.10%,ARV1
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.6551735465540658,-0.9689599673901359,0.6029411764705882,1.0,1.0,1/6,6.02%,ANTKMT
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.5047915462268768,-0.9689548495725699,0.5531914893617021,1.0,1.0,6/45,9.44%,H1-3;H1-4;H1-2;H1-0;POLR1C;PADI2
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.5317733260227498,0.9684213134030972,0.4444444444444444,1.0,1.0,4/8,17.33%,HAVCR1;MILR1;CD84;CD300LF
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),-0.5115815021965826,-0.9679342666563547,0.5256410256410257,1.0,1.0,2/21,9.76%,LPCAT1;PCTP
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.5639720271506303,-0.9679022343131772,0.5285714285714286,1.0,1.0,2/15,6.18%,VEGFA;DUOX1
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.5483908000239361,-0.9678322139301822,0.5061728395061729,1.0,1.0,6/22,24.90%,CNEP1R1;NR1H2;MID1IP1;MFSD2A;SORBS1;PPARA
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),-0.6642852094262609,-0.9674230964924959,0.5806451612903226,1.0,1.0,3/5,12.10%,DOCK5;SOD1;KCNMA1
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.6273907755997052,-0.9673282176266689,0.5370370370370371,1.0,1.0,1/5,9.15%,GNPAT
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.6273907755997052,-0.9673282176266689,0.5370370370370371,1.0,1.0,1/5,9.15%,GNPAT
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.3112069691538684,0.9672805774038824,0.6,1.0,1.0,12/115,9.05%,SESN2;RALB;MAP3K5;NUAK1;MIOS;SESN3;TP53;SIRT1;STK26;EIF2AK4;EIF2S1;LAMTOR1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),0.605291496967887,0.9671948866190794,0.5833333333333334,1.0,1.0,1/5,1.01%,LGALS9
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),-0.62496660750668,-0.9671400894107884,0.5454545454545454,1.0,1.0,1/5,8.66%,IL18
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),-0.62496660750668,-0.9671400894107884,0.5454545454545454,1.0,1.0,1/5,8.66%,IL18
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.5427877692515356,-0.9665674083722254,0.547945205479452,1.0,1.0,3/14,5.26%,LRP2;TGFB2;BASP1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.533704920707331,-0.9665166507179989,0.5542168674698795,1.0,1.0,5/21,18.00%,DDRGK1;ID2;APPL1;CDKN1B;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.5450652756708325,-0.9663660798153725,0.5657894736842105,1.0,1.0,2/17,5.60%,PPP1R15A;MASTL
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.43154768764529366,0.966264604300001,0.5555555555555556,1.0,1.0,3/17,7.40%,ARL2BP;TAF3;TAPT1
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.4393451573938589,0.9661505196852983,0.5,1.0,1.0,4/15,12.89%,HPN;TFAP4;EP300;ZNF639
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.562274040234357,-0.966039212175605,0.569620253164557,1.0,1.0,1/12,0.27%,NR4A3
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),-0.6930464553212068,-0.9657808642389468,0.6140350877192983,1.0,1.0,3/5,19.04%,ABHD12B;MGLL;FAAH
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.5623769243963687,-0.965673327467795,0.5833333333333334,1.0,1.0,2/14,2.46%,HTR2B;AGT
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.5107533492837102,-0.9656336148863517,0.5517241379310345,1.0,1.0,7/25,26.77%,RBM4B;RBM3;PGAM1;RPL10;EIF2A;APP;ROCK1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.445034787846516,-0.9654659419890782,0.59,1.0,1.0,36/214,14.87%,HTR2B;CHI3L1;SLC11A1;AGT;RAB7B;HIF1A;SULF2;RORA;TXK;POLR3F;PQBP1;IL7;ALOX15B;NOD2;SLC7A5;BRCA1;FGR;IL15;GAPDH;PRKCQ;POLR1C;DHX58;IL18;SOD1;HSPA1B;APPL1;BTN3A1;EIF2AK3;PDE4B;IRF1;RGCC;CD14;PYCARD;POLR3H;RPS3;TRAF2
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.5519062036219491,0.9651906744491316,0.41935483870967744,1.0,1.0,1/8,0.82%,SIRPA
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),-0.6310324048880442,-0.9650074413014229,0.6133333333333333,1.0,1.0,3/9,19.26%,SLC24A1;ATP2B4;SLC24A2
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),-0.6310324048880442,-0.9650074413014229,0.6133333333333333,1.0,1.0,3/9,19.26%,SLC24A1;ATP2B4;SLC24A2
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.4735264976407498,0.9643564559108447,0.5,1.0,1.0,1/17,0.08%,PLA2G4C
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),-0.6238246004866921,-0.9639538134160124,0.5915492957746479,1.0,1.0,1/8,9.99%,CTBP1
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.5806706858038642,-0.963917553348129,0.6521739130434783,1.0,1.0,4/11,16.53%,HERPUD1;EIF2AK3;HSPA5;IMPACT
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.5155769491948174,0.9634667144850335,0.45714285714285713,1.0,1.0,3/8,13.05%,NR3C1;PLPP1;NR3C2
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.4797993610891485,-0.9630875425750185,0.5568181818181818,1.0,1.0,6/52,8.01%,PRKAR2B;TSHR;ADCY3;CD163;FGR;HTR7
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),0.4383395790982009,0.9630544700707505,0.7222222222222222,1.0,1.0,4/17,6.57%,MAP3K10;STK36;PTCH1;TCTN3
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.5808681277205884,-0.9629874090420999,0.5066666666666667,1.0,1.0,2/9,2.26%,THBS1;ENPP4
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.46215566710321665,-0.9623846891692807,0.5851063829787234,1.0,1.0,9/59,17.55%,TAF6L;WDR5;YEATS2;MSL3;ING4;ING5;MORF4L2;TRIM16;BRCA2
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.5659608290969008,-0.9622442539586141,0.5882352941176471,1.0,1.0,5/14,21.77%,RAB11A;SPG11;LIMK2;KIF5A;KIF5C
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.4097337208633476,0.9622384041976924,0.35294117647058826,1.0,1.0,5/31,7.89%,NRP1;ARAP1;FSCN1;PPP1R16B;SRGAP2C
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.6296780118103291,-0.9622239316034368,0.6031746031746031,1.0,1.0,4/6,29.86%,THY1;RTN4RL1;EPHA4;PTPRS
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.353101473384299,0.9614851428281465,0.5,1.0,1.0,14/53,17.74%,BFAR;RNF19B;DDB2;RNF122;RNF208;RNF146;SH3RF3;TRAF6;RNF10;RNF185;SH3RF1;PRKN;RNF11;RNF187
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.6541407733218356,-0.9614607013872708,0.5757575757575758,1.0,1.0,3/6,24.54%,DHX58;C1QBP;RIOK3
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),-0.5837245094170211,-0.9614387107466617,0.5844155844155844,1.0,1.0,2/9,7.87%,VEGFA;IL15
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.5627442566505925,-0.9610989692379721,0.5714285714285714,1.0,1.0,1/12,2.54%,MYO1G
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.6546956738972686,-0.960488889969592,0.6428571428571429,1.0,1.0,1/7,9.24%,ID2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.5521879127423327,-0.9603426621588337,0.5652173913043478,1.0,1.0,3/13,8.65%,PLN;GNB5;CALM3
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.45693264956920626,-0.9601574829639938,0.5869565217391305,1.0,1.0,23/85,22.79%,CENPF;RPS27;ITGB3BP;CENPE;STIL;SBDS;INCENP;ZWILCH;GPSM2;CENPP;DSN1;CENPI;STMN1;KIF11;CENPU;KNTC1;DCTN2;NUP133;SEH1L;DYNC1I1;SEC13;CENPK;CKAP5
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),-0.6616627175693421,-0.9598250708938897,0.6527777777777778,1.0,1.0,1/6,6.41%,BRCA1
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.5483618292836908,-0.9593770292517062,0.5540540540540541,1.0,1.0,11/16,36.05%,EIF2B2;TLR2;SOX4;MYRF;APP;EIF2B1;NSUN5;EIF2B5;PICK1;MT3;CSPG5
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.3754539735028491,0.959050493350247,0.5789473684210527,1.0,1.0,4/22,4.71%,LGALS9;CD274;VSIG4;SCRIB
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.589155449283209,-0.9589922053208656,0.5714285714285714,1.0,1.0,1/7,8.93%,TTN
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.35367251804089095,0.9589522465624857,0.4444444444444444,1.0,1.0,9/49,8.08%,NEDD4;DDB2;MAPK13;ERCC4;TP53;SIRT1;SDE2;EIF2AK4;EIF2S1
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.5732324884624497,0.9589106436747175,0.5652173913043478,1.0,1.0,4/7,18.73%,RAP1A;SLC30A1;PRKN;FMR1
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.493544628463921,0.9588970088066876,0.5357142857142857,1.0,1.0,3/12,7.59%,TGFB1;SLIT3;JAG1
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),-0.612008680208538,-0.9583707261251158,0.6056338028169014,1.0,1.0,1/7,4.69%,MTHFD1
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.5583089453694656,-0.9583429954135514,0.5657894736842105,1.0,1.0,3/17,9.51%,KDM6B;TTN;NOTCH2
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.5684315679317669,-0.9583010638987817,0.5571428571428572,1.0,1.0,6/12,24.90%,ANTKMT;PINK1;PID1;ENO1;TMSB4X;PPARA
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.6103769161855453,-0.9582892722527429,0.5555555555555556,1.0,1.0,2/6,18.52%,NOD2;CRACD
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),-0.617892871898222,-0.9581529934399841,0.5714285714285714,1.0,1.0,1/7,3.82%,PTN
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.6651416382811299,-0.9580904553051964,0.5970149253731343,1.0,1.0,3/7,10.57%,PLN;ANK2;PDE4B
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.4423505847064214,-0.9576695261466723,0.5918367346938775,1.0,1.0,17/134,12.62%,CLEC4E;TRIM5;H2BC11;SLC11A1;IFITM3;MX1;NOD2;ADAM15;CR1;FGR;DHX58;TRIM25;COLEC12;RPL39;B2M;NLRC5;IFIT1
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.4783150298695792,-0.9573524848328386,0.5348837209302325,1.0,1.0,13/50,20.83%,IFITM3;RSAD2;MX1;PPIE;OAS3;IFIT1;IFIT5;PLSCR1;ILF3;ZC3HAV1;DDB1;EIF2AK2;TNIP1
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.5244484256841303,-0.9572490438502452,0.5542168674698795,1.0,1.0,9/25,31.03%,ITSN1;FCHO2;SIGLEC1;AP2S1;AP2A2;PIP5K1C;DNAJC6;SGIP1;AP2M1
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.33345469476240036,0.9571202587076696,0.5,1.0,1.0,8/40,9.40%,P3H2;CD276;IL17RD;NXN;PDPN;GPR161;TENM3;RAI14
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.45766332846862656,-0.9571114838376935,0.532608695652174,1.0,1.0,21/75,25.82%,MRPL33;MRPL19;EEF1B2;MRPL43;EEF1A2;MRPS7;MRPL20;MRPL51;EEF1A1;MRPL45;MRPL27;MRPL47;EEF2;GTPBP1;RACK1;MRPS15;MRPS21;MRPL13;MRPL32;MRPL52;MRPS25
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.6074355438808348,-0.956895044383228,0.5466666666666666,1.0,1.0,3/8,11.22%,VEGFA;RORB;AGTPBP1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.5371667119292005,-0.9566001350877136,0.5647058823529412,1.0,1.0,9/19,28.06%,VCAN;B3GAT2;CHST7;CSGALNACT2;CHSY1;XYLT2;B3GAT1;CHST12;NCAN
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.5026660868841193,-0.9563412057272673,0.525,1.0,1.0,3/26,3.82%,THBS1;VEGFA;PTN
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.5955740511048906,-0.9561490322701901,0.5694444444444444,1.0,1.0,7/9,33.59%,TYMP;UPP2;UCKL1;PUDP;DCK;HPRT1;TK2
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.4469297250679651,0.9561183981490798,0.4666666666666667,1.0,1.0,3/22,6.61%,AVIL;PRKAB2;ADIPOR2
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.5257606664077876,-0.9560304504492512,0.5949367088607594,1.0,1.0,6/23,22.96%,SLC11A1;B2M;CUTC;TF;FBXL5;HFE
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.44353369267834714,-0.9560128682388547,0.6288659793814433,1.0,1.0,23/113,14.16%,INSIG1;VIM;HMGB2;ADCY3;TNFRSF1B;RORA;GSTP1;NOD2;BRINP1;ADAM15;PDK3;ABCB4;RORB;PDCD1LG2;CFTR;PDE4B;EPHA3;CARD16;PID1;NR1D1;PTK7;CD14;PYCARD
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.48102742862062253,-0.9557453944871649,0.6526315789473685,1.0,1.0,17/65,22.19%,FLT1;MAPT;FGR;SOD1;TTN;EPHA3;NLRC5;NPRL2;EPHB1;ALK;CDKN1B;INSR;EEF1A1;IRS2;EPHA7;NTRK3;MUSK
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.5437923385225683,-0.9556355443272193,0.5657894736842105,1.0,1.0,10/17,32.80%,NR1H2;EPHA3;ARF6;MCTP1;CD300A;SCAMP5;SYT11;LILRB1;RAC1;LRSAM1
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.5641153624209188,0.9555807288342629,0.5806451612903226,1.0,1.0,1/5,5.25%,ZNF598
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.5486855975165793,0.9549512805018571,0.53125,1.0,1.0,1/6,6.37%,SIRT1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.4582563977216468,-0.9549422620039336,0.6086956521739131,1.0,1.0,36/82,26.87%,ST18;CACNB2;AMER2;CCK;FGF13;MOBP;SLC4A10;MOG;NRXN1;GRIA4;MCF2L2;FRRS1L;PCSK2;ASPA;SCN1A;SCN3B;SYP;ATP1B2;SLC24A2;ATP2B2;GAD2;ST8SIA3;SLC24A4;UNC13C;SV2B;RPH3A;SLC1A2;CADPS;XKR4;HCN1;GRIA2;B3GAT1;SCG3;SRRM4;UNC80;CACNG2
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.4718259740580957,0.9546631819653932,0.625,1.0,1.0,2/11,9.28%,APH1A;ADAM10
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),-0.6333681831478055,-0.9542285862257356,0.6865671641791045,1.0,1.0,2/5,16.62%,EIF3E;EIF3D
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.5359657658632395,-0.954036166005387,0.55,1.0,1.0,7/17,27.49%,PSMA3;PSMA5;ENC1;PSMB4;PSMB9;PSMB2;PSMB6
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.5142910083577291,-0.9535731449813952,0.5194805194805194,1.0,1.0,6/20,13.34%,MAP1B;HDGFL3;FGF13;APC2;MID1IP1;TTBK2
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.6638387085020024,-0.9533863920109436,0.6271186440677966,1.0,1.0,1/5,16.22%,NECAB1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3800344540501632,0.9532873552291483,0.42857142857142855,1.0,1.0,4/41,3.85%,MAP1S;DAB2IP;MAP4K4;SRGAP2
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.5211611559801628,-0.9530855025977878,0.5529411764705883,1.0,1.0,4/27,8.55%,LRP2;GLUL;SLC7A5;IL10RA
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.45511323234562073,-0.9530619791770247,0.5531914893617021,1.0,1.0,16/68,25.18%,RBX1;FHL1;PSMA3;PSMA5;RGCC;PSMD8;PSMB4;E2F7;FBXL7;KLF4;PSMD7;GPNMB;PSMD5;PSMC2;PSMB9;PSMB2
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.5108958266744292,-0.9528699563688179,0.6455696202531646,1.0,1.0,4/24,14.34%,TOM1L1;DUSP1;RGCC;INSR
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.5289870082464703,-0.9528595558309323,0.5897435897435898,1.0,1.0,3/21,8.67%,MYLK;DUOX1;PRKCE
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.49458173772408215,-0.9526144856394885,0.5465116279069767,1.0,1.0,9/32,27.57%,STAT1;EIF2B2;TRIM16;STAT2;STAT6;GNAI1;OGT;ROCK1;EIF2B1
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.6572047610425358,0.9524396433425355,0.6470588235294118,1.0,1.0,2/5,6.37%,BAHD1;SIRT1
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.6603889669656624,-0.9523696406013893,0.6307692307692307,1.0,1.0,4/6,28.74%,TFIP11;TERF2IP;RIF1;APEX1
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.40716976347219863,0.9520839121821368,0.6428571428571429,1.0,1.0,4/20,6.87%,FER;PKD2;SOCS6;NMI
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.3726319194827208,0.9520650231695612,0.5384615384615384,1.0,1.0,6/42,8.14%,RALB;IDE;EPB41;ABL1;CAPRIN2;TRIB3
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),-0.6347978087062591,-0.9519601244022872,0.5774647887323944,1.0,1.0,2/6,25.54%,SLX4;WRN
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.5070428782792314,0.9518388169220288,0.5,1.0,1.0,3/14,9.65%,FGL1;LAPTM5;DUSP3
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.5558098688546051,-0.9518222643523383,0.56,1.0,1.0,5/11,15.45%,DNAJB9;DDRGK1;COPS5;HSPA5;TMEM33
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.4531278212740749,-0.9517898879015346,0.6185567010309279,1.0,1.0,21/77,22.90%,RACGAP1;FCGR2B;CENPE;HLA-F;SEC24C;AP2S1;MFSD6;HLA-DMB;SH3GL2;KIF15;KIF3A;DCTN4;ACTR1B;KIF11;DCTN2;KIF5A;FCER1G;DYNC1I1;SEC13;AP2A2;DCTN1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.49165621524845693,-0.9517643198349172,0.5465116279069767,1.0,1.0,5/27,10.30%,RPL11;DDRGK1;NOP53;CAMLG;SDCBP
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.40143103585085776,0.951753383967735,0.5,1.0,1.0,5/31,3.51%,RPS6KA6;SIRPA;SPRED2;DAB2IP;SPRED1
prerank,PanglaoDB_Augmented_2021__Parietal Cells,-0.4561158272660306,-0.9517425119651751,0.5483870967741935,1.0,1.0,15/70,16.31%,HAMP;MYRIP;COBL;ANK3;PPP1R9A;SPARCL1;RAP1GAP;SYBU;EPB41L4B;MAPK4;PTPRT;BMI1;PHYHIPL;PLEKHA7;ARFGEF3
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.559156037770538,-0.9514539231985897,0.5138888888888888,1.0,1.0,5/9,22.75%,CALM3;SYT1;CALM1;RYR2;KCNMB1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.3860831325243209,0.951426857312072,0.7142857142857143,1.0,1.0,2/35,1.70%,NUP42;NUP188
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.5379715644878069,0.9512135070862351,0.5483870967741935,1.0,1.0,1/6,2.09%,TICAM1
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.6337889631939783,-0.9511940595526054,0.59375,1.0,1.0,1/5,18.31%,TRNT1
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.5444961589152935,0.9508682535903307,0.5185185185185185,1.0,1.0,4/11,23.34%,CDAN1;PDS5A;RAD17;SLFN11
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.47151133642928245,0.9507870851201403,0.45454545454545453,1.0,1.0,3/16,2.59%,RALB;TICAM1;CGAS
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.5132593824672327,-0.9507179572449733,0.5675675675675675,1.0,1.0,4/24,8.37%,AIM2;PQBP1;STAT1;PARP9
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.5175802343889759,-0.9506190000899019,0.5476190476190477,1.0,1.0,3/21,11.55%,VAV3;MNDA;TEC
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.5024875646736839,-0.9498288271916417,0.5324675324675324,1.0,1.0,4/22,8.89%,PLTP;ABCA5;NR1H2;ABCB4
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5069137936600527,0.9495387855092554,0.5,1.0,1.0,2/9,9.29%,ACOX1;EHHADH
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.6555988144953216,-0.9489427443741211,0.6231884057971014,1.0,1.0,1/5,19.15%,SEPTIN9
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.5682013952973556,-0.9488188920327537,0.6,1.0,1.0,1/12,2.56%,VEGFA
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.5504253290476447,-0.9485250684527139,0.6,1.0,1.0,4/12,25.50%,VBP1;CLU;CRYAB;APP
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.6074010822165952,-0.9478807806436398,0.5967741935483871,1.0,1.0,2/7,14.60%,DDX11;RPS3
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.5602755533136509,0.9477945697607577,0.43333333333333335,1.0,1.0,2/6,6.34%,PPARG;E2F3
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.5377722485774232,-0.9477898162817391,0.5822784810126582,1.0,1.0,8/21,24.94%,MYO10;KIF1B;TUBA1A;TUBA1B;KIF5A;DYNC1I1;KIF5C;CCDC88C
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.5598955119786155,-0.9476689958875485,0.6052631578947368,1.0,1.0,3/11,9.25%,HIF1A;NOD2;APPL1
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),0.5514903310872373,0.9476633866725167,0.6388888888888888,1.0,1.0,6/8,21.23%,ALOX5AP;MGST3;MGST2;ALOX5;FADS1;LTC4S
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.5069721448629159,-0.947577141193554,0.6292134831460674,1.0,1.0,3/33,3.88%,TRIM5;ARIH2;RNF126
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.34104226024546785,0.9475143595752654,0.625,1.0,1.0,13/47,14.47%,NRP1;FER;NCK2;BIN1;ABL1;VASP;SORBS3;CDC42EP3;P2RX7;HCK;CDC42;NCK1;EVL
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.49101951085357853,-0.9473322018417804,0.6559139784946236,1.0,1.0,4/52,7.03%,FGF1;NR4A1;FLRT1;POLR2G
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.48175779549054876,-0.9472409947730795,0.5487804878048781,1.0,1.0,4/26,7.97%,SPOCK1;AGT;CR1;GAPDH
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.4787153146610296,-0.9472383717419146,0.6210526315789474,1.0,1.0,12/60,17.39%,HTR2B;TNFRSF1B;PINK1;HSPA1B;BNIP3L;HLA-F;BNIP3;LRPAP1;TRAF2;IMPACT;ATG5;CLU
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.6289233956321942,-0.9471460987067413,0.6119402985074627,1.0,1.0,1/5,15.36%,SLC38A6
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.4836525201493157,0.9469237355900952,0.5714285714285714,1.0,1.0,1/10,2.47%,CPSF4
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.6207671125142278,-0.9468612193784525,0.6164383561643836,1.0,1.0,2/9,19.23%,ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),-0.6207671125142278,-0.9468612193784525,0.6164383561643836,1.0,1.0,2/9,19.23%,ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.4645426406824866,-0.9467764462617927,0.6144578313253012,1.0,1.0,5/40,11.31%,TFRC;MAPT;PINK1;BNIP3;DCC
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.43587534636499076,-0.9466532491203888,0.6105263157894737,1.0,1.0,24/104,25.18%,FZD6;RBMS3;LZTS2;RBX1;AMER2;DKK2;LIMD1;TLE1;PSMA3;APC2;PSMA5;LRP4;PSMD8;PSMB4;PSMD7;PRICKLE1;DVL1;PSMD5;EMD;PSMC2;PSMB9;UBAC2;CCDC88C;PSMB2
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.42254096603844715,0.946232307772077,0.55,1.0,1.0,7/27,11.58%,TGFB1;DAG1;MYH9;APH1A;CTSH;ADAM10;TRAF6
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.5817611743715361,-0.9461680178273782,0.6,1.0,1.0,3/7,16.10%,IQSEC1;EPB41L4B;ARF6
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.5872239117165388,-0.9460146241267361,0.5915492957746479,1.0,1.0,5/12,25.58%,DPYD;TYMP;DPYS;UPP2;CRMP1
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.4276850641224635,0.9458992248323367,0.43478260869565216,1.0,1.0,3/22,3.56%,SIRPA;ZMYND11;ZNF675
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.49229553158863887,-0.9456414644378055,0.5662650602409639,1.0,1.0,4/27,10.76%,RPS27A;MAP3K8;UBA52;UBC
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.47899049598915,0.9454593673733589,0.6206896551724138,1.0,1.0,5/11,17.45%,UBIAD1;COQ9;COQ5;PDSS2;PDSS1
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.5189788895499353,-0.9453644842882301,0.5783132530120482,1.0,1.0,3/26,7.66%,SLC38A4;SLC7A5;SFXN3
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),-0.6396429038305143,-0.9452459334115038,0.6818181818181818,1.0,1.0,1/5,2.38%,MYLK
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),-0.6861856630985528,-0.9451040820654667,0.6774193548387096,1.0,1.0,1/5,16.63%,SIRT5
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.45973738676149645,0.9450603790022096,0.4642857142857143,1.0,1.0,2/10,2.17%,LGALS9;CX3CR1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.44571208170060245,-0.9449427187752005,0.5833333333333334,1.0,1.0,17/90,16.47%,CDC37;RPL11;TOMM7;AQP11;NACA;SRP14;VPS37C;ZDHHC15;TIMM13;SDCBP;TOMM40;AKAP6;ZDHHC19;TOMM20;ZDHHC9;SRPRA;ZDHHC4
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.6329812500388333,-0.9447405842260844,0.5492957746478874,1.0,1.0,3/5,24.54%,DHX58;C1QBP;RIOK3
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),-0.6292199277508889,-0.944639513900482,0.5774647887323944,1.0,1.0,3/6,28.87%,PRPS1;GUK1;MACROD1
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.4181666487421931,-0.9444715070191713,0.6161616161616161,1.0,1.0,40/332,15.40%,DDIT4;BRIP1;NLRP12;ARAF;PRKAR2B;FGF1;VEGFA;RHOB;VAV3;AKAP12;RPL11;ARHGAP4;RPA2;RACGAP1;RASGRF2;BRCA1;PPP2R5B;FBXL2;RHOU;CHN1;MAPT;TRIP10;CHD3;DAPK2;ITSN1;NOP53;PPP1R13L;RPL5;RPA3;PAK5;PRDM1;ARAP2;AKAP6;ARHGAP23;PYCARD;ING5;PRR5;TRAF2;RFC4;GNA13
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.4122370850588201,0.9443756543979401,0.5,1.0,1.0,4/25,5.85%,ATRAID;TMEM119;TGFB1;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.5440020195626527,-0.9441579504534648,0.5342465753424658,1.0,1.0,2/11,8.66%,CD55;IL18
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.42289051227209207,0.9436255457285601,0.5789473684210527,1.0,1.0,1/16,0.78%,GSN
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.47888849105988995,0.9434970611686255,0.5,1.0,1.0,2/13,2.77%,DAB2IP;LRCH1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.5083875494471666,-0.9432433709467053,0.5411764705882353,1.0,1.0,2/23,5.75%,SLC11A1;NOCT
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.5242152985377416,-0.943214060230826,0.5921052631578947,1.0,1.0,4/20,11.38%,BHLHE40;RBM4B;ID2;PPP1CB
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.48921042664831893,0.9431795898591886,0.4827586206896552,1.0,1.0,1/9,5.16%,RNF20
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.6051493224473468,-0.943021442246636,0.5694444444444444,1.0,1.0,5/9,30.66%,RIPOR2;PLCB1;BTG1;LRRC8A;RANBP3L
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.5292596049649837,0.9429480012711694,0.575,1.0,1.0,3/6,21.91%,TWSG1;CASK;SLIT2
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.4527302430970096,-0.9424855569059959,0.5698924731182796,1.0,1.0,10/71,14.38%,POLR3F;PQBP1;GAPDH;POLR1C;DHX58;TRIM25;IRF1;NLRC5;CD14;POLR3H
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.3361568723188482,0.9424434919265053,0.5833333333333334,1.0,1.0,4/43,9.45%,NUP188;CC2D1B;CHMP2B;BANF1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.3361568723188482,0.9424434919265053,0.5833333333333334,1.0,1.0,4/43,9.45%,NUP188;CC2D1B;CHMP2B;BANF1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.5420814795679513,-0.9424427274291313,0.6341463414634146,1.0,1.0,8/22,25.84%,RIMS1;CPLX1;RAB5A;PNKD;MCTP1;RIMS2;RIMS3;MCTP2
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.3631277495598517,0.9422629846883521,0.5,1.0,1.0,5/46,7.99%,IDE;DAB2IP;CTSC;RAB7A;CTSH
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.4856862798797821,-0.9420990890635378,0.6521739130434783,1.0,1.0,9/46,14.34%,PRLR;TXK;FLT1;FGR;IL15;EPHA3;TEC;GHR;INSR
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.5032305214912978,-0.9419264621296373,0.5421686746987951,1.0,1.0,9/24,24.05%,HTR2B;ERO1A;SLC24A1;RYR3;ATP2B4;SLC24A2;GRIN2A;RYR2;IBTK
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),-0.5847806597555835,-0.9417809409772399,0.5797101449275363,1.0,1.0,3/6,18.50%,MAPT;KIF3A;FYCO1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.5566768043754529,-0.9417633778335309,0.6296296296296297,1.0,1.0,2/16,11.03%,FHL1;SLC4A10
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.4628778289078228,-0.9415335156220286,0.6,1.0,1.0,5/36,5.46%,FAAH2;ALOX12;ACSL1;ALOX15B;GSTP1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.458241147999927,-0.9414830587108275,0.6395348837209303,1.0,1.0,3/47,4.63%,ARIH2;RNF126;RBX1
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.44736961509127054,-0.9414584036125075,0.6391752577319587,1.0,1.0,18/142,13.71%,TFRC;ACVR1B;TP53TG5;PAPPA2;SPOCK1;AGT;TGFB2;TCHP;FBP1;FHL1;ADAM15;OGFR;PRKCQ;HSPA1B;SDCBP;PAK5;AKAP6;CDKN1B
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.43287413152670084,0.9411321938752375,0.6111111111111112,1.0,1.0,4/17,8.00%,RAP1A;ICAM1;PPP1R16B;MSN
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.5727311013028991,-0.9409513944271045,0.5441176470588235,1.0,1.0,3/11,24.90%,FBP1;CLK2;PPARA
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.5262459175499103,0.9406064142154,0.53125,1.0,1.0,2/9,9.65%,CRK;DUSP3
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),-0.6258090834916988,-0.9398288232652914,0.5797101449275363,1.0,1.0,1/6,8.83%,HSPA1B
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.38439434797573513,0.9396596360750408,0.7692307692307693,1.0,1.0,2/36,1.70%,NUP42;NUP188
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.41339768038698327,0.9395782628768203,0.48,1.0,1.0,5/18,14.11%,ABL1;MAPK11;CDON;CDC42;TCF3
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.5313382061016777,-0.9395049882566493,0.5694444444444444,1.0,1.0,1/17,6.25%,HERPUD1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.607289489827479,-0.9392515208700084,0.5942028985507246,1.0,1.0,4/8,25.20%,B3GAT2;CSGALNACT2;XYLT2;B3GAT1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.5371821686270273,-0.9392403554042723,0.6753246753246753,1.0,1.0,5/22,18.00%,THBS1;RGCC;ANGPT2;KLF4;ATP2B4
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.5503861179055674,-0.9392142153123091,0.6511627906976745,1.0,1.0,3/18,11.61%,KCNJ13;ATP1B3;SLC12A8
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),-0.5632769913958413,-0.9390938110645496,0.5857142857142857,1.0,1.0,4/8,24.87%,EEF1A2;EEF1A1;GFAP;CTSA
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.4975551512652605,-0.9389693800870867,0.6547619047619048,1.0,1.0,7/25,21.28%,SPOCK1;AGT;GAPDH;SERPING1;SERPINI1;SERPINF1;UBXN1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.4798795319594571,-0.9385585015238638,0.547945205479452,1.0,1.0,4/18,11.72%,RBX1;RPA2;RPA3;ERCC2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.4798795319594571,-0.9385585015238638,0.547945205479452,1.0,1.0,4/18,11.72%,RBX1;RPA2;RPA3;ERCC2
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.4293125551782965,0.9384837345491336,0.5789473684210527,1.0,1.0,3/16,7.28%,LGALS9;CD274;LAPTM5
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.5524115184220084,-0.9384006682167976,0.6307692307692307,1.0,1.0,7/11,28.96%,SOD1;B2M;ATP1B2;ACTG1;TF;HSPB1;BBS4
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.5346805305116191,-0.9381106155614639,0.6172839506172839,1.0,1.0,4/21,6.53%,OSMR;TNC;MYLK;NTN4
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.5742665938286414,-0.9381080914742508,0.5833333333333334,1.0,1.0,1/12,0.17%,GDPD1
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.4947708089274367,-0.9380642927083389,0.5340909090909091,1.0,1.0,4/28,15.14%,SOCS3;ITPKC;EFR3B;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.5074112033808709,-0.9379630705910097,0.5897435897435898,1.0,1.0,5/18,19.38%,OGN;CDKN1B;APOD;PDCD4;AIF1
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.45064229916104404,0.9377337238545856,0.6190476190476191,1.0,1.0,4/16,5.85%,PKD2;CSF1R;SCRIB;ACVR1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.45543431358169756,0.9376331893512322,0.6190476190476191,1.0,1.0,4/13,13.33%,IPPK;ISYNA1;ITPKB;FGF2
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),-0.5501499966894156,-0.9374343615366868,0.6521739130434783,1.0,1.0,4/11,23.51%,RAB3A;RAB15;SYT4;RAB3D
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.5564426045340225,0.9373802093483601,0.5555555555555556,1.0,1.0,2/8,5.27%,WDR18;NBN
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.5607618976577055,-0.9366690374980997,0.5694444444444444,1.0,1.0,2/10,2.89%,LRP2;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.5375868559726809,0.9365364730251128,0.5833333333333334,1.0,1.0,2/7,10.56%,TGFB1;LDLR
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.5497451009126477,-0.9364494600912472,0.5972222222222222,1.0,1.0,5/13,12.38%,TGFB2;HIF1A;LTBP1;ITGB8;FN1
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.465270932838059,-0.936443674030471,0.6049382716049383,1.0,1.0,8/43,13.11%,CBR1;VEGFA;OVOL2;BASP1;KDM6B;PGK1;GSTK1;CTSB
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),-0.6175028967041242,-0.9361625310350542,0.5909090909090909,1.0,1.0,1/6,3.83%,RXRB
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.4882558749944931,-0.936043732261324,0.5697674418604651,1.0,1.0,3/37,3.72%,TFRC;MX2;MX1
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),-0.6431053149953806,-0.93601986597987,0.6190476190476191,1.0,1.0,2/5,16.23%,CD36;STARD5
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),-0.6431053149953806,-0.93601986597987,0.6190476190476191,1.0,1.0,2/5,16.23%,CD36;STARD5
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.5182605033305125,-0.935778381908511,0.6363636363636364,1.0,1.0,4/27,12.34%,NR4A2;POLR2G;PAX8;PTMA
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.49084364398952174,0.9351744481444683,0.5172413793103449,1.0,1.0,2/11,15.27%,MEPCE;CCT3
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.49084364398952174,0.9351744481444683,0.5172413793103449,1.0,1.0,2/11,15.27%,MEPCE;CCT3
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.4889539567893317,-0.9349756597618455,0.6190476190476191,1.0,1.0,9/30,17.91%,RIMS1;MAPT;GOLGA4;GHR;INSR;UNC13A;SYT1;SYT4;PPIB
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.38460141097245576,0.9349503753754701,0.4666666666666667,1.0,1.0,6/22,18.96%,TGFB1;ZPR1;EFCAB7;BAG3;SMAD3;TPR
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.36005919997063796,0.9348659269405685,0.5384615384615384,1.0,1.0,3/41,4.56%,IDE;DAB2IP;SOCS6
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.39097102440944065,0.9348003619785868,0.5238095238095238,1.0,1.0,7/25,8.90%,NEXMIF;DAB2IP;SRGAP2;NTNG2;IGSF10;SRGAP2C;SHTN1
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),-0.5040734090329478,-0.9347235848693239,0.6097560975609756,1.0,1.0,3/29,5.65%,TGFB2;RBPJ;NOD2
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.5575579566501158,-0.9345788522703221,0.6153846153846154,1.0,1.0,3/9,25.09%,TET1;CTR9;JARID2
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.5107007902411735,0.9341344533639957,0.5172413793103449,1.0,1.0,3/9,8.17%,TGFA;IL1B;IL1A
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.534200086118626,-0.9340606648895846,0.5945945945945946,1.0,1.0,6/14,26.76%,MTHFD1;FOLH1;ASPA;NIT2;ADI1;GOT1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.4633826021829144,-0.9340458837639001,0.550561797752809,1.0,1.0,7/47,13.71%,NUDT16;TGFB2;MEIS2;HCFC1;RGCC;CCPG1;CDKN1B
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.523183857025069,-0.9339758172112398,0.618421052631579,1.0,1.0,4/21,11.38%,BHLHE40;RBM4B;ID2;PPP1CB
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.5377515027816545,-0.9337725538245126,0.6025641025641025,1.0,1.0,6/16,24.10%,UBXN2B;TARDBP;EMD;SPAST;DCTN1;NEMP1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.5734060791671185,-0.9337694856188762,0.6805555555555556,1.0,1.0,4/14,12.38%,DUSP1;COL11A1;LAMB1;FN1
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.5403979866466159,-0.9336988175750564,0.6623376623376623,1.0,1.0,3/14,8.14%,LSR;COBL;ARID5B
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.4585539171180458,-0.9335676489961886,0.6914893617021277,1.0,1.0,12/66,21.07%,NAPA;PLPP3;RACGAP1;CENPE;BNIP1;NSF;KDELR1;KIF15;KIF3A;ARFGAP1;KIF11;KIF5A
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.5247814294243541,0.9334213195338669,0.5384615384615384,1.0,1.0,2/5,9.02%,ICAM1;PLVAP
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.4785236781990572,-0.9333919250965571,0.6162790697674418,1.0,1.0,11/36,29.04%,TOMM7;TIMM13;TOMM40;TOMM20;TIMM21;PMPCA;TIMM29;PMPCB;PITRM1;BCAP31;MFN2
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.6162707966147647,-0.9332822099048091,0.6212121212121212,1.0,1.0,2/6,6.29%,SEMA3A;UNC5C
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.44478340812401745,-0.9332394448278216,0.6597938144329897,1.0,1.0,12/82,15.78%,TNFRSF11B;ST18;AIM2;TNFRSF1B;STAT1;TNFSF13B;PSMA3;PSMA5;PYCARD;TRAF2;PSMD8;PSMB4
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.4709918660366296,-0.9326371645975182,0.5679012345679012,1.0,1.0,5/30,5.46%,FAAH2;ALOX12;ACSL1;ALOX15B;GSTP1
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.551216738894339,0.9325689963203536,0.5625,1.0,1.0,2/6,11.16%,DNMT3A;MECP2
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.39347416865272355,0.9325560257174446,0.47058823529411764,1.0,1.0,2/20,0.87%,GCLC;HPGDS
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.5484917990643507,-0.9324884678631602,0.5942028985507246,1.0,1.0,2/11,20.20%,PGAM1;MCM7
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.5145437616353316,-0.932440330833654,0.5512820512820513,1.0,1.0,3/18,16.31%,CDK14;ID2;E2F7
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.465533826819594,-0.9324362234923206,0.6881720430107527,1.0,1.0,6/56,8.83%,THBS1;EYA2;GSTP1;FAIM2;BRCA1;HSPA1B
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.6225092874029045,-0.9323319297026912,0.582089552238806,1.0,1.0,5/5,37.78%,PPIB;VAPA;YTHDC2;TBC1D20;NUCKS1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.4768954998775071,-0.9320491212895888,0.6395348837209303,1.0,1.0,8/43,11.73%,THBS1;SEMA6A;SPARC;TGFB2;EPN1;STAT1;PGK1;RGCC
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.4809178385404675,-0.9318535362427972,0.651685393258427,1.0,1.0,5/44,3.75%,TNC;SPARC;ADAMTS2;TNS1;LAMA2
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.4775808395952569,-0.9315919163897938,0.6395348837209303,1.0,1.0,6/35,16.20%,MAPT;PINK1;INF2;USP36;PID1;STAT2
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.5971738123456352,-0.9315206839117751,0.6301369863013698,1.0,1.0,2/9,7.98%,CD55;PRKCQ
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.4189824570725793,-0.9314059175887395,0.7070707070707071,1.0,1.0,38/226,18.69%,SOCS3;TNC;ASB14;VCAN;DTL;HIF1A;ASB16;RBX1;WDR5;RAB11A;COPS5;LTBP1;GPC3;LAMB1;KLHL13;SPARCL1;PSMA3;PSMA5;RAB3A;SPSB1;VGF;CDH2;FN1;CHGB;TMEM132A;PSMD8;PSMB4;UBE2M;FBXL13;FBXL7;LGALS1;ATG5;SPSB3;CKAP4;SUMF2;ELOB;DDB1;RAB5A
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.5622211539411386,-0.9313983823824451,0.6233766233766234,1.0,1.0,1/11,5.10%,IL7
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.48846654908940673,-0.931313403064481,0.6071428571428571,1.0,1.0,8/28,24.34%,CLVS1;ABCA1;CLVS2;TPP1;ACP3;GAA;ATP10B;MBTPS1
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.44329359199339136,-0.9312286648749507,0.6770833333333334,1.0,1.0,12/76,16.85%,PRKAR2B;HAUS6;TUBB4A;TUBA4A;RAB11A;CC2D2A;TUBA1A;RPGRIP1L;TTBK2;CEP152;TCTN1;SCLT1
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.4410669043313041,-0.9308067829041935,0.6428571428571429,1.0,1.0,9/94,6.06%,HTR2B;CCL4;GLIPR2;CHI3L1;GPR183;C5AR1;CCL3;NOD2;MARCO
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.6185306199038412,-0.9307787712454845,0.5972222222222222,1.0,1.0,4/6,36.18%,TXN;PDE8A;GPR37;NFE2L2
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.4926016771643283,-0.9307439866942206,0.5647058823529412,1.0,1.0,4/25,10.76%,RPS27A;NOD2;UBA52;UBC
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),0.5400481440559126,0.9307244561983304,0.5428571428571428,1.0,1.0,1/5,2.09%,TICAM1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.4764101632735962,-0.9301935260401202,0.6206896551724138,1.0,1.0,8/33,16.03%,FANCB;RPA2;FIGNL1;POLQ;WDR48;KDM1A;TERF2IP;TIMELESS
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.6052383336669629,-0.9301650632707344,0.6619718309859155,1.0,1.0,2/6,8.31%,PLN;SESTD1
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.5601511829711252,0.9299875236097103,0.5,1.0,1.0,1/5,5.85%,ACVR1
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.4427695892810013,-0.9299629944910517,0.6808510638297872,1.0,1.0,13/120,15.78%,RPS27A;VIM;SLC11A1;CARHSP1;NOCT;UBA52;PSMA3;UBC;PSMA5;RIDA;PSMD8;UBB;PSMB4
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.543924696621603,-0.9299543489213965,0.6,1.0,1.0,3/11,8.68%,GSTP1;MAPT;SOD1
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.5742832471708134,-0.9298537971385802,0.6027397260273972,1.0,1.0,3/12,14.34%,VEGFA;CD63;INSR
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.5691281311657775,0.9297733089405524,0.5555555555555556,1.0,1.0,1/5,7.27%,SLIT3
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.5822838530662353,-0.9297587911253357,0.6417910447761194,1.0,1.0,1/8,11.08%,PIM3
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.554281189942006,-0.92973876254475,0.6052631578947368,1.0,1.0,5/13,24.90%,BRCA1;PINK1;SIRT5;TRAP1;PPARA
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.5242116087743094,0.9296724504188739,0.5789473684210527,1.0,1.0,3/8,15.46%,HACD4;TECR;HACD2
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.5242116087743094,0.9296724504188739,0.5789473684210527,1.0,1.0,3/8,15.46%,HACD4;TECR;HACD2
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.49717148004472317,-0.9296438342365063,0.6,1.0,1.0,10/27,22.46%,NEFL;SOD1;KIF1B;AP3M2;KIF3A;RAB21;KIF5A;KIF5C;MAP1A;SPAST
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),-0.5074760742322261,-0.9294660918504345,0.5641025641025641,1.0,1.0,8/23,20.49%,CR1;FCGR2B;MNDA;PDCD1LG2;TNFRSF21;LILRB2;GPNMB;CD300A
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.38478777844690737,0.9294229583388275,0.55,1.0,1.0,1/23,1.11%,MAP1S
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.49391911011304057,-0.9293758880096408,0.5930232558139535,1.0,1.0,2/25,5.86%,ENPP2;CARMIL1
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.6000110138486656,-0.9292424860269833,0.65625,1.0,1.0,1/6,3.59%,SULT4A1
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.5960714833192828,0.9291723524779107,0.59375,1.0,1.0,2/6,8.40%,ATP2C1;PKDCC
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.5035610118706401,0.9291174543782493,0.5185185185185185,1.0,1.0,3/10,8.90%,NRP1;P2RY12;SHTN1
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.4937411374473837,0.9289876238372926,0.5555555555555556,1.0,1.0,1/8,5.16%,RNF20
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),-0.5667701418896833,-0.9289821943945125,0.5970149253731343,1.0,1.0,1/7,4.14%,TNFRSF1B
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.6130632255229719,-0.9289451792042205,0.6285714285714286,1.0,1.0,2/6,24.85%,RPS15;NUP88
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.591044685400703,-0.9288584225064769,0.6,1.0,1.0,6/8,33.59%,TYMP;UPP2;UCKL1;PUDP;DCK;TK2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.591044685400703,-0.9288584225064769,0.6,1.0,1.0,6/8,33.59%,TYMP;UPP2;UCKL1;PUDP;DCK;TK2
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.4409624913224993,-0.9287347079526977,0.6494845360824743,1.0,1.0,14/90,17.75%,CCL4;RGS1;HMGB2;CCL3;GNB5;PINK1;CALM3;RAP1GAP;GBA3;LARS1;RPS3;ITGA6;CALM1;THY1
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.563933207805561,0.9286757171945109,0.4827586206896552,1.0,1.0,3/7,8.34%,SIRT1;EIF2AK4;IL6ST
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.532579523358838,-0.9286046557565621,0.6590909090909091,1.0,1.0,2/22,7.03%,MDFIC;POLR2G
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),0.47958847328604826,0.9285294425229337,0.5806451612903226,1.0,1.0,5/10,17.45%,UBIAD1;COQ9;COQ5;PDSS2;PDSS1
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),0.47958847328604826,0.9285294425229337,0.5806451612903226,1.0,1.0,5/10,17.45%,UBIAD1;COQ9;COQ5;PDSS2;PDSS1
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.45423935706238294,-0.9284960581900019,0.6195652173913043,1.0,1.0,9/58,17.66%,MIF4GD;POLR2G;EIF2B2;DDX1;ATF3;EIF2AK3;EIF3E;IMPACT;EIF4A2
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.31798407766094505,0.9284279999922896,0.8571428571428571,1.0,1.0,11/73,13.97%,NUP42;NUP188;BAG5;MAPKAPK2;SIRT1;NUP214;RAE1;BAG4;EP300;YWHAE;CAMK2G
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5794143044706802,-0.9282437595478762,0.6153846153846154,1.0,1.0,4/10,16.74%,THBS1;PIAS4;RGCC;PDCD4
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),-0.5032437379886602,-0.928142272778287,0.5930232558139535,1.0,1.0,2/23,6.90%,RHOB;FIGNL1
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.2811897217647679,0.9280830534601414,0.75,1.0,1.0,24/97,17.48%,RUBCNL;PRKAB2;VTA1;PIP4K2B;ILRUN;TOMM70;HDAC10;CHMP2B;STAM2;TBC1D5;SRC;MTMR14;DYNLL2;UBXN6;YOD1;PLEKHM1;EI24;MFN1;ATP13A2;TECPR1;VDAC1;VPS37A;ARL8B;PRKN
prerank,GO_Biological_Process_2021__protein de-ADP-ribosylation (GO:0051725),-0.626929056102977,-0.9280309174175645,0.6060606060606061,1.0,1.0,2/5,28.87%,ADPRS;MACROD1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.4960215594857004,0.9279879947203002,0.6666666666666666,1.0,1.0,2/12,6.72%,SIRT1;HLCS
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.523297345920736,0.9277791223313409,0.5483870967741935,0.999901797997772,1.0,1/7,5.60%,PHF8
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.4742695999464186,0.9277517962965476,0.48148148148148145,0.9986384984665422,1.0,3/15,10.48%,DOC2A;SYT17;SYT6
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.5449698458973563,-0.927643949289583,0.6133333333333333,1.0,1.0,3/10,8.68%,GSTP1;MAPT;SOD1
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.49510560298435585,-0.927642492315772,0.5975609756097561,1.0,1.0,6/27,18.45%,CFL1;SIPA1L1;ZDHHC15;SHANK3;NGEF;RELN
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.5241839311518264,-0.9276292042716219,0.6233766233766234,1.0,1.0,2/15,6.18%,THBS1;DUOX1
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.3470723110905761,0.9274961262588758,0.6470588235294118,0.9978334608519738,1.0,9/58,12.84%,SESN2;MAP3K5;MIOS;SESN3;EIF2AK4;EIF2S1;LAMTOR1;RRAGD;FAS
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.5575616192239505,-0.9273917663527451,0.6493506493506493,1.0,1.0,2/11,9.93%,ALOX12;THBD
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.5050009109295869,-0.9272020270535638,0.6375,1.0,1.0,3/17,6.01%,PTN;ALOX15B;RACGAP1
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.47097090667562846,0.9270493723630316,0.6086956521739131,0.997547530611343,1.0,4/15,17.18%,ARHGAP35;TAPT1;CROCC;KCTD17
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),-0.618037503923957,-0.9268969014753671,0.6268656716417911,1.0,1.0,2/6,9.93%,THBS1;THBD
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.34610043020863485,0.9268837364735237,0.625,0.9966365440245761,1.0,9/59,12.84%,SESN2;MAP3K5;MIOS;SESN3;EIF2AK4;EIF2S1;LAMTOR1;RRAGD;FAS
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.5220452803021185,0.9265716435198623,0.5416666666666666,0.9959154569464181,1.0,2/7,1.01%,GSN;LGALS9
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),0.5262054620781944,0.9262734679414281,0.6470588235294118,0.995352310649265,1.0,4/6,34.05%,EXOSC9;EXOSC6;EXOSC7;XRN1
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.646001551347009,-0.9262135310807383,0.6176470588235294,1.0,1.0,2/5,25.64%,ABCA1;ABCG1
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.6116430255547642,-0.9261170455489899,0.6470588235294118,1.0,1.0,2/5,15.22%,CARD16;SIGIRR
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.5638708606902135,-0.9258631160688574,0.6438356164383562,1.0,1.0,6/10,31.02%,CIDEB;ASPH;GRIN2A;RIPK2;TBC1D10A;CYFIP2
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.5246112768849256,0.9257865895432497,0.6333333333333333,0.9950243993659726,1.0,6/9,22.04%,ALOX5AP;MGST3;MGST2;ALOX5;LTC4S;GGT7
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.5619811953218408,-0.9257619811391072,0.6197183098591549,1.0,1.0,3/9,21.04%,VEGFA;SH3GL2;PDE2A
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.4547693238989718,-0.9256983821247668,0.5977011494252874,1.0,1.0,10/60,9.48%,RGS2;PAQR3;SEMA6A;AGT;DUSP1;SPRY1;GSTP1;PEBP1;CAMK2N1;PRDM15
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.4651736097854522,-0.9251297185190889,0.6144578313253012,1.0,1.0,11/41,19.21%,NR4A3;NR4A1;NR4A2;ATF5;CLIP3;CTBP1;PID1;MAFB;KLF4;ERAP1;PER2
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.4138983886356014,-0.9250926563624046,0.696969696969697,1.0,1.0,32/209,17.27%,HTR2B;ARAF;RPS27A;PAQR3;FGF1;WDR83;NEFL;RBX1;CCL3;MAP3K8;PEBP1;RASGRF2;PRKCQ;IL18;FGF13;UBA52;SHANK3;RASGRP4;PSMA3;UBC;PSMA5;PPP1CB;RASA2;ZDHHC9;PIK3CB;PSMD8;UBB;NRG4;PSMB4;IL3RA;IRS2;CALM1
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.5611674391318473,0.9246965191349078,0.5428571428571428,0.996284781886303,1.0,2/7,6.63%,ARHGAP35;CXCL12
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.5208664077837304,0.92464873888985,0.5384615384615384,0.9950705773525624,1.0,5/9,25.60%,CHKA;ETNK1;CEPT1;LPIN2;PISD
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.5866915801320041,-0.9246344070441859,0.65625,1.0,1.0,2/5,24.30%,ALDH6A1;BCAT1
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.6118725220936438,-0.9246307603730308,0.671875,1.0,1.0,2/5,21.75%,DNA2;LIG3
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),-0.5712488029070686,-0.9242861568691861,0.6266666666666667,1.0,1.0,3/8,14.60%,IL18;PYCARD;RPS3
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.5871614374555052,-0.9241952209940276,0.6538461538461539,1.0,1.0,2/12,6.05%,RGS2;PLN
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),-0.632243593079143,-0.9241726951997933,0.7272727272727273,1.0,1.0,1/5,2.56%,VEGFA
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),-0.632243593079143,-0.9241726951997933,0.7272727272727273,1.0,1.0,1/5,2.56%,VEGFA
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.5761404779944763,-0.9241651564864232,0.6619718309859155,1.0,1.0,3/8,21.71%,SGK1;NRG1;ACSL3
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.4199723248362185,0.9241395475018158,0.5294117647058824,0.9949305917855196,1.0,5/21,9.69%,ENPP1;PIP4K2B;APPL2;IL1B;INPP5K
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.48118699438403695,0.923022076731557,0.5714285714285714,0.9961396421022264,1.0,3/14,13.68%,SLC30A5;SLC30A10;SLC30A1
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),-0.6098106121248564,-0.9229884209690113,0.6285714285714286,1.0,1.0,1/5,9.24%,ID2
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.4451211804138643,-0.9229075645954459,0.6736842105263158,1.0,1.0,12/81,15.22%,NLRP12;ACVR1B;LRP2;CCL3;CXCR4;IL18;AKAP6;HCLS1;PID1;GHR;IL1RAPL1;SIGIRR
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.4406844371282139,-0.9228933880114915,0.6947368421052632,1.0,1.0,35/116,22.35%,F13A1;PPP1R15A;IL7R;AKAP12;TSPAN13;TNFRSF1B;ERO1A;EPB41L3;CXCR4;IL10RA;ID2;SPARCL1;PDCD1LG2;PRDM1;SPON1;ITGA2;GABRA3;APOD;DNMBP;ABCB1;SCG5;SNAP25;CPE;MAFB;KLF4;RELN;TSPAN7;GPNMB;ETV1;GPRC5B;CDADC1;ALDH1A2;FCER1G;KIF5C;MAP4K1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.5296944952330918,0.9226876766426365,0.47058823529411764,0.9956889913706494,1.0,2/7,4.79%,BIN1;CAB39
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.5253767325108265,0.9225430781160007,0.5714285714285714,0.9947138272110475,1.0,4/7,23.25%,SIRT1;TDP1;LIG4;APLF
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.5332196192392129,0.9225304355220648,0.6060606060606061,0.9934323795717406,1.0,1/6,2.63%,SMAD7
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),-0.42682502386818766,-0.9221034555153514,0.6428571428571429,1.0,1.0,7/90,14.79%,NAMPT;INSIG1;SYAP1;APPL1;PKM;INSR;RAB15
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.6190503556541054,-0.9219314724426705,0.6712328767123288,1.0,1.0,1/6,4.42%,DUSP1
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.5868837519951925,-0.921791889581923,0.6290322580645161,1.0,1.0,2/7,17.27%,PTS;CALM1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.45931946137306034,-0.9216815603571197,0.625,1.0,1.0,11/41,21.95%,CYCS;AIM2;DAPK1;GRAMD4;PYCARD;CIDEB;ASPH;GRIN2A;RIPK2;UACA;CARD9
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.5437130298242887,-0.9213795478629861,0.6666666666666666,1.0,1.0,2/14,10.65%,VEGFA;STIL
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.5372590007805185,-0.9212736215524533,0.5833333333333334,1.0,1.0,2/13,12.75%,DUSP1;PPP2R2B
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5679170775745408,-0.9211697731772469,0.6,1.0,1.0,2/9,14.43%,GSTP1;RNF13
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.48832008930485105,-0.9209557155406619,0.6375,1.0,1.0,3/21,11.37%,SH3PXD2B;SULF2;SBDS
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.49486986592383264,-0.9207043527027661,0.6153846153846154,1.0,1.0,1/18,6.19%,NHP2
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.46003224513761315,-0.9205552987925579,0.5697674418604651,1.0,1.0,12/58,17.79%,ARAF;ERO1A;FBXL2;SERP1;UBA52;GGCX;USP6;SLC35A1;UBE2M;CPE;DUSP12;PIGH
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.5821902799123316,-0.9202486747476071,0.6410256410256411,1.0,1.0,3/8,15.79%,NOD2;UHRF1;PLSCR1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.5913924245750842,-0.9202432758440645,0.68,1.0,1.0,1/8,2.46%,AGT
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.6131592468883039,-0.9202430541012123,0.5873015873015873,1.0,1.0,2/6,11.20%,BASP1;IQGAP1
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.6105212046340831,-0.9201732816799046,0.6571428571428571,1.0,1.0,3/7,21.27%,VEGFA;VEGFB;NTRK3
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),-0.5853396759503482,-0.9200635714447597,0.6785714285714286,1.0,1.0,2/8,7.76%,RBMS3;DAPK1
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.6229079600840075,-0.9196547455218572,0.6615384615384615,1.0,1.0,1/5,4.14%,TNFRSF1B
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.44248752501319555,-0.9195899940751509,0.6344086021505376,1.0,1.0,14/65,14.16%,VIM;HMGB2;TNFRSF1B;CCL3;GSTP1;NOD2;IL18;PRKCE;PDCD1LG2;PDE4B;CARD16;NR1D1;CD14;PYCARD
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.5811314352092887,-0.9195586283520877,0.6451612903225806,1.0,1.0,3/8,16.10%,IQSEC1;EPB41L4B;ARF6
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.5418490558107988,-0.9187640198433805,0.5925925925925926,1.0,1.0,4/13,18.66%,SCN9A;SCN1A;CACNA1C;SCN3B
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.4185125545469322,0.9185198939531661,0.5,1.0,1.0,4/14,6.63%,BCL2L1;ZNF385A;SIRT1;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.4172729381170727,-0.9184775221709074,0.6326530612244898,1.0,1.0,12/141,8.65%,TFRC;ALG10B;FGF1;VEGFA;SLCO3A1;PPP2R5A;CNEP1R1;MARCO;FAXDC2;PINK1;CLIP3;CALM3
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.4579668614511793,-0.9184348983072784,0.5714285714285714,1.0,1.0,9/47,15.79%,TGFB2;RSAD2;POLR3F;NOD2;FCGR2B;IL15;PYCARD;HLA-DMB;PLSCR1
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.44791697205763226,-0.9182226122028802,0.65625,1.0,1.0,4/77,3.88%,RHOBTB3;DENND2A;RAB7B;RNF126
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.4257446964766845,0.9181479761968997,0.5833333333333334,1.0,1.0,1/11,2.09%,TICAM1
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.5402037895703964,0.9181296175016531,0.5714285714285714,0.9998210929037836,1.0,2/6,7.14%,RYR1;P2RY6
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.47761914571647135,-0.9181220808703991,0.6666666666666666,1.0,1.0,4/29,10.45%,TFRC;GLUL;PARP9;EIF2AK3
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.4977969460673859,-0.9181172616080766,0.6625,1.0,1.0,6/23,19.58%,FBP1;APOD;PGM1;SORD;IRS2;GAA
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.4469577223682075,-0.9179709658329025,0.6813186813186813,1.0,1.0,29/74,26.20%,SH3PXD2B;DOCK1;DZIP1;MAP1B;CAMK2N1;SLC13A4;HSPA12A;SRRM3;APLP1;KAZN;LIFR;LRP4;TMEM132A;TNFRSF21;CPE;GNA11;NGEF;SEZ6L2;RBFOX2;GPRC5B;GFAP;MPDZ;TMEM59L;AGAP1;NR2F1;NLGN2;APP;SEMA3B;NDRG4
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.6177799590258749,-0.9178962770514948,0.7,1.0,1.0,2/7,19.23%,ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.5076599737610178,-0.9176865046839242,0.625,1.0,1.0,4/17,10.57%,TFRC;AIM2;FBP1;PDE4B
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.5685798812198684,0.9175002316035435,0.5833333333333334,1.0,1.0,2/7,15.52%,SIRT1;DIP2A
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.519576667698842,0.9174592436598568,0.6388888888888888,0.9991945699253014,1.0,1/7,0.41%,PFKP
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),-0.4623575697316302,-0.9170995900093013,0.6395348837209303,1.0,1.0,1/48,0.29%,NAMPT
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.4440825351204371,-0.9169855589792528,0.6593406593406593,1.0,1.0,9/77,8.24%,PRKAR2B;TSHR;ADCY3;CD163;CR1;FCGR2B;FGR;HTR7;DHX58
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.4809560436965437,-0.9167906073504426,0.6428571428571429,1.0,1.0,7/36,11.73%,THBS1;SEMA6A;SPARC;TGFB2;STAT1;PGK1;RGCC
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),-0.608113756557679,-0.9165549943826881,0.6567164179104478,1.0,1.0,2/7,8.03%,TNFRSF1B;NMD3
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),-0.4789687392636003,-0.9164284684590366,0.6081081081081081,1.0,1.0,7/16,29.34%,UGCG;TXNIP;ST14;CLIC4;ASAH1;PIP5K1A;CASP3
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.5071838332692354,0.9164136422006164,0.6666666666666666,1.0,1.0,3/10,4.72%,PKD2;TGFB1;PTCH1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.5783505494903479,-0.9161434985746658,0.6486486486486487,1.0,1.0,4/10,22.39%,FBN2;ID2;DYNC2I1;RYR2
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.29683630758637064,0.9159004238907115,0.7692307692307693,1.0,1.0,11/92,11.42%,SESN2;NEDD4;EXOC8;PRKAB2;SESN3;SIRT1;UBQLN2;LAMTOR1;TBC1D25;RRAGD;CLEC16A
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.5662575646569383,-0.915841003538198,0.5694444444444444,1.0,1.0,4/11,19.04%,ABHD12B;LIPE;MGLL;FAAH
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.35800376883912655,0.9157871010570057,0.6428571428571429,0.9991166360932517,1.0,7/40,10.99%,GCLC;PFKP;HHEX;MSRA;PRDX6;IPCEF1;PTPA
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.46053454745277855,0.9156915617154436,0.6206896551724138,0.9981190969609028,1.0,2/11,13.87%,ARCN1;CDC42
prerank,GO_Biological_Process_2021__pantothenate metabolic process (GO:0015939),-0.6186601075484051,-0.9154864652922282,0.6615384615384615,1.0,1.0,3/5,34.59%,VNN2;SLC5A6;VNN1
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.6386920800584501,-0.9154408192026384,0.6875,1.0,1.0,1/5,2.89%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.5500847114959164,0.9153807058038032,0.6,0.9963905026659466,1.0,1/5,2.08%,EPB41
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.5500847114959164,0.9153807058038032,0.6,0.9963905026659466,1.0,1/5,2.08%,EPB41
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.3110913114114594,0.9153480653901169,0.5,0.9952026598219286,1.0,15/72,11.68%,SGSM1;TBC1D22B;SCRIB;SIPA1;RHOG;TBC1D10B;TBC1D8B;SGSM2;EVI5;TBC1D25;TBC1D5;TBC1D16;SIPA1L2;ABR;TBC1D12
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.5906458302070919,-0.9153111923540975,0.6891891891891891,1.0,1.0,1/8,1.35%,ACVR1B
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.5153969545136393,-0.9150805100925048,0.620253164556962,1.0,1.0,3/17,8.70%,DUSP1;RIOK2;CENPE
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.4845292922713689,0.9146842839974861,0.5652173913043478,0.9951870275562594,1.0,1/11,2.22%,TAL1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.4426625977414632,0.9145703830543215,0.6190476190476191,0.9942767288125302,1.0,4/11,26.24%,CEP290;TREM2;CEP120;SCFD1
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.42693375837610315,-0.9145516068104764,0.6770833333333334,1.0,1.0,24/115,21.39%,CBR1;MT2A;TGFB2;MTHFD1;FBP1;BLVRB;PAPSS2;PINK1;ABCC3;ETS2;ID2;CD36;RAP1GAP;ADH5;SSR3;PTS;GAD1;ARG2;GABARAPL1;HACL1;FAH;SLC46A3;NFS1;CNDP2
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.4369870662061749,-0.9144940111169453,0.6526315789473685,1.0,1.0,10/56,14.47%,IFIT2;ADAM15;DDX11;B2M;CARD16;IFIT1;TTBK2;LRPAP1;TFIP11;KDM1A
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),-0.6594514526788662,-0.9144647994385124,0.671875,1.0,1.0,3/5,21.58%,TGFB2;ZFPM2;SOX4
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),-0.6405203162885729,-0.9140624657282328,0.7246376811594203,1.0,1.0,2/5,15.74%,CD14;TLR2
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),-0.6405203162885729,-0.9140624657282328,0.7246376811594203,1.0,1.0,2/5,15.74%,CD14;TLR2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.48137815716830445,-0.9139729360296361,0.6049382716049383,1.0,1.0,2/23,4.76%,PPP1R15A;ERO1A
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.41193291167398194,-0.9136787005426604,0.74,1.0,1.0,39/218,19.77%,BRIP1;RPS27A;FANCB;MPG;XRCC3;FANCI;RPA2;FANCM;BRCA1;WDHD1;NEIL1;PARP9;NOP53;POLQ;DDX1;UBA52;PIAS4;UBC;FAN1;RPA3;ERCC2;WDR48;ADPRS;RFC4;UBB;TIMELESS;POLL;KMT5C;DNA2;SLX4;BRCA2;ACTR5;DDB1;KDM4B;ABRAXAS1;DTX3L;VCPIP1;ZRANB3;MUS81
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.46139960980285166,-0.9135216751122386,0.575,1.0,1.0,1/19,2.89%,TGFB2
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.5838596798999538,-0.913379687098081,0.6461538461538462,1.0,1.0,2/6,23.99%,ING4;MEAF6
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.513571024171772,-0.9130554010995378,0.6626506024096386,1.0,1.0,10/22,26.85%,SLC4A10;RAB3A;NSMF;NCDN;RAB5A;SYP;MCTP1;CAMK2B;APP;GRIK2
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.4966890811711572,-0.912950372251833,0.6388888888888888,1.0,1.0,6/20,19.58%,PHKG1;NR1D1;PGM1;CALM1;PER2;GAA
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.4942102368039616,-0.9129455163559509,0.6153846153846154,1.0,1.0,1/19,0.99%,INSIG1
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.586152737016613,-0.9129013110696493,0.6666666666666666,1.0,1.0,1/7,7.45%,FCGR2B
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.4704074479715998,-0.9127617131864223,0.5955056179775281,1.0,1.0,5/48,4.68%,THBS1;LRP2;AGT;SULF2;SPRY1
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.44908836941189173,-0.9123859077932721,0.6043956043956044,1.0,1.0,17/53,23.28%,NFIL3;ATF5;ANTXR2;PDK3;ATF3;TM7SF2;SCD;PLSCR1;ERRFI1;CLU;TP53INP1;GUSB;ACTG1;IDI1;PNRC1;GNAI1;MVD
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.37253278052124494,0.9121796356170683,0.6923076923076923,0.9985635361229911,1.0,3/32,5.44%,GSN;FER;PPM1F
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.44286245336454627,-0.9121416098582269,0.6043956043956044,1.0,1.0,6/49,7.96%,NR4A1;RHOB;DUSP1;ALOX15B;BRINP1;CAMK2N1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.5294164247608355,-0.9120222833787384,0.6049382716049383,1.0,1.0,5/13,24.96%,PAICS;IMPDH1;AMPD2;GART;PFAS
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.6018881904753907,-0.9119836504509397,0.6,1.0,1.0,2/6,17.23%,SYT1;SYT4
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),-0.5950080538680241,-0.9119706696693272,0.6290322580645161,1.0,1.0,1/6,5.65%,NOD2
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.5122830337651391,-0.9116359577719534,0.6164383561643836,1.0,1.0,5/16,23.71%,PTPRD;IL1RAPL1;SS18L1;RELN;CAMK2B
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.4704601123749021,0.9112588629525781,0.5806451612903226,0.9996781051474812,1.0,2/12,13.97%,FFAR4;CAMK2G
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.5059414529327966,-0.9105009096758747,0.6265060240963856,1.0,1.0,5/23,13.36%,SOCS3;ST18;STAT1;PTPRT;PID1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.41141606731801117,0.9103721727870644,0.6818181818181818,1.0,1.0,5/22,8.14%,DCUN1D4;SMAD7;BAG5;ABL1;TRIB3
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.609050750638257,-0.9098314276775096,0.6557377049180327,1.0,1.0,3/5,33.99%,ANXA2;FLOT2;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.559335830195199,-0.9096266166920609,0.6417910447761194,1.0,1.0,3/10,16.04%,FCGR2B;PDCD1LG2;TNFRSF21
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.4863114075972622,-0.9096039752658005,0.632183908045977,1.0,1.0,7/34,19.71%,DTL;UVSSA;AANAT;ERCC2;SLC24A1;MAPK10;ZRANB3
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.3479338456483583,0.9095532594379304,0.5833333333333334,1.0,1.0,4/30,7.09%,RING1;DAB2IP;RYBP;RNF2
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.3479338456483583,0.9095532594379304,0.5833333333333334,1.0,1.0,4/30,7.09%,RING1;DAB2IP;RYBP;RNF2
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.4447362183469044,0.9093879355795724,0.5,0.9991720160619108,1.0,1/8,0.30%,ACTA2
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.566620307845159,-0.9090400996649098,0.6323529411764706,1.0,1.0,2/10,8.72%,CNEP1R1;NR1H2
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.4297969535611796,-0.9089704388531247,0.7340425531914894,1.0,1.0,12/79,13.92%,ACVR1B;TP53TG5;TGFB2;TCHP;FBP1;FHL1;ADAM15;HSPA1B;FGF13;DCC;CDKN1B;MAG
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.5895879575722189,-0.9089622974039964,0.6716417910447762,1.0,1.0,1/7,7.33%,SLIRP
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),0.5227154172650698,0.9086431017409902,0.53125,0.9998128167503558,1.0,1/6,1.24%,B4GALT7
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),-0.6215835079765367,-0.9086053114467092,0.6515151515151515,1.0,1.0,3/5,31.80%,TOX;STPG4;OTUD4
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),-0.6215835079765367,-0.9086053114467092,0.6515151515151515,1.0,1.0,3/5,31.80%,TOX;STPG4;OTUD4
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.4645589638775546,-0.9085291316033245,0.6404494382022472,1.0,1.0,15/31,27.61%,COL26A1;CALY;RAP1GAP;PHYHIPL;CPLX1;KLC4;SYT1;SYT4;FAAH;STMN2;ST8SIA3;LINGO1;PTOV1;SLC12A7;PCSK1N
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.4635487617393177,-0.9084623579353233,0.6352941176470588,1.0,1.0,7/35,11.47%,RPS27A;MAPT;UBA52;CD36;UBC;B2M;TGFBI
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.5915751697463216,-0.9083443251228551,0.7105263157894737,1.0,1.0,2/11,6.05%,RGS2;PLN
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.5837441977580248,-0.9082553867667794,0.6323529411764706,1.0,1.0,2/7,9.99%,BRCA1;CTBP1
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.4305726938233896,-0.908226427557604,0.6363636363636364,1.0,1.0,18/62,29.29%,MRPL33;MRPL19;MRPL43;MRPS7;MRPL20;MRPL51;MRPL45;MRPL27;MRPL47;MRPS15;MRPS21;MRPL13;MRPL32;MRPL52;MRPS25;MRPL3;OXA1L;MRPL14
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),0.49652870435807384,0.9081155191962763,0.53125,0.9999416273390457,1.0,1/8,4.82%,FFAR4
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.4790365902920982,-0.9080915553643747,0.6352941176470588,1.0,1.0,3/30,5.03%,PLPP3;FZD6;NR4A2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.5366017445914181,-0.9080521869386823,0.6764705882352942,1.0,1.0,1/9,7.80%,PINK1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.5346830744848624,-0.908047328423212,0.6216216216216216,1.0,1.0,3/11,16.03%,FANCB;WDR48;TIMELESS
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5510044374253649,-0.907861975344633,0.625,1.0,1.0,2/9,11.44%,ATF3;HSPA5
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.6119469268748026,-0.9077501813475959,0.696969696969697,1.0,1.0,2/6,23.18%,TBRG4;PNPT1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.5600746417165849,-0.9075200588449068,0.6461538461538462,1.0,1.0,8/11,41.20%,RYR2;BCAP31;DMTN;PTPRC;TRPM2;PRNP;ADGRL1;FIS1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.47485139146105015,0.9073376544857085,0.52,1.0,1.0,1/9,2.52%,PKD2
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.6015317591078837,0.9071645380513942,0.7142857142857143,0.9996891961133124,1.0,1/5,2.29%,DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5121355877267151,0.9069550099253821,0.5806451612903226,0.998965302637229,1.0,1/10,2.29%,DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.5225969269106541,0.9066892706323899,0.6,0.9982880399941095,1.0,2/8,7.28%,SIRT1;LAPTM5
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),-0.6089702539748776,-0.9064506784439179,0.7,1.0,1.0,3/8,19.23%,ATP1B3;KCNMA1;ATP1B2
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.4223271421314013,-0.9060893435713065,0.6938775510204082,1.0,1.0,8/115,7.80%,CEMIP;ARIH2;TOMM7;VPS11;ANK3;ABLIM3;RHOU;PINK1
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.5626843349953431,-0.9055079530148995,0.6666666666666666,1.0,1.0,2/13,8.80%,DHX58;NOP53
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.3257869398868811,0.905350701482215,0.75,1.0,1.0,6/55,7.12%,TAL1;LMO1;CBFB;RUNX1;ABL1;PSME4
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.4554229216795421,0.9052965482593447,0.6428571428571429,0.9990689641924211,1.0,1/18,0.57%,NDE1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.49859901757851444,-0.905088664763253,0.620253164556962,1.0,1.0,5/19,22.39%,DMD;TTN;SCN3B;GAA;RYR2
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.4312938863552167,-0.9050235595733226,0.7272727272727273,1.0,1.0,10/87,9.93%,NLRP12;THBS1;AGT;PTN;POLR3F;CCL3;IL15;DHX58;IL18;THBD
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),-0.5723025687908352,-0.9048524802906693,0.6666666666666666,1.0,1.0,1/8,5.77%,STXBP6
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5601661908490565,-0.9048518362588113,0.6486486486486487,1.0,1.0,3/12,19.23%,ATP1B3;KCNMA1;ATP1B2
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.5147110849008997,0.9046700113546665,0.5526315789473685,0.999212455266412,1.0,2/7,3.39%,GCLC;PSPH
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.5321178574297398,-0.9046295641709577,0.6486486486486487,1.0,1.0,2/10,16.20%,CCDC39;ADCY10
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4495966727353307,0.9044476079500765,0.6153846153846154,0.9984342609832733,1.0,4/14,11.66%,TGFA;NCK2;CBL;FBXW7
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.4898585997554997,0.9044129678826085,0.5588235294117647,0.9972721390110836,1.0,1/11,2.35%,CRK
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.42787482300579127,-0.9042608316085821,0.6630434782608695,1.0,1.0,12/52,20.75%,LRP2;VEGFA;SMARCD3;SHANK3;METRN;PTPRD;KDM1A;IL1RAPL1;NEURL1;SS18L1;ROBO2;SERPINF1
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.4609070691492002,-0.9042542663012497,0.651685393258427,1.0,1.0,5/32,12.35%,RBPJ;DTX3;STAT1;NOTCH2;TRAF7
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.32090668716819,0.9041797983455182,0.9090909090909091,0.9966020812984832,1.0,8/49,9.65%,ACER2;NEXMIF;MAP4K4;VCL;JAG1;CIB1;NF2;DUSP3
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.42348498352328023,0.9040040652814848,0.6206896551724138,0.9957708507720531,1.0,4/10,10.86%,RFWD3;TP53;SDE2;PLK3
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.6043419780079533,-0.9037426050821317,0.6507936507936508,1.0,1.0,2/6,17.27%,VMP1;CALM1
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.3730765061660385,0.9036815027911969,0.5714285714285714,0.9952669850321784,1.0,4/32,5.82%,ZNF703;SMAD7;VCL;CDHR3
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.42058984064064775,-0.9034272845693303,0.7171717171717171,1.0,1.0,19/161,14.34%,TFRC;THBS1;FGF1;VEGFA;HIF1A;PFKFB4;SLCO3A1;FLT1;MARCO;FAXDC2;PINK1;CLIP3;SDCBP;EPHA3;FAM20A;EPHB1;ALK;PFKFB3;INSR
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.5500534849627499,0.9032527522021127,0.6296296296296297,0.9948972827863732,1.0,2/7,2.15%,LCP1;MYOM1
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.5026563235179283,-0.9030365343028695,0.6790123456790124,1.0,1.0,2/22,4.49%,FA2H;DEGS2
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.3452953181654712,0.9029744978782704,0.5714285714285714,0.9944252579869604,1.0,6/35,8.18%,IPPK;PLD4;ISYNA1;OCRL;ITPKB;PLCB4
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.4948179648104871,0.9029458767572629,0.5862068965517241,0.9932620641826397,1.0,2/11,1.06%,NRP1;PLXNA2
prerank,GO_Biological_Process_2021__regulation of cell activation (GO:0050865),-0.5654018548573967,-0.9027200564777704,0.6486486486486487,1.0,1.0,2/6,11.55%,TXK;TEC
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.4631835453714504,-0.9026245678413065,0.65,1.0,1.0,5/34,13.29%,VEGFA;RPS14;ATP5IF1;ID2;HCLS1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.5606212463853907,0.9022527184303938,0.6129032258064516,0.9937201251019222,1.0,1/5,6.16%,TP53
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.4471936262642542,-0.9021968207566565,0.6436781609195402,1.0,1.0,7/40,14.95%,TGFB2;PKP2;CDH9;CDH12;CDH2;CDH8;CTNND2
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),-0.5465788799905892,-0.9019847850342086,0.6666666666666666,1.0,1.0,2/8,5.18%,ALOX12;ALOX15B
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.6151317652332401,-0.9017387297524255,0.7297297297297297,1.0,1.0,2/7,20.31%,APPL1;CTNS
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),0.5372279751953646,0.9015585154704419,0.5517241379310345,0.9941182727789102,1.0,1/6,3.11%,EYS
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.39865141418556976,0.9015384783898389,0.7307692307692307,0.9929597835181102,1.0,2/20,1.54%,GCLC;ALDH5A1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.5805040346885891,-0.9012992550943139,0.6268656716417911,1.0,1.0,1/5,2.89%,TGFB2
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.40254853718215994,0.9010747776854988,0.5714285714285714,0.9930207577116684,1.0,2/16,7.17%,MKKS;BBS10
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.5363402355527088,-0.9010221861041231,0.6547619047619048,1.0,1.0,2/15,15.46%,POLR2G;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.5363402355527088,-0.9010221861041231,0.6547619047619048,1.0,1.0,2/15,15.46%,POLR2G;TERF2IP
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.4815887225508722,-0.9009665413704756,0.6666666666666666,1.0,1.0,2/27,6.02%,MX2;ANTKMT
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.462507704290958,-0.9009523356944471,0.6666666666666666,1.0,1.0,5/36,6.86%,TNC;SPARC;ADAMTS2;LAMA2;SPON2
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.43550724885309405,-0.9009377331022607,0.6744186046511628,1.0,1.0,13/56,21.12%,RBX1;FANCI;FANCM;BRCA1;PINK1;ARRDC3;BMI1;KDM1A;RPS2;UBB;SEPTIN4;PRICKLE1;RIPK2
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.533167130767674,0.9006100752510442,0.6578947368421053,0.9929498241930502,1.0,1/6,4.07%,GNPDA1
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.4239244792763676,-0.9005340037127755,0.7263157894736842,1.0,1.0,24/128,22.08%,KCNE1;SLC11A1;SCN9A;ATP1B3;SLC6A15;KCNH8;TRPM3;TMEM175;SLC24A1;KCNC1;KCNK10;SLC9A6;NALCN;RYR3;SCN1A;CACNA1C;ATP2B4;SCN3B;SLC24A2;KCNH7;RHD;SLC24A4;KCNAB2;MCOLN1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.43672110860112334,-0.9003522544551179,0.6704545454545454,1.0,1.0,12/59,20.47%,TNFRSF1B;PINK1;SOD1;HLA-F;PTPRZ1;MAG;SNX6;TRAF2;CRLF1;NRBP2;GPNMB;RETREG1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.5693091193609271,-0.9002447121357456,0.6578947368421053,1.0,1.0,2/7,21.75%,DNA2;LIG3
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.4665599318988217,0.9001073717983856,0.7083333333333334,0.9928936874088762,1.0,3/12,18.46%,MMS19;YAE1;NFU1
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.44599175571296223,-0.8999234107721074,0.625,1.0,1.0,18/40,36.04%,PSMA3;PSMA5;AZIN1;PSMD8;PSMB4;PSMD7;PSMD5;PSMC2;PSMB9;PSMB2;PSMB6;PSMD14;PSMC6;ODC1;PSME2;PSMA4;PSME1;PSMC1
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.5250870911188275,-0.8999042829919137,0.6164383561643836,1.0,1.0,1/14,4.26%,INTS12
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.5559506183337588,-0.8997556538953336,0.6666666666666666,1.0,1.0,1/8,7.80%,PINK1
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.47658157824331354,-0.8994611017454477,0.6590909090909091,1.0,1.0,7/27,20.49%,PPP1R15A;MASTL;CALM3;PPP1R11;CALM1;PPP4R4;CD300A
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.5634706471397808,-0.899245751359518,0.6825396825396826,1.0,1.0,2/6,9.44%,HIF1A;PADI2
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.48750437784987843,-0.898728417398415,0.7333333333333333,1.0,1.0,8/28,19.28%,TGFB2;RSAD2;FCGR2B;IL15;B2M;ECHDC3;ARG2;IER5
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),-0.5983436062574918,-0.8983169282456307,0.6388888888888888,1.0,1.0,2/5,30.37%,CRHBP;DLG4
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),-0.5983436062574918,-0.8983169282456307,0.6388888888888888,1.0,1.0,2/5,30.37%,CRHBP;DLG4
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.42803362824141333,-0.8982054041214714,0.6774193548387096,1.0,1.0,16/83,14.87%,NLRP12;CYCS;ST18;BEX3;CASP5;MTCH1;FAM162A;EGLN3;MAPT;DAPK1;EIF2AK3;KHDC1;GRAMD4;PYCARD;RPS3;TRAF2
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.49120197847761804,-0.8981704184410971,0.6329113924050633,1.0,1.0,6/19,17.44%,VCAN;VEGFA;THBD;LRPAP1;TNFRSF21;S100A4
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.38074206584455866,0.8980867371713613,0.625,0.9962257151841392,1.0,7/23,10.47%,SMAD7;BAG5;ABL1;ERCC4;TP53;INPP5K;SRC
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.4550708283206404,0.8979447958821581,0.5416666666666666,0.9952322054435213,1.0,3/17,9.74%,ZNF675;ILRUN;TFAP4
prerank,PanglaoDB_Augmented_2021__Mast Cells,-0.41925451695878546,-0.8977970575120858,0.7777777777777778,1.0,1.0,28/124,14.70%,CD55;ENPP2;RGS1;PLPP3;SPARC;TNS1;LAMA2;SGCE;DUSP1;MEIS2;COBL;SLC7A5;PAPSS2;CDH9;EPB41L3;SLC31A2;RIOK2;CXCR4;SPARCL1;ENO2;ARMCX3;DGKI;ABCA1;GPM6A;PID1;SHROOM4;ENAH;ALDH1A1
prerank,PanglaoDB_Augmented_2021__Luteal Cells,-0.4410358907329892,-0.897661838856629,0.6559139784946236,1.0,1.0,15/65,17.01%,PRLR;ME1;RORA;PEBP1;GAPDH;PGAM1;ADGRL2;EPB41L4B;ZDHHC9;SH3D19;RND3;FKBP5;ERRFI1;CPE;GNA11
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.4961802874147904,-0.8975139133753102,0.5897435897435898,1.0,1.0,6/21,19.33%,PPP2R5A;CNEP1R1;CALM3;NSMF;CALM1;LILRB2
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),-0.5961022906591436,-0.8974030296630747,0.6865671641791045,1.0,1.0,3/6,35.45%,TXN;GUCY1B1;MT3
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.4944484445908378,-0.8973416260851128,0.6578947368421053,1.0,1.0,2/18,5.60%,PPP1R15A;MASTL
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.44176969898612456,0.8971271640738387,0.625,0.9961349324084704,1.0,1/8,0.98%,NEDD4
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.4970405333485677,0.8970301710818156,0.6,0.9951294255110886,1.0,2/6,11.15%,CD274;TWSG1
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.5655914518505195,-0.8970069808446333,0.6111111111111112,1.0,1.0,2/7,20.77%,MAPT;BEX4
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.3474096516395856,0.8969935530052899,0.7222222222222222,0.993995599132763,1.0,5/33,10.75%,ERCC4;TP53;MAP3K4;SRC;NVL
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.45659469501665373,0.8968546452767426,0.4838709677419355,0.9930967769928681,1.0,2/7,15.64%,ACVR1;NOTCH1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.4069562125199274,0.8964670479795072,0.5882352941176471,0.9927655113657307,1.0,5/19,15.31%,HMGA1;SIRT1;MAP2K1;NSMCE2;SMC6
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),-0.5959062054140387,-0.8964120393534549,0.676923076923077,1.0,1.0,1/7,7.60%,MAPT
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.5624915265976943,-0.8961171905539574,0.6212121212121212,1.0,1.0,6/8,27.93%,BRCA1;KDM1A;DNMT1;JARID2;RIF1;ZNF274
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.48037546264045444,-0.8958100198461578,0.6,1.0,1.0,5/16,21.95%,TGFB2;NOD2;RNF13;EIF2AK2;CARD9
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.43513800135618586,-0.895731702438485,0.7204301075268817,1.0,1.0,7/74,10.76%,RPS27A;ACVR1B;FOS;TGFB2;APPL1;UBA52;UBC
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),-0.6147089891703376,-0.8956508486585666,0.6984126984126984,1.0,1.0,1/5,18.45%,RELN
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.4188019048234801,-0.8956503501352254,0.7272727272727273,1.0,1.0,40/162,22.13%,DOK6;SEMA6A;SEMA3A;LAMA2;EMB;ANK3;UNC5C;NTN4;CCK;MAP1B;PRKCQ;CXCR4;SHANK3;NOTCH2;RAP1GAP;EPHA3;DCC;RAB3A;FEZ1;NLGN3;PALLD;NRXN1;EPHB1;ENAH;PIK3CB;SPG11;SLC9A6;S100A6;IRS2;RELN;PTPRA;ROBO2;EPHA7;NRXN3;PLPPR4;KIF5A;NTNG1;KIF5C;MAP1A;SPTBN5
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.3009635466204908,0.8955680983539889,0.8571428571428571,0.9934775142683798,1.0,8/66,7.59%,TAL1;LMO1;CBFB;NSUN2;RUNX1;ABL1;PSME4;JAG1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.4479937282224575,-0.8955607485803082,0.6436781609195402,1.0,1.0,5/48,10.45%,TFRC;DDRGK1;MAPT;PARP9;EIF2AK3
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.46736317701250385,-0.8954992635865577,0.6785714285714286,1.0,1.0,7/31,22.39%,ATP1B3;UHRF1;VMP1;PLSCR1;DNAJC9;ATP1B2;RYR2
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.48558393008841105,-0.8952504164165114,0.6951219512195121,1.0,1.0,2/30,3.58%,SPOCK1;ECM2
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.4287604347109972,-0.8951203617274394,0.7368421052631579,1.0,1.0,26/111,20.36%,INSIG1;PRKAR2B;PLPP3;BHLHE40;GCNT1;DUSP1;MAP1B;SIPA1L1;LTBP1;COL11A1;PRKCE;NOTCH2;ADGRL2;KCNMA1;CDKN1B;RASA2;RND3;MGLL;ANXA2;NFIB;AMPH;ATP2B4;INPP4B;CITED2;PMP22;APBB2
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.5710667526624679,-0.8950727882545754,0.7051282051282052,1.0,1.0,2/8,19.47%,PINK1;MCTP1
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,-0.46343324497873023,-0.8947408943004739,0.6265060240963856,1.0,1.0,13/31,26.51%,SEMA6A;ADAMTS19;COL26A1;GPC3;FRAS1;POU5F1;GABRB3;EPHA7;LINGO1;UNC5D;CACNA1B;CRMP1;CNTNAP2
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.46582617660734793,-0.8947095421549105,0.6463414634146342,1.0,1.0,3/29,5.63%,TGFB2;SPRY1;FBP1
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.42105180274418197,-0.8946806353859004,0.7216494845360825,1.0,1.0,17/112,17.75%,DDIT4;NLRP12;PAQR3;PLPP3;GSTP1;CAMK2N1;CALM3;DMD;PID1;CAV3;TERF2IP;ERRFI1;SH3GL2;IMPACT;CALM1;GSKIP;THY1
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.556419107256923,0.8946270486291403,0.6578947368421053,0.994346848502755,1.0,1/5,12.99%,CHD7
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.43141688039407466,-0.8938867209729648,0.7191011235955056,1.0,1.0,7/64,11.44%,DNAJB9;HERPUD1;ANKZF1;RNF175;SEC61B;TRIM25;HSPA5
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.4360694299661271,-0.8937871292131793,0.7263157894736842,1.0,1.0,3/44,7.80%,ARAF;DDRGK1;PINK1
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.44491468906052756,0.8935914930082809,0.6086956521739131,0.9954595981337113,1.0,4/13,5.44%,NRP1;MAP4K4;ABL1;PPM1F
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.38965006181118883,0.893283643008162,0.5714285714285714,0.9949251088906064,1.0,10/20,25.18%,SIRT1;HDAC10;ABHD10;LYPLA1;PPT1;HDAC5;ABHD17A;SIRT2;HDAC1;SIRT6
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.42887808577553044,-0.8932095217923937,0.7291666666666666,1.0,1.0,22/85,21.60%,TFRC;NAPA;VEGFA;SLF1;PINK1;NOP53;HCFC1;CD36;MPP7;HSPA5;ABCA1;TFIP11;RPS3;TRAF2;BMF;IMPACT;CLU;EIF2AK2;GFAP;NRG1;SEPTIN8;RACK1
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.4993624191873298,-0.8929934067995807,0.6708860759493671,1.0,1.0,2/14,7.98%,ALOX12;PRKCQ
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.5294485774927433,-0.8928692900708984,0.6811594202898551,1.0,1.0,2/14,16.58%,USP36;ATXN7L3
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.4676952036560884,-0.8927414807741795,0.5903614457831325,1.0,1.0,7/31,14.87%,AGT;VPS11;PINK1;HCFC1;CD36;RDX;TRAF2
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.39090722963597213,0.8924691838239542,0.6,0.9957462849000265,1.0,5/24,6.37%,SIRPA;MAP3K5;MAPK13;ABL1;SIRT1
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.5397831304885736,-0.8923443351219968,0.6142857142857143,1.0,1.0,3/10,15.06%,RORA;IL18;PNPLA8
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.5487720547214917,0.8921414069991803,0.5882352941176471,0.9951839649351653,1.0,4/7,17.88%,SALL1;MDM4;NOTCH1;ENG
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.5643140754996889,-0.8920190198859477,0.6338028169014085,1.0,1.0,1/7,5.79%,DDRGK1
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.559247089617553,-0.8918704035561755,0.6376811594202898,1.0,1.0,3/9,8.80%,COX7A2;PINK1;NOP53
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.43094489302573263,-0.8918464979603702,0.6590909090909091,1.0,1.0,11/52,15.91%,NLRP12;AIM2;CCL3;GSTP1;NOD2;CD36;MNDA;CARD16;PYCARD;GSDMD;TRIM16
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.5791456387837459,-0.8917392372521309,0.7432432432432432,1.0,1.0,4/8,32.40%,UBXN2B;CEP250;BICD1;NSFL1C
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.4470059126369914,-0.891535798795122,0.711340206185567,1.0,1.0,18/60,18.11%,PLPP3;SH3PXD2B;DOCK1;SPRY1;NTN4;CXCR4;LAMB1;DMD;HSPA12A;BMI1;PALLD;LIFR;ENAH;SH3D19;RND3;ERRFI1;GNA11;CALCR
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.5829119801627288,-0.89142077657371,0.6307692307692307,1.0,1.0,1/7,8.24%,DHX58
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.615287800475496,-0.8913995096978778,0.7313432835820896,1.0,1.0,1/6,7.80%,PINK1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.45619513881119333,-0.8911412896476254,0.6705882352941176,1.0,1.0,8/50,17.39%,THBS1;CCL3;NOD2;OAS3;CD14;PYCARD;TLR2;CLU
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4978384341260918,0.8910045077278831,0.6538461538461539,0.9961034458074189,1.0,1/9,2.47%,CPSF4
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),-0.5069319395962565,-0.8907507634721965,0.6231884057971014,1.0,1.0,2/11,8.72%,CNEP1R1;NR1H2
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.4750828177857943,0.8905192450611961,0.6923076923076923,0.996001439891803,1.0,3/13,2.63%,NRP1;PKD2;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.36246135159175896,0.8903603597462596,0.625,0.9951397477232942,1.0,3/26,3.37%,BCL2L1;FAIM;ICAM1
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.368751336620764,0.8902260099092506,0.6111111111111112,0.9941655712518059,1.0,5/27,7.28%,FGL1;SIRPA;ABL1;TNFSF8;LAPTM5
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.43579243782225946,0.890210060661006,0.5454545454545454,0.9930650142998576,1.0,3/13,13.06%,ALG1;MPDU1;ALG3
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.4774534041507595,-0.8900885656999074,0.6666666666666666,1.0,1.0,6/24,19.58%,CLVS1;ABCA1;CLVS2;TPP1;ACP3;GAA
prerank,PanglaoDB_Augmented_2021__Microglia,-0.4139575606131754,-0.8900587745628213,0.7070707070707071,1.0,1.0,22/134,14.02%,CLEC12A;CCL4;JAML;GPR183;FOS;CD93;C5AR1;TNFRSF1B;CD163;CCL3;MS4A4A;FCGR2B;FGR;IL10RA;MS4A6A;MNDA;COLEC12;NCF4;FPR1;LSP1;SIGLEC1;CD14
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.4508430542544695,-0.889947475816773,0.7083333333333334,1.0,1.0,25/66,25.05%,HTR2B;TNFRSF1B;HSPA1B;CD36;BNIP3L;BNIP3;DCC;EPHB1;CDKN1B;LRPAP1;UBB;CIDEB;IMPACT;ATG5;CLU;CALCR;RIPK2;RRAS2;SOX4;TRIM13;CRYAB;VPS35;ACER3;PDE8A;NPAS2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.454516510023932,-0.8898332386968978,0.6588235294117647,1.0,1.0,8/52,17.39%,THBS1;CCL3;NOD2;OAS3;CD14;PYCARD;TLR2;CLU
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.503365640248669,-0.8898209856521451,0.618421052631579,1.0,1.0,4/14,21.98%,NEFL;SOD1;KIF5A;MAP1A
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),-0.47818723756838444,-0.8897557899711931,0.5735294117647058,1.0,1.0,7/14,25.45%,NLGN3;BSN;PTPRD;IL1RAPL1;LRP4;DVL1;NLGN2
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.5346614682277261,-0.8894637013357438,0.6375,1.0,1.0,5/9,39.90%,PNPLA8;PLA2G4A;PGS1;HADHA;TAMM41
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.43235259736249576,0.889308273392928,0.6086956521739131,0.9939386460559307,1.0,2/13,5.63%,DAG1;VCL
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),0.4729083239834195,0.8891807274971599,0.5862068965517241,0.9929266300272059,1.0,3/7,13.92%,DAGLB;PTGS1;TBXAS1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),-0.5695059288619762,-0.8889861930023585,0.6231884057971014,1.0,1.0,1/7,0.73%,THBS1
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.5494877978080055,-0.8887837586303227,0.625,1.0,1.0,2/5,5.97%,SLC16A10;SLC7A5
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.49697240622142785,0.8887791735963914,0.6071428571428571,0.9926296542213334,1.0,1/6,3.65%,RAB22A
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.39230780991859365,-0.8885968930625147,0.89,1.0,1.0,114/716,19.27%,SOCS3;THBS1;ALG10B;ARAF;PP2D1;NEK11;ACVR1B;TNC;F13A1;ASB14;VCAN;CDK14;CTDSP1;TGFB2;DTL;HIF1A;ASB16;DUSP1;RBX1;TXK;ERO1A;HS3ST5;PPP2R5A;WDR5;EGLN3;PPP2R3B;PPP2R5B;FBXL2;RAB11A;COPS5;SERP1;FGR;DAPK1;PINK1;DAPK2;LTBP1;PARP9;PRKCE;GPC3;PDK3;LAMB1;UGCG;KLHL13;NUAK2;UBA52;SPARCL1;NIM1K;CTBP1;PSMA3;GGCX;EIF2AK3;LIPE;MAP3K12;PIM3;PSMA5;PPP1CB;MGAT1;TEC;FAM20A;MTMR7;RAB3A;PXK;SPSB1;USP6;VGF;CDH2;FN1;PAK5;PTPRT;ST8SIA1;PARP14;PTPRZ1;OGA;PTPRD;SLC35A1;INSR;STK17B;GRK4;MAK;CHGB;PIK3R4;TMEM132A;PSMD8;PSMB4;UBE2M;FBXL13;SIRT3;CPE;SIRT5;FBXL7;LGALS1;ATG5;SPSB3;GAD1;DUSP12;CKAP4;SUMF2;ILF3;ZC3HAV1;PIGH;PTPRB;ELOB;MAPK10;VRK1;DDB1;PTPRG;CLK2;RAB5A;VRK2;LIMK2;PTPRA;NRBP2;SGK1;BMPR1B
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.5653508337980926,-0.8885900574504145,0.7049180327868853,1.0,1.0,3/7,26.03%,KDM1A;KDM5C;KDM5B
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.5242773975678341,-0.888076603128551,0.6493506493506493,1.0,1.0,3/19,15.46%,NHP2;RFC1;TERF2IP
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.5017868518696279,-0.8879953682894467,0.6233766233766234,1.0,1.0,2/17,4.79%,PLTP;AQP11
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),-0.4939769474961172,-0.8879411406152354,0.6753246753246753,1.0,1.0,7/15,25.45%,SHANK3;NLGN3;NRXN1;LRP4;NRXN2;MUSK;NLGN2
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.41198254653647776,-0.8879130135218751,0.7346938775510204,1.0,1.0,22/123,21.25%,THEMIS2;TXK;PRKCQ;EIF2B2;BTN2A2;BTN3A1;PSMA3;PDE4B;PSMA5;MOG;TEC;PIK3CB;PSMD8;PSMB4;TNFRSF21;BTN2A1;THY1;NFKBIZ;PSMD7;NFKBID;RIPK2;PSMD5
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.500819709937243,0.8878614460221194,0.64,0.9924217242507969,1.0,2/8,6.37%,ZNF385A;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.500819709937243,0.8878614460221194,0.64,0.9924217242507969,1.0,2/8,6.37%,ZNF385A;SIRT1
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.5794448323083043,-0.8878531440868158,0.6716417910447762,1.0,1.0,1/8,7.55%,TENT4B
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.4482928796047906,-0.8876863382336225,0.5930232558139535,1.0,1.0,9/27,26.38%,PIGL;ST8SIA1;PIGG;PIGA;PIGH;ST8SIA3;MPPE1;PIGF;SCCPDH
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.5012440859356402,-0.8874921739795687,0.6842105263157895,1.0,1.0,4/15,22.29%,DGAT1;SCD;ACSL3;SCD5
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.3558255540091821,0.8873445396746497,0.5294117647058824,0.9923536353022339,1.0,4/27,10.49%,NEDD4;SEMA4D;CAPRIN2;RAP2A
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.5257123508188628,-0.8873231990919952,0.691358024691358,1.0,1.0,5/13,26.42%,PIK3CB;ARF6;STMN3;OGT;RASGRF1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.4734913721581571,-0.8873202672167841,0.6705882352941176,1.0,1.0,3/27,4.49%,FA2H;PLPP3;DEGS2
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.41748773994026095,-0.8870062094369165,0.7083333333333334,1.0,1.0,19/103,19.16%,TFRC;PAPPA2;SPOCK1;AGT;OGFR;ATF5;PINK1;PRKCQ;HCFC1;CD36;ERMN;PAK5;AP2S1;TRAF2;ATAD3A;ARFGAP1;RAB5A;METTL4;SGK1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.4146574295904429,0.8868961740339937,0.6666666666666666,0.9921864227163759,1.0,3/17,6.76%,ZNRF3;PTCH1;SALL1
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.589273979304764,-0.8866825666770572,0.6610169491525424,1.0,1.0,3/6,37.85%,STMN2;CFL2;WDR1
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.48347930848738463,-0.8866362877667952,0.7160493827160493,1.0,1.0,13/29,32.10%,B2M;LRPAP1;PIK3CB;ARF6;CLU;RAB21;TF;HFE;HIP1;SGIP1;RAC1;BICD1;HNRNPK
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),-0.5836991617821905,-0.8865385239759858,0.6301369863013698,1.0,1.0,2/5,24.19%,ERCC2;XPA
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.4269706148184585,-0.8863330751316136,0.7011494252873564,1.0,1.0,8/55,20.17%,HAUS6;RAB11A;GOLGA8B;TUBGCP2;RPS3;ABRAXAS1;KIF11;MAP9
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.5267311772319185,-0.8860884072090421,0.6538461538461539,1.0,1.0,2/16,2.89%,LRP2;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.5635103172576834,-0.8857950148531724,0.6666666666666666,1.0,1.0,5/8,24.90%,PINK1;PID1;ENO1;TMSB4X;PPARA
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.5635103172576834,-0.8857950148531724,0.6666666666666666,1.0,1.0,5/8,24.90%,PINK1;PID1;ENO1;TMSB4X;PPARA
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),0.41382748495271443,0.8856268400666356,0.5769230769230769,0.9936629649358283,1.0,1/12,2.09%,TICAM1
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.2793940205286945,0.8856225254616736,1.0,0.9925040927862337,1.0,32/203,10.55%,ATRAID;CGRRF1;P3H2;B4GALT7;HPN;DAB2IP;PKD2;SH2B3;CTBP2;CEBPA;BAP1;PPARG;PDPN;HMGA1;NCK2;TGFB1;TP53;E2F3;TMEM127;APPL2;ZBTB49;NMI;IL1B;CIB1;IL1A;NF2;ADRA1A;CTCF;TFAP4;SKI;PLPP1;MAP2K1
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),-0.5348054560575924,-0.8855688808840805,0.684931506849315,1.0,1.0,1/8,2.56%,VEGFA
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),-0.5790865414051802,-0.8853029144552426,0.647887323943662,1.0,1.0,2/6,26.77%,THBS4;ROCK1
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),0.5109884506780564,0.8852135521857487,0.5862068965517241,0.992309033189097,1.0,2/6,2.71%,CX3CR1;P2RY12
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.3051155596252458,0.8849100435266433,0.7142857142857143,0.9918038822763653,1.0,16/82,11.50%,PLXNA2;DSCAM;NUAK1;ARHGDIB;SEMA4D;SIPA1;ABL1;ZDHHC2;CXCL12;TFE3;PLXNA4;ADAM10;EPHB3;SRC;ABL2;PLXNB2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.3206397420408465,0.8848287108804945,0.7,0.9908346542235837,1.0,11/51,16.89%,WDR33;CPSF4;SNRPB;GTF2H2;LSM11;PAPOLA;TAF1A;SCAF8;MNAT1;CSTF1;UBTF
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),-0.4501110184366631,-0.8847392406421031,0.6705882352941176,1.0,1.0,12/33,27.69%,NLGN3;NRXN1;EPHB1;PTPRD;IL1RAPL1;TLR2;ROBO2;MUSK;VPS35;NLGN2;APP;IL1RAPL2
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.4115825701360453,0.8847294068400561,0.6521739130434783,0.9898958963632287,1.0,3/16,10.19%,TLR7;IRF5;CHUK
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),-0.5961068158944289,-0.8846573050274761,0.696969696969697,1.0,1.0,1/5,4.29%,RORA
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.4101382185557204,-0.8845996088418772,0.7551020408163265,1.0,1.0,24/138,21.25%,VAV3;THEMIS2;TXK;PRKCQ;EIF2B2;BTN2A2;MNDA;BTN3A1;PSMA3;PDE4B;PSMA5;MOG;TEC;PIK3CB;PSMD8;PSMB4;TNFRSF21;BTN2A1;THY1;NFKBIZ;PSMD7;NFKBID;RIPK2;PSMD5
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.35734195285606896,0.8845872738070509,0.875,0.989142225032488,1.0,12/44,9.79%,LGALS9;CEBPA;CSF1R;PPARG;PIR;RUNX1;TGFBR2;MYH9;SIRT1;GAB2;PDE1B;THOC5
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),0.4705773667077669,0.8845869596782667,0.7096774193548387,0.9879688653349405,1.0,2/7,17.43%,APH1A;DYRK1A
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.45435927938290743,-0.884578056979164,0.7058823529411765,1.0,1.0,7/34,17.55%,TAF6L;WDR5;YEATS2;ING4;ING5;TRIM16;BRCA2
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.4463152847170977,-0.8845677499377825,0.627906976744186,1.0,1.0,10/39,19.66%,TFRC;TNFRSF1B;CR1;IL15;PDCD1LG2;HLA-DMB;TNFRSF21;LILRB2;AIF1;GPNMB
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.5899006475029612,-0.8845119302440653,0.7049180327868853,1.0,1.0,3/5,29.86%,RTN4RL1;EPHA4;PTPRS
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),-0.5276230698873865,-0.8839813752258127,0.6962025316455697,1.0,1.0,6/14,28.06%,VCAN;CHST7;CSGALNACT2;CHSY1;CHST12;NCAN
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),-0.4724564314964812,-0.8839147341976145,0.6829268292682927,1.0,1.0,3/22,8.88%,RORA;FBP1;PDK3
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),-0.41407795104484735,-0.8835403036071368,0.7319587628865979,1.0,1.0,14/109,14.03%,PP2D1;EYA2;PPP1R15A;CTDSP1;DUSP1;PPP2R5A;PPP2R3B;PPP2R5B;PPP1CB;MTMR7;PPP2R2B;PTPRT;PTPRZ1;PTPRD
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),-0.5957147053071589,-0.8834161437434636,0.6805555555555556,1.0,1.0,2/5,9.59%,HIF1A;PAX8
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.575657986740369,-0.8832341918372929,0.6764705882352942,1.0,1.0,2/5,8.09%,CCL3;ANK2
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.49242936020350414,-0.8831949005072681,0.6794871794871795,1.0,1.0,4/26,14.30%,PPP1R15A;VAV3;LARS1;RDX
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.588867489161913,-0.8829399226610632,0.726027397260274,1.0,1.0,2/6,9.44%,UGCG;CD36
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.45095108565939523,-0.8829174220699726,0.6463414634146342,1.0,1.0,5/28,14.30%,SH2D4A;NEIL1;ATP5IF1;RRP1B;RDX
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.5055606592554945,0.8828717985638208,0.5666666666666667,0.9894428191431905,1.0,2/7,20.57%,ADAM10;WNK1
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.5055606592554945,0.8828717985638208,0.5666666666666667,0.9894428191431905,1.0,2/7,20.57%,ADAM10;WNK1
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.4843713794214793,-0.8827723217817662,0.6987951807228916,1.0,1.0,9/24,17.29%,LRP2;FBP1;CRYL1;TGFBI;GBA3;GHR;DPYS;SORD;SLC13A3
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.4426342473673208,-0.8827484682738054,0.6629213483146067,1.0,1.0,9/33,15.39%,RPS8;NGDN;RPS14;NOB1;RIOK2;UTP3;RRP36;RPS16;WDR46
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),-0.5913783087824643,-0.8827246023948649,0.671875,1.0,1.0,2/5,9.59%,FGF1;PAX8
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.5467003073613251,-0.8824758261483859,0.6714285714285714,1.0,1.0,3/10,19.33%,PLN;CAV3;LILRB2
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.5809798514610578,-0.8824583937524518,0.6911764705882353,1.0,1.0,3/6,31.23%,INSR;CLEC7A;RAC1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.43491691439639746,0.8823430847530929,0.5652173913043478,0.9893232195811994,1.0,3/15,4.94%,SH2B3;CBFB;RUNX1
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.4810777014143992,-0.8819932858300287,0.7176470588235294,1.0,1.0,5/29,9.44%,THBS1;DOCK1;MARCO;FCGR2B;CD36
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.40388022088880215,-0.8819264973228218,0.7040816326530612,1.0,1.0,13/86,15.09%,TFRC;VEGFA;SLF1;RBX1;RPA2;CD36;MED25;MPP7;RPA3;ERCC2;ABCA1;RPS3;BMF
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),-0.45862066389682304,-0.8816114589025803,0.6818181818181818,1.0,1.0,6/31,14.51%,LRP2;NLGN3;NRXN1;EPHB1;PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.468161681919035,-0.8814545820865509,0.6025641025641025,1.0,1.0,11/24,24.86%,RIMS1;STX19;RAB3A;CPLX1;SNAP25;UNC13A;SYT1;UNC13C;PIP5K1C;RIMS2;RIMS3
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.5675922023305624,-0.8814212910266032,0.7014925373134329,1.0,1.0,2/6,11.31%,FGF13;DCC
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.45560320103728913,-0.8814121267177565,0.6521739130434783,1.0,1.0,9/44,14.79%,OSBPL5;PRELID1;PLTP;ATP8B1;ATP10A;ABCB4;PCTP;ABCA1;ABCB1
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.37128729122319765,0.8810350329932036,0.65,0.9910076921956029,1.0,2/21,1.20%,NRP1;TGFA
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.42044629703554837,-0.8804858267909219,0.7395833333333334,1.0,1.0,23/91,21.21%,CCL4;JAML;NAPSB;MS4A4A;FCGR2B;FGR;IL10RA;MS4A6A;MNDA;HLA-F;NCF4;LSP1;SIGLEC1;HLA-DMB;TLR2;NCF2;FCGR2C;LILRB2;AIF1;GPNMB;PARVG;CD300A;FCER1G
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.4287751577923661,-0.8802177226380806,0.6931818181818182,1.0,1.0,6/62,8.66%,NLRP12;AGT;POLR3F;CCL3;IL15;IL18
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.4679861920301965,-0.8802060835212656,0.6951219512195121,1.0,1.0,2/27,6.41%,GLA;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.4257573664958402,-0.8801014974431984,0.7127659574468085,1.0,1.0,11/65,15.74%,POLR3F;PQBP1;GAPDH;STAT1;POLR1C;DHX58;IRF1;OAS3;CD14;POLR3H;TLR2
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.3443044699702142,0.880003950645357,0.6875,0.9919619403830172,1.0,3/28,3.22%,LYL1;HHEX;BLNK
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.41609237284638095,-0.8798436131261506,0.7272727272727273,1.0,1.0,15/66,25.82%,MRPL33;MRPL19;MRPL43;MRPS7;MRPL20;MRPL51;MRPL45;MRPL27;MRPL47;MRPS15;MRPS21;MRPL13;MRPL32;MRPL52;MRPS25
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.5697655450589241,0.8795271749109954,0.7105263157894737,0.9919932454664154,1.0,1/5,7.78%,PPP1R12B
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),0.48900308702739126,0.879491465576063,0.59375,0.9908958621650586,1.0,2/9,2.81%,ZNF703;SH2B3
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.4338102927135785,0.8794853661529672,0.6333333333333333,0.9897314721977672,1.0,1/13,0.19%,ACER2
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.4298314410794121,-0.8794002550191662,0.7,1.0,1.0,9/60,10.86%,OMD;VCAN;OGN;B4GAT1;GSTP1;PAPSS2;GSTM3;MAT2A;GSTK1
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.4896947585375833,0.8793112100668276,0.5862068965517241,0.9889451373387225,1.0,1/5,5.16%,RNF20
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.5672667486597396,-0.8788180433810577,0.6212121212121212,1.0,1.0,3/6,35.45%,SNX17;CYP27A1;MT3
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.5672667486597396,-0.8788180433810577,0.6212121212121212,1.0,1.0,3/6,35.45%,SNX17;CYP27A1;MT3
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.5672667486597396,-0.8788180433810577,0.6212121212121212,1.0,1.0,3/6,35.45%,SNX17;CYP27A1;MT3
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.45165204068088743,-0.8785670804458638,0.6559139784946236,1.0,1.0,9/30,25.96%,FCGR2B;CD36;SNX6;CALCR;GRIN2A;CACNA1B;APP;EPHA4;ITGA4
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.500244694397084,0.8783258047345902,0.5555555555555556,0.9900489396649516,1.0,4/7,23.82%,SORL1;ARHGAP1;INPP5F;RAB11B
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.3744113943699335,0.8783033941443621,0.7,0.9889451047841384,1.0,3/19,10.19%,TLR7;IRF5;CHUK
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.4243744320030337,-0.8782024570138345,0.7291666666666666,1.0,1.0,19/73,22.90%,RACGAP1;FCGR2B;CENPE;SEC24C;AP2S1;HLA-DMB;SH3GL2;KIF15;KIF3A;DCTN4;ACTR1B;KIF11;DCTN2;KIF5A;FCER1G;DYNC1I1;SEC13;AP2A2;DCTN1
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.49536278439479464,-0.8778553519762576,0.7402597402597403,1.0,1.0,4/20,18.44%,JAML;PTPRD;IL1RAPL1;CADM1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.33458030259846183,0.8775814553509985,0.8461538461538461,0.9893952796230663,1.0,5/34,9.50%,NPR2;PANK1;PANK3;GUCY1A1;AMPD3
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.528812360844401,-0.8775467261353711,0.6666666666666666,1.0,1.0,7/10,40.74%,ZWILCH;CHAMP1;IK;KNL1;MIS12;CENPT;MTBP
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.4870867565880065,-0.8774915916110346,0.684931506849315,1.0,1.0,4/22,13.92%,FGF13;DCC;CDKN1B;MAG
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.4520007138593989,-0.8772387868622721,0.6785714285714286,1.0,1.0,6/34,12.95%,FTH1;AGT;GSTP1;MED25;FN1;BMI1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.46045594326981804,-0.8771075259545265,0.6896551724137931,1.0,1.0,7/31,21.60%,HIF1A;PDK3;NR1D1;ADCY8;HK2;SOX4;RACK1
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.5491836733365661,-0.8769765393293465,0.7014925373134329,1.0,1.0,2/10,9.99%,BRCA1;CTBP1
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.42450275346261845,-0.876689400853601,0.7555555555555555,1.0,1.0,8/64,17.30%,PLPP3;NIT1;MTHFD1;ACOT13;VNN2;BTD;CPE;NSMAF
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.5210867746064289,-0.8766029159972237,0.68,1.0,1.0,2/12,13.44%,TNFRSF1B;NR1D1
prerank,GO_Biological_Process_2021__leukocyte aggregation (GO:0070486),0.5423740609439964,0.8764993261087072,0.6470588235294118,0.9904670159154306,1.0,3/5,14.02%,SEMA4D;IL1B;JAM2
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.5265555686318689,-0.8764246941306862,0.6875,1.0,1.0,5/14,17.27%,ANK2;CALM3;DMD;CAV3;CALM1
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),-0.5828936462781806,-0.8763966022722268,0.6935483870967742,1.0,1.0,2/5,14.16%,CARMIL1;PYCARD
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),-0.494943516248222,-0.8761635999037782,0.6,1.0,1.0,2/9,13.05%,C5AR1;NLGN3
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.451541633677967,0.8760132426404782,0.7333333333333333,0.9902648381401769,1.0,3/10,17.43%,APH1A;ADAM10;DYRK1A
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.3194820640071391,0.8758329196927905,0.5833333333333334,0.9894557732898577,1.0,8/42,8.58%,MOSMO;MMD;BIN1;ZC4H2;CNTN4;EIF2AK4;YWHAG;BRINP3
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.5063742573345456,-0.8755662196344943,0.7215189873417721,1.0,1.0,6/15,25.57%,MEIS2;MAFB;ZFP36;ZBTB16;CTR9;HSPA9
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.34822969748776716,0.8755220906600008,0.6,0.9891311557094957,1.0,4/48,5.46%,ATRAID;DAB2IP;SORL1;LEPR
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),-0.5799340329886449,-0.8754612881332237,0.7101449275362319,1.0,1.0,2/5,15.79%,SIGIRR;PLSCR1
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.5742036109338156,-0.8753804086538318,0.7272727272727273,1.0,1.0,2/7,23.93%,DICER1;PRKRA
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.3696689120323862,0.8751475386125643,0.7647058823529411,0.9887108925711365,1.0,5/26,9.65%,FGL1;CD274;VSIG4;LAPTM5;DUSP3
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.5357984975017901,-0.8751115194754551,0.6811594202898551,1.0,1.0,1/11,1.32%,MX2
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.4135096839140134,-0.8750751871520617,0.71875,1.0,1.0,15/90,24.62%,TFRC;DDX11;CD36;INCENP;DHX16;TIMELESS;EIF3D;ILF3;MCM3;DDB1;TBRG4;GART;PDCD11;NEMP1;EIF3A
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.5184310469882532,-0.8750013263625607,0.6933333333333334,1.0,1.0,1/14,2.54%,MYO1G
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.5612730735134737,-0.8748287910810358,0.7,1.0,1.0,2/9,16.90%,CFTR;ADCY8
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.4442304966721681,-0.8746844872647335,0.686046511627907,1.0,1.0,5/47,11.20%,RHOBTB3;RHOB;GPM6B;EPHA3;IQGAP1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.35893828977609527,0.8745805722927379,0.6818181818181818,0.9887730482498149,1.0,7/25,9.69%,SH2B3;DAG1;SIRT1;CIB1;TRIB3;ARRB2;INPP5K
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.5393870292403684,-0.8745774577641197,0.6842105263157895,1.0,1.0,3/10,9.55%,NTN4;LAMB1;GPM6B
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.40838078893443575,-0.8744609402135174,0.78,1.0,1.0,36/160,20.31%,DDIT4;GRIK1;SPOCK1;VCAN;MAL;NR4A2;MEIS2;LSR;GSTP1;EIF2B2;CXCR4;MARCKSL1;PAX8;UTP3;MOG;ADGRL2;CDH2;ADGRL3;TUBGCP2;APOD;PTPRZ1;SHROOM4;POU6F1;BTD;SH3GL2;TAGLN3;PTS;NFIB;ADAM23;RELN;TPP1;SERPINI1;ROBO2;EPHA7;HPCAL4;CTNS
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.596082348991217,-0.8744073905054957,0.676056338028169,1.0,1.0,4/5,40.42%,VIPAS39;PLOD1;PLOD3;PLOD2
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.44028038848406365,-0.8744073815114686,0.6590909090909091,1.0,1.0,11/60,17.39%,TFRC;VEGFA;SLF1;SDCBP;MPP7;RGCC;SNF8;RPS3;BMF;SLX4;CLU
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),0.4578013397995969,0.8743594528724291,0.5862068965517241,0.9880931242812308,1.0,2/10,1.01%,SIRPA;LGALS9
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.5757759165910197,-0.8743194037140559,0.7236842105263158,1.0,1.0,1/7,6.19%,NHP2
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.5047605591437357,-0.8742368905355388,0.6883116883116883,1.0,1.0,5/14,12.13%,TOM1L1;ADGRG6;PKP2;BAIAP2L1;EPB41L4B
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.5930469185805379,-0.8742115854276614,0.704225352112676,1.0,1.0,1/5,0.77%,GLA
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.5930469185805379,-0.8742115854276614,0.704225352112676,1.0,1.0,1/5,0.77%,GLA
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.5613652097846725,-0.8741053085044904,0.7083333333333334,1.0,1.0,3/8,15.87%,CBLB;SNX6;ERRFI1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.4021514846419868,-0.8738329442370959,0.7083333333333334,1.0,1.0,25/118,25.18%,FZD6;RBMS3;LZTS2;RBX1;AMER2;DKK2;LIMD1;TLE1;PSMA3;APC2;PSMA5;LRP4;PSMD8;PSMB4;PSMD7;PRICKLE1;DVL1;PSMD5;RACK1;EMD;PSMC2;PSMB9;UBAC2;CCDC88C;PSMB2
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),-0.5944708748235126,-0.8733861094471427,0.6785714285714286,1.0,1.0,1/5,7.65%,ANTXR2
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),-0.5783318682946437,-0.8730549886557877,0.6716417910447762,1.0,1.0,2/5,24.26%,PMPCA;PMPCB
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.5705906809786385,-0.8728729621818544,0.7246376811594203,1.0,1.0,1/6,2.56%,VEGFA
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.41298663512377587,-0.872536850580818,0.7391304347826086,1.0,1.0,13/70,15.19%,PLPP3;ENPP4;TAMALIN;DOCK1;STXBP6;NTN4;PROCR;THBD;FN1;SVEP1;PALLD;NR1D1;SH3D19
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),-0.6068385465180332,-0.8720414709889373,0.7941176470588235,1.0,1.0,1/5,16.53%,IMPACT
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.5147852888559049,-0.8719886109861785,0.6363636363636364,1.0,1.0,1/13,3.27%,RBPJ
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),-0.5492475503443569,-0.8717068480977377,0.6835443037974683,1.0,1.0,1/8,9.99%,CTBP1
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.4590420067056074,-0.8716752119477004,0.6547619047619048,1.0,1.0,9/30,22.96%,VEGFA;CD63;B2M;INSR;ANXA2;CLU;RAB21;TF;HFE
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.4011140579116268,0.8715996681100925,0.7083333333333334,0.9929591202946259,1.0,3/18,7.41%,LGALS9;APPL2;IL1B
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.45871273307093013,0.8713057945897905,0.5862068965517241,0.9924541258608872,1.0,2/9,12.60%,P2RY12;P2RX7
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.4193896156599855,-0.8705612427053143,0.7386363636363636,1.0,1.0,15/61,25.82%,MRPL33;MRPL19;MRPL43;MRPS7;MRPL20;MRPL51;MRPL45;MRPL27;MRPL47;MRPS15;MRPS21;MRPL13;MRPL32;MRPL52;MRPS25
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.32516942010351113,0.8704919092933869,0.75,0.9930045748425149,1.0,8/44,10.48%,PKD2;RYR1;ALOX5AP;SYT17;ITPKB;RASGRP2;CPNE4;SYT6
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.43532475384145064,-0.8701946128443268,0.6813186813186813,1.0,1.0,3/44,3.72%,TFRC;MX2;MX1
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),-0.43047204875684497,-0.8697028790434721,0.7,1.0,1.0,10/44,19.31%,OMG;CHN1;SIPA1L1;LRRC4C;METRN;CDH2;MAG;LRP4;THY1;ROBO2
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.3341932929298534,0.8696063953831394,0.625,0.9936768373262217,1.0,6/36,8.18%,IPPK;PLD4;ISYNA1;OCRL;ITPKB;PLCB4
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.5089413115822683,0.8695462009723578,0.6216216216216216,0.9926126897943298,1.0,2/7,4.79%,BIN1;CAB39
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),-0.5601370890617149,-0.8693337658770864,0.6865671641791045,1.0,1.0,1/6,9.44%,CD36
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.277254414351006,0.8693130657525027,1.0,0.9920831324948193,1.0,8/104,6.37%,NUP42;NUP188;NUAK1;BAG5;MAPKAPK2;NEK6;ABL1;SIRT1
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.3540667833396753,0.868914995006221,0.75,0.9919636600635238,1.0,8/39,7.19%,ACER2;SESN2;TIPRL;NBN;ABL1;BID;TP53;INTS7
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.45877736538763164,0.8684102162804018,0.6521739130434783,0.991939754712574,1.0,5/12,25.25%,TRAK2;MFN1;MARK2;TRAK1;NECTIN2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.37649099301056776,0.8683140475226443,0.7666666666666667,0.9909912691504209,1.0,4/19,10.24%,IPPK;PHF8;WDR43;NOL11
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.5547252499093663,-0.8680624804038987,0.746268656716418,1.0,1.0,5/9,30.78%,CD36;EIF2AK2;NLRC3;GBP5;DHX33
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.3471643115084596,0.8678513575614684,0.6875,0.9894942431136171,1.0,4/30,5.85%,SMAD7;SMURF1;TGFB1;ACVR1
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.3471643115084596,0.8678513575614684,0.6875,0.9894942431136171,1.0,4/30,5.85%,SMAD7;SMURF1;TGFB1;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.4904247853726391,-0.867760824859096,0.6578947368421053,1.0,1.0,3/15,21.27%,FLT1;GNA13;NTRK3
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),0.5095910451236492,0.8676573099188467,0.6842105263157895,0.9887279730097017,1.0,1/6,1.01%,LGALS9
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.41710523743719674,-0.8673381104419093,0.7010309278350515,1.0,1.0,17/63,26.77%,VAV3;CHN1;SIPA1L1;ITSN1;SDCBP;EPHA3;EPHB1;AP2S1;NGEF;DNM1;EPHA7;ACTG1;AP2A2;ANKS1B;EPHA4;APH1B;ROCK1
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.43645837965405165,0.8672130378390795,0.6470588235294118,0.9886808313594185,1.0,3/9,12.55%,TAPT1;PKDCC;SOX5
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.5360687162256038,-0.8672086897286442,0.6911764705882353,1.0,1.0,3/9,17.09%,XRCC3;DNA2;SLX4
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.5360687162256038,-0.8672086897286442,0.6911764705882353,1.0,1.0,3/9,17.09%,XRCC3;DNA2;SLX4
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.5360687162256038,-0.8672086897286442,0.6911764705882353,1.0,1.0,3/9,17.09%,XRCC3;DNA2;SLX4
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.5842789955880218,-0.8670722524506194,0.7236842105263158,1.0,1.0,3/5,18.67%,RIOK2;CENPE;HECW2
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),-0.5429027859543153,-0.8668894233874412,0.6486486486486487,1.0,1.0,2/9,8.68%,TRMT9B;GTPBP3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.5218314212082931,-0.866676644142115,0.7837837837837838,1.0,1.0,4/16,11.31%,BCL2A1;APPL1;BCL2L2;DCC
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.27962905050266973,0.8664227833556356,0.8,0.9894585151005995,1.0,10/62,12.60%,PKD2;ATP2C1;MCU;MICU3;MAIP1;SLC35G1;SMDT1;TRPC1;ATP2A3;P2RX7
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.43837851290866225,0.866252133598759,0.64,0.988586870578695,1.0,2/14,4.71%,FSCN1;SCRIB
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),-0.5775846621453853,-0.8659139465458034,0.7162162162162162,1.0,1.0,1/7,9.51%,NOTCH2
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.45841400284071854,-0.8657719758626045,0.686046511627907,1.0,1.0,7/25,26.85%,RIMS1;NSF;SYT1;ANXA2;RIMS2;RIMS3;GRIK2
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.3724684210324575,0.8657101902127096,0.5714285714285714,0.988607496544238,1.0,4/21,12.08%,TGFB1;TP53;MAP2K1;MAP2K2
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3443392923126048,0.8656965622148383,0.7894736842105263,0.9875097485114518,1.0,7/24,19.96%,AGO1;PUS10;SMAD2;SRRT;SMAD3;TUT7;PUM1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3989866098333407,0.865419254745622,0.45,0.986939377209017,1.0,1/12,1.53%,BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.46063778249170717,0.8654091712704515,0.5277777777777778,0.9858460146647674,1.0,2/5,5.44%,NEXMIF;PPM1F
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.5222534862043979,0.8653886365684572,0.6451612903225806,0.9847417034098899,1.0,3/5,7.21%,SPRED2;SPRED1;SPRY2
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.4474006480069759,-0.8650917723955502,0.6666666666666666,1.0,1.0,4/32,6.91%,RHOB;ARHGAP4;CFL1;RHOU
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.5199971303947116,-0.8648229322457152,0.6883116883116883,1.0,1.0,3/20,15.46%,NHP2;RFC1;TERF2IP
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.35501354281267594,0.8644297089228494,0.631578947368421,0.9854506192036732,1.0,3/23,2.19%,CLEC5A;CX3CR1;VEZF1
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),-0.5247805550449177,-0.8643821928344622,0.7121212121212122,1.0,1.0,2/9,8.34%,GAS2L3;BAIAP2L1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.42772501896789444,-0.8643797834642987,0.7608695652173914,1.0,1.0,6/69,8.83%,RNF144B;ARIH2;RBX1;DDRGK1;NOP53;HSPA1B
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.322745824550107,0.8643462519278147,0.85,0.9845502178310472,1.0,5/31,11.50%,PLXNA2;SEMA4D;PLXNA4;SHTN1;PLXNB2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),-0.532538341758339,-0.864127788295648,0.7808219178082192,1.0,1.0,2/8,15.05%,GPM6B;CAV3
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.3275497596096316,0.8640791476918072,0.8125,0.9840399429564579,1.0,8/41,15.47%,LRP10;ABHD11;TMEM79;DENND1C;ANXA11;PIEZO1;RHBDF2;SCAMP2
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.38904699343075355,-0.863637220729735,0.96,1.0,1.0,114/645,19.39%,TFRC;RPL23;SAP30;ACVR1B;TRIM5;NFIL3;SLC11A1;FGF1;BHLHE40;RBMS3;VEGFA;HINT1;OVOL2;TGFB2;RIMS1;RBPJ;HIF1A;FAM50A;GLRX2;RPL11;RORA;TXK;PQBP1;CCL3;TAF6L;APBB3;NOCT;DDRGK1;SLC7A5;ANK3;BRCA1;PLAG1;ATF5;MAPT;PINK1;CAMK2N1;PRKCQ;CHD3;ANK2;MSL3;PARP9;BTN2A2;KDM6B;HSPA1B;TTN;RORB;HCFC1;ID2;LIMD1;CD36;NOTCH2;AHNAK;PPIE;TLE1;ITGB8;RRP1B;DRAP1;BTN3A1;EIF2AK3;CCDC3;CGGBP1;RPL6;TCF7;OLFM1;MOG;USP36;RPL5;RGCC;EPB41L4B;RPS7;FN1;PRDM1;BMI1;HCLS1;PARP14;PID1;SNF8;ZNF100;ZKSCAN5;ZNF519;RDX;INSR;RPS3;CREM;PIK3CB;TERF2IP;TLR2;PLSCR1;SH3GL2;MLX;HMGN5;MAFB;CIAO3;BCL6;PTRH2;POU5F1;DICER1;CLU;KLF4;BRCA2;BTN2A1;ATP2B4;CLK1;CALCR;ACTR5;TRIM22;CLK2;METTL4;TRIM14;PARP15;NFKBIZ;MYBL1;AIF1;CITED2
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.4873494366292549,-0.8627374958569549,0.6756756756756757,1.0,1.0,2/15,10.30%,TGFB2;SDCBP
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.41988055542459607,-0.8626699555815991,0.7191011235955056,1.0,1.0,13/47,25.18%,PSMA3;PSMA5;AZIN1;PSMD8;PSMB4;SIRT5;PSMD7;PSMD5;PSMC2;PSMB9;PRKAG2;PPARA;PSMB2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.4544429216274309,0.862558193768697,0.6666666666666666,0.9861508240308849,1.0,1/11,1.96%,ZNF385A
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.3636848984784708,0.8625358718953963,0.75,0.9851058033040331,1.0,4/27,9.64%,BACH2;SNRPB;SNUPN;PHAX
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.538566885387178,-0.8624513376991964,0.6666666666666666,1.0,1.0,3/8,15.50%,DUOX1;ALDH1A1;ST14
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.5287378825512399,-0.8624301387076893,0.6578947368421053,1.0,1.0,2/9,25.22%,EIF2D;DHX29
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.4826369483263327,-0.862304874923842,0.7349397590361446,1.0,1.0,5/23,8.68%,TBC1D8;PLN;STAT1;HTR7;SOD1
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.5574992148834349,-0.8622951594612969,0.7671232876712328,1.0,1.0,3/9,15.90%,MX1;IFIT1;ATAD3A
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),-0.41846237314320245,-0.8618997483774468,0.7708333333333334,1.0,1.0,15/76,15.14%,ACVR1B;PTN;FLT1;GP6;FGR;RASGRP4;EPHA3;ANGPTL1;PTPRT;LIFR;EPHB1;ALK;PTPRD;INSR;PIK3CB
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),-0.6117945264198321,-0.8617741449626866,0.8208955223880597,1.0,1.0,1/6,14.87%,TRAF2
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),0.522614405623897,0.8616997964642306,0.5714285714285714,0.9856369330380442,1.0,2/6,8.78%,LGALS9;ARRB2
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.43629665578371846,-0.8615530399335892,0.7471264367816092,1.0,1.0,7/36,14.88%,TFRC;IL15;IL18;PDCD1LG2;PYCARD;RPS3;HLA-DMB
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.42015992158133514,0.8614730979459069,0.6818181818181818,0.9851010871944628,1.0,1/10,0.86%,PUS1
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.5471166173689744,-0.8609552515134984,0.6984126984126984,1.0,1.0,6/8,40.74%,ZWILCH;CHAMP1;IK;KNL1;MIS12;MTBP
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),-0.5111118367958293,-0.8604829276989848,0.6976744186046512,1.0,1.0,5/16,20.74%,GPR183;SNX10;ANXA2;FOXP1;OSCAR
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.42212878880073185,-0.8604453834752993,0.7471264367816092,1.0,1.0,16/42,22.75%,PLPP3;ASPN;MYLK;TNS1;LAMA2;GSTM3;SAT2;SVEP1;SH3D19;ABCA8;PMP22;CALD1;UACA;MATN2;CRYAB;KCNMB1
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.4519225548289778,-0.8603255884720956,0.675,1.0,1.0,3/28,17.27%,FZD6;GNAO1;CALM1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.42094378860705955,-0.8602447961468993,0.7582417582417582,1.0,1.0,16/60,19.33%,VIM;HMGB2;TNFRSF1B;GSTP1;NOD2;FCGR2B;PDCD1LG2;PDE4B;CARD16;NR1D1;CD14;PYCARD;TLR2;PDCD4;CHMP5;LILRB2
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.4112423838711907,-0.8601424298786616,0.7473684210526316,1.0,1.0,14/65,24.17%,FAM50A;RPS13;PQBP1;AHNAK;RRP1B;C9ORF78;CLK1;CLK2;METTL4;MBNL2;AKAP17A;RPS26;U2AF2;SRSF3
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.48909216261370303,0.8599028278356087,0.696969696969697,0.9871613669968408,1.0,1/6,15.01%,IL12RB1
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.47696867081174094,-0.8597312208990379,0.7142857142857143,1.0,1.0,4/22,9.72%,TRIM5;IFITM3;HS3ST5;TRIM25
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.43432464295887413,-0.8595124281948628,0.7142857142857143,1.0,1.0,5/33,9.55%,SRGN;PTN;CCL3;FBN2;GPM6B
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),-0.47959579262582963,-0.8593366131112383,0.7176470588235294,1.0,1.0,5/21,15.71%,SEMA3A;MAP1B;NLGN3;SPG11;SLC9A6
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.47048737890987175,-0.8592529041839222,0.6707317073170732,1.0,1.0,4/22,15.30%,KNSTRN;SYAP1;IQGAP1;EEF1A1
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.5288263594409757,-0.859001417661321,0.7205882352941176,1.0,1.0,4/9,40.81%,PSMD5;OTUD6B;POMP;PSMG1
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.5378946469530445,-0.8589887592705784,0.726027397260274,1.0,1.0,1/8,4.69%,MTHFD1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.47420745869960035,-0.858744957947481,0.7160493827160493,1.0,1.0,4/25,18.79%,SLF1;RPA2;TERF2IP;TPP1
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.3776113830820099,0.8584873267658873,0.6666666666666666,0.9890176368356449,1.0,2/18,2.08%,DGUOK;ADK
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.4577726394258942,-0.8582032962035784,0.6756756756756757,1.0,1.0,1/18,0.73%,THBS1
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.5550812457475253,-0.8577248509264184,0.7285714285714285,1.0,1.0,2/7,11.44%,SEC61B;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.4554409029025039,0.8575279520706888,0.6666666666666666,0.9900199876577591,1.0,2/7,9.02%,ICAM1;PLVAP
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.5545245824385762,-0.8574274567665247,0.6805555555555556,1.0,1.0,3/8,20.04%,VPS11;RDX;RAB21
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.4321112607030573,-0.8573373675594649,0.7160493827160493,1.0,1.0,5/30,14.79%,TVP23A;RAB3A;ABCA1;RAB3C;RAB15
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.5237654069850581,-0.8570781174072305,0.7027027027027027,1.0,1.0,4/11,12.62%,PLN;ATP5IF1;PXK;IFIT1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.409200328878146,-0.8570241186440762,0.7604166666666666,1.0,1.0,15/69,20.33%,EIF4A3;ZNF540;DAPK1;RPL13A;CAMK2N1;GAPDH;EIF2AK3;RIDA;ENC1;RPS3;CNOT8;ILF3;PATL2;PUS7;EIF2AK2
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.4636431948050355,0.8566604728764111,0.6470588235294118,0.9905956908726515,1.0,1/10,0.94%,SNAP47
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.4026787753349218,-0.856581843659668,0.6989247311827957,1.0,1.0,7/71,10.76%,RPS27A;FOS;OVOL2;TGFB2;APPL1;UBA52;UBC
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.4288013211051087,-0.8563104614576497,0.7282608695652174,1.0,1.0,5/46,3.75%,PLPP3;SPARC;VEGFA;ADAMTS2;LAMA2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.42745789918822563,-0.8561287132394946,0.7333333333333333,1.0,1.0,11/50,17.27%,CENPV;SVIL;RACGAP1;RAB11A;CALM3;PRKCE;KLHL13;CIT;PIK3R4;E2F7;CALM1
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),-0.5540163474882668,-0.8558778183528593,0.7662337662337663,1.0,1.0,3/7,33.46%,TERF2IP;DAXX;H3-3A
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),-0.5540163474882668,-0.8558778183528593,0.7662337662337663,1.0,1.0,3/7,33.46%,TERF2IP;DAXX;H3-3A
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.41995211191811593,0.855723851385094,0.72,0.9914218133973433,1.0,5/15,9.81%,CSF1R;TGFB1;PLD4;TP53;MLF1
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.4894246554007182,0.8556906145963954,0.5714285714285714,0.9892749091702434,1.0,2/5,4.43%,PPARG;TGFB1
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.4894246554007182,0.8556906145963954,0.5714285714285714,0.9892749091702434,1.0,2/5,4.43%,PPARG;TGFB1
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.40400780643948636,-0.8551340581310867,0.7731958762886598,1.0,1.0,10/75,12.92%,JAML;MYO1G;IL7R;CD69;SELL;IL10RA;ACAP1;ITGAE;TCF7;LSP1
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.4720106285917569,-0.8550623808024359,0.6438356164383562,1.0,1.0,4/13,14.20%,OVOL2;ID2;CFTR;PIEZO2
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.5307063334775565,-0.8549199359313433,0.6666666666666666,1.0,1.0,1/7,11.27%,IRF1
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.4119897551395667,-0.8543463809219838,0.6451612903225806,1.0,1.0,12/39,21.36%,FGF13;SHANK3;CDH2;ADGRL3;GPM6A;NLGN3;NRXN1;GABRG2;NRXN2;GABRB3;DVL1;GABRA2
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.4824592627260268,-0.8541552330850806,0.7236842105263158,1.0,1.0,3/17,10.65%,MMP21;CCDC39;STIL
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.3977958386453879,-0.8541492411079271,0.826530612244898,1.0,1.0,27/122,20.05%,AGT;PRELID1;NDRG1;DAPK1;PINK1;STAT1;DAPK2;NOP53;PAX8;TPT1;BEX2;BNIP3L;BNIP3;USP36;CTSB;ALK;RPS3;BCL2L14;TRAF2;CIDEB;LGALS1;BCL6;CLU;TP53INP1;SRA1;SGK1;SEPTIN4
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.5864168793804359,-0.8541392987833868,0.7076923076923077,1.0,1.0,1/6,8.72%,NR1H2
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),-0.4491974679294714,-0.8541248962396062,0.7023809523809523,1.0,1.0,11/34,24.87%,GLA;GALC;UGCG;ST8SIA1;GBA3;SUMF2;ST8SIA3;STS;ASAH1;SUMF1;CTSA
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.31135485780860844,0.8539316545337017,0.75,0.9921066644365755,1.0,12/71,6.95%,LYL1;TAL1;P2RX1;SH2B3;HHEX;ARHGDIB;RPIA;SIPA1;RHOG;VASP;NMI;STK10
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),0.44334824073503204,0.8537685373157649,0.5714285714285714,0.9913315870781453,1.0,4/10,17.83%,MRPS27;FASTKD2;RPUSD3;UQCC2
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.5756625924395744,-0.8533739441459796,0.7285714285714285,1.0,1.0,1/6,9.44%,CD36
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.5690477389559367,-0.8532918486428216,0.6901408450704225,1.0,1.0,3/5,34.91%,KLF4;SLC25A37;PRMT1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.38998693935954765,-0.852730495316423,0.8787878787878788,1.0,1.0,57/304,23.65%,DIAPH3;CYCS;SEMA6A;CATIP;ATP8B1;ARHGAP4;CFL1;CCL3;VPS11;RHOU;PINK1;FGD6;HCFC1;LIMD1;MTERF1;BNIP1;EIF2AK3;LNPK;AGTPBP1;PAK5;UBXN2B;VPS51;PALLD;GOLGA8B;GOLGB1;VMP1;SH3D19;BCS1L;PEX3;ATAD3A;SIRT3;SIRT5;MICAL2;THY1;KIF3A;CHCHD2;FGD3;REEP5;CHMP5;PDCD6IP;FAM174B;SLC25A36;POLG2;SYNE3;GORASP1;DYNC2H1;KIF5C;MCOLN1;SPTBN5;ZMYM3;PPID;SPRYD3;VAPA;PEX10;TFAM;NEDD9;ARHGAP10
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),-0.5512569868613517,-0.8527008961088505,0.7096774193548387,1.0,1.0,2/7,14.16%,CARMIL1;PYCARD
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.4956662847771591,-0.8525994058591624,0.6621621621621622,1.0,1.0,2/15,7.80%,HIF1A;PINK1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.38705987863055513,0.85253762879847,0.5454545454545454,0.9928373479343486,1.0,10/24,24.73%,SCRIB;MSN;RAP2A;CDC42;OPHN1;LIN7B;MARK2;LIN7A;PRKCI;ERBIN
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.5684638917058555,-0.8522792470378047,0.7424242424242424,1.0,1.0,2/7,19.23%,ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.4253331751259336,-0.8521314980746945,0.782608695652174,1.0,1.0,6/64,8.83%,RNF144B;ARIH2;RBX1;DDRGK1;NOP53;HSPA1B
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.3913445142159705,0.8519305639723909,0.5862068965517241,0.9929843412665903,1.0,4/17,9.28%,DAG1;MYH9;APH1A;ADAM10
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.3951454527972857,-0.8519190820568402,0.8080808080808081,1.0,1.0,26/180,16.53%,TFRC;PAQR3;PLPP3;FGF1;VEGFA;SLCO3A1;PPP2R5A;MARCO;PPP2R5B;FAXDC2;FGR;PINK1;CLIP3;SOD1;NOP53;TTN;ATF3;EIF2AK3;FAM20A;FN1;PID1;INSR;TERF2IP;SH3GL2;STAT2;IMPACT
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.3984959953694798,0.8518451105169185,0.6521739130434783,0.9920005533082076,1.0,6/15,18.04%,SPIN1;GTF3C2;GTF3C3;NIFK;GTF3C5;GTF3C4
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.505322082666569,-0.8516251832868864,0.7,1.0,1.0,5/15,15.94%,SLC5A9;CYP3A5;FMO5;GBA3;GIPC2
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.4224365660229376,-0.8515220488673838,0.7272727272727273,1.0,1.0,18/41,36.04%,PSMA3;PSMA5;AZIN1;PSMD8;PSMB4;PSMD7;PSMD5;PSMC2;PSMB9;PSMB2;PSMB6;PSMD14;PSMC6;ODC1;PSME2;PSMA4;PSME1;PSMC1
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.5566306433454057,-0.8515143979989918,0.71875,1.0,1.0,1/7,2.89%,TGFB2
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),0.35939438714552197,0.8513361647708624,0.56,0.9920562366547766,1.0,3/18,9.57%,MMS19;HSCB;ABCB7
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.5434490594056496,-0.8513028674754037,0.7432432432432432,1.0,1.0,6/11,29.12%,TYMP;CAD;UPP2;UCKL1;PUDP;DCK
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.44640431326354946,-0.8511764548864578,0.7011494252873564,1.0,1.0,2/28,11.81%,PLPP3;MTMR7
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.4600782478173775,0.8509753301359122,0.6764705882352942,0.9916396310425982,1.0,2/9,7.41%,SORL1;IL1B
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.529362132263426,-0.8508918755226745,0.7575757575757576,1.0,1.0,5/9,27.99%,GSTP1;TRAP1;ASXL3;PPARA;CIITA
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),-0.584537135228097,-0.8508111233653641,0.7384615384615385,1.0,1.0,1/5,3.44%,ADCY3
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),-0.495109310706911,-0.8507412219574426,0.6721311475409836,1.0,1.0,4/9,15.55%,NLGN3;PTPRD;IL1RAPL1;LRP4
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.39353734300607796,-0.8506127093453588,0.8247422680412371,1.0,1.0,28/128,21.55%,PAQR3;SPOCK1;SEMA3A;PTN;CFL1;CHN1;SIPA1L1;ZDHHC15;LRRC4C;SHANK3;RTN4IP1;EPHA3;DCC;CDH2;PTK7;MAG;IL1RAPL1;TOX;ITGA6;RELN;SERPINI1;ATP1B2;STMN2;LRRC7;RTN4RL1;NTRK3;NTNG1;CSMD3
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.3864520064994661,0.850504034991118,0.7222222222222222,0.9916431856326647,1.0,2/14,8.78%,LGALS9;ARRB2
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.39666395541159244,-0.850426768718119,0.8229166666666666,1.0,1.0,6/98,5.60%,PRKAR2B;CDK14;HAUS6;TUBB4A;TUBA4A;MASTL
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.403935535126525,-0.8503365558370669,0.8020833333333334,1.0,1.0,22/136,14.27%,HTR2B;CCL4;GLIPR2;CHI3L1;GPR183;SEMA6A;C5AR1;SPRY1;CCL3;GSTP1;NOD2;MARCO;CAMK2N1;CD36;NOTCH2;MAP3K12;APIP;TRAF7;FN1;EPHB1;PYCARD;CD44
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.4208978725999639,-0.8500755667099541,0.7252747252747253,1.0,1.0,8/58,14.27%,ENPP2;AGT;VEGFA;IL15;TEC;HCLS1;GHR;CD44
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.4950892540903449,0.8500463252582288,0.6666666666666666,0.9914896916442429,1.0,3/6,14.77%,AMPD3;AK3;NUDT2
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),-0.48669042485977615,-0.8493286403489622,0.6290322580645161,1.0,1.0,4/10,15.55%,NLGN3;PTPRD;IL1RAPL1;LRP4
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.442302255497658,-0.8492813120915066,0.7555555555555555,1.0,1.0,7/31,13.85%,PTN;COBL;ZDHHC15;RTN4IP1;DCC;ALK;NSMF
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.5434683679700871,0.8491023277041313,0.7272727272727273,0.992120873439194,1.0,2/7,7.59%,PKD2;JAG1
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),-0.5597578963602022,-0.8490988982860087,0.765625,1.0,1.0,1/8,7.11%,AKR1B1
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),-0.5140257807192902,-0.8487490748888445,0.6578947368421053,1.0,1.0,3/9,38.88%,HMOX1;ERN1;ITGB1BP1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.4659529005452645,-0.8487094725364355,0.7341772151898734,1.0,1.0,7/28,15.60%,PRELID1;MAPT;PINK1;ATP5IF1;SOD1;PID1;UBB
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.48329501129764274,-0.8487041505403428,0.7402597402597403,1.0,1.0,2/13,10.65%,BRCA1;STIL
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),0.4459836558599547,0.8485918845946302,0.5483870967741935,0.9919019018993467,1.0,2/10,9.30%,TICAM1;SCIMP
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.3375752579592398,0.8483593413339469,0.7777777777777778,0.9913703689436139,1.0,2/36,2.29%,IDE;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.5008735012834227,-0.8482159832752261,0.7126436781609196,1.0,1.0,3/14,14.30%,VPS11;ATP5IF1;RDX
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),-0.5512713577827822,-0.8481172874727907,0.6833333333333333,1.0,1.0,2/5,15.05%,ANK2;CAV3
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.4984733148205511,0.8481092963439371,0.7297297297297297,0.9906836558025783,1.0,6/8,9.79%,CSF1R;PPARG;PIR;MYH9;PDE1B;THOC5
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.41608929679038703,-0.8480205485456266,0.7640449438202247,1.0,1.0,5/47,13.29%,TFRC;NMD3;PARP9;EIF2AK3;HCLS1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),-0.5031296354104466,-0.8475311143423074,0.7222222222222222,1.0,1.0,5/11,26.88%,TRPS1;MBOAT2;BMPR1B;ZBTB16;SOX6
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.4187287369848523,-0.8471328751162019,0.7386363636363636,1.0,1.0,7/39,21.50%,GRM8;COL11A1;SLC4A10;SLC24A1;OAT;KIFC3;EML2
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.3958620241067782,0.847111604960939,0.6818181818181818,0.9914040526785188,1.0,2/17,0.72%,CTBS;HPSE
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.43590768274786956,-0.8470915913329244,0.6829268292682927,1.0,1.0,10/27,20.33%,HIF1A;IL7;ALOX15B;IL18;PYCARD;SIGIRR;TLR2;AIF1;FOXP1;EIF2AK2
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.4835594939256228,-0.8469436176322207,0.7415730337078652,1.0,1.0,1/18,3.88%,RNF126
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.40978291874328626,-0.8469297012634949,0.7604166666666666,1.0,1.0,19/75,22.90%,RACGAP1;FCGR2B;CENPE;SEC24C;AP2S1;HLA-DMB;SH3GL2;KIF15;KIF3A;DCTN4;ACTR1B;KIF11;DCTN2;KIF5A;FCER1G;DYNC1I1;SEC13;AP2A2;DCTN1
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.5215974638655552,-0.8467694746102518,0.7702702702702703,1.0,1.0,2/8,15.79%,SIGIRR;PLSCR1
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),-0.5395509203235795,-0.8467309599734564,0.7580645161290323,1.0,1.0,3/7,33.88%,GRIA2;APP;GRIN3A
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.4241214475602826,-0.8467185360754338,0.6867469879518072,1.0,1.0,3/36,7.91%,EYA2;BRCA1;TMEM161A
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.4503755416203442,-0.8465021685969522,0.7125,1.0,1.0,3/28,8.89%,CCL3;IL18;ABCB4
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.39116975771401663,-0.8464602686873537,0.8315789473684211,1.0,1.0,22/107,21.78%,PP2D1;PLPP3;CTDSP1;DUSP1;PPP2R5A;FBP1;PPP2R3B;PPP2R5B;PPP1CB;MTMR7;PTPRT;PTPRZ1;PTPRD;DUSP12;PTPRB;PTPRG;ACP3;PTPRA;PPP2R3A;PLPPR4;PTPRK;DUSP16
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.5630809043115164,-0.8463740832511693,0.7464788732394366,1.0,1.0,3/6,34.91%,KLF4;SLC25A37;PRMT1
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),-0.5827889505892633,-0.8463358811727884,0.703125,1.0,1.0,3/5,37.94%,CACNG2;DLG4;CACNG8
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),-0.5827889505892633,-0.8463358811727884,0.703125,1.0,1.0,3/5,37.94%,CACNG2;DLG4;CACNG8
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.532952740402437,-0.8461150437457223,0.7076923076923077,1.0,1.0,1/8,3.42%,C5AR1
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.566630554752272,-0.8460976267607039,0.7391304347826086,1.0,1.0,2/5,29.52%,PRUNE1;ATCAY
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.46184196025766905,0.8458776010500373,0.6666666666666666,0.9930589065603419,1.0,4/8,5.85%,SMAD7;TGFB1;TGFBR2;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.4342371796073538,-0.8458293464808987,0.7608695652173914,1.0,1.0,10/49,17.03%,AGT;TGFB2;FLT1;FGR;IL18;FN1;HCLS1;INSR;PIK3CB;IRS2
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.5188668048618215,-0.8456347064422294,0.7391304347826086,1.0,1.0,3/9,18.64%,PDCL;TXNDC15;TTC23
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.436715333010585,0.8456321954813606,0.7,0.9924894774023877,1.0,3/11,6.63%,LRCH1;SH2B3;CXCL12
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.49170593942446683,-0.8456188624574678,0.7631578947368421,1.0,1.0,2/17,5.45%,HMGB2;H1-0
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.4056310361060195,-0.8455612582663953,0.7835051546391752,1.0,1.0,24/83,21.47%,SH3PXD2B;ADGRA3;DOCK1;MYO10;LAMB1;BNIP3;ADGRL2;COL4A5;FRAS1;LIFR;PTK7;ENAH;SH3D19;RND3;LRP4;ITGA6;POU5F1;KLF4;THY1;PTPRG;KITLG;RBFOX2;GULP1;UACA
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),-0.5710026364442106,-0.845428570563619,0.7384615384615385,1.0,1.0,2/6,10.65%,COBL;STIL
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.4890506619403321,-0.8453054296316461,0.75,1.0,1.0,2/11,10.00%,TGFB2;HLA-F
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),-0.565148395383149,-0.8451385095633056,0.7090909090909091,1.0,1.0,1/5,16.45%,ANXA2
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.46093781042095316,0.8449452686117573,0.65625,0.9927904234307572,1.0,2/8,12.60%,P2RY12;P2RX7
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.5506210500734079,-0.8447262504689405,0.7681159420289855,1.0,1.0,1/7,4.69%,MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.4402131522909225,-0.8443982977275954,0.7790697674418605,1.0,1.0,6/29,16.76%,CR1;DHX58;NLRC5;OAS3;STAT2;SERPING1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.5003030768607348,-0.8441488381891683,0.6923076923076923,1.0,1.0,4/12,17.23%,RIMS1;UNC13A;SYT1;SYT4
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.5003030768607348,-0.8441488381891683,0.6923076923076923,1.0,1.0,4/12,17.23%,RIMS1;UNC13A;SYT1;SYT4
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.3958681825400687,-0.8438661600036106,0.8526315789473684,1.0,1.0,6/99,5.60%,PRKAR2B;CDK14;HAUS6;TUBB4A;TUBA4A;MASTL
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.5773299969217226,-0.8433773245866358,0.7424242424242424,1.0,1.0,1/5,8.12%,RDH11
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),-0.49304000546615845,-0.8432500595461014,0.7076923076923077,1.0,1.0,5/14,22.88%,INTS12;ZCCHC8;INTS10;INTS8;INTS3
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.5159612289539879,-0.8432436955747311,0.6944444444444444,1.0,1.0,1/9,0.73%,THBS1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.47026387861776714,-0.8432237047419172,0.7662337662337663,1.0,1.0,3/19,10.64%,ACSL1;CD36;MID1IP1
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.4217888708884161,0.8432079131991393,0.5416666666666666,0.995539747264361,1.0,4/13,6.76%,NRP1;PKD2;TGFBR2;SALL1
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.5135683515052012,-0.8430153627773993,0.7051282051282052,1.0,1.0,6/9,32.06%,SYNE3;CLMN;DCTN1;SYNE2;DYNC1H1;SUN2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.46673760897761885,0.8429220095939612,0.64,0.9950989108117579,1.0,1/8,0.98%,NEDD4
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.5649855943695598,-0.8428364740396975,0.7424242424242424,1.0,1.0,1/7,8.08%,PRDX4
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),0.4925867367807292,0.8428181857121757,0.7352941176470589,0.994219431439477,1.0,1/6,2.09%,TICAM1
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.5525382003437654,-0.8425857544861645,0.6956521739130435,1.0,1.0,3/5,34.43%,HOOK3;AKTIP;HOOK2
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.5284326455679427,0.842524557815815,0.65,0.9936518415627775,1.0,1/5,14.74%,ITM2B
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.4565515728515549,0.8424389202439395,0.6551724137931034,0.9927629531928178,1.0,4/9,17.23%,IPPK;ITPKB;FGF2;PPIP5K1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",-0.5523152198821288,-0.8424267707500731,0.7361111111111112,1.0,1.0,1/7,0.74%,CD55
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.4216651185494254,-0.8424219667136481,0.7073170731707317,1.0,1.0,9/40,20.47%,HIF1A;PINK1;SOD1;PTPRZ1;MAG;SNX6;CRLF1;NRBP2;RETREG1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.39434034469071344,-0.842097748753662,0.776595744680851,1.0,1.0,5/80,6.18%,ENPP2;FGF1;RHOB;TMSB10;DUOX1
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.447618221521603,0.8420172110339239,0.6923076923076923,0.9925976916966865,1.0,3/10,7.21%,SEMA4D;NTNG2;SPRY2
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.5406947184297552,0.8418903213925994,0.7272727272727273,0.9916475147259581,1.0,1/5,6.46%,PTPN12
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),-0.5281667461195989,-0.8417473633384545,0.684931506849315,1.0,1.0,1/7,6.12%,ANK3
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.4326013881773915,-0.8414031289134828,0.8131868131868132,1.0,1.0,10/51,19.57%,RGS2;RGS20;RASGRP4;RPGRIP1L;GRK4;MGLL;CALM1;CALCR;SYP;DYNLT1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.4367810913703882,-0.8411669364039029,0.7311827956989247,1.0,1.0,3/44,7.03%,FGF1;FLRT1;POLR2G
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.4498319411203645,-0.8410075548318839,0.725,1.0,1.0,10/30,23.51%,CFTR;SDCBP;RAB3A;RAB2B;SNF8;RAB15;RAB5A;PDCD6IP;CADPS;RAB3D
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.44950010099343907,0.8401660947607045,0.7058823529411765,0.9935156050688693,1.0,2/9,6.09%,LOXL3;PHACTR4
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.2740121528175432,0.8401137592242803,0.8333333333333334,0.992579339083425,1.0,8/84,7.90%,RP9;SNRNP35;SCNM1;LSM6;SNRPB;KHSRP;PPARGC1A;U2AF1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.3170951352859743,0.8400574679570681,0.7777777777777778,0.9916322703288671,1.0,8/39,11.38%,FER;CSF1R;ABI3;ABL1;SYK;PKDCC;SRC;ABL2
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.49186714278238897,-0.8389396237126668,0.7123287671232876,1.0,1.0,1/13,6.46%,RBM3
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.3905915128539166,-0.8386782123285828,0.8787878787878788,1.0,1.0,29/133,19.90%,DOK6;SEMA6A;VEGFA;SEMA3A;LAMA2;EMB;UNC5C;NTN4;CHN1;PRKCQ;CXCR4;SHANK3;NOTCH2;RAP1GAP;EPHA3;DCC;FEZ1;PALLD;NRXN1;EPHB1;ENAH;PIK3CB;IRS2;NFIB;RELN;PTPRA;ROBO2;EPHA7;NRXN3
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),-0.5176230931625103,-0.8383230500593812,0.7407407407407407,1.0,1.0,3/9,24.69%,INSR;IRS2;SORBS1
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.30617280669457797,0.8382218885401855,0.5,0.9941736462021774,1.0,3/42,7.92%,EHD4;RAB7A;DENND1C
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),-0.4761966990211039,-0.8381291953265402,0.782608695652174,1.0,1.0,2/13,15.45%,LNPK;TMEM33
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.40567667465676305,-0.8380998500449102,0.7634408602150538,1.0,1.0,1/47,0.24%,GPR18
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.38264571872807324,-0.837810053659154,0.84,1.0,1.0,58/254,21.20%,SCRG1;ACVR1B;GRIK1;SEMA6A;SPOCK1;VCAN;VEGFA;ADGRG6;PTN;MAL;GSTP1;BTBD2;EIF2B2;CXCR4;MARCKSL1;FGF13;MOBP;SHANK3;NOTCH2;GPM6B;PAX8;APC2;STIL;MOG;RAPGEFL1;APLP1;CDH2;FN1;ADGRL3;FEZ1;GPM6A;NLGN3;NRXN1;EPHB1;PTPRZ1;C3ORF70;NRSN1;PRPS1;BTD;SH3GL2;TAGLN3;PTS;NEURL1;CRIM1;ADAM23;STMN3;RELN;NRXN2;TPP1;SERPINI1;ROBO2;PMP22;HPCAL4;RBFOX2;NINJ2;DVL1;NRG1;ALDH1A2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.37814734153686813,0.8377240197374828,0.7307692307692307,0.994123165534945,1.0,5/17,11.55%,HPSE;HS3ST4;GLCE;UGDH;HS6ST1
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.43694645230446205,-0.837610705262152,0.7037037037037037,1.0,1.0,5/28,20.87%,SLC11A1;DMXL2;RAB20;ATP6V1D;ATP6V1E2
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.5068102878125924,-0.8375341730355986,0.7236842105263158,1.0,1.0,3/9,32.94%,OGA;STT3B;FBXO27
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),-0.5453420969807835,-0.8372380736810667,0.7761194029850746,1.0,1.0,2/8,13.61%,TYSND1;ALK
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.4665391460905163,-0.8371192436876193,0.7558139534883721,1.0,1.0,7/20,25.77%,PTN;SHANK3;ADCY8;RELN;LILRB2;APP;EPHA4
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),-0.5401930013197159,-0.8369151908848925,0.7733333333333333,1.0,1.0,2/9,11.17%,HSPA1B;HSPA2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.5684871483580982,-0.8365964772665819,0.7794117647058824,1.0,1.0,2/6,19.23%,ATP1B3;ATP1B2
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.4478290669927724,-0.8365574152553992,0.7361111111111112,1.0,1.0,4/28,9.60%,GK;LPCAT1;GNPAT;ITPKC
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.41775667736678,0.8360233938006363,0.6,0.9964005636499337,1.0,2/11,7.99%,HPN;CTSH
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.40190041561899253,0.8357284524215184,0.6666666666666666,0.9959517290669996,1.0,2/15,7.29%,SNAP47;SYNGR1
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.48229188475347845,0.8356770272357034,0.6153846153846154,0.9950954656667819,1.0,1/5,1.54%,ALDH5A1
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.5404214251176411,-0.835659265615201,0.8142857142857143,1.0,1.0,3/10,18.99%,SLC4A10;RAB3A;SYP
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.3276166165447034,0.8354439269543731,0.6842105263157895,0.9946235049174578,1.0,4/33,6.16%,SESN2;NUAK1;SESN3;TP53
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.3688061660309395,-0.8354051897273835,0.92,1.0,1.0,48/306,20.40%,HTR2B;NEK11;ACVR1B;CDK14;TGFB2;TXK;GK;FGR;DAPK1;PINK1;DAPK2;PRKCE;PDK3;NUAK2;LIMD1;PGK1;NIM1K;CTBP1;EIF2AK3;LIPE;MAP3K12;PIM3;DGKG;DGKI;TEC;FAM20A;PXK;PAK5;ALK;INSR;STK17B;GRK4;MAK;PIK3CB;PIK3R4;ILF3;MAPK10;VRK1;CLK2;VRK2;LIMK2;NRBP2;SGK1;BMPR1B;EPHA7;GK5;EIF2AK2;PRRT1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.4464661152019468,-0.8349719414071545,0.7228915662650602,1.0,1.0,3/30,7.61%,FANCM;DDX11;DONSON
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),0.5224385816348739,0.8348112870321219,0.6,0.9948020407299548,1.0,2/5,1.84%,NRP1;DSCAM
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.48419091111126733,-0.8345570790559533,0.6666666666666666,1.0,1.0,2/13,9.44%,OSBPL5;CD36
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.4974323507341359,-0.8345200336949578,0.7246376811594203,1.0,1.0,5/12,25.64%,ABCA5;ABCA1;ABCA8;STX12;ABCG1
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.45365953928521285,0.8344863699283546,0.6363636363636364,0.994420457812504,1.0,3/5,27.40%,CEP120;VPS4B;CHMP2A
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.5632625335512209,-0.8344357138526389,0.7846153846153846,1.0,1.0,3/6,22.39%,RBPJ;CPE;RYR2
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.47509926619718507,-0.8343408304999442,0.6986301369863014,1.0,1.0,2/12,10.51%,SULT4A1;PPA1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.5156686598441406,-0.8343270242224855,0.7763157894736842,1.0,1.0,2/9,23.17%,LIMD1;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.49954294578789293,-0.8341309378364433,0.7142857142857143,1.0,1.0,1/12,7.98%,PRKCQ
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.5098607689736571,-0.834073660494452,0.7662337662337663,1.0,1.0,5/13,27.34%,LPCAT1;PNPLA8;LPCAT4;ABCA3;PLA2G4A
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.5065092744523858,-0.8338040233011562,0.6794871794871795,1.0,1.0,1/9,8.00%,STAT1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.4554704827958978,-0.833452157260509,0.7341772151898734,1.0,1.0,4/29,18.28%,FBP1;ALK;AZIN1;FMN2
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.44782799564055115,0.8334487926644988,0.65625,0.995539191132851,1.0,1/8,4.07%,GNPDA1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.29871292521839465,0.8333243969551378,0.85,0.9946879586596807,1.0,8/41,9.69%,CEBPA;MCU;PPARG;LEPR;ADIPOR2;APPL2;MBD5;INPP5K
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.3873158462003007,0.8330669378991201,0.7,0.9942062803759789,1.0,2/12,6.00%,NBN;ERCC4
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.44871816017482524,-0.8330134874911973,0.6933333333333334,1.0,1.0,3/24,8.33%,TUB;FSIP2;SNX10
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.4153333205447745,-0.8329673850560306,0.7741935483870968,1.0,1.0,9/46,10.76%,RPS27A;ASPN;VASN;SPRY1;FBN2;PEG10;LTBP1;UBA52;UBC
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.3931748729966612,-0.8329149745265583,0.7741935483870968,1.0,1.0,7/76,11.44%,DNAJB9;HERPUD1;ANKZF1;RNF175;SEC61B;TRIM25;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.47277016940059485,-0.8328434798481977,0.6875,1.0,1.0,2/16,20.09%,POLR2G;RPS6KB2
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.4746360279000317,-0.8327907991084477,0.6951219512195121,1.0,1.0,4/15,18.12%,WDR12;MPHOSPH6;MAK16;PES1
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.4716630316653825,-0.8326235660306497,0.7088607594936709,1.0,1.0,1/16,3.56%,SH2D4A
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.4403052219927893,-0.8325745298765881,0.7142857142857143,1.0,1.0,8/28,21.20%,VEGFA;SULF2;BRCA1;STIL;DEAF1;PCSK5;DVL1;ALDH1A2
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.3112800070516557,0.8324312706207939,0.8421052631578947,0.9944983091684149,1.0,4/39,6.39%,MIER3;MTA2;SIRT1;HDAC10
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.4500020607548722,-0.8324107568452583,0.782051282051282,1.0,1.0,1/17,2.87%,RTN1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.46746846257573926,-0.8323817027567263,0.6944444444444444,1.0,1.0,3/12,32.94%,OGA;STT3B;FBXO27
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),0.5285224434469226,0.8322845691790539,0.696969696969697,0.9905267649814521,1.0,1/5,16.97%,EXOSC9
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),0.5285224434469226,0.8322845691790539,0.696969696969697,0.9905267649814521,1.0,1/5,16.97%,EXOSC9
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),0.5285224434469226,0.8322845691790539,0.696969696969697,0.9905267649814521,1.0,1/5,16.97%,EXOSC9
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),0.5285224434469226,0.8322845691790539,0.696969696969697,0.9905267649814521,1.0,1/5,16.97%,EXOSC9
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.3689063287449375,0.8321483081058714,0.8,0.9897502011176191,1.0,5/15,12.36%,DUSP7;PPM1F;DUSP18;PPM1A;DUSP6
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),0.39680555661781525,0.8316810126789362,0.7307692307692307,0.989529074654088,1.0,4/15,17.83%,MRPS27;FASTKD2;RPUSD3;UQCC2
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.3972643767389768,-0.8314492893475673,0.8260869565217391,1.0,1.0,16/76,22.39%,HTR2B;CCL3;PLN;HERPUD1;ANK2;TPT1;CDH23;SLC24A1;CAV3;ADCY8;ATP2B4;SLC24A2;ATP2B2;TMEM178A;SLC24A4;RYR2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.3975379380061913,-0.8311636701130949,0.7835051546391752,1.0,1.0,19/83,19.95%,CATIP;PQBP1;CARMIL1;RAB11A;PPP1R9A;MAPT;HDGFL3;PLP1;LAMB1;GPM6B;MANF;GPM6A;NCDN;SH3GL2;STMN3;STMN1;ATP1B2;MICALL2;STMN2
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.3887918658328405,-0.831103861470729,0.8,1.0,1.0,10/64,20.24%,TGFB2;SPRY1;FBP1;NOTCH2;RASGRP4;RDX;ARF6;IRS2;ARFGAP1;STARD8
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.42922176005466445,-0.8310465119200092,0.7471264367816092,1.0,1.0,17/44,23.23%,CBR1;VEGFA;MTHFD1;STAT1;PGK1;PAX8;STIL;GSTK1;CTSB;ERRFI1;TIMELESS;TPP1;PPP2R3A;DVL1;ALDH1A2;MFSD2A;IFT122
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.540966894692679,0.8309394710479336,0.7027027027027027,0.9898238985677289,1.0,1/5,11.42%,CLEC16A
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),-0.5320660084037617,-0.830904571119371,0.782051282051282,1.0,1.0,2/10,11.17%,HSPA1B;HSPA2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.4180871999618896,-0.8307722527601512,0.7191011235955056,1.0,1.0,10/37,21.60%,HERPUD1;PINK1;DAPK2;EIF2AK3;BCL2L2;PYCARD;BMF;MCL1;SEPTIN4;RACK1
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.42926234480823117,-0.8300075610089294,0.735632183908046,1.0,1.0,8/36,14.16%,SLC11A1;TXK;SLC7A5;IL18;BTN3A1;PDE4B;CD14;PYCARD
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.5290091597851002,-0.8299271178920571,0.71875,1.0,1.0,1/6,8.71%,KDM6B
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.4098394059609105,-0.8298855202894249,0.8333333333333334,1.0,1.0,10/53,14.02%,RGS2;JAML;CASP5;FGR;MS4A6A;MNDA;MXD1;NREP;NCF4;CD14
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.4926502615590329,-0.8296598924580522,0.676923076923077,1.0,1.0,2/11,19.61%,PINK1;HK2
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.49049912808697255,0.8296553648867593,0.696969696969697,0.9913865937711898,1.0,2/6,5.31%,PTCH1;GRAMD1A
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.5031132184107723,-0.8294942726508037,0.6818181818181818,1.0,1.0,2/8,17.27%,PTS;CALM1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.4044636004866246,-0.8293985710078465,0.782608695652174,1.0,1.0,6/57,10.76%,RPS27A;FOS;TGFB2;APPL1;UBA52;UBC
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.2671978257041532,0.8292836418465267,1.0,0.9911518905056189,1.0,17/88,13.17%,PLXNA2;AVIL;RAP1A;DAB2IP;ARHGAP35;CAPRIN2;PLXNA4;TENM3;ARSB;DVL2;P3H1;ABL2;PLXNB2;RIT2;DVL3;EP300;KIDINS220
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.45526131617238375,-0.8286396896968962,0.7529411764705882,1.0,1.0,3/21,3.21%,OSBPL5;PRELID1;PLTP
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.4240019383718398,-0.8284301072216128,0.7021276595744681,1.0,1.0,13/44,19.49%,AGT;TGFB2;PLN;ATP1B3;ANK2;CALM3;CAV3;RYR3;CALM1;ATP2B4;ASPH;ATP1B2;ATP2B2
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.5084809657148361,-0.8282995500943118,0.7432432432432432,1.0,1.0,2/12,8.00%,RBPJ;STAT1
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.4942094023359993,-0.8282143013651272,0.75,1.0,1.0,5/14,20.73%,GGCX;AGTPBP1;TTLL7;TPGS1;TTLL5
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.4147154968294145,-0.8280044531759689,0.797752808988764,1.0,1.0,12/55,26.70%,SEC61B;SERP1;BNIP1;EIF2AK3;LNPK;TMEM33;REEP5;VCPIP1;EMD;VAPA;APP;REEP2
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),-0.4702631289544702,-0.8278892447536845,0.7066666666666667,1.0,1.0,1/10,2.08%,TALDO1
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),-0.5508223352778996,-0.8277016984302946,0.7794117647058824,1.0,1.0,2/6,25.40%,PAICS;CTPS1
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.4251189578149209,-0.8276135351480782,0.7349397590361446,1.0,1.0,3/38,4.69%,MDH1;ME1;MTHFD1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.40168806556238873,0.827453598109976,0.8,0.9936247669065708,1.0,3/13,9.07%,SIRPA;APPL2;CHID1
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.4614748355018383,0.8273344690807695,0.6666666666666666,0.9906053160393837,1.0,2/10,10.92%,ANAPC4;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.4614748355018383,0.8273344690807695,0.6666666666666666,0.9906053160393837,1.0,2/10,10.92%,ANAPC4;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.4614748355018383,0.8273344690807695,0.6666666666666666,0.9906053160393837,1.0,2/10,10.92%,ANAPC4;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.3834911346293769,-0.8272079901396733,0.95,1.0,1.0,54/347,18.45%,HTR2B;CCL4;TFRC;NLRP12;RPL23;THBS1;TRIM5;LRP2;CHI3L1;FGF1;AGT;RPS20;VEGFA;TGFB2;RPL37;CCL3;FLT1;NOD2;LITAF;FGR;PINK1;GAPDH;DHX58;IL18;DDX1;TRIM25;RPS15;IQGAP1;CARD16;TRAF7;FN1;HCLS1;CD14;LARS1;INSR;RNF13;RPS3;IFIT5;TRAF2;BMF;PIK3CB;TERF2IP;NRG4;TLR2;LGALS1;PDCD4;IRS2;APOL3;S100A4;HEXIM1;CALCR;TXN;TRIM22;RELN
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.42281734317077135,-0.8271816062774378,0.8351648351648352,1.0,1.0,10/53,14.27%,ECM2;SGCE;ADAM15;OTOA;ITGB8;CD63;FN1;ITGA2;SIGLEC1;CD44
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.5265617593480652,-0.8267288450603884,0.6811594202898551,1.0,1.0,5/6,47.35%,WARS1;KAT2B;PNKP;XRCC1;HPF1
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.3870016749603409,0.826699404080019,0.7777777777777778,0.9907096317056899,1.0,2/18,6.63%,ARHGAP35;CXCL12
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.463041015746465,-0.8264510747325011,0.68,1.0,1.0,1/16,1.39%,PRKAR2B
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.4698663992229566,-0.8262755794044053,0.7638888888888888,1.0,1.0,1/14,7.45%,FCGR2B
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.5082818414822582,-0.8256515897796367,0.726027397260274,1.0,1.0,1/9,5.15%,MPG
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.5082818414822582,-0.8256515897796367,0.726027397260274,1.0,1.0,1/9,5.15%,MPG
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),-0.4943670906757024,-0.8253932549317797,0.7536231884057971,1.0,1.0,4/13,22.88%,INTS12;INTS10;INTS8;INTS3
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.4196989903753884,-0.8252906425835645,0.8202247191011236,1.0,1.0,11/61,17.03%,PAQR3;PLPP3;FBP1;MAPT;NPRL2;PID1;CDKN1B;TERF2IP;SH3GL2;IMPACT;IRS2
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.48591641917922707,-0.8251051426823477,0.6666666666666666,1.0,1.0,2/9,17.15%,GRM8;GRM3
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.4428478202761278,-0.824917746072341,0.7142857142857143,1.0,1.0,4/25,21.60%,PDK3;ADCY8;SOX4;RACK1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),-0.42454985585671606,-0.824704422081079,0.7411764705882353,1.0,1.0,9/30,25.88%,C5AR1;GPR155;TUSC3;SHROOM4;CBR3;CTNS;MFSD2A;APP;HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),-0.4561121049544903,-0.8245740388836954,0.7560975609756098,1.0,1.0,5/20,14.51%,NLGN3;NRXN1;EPHB1;PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.5406847467772594,-0.8245474087472091,0.746031746031746,1.0,1.0,4/8,38.88%,AP1AR;KANK1;DMTN;ITGB1BP1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.5406847467772594,-0.8245474087472091,0.746031746031746,1.0,1.0,4/8,38.88%,AP1AR;KANK1;DMTN;ITGB1BP1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.45792201395773774,-0.8244216198397426,0.7011494252873564,1.0,1.0,1/19,3.11%,RSAD2
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.5011174578688231,-0.8242470504026109,0.7230769230769231,1.0,1.0,5/12,25.30%,TGFB2;PCSK5;BMPR1B;IQCE;ZNF141
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.45705715077658704,0.8239727706694422,0.75,0.9950524497319632,1.0,1/8,0.79%,ZNRF3
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.507026630474525,-0.8238514157070451,0.7794117647058824,1.0,1.0,5/10,31.18%,TYMP;SLC25A19;SLC19A2;DCK;ENPP3
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",0.49672008014709,0.8238418107975657,0.6666666666666666,0.9941555721342974,1.0,1/5,1.77%,ITGA5
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.4573718931035771,-0.8237641809321159,0.7439024390243902,1.0,1.0,3/24,11.73%,VIM;CD36;RGCC
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.4615616369364001,-0.8237215499417683,0.7534246575342466,1.0,1.0,1/15,2.87%,RTN1
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.4122416477418327,-0.8236825842497342,0.8,1.0,1.0,6/34,22.57%,VBP1;AZIN1;CLU;FMN2;LILRB2;CRYAB
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.40683878763621556,-0.8236763662485928,0.7415730337078652,1.0,1.0,11/52,19.97%,CASP5;NOD2;FCGR2B;FGR;DHX58;APPL1;IRF1;MGLL;BCL6;ERAP1;FOXP1
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.4737294624613979,-0.8230842054763248,0.7464788732394366,1.0,1.0,4/12,32.07%,HEXIM1;NELFB;RECQL5;NELFA
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.44708580495502337,-0.8229957636787617,0.7272727272727273,1.0,1.0,1/19,4.80%,POLR3F
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.49055481392215744,-0.8228957015370418,0.7611940298507462,1.0,1.0,4/12,25.50%,CLIP3;SPG11;DYNC1I1;APP
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.2899105208460532,0.8226665247067106,0.8,0.9952884028105891,1.0,10/52,9.69%,CEBPA;MCU;PPARG;LEPR;SIRT1;PPARGC1A;ADIPOR2;APPL2;MBD5;INPP5K
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.4788236064175186,-0.8222773322616488,0.7702702702702703,1.0,1.0,2/18,7.99%,RACGAP1;SLC13A4
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.4626868309303976,-0.8216734790083348,0.6857142857142857,1.0,1.0,5/16,16.04%,FAM162A;GAPDH;CIT;BNIP3;TNFRSF21
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.43330689844003517,0.8214937781358139,0.5769230769230769,0.9966425526056373,1.0,3/13,9.12%,HPN;TMEM106A;MTPN
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.3739930224533173,0.8214709457012808,0.6470588235294118,0.9956723412582268,1.0,4/14,14.56%,NTNG2;DVL2;DVL3;MOV10
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.36680490680415795,-0.8213518232210097,0.96,1.0,1.0,68/426,18.41%,NR4A3;RPL23;RPS27A;SAP30;NFIL3;BHLHE40;VEGFA;HAMP;RBPJ;MXI1;NR4A2;MEIS2;H1-0;FBP1;YEATS2;UXT;RPS14;STAT1;CHD3;ARID5B;PARP9;NR1H2;NOP53;ETS2;TGIF1;HCFC1;ID2;UBA52;TRPS1;CTBP1;ZNF550;DRAP1;MXD1;ATF3;SDCBP;MED25;UBC;CGGBP1;MAX;PRDM1;UHRF1;KCTD1;BMI1;ZNF266;NR1D1;DEAF1;SUV39H2;KDM1A;POU6F1;CREM;ZNF20;UBB;NFIX;MLX;CBX5;E2F7;IMPACT;BCL6;ZNF778;POU5F1;DICER1;KLF4;MNT;NFIB;HEXIM1;RPL10;ZNF558;ZFPM2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.3773985440616981,0.8206596070007502,0.8,0.996105537817805,1.0,2/20,2.09%,SIRPA;TICAM1
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),-0.589059481110978,-0.820549693563738,0.8507462686567164,1.0,1.0,1/5,6.41%,BRCA1
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.3922873200089734,-0.8204431235147505,0.7613636363636364,1.0,1.0,17/67,21.58%,SH3PXD2B;TGFB2;PKP2;MTHFD1;KDM6B;ID2;FN1;CDKN1B;LDB3;POU6F1;MICAL2;CACNA1C;ZFPM2;PCSK5;CITED2;NTRK3;SOX4
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.42127674862043146,-0.8202932923511519,0.7294117647058823,1.0,1.0,3/28,10.64%,NOD2;SOD1;MID1IP1
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.402730251206678,-0.820237663141897,0.7472527472527473,1.0,1.0,3/45,10.16%,GPR183;DNAJB9;TPD52
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),-0.4605079148200754,-0.8197670274512607,0.72,1.0,1.0,7/14,21.03%,ASTN2;NLGN3;NRXN1;NCAM2;NRXN2;NRXN3;NINJ2
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.3829904734871857,0.8197077754664969,0.7916666666666666,0.9968723199204508,1.0,5/19,12.37%,LCP1;FSCN1;LIMA1;EPS8;PLS1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.38677837007814153,-0.8194365467999992,0.8202247191011236,1.0,1.0,11/67,17.86%,SH3BP5;GSTP1;CAMK2N1;SH3BP5L;PTPRT;CDKN1B;PYCARD;CAV3;GSKIP;THY1;PTPRB
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),0.4539894637819374,0.8192050301040068,0.7037037037037037,0.9967588290842735,1.0,2/7,13.01%,MAN2B2;MAN2B1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.39126534638414867,-0.8187661493438001,0.8089887640449438,1.0,1.0,6/66,7.45%,GADD45B;VEGFA;SEMA3A;TGFB2;NOD2;FCGR2B
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.5001395866008269,-0.8183606757188384,0.7236842105263158,1.0,1.0,2/7,18.30%,CNEP1R1;VRK1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.36850200733872673,-0.8178955585909854,0.93,1.0,1.0,41/310,18.24%,TOM1L1;SAP30;ACVR1B;NFIL3;BHLHE40;HINT1;HIF1A;GLRX2;RORA;PQBP1;TAF6L;APBB3;RBM4B;RBM3;PLAG1;ATF5;PRKCQ;CHD3;MSL3;RORB;HCFC1;LIMD1;PPIE;DRAP1;RPL6;TCF7;HCLS1;ZNF100;ZKSCAN5;ZNF519;INSR;CREM;TERF2IP;MLX;HMGN5;MAFB;POU5F1;BRCA2;RPL10;ACTR5;TRIM22
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.40631749707613346,-0.817818698223704,0.7717391304347826,1.0,1.0,7/43,15.52%,TOMM7;TIMM13;TMEM14A;BNIP3;TOMM40;TOMM20;BCS1L
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.4508874371138957,-0.8177022213265264,0.7671232876712328,1.0,1.0,4/15,14.02%,CCL3;IL18;PRKCE;CD14
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.517194570532838,-0.8174030778414296,0.75,1.0,1.0,1/8,5.46%,GSTP1
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),-0.5166830099255494,-0.8170508457558583,0.7352941176470589,1.0,1.0,3/6,39.90%,CDS2;PGS1;TAMM41
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.47040020354683565,-0.8168260951911518,0.7435897435897436,1.0,1.0,3/11,12.19%,DUOX1;STAT1;VGF
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),-0.4780595058568718,-0.8165348062281136,0.7283950617283951,1.0,1.0,3/10,17.87%,CHST7;OGA;AMDHD2
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.4473866796045265,0.816446879879459,0.6666666666666666,1.0,1.0,3/7,10.12%,ENPP1;ITPA;AK3
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.5132508497759936,-0.8163985426166774,0.775,1.0,1.0,3/9,23.24%,E2F7;WIZ;DBF4
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.4351184772015405,-0.8163603192158185,0.7738095238095238,1.0,1.0,7/20,34.10%,CMPK1;NUDT13;GUK1;CTPS1;RRM1;AK2;AK5
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.432094958312843,0.8157924570995917,0.76,1.0,1.0,3/12,13.87%,ALMS1;FHOD1;CDC42
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.39092929813023314,0.8153164125699199,0.7037037037037037,1.0,1.0,3/10,23.61%,RNF185;TOR1A;UFD1
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.4498091618785855,-0.8152749496254919,0.7125,1.0,1.0,5/21,22.04%,GK;DGAT1;CAV3;GK5;SLC27A5
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.4987484782059856,0.8152196771887705,0.6571428571428571,0.9996840389873168,1.0,1/5,9.50%,AMPD3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.3643121918546965,0.8151864981775453,0.6923076923076923,0.9986694890255061,1.0,3/14,18.13%,ERCC4;PARP1;NAF1
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.4800668698285864,0.8151261039781285,0.6666666666666666,0.9977677329273376,1.0,1/6,2.09%,TICAM1
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.48147074253802447,0.8151126688675967,0.6341463414634146,0.996769561486114,1.0,2/5,7.27%,SH2B3;SLIT3
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.5203019544008203,-0.8145778241910743,0.7647058823529411,1.0,1.0,4/9,30.28%,PMPCA;PMPCB;SPG7;AFG3L2
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),-0.4757465563510995,-0.8137778026783329,0.7567567567567568,1.0,1.0,5/11,26.88%,TRPS1;MBOAT2;BMPR1B;ZBTB16;SOX6
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.38180369458650476,-0.813512536346042,0.8229166666666666,1.0,1.0,14/97,15.05%,TRIM5;DUSP1;GSTP1;FLT1;PEBP1;PRDM15;IQGAP1;APIP;TRAF7;FN1;PAK5;EPHB1;INSR;CAV3
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.5684429859035159,-0.8134972292243172,0.7846153846153846,1.0,1.0,1/5,14.38%,POLR3H
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5061480483581107,-0.8133982827410351,0.7777777777777778,1.0,1.0,6/10,25.50%,SHANK3;NEURL1;RAB5A;SYP;CAMK2B;APP
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.5408022607899645,-0.8131795968601544,0.7288135593220338,1.0,1.0,3/5,31.18%,PRPS1;DCK;ENPP3
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.4766309232268207,-0.8131059722029971,0.7297297297297297,1.0,1.0,2/14,8.80%,DDX11;NOP53
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),-0.4818258402168374,-0.8127609419875962,0.8,1.0,1.0,2/10,5.86%,COBL;CARMIL1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),-0.53522683548406,-0.8120778242752141,0.7846153846153846,1.0,1.0,1/5,25.10%,MACROH2A2
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.47976867907348836,-0.8117642422267761,0.7,1.0,1.0,1/10,7.06%,COPS5
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.30959879682445945,0.8115348469835226,1.0,1.0,1.0,6/59,7.12%,TAL1;LMO1;CBFB;RUNX1;ABL1;PSME4
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.45646392512010475,-0.8111067089065827,0.7435897435897436,1.0,1.0,6/19,30.65%,PDK3;ADCY8;SOX4;RACK1;SLC2A5;PRKAA2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.5670388346149957,-0.8109826183432178,0.7704918032786885,1.0,1.0,3/8,15.14%,SEMA6A;CD63;PIK3CB
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.2784601499147436,0.810903230729484,1.0,1.0,1.0,14/113,10.88%,ATRAID;SIRPA;IGF2BP3;HMG20A;TRIM38;KHSRP;ZNF711;TOB2;TRIM11;LAMTOR1;CTCF;TBC1D16;LDLR;PCBP3
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.4582813813222688,-0.8106728165058416,0.7764705882352941,1.0,1.0,3/19,8.88%,RORA;FMO5;PDK3
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.37058734523308307,-0.8104658365546388,0.98,1.0,1.0,83/564,19.43%,NR4A3;NAMPT;FOSL2;RPS27A;MACC1;SLC11A1;FGF1;NR4A1;ST18;FOS;VEGFA;HMGB2;TGFB2;RBPJ;HIF1A;RXRB;RORA;TXK;BEX1;NR4A2;MEIS2;TAF6L;NOD2;DDRGK1;LITAF;BRCA1;PLAC8;PLAG1;COPS5;ATF5;STAT1;SMARCD3;JUNB;IL18;KDM6B;NR1H2;RORB;CRTC3;HCFC1;UBA52;PRDM15;PAX8;RRP1B;DRAP1;ATF3;MED25;UBC;IRF1;MAX;NLRC5;RGCC;HSF2;PAXBP1;UHRF1;HCLS1;PID1;NR1D1;CREBRF;CCNC;KDM1A;UBB;NFIX;TLR2;PLSCR1;GNL3;MLX;E2F7;ITGA6;PRPF6;MICAL2;POU5F1;KLF4;NFIB;SS18L1;TET1;CHCHD2;ZFPM2;VENTX;MYBL1;BMPR1B;IER5;CITED2;STAT6
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.4651545691475843,-0.8103149772390745,0.75,1.0,1.0,3/13,14.16%,FCGR2B;IRF1;PYCARD
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.4370208374191419,-0.8099874104198773,0.7857142857142857,1.0,1.0,7/27,15.91%,RXRB;BRINP1;TMEM161A;RORB;EPHA3;PTK7;TRIM16
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.5437639239645174,-0.8099376314751647,0.7638888888888888,1.0,1.0,4/5,44.38%,ASAH1;MT3;HEBP2;SLC6A6
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.4779179127228359,-0.8099174638016529,0.7702702702702703,1.0,1.0,2/13,8.83%,EYA2;HSPA1B
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.4779179127228359,-0.8099174638016529,0.7702702702702703,1.0,1.0,2/13,8.83%,EYA2;HSPA1B
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.49616750055939784,0.8096989158962179,0.7058823529411765,1.0,1.0,1/7,14.74%,ITM2B
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),-0.5323713827612802,-0.8096464737505502,0.7878787878787878,1.0,1.0,1/5,2.62%,SLC16A10
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4936401889759012,-0.8096160697962318,0.696969696969697,1.0,1.0,4/9,27.07%,PKP2;CACNA1C;RYR2;DSC2
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.49408642061458286,-0.8093899900652559,0.7746478873239436,1.0,1.0,1/8,16.80%,AP3M2
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.49408642061458286,-0.8093899900652559,0.7746478873239436,1.0,1.0,1/8,16.80%,AP3M2
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.5416552353243639,-0.8093415019911635,0.7096774193548387,1.0,1.0,1/5,8.71%,KDM6B
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.441231143687842,-0.8092473804212181,0.8148148148148148,1.0,1.0,6/22,21.60%,AQP11;HERPUD1;NR1H2;CLU;UBXN1;RACK1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.43599037514702405,0.8091824629911843,0.64,1.0,1.0,5/12,13.67%,ELAVL4;MAPKAPK2;TIRAP;HNRNPC;ELAVL1
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3238221591188768,0.8090827983437402,0.7857142857142857,1.0,1.0,5/35,7.83%,NRP1;CRK;PDPN;ABL1;CIB1
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.5151375819678854,-0.8090193738859556,0.7638888888888888,1.0,1.0,1/7,7.38%,GTF3C6
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.37432107430791084,-0.8087438804695543,0.94,1.0,1.0,28/252,14.34%,THBS1;ENPP2;CEMIP;FGF1;SEMA6A;MYLK;VEGFA;RHOB;SEMA3A;ARHGAP4;CCL3;ALOX15B;TMSB10;FLT1;DDRGK1;CARMIL1;ADAM15;FGR;LAMB1;APPL1;SDCBP;PLET1;HSPA5;SST;PTPRT;TTBK2;RDX;INSR
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.4000742329593337,-0.8086410282463422,0.8172043010752689,1.0,1.0,11/51,20.53%,AQP11;NACA;RAB11A;VPS37C;ZDHHC15;SDCBP;ZDHHC19;ZDHHC9;ZDHHC4;SYNE3;GORASP1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.4213144464655296,-0.8085985208285414,0.8117647058823529,1.0,1.0,1/26,1.27%,NAPA
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.38976470990039813,-0.8085182005056701,0.8131868131868132,1.0,1.0,17/70,25.67%,NEK11;PSMA3;PSMA5;ERCC2;CDKN1B;PSMD8;PSMB4;ATP2B4;DDB1;PSMD7;PSMD5;PSMC2;DBF4;PSMB9;ZNF16;PSMB2;ANAPC7
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.38906618865638426,0.8084341341445856,0.6818181818181818,1.0,1.0,3/9,16.86%,SRC;PIEZO1;FERMT2
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.3222501816144718,0.8084309046652707,0.8571428571428571,1.0,1.0,12/48,13.87%,HPN;PPM1F;DDX49;ZPR1;SLC25A33;CIB1;MTPN;ADAM10;RPS6KA1;ZNF639;TGFBR1;CDC42
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.37234751091254736,0.8084088864661064,0.75,1.0,1.0,4/20,9.69%,ENPP1;PIP4K2B;IL1B;INPP5K
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.4574681152767624,-0.8082929144221523,0.7142857142857143,1.0,1.0,3/11,22.88%,ZWILCH;NABP1;INTS3
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.3853495829087468,-0.8078820354311937,0.8125,1.0,1.0,14/84,14.16%,VIM;SLC11A1;HMGB2;TNFRSF1B;GSTP1;NOD2;NOCT;PDCD1LG2;PDE4B;HNRNPA0;CARD16;NR1D1;CD14;PYCARD
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),-0.5510499510877249,-0.8078585660376834,0.7692307692307693,1.0,1.0,1/5,2.70%,SEMA3A
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.42353137218232195,-0.8078447652020501,0.7402597402597403,1.0,1.0,4/18,18.84%,TCHP;RAP1GAP;ODF2L;LIMK2
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.43602614941603285,0.8074777636782661,0.6388888888888888,1.0,1.0,3/6,20.58%,SMPD3;SGMS1;SAMD8
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.5328658794607252,-0.8074300877101301,0.7974683544303798,1.0,1.0,3/7,25.40%,PRPS1;CAD;CTPS1
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.4044907882345794,-0.807380103222128,0.7865168539325843,1.0,1.0,2/49,3.81%,NLRP12;AIM2
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),-0.5116193560019281,-0.8073109494966634,0.7702702702702703,1.0,1.0,1/8,2.56%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.48506965327763557,-0.8067850670767974,0.821917808219178,1.0,1.0,3/11,17.27%,GNB5;CALM3;CALM1
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.3909917213457214,-0.8060094090506077,0.8617021276595744,1.0,1.0,30/96,26.77%,TGFB2;PQBP1;RAB11A;PPP1R9A;MAPT;HDGFL3;PLP1;LAMB1;UGCG;GPM6B;MANF;GPM6A;ALK;NCDN;SH3GL2;STMN3;STMN1;MICALL2;STMN2;ETV1;MAP2;VAPA;ERCC6;APP;ATP8A2;RASGRF1;CNTNAP2;TMEM108;SRRM4;ROCK1
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.3789080223681474,0.8059095823390321,0.75,1.0,1.0,3/11,19.28%,WHAMM;ARPC2;ACTR2
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.4132988623550633,-0.8055443762790792,0.7857142857142857,1.0,1.0,7/37,14.51%,AGT;VEGFA;NLGN3;NRXN1;EPHB1;PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.4087438906498624,-0.8051677362847267,0.7586206896551724,1.0,1.0,5/36,10.92%,RPS27A;NOD2;UBA52;UBC;MAP3K12
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.4537439437956492,-0.8051137583390363,0.7317073170731707,1.0,1.0,5/16,24.96%,PAICS;IMPDH1;AMPD2;GART;PFAS
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.41775922264775023,-0.8050602314014867,0.7865168539325843,1.0,1.0,6/35,15.74%,CHI3L1;NOD2;HSPA1B;CD14;PYCARD;TLR2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.4614742741778576,-0.8046321392204766,0.7662337662337663,1.0,1.0,2/16,8.83%,EYA2;HSPA1B
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),-0.5458550608199587,-0.8045285044713522,0.8125,1.0,1.0,1/6,9.51%,NOTCH2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3135622720092915,0.8043222777440454,0.875,1.0,1.0,7/40,13.98%,ZNF385A;PLAGL1;TP53;PIDD1;PLK3;EP300;MDM4
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.4435811856585337,0.804090528429513,0.6285714285714286,1.0,1.0,1/7,4.41%,PDE3A
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),-0.3975521063673189,-0.8040768269717127,0.7701149425287356,1.0,1.0,2/47,4.00%,GDPD1;PIGL
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.39001082147252947,-0.8039734659927383,0.8404255319148937,1.0,1.0,26/106,22.80%,LRP2;ANK3;FLRT1;CCK;MAP1B;EPB41L3;SHANK3;IQGAP1;DCC;RAB3A;GPM6A;EPHB1;CTNND2;LRP4;UBB;SLC9A6;S100A6;IMPACT;DICER1;SGK1;PLPPR4;DVL1;NTNG1;MAP1A;MAP2;S100B
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.4921236733536858,-0.8034457339591444,0.810126582278481,1.0,1.0,7/12,32.06%,SYNE3;CLMN;DCTN1;SYNE2;HOOK3;DYNC1H1;SUN2
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),0.35282332314501885,0.8033913612329435,0.8181818181818182,1.0,1.0,3/19,9.57%,MMS19;HSCB;ABCB7
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",0.4811274913756602,0.803310206254992,0.7058823529411765,1.0,1.0,1/6,1.11%,MAP1S
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.48823879779747037,-0.8032117788649294,0.7763157894736842,1.0,1.0,6/11,29.35%,PARP9;KMT5C;DTX3L;SMCHD1;RIF1;PRKDC
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.4909740368730098,-0.8030932713688906,0.8,1.0,1.0,2/13,9.77%,LIMD1;CIT
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.45322815028541075,0.802981914689703,0.6590909090909091,1.0,1.0,2/6,4.07%,CTBS;GNPDA1
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.5162979282523776,-0.8028748605141613,0.7464788732394366,1.0,1.0,1/6,7.38%,GTF3C6
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.5162979282523776,-0.8028748605141613,0.7464788732394366,1.0,1.0,1/6,7.38%,GTF3C6
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),-0.4467464285960217,-0.8028162355870269,0.7948717948717948,1.0,1.0,3/17,17.09%,BRCA1;DNA2;SLX4
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4416293585928177,0.802584821873015,0.6470588235294118,1.0,1.0,2/8,10.88%,IGF2BP3;PCBP3
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),-0.48553187480938287,-0.8023325318054708,0.8076923076923077,1.0,1.0,4/14,19.23%,ATP1B3;SLC12A8;KCNMA1;ATP1B2
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),-0.38577464116821775,-0.8022348273560843,0.8152173913043478,1.0,1.0,11/61,24.14%,CENPV;VPS11;MAPT;PINK1;RDX;TMEM33;CLIC4;STMN3;PDE2A;VPS35;AKAP9
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.4326954364466825,-0.8022344505326714,0.7926829268292683,1.0,1.0,8/23,25.50%,SOD1;OLFM1;GHR;INSR;MUSK;MFSD2A;PLCB1;APP
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.4532202824612796,0.8021787851013358,0.7741935483870968,1.0,1.0,4/7,31.31%,CDC42;STK25;ARHGAP21;COPG1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.4581985640254465,-0.8021241937904139,0.7710843373493976,1.0,1.0,6/20,25.88%,HLA-B;HLA-F;CADM1;KLRD1;SLAMF6;HLA-DRA
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.4495666562716686,-0.8015684762664359,0.7808219178082192,1.0,1.0,2/15,14.34%,BNIP3;INSR
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.4954784256842146,0.8012901668819163,0.7727272727272727,1.0,1.0,3/6,6.16%,LGALS9;CD274;TP53
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.3124609807316159,0.8012389067706194,0.9333333333333333,1.0,1.0,6/40,8.78%,SMAD7;NXN;BAG5;ABL1;SPRY2;ARRB2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.3672043695019178,-0.8009032603351295,0.91,1.0,1.0,23/238,14.03%,NR4A3;CEBPD;NR4A1;RBPJ;C5AR1;RXRB;INTS12;RORA;NR4A2;NFE2L3;NOCT;POLR2G;NR1H2;SNAPC1;RORB;NOTCH2;DRAP1;RNMT;ERCC2;NR1D1;DEAF1;EAF1;BTF3
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.5035614088753788,0.800535900434556,0.7333333333333333,1.0,1.0,3/5,7.21%,SPRED2;SPRED1;SPRY2
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.5280586642640551,-0.8002350819054032,0.8169014084507042,1.0,1.0,2/8,9.51%,RBPJ;NOTCH2
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.45176116027764984,-0.8001501656599265,0.7878787878787878,1.0,1.0,4/13,29.61%,ASPA;PIPOX;GOT1;CRYM
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.5179152479388356,-0.8000273498313186,0.7681159420289855,1.0,1.0,2/8,13.71%,CBLB;APOD
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.4623160819475073,-0.7998939512156825,0.7407407407407407,1.0,1.0,2/17,11.53%,PINK1;USP36
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.4210349331860214,0.7997932390590106,0.7,1.0,1.0,3/8,21.39%,TIRAP;MFHAS1;TREM2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.3893216787017583,-0.7997022976483859,0.8556701030927835,1.0,1.0,12/74,15.14%,AGT;TGFB2;FLT1;PPP2R5B;FBXL2;FGR;IL18;NOP53;FN1;HCLS1;INSR;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.4066864779701407,-0.7996791260981697,0.7375,1.0,1.0,3/42,3.58%,VEGFA;TGFB2;ECM2
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.4314121502009882,-0.799509331569031,0.7894736842105263,1.0,1.0,3/23,12.24%,INSIG1;FAXDC2;TM7SF2
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),-0.48762099879323406,-0.7993963500068131,0.7837837837837838,1.0,1.0,4/8,22.79%,STMN3;STMN1;STMN2;CKAP5
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.512880707763543,-0.7990788875219518,0.8333333333333334,1.0,1.0,2/10,13.44%,CCL3;NR1D1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.357915139805496,-0.7989979566880094,0.8686868686868687,1.0,1.0,27/178,19.71%,HTR2B;TRIM5;DEPP1;FBXL2;MAPT;DAPK1;PINK1;GAPDH;DAPK2;IL10RA;EEF1A2;BNIP3;USP36;NPRL2;SNX6;TBC1D14;BMF;PIK3CB;EEF1A1;MCL1;TP53INP1;TRIM22;TRIM14;ATP6V1D;UCHL1;DRAM1;CAPNS1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.4791452280016386,-0.7986544087163155,0.775,1.0,1.0,3/11,18.67%,RIOK2;CENPE;HECW2
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.49698300704887055,-0.7985386011944017,0.7096774193548387,1.0,1.0,3/10,15.51%,TOMM40;TOMM20;TIMM21
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.4468332808457916,-0.7981512916892243,0.8235294117647058,1.0,1.0,3/27,11.72%,POLR2G;RNMT;ERCC2
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.4468332808457916,-0.7981512916892243,0.8235294117647058,1.0,1.0,3/27,11.72%,POLR2G;RNMT;ERCC2
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.44343586302481236,-0.7978153878369808,0.821917808219178,1.0,1.0,1/17,5.68%,VPS11
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.3846862472033995,-0.7977629580608864,0.7613636363636364,1.0,1.0,8/40,24.27%,TVP23A;RAB3A;ABCA1;RAB3C;RAB15;PCSK5;RAB3D;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.39199212957965973,-0.7974999536521132,0.8444444444444444,1.0,1.0,15/51,25.13%,PPP2R5A;GSTP1;MAPT;CAMK2N1;NPRL2;CDKN1B;CAV3;IRS2;GSKIP;THY1;DVL1;RTRAF;TAF7;PRKAG2;WARS1
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.5250421585387186,-0.797490802545167,0.7666666666666667,1.0,1.0,1/5,19.39%,CITED2
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.5000269126917035,0.7971879554428006,0.6785714285714286,1.0,1.0,1/5,4.59%,MKKS
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.398374240465973,-0.797184005150395,0.7717391304347826,1.0,1.0,6/43,12.38%,ECM2;DOCK1;CARMIL1;DOCK5;CD36;FN1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.49063689690692486,-0.7971558092303896,0.7571428571428571,1.0,1.0,1/9,2.89%,TGFB2
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),-0.5135255398690904,-0.7969548431841535,0.8082191780821918,1.0,1.0,3/8,13.36%,CHI3L1;PTPRT;PID1
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.4841173200308753,-0.7968772816484387,0.7402597402597403,1.0,1.0,4/9,36.08%,AP2S1;AP2A2;AP2M1;VLDLR
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.4841173200308753,-0.7968772816484387,0.7402597402597403,1.0,1.0,4/9,36.08%,AP2S1;AP2A2;AP2M1;VLDLR
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.414384737546159,0.7968697518732972,0.84375,1.0,1.0,2/12,6.08%,CAP1;STIM1
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.4495649403275312,-0.7966943137927742,0.6944444444444444,1.0,1.0,3/13,19.58%,PHKG1;CALM1;GAA
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.47633715946044847,-0.7965026315227571,0.7894736842105263,1.0,1.0,3/12,16.76%,ATP8B1;CFTR;SERPING1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),-0.5641654163033754,-0.7964239390580091,0.8064516129032258,1.0,1.0,2/5,18.11%,CCL3;CALCR
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.4328418339651442,-0.7963041346131805,0.7738095238095238,1.0,1.0,6/18,24.74%,PIGL;PIGG;PIGA;PIGH;MPPE1;PIGF
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.38011542013619837,-0.7959775904986286,0.8736842105263158,1.0,1.0,29/105,21.47%,PLPP3;VEGFA;THSD4;SH2D4A;DOCK1;NTN4;MAPT;DOCK5;EMC7;LAMB1;HSPA12A;ADGRL2;COL4A5;PALLD;LIFR;ENAH;SH3D19;RND3;CPE;MAFB;NFIB;PTPRG;APBB2;KITLG;RBFOX2;CALD1;MPDZ;EMC2;UACA
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.44485586782147657,0.7957686320895065,0.7058823529411765,1.0,1.0,1/7,11.61%,NMNAT3
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.4118362299076035,-0.7955370462224522,0.7764705882352941,1.0,1.0,8/36,22.96%,CLIP3;GPC3;CALY;B2M;CLU;RAB21;TF;HFE
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.3770407098172086,0.7953550429447128,0.7857142857142857,1.0,1.0,2/17,4.94%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.3025926001790613,0.7951905150709195,0.85,1.0,1.0,6/36,9.29%,ECI1;ACADS;MTLN;ACOX1;IVD;EHHADH
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.45906951604365376,-0.7949546202029713,0.8024691358024691,1.0,1.0,7/17,23.79%,DAPK2;C5AR2;MPP1;C1QBP;JAM3;THBS4;RIPOR2
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.4697268802874034,-0.7947061804417367,0.8194444444444444,1.0,1.0,2/10,21.91%,PLSCR1;GPR137B
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.37693116952355554,-0.794563524921761,0.8877551020408163,1.0,1.0,22/144,20.71%,SRGN;ATP8B1;VPS11;ANK3;CR1;SERP1;SNX10;BNIP1;EIF2AK3;LNPK;UBXN2B;VPS51;GOLGA8B;GOLGB1;VMP1;CAV3;SYP;REEP5;DNM1;FAM174B;GORASP1;DYNC2H1
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),-0.5566259852033602,-0.794528814501136,0.8591549295774648,1.0,1.0,1/6,18.79%,METTL4
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.42338548738774023,-0.7940702284215867,0.797752808988764,1.0,1.0,8/26,24.83%,NOD2;STAT1;EIF2B2;STAT2;CALCR;STAT6;GNAI1;CACNA1B
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.530796850051973,-0.793981061175719,0.8524590163934426,1.0,1.0,2/5,19.77%,SLX4;MUS81
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.5195884587616335,-0.7939125955648964,0.7215189873417721,1.0,1.0,1/6,7.17%,LPCAT1
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),-0.5231633751261746,-0.793811801135827,0.7571428571428571,1.0,1.0,1/6,3.68%,APOLD1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.4419887274337536,-0.7938070233874458,0.7272727272727273,1.0,1.0,3/15,10.47%,FTH1;GSTP1;MED25
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.4569621298536407,-0.7937538483196726,0.8484848484848485,1.0,1.0,1/12,2.89%,TGFB2
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.3641510318899735,-0.793605029570899,0.898989898989899,1.0,1.0,14/168,9.82%,HTR2B;TFRC;NLRP12;TRIM5;RORA;GSTP1;NOD2;LITAF;PINK1;GAPDH;STAT1;DDX1;TRIM25;TLE1
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.40911192858509327,0.7935332290536053,0.6666666666666666,1.0,1.0,4/11,18.96%,EIF4EBP1;EIF2AK4;FMR1;TPR
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.4266710278067545,-0.7933853853408709,0.7738095238095238,1.0,1.0,2/23,2.70%,SEMA6A;SEMA3A
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.4730489016119309,-0.7933151168694925,0.7763157894736842,1.0,1.0,6/16,30.61%,MTHFD1;PRPS1;GART;GUK1;GDA;HPRT1
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.36937393966224136,-0.7932043454495119,0.8241758241758241,1.0,1.0,15/75,25.82%,MRPL33;MRPL19;MRPL43;MRPS7;MRPL20;MRPL51;MRPL45;MRPL27;MRPL47;MRPS15;MRPS21;MRPL13;MRPL32;MRPL52;MRPS25
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.41148860206880733,-0.7930699966843225,0.7831325301204819,1.0,1.0,7/36,16.74%,TALDO1;CFL1;SOD1;RPLP0;LMNB1;ANXA2;PDCD4
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.4918657887836728,-0.7920776574163552,0.7714285714285715,1.0,1.0,2/9,7.80%,COX7A2;PINK1
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.5366842273502317,-0.7920504631645312,0.803030303030303,1.0,1.0,1/5,1.72%,CYP3A5
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.5366842273502317,-0.7920504631645312,0.803030303030303,1.0,1.0,1/5,1.72%,CYP3A5
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.5366842273502317,-0.7920504631645312,0.803030303030303,1.0,1.0,1/5,1.72%,CYP3A5
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.5127958685043549,-0.7919144399132064,0.7575757575757576,1.0,1.0,3/7,33.07%,YBX3;SLC25A4;PELI1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.5127958685043549,-0.7919144399132064,0.7575757575757576,1.0,1.0,3/7,33.07%,YBX3;SLC25A4;PELI1
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.4217472506223736,0.7918781826123633,0.6451612903225806,1.0,1.0,2/10,3.83%,FER;PDPN
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.4654262748223839,0.791780167984959,0.7272727272727273,1.0,1.0,1/6,3.16%,NFATC3
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.46765074627012093,-0.791755003838386,0.8378378378378378,1.0,1.0,3/12,15.06%,RORA;IL18;PNPLA8
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.46330485447872305,-0.7915983347685606,0.7205882352941176,1.0,1.0,3/12,19.58%,PHKG1;CALM1;GAA
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.4991513464586006,-0.7914088888472303,0.8,1.0,1.0,1/9,2.89%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.4503365177912905,-0.7912148045496857,0.8452380952380952,1.0,1.0,1/18,0.73%,THBS1
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.43195431859899724,-0.7908184492445256,0.759493670886076,1.0,1.0,1/20,0.99%,INSIG1
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.38297368656175973,-0.7906129185730486,0.7978723404255319,1.0,1.0,14/55,18.96%,VAV3;CHN1;SIPA1L1;FGD6;ATP5IF1;SOD1;RAP1GAP;EPHA3;TBC1D15;RDX;NGEF;STMN3;ARHGAP9;FGD3
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.4233740097843462,-0.7905640876235004,0.9032258064516129,1.0,1.0,9/39,20.94%,KCNJ13;ATP1B3;SLC12A8;SLC24A1;SLC9A6;ATP2B4;ATP1B2;SLC24A2;KCNJ3
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.4416270750491046,-0.7905428889320707,0.7974683544303798,1.0,1.0,2/19,6.14%,GCNT1;GK
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.4311946425963912,-0.7902478332945841,0.8068181818181818,1.0,1.0,3/26,16.69%,POLR1C;ERCC2;TAF1D
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.36894596830129517,-0.7901464921253369,0.9183673469387755,1.0,1.0,21/124,18.96%,CCL4;RGS1;VAV3;CCL3;GNB5;CHN1;SIPA1L1;FGD6;SOD1;RRP1B;RAP1GAP;EPHA3;TBC1D15;LARS1;RDX;ITGA6;NGEF;THY1;STMN3;ARHGAP9;FGD3
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.3897362995788392,0.7900560172806824,0.76,1.0,1.0,5/18,12.37%,LCP1;FSCN1;LIMA1;EPS8;PLS1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.37572083965445624,-0.7899638954351658,0.8556701030927835,1.0,1.0,21/125,18.76%,ACVR1B;TXK;FLT1;FGR;DAPK1;PINK1;DAPK2;RIOK2;EIF2AK3;MAP3K12;PIM3;TEC;EPHB1;ALK;INSR;STK17B;MAK;CAD;VRK1;CLK2;VRK2
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.38779932646754856,-0.7899354495460099,0.8494623655913979,1.0,1.0,8/62,14.47%,IFIT2;PLN;DDX11;CARD16;IFIT1;LRPAP1;TFIP11;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.48502632124602857,-0.7898983711021031,0.7536231884057971,1.0,1.0,3/11,17.39%,PRELID1;GHITM;CLU
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.4670260592741112,-0.789888150988936,0.7125,1.0,1.0,3/12,23.19%,ZNF93;MYBL1;UBR2
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),-0.5246145732561232,-0.7898786941713739,0.7666666666666667,1.0,1.0,1/5,10.45%,EIF2AK3
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.4679345041304416,-0.7895196245475011,0.821917808219178,1.0,1.0,5/13,21.75%,MCMDC2;RFC4;MCM3;MCM7;LIG3
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.5244325722924277,-0.7886925100868797,0.8285714285714286,1.0,1.0,1/6,8.72%,NR1H2
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.3786337258034463,-0.7870701520061041,0.8021978021978022,1.0,1.0,14/63,25.18%,FZD6;PSMA3;PSMA5;AP2S1;PSMD8;PSMB4;PSMD7;PRICKLE1;DVL1;PSMD5;AP2A2;PSMC2;PSMB9;PSMB2
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.44975929696949196,0.7870302259393573,0.7272727272727273,1.0,1.0,1/9,2.84%,CTBP2
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.35322775798276085,0.7870016168396329,0.8947368421052632,1.0,1.0,2/22,5.43%,NRP1;ABL1
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.46468243994162006,-0.7867818838036356,0.7638888888888888,1.0,1.0,1/11,5.20%,XRCC3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.4964828061230268,-0.7866357845856283,0.7974683544303798,1.0,1.0,2/11,11.55%,TXK;TEC
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),-0.5143692671295614,-0.7862925274249253,0.7692307692307693,1.0,1.0,2/9,8.68%,TRMT9B;GTPBP3
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.4998373723715167,-0.7862586301955609,0.7733333333333333,1.0,1.0,4/7,33.64%,WIZ;DBF4;TIPIN;CDC7
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3473579604350633,0.7862509465410017,0.75,1.0,1.0,2/14,6.37%,BAG5;SIRT1
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),-0.4865118049789133,-0.7861963469459592,0.7638888888888888,1.0,1.0,1/8,1.18%,VIM
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.5129295879510796,-0.7861774567295551,0.7714285714285715,1.0,1.0,2/9,8.80%,PRELID1;NOP53
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.430331007030753,0.7859322124727146,0.52,1.0,1.0,2/8,4.06%,DAB2IP;PIP4K2B
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.4191178574837937,-0.7858041106727095,0.7586206896551724,1.0,1.0,7/27,25.96%,FCGR2B;CD36;SNX6;GRIN2A;APP;EPHA4;ITGA4
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.41098059714009316,-0.7857934441821564,0.8181818181818182,1.0,1.0,7/26,18.67%,ANK3;PRKCE;DMD;FGF13;CAV3;SCN3B;HECW2
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.3182352168452739,0.7857567790991222,0.8666666666666667,1.0,1.0,7/21,21.58%,OCRL;INPP5K;PIP4P2;MTMR10;SYNJ1;MTMR2;INPP5F
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.3770220740978911,-0.7856787132031057,0.797752808988764,1.0,1.0,2/55,2.63%,ACVR1B;CDK14
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),-0.39500528254200706,-0.7851997484958585,0.8555555555555555,1.0,1.0,4/38,11.44%,HERPUD1;HSPA1B;HSPA2;HSPA5
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.4056535509100038,0.7851335560605757,0.6521739130434783,1.0,1.0,1/11,0.97%,SLC7A8
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.3869079718577805,-0.7846038539837176,0.8,1.0,1.0,11/44,19.38%,TFRC;IL7;NOD2;IL15;PRKCQ;PDCD1LG2;PYCARD;HLA-DMB;THY1;LILRB2;AIF1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.43089168892776564,-0.7843554358869206,0.7901234567901234,1.0,1.0,7/26,19.39%,PLPP3;ANK3;RNASE10;CD44;DENND6A;THY1;CITED2
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.3875306376462405,-0.7839517726119801,0.7640449438202247,1.0,1.0,7/40,21.17%,HINT1;SULT4A1;ACOT13;AMPD2;ACAT1;ACSM3;GTPBP1
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.5201806040658538,-0.7839417309021772,0.7945205479452054,1.0,1.0,3/8,28.87%,TYMP;UPP2;MACROD1
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.42994972081487604,-0.7838697240233126,0.782051282051282,1.0,1.0,6/20,26.03%,KDM6B;KDM1A;KDM3A;KDM4B;KDM5C;KDM5B
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.5330227005246436,-0.7838635397776118,0.765625,1.0,1.0,1/5,15.14%,PIK3CB
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.37388244554323313,-0.7836082720725402,0.8313253012048193,1.0,1.0,4/46,9.33%,TRMT9B;FTSJ1;SSB;DDX1
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.39156685370867544,-0.7835760421097488,0.8170731707317073,1.0,1.0,4/36,13.36%,PINK1;BTN2A2;PDK3;PID1
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.5110137031312125,-0.7835470907300347,0.7538461538461538,1.0,1.0,1/7,2.70%,SEMA3A
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),0.4481990571617662,0.7834096854595648,0.75,1.0,1.0,1/6,3.00%,CSF1R
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.36784796872691417,0.7834038550312274,0.7352941176470589,1.0,1.0,2/12,7.60%,PHF8;WDR43
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.2961472337885168,0.7833376895611799,0.9411764705882353,1.0,1.0,4/38,6.39%,MIER3;MTA2;SIRT1;HDAC10
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.49550371429034146,-0.7831440375523209,0.7611940298507462,1.0,1.0,2/6,37.03%,XPO1;NPM1
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.5179996290911771,-0.7829285260946335,0.7972972972972973,1.0,1.0,1/7,9.84%,DMGDH
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.5059764053584108,0.7828530599095468,0.7037037037037037,1.0,1.0,1/5,3.16%,NFATC3
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.33355742505432295,0.7827795521010559,1.0,1.0,1.0,4/18,5.44%,NRP1;MAP4K4;ABL1;PPM1F
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.3706346603817939,-0.782648708341558,0.782608695652174,1.0,1.0,5/71,11.00%,CEMIP;ANK3;CLIP3;PRKCE;EPHA3
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.4703228119999619,-0.7822919270815021,0.7922077922077922,1.0,1.0,1/14,5.50%,MTCH1
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.40511984037100274,0.7822758465643384,0.7666666666666667,1.0,1.0,1/9,6.37%,SIRT1
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),-0.49932979989863757,-0.7821240835427309,0.7916666666666666,1.0,1.0,2/8,11.73%,VIM;RGCC
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.514985165827549,-0.7818449342817104,0.7936507936507936,1.0,1.0,2/5,26.97%,RPS3;RNF169
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),0.4677739300028214,0.7816535336794924,0.7435897435897436,1.0,1.0,1/5,2.77%,LRCH1
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),-0.45218836523421335,-0.7815861852484759,0.7424242424242424,1.0,1.0,4/9,18.58%,NLGN3;NRXN1;LRP4;NRXN2
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3012077110781607,0.7814387823433341,0.8823529411764706,1.0,1.0,9/48,13.98%,ZNF385A;RFWD3;PLAGL1;TP53;SDE2;PIDD1;PLK3;EP300;MDM4
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.5233270710728336,-0.7814256008810527,0.7910447761194029,1.0,1.0,2/6,26.77%,LRPAP1;ROCK1
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.34942675203389517,0.7813457484422559,0.8181818181818182,1.0,1.0,3/27,4.96%,VCPKMT;SNRPB;SETD3
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.4791012182306908,-0.7812877238725662,0.7682926829268293,1.0,1.0,3/11,32.29%,PARP11;PARP12;PARP10
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.4161256748494404,-0.781276486782968,0.7674418604651163,1.0,1.0,4/21,5.18%,CBR1;FAAH2;ALOX12;ALOX15B
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4967967625450808,-0.7809439763325715,0.8333333333333334,1.0,1.0,3/9,12.74%,ABCA5;NR1H2;ABCA1
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),-0.36160680493423447,-0.7809415859301932,0.9148936170212766,1.0,1.0,8/98,9.44%,HMGB2;FAM50A;TAF6L;DDX11;SMARCD3;KDM6B;HCFC1;PADI2
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.47076700276329053,0.7808367558387671,0.7037037037037037,1.0,1.0,1/6,11.49%,SERPINB9
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),-0.4527025546225105,-0.7807221418409882,0.8133333333333334,1.0,1.0,1/12,3.21%,PLTP
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.5491414888526849,-0.7805249861103825,0.7936507936507936,1.0,1.0,1/5,15.79%,PLSCR1
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.4350828074039508,-0.7805045327229038,0.8488372093023255,1.0,1.0,3/24,16.69%,POLR1C;ERCC2;TAF1D
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.4076122863601732,-0.7801958404029854,0.7816091954022989,1.0,1.0,6/38,14.02%,SLC11A1;HMGB2;NOCT;FCGR2B;HNRNPA0;CD14
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.41033520596274287,-0.7798183236592955,0.8505747126436781,1.0,1.0,7/38,16.74%,NLRP12;NOD2;CD14;RPS3;TERF2IP;TLR2;PDCD4
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.5366988864628307,-0.7797959046676451,0.8529411764705882,1.0,1.0,3/5,43.62%,NCBP2;DHX9;CPSF6
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.5366988864628307,-0.7797959046676451,0.8529411764705882,1.0,1.0,3/5,43.62%,NCBP2;DHX9;CPSF6
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.552145900925678,-0.7796056791897501,0.896551724137931,1.0,1.0,1/5,5.46%,GSTP1
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.4356729443848612,-0.7795309287980992,0.7625,1.0,1.0,8/20,26.01%,ENO4;ENO2;NPRL2;TBC1D14;ANXA2;RAB5A;ENO1;C9ORF72
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.3521761197801689,0.7794673159115256,0.7142857142857143,1.0,1.0,2/17,8.97%,SETD6;FBL
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.40353533072036696,-0.7794470082605416,0.8313253012048193,1.0,1.0,7/30,20.83%,TNFRSF1B;PINK1;ATP5IF1;WDR48;SH3D19;ASPH;TNIP1
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),-0.4588016498932184,-0.779261647452182,0.8266666666666667,1.0,1.0,4/14,28.84%,B4GAT1;SDF2L1;CRPPA;POMT1
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.4900748658903931,0.7792026711297289,0.7941176470588235,1.0,1.0,2/7,3.39%,PSAT1;PSPH
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.40799672112042884,0.7788996182833342,0.8,1.0,1.0,2/6,9.39%,SLC35D1;UGDH
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.4130781951110615,-0.7786484654229343,0.7647058823529411,1.0,1.0,6/24,21.98%,RAB11A;VPS37C;SNF8;CHMP5;PDCD6IP;MVB12A
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.40846954480503816,-0.7782896260077498,0.7764705882352941,1.0,1.0,6/25,21.98%,RAB11A;VPS37C;SNF8;CHMP5;PDCD6IP;MVB12A
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),-0.4725475898410664,-0.7780138023173914,0.8170731707317073,1.0,1.0,3/10,24.69%,INSR;IRS2;SORBS1
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.4882480695413406,-0.7780020614710088,0.746268656716418,1.0,1.0,1/8,3.05%,RAB7B
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.3571816130753928,-0.7776879868006376,0.97,1.0,1.0,52/332,17.63%,HTR2B;ACVR1B;FTH1;TP53TG5;NR4A1;ST18;RHOB;TGFB2;TNFRSF1B;DUSP1;AQP11;TCHP;ALOX15B;IFIT3;FBP1;FHL1;BRINP1;ADAM15;CR1;ATF5;FCGR2B;CAMK2N1;BTN2A2;NR1H2;HSPA1B;BNIP3L;CTBP1;EIF2AK3;BNIP3;IRF1;TGFBI;TXNIP;RGCC;SST;ING4;CDKN1B;LRPAP1;ING5;TLR2;PLSCR1;TNFRSF21;E2F7;IMPACT;BCL6;PDCD4;ATG5;ORC6;CLU;KLF4;MNT;TP53INP1;NEURL1
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.3495664093505177,-0.7773453103727371,0.99,1.0,1.0,109/599,21.54%,NR4A3;CENPF;RPL23;RPS27A;SAP30;NFIL3;BHLHE40;VEGFA;HMGB2;HAMP;RBPJ;ATP8B1;MXI1;ZNF540;NR4A2;MEIS2;BASP1;H1-0;FBP1;YEATS2;ZNF93;BRCA1;L3MBTL3;MDFIC;ATF5;UXT;RPS14;STAT1;CHD3;ARID5B;PARP9;NR1H2;NOP53;ETS2;TGIF1;RORB;HCFC1;ID2;LIMD1;UBA52;HIC2;TLE1;TRPS1;CTBP1;ZNF550;DRAP1;MXD1;ATF3;SDCBP;PIAS4;MED25;UBC;CGGBP1;IRF1;MAX;TSHZ3;PRDM1;UHRF1;KCTD1;BMI1;ZNF266;ING4;NR1D1;DEAF1;CDKN1B;SUV39H2;KDM1A;SNX6;POU6F1;CREM;ZNF20;UBB;NFIX;TIMELESS;MLX;CBX5;E2F7;IMPACT;BCL6;PDCD4;ZNF778;POU5F1;DICER1;KLF4;MNT;ILF3;HEXIM1;RPL10;ZNF558;ZFPM2;LANCL2;PARP15;PER2;CITED2;SUDS3;FOXP1;GCFC2;C1QBP;RBFOX2;KLF2;PRICKLE1;ZNF529;PDE2A;PTPRK;NRG1;ZNF248;ESR2;RUNX1T1;ZNF589
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.3524750823448236,0.7773305015368872,0.8181818181818182,1.0,1.0,3/17,6.37%,BAHD1;HMGA1;SIRT1
prerank,MSigDB_Hallmark_2020__Complement,-0.37150674329897343,-0.7773016706312382,0.9292929292929293,1.0,1.0,23/137,19.92%,CD55;ME1;F8;CASP5;CR1;CALM3;CD36;AKAP10;IRF1;HSPA5;DGKG;FN1;CTSB;CBLB;ATOX1;PLSCR1;GPD2;SERPING1;CALM1;CLU;ZFPM2;VCPIP1;HPCAL4
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.46865302093680594,-0.7772565055971831,0.7792207792207793,1.0,1.0,3/9,22.90%,CNEP1R1;VRK1;DCTN1
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.35719440958643217,-0.7771854875863979,0.92,1.0,1.0,14/162,12.52%,RPS27A;RNF144B;ARIH2;DTL;RNF126;RBX1;HERPUD1;PINK1;UBA52;TRIM25;UBC;SPSB1;RNF149;UHRF1
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.5169983529447774,-0.7769138471213952,0.7777777777777778,1.0,1.0,3/6,35.02%,GMFB;GMFG;PICK1
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.4354779955152969,0.7767624950910568,0.7894736842105263,1.0,1.0,1/7,2.81%,SH2B3
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.3787970176594486,-0.7766734753365052,0.8723404255319149,1.0,1.0,10/68,11.26%,THBS1;RPS27A;ASPN;VASN;SPRY1;PEG10;UBA52;SDCBP;UBC;NREP
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.29374148958683344,0.7765963069178816,1.0,1.0,1.0,4/42,4.52%,SIRPA;TLR7;IRF5;TOMM70
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.45379407204181554,-0.7765401773101157,0.8059701492537313,1.0,1.0,2/14,11.06%,PINK1;BNIP3
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.5199390627218975,-0.776316313515134,0.8524590163934426,1.0,1.0,1/5,15.49%,KCNK10
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.5355907668736021,-0.776237354434632,0.7419354838709677,1.0,1.0,3/5,35.02%,GMFB;GMFG;PICK1
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.4216680394039402,-0.7761766240330044,0.7837837837837838,1.0,1.0,4/18,19.38%,C5AR1;MAPT;CLU;AIF1
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),-0.499523299405988,-0.776148402633072,0.7878787878787878,1.0,1.0,2/7,11.73%,VIM;RGCC
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.4066400661732572,0.7759715349037831,0.8064516129032258,1.0,1.0,2/10,12.30%,NIPAL2;NIPA1
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),-0.4761864041609274,-0.775918680156225,0.7076923076923077,1.0,1.0,1/6,5.79%,DDRGK1
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),0.39305907600014267,0.7756905608064393,0.6875,1.0,1.0,2/11,2.59%,RALB;CGAS
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.42461254068772303,-0.7750485826387525,0.7972972972972973,1.0,1.0,4/18,15.74%,APPL1;CD36;IRF1;TLR2
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.42820087448494165,-0.7746131710468241,0.7804878048780488,1.0,1.0,2/22,8.95%,TENT4B;SSB
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.43315240705845953,-0.7745615139118361,0.7682926829268293,1.0,1.0,3/22,15.46%,NHP2;RFC1;TERF2IP
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.2627881752189616,0.7744637137450926,1.0,1.0,1.0,10/57,16.88%,PDE12;MMS19;ENPP1;POLR2C;HNRNPC;GTF2F1;LSM8;DNASE2;LSM1;RBMX
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),-0.532308425020124,-0.7742467958700581,0.8793103448275862,1.0,1.0,1/6,13.90%,GHR
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),-0.41713129000007365,-0.7737192526977885,0.8181818181818182,1.0,1.0,10/28,26.98%,GRIK1;LRRC4C;PXK;NLGN3;RELN;IQSEC2;CACNA1B;NLGN2;GRIK2;GRIK4
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3602952804484451,-0.7735773355120147,0.8842105263157894,1.0,1.0,4/86,3.81%,NLRP12;FZD6;BHLHE40;AIM2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.3969607241055633,-0.773554226884083,0.8505747126436781,1.0,1.0,7/43,16.31%,TOM1L1;BRCA1;UXT;MAX;BMI1;CBX5;E2F7
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.3878214513515064,-0.7734008713678208,0.8255813953488372,1.0,1.0,7/40,18.18%,UBXN2B;TMEM41B;VMP1;ATG2A;ATG5;TP53INP1;GABARAPL1
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),-0.4934009841290881,-0.7733945124302843,0.746031746031746,1.0,1.0,1/5,1.95%,GPR183
prerank,GO_Biological_Process_2021__positive regulation of microglial cell migration (GO:1904141),-0.509974741017176,-0.7733817149721767,0.8309859154929577,1.0,1.0,1/5,5.14%,CCL3
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.38213622577345147,-0.7733590595274732,0.8842105263157894,1.0,1.0,7/64,8.73%,MYO1G;VAV3;DOCK1;FCGR2B;FGR;PRKCE;MYO10
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),-0.4250411190575234,-0.7732355806175366,0.7974683544303798,1.0,1.0,4/23,14.56%,MAPT;AANAT;ING4;ING5
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.3999694165654927,-0.7731324042782054,0.8631578947368421,1.0,1.0,17/38,28.90%,SCN9A;ATP1B3;SLC6A15;SLC24A1;SLC9A6;NALCN;SCN1A;SCN3B;ATP1B2;SLC24A2;SLC24A4;HCN1;SLC9A7;SLC24A3;SCN2A;SLC6A1;ASIC2
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),-0.47030543699771055,-0.7729439625909181,0.8194444444444444,1.0,1.0,3/9,21.77%,SPG11;KIF5A;KIF5C
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.4654191253357057,-0.7729366818467308,0.7246376811594203,1.0,1.0,4/10,28.45%,CTSB;RDX;KLF9;BRD8
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.44390335573824635,0.7725478721569115,0.7419354838709677,1.0,1.0,1/8,6.08%,STIM1
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.2560592180517895,0.772342975028407,1.0,1.0,1.0,24/173,12.63%,NEDD4;SPSB2;BFAR;GID4;SMURF1;SOCS6;KCTD5;RNF122;ZFAND2A;RCN3;SIRT1;BTRC;PSME4;APPBP2;SHARPIN;ARRB2;FBXO45;KLHL42;AREL1;FBXW7;DNAJB12;PSME3;FBXW11;UBXN6
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.40386684010892465,-0.7722717989519088,0.8227848101265823,1.0,1.0,7/29,14.75%,NR4A2;DAPK2;TRAF7;PYCARD;ING5;RPS3;BCL2L14
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.4653069459981747,-0.7722472347948474,0.7936507936507936,1.0,1.0,3/12,19.58%,PHKG1;CALM1;GAA
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.3932093658401192,-0.7718460475186477,0.8555555555555555,1.0,1.0,13/65,21.27%,PAQR3;PPP1R15A;PLPP3;MAPT;DMD;PID1;TERF2IP;SH3GL2;IMPACT;ATP2B4;BEX4;TARDBP;NTRK3
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.40283249793147546,-0.7714172065725352,0.7976190476190477,1.0,1.0,3/23,13.13%,ANK3;NSF;GOLGA4
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),-0.5087365689614939,-0.7712288623628019,0.7857142857142857,1.0,1.0,1/5,9.87%,ATP5F1D
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.5032391638828103,-0.7711964563122621,0.8115942028985508,1.0,1.0,3/8,27.34%,CENPE;SEH1L;CHAMP1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2831003355937209,0.7711786921352529,1.0,1.0,1.0,10/50,14.50%,PKD2;CEBPA;HHEX;LATS2;CCNYL1;TFAP4;CCNG2;CCNG1;MNAT1;CCNI
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.3367222927554935,0.7705932677187947,0.8,1.0,1.0,7/22,11.60%,MCU;MICU3;MAIP1;SLC35G1;ADRA1A;SMDT1;ATP2A3
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),0.4688692269103754,0.7702230397897788,0.7272727272727273,1.0,1.0,2/6,14.18%,SERPINE1;ALOX5
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),-0.3773300606690758,-0.7700301609722529,0.7956989247311828,1.0,1.0,12/52,22.86%,TGFB2;APBB3;TTN;CFTR;RGCC;RAB3A;RAB2B;ARF6;RAB5A;MYH10;CADPS;PPID
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.4633333179824709,-0.7699275745177104,0.7391304347826086,1.0,1.0,1/7,17.73%,GARS1
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.3702368226453899,-0.7698654340832579,0.8777777777777778,1.0,1.0,13/62,25.18%,CHI3L1;PSMA3;PSMA5;TRAF2;PSMD8;PSMB4;DICER1;PSMD7;PSMD5;REL;PSMC2;PSMB9;PSMB2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.45091898287685517,-0.7698245479118809,0.76,1.0,1.0,1/13,5.49%,FLT1
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.36374248398177556,-0.7695235217459849,0.7888888888888889,1.0,1.0,5/42,11.59%,ENPP2;LPCAT1;NR1H2;PCTP;MBOAT2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.37167986002072223,-0.768814484272155,0.8351648351648352,1.0,1.0,15/65,26.10%,FZD6;PSMA3;PSMA5;AP2S1;PSMD8;PSMB4;PSMD7;PRICKLE1;DVL1;PSMD5;AP2A2;PSMC2;PSMB9;PSMB2;MAGI2
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.3523186594903048,-0.7686787556385082,0.98,1.0,1.0,66/369,21.60%,CENPF;EIF4A3;NFIL3;BHLHE40;HMGB2;RBPJ;ATP8B1;ZNF540;BASP1;YEATS2;ZNF93;BRCA1;L3MBTL3;MDFIC;ATF5;DAPK1;RPL13A;GAPDH;ARID5B;NR1H2;RORB;ID2;LIMD1;HIC2;TLE1;CTBP1;PIAS4;EIF2AK3;IRF1;RIDA;ENC1;TSHZ3;KCTD1;ING4;NR1D1;DEAF1;CDKN1B;SUV39H2;KDM1A;SNX6;RPS3;CNOT8;TIMELESS;MLX;CBX5;BCL6;PDCD4;KLF4;ILF3;HEXIM1;ZFPM2;LANCL2;PER2;CITED2;SUDS3;FOXP1;PATL2;PUS7;GCFC2;EIF2AK2;RBFOX2;PRICKLE1;PTPRK;NRG1;RUNX1T1;RACK1
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.40890802073266513,-0.7685118875648744,0.7532467532467533,1.0,1.0,3/16,13.13%,VEGFA;MAPT;GOLGA4
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.41802833389258504,-0.7681044463760693,0.8795180722891566,1.0,1.0,2/26,8.49%,PAQR3;ZDHHC15
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.38400617157581535,0.7680915134346992,0.8620689655172413,1.0,1.0,1/9,3.25%,DOCK10
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.3649941362627158,-0.7679613642749171,0.8850574712643678,1.0,1.0,11/54,21.12%,FANCI;BRCA1;PINK1;PIAS4;WDR48;UBB;GNL3;SEPTIN4;PRICKLE1;TNIP1;RIPK2
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.3689590736306444,-0.7679499068337646,0.8522727272727273,1.0,1.0,5/49,8.95%,TRMT9B;FTSJ1;METTL2A;GTPBP3;SSB
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.404267163613433,-0.767917564678225,0.7926829268292683,1.0,1.0,3/18,5.65%,CASP5;FBP1;NOD2
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),0.30465976296141684,0.7678213633700256,1.0,1.0,1.0,3/34,6.25%,SIRPA;ILRUN;UBA7
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.4290206676318431,-0.7675054599761535,0.8607594936708861,1.0,1.0,9/15,22.94%,GAPDH;PGK1;ENO2;PGAM1;PKM;HK2;PFKL;GPI;ENO1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.4290206676318431,-0.7675054599761535,0.8607594936708861,1.0,1.0,9/15,22.94%,GAPDH;PGK1;ENO2;PGAM1;PKM;HK2;PFKL;GPI;ENO1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.4553812747022412,-0.7674665563810353,0.8395061728395061,1.0,1.0,5/17,17.29%,SLCO1A2;SLC13A4;SLC17A7;LRRC8B;SLC13A3
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),-0.45265876269197375,-0.7670536355508633,0.7681159420289855,1.0,1.0,4/8,18.58%,NLGN3;NRXN1;LRP4;NRXN2
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.41748015643497804,-0.7669899947230748,0.8505747126436781,1.0,1.0,3/28,16.69%,POLR1C;ERCC2;TAF1D
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.41915116326125,0.7669645554636635,0.75,1.0,1.0,2/9,4.51%,RAB33B;RAB7A
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.37524090845024105,-0.7668830302951082,0.8604651162790697,1.0,1.0,6/45,20.16%,PRKCQ;RGCC;RFC4;KLF4;CHTF18;POLG2
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.41020303616098275,-0.7666446044373979,0.7875,1.0,1.0,3/24,8.72%,PLTP;ABCA5;NR1H2
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.34991396664075636,0.7664781227585422,0.8928571428571429,1.0,1.0,2/14,7.41%,PPARG;IL1B
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.4913425022589854,-0.7663509580026583,0.8333333333333334,1.0,1.0,1/8,3.30%,HIF1A
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.35776946312757407,-0.7658086344655431,0.9,1.0,1.0,16/114,14.34%,TFRC;ENPP2;ACVR1B;VEGFA;PTN;CFL1;BASP1;COBL;PINK1;ZDHHC15;SHANK3;PPP1R13L;BNIP3;NRXN1;ALK;INSR
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.43460742824440235,0.7656367287568132,0.7837837837837838,1.0,1.0,2/6,19.08%,RABEP1;RAB29
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.3649133387767684,-0.7654800133240574,0.94,1.0,1.0,13/98,18.85%,SOCS3;PIGL;ITPKC;EFR3B;MTMR7;INPP4A;PIGG;PIK3CB;PIK3R4;PIGA;PIGH;RAB5A;INPP4B
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.46742289374728635,-0.7651798440365959,0.8266666666666667,1.0,1.0,3/9,18.66%,FHL1;CAV3;SCN3B
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.3197353323325407,0.7649684017996534,1.0,1.0,1.0,4/48,5.07%,NRP1;FER;SRGAP2;NTNG2
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.36937232349302324,-0.7647189334143851,0.9381443298969072,1.0,1.0,17/123,18.58%,CLDN18;INSIG1;TNFRSF11B;VCAN;SGCE;ALOX15B;ADAM15;TGFBI;NLGN3;ITGA2;CDH8;DHX16;PIK3CB;CNTN1;ADAM23;THY1;NRXN2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.3730759672425953,-0.7644204373076146,0.8333333333333334,1.0,1.0,2/43,7.98%,TENT4B;PRKCQ
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),-0.5156358458837889,-0.764393062236061,0.7903225806451613,1.0,1.0,1/5,9.25%,APPL1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.36471777946535977,0.7641254171667915,0.8636363636363636,1.0,1.0,4/21,4.43%,PTPRM;DAB2IP;PPARG;TGFB1
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),-0.47225609586340017,-0.7639377509980518,0.7733333333333333,1.0,1.0,1/10,0.77%,GLA
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.42603404379079785,-0.7637390779974549,0.7721518987341772,1.0,1.0,6/15,22.84%,TALDO1;HK2;PGLS;RBKS;GPI;TKT
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.30096215052384234,0.7637381954176619,1.0,1.0,1.0,7/77,6.98%,TIFA;EHD4;PKD2;RYR1;ALOX5AP;APPL2;ALDH9A1
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.3503422930126462,0.7637191056650593,0.8518518518518519,1.0,1.0,2/17,6.42%,NBN;MAP3K4
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.450280720386477,-0.7636742871919099,0.7974683544303798,1.0,1.0,5/16,24.86%,RIMS1;SYT1;SYT4;RIMS2;RIMS3
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.39279441404215976,-0.7636151320486767,0.8433734939759037,1.0,1.0,4/31,12.25%,SYAP1;NOCT;ID2;AAMDC
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.3501773974280627,0.7634039216318198,0.8260869565217391,1.0,1.0,4/27,7.64%,P2RY12;VCL;MYH9;GNAS
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.40305444880535174,-0.7633406352284591,0.8313253012048193,1.0,1.0,8/28,23.79%,MAPT;GPM6B;UBXN2B;TTBK2;CAV3;MAP1A;OTUD7B;RIPOR2
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),0.46373993153051757,0.7632346714008422,0.6296296296296297,1.0,1.0,1/5,5.38%,ZRANB1
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.46664978047956773,0.7631430503297243,0.8333333333333334,1.0,1.0,5/5,53.35%,DDX23;SRPK2;PRIMPOL;SIRT7;DDX21
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),-0.446254762926796,-0.7631328044802638,0.8227848101265823,1.0,1.0,1/17,1.51%,LRP2
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.5548399137221984,-0.7626971143562965,0.8833333333333333,1.0,1.0,1/5,2.00%,SEMA6A
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.33510377981434963,0.7626779049502563,0.8461538461538461,1.0,1.0,6/22,14.32%,DCUN1D4;CDC14B;BTRC;TRIB3;FBXW7;UBE2N
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.5190669283175298,-0.7625131147112916,0.8676470588235294,1.0,1.0,1/5,25.61%,OGT
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.3757037366427297,-0.7624950303570537,0.8854166666666666,1.0,1.0,7/65,8.73%,MYO1G;VAV3;DOCK1;FCGR2B;FGR;PRKCE;MYO10
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.4483147663929994,-0.7622816323740459,0.7948717948717948,1.0,1.0,2/13,11.41%,TGFB2;OLFM1
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),-0.38277183077855437,-0.7618808052187347,0.8043478260869565,1.0,1.0,8/48,17.47%,CHI3L1;NOD2;HSPA1B;C5AR2;CD14;PYCARD;TLR2;KLF4
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.4220596130049954,-0.7617862524373058,0.7901234567901234,1.0,1.0,5/22,22.89%,MAPT;HCLS1;PRUNE1;MAP2;ARHGAP18
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5314634348349204,-0.761653781618185,0.875,1.0,1.0,3/6,18.00%,SEMA6A;PIK3CB;ATP2B4
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.35316916936006437,-0.7616492393160659,0.9587628865979382,1.0,1.0,21/171,15.78%,FZD6;RBMS3;CDK14;LZTS2;RBX1;AMER2;DKK2;GPC3;LIMD1;PRDM15;TLE1;GPC5;PSMA3;APC2;PSMA5;DAAM2;PTK7;CTNND2;LRP4;PSMD8;PSMB4
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.40068211045905067,0.7615747046236423,0.75,1.0,1.0,1/9,9.38%,NR3C1
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.5093549234639388,-0.7614402110731607,0.8095238095238095,1.0,1.0,3/7,40.63%,FES;HLA-DRB1;ACIN1
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.4984344072559804,-0.7613827516427143,0.7941176470588235,1.0,1.0,1/7,2.89%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.4768606539211347,-0.7611171745566079,0.7792207792207793,1.0,1.0,2/10,10.00%,IL18;HLA-F
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.33896149626015837,0.7611003875056391,0.8076923076923077,1.0,1.0,3/22,5.46%,NRP1;EPB41;LEPR
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.3737960923717197,0.7610999963103349,0.7647058823529411,1.0,1.0,2/11,14.06%,NR3C1;PCK2
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),-0.4130530110131571,-0.7610285194435723,0.8117647058823529,1.0,1.0,1/18,1.37%,KCNJ13
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.4607892957184419,-0.7609254162877066,0.7794117647058824,1.0,1.0,1/9,8.83%,HSPA1B
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.35558369161750203,0.7609234766354636,0.7692307692307693,1.0,1.0,3/17,6.87%,PKD2;SOCS6;NMI
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.3456422001553937,-0.7608068852609314,1.0,1.0,1.0,94/739,17.60%,NR4A3;NAMPT;FOSL2;RPS27A;MACC1;NFIL3;SLC11A1;FGF1;NR4A1;ST18;FOS;AGT;VEGFA;HMGB2;RBPJ;HIF1A;RXRB;H1-3;H1-4;RORA;CREB5;TXK;BEX1;NR4A2;MEIS2;H1-2;TAF6L;H1-0;NOD2;DDRGK1;LITAF;BRCA1;PLAC8;PLAG1;MDFIC;COPS5;ATF5;STAT1;SMARCD3;PARP9;JUNB;IL18;KDM6B;NR1H2;ETS2;RORB;CRTC3;HCFC1;ID2;UBA52;PADI2;PRDM15;PAX8;RRP1B;DRAP1;ATF3;EIF2AK3;MED25;UBC;MAP3K12;IRF1;MAX;NLRC5;RGCC;HSF2;PAXBP1;UHRF1;HCLS1;PID1;NR1D1;DEAF1;CREBRF;CCNC;KDM1A;ING5;KDM3A;UBB;NFIX;TLR2;PLSCR1;TRIM16;MLX;E2F7;ITGA6;ATXN7L3;HMGN5;MAFB;PRPF6;POU5F1;KLF4;BRCA2;ILF3;NFIB;TP53INP1
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.385149394604023,-0.7607193803636337,0.8295454545454546,1.0,1.0,6/43,14.30%,NR4A3;PAX8;CTSB;NSMF;GHR;RDX
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.36851756713112405,-0.7606147747463006,0.8352941176470589,1.0,1.0,6/41,16.29%,FAM162A;PINK1;BNIP3;PYCARD;BMF;CIDEB
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.46194789693370575,-0.760398049824638,0.75,1.0,1.0,4/11,25.50%,INSR;MAP1A;DCTN1;APP
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),-0.47651014677681564,-0.7603743240135881,0.7846153846153846,1.0,1.0,1/6,5.95%,RPA2
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.3844912037218482,0.7603413616193316,0.7586206896551724,1.0,1.0,2/12,5.43%,NRP1;ABL1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),-0.47986230755722353,-0.7601483379555097,0.8,1.0,1.0,2/10,9.24%,PKP2;ID2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.35902220249194133,-0.7600173105442083,0.925531914893617,1.0,1.0,24/137,22.93%,CD55;NAPA;F8;CNIH4;ANK3;ANK2;NSF;SEC24C;GOLGB1;KDELR1;ARFGAP1;DCTN4;NRBP2;DCTN2;GORASP1;DYNC1I1;CNIH1;SEC13;MPPE1;SPTBN5;MCFD2;SPAST;DCTN1;VAPA
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.4264763422585959,-0.7595023557446755,0.825,1.0,1.0,9/16,22.94%,GAPDH;PGK1;ENO2;PGAM1;PKM;HK2;PFKL;GPI;ENO1
prerank,GO_Biological_Process_2021__chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),-0.5117427218249955,-0.7594506249183212,0.8088235294117647,1.0,1.0,1/5,8.53%,CXCR4
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),0.30907274746843805,0.7592934815718801,0.9,1.0,1.0,11/47,13.22%,NSUN2;ALKBH8;METTL16;MEPCE;FBL;TFB1M;METTL8;BUD23;NSUN4;MTERF4;TRMT6
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.34657572397517333,-0.7590827258470296,0.9166666666666666,1.0,1.0,15/152,16.67%,ACVR1B;PRKAR2B;CDK14;HAUS6;TUBB4A;TUBA4A;MASTL;TUBA1A;MAX;PPP1CB;CDKN1B;CEP152;ABCB1;FBXL7;CCNB3
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.4794713693351836,-0.7588042169739735,0.8243243243243243,1.0,1.0,4/9,33.74%,MFSD2A;ABCA3;MTMR4;DNAJC19
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.38307256295456743,0.7587047299213278,0.8387096774193549,1.0,1.0,3/13,16.26%,ARHGAP35;ABL2;HEG1
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.4765080249016656,-0.7585213339920831,0.796875,1.0,1.0,2/9,24.34%,HSPA5;MBTPS1
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.2783941482624306,0.7584653662687244,1.0,1.0,1.0,7/37,17.32%,MTA2;ARID1A;GATAD2B;HNRNPC;RBBP4;ARID1B;INO80
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.2916467674809333,0.7584466655245601,1.0,1.0,1.0,2/35,7.60%,PUS1;WDR43
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.44887826290286015,-0.7582484233849469,0.8481012658227848,1.0,1.0,3/13,15.05%,CCL3;PLN;CAV3
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.32301872002529725,0.7581487011654867,0.9375,1.0,1.0,2/23,2.52%,SLC7A8;PKD2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.4859906343952524,-0.7580780321715113,0.8153846153846154,1.0,1.0,4/6,36.17%,CD300A;CD200;HMOX1;SLAMF8
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.4615250671525698,-0.7580620484184936,0.8055555555555556,1.0,1.0,2/10,19.39%,IMPACT;CITED2
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.4907417355590656,-0.7580215966873258,0.796875,1.0,1.0,1/5,6.82%,RAB11A
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.3505426958298365,-0.7579196699996374,0.9387755102040817,1.0,1.0,28/200,19.73%,RPS27A;HIF1A;MINDY1;BRCA1;COPS5;OTUD1;HCFC1;UBA52;CLSPN;CFTR;PSMA3;UBC;PSMA5;USP36;USP6;WDR48;TOMM20;TRAF2;PSMD8;UBB;PSMB4;ATXN7L3;ACTR5;ABRAXAS1;UCHL1;VCPIP1;PSMD7;SUDS3
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.35043010652320217,-0.7578271895505398,0.97,1.0,1.0,43/208,26.69%,EIF4A3;WDR83;PQBP1;SNRPD2;RAVER2;RBM4B;BCAS2;POLR2G;WBP4;PPIE;WBP11;HNRNPA0;PNN;TFIP11;DHX16;SRSF5;SNRNP27;ZCCHC8;PRPF6;SRSF2;SNRPA;CSTF2T;FRG1;RNPC3;LSM5;PRPF40B;GCFC2;SRSF9;MFAP1;SART3;U2AF2;PRPF3;SRSF12;SRSF8;SRSF3;DDX46;SNU13;NOVA1;U2SURP;DBR1;RBM5;ZCRB1;PDCD7
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.37322489658993657,-0.7577853307370813,0.9101123595505618,1.0,1.0,14/56,26.15%,XRCC3;RPA2;BRCA1;POLQ;FAN1;RPA3;POLL;SLX4;BRCA2;NABP1;LIG3;SWI5;WRN;RAD54B
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),0.4770811952150428,0.7577095769537161,0.7,1.0,1.0,2/5,29.48%,IDH3A;IDH2
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.40814651339882846,0.7576743142256994,0.6785714285714286,1.0,1.0,2/10,6.73%,ZNF703;SYK
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.43824095842976374,-0.7575855569387987,0.8,1.0,1.0,7/12,32.85%,SVIL;MYL6;SGCZ;SGCD;IGSF8;CFLAR;ZBTB18
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.36533210943180866,-0.7574340861019414,0.8829787234042553,1.0,1.0,7/89,8.66%,THBS1;LRP2;CHI3L1;FGF1;CCL3;PINK1;IL18
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.39813909802630726,-0.7572751886353445,0.8021978021978022,1.0,1.0,11/39,23.43%,KCNJ13;ANK3;B2M;PXK;SNX6;SYT1;SYT4;KCNJ3;TF;HFE;PER1
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.312219179460996,0.7569727652958947,0.9090909090909091,1.0,1.0,6/33,14.90%,MIOS;TELO2;LAMTOR1;RRAGD;CLEC16A;SMCR8
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.41512255283596117,-0.7566374869887739,0.8,1.0,1.0,7/25,27.71%,LIMD1;CNOT8;DICER1;ZFP36;PRKRA;CNOT6;AGO4
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.3738121411054938,-0.7565792934481952,0.8636363636363636,1.0,1.0,5/43,9.15%,ENPP2;PLPP3;ALOX15B;LPCAT1;GNPAT
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.4558372100009189,-0.7562658940055449,0.7866666666666666,1.0,1.0,2/12,8.93%,PKP2;TTN
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.2960383751708394,0.7560528624887228,1.0,1.0,1.0,12/111,13.11%,NUFIP1;RNASEL;ELAVL4;AGO1;POLR2C;FASTKD2;PCBP3;PAPOLA;ADARB1;NOL9;HNRNPC;GTF2F1
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.3880224655738589,-0.7559534269057855,0.9186046511627907,1.0,1.0,10/38,14.21%,CACNB2;TMEM266;GREB1;ZNF483;MAPT;FGF13;CKMT2;PREX2;SYCP2L;LDB3
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.37835799103992196,-0.7557470281608382,0.8314606741573034,1.0,1.0,9/44,17.79%,GLUL;PIGL;ZDHHC15;UGCG;PIGG;ZDHHC9;PIGA;ATG5;PIGH
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.43007013091686147,0.7557461768953098,0.7142857142857143,1.0,1.0,2/6,6.76%,PKD2;SALL1
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.4882011964132032,0.7555535570514704,0.7916666666666666,1.0,1.0,1/5,0.78%,GSN
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.4324081802720585,-0.7552446619579193,0.8571428571428571,1.0,1.0,1/16,3.23%,ACSL1
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),-0.4328487855015124,-0.7550643688503309,0.8051948051948052,1.0,1.0,5/14,24.92%,CD36;MID1IP1;SLC27A5;PRKAG2;SLC2A1
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.3393303280486316,-0.7550005602614321,0.98,1.0,1.0,37/281,18.24%,SAP30;ACVR1B;NFIL3;BHLHE40;HINT1;HIF1A;GLRX2;RORA;PQBP1;TAF6L;APBB3;PLAG1;ATF5;PRKCQ;CHD3;MSL3;RORB;HCFC1;LIMD1;PPIE;DRAP1;RPL6;TCF7;HCLS1;ZNF100;ZKSCAN5;ZNF519;INSR;CREM;TERF2IP;MLX;HMGN5;MAFB;POU5F1;BRCA2;ACTR5;TRIM22
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.2860778207916313,0.7548094801240693,0.875,1.0,1.0,15/57,20.78%,SUPT16H;ELOA;GTF2H2;POLR2C;ELOC;ELP4;GTF2F1;MNAT1;CDK13;CDK7;CDC73;SUPT5H;LEO1;SETD2;SSRP1
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4276636251651029,-0.7545411025097402,0.8313253012048193,1.0,1.0,3/17,20.69%,RPS3;FOXP1;TESPA1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.3651736056163558,-0.7544976003875765,0.8111111111111111,1.0,1.0,6/62,11.20%,RHOBTB3;RHOB;NOTCH2;GPM6B;EPHA3;IQGAP1
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.4164002235273192,-0.7539961907379228,0.8048780487804879,1.0,1.0,5/23,26.33%,SRSF5;SRSF9;SRSF12;CELF2;PRPF39
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),-0.37520846976244465,-0.7537823129794524,0.8901098901098901,1.0,1.0,10/50,18.90%,TBC1D8;TCHP;TBC1D13;ODF2L;TBC1D15;TBC1D2B;TBC1D14;ATG5;LIMK2;DYNC2LI1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.4888579105649635,-0.7537365512276694,0.84375,1.0,1.0,1/6,2.89%,TGFB2
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),-0.3798325164347793,-0.7534103171090756,0.8666666666666667,1.0,1.0,14/59,22.78%,GLRA1;AQP11;SLC17A7;TRPM3;PIEZO2;SLC24A1;GABRB1;SLC9A6;SLC24A2;CTNS;SLC24A4;SLC20A2;MCOLN1;SLC1A2
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),-0.40702071926264993,-0.7532686393906197,0.810126582278481,1.0,1.0,7/29,22.54%,PTN;SHANK3;EPHB1;CTNND2;LRP4;DVL1;MAP2
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.4098611346043846,-0.7526109296388576,0.8108108108108109,1.0,1.0,6/23,27.29%,POLR3F;NLRC5;PLSCR1;RIOK3;IFI35;GBP5
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.39764989348769,-0.7525900921014937,0.875,1.0,1.0,7/38,23.18%,POLR2G;RIDA;CNOT8;ZC3HAV1;GTPBP1;ZFP36;PNPT1
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.45495503433701284,-0.7524592198516517,0.8625,1.0,1.0,2/12,11.03%,CFTR;SLC4A10
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.36643972990411044,-0.7523563445421013,0.8764044943820225,1.0,1.0,3/55,6.90%,RHOB;BRCA1;FIGNL1
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.3115103706947791,0.7522715706487597,0.84,1.0,1.0,6/19,16.85%,PPARGC1A;IL1B;RPS6KA4;TADA2B;KAT7;ARRB1
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.3987244499374566,-0.7521264699698538,0.875,1.0,1.0,7/35,17.03%,AQP11;TENT4B;ABCB4;SLC4A10;VGF;PNPLA8;IRS2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.4609042880604632,-0.7518959738999148,0.8260869565217391,1.0,1.0,5/13,17.27%,ANK2;CALM3;AKAP6;VMP1;CALM1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.39852164626206893,-0.7518112397521555,0.8522727272727273,1.0,1.0,11/35,26.74%,GLA;GALC;UGCG;GBA3;SUMF2;STS;ASAH1;SUMF1;CTSA;SCCPDH;UGT8
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),-0.45990012231218613,-0.7512715688772146,0.8,1.0,1.0,1/10,4.14%,TNFRSF1B
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.46550212416734277,-0.7511609139209282,0.7536231884057971,1.0,1.0,3/10,21.17%,KDM6B;PLD3;NRG1
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.37639099296899287,-0.7511347418119497,0.8064516129032258,1.0,1.0,18/48,26.87%,RIMS1;SHANK3;TSHZ3;NLGN3;NRXN1;SLC24A1;SYT1;ADCY8;RELN;SLC24A2;GRIN2A;RIMS2;SHANK2;RIMS3;NLGN2;APP;GRIK2;CACNG2
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),-0.484764015346507,-0.7510809203017444,0.8,1.0,1.0,4/5,33.22%,ROBO2;APP;ROBO1;GAP43
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.4425226727051036,-0.7508577704113591,0.7625,1.0,1.0,2/12,4.39%,GCNT1;SELL
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.40350458913428544,-0.7506545271844447,0.8375,1.0,1.0,5/24,16.04%,NOD2;FCGR2B;PDCD1LG2;PYCARD;TNFRSF21
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.4825229530503832,-0.7505544047154469,0.8169014084507042,1.0,1.0,2/8,13.44%,RAB7B;NR1D1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.4412610799169809,-0.7503452885323962,0.75,1.0,1.0,2/13,4.39%,GCNT1;SELL
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.46508196886456554,-0.7502123274471219,0.8051948051948052,1.0,1.0,4/14,20.22%,SOD1;NREP;APOD;RTN4RL1
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.3571784030204289,-0.7500057481984437,0.8695652173913043,1.0,1.0,3/48,8.24%,NLRP12;RORA;DHX58
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.44212460366049394,-0.7496058964046598,0.8115942028985508,1.0,1.0,3/12,10.86%,GSTP1;GSTM3;GSTK1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.44212460366049394,-0.7496058964046598,0.8115942028985508,1.0,1.0,3/12,10.86%,GSTP1;GSTM3;GSTK1
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.5002324005683301,-0.7493310401194611,0.8115942028985508,1.0,1.0,1/5,3.82%,PTN
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.37175465678629704,-0.7490837226179765,0.8795180722891566,1.0,1.0,1/29,2.87%,RTN1
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),-0.44574910611661755,-0.7486723689579664,0.8382352941176471,1.0,1.0,2/11,10.55%,GNPAT;LIPE
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.3459278069908089,-0.748549066206923,0.9191919191919192,1.0,1.0,22/113,21.04%,NLRP12;AGT;TNFRSF1B;RORA;CASP5;CCL3;NOD2;IL15;IL18;NR1D1;SNX6;TLR2;MGLL;BCL6;PDCD4;KLF4;MACIR;NFKBIZ;FOXP1;GPRC5B;TNIP1;PDE2A
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.28771726955716875,0.7481514187395798,0.8333333333333334,1.0,1.0,17/42,28.40%,KHDRBS3;SAP18;SMU1;THRAP3;CELF1;RBMX;FMR1;FXR2;ZBTB7A;WTAP;MBNL3;NSRP1;PUF60;RBM25;RBFOX3;REST;MBNL1
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),-0.502804973183071,-0.7480058937618153,0.8648648648648649,1.0,1.0,2/7,7.81%,SCN9A;NIPSNAP1
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.3917096774246172,-0.7479929831331461,0.8850574712643678,1.0,1.0,4/37,8.68%,RHOB;GLRX2;ANKZF1;SOD1
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.3659647677552378,-0.7478627654455428,0.8723404255319149,1.0,1.0,10/47,18.52%,CARMIL1;MAPT;PINK1;BAIAP2L1;PRKCE;PYCARD;RPS3;CAV3;ARF6;CRACD
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.5336728800480336,-0.7471708284687726,0.8805970149253731,1.0,1.0,2/5,24.15%,POU5F1;CTR9
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),-0.49721268316342154,-0.7467147247304748,0.8333333333333334,1.0,1.0,1/7,14.34%,INSR
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.42725091186897407,-0.746684659006271,0.8421052631578947,1.0,1.0,1/14,3.11%,RSAD2
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.38374056418958125,-0.7465858145500879,0.8795180722891566,1.0,1.0,8/31,27.34%,LPCAT1;GNPAT;DGKG;DGKB;PLD1;LPCAT4;DDHD2;PLA2G4A
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.48723664127049937,-0.7462527813797628,0.7746478873239436,1.0,1.0,2/5,9.26%,SLC7A5;SLC6A15
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.39835946376510695,0.7458380031729097,0.8,1.0,1.0,2/7,19.35%,TCF3;LIG4
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.44472510666861387,-0.7458186461019577,0.8170731707317073,1.0,1.0,3/12,41.62%,ZFP36;PABPC1;CNOT1
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.44472510666861387,-0.7458186461019577,0.8170731707317073,1.0,1.0,3/12,41.62%,ZFP36;PABPC1;CNOT1
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.42582841873248994,-0.745419921670615,0.8378378378378378,1.0,1.0,1/16,2.38%,MYLK
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.37689874183448047,-0.7453771384779951,0.8764044943820225,1.0,1.0,11/48,22.90%,RAB11A;FIGNL1;MAPT;CLIP3;TUBGCP2;KATNAL2;STMN3;LIMK2;FIGN;SPAST;DCTN1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.3905498372403993,-0.7452372988079717,0.8588235294117647,1.0,1.0,3/27,11.90%,SLC11A1;NOCT;HNRNPA0
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.3384561701411019,-0.7450277956118663,0.94,1.0,1.0,18/163,14.07%,TOP2A;CENPF;TUBA4A;ARHGAP4;RACGAP1;UXT;ITSN1;FGD6;CENPE;NOTCH2;KIF1B;RFC1;MID1IP1;ANLN;INCENP;PALLD;TUBGCP2;RASA2
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.274598736765969,0.7445083774513703,1.0,1.0,1.0,4/46,9.45%,NUP188;CC2D1B;CHMP2B;BANF1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.36503159586835865,0.7444660863174858,0.8518518518518519,1.0,1.0,4/11,23.51%,DVL2;DVL3;GSK3B;LRP6
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),-0.48536236188199855,-0.7442562149749719,0.75,1.0,1.0,1/6,2.56%,VEGFA
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.37254468186350737,-0.7439431429088719,0.8620689655172413,1.0,1.0,3/50,5.65%,TGFB2;RBPJ;NOD2
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.3776434129924063,-0.74378065532233,0.9148936170212766,1.0,1.0,8/57,19.53%,RPS27A;UBA52;UBC;CTSB;NR1D1;UBB;DDB1;PDCD6IP
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.4900204012958538,-0.743373129318179,0.8153846153846154,1.0,1.0,1/6,3.05%,RAB7B
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.3331978661892861,0.7432893041287819,0.7307692307692307,1.0,1.0,3/14,19.28%,WHAMM;ARPC2;ACTR2
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),-0.4577070707235391,-0.7427090875686444,0.8311688311688312,1.0,1.0,2/11,15.96%,DDX11;GNL3
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.324230639161312,0.7420234539185935,0.7692307692307693,1.0,1.0,21/21,67.63%,RNF185;TOR1A;UFD1;STUB1;CUL3;YME1L1;KLHL15;NGLY1;POMT2;VCP;UGGT1;BAG6;HDAC6;ZYG11B;ATXN3;LONP1;FBXL17;ZER1;AUP1;UGGT2;DERL1
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.5030585129630119,-0.7417459627775943,0.8108108108108109,1.0,1.0,1/5,13.53%,COA6
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),-0.4599011159460237,-0.7417364148400207,0.8108108108108109,1.0,1.0,1/10,7.60%,MAPT
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.4373156083894705,-0.7416283152994739,0.8356164383561644,1.0,1.0,1/14,5.10%,IL7
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.3753749978163268,-0.7415387167949997,0.8888888888888888,1.0,1.0,10/52,14.16%,SLC11A1;TXK;SLC7A5;CR1;IL18;PDCD1LG2;BTN3A1;PDE4B;CD14;PYCARD
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.3951469518763885,-0.7412976967608153,0.8554216867469879,1.0,1.0,5/22,12.33%,VEGFA;RBPJ;FLT1;ITGB8;CDH2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.28039240881428507,0.7411540486047271,0.875,1.0,1.0,15/58,20.78%,SUPT16H;ELOA;GTF2H2;POLR2C;ELOC;ELP4;GTF2F1;MNAT1;CDK13;CDK7;CDC73;SUPT5H;LEO1;SETD2;SSRP1
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.35357847585602864,-0.7410414192753142,0.8888888888888888,1.0,1.0,11/69,17.75%,MTCP1;CDC37;SYAP1;CALM3;INCENP;SNF8;CDKN1B;PYCARD;CCNB3;CALM1;THY1
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.40283520679706586,-0.7404988304081411,0.8717948717948718,1.0,1.0,3/18,16.10%,SDCBP;LRPAP1;ARF6
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.3816304709074815,-0.740487409481521,0.8888888888888888,1.0,1.0,8/32,27.34%,LPCAT1;GNPAT;DGKG;DGKB;PLD1;LPCAT4;DDHD2;PLA2G4A
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.26362824451218375,0.7404287130310226,1.0,1.0,1.0,17/73,14.92%,RAP1A;MYOM1;ARFIP1;SERGEF;ITPR2;TGFB1;GOLPH3L;IL1B;IL1A;FRMD4A;P3H1;STXBP5;CACNA1A;ALOX5;UNC13B;HMGCR;RHBDF2
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.43855708248540815,-0.7397435992556958,0.8354430379746836,1.0,1.0,2/11,20.69%,RPS3;TESPA1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.43652634857261485,-0.7396639868567886,0.8767123287671232,1.0,1.0,5/17,24.99%,ADGRG6;AKAP6;PDE2A;RIMS2;RAPGEF3
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.3407879215064614,-0.7396506143621132,0.9278350515463918,1.0,1.0,23/109,21.35%,CGNL1;RHOB;VAV3;ARHGAP4;RACGAP1;RASGRF2;RHOU;CHN1;TRIP10;ITSN1;ARAP2;ARHGAP23;GNA13;FAM13A;NGEF;RELN;ARHGAP9;ARHGEF4;FGD3;SRGAP3;STARD8;PLEKHG5;OBSCN
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.46042105039846726,-0.739553641470974,0.8378378378378378,1.0,1.0,1/10,5.65%,NOD2
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),0.33916260917205504,0.7394967030696121,0.9473684210526315,1.0,1.0,6/17,13.03%,THUMPD1;FBL;TFB1M;BUD23;NSUN4;MTERF4
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.3348740040391842,0.7388304700508197,0.7142857142857143,1.0,1.0,4/20,5.99%,P2RY12;SRGAP2;VCL;WHAMM
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.3854477176515829,0.738262102858114,0.72,1.0,1.0,1/11,3.09%,ARHGAP35
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),0.4418285057624707,0.7377044325354084,0.8125,1.0,1.0,1/7,3.56%,ZNF675
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.3613792987717534,0.7376327976974614,0.8095238095238095,1.0,1.0,1/15,2.52%,PKD2
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.3549679609879078,0.7374574666771032,0.7333333333333333,1.0,1.0,5/10,32.06%,VTI1A;TMED5;STX6;GCC2;TRIP11
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.5090367188292628,-0.737211482113827,0.8421052631578947,1.0,1.0,3/5,36.76%,CLU;HSP90AB1;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.4452305399388313,-0.7370694169581701,0.9104477611940298,1.0,1.0,1/8,3.82%,PTN
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),-0.4488316849509212,-0.736530103447546,0.7808219178082192,1.0,1.0,4/8,24.90%,TYSND1;IRS2;MFSD2A;PPARA
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.4373049697424274,-0.7364161558767751,0.8382352941176471,1.0,1.0,2/9,14.29%,SDCBP;LRPAP1
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.41749792964670907,-0.7364072153272221,0.8378378378378378,1.0,1.0,4/13,32.07%,HEXIM1;NELFB;RECQL5;NELFA
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.40052025088332177,-0.736125919059915,0.8701298701298701,1.0,1.0,4/16,21.91%,CCL3;MAFB;TMEM178A;GPR137B
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.46104674959258113,-0.7360905029700013,0.8378378378378378,1.0,1.0,1/6,5.14%,CCL3
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),0.479054199079377,0.7358672619092134,0.7586206896551724,1.0,1.0,2/5,12.30%,METTL16;BUD23
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.3395614151631627,-0.7358616120009664,0.9072164948453608,1.0,1.0,13/121,15.78%,CKS2;NEK11;MEIS2;BRINP1;SDCBP;PSMA3;PIM3;PSMA5;IQGAP1;ERCC2;CDKN1B;PSMD8;PSMB4
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.42215196034792335,-0.7356203853480118,0.8082191780821918,1.0,1.0,1/14,7.55%,TENT4B
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.3454868405405329,0.7356186587809326,0.8620689655172413,1.0,1.0,2/13,14.13%,UBQLN2;SCYL2
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),-0.5102285957527415,-0.7356012577262315,0.8529411764705882,1.0,1.0,3/5,26.58%,SLC9A6;SH3GL2;TMEM108
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.42210356351335326,-0.7354007886802539,0.8414634146341463,1.0,1.0,2/13,7.86%,RORA;FMO5
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.3023564310384243,0.7351775323246866,0.8125,1.0,1.0,5/30,9.60%,PKD2;RYR1;APPL2;ALDH9A1;KCNJ2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.43200265236672486,-0.734750259793915,0.8783783783783784,1.0,1.0,2/14,9.02%,FANCB;POLQ
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.3329955781181803,0.7347383957792669,0.9130434782608695,1.0,1.0,1/16,0.78%,GSN
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.4041140680282867,-0.734708346249712,0.8024691358024691,1.0,1.0,9/20,23.12%,CACNB2;ANK3;LRP4;UNC13A;DVL1;UNC13C;MUSK;DCTN1;PPFIBP1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.46195853835380934,-0.7343790186100189,0.8611111111111112,1.0,1.0,3/9,24.81%,ABCB1;SLC1A2;BEST1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.4361890425862067,-0.7341833472929165,0.7878787878787878,1.0,1.0,4/9,17.39%,TMEM161A;TPT1;RPS3;CLU
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.49946124521502333,-0.7336579636454874,0.8450704225352113,1.0,1.0,1/5,17.47%,KLF4
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.49946124521502333,-0.7336579636454874,0.8450704225352113,1.0,1.0,1/5,17.47%,KLF4
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.3220715229189491,0.7335821122188609,0.9047619047619048,1.0,1.0,5/22,11.28%,UBE2J1;RPN2;ST6GAL1;ALG5;DDOST
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.42423090587977713,-0.7335538609595378,0.8157894736842105,1.0,1.0,3/11,30.65%,TERF2IP;RAPGEF3;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.41675328064259193,-0.7333474521521754,0.8705882352941177,1.0,1.0,4/23,17.03%,MYRIP;CFTR;ADCY8;IRS2
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.41479161291047933,-0.7332188331931763,0.8395061728395061,1.0,1.0,3/20,10.64%,BRCA1;NR1H2;MID1IP1
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.42874623798892614,-0.7328333424937682,0.8378378378378378,1.0,1.0,4/12,17.79%,PIGL;PIGG;PIGA;PIGH
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.33796797916619103,-0.7327800301355673,0.9473684210526315,1.0,1.0,14/96,21.25%,FOS;VAV3;PRKCQ;PSMA3;PSMA5;TEC;PIK3CB;PSMD8;PSMB4;CALM1;MAPK10;PSMD7;FCER1G;PSMD5
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),-0.5038563844033209,-0.7327705975423648,0.8571428571428571,1.0,1.0,3/5,39.04%,MAN1A1;MAN1B1;EDEM1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),-0.5038563844033209,-0.7327705975423648,0.8571428571428571,1.0,1.0,3/5,39.04%,MAN1A1;MAN1B1;EDEM1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),-0.5038563844033209,-0.7327705975423648,0.8571428571428571,1.0,1.0,3/5,39.04%,MAN1A1;MAN1B1;EDEM1
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",0.38191987358961355,0.7324677808574412,0.8235294117647058,1.0,1.0,1/7,6.74%,APPL2
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.3643905916306581,-0.7324564636212187,0.8636363636363636,1.0,1.0,9/52,15.74%,RPS27A;AZI2;PRDX4;UBA52;UBC;CD14;TRAF2;UBB;TLR2
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.37738002667936343,-0.7322332927355634,0.8636363636363636,1.0,1.0,11/37,22.57%,HAMP;FCGR2B;NR1H2;EPHA3;PXK;TLR2;PLSCR1;MCTP1;NRG1;RACK1;CRYAB
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.34953370672992734,0.7322151739093162,0.8695652173913043,1.0,1.0,4/18,5.85%,PKD2;MKKS;TGFBR2;ACVR1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),-0.5250726484524494,-0.7320673056646516,0.9206349206349206,1.0,1.0,3/5,44.01%,GUCY1B1;MT3;MTR
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),-0.5250726484524494,-0.7320673056646516,0.9206349206349206,1.0,1.0,3/5,44.01%,GUCY1B1;MT3;MTR
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.43132827889206005,-0.7315203554481949,0.7627118644067796,1.0,1.0,2/9,16.74%,GSTP1;PDCD4
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.45562650844841046,-0.7314960318317726,0.8493150684931506,1.0,1.0,2/11,15.74%,DHX58;TLR2
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.41876217633007135,-0.7313313530686186,0.8313253012048193,1.0,1.0,1/20,3.67%,MINDY1
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.4108071356923836,0.731006392531924,0.8181818181818182,1.0,1.0,1/7,5.55%,DDR1
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),0.4281498107461283,0.7308382981828705,0.6451612903225806,1.0,1.0,2/5,22.85%,MMAA;PCCB
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.36630946630074335,-0.7304493804253465,0.898876404494382,1.0,1.0,12/58,20.49%,JAML;MYO1G;SELL;IL10RA;LSP1;HCLS1;VNN2;GNLY;GPR65;ARHGAP9;PARVG;CD300A
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.36459333185366505,-0.7304120095051464,0.9213483146067416,1.0,1.0,12/57,24.17%,EIF4A3;SIDT2;SRSF5;SRSF2;SRSF9;KIF5C;U2AF2;CKAP5;ZFP36;PNPT1;RTRAF;SRSF3
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.45352206024772623,-0.7302888323031669,0.7894736842105263,1.0,1.0,2/9,14.47%,CD44;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.3481037038125414,-0.7302475738844092,0.9021739130434783,1.0,1.0,12/96,9.33%,OVOL2;VASN;RORA;PKP2;SPRY1;MEIS2;NOCT;ABCA5;NR1H2;RORB;ID2;LIMD1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.37655118096871204,-0.730142771345958,0.8518518518518519,1.0,1.0,12/26,33.00%,HSPA1B;GPSM2;CHMP5;PDCD6IP;MAP9;GNAI1;DCTN1;PSRC1;DRG1;TACC3;DYNC1H1;CHMP4B
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.3518868580475411,0.7300802352983929,0.8518518518518519,1.0,1.0,4/11,23.17%,SETD3;ZDHHC21;DAPK3;ADRB2
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.46842888809479455,-0.7300205030501609,0.7638888888888888,1.0,1.0,3/6,23.28%,DHDDS;IDI1;MVD
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.39764431841534026,0.7299481580648824,0.8181818181818182,1.0,1.0,4/13,5.31%,TGFB1;PTCH1;TGFBR2;GRAMD1A
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.3644246379989993,-0.7298497718312389,0.925531914893617,1.0,1.0,12/53,18.90%,TBC1D8;ATP8B1;TBC1D13;MYO10;TBC1D15;TBC1D2B;RDX;TBC1D14;ARF6;ATG5;RAB5A;DYNC2LI1
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.3822137234400551,-0.7297761078269349,0.8607594936708861,1.0,1.0,7/23,26.94%,TENT4B;MAPT;ZCCHC8;DICER1;PRKRA;TDRD1;MOV10L1
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),-0.4777627823313,-0.7295213554845615,0.7945205479452054,1.0,1.0,1/7,2.70%,SEMA3A
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),-0.4777627823313,-0.7295213554845615,0.7945205479452054,1.0,1.0,1/7,2.70%,SEMA3A
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.3271867479023083,0.7294533167673654,0.8695652173913043,1.0,1.0,6/17,18.54%,WHAMM;TRIP6;SRC;TAOK2;FERMT2;BCR
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.30313882609587006,0.7293569366691235,0.8947368421052632,1.0,1.0,1/25,1.75%,RUBCNL
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.4491670566879055,-0.7292636357231111,0.796875,1.0,1.0,2/6,25.83%,TMED2;ARFGAP2
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.4491670566879055,-0.7292636357231111,0.796875,1.0,1.0,2/6,25.83%,TMED2;ARFGAP2
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.4491670566879055,-0.7292636357231111,0.796875,1.0,1.0,2/6,25.83%,TMED2;ARFGAP2
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.450031317717169,0.7292558694331243,0.7272727272727273,1.0,1.0,1/5,13.84%,RBBP4
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.450031317717169,0.7292558694331243,0.7272727272727273,1.0,1.0,1/5,13.84%,RBBP4
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.4648760807862369,-0.7290859505482216,0.8169014084507042,1.0,1.0,1/9,8.53%,CXCR4
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.3985330471595239,0.7290048371502852,0.8333333333333334,1.0,1.0,1/9,0.78%,GSN
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.39888214171655356,-0.7289956131879759,0.8076923076923077,1.0,1.0,7/14,28.69%,CR1;IRF1;BCL6;LILRB2;IL4I1;DUSP10;FANCA
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.395799170303343,-0.7289376870840477,0.8658536585365854,1.0,1.0,6/24,16.47%,GLUL;CLIP3;ZDHHC15;ZDHHC19;ZDHHC9;ZDHHC4
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.43913885214737236,0.7285293389747212,0.8695652173913043,1.0,1.0,1/10,1.53%,BCL2L1
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),0.3828591359308957,0.7280944866148796,0.7714285714285715,1.0,1.0,3/8,26.47%,CDK13;CDK7;GTF2H5
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.32772331691630935,-0.7280921128562193,0.95,1.0,1.0,4/144,1.94%,PCSK1;SRGN;ERMP1;PAPPA2
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.44276742712528694,-0.7280655624821115,0.8461538461538461,1.0,1.0,1/10,2.56%,VEGFA
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.3851348728041813,-0.7280312936036727,0.8505747126436781,1.0,1.0,2/30,5.49%,THBS1;HLA-B
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.3696749197143522,-0.7278740430857447,0.8555555555555555,1.0,1.0,10/41,17.33%,LRP2;VEGFA;ANK2;SST;RAB3A;CTNND2;SCG5;SH3GL2;CPE;SEZ6L2
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.322016776409496,0.727691945704139,0.9,1.0,1.0,5/23,11.28%,UBE2J1;RPN2;ST6GAL1;ALG5;DDOST
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.4607303114396058,-0.7276351519318123,0.803030303030303,1.0,1.0,1/8,16.22%,NECAB1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.3937791706394629,-0.7275172904818396,0.8292682926829268,1.0,1.0,6/25,26.74%,GPM6B;CAV3;KCNAB2;MAP1A;HFE;ACTN2
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),-0.41097822260420375,-0.7274361089913326,0.8395061728395061,1.0,1.0,4/21,14.95%,SHANK3;EPHB1;INSR;CTNND2
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.47237818914197527,-0.7274190314124208,0.859375,1.0,1.0,1/6,4.79%,AQP11
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.45337387698314263,0.7273869243019162,0.7916666666666666,1.0,1.0,6/8,18.34%,DAB2IP;TLR7;CHUK;MAP3K7;TLR3;ERC1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.3468276461394779,-0.7272200536192984,0.8421052631578947,1.0,1.0,12/76,17.92%,THBS1;CCL3;GSTP1;NOD2;OAS3;C5AR2;CD14;PYCARD;TLR2;DICER1;CLU;ARG2
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.28538018800180703,0.7271680546594972,1.0,1.0,1.0,6/36,14.18%,RAP1A;ITPR2;IL1B;CHD7;CACNA1A;ALOX5
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),-0.3673123764803016,-0.727072922177872,0.8977272727272727,1.0,1.0,3/47,10.92%,ACVR1B;CIT;MAP3K12
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.34403132812870196,-0.7270070995087117,0.9130434782608695,1.0,1.0,8/86,13.89%,ALG10B;AQP11;B4GAT1;SERP1;MGAT1;ST8SIA1;TUSC3;OGA
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.48905669695285137,-0.7267534384719571,0.8666666666666667,1.0,1.0,1/5,18.95%,ACP3
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.23837870525230798,0.7266606966062068,1.0,1.0,1.0,17/98,15.98%,PLEKHM2;BET1;BAG5;GOLPH3L;TMED4;TRAPPC12;BLZF1;LYSMD3;TMED3;PLK3;ATP8B4;COG1;VTI1A;CDC42;UBXN2A;GBF1;TJAP1
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.41222436043476735,-0.7265438749502944,0.8846153846153846,1.0,1.0,5/18,21.12%,PGK1;CIDEB;ASPH;GRIN2A;RIPK2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.4598508804753962,0.7263468483667143,0.8181818181818182,1.0,1.0,1/5,6.74%,APPL2
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.3331845587724503,0.7260615395615594,0.9523809523809523,1.0,1.0,3/22,10.47%,MATK;PTPN12;SRC
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.4676425014880353,-0.725909083555296,0.8428571428571429,1.0,1.0,1/6,6.66%,ATP10A
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),-0.40974837692645616,-0.7254156841291326,0.8536585365853658,1.0,1.0,3/16,17.03%,PPP1R3B;INSR;IRS2
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.38254093639617104,0.7246672140030884,0.7692307692307693,1.0,1.0,2/11,14.56%,KHSRP;MOV10
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.3378389030730938,-0.7244610247767187,0.9693877551020408,1.0,1.0,18/135,17.75%,CCL4;RGS1;TBC1D8;CCL3;GNB5;SIPA1L1;TBC1D13;APC2;RAP1GAP;USP6;TBC1D15;TBC1D2B;LARS1;TBC1D14;ITGA6;GPR65;NGEF;THY1
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.26547647209731395,0.7243920479867231,1.0,1.0,1.0,16/75,14.38%,NRP1;RAB5B;RAB33B;ABL1;STON2;SYK;RAB10;SRC;MAP2K1;ABL2;RIT2;MAP2K2;DNAJC13;STXBP5;HCK;OPHN1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.30973832369908727,0.7241934497750446,0.9545454545454546,1.0,1.0,3/18,7.41%,PKD2;TMEM106A;IL1B
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.41176001211092705,0.7240392389850738,0.7567567567567568,1.0,1.0,2/6,21.73%,JAM2;CD81
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),0.3941534486041477,0.7238880943597159,0.7931034482758621,1.0,1.0,4/10,19.58%,SETD1B;TET2;KMT2A;KMT2D
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.3402482576416674,0.7237541742988143,0.8620689655172413,1.0,1.0,2/12,4.43%,ZNF675;TGFB1
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),0.429041938777078,0.7237481143791639,0.8484848484848485,1.0,1.0,2/7,22.74%,PPT1;GRN
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.3858614449768146,-0.7236606293252411,0.9156626506024096,1.0,1.0,5/31,12.82%,HS3ST2;HS3ST5;GPC3;GPC5;B3GAT2
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.46692520024353235,-0.7234933272258592,0.85,1.0,1.0,1/6,6.25%,HERPUD1
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.377719513483803,0.7234507496502767,0.7692307692307693,1.0,1.0,4/13,10.56%,PPARG;LPL;SYK;LDLR
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.4465297251317013,0.7234433346270144,0.8378378378378378,1.0,1.0,2/5,17.48%,EIF2AK4;PRKN
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),-0.476997351860997,-0.7233801322770916,0.8571428571428571,1.0,1.0,1/8,12.95%,AKAP6
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.476997351860997,-0.7233801322770916,0.8571428571428571,1.0,1.0,1/8,12.95%,AKAP6
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.38031516859879855,-0.7229525833714691,0.8313253012048193,1.0,1.0,5/23,22.50%,XRCC3;STIL;CHMP5;PDCD6IP;C10ORF90
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.3422949749037571,-0.7229250466690583,0.9489795918367347,1.0,1.0,26/126,22.93%,HTR2B;TFRC;TRIM5;NOD2;LITAF;PINK1;GAPDH;DDX1;TRIM25;CARD16;IFIT5;TRAF2;TERF2IP;LGALS1;APOL3;S100A4;TRIM22;TRIM14;GPRC5B;PLEKHG5;RIPK2;CARD9;REL;TRIM13;S100B;VAPA
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.33346341795784484,-0.7227965992054549,1.0,1.0,1.0,38/274,20.90%,TOP2A;PPP1R15A;DTL;BCL2A1;VAV3;SLF1;TNFRSF1B;XRCC3;MASTL;DDX11;BRCA1;WDHD1;NOP53;POLQ;MNDA;BCL2L2;FAN1;WDR48;ADPRS;RPS3;RFC4;TIMELESS;CBX5;CIDEB;BCL6;KMT5C;SLX4;MCL1;FMN2;DDB1;DTX3L;VCPIP1;ZRANB3;MUS81;FOXP1;MCM7;POLE2;NABP1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.32638731150005956,-0.7226194604797317,1.0,1.0,1.0,164/1260,18.41%,NR4A3;NAMPT;BRIP1;RPL23;FOSL2;RPS27A;MACC1;CEBPD;SAP30;NFIL3;ZNF793;ZNF382;SLC11A1;FGF1;BHLHE40;NR4A1;ST18;FOS;VEGFA;HMGB2;OVOL2;CTDSP1;HAMP;RBPJ;HIF1A;RXRB;RORA;CREB5;TXK;MXI1;ZNF540;BEX1;NR4A2;MEIS2;ZNF789;TAF6L;H1-0;FBP1;NOD2;NFE2L3;DDRGK1;YEATS2;ZNF93;LITAF;ZNF549;BRCA1;ZNF260;PLAC8;PLAG1;COPS5;ZNF814;ATF5;ZNF483;UXT;RPS14;STAT1;HDGFL3;CHD3;ARID5B;SMARCD3;PARP9;JUNB;ZNF235;IL18;KDM6B;NR1H2;NOP53;ETS2;TGIF1;RORB;CRTC3;HCFC1;ID2;UBA52;PRDM15;PAX8;HIC2;TRPS1;ZNF805;RRP1B;CTBP1;ZNF550;DRAP1;PPP1R13L;MXD1;ATF3;SDCBP;PIAS4;ZNF518A;MED25;TSHZ2;UBC;CGGBP1;IRF1;MAX;TCF7;ZNF654;NLRC5;RGCC;ZNF850;ZNF41;HSF2;TSHZ3;PRDM1;ZNF213;PAXBP1;UHRF1;KCTD1;BMI1;ZNF266;HCLS1;PID1;NR1D1;SNF8;DEAF1;ZKSCAN5;CREBRF;SUV39H2;CCNC;KDM1A;POU6F1;ZNF565;ZNF445;CREM;ZNF449;TEF;HIRA;KDM3A;ZNF20;UBB;HBP1;NFIX;TOX;TLR2;PLSCR1;MLX;STAT2;CBX5;E2F7;ZNF197;ITGA6;IMPACT;ATXN7L3;MAFB;BCL6;ZNF354A;KLF13;SP110;ZNF778;PRPF6;POU5F1;DICER1;KLF4;MNT;NFIB;ZNF302;HEXIM1;RPL10;SS18L1;ATP2B4;ZNF558;TET1;CHCHD2;ZFPM2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.4263712547023227,0.7223106576702609,0.8333333333333334,1.0,1.0,1/6,3.16%,NFATC3
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.34705791683483495,-0.7222325123666525,0.9278350515463918,1.0,1.0,25/120,19.95%,OMG;PQBP1;RAB11A;PPP1R9A;MAPT;HDGFL3;EPB41L3;PLP1;LAMB1;SHANK3;GPM6B;MANF;GPM6A;EPHB1;CTNND2;UBB;SLC9A6;NCDN;SH3GL2;DICER1;STMN3;SGK1;STMN1;MICALL2;STMN2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.43197789220424904,-0.7219419392800992,0.8690476190476191,1.0,1.0,2/10,10.00%,FGR;HLA-F
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.43326315084381806,-0.7218330526836889,0.8648648648648649,1.0,1.0,1/12,7.11%,AKR1B1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.3817865019995944,-0.7217227259317767,0.8522727272727273,1.0,1.0,4/21,19.66%,FHL1;E2F7;KLF4;GPNMB
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.4107395584009184,-0.7213891574895962,0.8289473684210527,1.0,1.0,1/18,3.11%,RSAD2
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.4152212503893328,-0.721266964144007,0.8888888888888888,1.0,1.0,4/20,18.45%,NOTCH2;RASGRP4;IRS2;RELN
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.412306968020787,-0.7211846112249085,0.8289473684210527,1.0,1.0,6/18,17.39%,TMEM161A;TPT1;CD44;KDM1A;RPS3;CLU
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.3339210728709384,-0.7208631299434595,0.9489795918367347,1.0,1.0,29/148,21.05%,SH3PXD2B;PTN;PKP2;CACNB2;ANK3;RAB11A;ATP1B3;ANK2;EPB41L3;ZDHHC15;FGF13;SHANK3;FCHO2;EFR3B;RAB3A;RAB3C;NRXN1;RDX;RAB15;CAV3;TSPAN32;CPE;THY1;NRXN2;SCN3B;LRRC7;SYNE3;SAV1;DVL1
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.3661893588350106,-0.720806602795344,0.875,1.0,1.0,4/25,13.49%,MAPT;HDGFL3;FGF13;TUBGCP2
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.3872889906416872,-0.7206081393878939,0.8108108108108109,1.0,1.0,10/18,35.02%,SLC24A1;PNKD;SLC24A2;PRRT1;SHANK2;STXBP1;SYT11;PLK2;NLGN4X;PICK1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.4376104512758326,-0.7203375212549988,0.8311688311688312,1.0,1.0,1/10,6.41%,BRCA1
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.45736896486258116,-0.7201252649517151,0.8591549295774648,1.0,1.0,1/8,1.97%,SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),0.44046732132492983,0.7201178075715178,0.76,1.0,1.0,2/6,8.00%,SORL1;MSN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),0.44046732132492983,0.7201178075715178,0.76,1.0,1.0,2/6,8.00%,SORL1;MSN
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),0.44046732132492983,0.7201178075715178,0.76,1.0,1.0,2/6,8.00%,SORL1;MSN
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),0.36639054801921095,0.7195806800450341,0.7241379310344828,1.0,1.0,1/8,2.29%,DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.3640692481490959,-0.7195612452973038,0.9166666666666666,1.0,1.0,7/48,14.87%,GADD45B;SEMA3A;NOD2;FCGR2B;SDCBP;PYCARD;TRAF2
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.33699018207587866,-0.7194562213964539,0.8901098901098901,1.0,1.0,12/67,17.81%,THBS1;CALM3;TTN;IQGAP1;KCNMA1;CPNE8;SYT1;ADCY8;SYT4;RYR3;CALM1;CLIC4
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.34912027929566314,-0.7194293147076697,0.956989247311828,1.0,1.0,7/61,11.34%,HMGB2;RPL11;DDX11;NMD3;PARP9;MED25;B2M
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.3958505795226602,0.7189350731333375,0.8157894736842105,1.0,1.0,1/7,1.59%,IDE
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.3402491864149447,-0.7188544770389133,0.9263157894736842,1.0,1.0,4/69,5.65%,NLRP12;RAB7B;HLA-B;NOD2
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.4152506633259436,0.7188540782306398,0.8235294117647058,1.0,1.0,2/7,7.65%,CNTN4;EIF2AK4
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.3810403085311774,0.7187909535998092,0.7391304347826086,1.0,1.0,1/10,1.05%,P3H2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.39803532644297474,-0.7187117475399838,0.8414634146341463,1.0,1.0,8/21,22.54%,MAP1B;MAPT;PRUNE1;STMN3;STMN1;STMN2;MAP1A;MAP2
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.3603798358509164,-0.7186185928376235,0.8876404494382022,1.0,1.0,7/36,23.25%,ALOX12;SCD;FADS3;ELOVL4;ACSM3;SCD5;LTA4H
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.36628161525719266,-0.7185615883597696,0.9368421052631579,1.0,1.0,12/64,22.69%,KNSTRN;RAB11A;CENPE;TTN;DSN1;CHMP5;PDCD6IP;DCTN2;SEH1L;SMC4;TEX14;CENPK
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.32514875159362927,-0.7185444249726871,0.99,1.0,1.0,27/272,15.33%,CENPF;TFRC;NAPA;LRP2;TBC1D8;ANK3;TVP23A;SCAMP3;TBC1D13;IL10RA;CD36;STX19;TXNIP;ARRDC3;RAB3A;USP6;NSF;ABCA1;GOLGA4;RAB3C;TBC1D15;TBC1D2B;SNX6;TBC1D14;RAB15;VMP1;SCG5
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.4787793861487152,-0.7182227935632627,0.8055555555555556,1.0,1.0,2/6,11.71%,CBR1;PTGES2
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),-0.39509806594281666,-0.7180836827633053,0.9012345679012346,1.0,1.0,8/21,25.45%,FCHO2;RAB3A;NLGN3;SYT1;AMPH;RAB5A;PIP5K1C;NLGN2
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.3621467016184716,0.717378900463775,0.8,1.0,1.0,5/12,21.17%,EFL1;AK3;MFN1;GIMAP7;RHOQ
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.32858522644135785,-0.7172951535131353,0.97,1.0,1.0,63/305,23.57%,CENPF;NFIL3;BHLHE40;HMGB2;RBPJ;ATP8B1;ZNF540;BASP1;YEATS2;ZNF93;BRCA1;L3MBTL3;MDFIC;ATF5;ARID5B;NR1H2;RORB;ID2;LIMD1;HIC2;TLE1;CTBP1;PIAS4;IRF1;TSHZ3;KCTD1;ING4;NR1D1;DEAF1;CDKN1B;SUV39H2;KDM1A;SNX6;TIMELESS;MLX;CBX5;BCL6;PDCD4;KLF4;ILF3;EIF4A2;HEXIM1;ZFPM2;LANCL2;PER2;CITED2;SUDS3;FOXP1;GCFC2;RBFOX2;PRICKLE1;PTPRK;NRG1;RUNX1T1;KDM5C;CRYAB;SCML4;BTAF1;ENO1;EID1;NIF3L1;PER1;RLIM
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.4074700319208459,-0.7170695627962501,0.8529411764705882,1.0,1.0,4/13,21.91%,CCL3;MAFB;TMEM178A;GPR137B
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.33478509339833507,-0.7170570789010553,0.9042553191489362,1.0,1.0,18/89,25.18%,FZD6;PSMA3;PSMA5;GNAO1;AP2S1;PSMD8;PSMB4;CALM1;PSMD7;PRICKLE1;DVL1;PSMD5;AP2A2;PSMC2;PLCB1;PSMB9;CCDC88C;PSMB2
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.2916661328232123,0.7170568806736936,0.75,1.0,1.0,7/32,15.58%,RALB;PIP4K2B;UBQLN2;TBC1D12;SMCR8;PIKFYVE;SH3GLB1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.3116827799091672,0.7170056824608961,1.0,1.0,1.0,6/25,11.66%,DAB2IP;SMURF1;CTSC;LAPTM5;TMTC3;FBXW7
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.4158029338585126,-0.716965637502791,0.8133333333333334,1.0,1.0,1/17,6.46%,RBM3
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.40788584873280637,-0.7167463071142836,0.7894736842105263,1.0,1.0,4/18,23.71%,SHANK3;NEURL1;RELN;CAMK2B
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.4291926935227438,-0.7167246069444392,0.8028169014084507,1.0,1.0,2/11,17.93%,B4GAT1;CSGALNACT2
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),-0.4768225981902109,-0.7165969329020544,0.8194444444444444,1.0,1.0,2/6,30.37%,ANAPC7;TACC3
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),-0.4768225981902109,-0.7165969329020544,0.8194444444444444,1.0,1.0,2/6,30.37%,ANAPC7;TACC3
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.33201956387553255,-0.7165937438983022,0.9393939393939394,1.0,1.0,18/144,13.11%,TFRC;TNS1;MXI1;H1-0;SIDT2;BLVRB;PPP2R5B;ENDOD1;NARF;BNIP3L;SDCBP;RAP1GAP;UROS;MBOAT2;PPOX;NUDT4;ALDH6A1;CTSB
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.35562163852104023,-0.7165585808793058,0.9090909090909091,1.0,1.0,10/58,19.49%,LRP2;SLC11A1;CCL3;TPT1;CDH23;TUSC3;SLC24A1;RYR3;CACNA1C;ATP2B2
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.3311416988691209,-0.7165200935235327,0.99,1.0,1.0,49/226,28.15%,EIF4A3;WDR83;PQBP1;SNRPD2;RAVER2;RBM4B;BCAS2;POLR2G;WBP4;DDX1;PPIE;WBP11;HNRNPA0;PNN;TFIP11;DHX16;SRSF5;SNRNP27;ZCCHC8;PRPF6;SRSF2;SNRPA;CSTF2T;FRG1;RNPC3;LSM5;PRPF40B;GCFC2;SRSF9;MFAP1;SART3;U2AF2;PRPF3;SRSF12;SRSF8;SRSF3;DDX46;SNU13;NOVA1;U2SURP;DBR1;RBM5;ZCRB1;PDCD7;RBM22;CLNS1A;BUD31;GEMIN2;NCBP2
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.3364637886627677,-0.7164889836923104,0.9387755102040817,1.0,1.0,9/114,8.80%,THBS1;LRP2;CHI3L1;FGF1;CCL3;PPP2R5B;PINK1;IL18;NOP53
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.33724299421573395,0.716329111661341,0.8461538461538461,1.0,1.0,3/15,15.33%,USP30;GDAP1;MFN1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.36999718253809855,-0.7162424116184021,0.8421052631578947,1.0,1.0,2/36,6.90%,RHOB;FIGNL1
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.35887840747062105,-0.7160848579908284,0.8837209302325582,1.0,1.0,2/44,3.22%,NFIL3;DNAJB9
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),-0.41142169065603296,-0.7159226449605023,0.8641975308641975,1.0,1.0,6/18,28.06%,VCAN;CHST7;CSGALNACT2;CHSY1;CHST12;NCAN
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.4094525001289244,-0.7159183520121608,0.8356164383561644,1.0,1.0,7/13,32.04%,GPSM2;MAP9;GNAI1;DCTN1;PSRC1;TACC3;DYNC1H1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.3725495509509674,-0.7155023192310848,0.896551724137931,1.0,1.0,1/46,0.40%,HTR2B
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.4093131203749274,-0.715102350676617,0.8493150684931506,1.0,1.0,4/11,18.63%,HLA-F;B2M;TAP1;ERAP1
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.3046852820572305,0.7150900442686364,1.0,1.0,1.0,5/23,7.27%,SMAD7;TGFBR2;ACVR1;SALL1;SLIT3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-0.46048651387394646,-0.7149362042396412,0.8,1.0,1.0,1/7,3.30%,HIF1A
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.33303266684781285,-0.71440641173555,0.9052631578947369,1.0,1.0,6/59,17.03%,INSIG1;SYAP1;PKM;INSR;RAB15;IRS2
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.36761898811083876,-0.7143935729037362,0.8604651162790697,1.0,1.0,5/29,18.73%,ITGB8;PDZD2;PTPRT;TCTN1;DNAH7
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.3658734707524999,-0.7143489604812826,0.8977272727272727,1.0,1.0,7/45,17.03%,TGFB2;MYRIP;APBB3;TTN;TLR2;ARF6;IRS2
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.41357710840042883,-0.7140427062166811,0.8846153846153846,1.0,1.0,2/13,9.83%,VEGFA;ITGB8
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.37289090947763703,-0.7138249646502278,0.9,1.0,1.0,5/32,14.32%,SLCO3A1;SLCO1A2;CFTR;SLC4A10;SLC35A1
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.3701564075992691,-0.7129682686004779,0.92,1.0,1.0,7/28,23.60%,MRPS7;MRPL51;MRPL47;TEFM;MRPS15;MRPS21;TFAM
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.35142899453956045,-0.7128873706615036,0.9052631578947369,1.0,1.0,14/58,22.80%,ANK3;CCK;MAP1B;MAPT;PLP1;NREP;DCC;RAB3A;S100A6;RTN4RL1;PLPPR4;NTNG1;MAP1A;S100B
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.427407645204005,-0.7127488023270431,0.8481012658227848,1.0,1.0,1/15,3.07%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.34766863310944995,0.7121345273084667,0.7333333333333333,1.0,1.0,2/7,11.85%,DVL2;DVL3
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.38131978976824216,-0.7120241333893504,0.8554216867469879,1.0,1.0,3/28,6.24%,THBS1;SPOCK1;ADAM15
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),-0.409594102805958,-0.7116414935688427,0.8414634146341463,1.0,1.0,1/10,5.49%,FLT1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.34809328264541856,-0.7114319959926639,0.9468085106382979,1.0,1.0,8/68,10.76%,RPS27A;LRP2;ASPN;VASN;SPRY1;PEG10;UBA52;UBC
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3569736461184184,-0.7108203829141366,0.9270833333333334,1.0,1.0,4/53,5.49%,VEGFA;VAV3;DOCK1;FLT1
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),-0.39040476622141734,-0.7106664929653191,0.8205128205128205,1.0,1.0,3/15,23.93%,TENT4B;DICER1;PRKRA
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.43331963839409365,-0.7105644802482126,0.8666666666666667,1.0,1.0,1/11,6.41%,BRCA1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.3419483925674302,-0.7105536057822321,0.9696969696969697,1.0,1.0,3/101,3.88%,RHOBTB3;DENND2A;RNF126
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.41147242147078966,-0.7104497615231659,0.8481012658227848,1.0,1.0,2/13,14.47%,CD44;KDM1A
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.37926668464829455,-0.7099969916343417,0.8651685393258427,1.0,1.0,7/29,27.88%,SNRPD2;PRPF6;SART3;PRPF3;SRSF12;CLNS1A;GEMIN2
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.4185713377413986,0.7099903242709178,0.6944444444444444,1.0,1.0,2/7,9.14%,ALDH9A1;CPT1C
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.43349220909372266,-0.7098673207538668,0.8732394366197183,1.0,1.0,2/9,26.76%,GPT2;GOT1
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.42364346106642253,-0.709811690995321,0.8356164383561644,1.0,1.0,1/14,5.04%,PQBP1
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.44075490838562437,0.7094682312425382,0.7857142857142857,1.0,1.0,2/5,6.32%,ELAVL4;METTL16
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.45773559513371626,-0.7092014919854005,0.8666666666666667,1.0,1.0,3/8,29.92%,OGA;MAN2A1;MAN2A2
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.39651475264212277,-0.7087367553748511,0.9186046511627907,1.0,1.0,2/20,8.74%,HHIP;GPC3
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.3503973958725114,-0.7087308523391734,0.9534883720930233,1.0,1.0,3/44,8.95%,TRMT9B;FTSJ1;SSB
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.32390441075872756,0.7086061223145687,0.9259259259259259,1.0,1.0,2/21,5.13%,RAB7A;RAB39A
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.43260211558953854,0.7085339016296192,0.7666666666666667,1.0,1.0,2/5,6.74%,ADIPOR2;APPL2
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),-0.44682069505390465,-0.7080842987051424,0.8918918918918919,1.0,1.0,2/8,13.44%,THBD;NR1D1
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.4539889563577911,0.7075942929709802,0.7631578947368421,1.0,1.0,1/5,6.08%,STIM1
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.4755549988688371,-0.7074630644376878,0.8870967741935484,1.0,1.0,1/5,2.56%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.3282597479379727,-0.7073880116327345,0.9381443298969072,1.0,1.0,20/156,15.91%,FGF1;TGFB2;RIMS1;RBPJ;HIF1A;IL7R;SULF2;PDCL;IL7;NOD2;SHANK3;CD63;TRAF7;NLGN3;NRXN1;ING5;RPS3;TXNDC15;TLR2;TRIM16
prerank,GO_Biological_Process_2021__negative regulation of leukocyte degranulation (GO:0043301),0.3677846609014934,0.7072857048602242,0.8636363636363636,1.0,1.0,1/8,1.01%,LGALS9
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.4721354186101906,-0.7072539100765906,0.9027777777777778,1.0,1.0,3/7,25.40%,CAD;CMPK1;CTPS1
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.3510297655341757,-0.7066707742522552,0.9456521739130435,1.0,1.0,11/60,16.47%,AQP11;NACA;SRP14;VPS37C;ZDHHC15;SDCBP;ZDHHC19;ZDHHC9;SRPRA;PEX3;ZDHHC4
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.34824460651683975,-0.7062139899073437,0.9347826086956522,1.0,1.0,9/48,19.66%,FHL1;ID2;APPL1;RGCC;RDX;E2F7;KLF4;AIF1;GPNMB
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.38261242378292293,-0.7061765399272779,0.8513513513513513,1.0,1.0,3/17,18.59%,FBP1;DDB1;CLK2
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.4840342658741549,-0.7050616209556285,0.863013698630137,1.0,1.0,1/6,8.72%,NR1H2
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),0.37726028507252185,0.7049849837900187,0.8235294117647058,1.0,1.0,3/8,7.41%,LGALS9;SYK;IL1B
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.390317448384524,-0.7046500153326992,0.8961038961038961,1.0,1.0,4/20,20.62%,GPM6B;EPHA3;PTPRA;ACTG1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.3923857068009321,-0.7044057530918604,0.8795180722891566,1.0,1.0,3/20,15.60%,PINK1;ATP5IF1;UBB
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),-0.44228131264991494,-0.704365624641032,0.84375,1.0,1.0,2/8,15.85%,RBX1;UBE2M
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.449060972287604,-0.7041678365877054,0.84,1.0,1.0,1/7,7.68%,FGR
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.33657775573202015,-0.7039662090690956,0.9139784946236559,1.0,1.0,14/78,18.67%,AGT;DTL;IL18;NR1H2;GPC3;APC2;UHRF1;NSF;SNF8;CDKN1B;CLU;KLF4;DDB1;HECW2
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3621791758921975,-0.7037807552559421,0.9166666666666666,1.0,1.0,14/39,27.25%,RPL11;HSPA1B;CAMLG;RPL5;COPS9;RPS3;PER2;UBXN1;SOX4;U2AF2;OGT;TNFAIP3;UFL1;VPS28
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.4089061361847568,-0.7034196076959865,0.84,1.0,1.0,1/11,6.25%,HERPUD1
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),-0.47232736813706233,-0.7034176610457759,0.8305084745762712,1.0,1.0,4/5,31.23%,ARF6;AIF1;PIP5K1A;RAC1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.34951334512517834,-0.7034090897489891,0.9058823529411765,1.0,1.0,7/40,15.09%,AGT;TRAF7;PYCARD;ING5;RPS3;TRAF2;BMF
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),-0.3217986539403937,-0.703265492408175,0.98989898989899,1.0,1.0,19/144,12.33%,GLIPR2;AGT;TGFB2;PTN;SYAP1;ALOX15B;FBN2;NOCT;BRINP1;IL18;ID2;CD36;PAX8;PPP1R13L;SDCBP;OLFM1;RGCC;AAMDC;CDH2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.3860023191553379,-0.7031882822325713,0.8571428571428571,1.0,1.0,2/17,8.72%,PLTP;NR1H2
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.4564178217264491,-0.702901340443569,0.8,1.0,1.0,1/7,6.82%,RAB11A
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.3530197303649693,-0.7026619369661823,0.9354838709677419,1.0,1.0,12/61,18.67%,DTL;TNFRSF1B;VPS11;GPC3;APC2;NSF;SNF8;CDKN1B;RDX;SH3D19;DDB1;HECW2
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.3629325755693969,-0.7026150785280209,0.8875,1.0,1.0,5/31,15.74%,POLR3F;DHX58;IRF1;OAS3;TLR2
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.4556250862479494,-0.7025805351053354,0.890625,1.0,1.0,1/6,3.80%,PPP1R3B
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.37863443557467935,0.7020088970056277,0.8157894736842105,1.0,1.0,3/8,7.20%,UBQLN2;SGTA;USP14
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.3703666196041489,-0.701791754024567,0.8589743589743589,1.0,1.0,8/18,30.98%,IL18;TXNIP;PYCARD;TXN;APP;CASP1;PSTPIP1;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3300486736972499,0.7017595381332181,0.782608695652174,1.0,1.0,2/15,9.22%,PKD2;CCNYL1
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.4507006338091108,-0.7016617247290428,0.875,1.0,1.0,2/5,16.31%,SOD1;E2F7
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.3205338979863797,-0.7013259416051607,0.96875,1.0,1.0,14/79,25.18%,CLEC4E;PSMA3;PSMA5;PSMD8;PSMB4;PSMD7;FCER1G;PSMD5;CARD9;KLRD1;PSMC2;PRKACB;PSMB9;PSMB2
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.3205338979863797,-0.7013259416051607,0.96875,1.0,1.0,14/79,25.18%,CLEC4E;PSMA3;PSMA5;PSMD8;PSMB4;PSMD7;FCER1G;PSMD5;CARD9;KLRD1;PSMC2;PRKACB;PSMB9;PSMB2
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.43586439695701706,-0.7005828421483653,0.8378378378378378,1.0,1.0,3/10,22.93%,FBXL2;PPIB;VAPA
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),0.4469269710606928,0.7005313180240927,0.8285714285714286,1.0,1.0,2/6,22.76%,UQCC2;MEF2C
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.42980372565969854,-0.7004648801161435,0.8461538461538461,1.0,1.0,3/11,26.77%,LRPAP1;CLU;ROCK1
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.36065594114551985,-0.6989495405030514,0.872093023255814,1.0,1.0,5/29,20.47%,DDRGK1;ATG2A;VRK1;EIF2D;RETREG1
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.315981351804955,0.6989440900321406,1.0,1.0,1.0,3/22,5.74%,LGALS9;TOMM70;MAPK11
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.3343472305023311,-0.6988408530562588,0.99,1.0,1.0,21/168,18.09%,CEBPD;NR4A2;NFE2L3;NOCT;POLR2G;GTF3C6;POLR1C;PAX8;MTERF1;DRAP1;RNMT;ERCC2;PTMA;DEAF1;EAF1;BTF3;POLR3H;NFIX;KLF13;MNT;ELOB
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.4762938200374194,-0.6979095945153334,0.8484848484848485,1.0,1.0,1/5,13.22%,PDHB
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.47182385598785637,-0.6977262754008116,0.8918918918918919,1.0,1.0,3/6,33.64%,WIZ;DBF4;CDC7
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.40063810080484025,0.6970589316002476,0.8157894736842105,1.0,1.0,2/8,6.54%,SIRT1;PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.37641518986734296,-0.6970427903474221,0.8947368421052632,1.0,1.0,5/17,33.51%,CLU;ABCG1;EPHA4;CASP3;GSAP
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.33814031118323695,-0.6967702975056937,0.8977272727272727,1.0,1.0,12/49,23.96%,SYAP1;RORA;NOCT;ID2;AAMDC;NR1D1;ZFPM2;RUNX1T1;ANKRD26;LMO3;ZFP36;ZBTB16
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.3694668011279971,-0.696584489241811,0.9213483146067416,1.0,1.0,6/31,20.99%,RAB11A;CENPE;CHMP5;PDCD6IP;DCTN2;SEH1L
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.41338931403535073,-0.6965161175151282,0.8783783783783784,1.0,1.0,3/17,12.38%,COL11A1;LAMB1;FN1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.3918922929934412,-0.6961251104384718,0.9285714285714286,1.0,1.0,5/14,33.51%,CLU;ABCG1;EPHA4;CASP3;GSAP
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),-0.42229593147832284,-0.6960901165653631,0.8970588235294118,1.0,1.0,4/11,15.05%,DMD;TTN;CDH2;CAV3
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.3895090514434393,0.6959313620017054,0.7428571428571429,1.0,1.0,2/5,14.26%,EIF2AK4;NCK1
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),-0.44042819246354364,-0.6955760648877125,0.875,1.0,1.0,4/9,19.33%,HLA-B;FCGR2B;LGALS1;LILRB2
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.36270432847521206,-0.6951654557100394,0.881578947368421,1.0,1.0,6/24,24.69%,APPL1;PID1;INSR;IRS2;PRKAG2;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),0.3854185442428813,0.6950881346834921,0.9375,1.0,1.0,3/8,12.30%,RIOK1;WDR43;BUD23
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),0.3041054232133807,0.6947683307507425,0.8571428571428571,1.0,1.0,11/11,69.62%,DIS3L;EXOSC9;EXOSC6;EXOSC2;EXOSC7;DIS3;XRN1;EXOSC8;EXOSC10;DEDD2;TRIR
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.3770089954546662,-0.6944249746528043,0.9310344827586207,1.0,1.0,3/23,11.44%,HSPA1B;HSPA2;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.45541545293514574,0.6940117091177237,0.9142857142857143,1.0,1.0,2/5,11.36%,NR1H3;TIRAP
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.3748913467480555,-0.6939204316180964,0.8902439024390244,1.0,1.0,6/20,27.07%,PKP2;RNASE10;LILRB2;JAM3;ITGA4;DSC2
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.44382672669939527,-0.693862016900365,0.875,1.0,1.0,2/10,11.44%,SEC61B;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.40735082706578407,-0.6938308910779627,0.868421052631579,1.0,1.0,4/18,30.70%,CAMK2N1;EPHA4;ROCK1;CSTB
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.4075443475694853,-0.693368685938601,0.8194444444444444,1.0,1.0,3/10,18.45%,SHANK3;ADCY8;RELN
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),0.36331390929820123,0.6924958028194855,0.8571428571428571,1.0,1.0,8/8,63.69%,PRKN;BECN1;SQSTM1;AMBRA1;PHB2;ATG13;ATG14;MAP1LC3B
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),0.37066728022057305,0.6920819083332777,0.7647058823529411,1.0,1.0,1/9,1.90%,PGM2
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),0.37066728022057305,0.6920819083332777,0.7647058823529411,1.0,1.0,1/9,1.90%,PGM2
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.2861989591559043,0.6920249352419774,0.8888888888888888,1.0,1.0,4/19,9.72%,MCU;MICU3;MAIP1;SMDT1
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.23860060926262824,0.6919507561989079,1.0,1.0,1.0,14/62,15.56%,RPAP2;POU2F1;RPRD1B;TAF13;INTS7;POLR2C;PHAX;GTF2E1;GTF2F1;RPRD1A;INTS9;SRRT;POU2F2;GTF2B
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3981545293706846,-0.6915650105388905,0.8918918918918919,1.0,1.0,3/16,13.44%,RAB7B;APPL1;NR1D1
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.3726402256279706,-0.6913491558012406,0.8666666666666667,1.0,1.0,4/18,19.27%,SULF2;EIF2AK3;NFIB;BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.3485302039218161,-0.6911629419305687,0.8658536585365854,1.0,1.0,7/34,15.74%,HIF1A;IL7;ALOX15B;IL18;OAS3;PYCARD;TLR2
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.37537519387024487,-0.6909129617537793,0.918918918918919,1.0,1.0,5/27,11.73%,GLIPR2;TGFB2;SDCBP;OLFM1;RGCC
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.39597592226906964,-0.6906033916909129,0.855072463768116,1.0,1.0,2/12,10.38%,PINK1;PSMA3
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.3953532390755119,-0.6901522788490884,0.8461538461538461,1.0,1.0,3/17,14.28%,CSKMT;ANTKMT;SUV39H2
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.29745049448125405,0.6900823822324151,0.8095238095238095,1.0,1.0,6/14,23.08%,METTL16;CELF1;ZC3H18;PUM1;YTHDF2;ROCK2
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.33708700794750496,0.6899864119111832,0.8636363636363636,1.0,1.0,4/16,11.66%,SORL1;APPL2;IL1B;FBXW7
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.34715061011912,-0.6899546033295207,0.9333333333333333,1.0,1.0,7/54,16.74%,NLRP12;NOD2;CD14;RPS3;TERF2IP;TLR2;PDCD4
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.3385831372617404,0.6894619422163303,0.8888888888888888,1.0,1.0,3/14,7.41%,SORL1;APPL2;IL1B
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.38330843315116847,-0.6891183208701878,0.8271604938271605,1.0,1.0,4/16,22.86%,PPIE;FKBP5;PPIB;PPID
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.3600683466564817,0.6889313407064704,0.8,1.0,1.0,1/8,1.73%,HPN
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.4161233527212295,0.6887611993298277,0.8064516129032258,1.0,1.0,3/7,23.36%,ST6GAL1;PARP1;SETD5
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.3835713685537596,0.6886600756339265,0.8571428571428571,1.0,1.0,3/9,22.36%,JAG1;NOTCH1;YTHDF2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.2969849754579533,0.6885455285941241,0.95,1.0,1.0,8/25,13.57%,DUSP7;DUSP18;PTPN12;DUSP3;PTPN13;PTPRO;DUSP6;UBASH3B
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.3088085121283341,0.6883606689623842,0.95,1.0,1.0,3/17,10.71%,SLC9C2;SLC9A9;SLC9A8
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.27404646103936947,0.6882381718831386,1.0,1.0,1.0,8/37,12.54%,ATP2C1;RHOG;ZDHHC2;CIB1;STAC3;WNK3;PLS1;ZDHHC5
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.3560078151089501,-0.687999963711381,0.8705882352941177,1.0,1.0,9/30,23.23%,IFT81;IFT74;IFT52;DYNC2I1;KIF3A;DYNC2LI1;DYNC2H1;IFT46;IFT122
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),0.3484192850988663,0.6879477367071773,0.84375,1.0,1.0,2/5,15.72%,PLK3;GBF1
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.4142947851452686,-0.6879336544049427,0.8831168831168831,1.0,1.0,5/12,25.50%,SOD1;GHR;PPIB;MFSD2A;APP
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.2912119286641725,0.6877054649928739,0.9411764705882353,1.0,1.0,4/13,25.40%,MSN;BCL2;MEF2C;PIK3CG
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),-0.413534387026509,-0.6875546046657957,0.8356164383561644,1.0,1.0,4/10,38.39%,ROCK1;FLOT2;PRNP;ABCA7
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.41688519926951273,-0.6875383243219307,0.8591549295774648,1.0,1.0,1/11,3.16%,HAMP
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.34744463204311216,-0.6874349125522917,0.9130434782608695,1.0,1.0,7/45,17.39%,HERPUD1;PINK1;TMEM161A;TPT1;BCL2L2;MCL1;CLU
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),-0.4262104271951165,-0.6874277844683014,0.8428571428571429,1.0,1.0,1/7,8.09%,ANK2
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.3168639687997021,-0.6873619607047079,1.0,1.0,1.0,48/248,26.69%,EIF4A3;WDR83;PQBP1;SNRPD2;RAVER2;RBM4B;BCAS2;POLR2G;WBP4;PPIE;WBP11;RNMT;ERCC2;HNRNPA0;PNN;TFIP11;DHX16;SRSF5;SNRNP27;ZCCHC8;PRPF6;SRSF2;SNRPA;CSTF2T;FRG1;RNPC3;LSM5;PRPF40B;GCFC2;SRSF9;MFAP1;TBRG4;SART3;U2AF2;PRPF3;SRSF12;SRSF8;SRSF3;DDX46;SNU13;NOVA1;U2SURP;DBR1;KIN;RBM5;ZCRB1;SRRM4;PDCD7
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.41108815557868855,-0.6871949070225267,0.9,1.0,1.0,4/12,23.60%,MTERF1;TEFM;PNPT1;TFAM
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),-0.4335032001940216,-0.6871243718637192,0.9014084507042254,1.0,1.0,2/6,16.10%,IQSEC1;ARF6
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),-0.4335032001940216,-0.6871243718637192,0.9014084507042254,1.0,1.0,2/6,16.10%,IQSEC1;ARF6
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.40385364582919075,-0.6868695840588344,0.863013698630137,1.0,1.0,2/11,13.44%,FCGR2B;NR1D1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.3436039329288344,-0.6866079932748692,0.9444444444444444,1.0,1.0,5/48,12.93%,ALG10B;GCNT1;SERP1;MGAT1;ST8SIA1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.370798851545347,0.6863121169025714,0.7931034482758621,1.0,1.0,7/7,62.94%,EIF4E2;TNRC6B;DDX6;AGO2;STAT3;EIF4ENIF1;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.370798851545347,0.6863121169025714,0.7931034482758621,1.0,1.0,7/7,62.94%,EIF4E2;TNRC6B;DDX6;AGO2;STAT3;EIF4ENIF1;EIF4G1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.42123794358275185,-0.686262508468155,0.8701298701298701,1.0,1.0,2/12,7.66%,SLC7A5;SFXN3
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.4371614025802282,-0.6862175465867296,0.8695652173913043,1.0,1.0,1/5,7.52%,SEC61B
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.3134649755293085,0.6859790060301676,0.875,1.0,1.0,4/21,8.14%,ENPP1;TGFB1;SIRT1;TRIB3
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.4296971603645336,-0.6854329241305805,0.8888888888888888,1.0,1.0,1/8,5.20%,XRCC3
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.3077509242575102,0.6847329592698778,0.9130434782608695,1.0,1.0,3/14,9.42%,PGM5;FLII;TMOD2
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.4504704305139045,-0.6845255793015792,0.927536231884058,1.0,1.0,1/6,9.25%,APPL1
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.36707957764413834,0.6840871359490568,0.8823529411764706,1.0,1.0,4/10,19.26%,ABCC4;LRRC8D;SLC19A1;ABCC5
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.398899795307234,0.6840869959073537,0.8064516129032258,1.0,1.0,1/7,4.15%,HVCN1
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),-0.4622335290087449,-0.6837046967674658,0.8813559322033898,1.0,1.0,1/5,9.37%,SHANK3
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.3062983031058757,0.6834036295731739,0.92,1.0,1.0,2/17,4.94%,CBFB;RUNX1
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.3708515388024712,-0.6832663613187968,0.9375,1.0,1.0,4/30,10.65%,TGFB2;RBPJ;COBL;STIL
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.3871849078048379,0.6831473930425421,0.9,1.0,1.0,1/7,4.91%,AGO1
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.3304908824415885,-0.68288800287187,0.9444444444444444,1.0,1.0,10/65,19.08%,TRIM5;DAPK1;PINK1;BNIP3L;BNIP3;NPRL2;PIK3CB;TP53INP1;TRIM22;TRIM14
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),-0.41455998587534404,-0.6826266278462444,0.8787878787878788,1.0,1.0,1/9,5.95%,RPA2
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.3118020052501711,-0.6826112133218791,0.9895833333333334,1.0,1.0,14/80,25.18%,CLEC4E;PSMA3;PSMA5;PSMD8;PSMB4;PSMD7;FCER1G;PSMD5;CARD9;KLRD1;PSMC2;PRKACB;PSMB9;PSMB2
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.3337966794724941,-0.6826025495842746,0.9529411764705882,1.0,1.0,14/69,25.18%,RBX1;FBXL2;PSMA3;PSMA5;PSMD8;PSMB4;FBXL13;FBXL7;PSMD7;PSMD5;FBXL5;PSMC2;PSMB9;PSMB2
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.3413416464287802,0.6822197820795582,0.7692307692307693,1.0,1.0,2/10,19.46%,BOD1;PDS5A
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.38653028262263917,-0.6810824452869195,0.872093023255814,1.0,1.0,1/19,1.37%,KCNJ13
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.3283588349844527,-0.6808351936222211,0.8936170212765957,1.0,1.0,23/69,27.88%,CACNB2;CCL3;ANK2;TPT1;TRPM3;CDH23;SLC24A1;NALCN;RYR3;CACNA1C;ATP2B4;SLC24A2;ATP2B2;SLC24A4;MCOLN1;RYR2;MCUR1;CACNA1B;SLC24A3;TRPC4;ORAI2;TRPM7;MCOLN2
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),-0.4597241779841795,-0.680813248612681,0.8333333333333334,1.0,1.0,1/6,15.87%,ERRFI1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.37519991206415265,-0.6803148101201587,0.881578947368421,1.0,1.0,3/19,24.36%,CNOT8;ZFP36;CNOT6
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.3073761838733236,0.6801666496255491,0.9545454545454546,1.0,1.0,9/23,26.14%,SIRT1;EP300;SAFB2;PKN1;KDM5D;HDAC1;ZBTB7A;DAB2;NCOA2
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.45725580562000345,-0.6800366792727355,0.8412698412698413,1.0,1.0,2/5,39.83%,NUCKS1;XRCC6
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.43946899161638003,-0.679881382025555,0.8732394366197183,1.0,1.0,2/8,24.20%,CTBP1;TAF7
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.3888770758002349,-0.6798141391761975,0.8571428571428571,1.0,1.0,7/18,28.42%,SCN9A;ATP5IF1;SCN1A;SCN3B;CACNA1B;CACNG2;SCN2A
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.3292817076943188,-0.6796629095354947,0.9560439560439561,1.0,1.0,15/60,25.50%,CARMIL1;MAPT;BAIAP2L1;PRKCE;PYCARD;RPS3;CAV3;ARF6;CLU;CRACD;STMN2;DCTN1;FES;AKAP9;APP
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.3648094641658315,-0.6795560715141137,0.9759036144578314,1.0,1.0,2/24,15.05%,SHANK3;CAV3
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.3300159339662056,-0.6791847350488961,0.9247311827956989,1.0,1.0,16/58,25.63%,RAB11A;HEATR3;PINK1;ZDHHC15;IL10RA;APPL1;HK2;NUP133;PRICKLE1;RANBP17;SEC13;FAM53C;RYR2;NUP88;TNPO2;NUP50
prerank,MSigDB_Hallmark_2020__Coagulation,-0.3455304149603575,-0.6789810406525352,0.9340659340659341,1.0,1.0,7/66,13.11%,THBS1;SPARC;F8;THBD;FN1;ITGA2;CTSB
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.24052392388298463,0.6789108388981338,1.0,1.0,1.0,14/61,15.56%,RPAP2;POU2F1;RPRD1B;TAF13;INTS7;POLR2C;PHAX;GTF2E1;GTF2F1;RPRD1A;INTS9;SRRT;POU2F2;GTF2B
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.3058766899639113,-0.6788939767356578,1.0,1.0,1.0,158/1271,18.24%,NR4A3;CENPF;BRIP1;FOSL2;CEBPD;SAP30;ACVR1B;NFIL3;ZNF793;ZNF382;BHLHE40;NR4A1;ST18;FOS;AGT;VEGFA;HMGB2;CDK14;HINT1;OVOL2;CTDSP1;RBPJ;HIF1A;GLRX2;RXRB;ATP8B1;RORA;CREB5;MXI1;ZNF540;POLR3F;NR4A2;PQBP1;MEIS2;ZNF789;TAF6L;BASP1;APBB3;NFE2L3;YEATS2;ZNF93;LITAF;ZNF549;BRCA1;ZNF260;L3MBTL3;PLAG1;MDFIC;ZNF814;ATF5;ZNF483;UXT;PRKCQ;STAT1;HDGFL3;CHD3;ARID5B;SMARCD3;MSL3;PARP9;JUNB;ZNF235;NR1H2;ETS2;TGIF1;RORB;HCFC1;ID2;LIMD1;PRDM15;PAX8;PPIE;HIC2;TLE1;TRPS1;ZNF805;CTBP1;ZNF550;DRAP1;PPP1R13L;MXD1;ATF3;PIAS4;ZNF518A;TSHZ2;MAP3K12;IRF1;MAX;RPL6;TCF7;ZNF654;ZNF850;ZNF41;HSF2;TSHZ3;PRDM1;ZNF213;KCTD1;ZNF266;HCLS1;ING4;NR1D1;SNF8;DEAF1;CDKN1B;ZNF100;ZKSCAN5;ZNF519;CREBRF;SUV39H2;INSR;CCNC;KDM1A;SNX6;POU6F1;ING5;ZNF565;ZNF445;CREM;ZNF449;TEF;HIRA;KDM3A;TERF2IP;ZNF20;HBP1;NFIX;TOX;TRIM16;TIMELESS;MLX;STAT2;CBX5;E2F7;ZNF197;ATXN7L3;HMGN5;MAFB;BCL6;PDCD4;ZNF354A;KLF13;SP110;ZNF778;POU5F1;KLF4;MNT;BRCA2;ILF3;NFIB;TP53INP1;ZNF302;HEXIM1;SS18L1;ATP2B4;ACTR5;ZNF558;TRIM22
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.3373890168690252,-0.6786114223242936,0.9139784946236559,1.0,1.0,9/67,17.23%,TGFB2;RIMS1;MAPT;SDCBP;AKAP6;GOLGA4;UNC13A;SYT1;SYT4
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.3281002812996554,-0.6782054293510263,0.9285714285714286,1.0,1.0,1/48,0.79%,ALG10B
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.4330545530813797,-0.6780974627212253,0.9047619047619048,1.0,1.0,1/6,6.82%,RAB11A
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.3546510509902581,0.6780256604191396,0.868421052631579,1.0,1.0,4/9,21.73%,SH3GLB1;ATP13A2;LAMTOR4;CD81
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),-0.43678131220560895,-0.6776783269480241,0.863013698630137,1.0,1.0,2/5,25.92%,FYCO1;CALCOCO2
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),-0.3773180575110813,-0.6775762232415327,0.8795180722891566,1.0,1.0,3/20,11.61%,ANK3;FAM20A;SLC12A8
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.3196420827921908,0.6774814029098056,0.7666666666666667,1.0,1.0,4/13,12.58%,PPARG;LPL;NR1H3;TTC39B
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.348583214750465,-0.6769549381537016,0.9487179487179487,1.0,1.0,5/22,23.42%,IFIT2;BNIP3;CLU;HK2;VPS35
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.36901258804061937,-0.6768432237381922,0.8947368421052632,1.0,1.0,6/19,29.86%,SHANK3;ARF6;NEURL1;CAMK2B;PPFIA2;PTPRS
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.4525860937471908,-0.6765419028575318,0.8769230769230769,1.0,1.0,3/5,32.29%,GPS2;PLAA;PARP10
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.40561233008897984,-0.6762063999054724,0.9452054794520548,1.0,1.0,4/11,28.13%,KLF4;OTUD7B;TMSB4X;PTPN22
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),-0.3547984677889787,-0.6760381383515516,0.9545454545454546,1.0,1.0,2/40,3.27%,LRP2;RBPJ
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.3428209459459458,0.6760301736800048,0.9545454545454546,1.0,1.0,9/9,65.74%,MMAA;ABCC1;MMAB;ABCD4;MTRR;MTR;LMBRD1;MMADHC;MMUT
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.3428209459459458,0.6760301736800048,0.9545454545454546,1.0,1.0,9/9,65.74%,MMAA;ABCC1;MMAB;ABCD4;MTRR;MTR;LMBRD1;MMADHC;MMUT
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.34282764527375376,-0.6754993722429417,0.956989247311828,1.0,1.0,4/50,13.03%,NAPA;F8;NSF;SEC24C
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.34282764527375376,-0.6754993722429417,0.956989247311828,1.0,1.0,4/50,13.03%,NAPA;F8;NSF;SEC24C
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.34282764527375376,-0.6754993722429417,0.956989247311828,1.0,1.0,4/50,13.03%,NAPA;F8;NSF;SEC24C
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.4003890885999247,-0.6752306120301632,0.8701298701298701,1.0,1.0,3/12,14.95%,SHANK3;EPHB1;CTNND2
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),0.3550642797219551,0.6750414779968625,0.896551724137931,1.0,1.0,2/12,9.65%,LAPTM5;DUSP3
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.32674545210248807,0.674792251062803,0.9230769230769231,1.0,1.0,2/13,7.99%,IDE;CTSH
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.3994934242453708,0.674706172722811,0.7567567567567568,1.0,1.0,3/5,29.28%,ATP6V1G1;ATP6AP1;ATP6V0D1
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.3835703651627747,-0.6740733024973966,0.8823529411764706,1.0,1.0,3/13,30.51%,NUP133;SEH1L;AHCTF1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.3696574344225728,-0.6736068568048966,0.9397590361445783,1.0,1.0,7/31,15.98%,RNF126;SPRY1;EPN1;CBLB;SNX6;ERRFI1;SH3GL2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3379060011727876,-0.6734801567948931,0.9101123595505618,1.0,1.0,14/57,22.97%,ANK3;CCK;MAP1B;DCC;RAB3A;LRP4;S100A6;PLPPR4;DVL1;NTNG1;MAP1A;MAP2;S100B;MFSD2A
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.41563784527322545,0.6728148648381347,0.8333333333333334,1.0,1.0,2/6,6.93%,TGFBR2;PDGFA
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.3856924327767452,-0.6722202139755995,0.8888888888888888,1.0,1.0,1/14,4.69%,MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.4128643430887702,-0.6718418004872821,0.8904109589041096,1.0,1.0,4/12,23.18%,CNOT8;ZC3HAV1;GTPBP1;PNPT1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.32412249742515864,-0.6697351619809051,0.9662921348314607,1.0,1.0,10/67,15.74%,RPS27A;UBA52;CD36;COLEC12;UBC;CTSB;CD14;PIK3R4;UBB;TLR2
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.43404939153862143,-0.6696712733442117,0.9180327868852459,1.0,1.0,1/5,18.59%,CLK2
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),-0.44684227718123715,-0.6695973288871843,0.8852459016393442,1.0,1.0,4/6,37.45%,EZH1;RIF1;EZH2;DOT1L
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.33729858601350116,-0.6695386466166011,0.9550561797752809,1.0,1.0,4/47,7.60%,FOS;RHOB;ANKZF1;MAPT
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.31644896785945903,-0.6691144959966681,0.9897959183673469,1.0,1.0,18/84,25.13%,C5AR1;GSTP1;FGR;CAMK2N1;SOD1;CENPE;TTN;IQGAP1;CAV3;GSKIP;THY1;RELN;DVL1;SPDYA;RTRAF;TAF7;PRKAG2;WARS1
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),-0.33210033343748235,-0.669098063245091,0.9444444444444444,1.0,1.0,5/52,8.10%,DEPP1;FBXL2;MAPT;DAPK1;DAPK2
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),-0.40063277378603734,-0.6689847262157815,0.9180327868852459,1.0,1.0,2/11,15.96%,PIAS4;GNL3
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.33169350739557824,-0.6685375829590045,0.9550561797752809,1.0,1.0,14/44,23.96%,SYNC;LAMB1;TTN;FN1;PALLD;ANGPT2;RND3;FBXL7;COL5A1;CALD1;UACA;MUSK;CRYAB;ZBTB16
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.3893245151860963,-0.6682080741287213,0.9295774647887324,1.0,1.0,1/17,5.14%,CCL3
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.38408189159364664,-0.6681556841355856,0.9,1.0,1.0,3/18,9.33%,NOCT;RORB;LIMD1
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.3245571649323069,0.6679338511125661,0.8846153846153846,1.0,1.0,3/15,4.98%,PKD2;MKKS;TGFBR2
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.3404926428138271,0.6674634894796527,0.9428571428571428,1.0,1.0,2/10,10.56%,EIF2AK4;LDLR
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.4172692257251891,-0.6674314320014955,0.8985507246376812,1.0,1.0,1/9,11.14%,PLD3
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.32960520085887934,0.6671174094894313,0.9393939393939394,1.0,1.0,3/11,14.90%,TBC1D25;CLEC16A;SMCR8
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.419265207520209,0.6667149726676104,0.868421052631579,1.0,1.0,1/5,3.25%,DOCK10
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.39835014540780594,0.6660271215663408,0.8292682926829268,1.0,1.0,1/5,4.17%,FSCN1
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.30688018486290347,-0.6659762351788148,1.0,1.0,1.0,26/210,19.73%,RPS27A;HIF1A;BRCA1;COPS5;OTUD1;HCFC1;UBA52;CLSPN;CFTR;PSMA3;UBC;PSMA5;USP36;USP6;WDR48;TOMM20;TRAF2;PSMD8;UBB;PSMB4;ACTR5;ABRAXAS1;UCHL1;VCPIP1;PSMD7;SUDS3
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.3741848611005013,-0.6659268947356413,0.9047619047619048,1.0,1.0,5/17,27.71%,LIMD1;CNOT8;CNOT6;MOV10L1;AGO4
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.32968756051092046,-0.6658331096892198,0.9772727272727273,1.0,1.0,11/62,17.36%,CDK14;SULF2;AMER2;MDFIC;GPC3;TLE1;DAAM2;PTK7;CTNND2;TLR2;GSKIP
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.405241576740052,0.6657659471382203,0.9,1.0,1.0,1/6,4.91%,AGO1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.3943192987222059,-0.6656764237640077,0.881578947368421,1.0,1.0,2/12,20.12%,LIMD1;PATL2
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.27373587976482705,0.6655711570081256,1.0,1.0,1.0,7/28,17.39%,CBFB;RUNX1;EP300;SAFB2;PKN1;UFM1;KDM5D
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.3637238918200366,0.6652904985764202,0.9,1.0,1.0,1/10,3.06%,NAA35
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.3482158570649611,-0.6648746003616464,0.898876404494382,1.0,1.0,4/23,19.66%,FHL1;E2F7;KLF4;GPNMB
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.4273111754251767,-0.6646657468193169,0.9,1.0,1.0,1/8,4.07%,ENTPD3
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.36287781546812803,0.6646491426500692,0.8787878787878788,1.0,1.0,1/7,4.94%,RUNX1
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.41884400750524214,-0.6645063127378279,0.8939393939393939,1.0,1.0,2/10,24.09%,FOXP1;FES
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.33339891146681455,-0.6641280257666233,0.9883720930232558,1.0,1.0,5/43,10.87%,HIF1A;COX7A2;PINK1;ATP5IF1;PGAM1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.3250914305098444,-0.6633841132967889,0.9591836734693877,1.0,1.0,17/71,25.77%,FLT1;MAPT;CENPE;EEF1A2;EPHA3;IQGAP1;EPHB1;ALK;INSR;RELN;EPHA7;NTRK3;SPDYA;MUSK;ZNF16;PRKAG2;EPHA4
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.2909452427829236,0.6633530160700312,1.0,1.0,1.0,1/17,5.16%,RNF20
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.32148127013847555,-0.6629790399238281,0.9565217391304348,1.0,1.0,12/58,25.63%,RPL23;HEATR3;APPL1;CBLB;NUP133;PRICKLE1;RANBP17;SEC13;FAM53C;NUP88;TNPO2;NUP50
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.38192707052528746,0.6628692123077832,0.868421052631579,1.0,1.0,1/7,6.08%,LPL
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.4095173954961405,-0.6628091392860366,0.8734177215189873,1.0,1.0,3/10,15.06%,CBR1;PTGES2;PNPLA8
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.3667208179077032,-0.6622734550107143,0.9358974358974359,1.0,1.0,3/16,12.66%,OVOL2;UGCG;SVEP1
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.32923838708043585,-0.6618127026710995,0.9431818181818182,1.0,1.0,6/57,10.92%,RPS27A;NOD2;MAP3K8;UBA52;UBC;MAP3K12
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.34167146521282454,-0.6616596032689466,0.9247311827956989,1.0,1.0,4/46,5.80%,AGT;RNF126;SPRY1;EPN1
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.34352357922713467,0.6616224135714314,0.9130434782608695,1.0,1.0,1/11,2.08%,ADK
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.33913099032165395,-0.6614971146820009,0.92,1.0,1.0,1/30,7.98%,PRKCQ
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.4341789314353872,-0.6611754507024786,0.873015873015873,1.0,1.0,2/5,26.33%,SRSF12;PRPF39
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.3058225646664414,-0.6611284251447769,0.98989898989899,1.0,1.0,28/254,19.66%,RPS27A;TRIM5;RNF144B;ARIH2;DTL;RNF126;RBX1;BRCA1;UBA52;PSMA3;UBE2QL1;UBC;HERC6;PSMA5;SPSB1;DZIP3;TRAF2;PSMD8;UBB;PSMB4;FBXL13;FBXL7;TRIM22;HECW2;TRIM14;DTX3L;TRIM69;PSMD7
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.3977606925299845,-0.6607099719188175,0.9285714285714286,1.0,1.0,1/11,6.82%,RAB11A
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.3977606925299845,-0.6607099719188175,0.9285714285714286,1.0,1.0,1/11,6.82%,RAB11A
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.3977606925299845,-0.6607099719188175,0.9285714285714286,1.0,1.0,1/11,6.82%,RAB11A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.3977606925299845,-0.6607099719188175,0.9285714285714286,1.0,1.0,1/11,6.82%,RAB11A
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.3503073238584009,-0.6606780968870734,0.9560439560439561,1.0,1.0,12/37,28.80%,RPL13A;NOP53;HSPA5;TFIP11;IMPACT;CLU;JAM3;CRYAB;RIOK3;NLRC3;THRA;PTGER4
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.3246817379528765,0.660552888655603,1.0,1.0,1.0,3/13,15.61%,NPC2;LDLR;NPC1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.3856574690407001,0.6599895346716541,0.8387096774193549,1.0,1.0,1/6,7.65%,EIF2AK4
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.4311130082780139,-0.6599589790301758,0.8695652173913043,1.0,1.0,1/6,19.97%,FOXP1
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.3960316118305993,-0.6598998962680872,0.9166666666666666,1.0,1.0,1/13,4.69%,MTHFD1
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.3813223000928818,0.6590610492182106,0.8571428571428571,1.0,1.0,6/6,61.89%,CD81;C1S;C1QC;C1QB;ZP3;C1QA
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.4024724969727484,-0.6590517947393071,0.8714285714285714,1.0,1.0,1/10,7.60%,MAPT
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.34337196473575204,-0.6587007066895779,0.9583333333333334,1.0,1.0,1/28,7.98%,PRKCQ
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.34717116293186545,-0.6586083285907992,0.9285714285714286,1.0,1.0,5/26,22.15%,BRCA1;CTBP1;KDM1A;TET1;SART3
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.41467197366701813,-0.6585046715836752,0.8888888888888888,1.0,1.0,2/7,8.90%,NTN4;LAMB1
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.34089937774656126,-0.6582770622084827,0.9021739130434783,1.0,1.0,5/36,13.12%,MYOT;EMB;CDH2;PTPRT;PALLD
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.377578981117478,-0.6580052806746256,0.9324324324324325,1.0,1.0,4/14,28.01%,AP1AR;VPS13A;VPS13C;KIF16B
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.285033694258753,0.6576136660768237,0.96,1.0,1.0,8/23,19.58%,SETD6;SETD3;SETD1B;KMT2B;RBBP5;SETDB1;KMT2A;KMT2D
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3622178384561576,-0.6575597294049402,0.8974358974358975,1.0,1.0,5/17,16.47%,CLIP3;ZDHHC15;ZDHHC19;ZDHHC9;ZDHHC4
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3622178384561576,-0.6575597294049402,0.8974358974358975,1.0,1.0,5/17,16.47%,CLIP3;ZDHHC15;ZDHHC19;ZDHHC9;ZDHHC4
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.26672162035845415,0.6573278339682496,0.9130434782608695,1.0,1.0,7/25,18.85%,DNMT3A;TASOR;RBBP4;AEBP2;EED;CREBZF;SPI1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.3919425550762967,-0.657119657374902,0.948051948051948,1.0,1.0,4/13,23.28%,SRSF9;C1QBP;U2AF2;SRSF12
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.30403356063128156,-0.6569582878753526,0.979381443298969,1.0,1.0,28/136,20.84%,HTR2B;PLPP3;PFKFB4;ALOX15B;FBP1;GK;LIMD1;PGK1;ITPKC;PPA1;NUDT4;INPP4A;ALK;PFKFB3;PTPRD;PIK3CB;GPD2;CALM1;DUSP12;PTPRB;LIMK2;INPP4B;ACP3;HK2;EPHA7;GK5;PFKL;PLPPR4
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.3889909768632326,-0.6568530232290739,0.9466666666666667,1.0,1.0,4/14,23.28%,SRSF9;C1QBP;U2AF2;SRSF12
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.34324148586454706,-0.6565994830454659,0.9487179487179487,1.0,1.0,13/32,31.47%,PLPP3;FN1;PIK3CB;ACTG1;MYL12A;MEGF11;DSC2;CLIC1;HSPB1;TYRO3;STXBP1;FIBP;ACTN1
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.438925098564801,-0.6563685642549522,0.9393939393939394,1.0,1.0,3/5,43.49%,PLA2G4A;HADHA;HADHB
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.33763362936907765,-0.6561952825445695,0.9294117647058824,1.0,1.0,7/39,14.95%,PKP2;CDH9;EPB41L3;CDH12;CDH2;CDH8;CTNND2
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.3410663492685956,-0.655929755659783,0.9382716049382716,1.0,1.0,8/22,26.74%,FN1;ITGA6;PLEC;THY1;PTPRK;SORBS1;PIP5K1A;ACTN2
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.3728627697045003,-0.6554932234047508,0.926829268292683,1.0,1.0,4/16,20.31%,SLC7A5;SLC6A15;SLC38A6;CTNS
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.3441450421079405,-0.654912367348567,0.95,1.0,1.0,4/34,14.20%,CASP5;BNIP3;IRF1;PIEZO2
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.4206209174880424,-0.6547134639265172,0.9324324324324325,1.0,1.0,3/9,21.60%,SIRT3;NSMAF;RACK1
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.4206209174880424,-0.6547134639265172,0.9324324324324325,1.0,1.0,3/9,21.60%,SIRT3;NSMAF;RACK1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.3310937894647107,-0.6540562338390719,0.8470588235294118,1.0,1.0,8/29,18.98%,HIF1A;NOD2;APPL1;PLD3;APOD;PYCARD;PDCD4;MACIR
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.40264306174851827,-0.6540152110297738,0.9210526315789473,1.0,1.0,2/14,8.09%,PLN;ANK2
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.36521658537301716,-0.6538425535656486,0.935064935064935,1.0,1.0,3/14,22.29%,SCD;ACAT1;SCD5
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.3747104074219616,-0.653836775407779,0.863013698630137,1.0,1.0,3/16,20.56%,ACOT13;ACAT1;ACSM3
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.3747104074219616,-0.653836775407779,0.863013698630137,1.0,1.0,3/16,20.56%,ACOT13;ACAT1;ACSM3
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.32929701374831294,0.653676870894322,1.0,1.0,1.0,2/13,12.50%,BAG5;PPP1R3F
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.3370862298975394,0.6528649548040619,0.8947368421052632,1.0,1.0,3/9,26.27%,TPR;NUP98;NUP153
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.39076834131187704,-0.6523217305301754,0.9206349206349206,1.0,1.0,2/9,13.71%,PADI2;APOD
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.3095550990307816,-0.6522104605025427,0.9789473684210527,1.0,1.0,18/97,22.19%,FLT1;PINK1;PRKCQ;EPHA3;ARRDC3;BMI1;EPHB1;ALK;INSR;RPS2;RFC4;KLF4;DTX3L;EPHA7;CHTF18;POLG2;NTRK3;MUSK
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.3491661863588945,-0.6520216798469881,0.974025974025974,1.0,1.0,5/23,25.75%,FCGR2B;IL1RAPL1;NTNG1;VPS35;ZNF804A
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.3751647701893367,-0.651654494325991,0.8888888888888888,1.0,1.0,10/17,37.70%,FCGR2B;THY1;CD300A;PTPN22;CD22;GPS2;PTPN2;DGKZ;CEACAM1;PRNP
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.34494800862243913,0.6516184206197596,0.84375,1.0,1.0,1/10,3.27%,PPARG
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),-0.44279020664430696,-0.6514106683368576,0.875,1.0,1.0,1/5,8.88%,PDK3
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3146405653053341,0.6512601565036551,0.9130434782608695,1.0,1.0,2/16,9.22%,PKD2;CCNYL1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.33638610566753707,-0.6509009699207691,0.922077922077922,1.0,1.0,1/21,5.36%,WDR5
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.2926666569570839,0.6508178786516747,0.875,1.0,1.0,6/18,16.85%,PPARGC1A;IL1B;RPS6KA4;TADA2B;DIP2A;ARRB1
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.32730412279411686,-0.6505802848555818,0.9891304347826086,1.0,1.0,2/57,3.70%,NAPA;F8
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.3268597176760462,-0.6505645280208818,0.9545454545454546,1.0,1.0,6/35,18.90%,PPA1;DARS1;LARS1;NARS1;GARS1;HARS2
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.39640970312303425,-0.6504598143365935,0.9154929577464789,1.0,1.0,1/13,6.41%,BRCA1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.380784903431092,-0.6503074042893646,0.9178082191780822,1.0,1.0,1/15,5.05%,HS3ST5
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.3763464995595248,-0.6501323183200273,0.935064935064935,1.0,1.0,5/16,19.33%,PLN;GPM6B;PXK;CAV3;LILRB2
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),-0.4010421924986486,-0.6489649164530216,0.873015873015873,1.0,1.0,1/6,11.27%,IRF1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.4133419556529172,-0.6482965103683948,0.9722222222222222,1.0,1.0,2/10,13.01%,SHANK3;VPS51
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.39514608086056546,0.6482702641552734,0.8787878787878788,1.0,1.0,1/6,3.10%,SMURF1
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.32440180543100716,-0.6480265844856111,0.9130434782608695,1.0,1.0,9/62,15.91%,SLC11A1;HMGB2;RXRB;NOCT;TMEM161A;CD36;HNRNPA0;SCD;TRIM16
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.41504032518151546,-0.6474846045624847,0.9142857142857143,1.0,1.0,4/8,17.42%,COL11A1;LHFPL5;PIEZO2;SCN1A
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.3187213711368154,-0.6473519824440268,0.9318181818181818,1.0,1.0,7/42,18.18%,UBXN2B;TMEM41B;VMP1;ATG2A;ATG5;TP53INP1;GABARAPL1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),-0.31387298291072585,-0.6471653780928032,0.9222222222222223,1.0,1.0,15/57,25.63%,HIF1A;PFKFB4;FBP1;PGAM1;PFKFB3;INSR;NUP133;SEH1L;SEC13;PRKAG2;NUP88;PPARA;APP;OGT;NUP50
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.36776350795645846,-0.6470121014503104,0.8902439024390244,1.0,1.0,9/22,24.86%,RIMS1;RAB3A;RAB15;SYT1;SYT4;RAB5A;RAB3D;RIMS2;RIMS3
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.40586593236835805,-0.646747846324191,0.918918918918919,1.0,1.0,2/9,29.76%,MUS81;DNASE1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),-0.36445718042707653,-0.6461938393835199,0.9692307692307692,1.0,1.0,2/14,12.27%,GSTP1;CARD16
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.30700672739738055,0.6458792394670821,0.9583333333333334,1.0,1.0,1/14,1.77%,ITGA5
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),0.33890252069553334,0.6456549180550032,0.8461538461538461,1.0,1.0,1/9,5.16%,RNF20
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.4148643258902178,-0.6456481407825342,0.9295774647887324,1.0,1.0,2/8,21.61%,ADCY10;DYNC1I1
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.3773068440325643,0.6451886965252145,0.8333333333333334,1.0,1.0,2/5,15.38%,TENM3;PTPN23
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.3320042375266744,-0.6451407246209581,0.9550561797752809,1.0,1.0,9/44,23.78%,TRIM5;TRIM25;KDM1A;TRIM22;TRIM14;DVL1;RACK1;MAP2;DZIP1L
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.35039759368572443,-0.6450180777865279,0.9390243902439024,1.0,1.0,6/26,18.00%,GLA;CD36;INSR;CLU;KLF4;ATP2B4
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.32589325698950516,-0.6448863441202057,0.9651162790697675,1.0,1.0,4/42,7.06%,TGFB2;GSTP1;NOD2;COPS5
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),0.3542886654895773,0.6448717881859977,0.8529411764705882,1.0,1.0,4/8,19.97%,ALOX5;MOCS1;GCH1;MOCS2
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.37381619336505356,-0.6448290722597682,0.8875,1.0,1.0,1/12,9.24%,ID2
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.439167683639266,-0.6447701475014306,0.9365079365079365,1.0,1.0,2/6,37.20%,CHAMP1;MID1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.40698504540408087,-0.6447022427501933,0.9342105263157895,1.0,1.0,1/13,9.25%,APPL1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.3512161979345649,-0.6445264577611546,0.9375,1.0,1.0,2/26,11.38%,RBPJ;TCF7
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.3453121962422083,0.6444873672330628,0.8809523809523809,1.0,1.0,5/9,30.03%,SIRT2;HDAC1;HDAC9;REST;RCOR1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.2847321696998888,0.6442543037702401,0.9310344827586207,1.0,1.0,5/15,15.49%,SLC25A33;ABCB7;SLC30A10;ALOX5;PIKFYVE
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.3740463434995747,0.6437959751614103,0.8108108108108109,1.0,1.0,1/6,5.80%,PEX16
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.3740463434995747,0.6437959751614103,0.8108108108108109,1.0,1.0,1/6,5.80%,PEX16
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.33226359259529326,-0.6437616971976297,0.9529411764705882,1.0,1.0,3/35,8.37%,RBM4B;RBM3;PARP9
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.30321377562679697,-0.6437013914812213,0.96875,1.0,1.0,16/101,15.87%,PKP2;CACNB2;ANK3;RAB11A;ATP1B3;ANK2;EPB41L3;FGF13;FCHO2;EFR3B;RAB3A;RAB3C;RDX;RAB15;CAV3;TSPAN32
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.3595913261535082,-0.6436073966825698,0.9565217391304348,1.0,1.0,6/19,28.42%,CCL3;MAFB;TMEM178A;GPR137B;CAMK4;LILRB3
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),0.33590636445696276,0.6435704911245067,1.0,1.0,1.0,2/16,4.93%,VCPKMT;SNRPB
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3476865656024999,-0.6431991699958086,0.9240506329113924,1.0,1.0,4/24,19.38%,DDRGK1;RGCC;RDX;AIF1
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.3771367975377695,-0.643044877171458,0.8863636363636364,1.0,1.0,6/14,21.60%,FCGR2B;APPL1;TLR2;PLSCR1;CD300A;RACK1
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),-0.4415636078991718,-0.6428120511533106,0.8823529411764706,1.0,1.0,2/5,13.30%,NR1H2;PARP14
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),-0.4415636078991718,-0.6428120511533106,0.8823529411764706,1.0,1.0,2/5,13.30%,NR1H2;PARP14
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.31457371976548965,-0.6427250775128669,0.9468085106382979,1.0,1.0,13/63,19.53%,TBC1D8;VPS11;TBC1D13;STIL;NPRL2;TBC1D15;TBC1D2B;RDX;TBC1D14;ATG5;RAB5A;DYNC2LI1;PDCD6IP
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.4193032620233297,-0.6426238661567854,0.90625,1.0,1.0,2/7,14.89%,CD36;VMP1
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),0.3745358820713144,0.6423711995626155,0.85,1.0,1.0,1/5,5.68%,KHSRP
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.30913761064342526,0.641891148346376,1.0,1.0,1.0,5/23,14.11%,ABL1;MAPK11;CDON;CDC42;TCF3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.4017177032443475,-0.6418344036501987,0.8529411764705882,1.0,1.0,2/11,13.67%,DDRGK1;ATAD5
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.3395359359440401,-0.6414548630746183,0.9404761904761905,1.0,1.0,3/25,8.63%,DOCK1;CARMIL1;DOCK5
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.39345875736281466,-0.6414234081036171,0.9027777777777778,1.0,1.0,1/10,6.37%,DDX11
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),0.3083544708758693,0.6407064505073651,0.9354838709677419,1.0,1.0,2/13,6.63%,LRCH1;CXCL12
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.3402798173171532,-0.6404481025628853,0.96,1.0,1.0,5/32,15.51%,SEC61B;HSPA5;TOMM40;TOMM20;TIMM21
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.35488903534531024,-0.6403522776632613,0.9402985074626866,1.0,1.0,5/17,25.79%,SRP14;SRPRA;RYR2;MAN1A1;SRP54
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),0.4084377685710844,0.640229578352311,0.9032258064516129,1.0,1.0,1/6,7.28%,LAPTM5
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.3880947848328378,-0.6399054157178884,0.835820895522388,1.0,1.0,1/7,8.68%,SOD1
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.3390572032208798,0.6397195512733972,0.9310344827586207,1.0,1.0,3/12,13.87%,TGFB1;MAML1;PIEZO1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.36659394763020786,-0.6389069205920846,0.9210526315789473,1.0,1.0,2/17,10.45%,HERPUD1;EIF2AK3
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.33468396005131845,-0.638147008646035,0.9625,1.0,1.0,3/26,10.26%,ADCY3;ADAM15;CFTR
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.34095733168357556,-0.6377077519091915,0.9529411764705882,1.0,1.0,3/27,13.71%,MDFIC;HCLS1;APOD
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.4120229652144546,0.6376741694879834,0.9230769230769231,1.0,1.0,5/5,58.82%,PEX11B;DNM1L;ACOT8;MFF;FIS1
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.3189377556248919,-0.6375551782517273,0.9195402298850575,1.0,1.0,9/49,19.47%,CLIP3;GPC3;CALY;EPHA3;AP2S1;LRPAP1;ARFGAP1;RAB5A;MCTP1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.31655916511806015,0.6371300336133935,0.9615384615384616,1.0,1.0,3/13,17.59%,KPNA6;KPNA4;KPNA3
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.2909244116252719,0.6370602359115153,0.967741935483871,1.0,1.0,2/13,13.89%,AGO1;CELF1
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.35102857570789736,-0.637011461795976,0.9764705882352941,1.0,1.0,3/29,5.80%,RNF126;SPRY1;EPN1
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.30344067993788615,0.6370043729821714,0.9545454545454546,1.0,1.0,3/17,7.98%,PPARG;CNRIP1;CBL
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.3592378223950129,-0.6369180988758706,0.9375,1.0,1.0,2/22,7.54%,SEC61B;SERP1
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.37837864567720325,-0.6366019033964118,0.9333333333333333,1.0,1.0,2/12,19.85%,TYMP;SLC25A36
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),-0.3521367366753512,-0.6360898336552353,0.948051948051948,1.0,1.0,4/25,9.44%,DOCK1;MARCO;FCGR2B;CD36
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.3706350882582413,-0.6360043975083591,0.9066666666666666,1.0,1.0,3/13,16.76%,F8;THBD;SERPING1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.40664698858044834,-0.6358249182808877,0.9342105263157895,1.0,1.0,3/11,19.97%,OAS3;KLF4;FOXP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.3872881531114719,-0.6355598043298724,0.92,1.0,1.0,2/12,7.98%,SLC7A5;PRKCQ
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.30790989210376984,0.6354186083868563,0.9545454545454546,1.0,1.0,4/14,14.02%,MKKS;CIB1;CDYL;JAM2
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.3793062236846119,0.6351572210858787,0.9117647058823529,1.0,1.0,2/7,12.32%,TGFBR2;BATF3
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.37039851401553536,0.6347596654605252,0.9111111111111111,1.0,1.0,5/5,62.98%,C17ORF75;TBC1D23;TRIP11;FAM91A1;WDR11
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),-0.42202715473445473,-0.6347009349529102,0.90625,1.0,1.0,3/7,25.54%,CARD16;IMPACT;WRN
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.4299710530953638,-0.6346890040336258,0.8620689655172413,1.0,1.0,2/6,12.38%,SEMA3A;FN1
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),-0.42360715289841844,-0.6343814675199271,0.8888888888888888,1.0,1.0,1/6,16.61%,KDELR1
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.30021883549571304,-0.6343429901150618,1.0,1.0,1.0,29/201,22.96%,NAPA;SH3PXD2B;RIMS1;F8;AIM2;RBX1;DMD;TLE1;TCF7;FN1;NSF;SEC24C;TUBGCP2;DARS1;TRAF2;GSDMD;PLEKHA7;FBXL7;ADCY8;ELOB;KNTC1;GORASP1;WASF1;CNIH1;SEC13;MCFD2;PPID;REPS2;HFE
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.3020499388191872,-0.6341264879075023,0.978494623655914,1.0,1.0,16/103,15.87%,PKP2;CACNB2;ANK3;RAB11A;ATP1B3;ANK2;EPB41L3;FGF13;FCHO2;EFR3B;RAB3A;RAB3C;RDX;RAB15;CAV3;TSPAN32
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.34402642121427535,-0.6341249198132954,0.926829268292683,1.0,1.0,2/22,10.30%,TGFB2;SDCBP
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.42603510467717426,-0.6339733573197052,0.9253731343283582,1.0,1.0,3/6,23.51%,IL7;TPP1;RAB3D
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.2787608900542161,0.6336136558722117,0.8571428571428571,1.0,1.0,1/15,4.91%,AGO1
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.3132765601889165,0.6335068622823006,0.9090909090909091,1.0,1.0,4/9,24.45%,UBE2N;MTHFR;SETD5;AKAP8L
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.2668517117308848,0.6335028615678588,1.0,1.0,1.0,3/37,5.44%,RALB;LCP1;PPM1F
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),-0.39037058085850257,-0.6331481456263421,0.9571428571428572,1.0,1.0,1/10,7.87%,IL15
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.3486231737807142,-0.6329746988362209,0.9324324324324325,1.0,1.0,2/20,13.29%,ID2;HCLS1
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),0.38071193601328424,0.6325862531547946,0.9142857142857143,1.0,1.0,1/7,6.16%,TP53
prerank,GO_Biological_Process_2021__regulation of defense response to bacterium (GO:1900424),-0.433186276385766,-0.6318377347130316,0.9523809523809523,1.0,1.0,1/5,19.97%,FOXP1
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.28555876164541383,-0.6313267273618253,1.0,1.0,1.0,36/316,17.98%,NFIL3;FOS;AGT;HMGB2;HIF1A;RXRB;RORA;CREB5;BRCA1;MDFIC;ATF5;STAT1;SMARCD3;PARP9;NR1H2;ETS2;RORB;HCFC1;ID2;PAX8;MAP3K12;IRF1;NR1D1;DEAF1;ING5;KDM3A;TRIM16;ATXN7L3;HMGN5;MAFB;KLF4;BRCA2;ILF3;NFIB;TP53INP1;SS18L1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.4196405938666823,-0.6308261911145975,0.9142857142857143,1.0,1.0,2/5,21.95%,IL18;CARD9
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.3221660158535691,0.6307050212135789,0.8888888888888888,1.0,1.0,1/6,6.37%,SIRT1
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.40271348579671196,-0.6306780614916223,0.9512195121951219,1.0,1.0,2/9,9.59%,BASP1;PAX8
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,-0.32061892554370375,-0.6305752423185759,0.9883720930232558,1.0,1.0,15/45,21.30%,KIAA1549;DZIP1;MAP1B;HSPA12A;ADGRL2;CDH2;LIFR;TUSC3;ENAH;LRP4;SEZ6L2;PTPRG;FIGN;RBFOX2;MPDZ
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),0.36087046035094517,0.6298934199857571,0.9,1.0,1.0,3/9,21.99%,CDK13;DAPK3;OBSL1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.35834451036514614,-0.6293699062587358,0.92,1.0,1.0,2/10,10.00%,HLA-B;HLA-F
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),-0.3543142148044621,-0.6292952693213685,0.9166666666666666,1.0,1.0,2/18,7.49%,B4GAT1;DPY19L2
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.3403567469581804,0.6289243989002303,0.875,1.0,1.0,1/8,3.54%,PRKAB2
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),-0.3360944593402677,-0.6288688176396996,0.9047619047619048,1.0,1.0,7/28,33.51%,CAMK2N1;ASPH;OGT;CSTB;TBC1D10A;CYFIP2;GSAP
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.3357405205806277,-0.6288646165054503,0.9529411764705882,1.0,1.0,4/23,15.71%,CFTR;SLC4A10;SLC9B1;SLC9A6
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.3991988093412015,-0.6285798079419351,0.9137931034482759,1.0,1.0,3/6,26.69%,PTPRT;PTPRB;DUSP10
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.2860812511406422,-0.6282030255976802,0.9895833333333334,1.0,1.0,32/165,25.45%,SYCE2;RIMS1;PKP2;ANK3;RHOU;BAIAP2L1;GPM6B;LRGUK;NLGN3;TUBGCP2;BSN;DARS1;TRAF2;VMP1;STAG3;ELOB;AIF1;VCPIP1;PARVG;KNTC1;ACTG1;WASF1;DVL1;CALD1;PPID;REPS2;HFE;NEDD9;PARVB;NDUFAF1;SLC2A1;NLGN2
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.2962325023769639,-0.6275593771628805,0.967032967032967,1.0,1.0,10/67,20.44%,NLRP12;RORA;DHX58;CARD16;NR1D1;SIGIRR;KLF4;MACIR;RTN4RL1;C1QBP
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3193437364281614,0.6272684527125033,0.9393939393939394,1.0,1.0,1/12,2.47%,CPSF4
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.33181280621726617,0.6270233672893873,0.9523809523809523,1.0,1.0,11/11,66.85%,SAFB2;CDK11B;SAFB;IWS1;SRPK2;PTCD2;SLTM;SUPT6H;NCBP1;DHX9;SRPK1
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3500608203308005,0.6269312126002522,0.8947368421052632,1.0,1.0,2/8,7.81%,IL1B;GCNT2
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.39758527524484966,0.6266084496383244,0.8421052631578947,1.0,1.0,5/5,60.26%,RHOA;FGFR1;PDPK1;FGFR3;FGFR2
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.36436209299612726,-0.6264294477856586,0.9230769230769231,1.0,1.0,3/18,8.89%,ABCA5;NR1H2;ABCB4
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.4119119627203434,-0.6251573433682911,0.873015873015873,1.0,1.0,4/6,26.20%,CITED2;RYR2;IFT122;NDRG4
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.36528860490225973,-0.625126720219244,0.9420289855072463,1.0,1.0,3/14,15.00%,AIM2;APIP;GSDMD
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),0.34765394400755173,0.625081964393354,0.9210526315789473,1.0,1.0,2/5,19.38%,SRC;BCL2
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),0.3561053876034454,0.624937530650772,0.8529411764705882,1.0,1.0,7/7,64.41%,EXOSC9;EXOSC6;EXOSC7;XRN1;EXOSC8;EXOSC10;PCID2
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),-0.3844706236698946,-0.6249234504730813,0.9714285714285714,1.0,1.0,3/9,23.60%,MTERF1;TEFM;TFAM
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.40736291581126066,-0.624804226802728,0.9565217391304348,1.0,1.0,2/6,26.94%,MYBL1;MOV10L1
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.3685256051914617,-0.6246055067004631,0.9523809523809523,1.0,1.0,3/20,10.22%,GPC3;APPL1;GPC5
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.3086911350087762,-0.6242915497240638,0.9775280898876404,1.0,1.0,8/57,18.00%,PPP2R5A;CLIP3;PRKCE;APPL1;EPHA3;PID1;ARF6;ATP2B4
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.3361960533914009,-0.6232831113378113,0.9875,1.0,1.0,5/31,14.56%,GLUL;ZDHHC15;ING4;ZDHHC9;ING5
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.25750592152374324,0.6230986757663893,1.0,1.0,1.0,4/24,13.07%,STAMBPL1;ZRANB1;ABRAXAS2;YOD1
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.35917392807473336,-0.6227489862000919,0.9375,1.0,1.0,2/15,7.98%,SLC7A5;PRKCQ
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.3943673117954037,-0.6225476753621545,0.8873239436619719,1.0,1.0,4/6,28.63%,NHP2;METTL4;NOP10;DKC1
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.40007340001022773,-0.6223557279276457,0.9285714285714286,1.0,1.0,3/8,18.85%,KDM1A;KDM3A;KDM4B
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.36390574284462085,-0.6215866176385484,0.9534883720930233,1.0,1.0,2/16,18.00%,AKAP6;ATP2B4
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.3132571752526799,0.6203095902740938,0.9642857142857143,1.0,1.0,3/13,10.30%,SCRIB;LAMTOR1;TBC1D16
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.29287661226584205,-0.6199052549766529,1.0,1.0,1.0,16/113,18.57%,RBX1;MPG;RPA2;POLR2G;POLR1C;RNMT;SDCBP;CMPK2;PDE4B;RPA3;ERCC2;HCLS1;RFC4;POLL;DDB1;DCTN4
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.38164358774375284,0.6195054921101923,0.8947368421052632,1.0,1.0,1/5,4.94%,RUNX1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.3283967036686326,-0.6191367417620655,0.95,1.0,1.0,7/21,29.15%,DHX58;CARD16;SIGIRR;C1QBP;TNFAIP3;NLRC3;TYRO3
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),-0.33953507634838026,-0.6190423450958205,0.9647058823529412,1.0,1.0,8/27,19.49%,AGT;ATP1B3;ANK2;RYR3;ATP2B4;ASPH;ATP1B2;ATP2B2
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.3479717118734551,-0.618927124450334,0.9054054054054054,1.0,1.0,6/14,38.80%,GPNMB;WARS1;HTATIP2;HMOX1;PLXND1;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),-0.38875324036463155,-0.6186792468638992,0.9393939393939394,1.0,1.0,2/8,16.45%,NSF;ANXA2
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.36543847871218194,-0.6182628509465876,0.9701492537313433,1.0,1.0,1/12,2.64%,ETFB
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.2960028088065263,-0.6175058870418678,1.0,1.0,1.0,20/96,25.18%,DKK2;GPC3;PRDM15;GPC5;PSMA3;PSMA5;DAAM2;PTK7;PSMD8;PSMB4;GSKIP;PSMD7;GPRC5B;PSMD5;SOX4;PSMC2;PLEKHA4;CSNK1G2;PSMB9;PSMB2
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.3241318993707075,0.6174877332213374,0.9696969696969697,1.0,1.0,1/10,6.16%,TP53
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.40830809814660807,-0.6173266234133014,0.9,1.0,1.0,1/5,25.77%,EPHA4
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.3166358044370897,-0.6168474747480526,0.9772727272727273,1.0,1.0,5/35,16.96%,XRCC3;RPA2;RPA3;TERF2IP;DNA2
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.3600841767578528,-0.6167444196590671,0.9452054794520548,1.0,1.0,4/13,17.19%,ADCY3;ADCY10;ADCY8;AMPD2
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.3640442937605226,-0.6166616552546232,0.9066666666666666,1.0,1.0,2/10,18.65%,NR1H2;PCSK5
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.419667259345481,-0.6161864256223997,0.953125,1.0,1.0,1/6,9.24%,ID2
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.28057576607276896,-0.6160511394065821,1.0,1.0,1.0,45/285,21.09%,CENPF;SH3PXD2B;HAUS6;ABLIM3;RPS23;DZIP1;RAB11A;VPS37C;MAPT;SNX10;CENPE;LIMD1;CC2D2A;IFT81;ANLN;UBXN2B;TMEM41B;GOLGA8B;TTBK2;IFT74;SNF8;TUBGCP2;RPS3;MAK;VMP1;ATG2A;TXNDC15;TCTN1;ATG5;SCLT1;IFT52;TP53INP1;DYNC2I1;GABARAPL1;KIF3A;MACIR;CHMP5;ATP6V1D;ATAT1;PDCD6IP;PATL2;RFX2;DYNC2H1;IFT46;TMEM138
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.3353051754990318,0.615636294569075,0.8529411764705882,1.0,1.0,1/6,6.37%,SIRT1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.4182552025575016,-0.6152278751846083,0.9078947368421053,1.0,1.0,2/5,25.40%,CAD;CTPS1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),-0.39415383891577754,-0.6148834469180413,0.8805970149253731,1.0,1.0,1/5,19.31%,ROBO2
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.3833086442523639,-0.6145995284481616,0.9142857142857143,1.0,1.0,1/9,5.91%,CSKMT
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.27641825127834796,-0.6144910656734741,1.0,1.0,1.0,55/366,20.40%,NEK11;ACVR1B;CDK14;TGFB2;TXK;FLT1;MASTL;FGR;DAPK1;PINK1;PRKCQ;PRDX4;DAPK2;RIOK2;PRKCE;PDK3;NUAK2;CLSPN;CIT;NIM1K;CTBP1;EIF2AK3;LIPE;MAP3K12;EPHA3;PIM3;TEC;FAM20A;INCENP;PXK;PAK5;EPHB1;TTBK2;ALK;INSR;STK17B;GRK4;MAK;PIK3R4;TLR2;ILF3;CAD;MAPK10;VRK1;RELN;CLK2;VRK2;LIMK2;NRBP2;SGK1;BMPR1B;RPS6KA2;RPS6KB2;EIF2AK2;PRRT1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.37947265093605165,-0.6143868213891912,0.9393939393939394,1.0,1.0,2/9,19.22%,PDHB;ACAT1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.27470114507540144,0.6142060897190319,1.0,1.0,1.0,11/35,23.34%,BCAR3;CDAN1;ZBTB38;BRPF3;KAT7;ANKRD17;CTC1;PDS5A;RAD17;RBBP6;SLFN11
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),-0.4361681472201314,-0.6138474373493883,0.9436619718309859,1.0,1.0,2/5,44.90%,PRNP;TMEM59
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),-0.39234003582410637,-0.6135532249680146,0.8888888888888888,1.0,1.0,1/5,8.63%,DOCK5
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.36310583227756027,-0.613288684973572,0.9594594594594594,1.0,1.0,2/12,13.36%,FBP1;PID1
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.2832227578318788,0.6132606594959352,1.0,1.0,1.0,5/15,17.48%,SYT17;SYT6;SYT13;GRK2;PRKN
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.3379085071580276,-0.6127308292650142,0.9493670886075949,1.0,1.0,7/25,22.97%,SPARC;CFL1;CD44;SH3D19;NTNG1;ZMYM3;MFSD2A
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.2772022990517202,0.6125572812870479,1.0,1.0,1.0,6/19,23.28%,RHOG;EPS8;CDH13;CYFIP1;ELMO1;TIAM1
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),-0.4019402297761329,-0.6125383766574479,0.9027777777777778,1.0,1.0,2/7,22.46%,MAT2A;SPAST
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.4042029826692699,-0.612116621253895,0.9861111111111112,1.0,1.0,3/9,18.96%,FGD6;ARHGEF4;FGD3
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.36391161940933714,-0.6115807311619819,0.918918918918919,1.0,1.0,3/13,20.47%,DDRGK1;ATG2A;RETREG1
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),-0.39710292201243014,-0.6115417656864472,0.8970588235294118,1.0,1.0,2/5,18.50%,KIF3A;FYCO1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.28783814186622103,-0.6114269099021058,0.9782608695652174,1.0,1.0,20/64,26.63%,PTN;COBL;ZDHHC15;EPHA3;PTK7;ALK;TOX;ITGA6;RELN;SERPINI1;ATP1B2;STMN2;LRRC7;NTRK3;CAMK2B;FES;ZNF804A;MAGI2;NDRG4;TWF1
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.3939340943030544,-0.6112933998703142,0.92,1.0,1.0,1/6,6.65%,BLVRB
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.3939340943030544,-0.6112933998703142,0.92,1.0,1.0,1/6,6.65%,BLVRB
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.32576966771411175,0.6112756995189267,0.9166666666666666,1.0,1.0,1/8,6.81%,CAPRIN2
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.28209729868136446,-0.6111533433621369,0.99,1.0,1.0,35/240,21.94%,NAPA;TBC1D8;SH3PXD2B;TBC1D13;ANK2;EPB41L3;ITSN1;ZDHHC15;DMD;STX19;CD63;ARMCX3;USP6;NSF;TBC1D15;TBC1D2B;SNX6;TBC1D14;SCG5;ARF6;RAB20;CPE;RAB5A;EIF2D;SEPTIN9;RAB21;SEPTIN4;ARL17A;PRRT1;PTPRK;CEP68;SEPTIN8;JAM3;SEC13;ARL4C
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.3306544670133226,-0.6107778458609837,0.9620253164556962,1.0,1.0,3/25,17.09%,PRKCQ;GNL3;SLX4
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.3131356258810679,0.6107216055625405,0.9666666666666667,1.0,1.0,1/13,2.47%,CPSF4
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.380123846648741,-0.610631147284265,0.948051948051948,1.0,1.0,3/11,20.04%,VPS11;RDX;RAB21
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.3046798000450943,-0.6092369367327716,0.9880952380952381,1.0,1.0,9/50,22.69%,KNSTRN;RAB11A;DSN1;ABRAXAS1;KIF11;MAP9;SMC4;SPAST;CENPK
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.3926364461449094,-0.6087482189851678,0.9710144927536232,1.0,1.0,1/8,11.41%,OLFM1
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.33107071970313434,-0.6072506008355772,0.9753086419753086,1.0,1.0,4/20,19.53%,HSPA1B;GPSM2;CHMP5;PDCD6IP
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),0.35329812085053525,0.6070673329059871,0.9333333333333333,1.0,1.0,1/6,10.74%,CYP19A1
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.2339989107974319,0.607044856275444,1.0,1.0,1.0,7/46,12.95%,PKD2;RYR1;APPL2;ALDH9A1;KCNJ2;KRT10;HOMER1
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.3568238317576251,-0.6068072348290021,0.922077922077922,1.0,1.0,7/17,22.79%,CFL1;MICAL2;STMN3;STMN1;STMN2;DSTN;CKAP5
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.2781030187700865,-0.6064666758849733,1.0,1.0,1.0,49/390,20.23%,RPS27A;TRIM5;RNF144B;H2BC11;ARIH2;DTL;HIF1A;UVSSA;RNF126;DTX3;RBX1;VPS11;BRCA1;FBXL2;PINK1;KLHL13;UBA52;TRIM25;PSMA3;UBE2QL1;UBC;HERC6;PSMA5;ENC1;SPSB1;TRAF7;UHRF1;H2BC9;DZIP3;RNF13;TRAF2;PSMD8;UBB;PSMB4;FBXL13;FBXL7;H2BC5;NEURL1;ELOB;TRIM22;DDB1;HECW2;TRIM14;DTX3L;VCPIP1;TRIM69;PSMD7;GAN;MAGEF1
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.27604869093605044,-0.6060644845650408,1.0,1.0,1.0,35/207,21.09%,PRKAR2B;HAUS6;TUBB4A;TUBA4A;CCDC39;ABLIM3;DZIP1;RAB11A;SNX10;CC2D2A;LRGUK;IFT81;TUBA1A;RPGRIP1L;TTBK2;IFT74;SPATA6;CEP152;MAK;TXNDC15;BBOF1;TCTN1;SCLT1;IFT52;DYNC2I1;KIF3A;DYNC2LI1;MACIR;ATP6V1D;ATAT1;DCTN2;RFX2;DYNC2H1;IFT46;TMEM138
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.35064408242509587,-0.6060040656079628,0.9736842105263158,1.0,1.0,1/15,4.14%,TNFRSF1B
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.3838412372412378,-0.6054263335370798,0.9375,1.0,1.0,2/7,19.00%,CACNA1C;ISCU
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),-0.40215369003116175,-0.6054164435394621,0.9696969696969697,1.0,1.0,4/7,27.87%,TTLL7;TPGS1;TTLL5;TTLL4
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.3703809974988036,-0.6051019355763216,0.9428571428571428,1.0,1.0,2/11,22.60%,TET1;DNMT1
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.30769896281718034,-0.6046365189834173,1.0,1.0,1.0,18/51,21.47%,DOCK1;LAMB1;ADGRL2;FN1;LIFR;ENAH;SH3D19;RND3;LRP4;ERRFI1;GNA11;PTPRG;TTC23;FIGN;KITLG;RBFOX2;MPDZ;UACA
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.2911608004777495,-0.6037082111096445,0.989010989010989,1.0,1.0,9/53,24.17%,EIF4A3;TENT4B;SRSF5;SRSF2;CSTF2T;SRSF9;U2AF2;PNPT1;SRSF3
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.42057107543713657,-0.6034707826319237,0.9577464788732394,1.0,1.0,3/5,15.54%,MMP24;CDH2;PLEKHA7
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.3225732506005129,-0.6030212456327698,0.9397590361445783,1.0,1.0,6/22,24.74%,PIGL;PIGG;PIGA;PIGH;MPPE1;PIGF
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.4023951442402084,-0.6026303157092647,0.9016393442622951,1.0,1.0,1/6,10.79%,CD63
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),-0.39553891507167643,-0.6023384931622351,0.9384615384615385,1.0,1.0,1/5,9.24%,ID2
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.2833782389620102,0.6018705574423484,0.9642857142857143,1.0,1.0,3/12,17.86%,USP30;PEX5;TRAPPC8
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.38246866999659707,-0.6018408337547981,0.971830985915493,1.0,1.0,2/5,41.07%,GPS2;ATG14
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.40049653333215396,-0.6018347022466379,0.96875,1.0,1.0,3/7,42.76%,CHAMP1;MID1;HNRNPU
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),-0.31279202963660147,-0.6002658122705291,0.9767441860465116,1.0,1.0,1/24,2.46%,AGT
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.34464592074911643,-0.5999400118741719,0.9743589743589743,1.0,1.0,5/17,20.50%,CD36;INSR;CLU;KLF4;KLF2
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.36854474301874074,-0.5995629204360654,0.9142857142857143,1.0,1.0,2/9,19.46%,VRK1;VCPIP1
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.3498849053714242,0.5994391085964978,1.0,1.0,1.0,3/7,20.61%,ALOX5AP;SLC1A5;CLYBL
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.3498849053714242,0.5994391085964978,1.0,1.0,1.0,3/7,20.61%,ALOX5AP;SLC1A5;CLYBL
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),-0.30159402970828986,-0.5994006277433104,0.989010989010989,1.0,1.0,5/52,17.77%,ACVR1B;CIT;MAP3K12;GALNTL6;CAD
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.343331096771048,-0.5989721413361725,0.9634146341463414,1.0,1.0,3/17,20.04%,VPS11;RDX;RAB21
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),-0.33020424087614997,-0.5986386822378771,0.9743589743589743,1.0,1.0,5/18,22.54%,MAP1B;MAPT;PRUNE1;MAP1A;MAP2
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),-0.3203825893090638,-0.598427595103795,0.9425287356321839,1.0,1.0,8/31,28.27%,RPA2;MAPT;MCL1;NPAS2;PARG;WDR76;ETAA1;IER3
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.3754402196811154,-0.5982009712940214,0.9459459459459459,1.0,1.0,1/8,10.45%,EIF2AK3
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),-0.4061120467885512,-0.5981148466991247,0.9705882352941176,1.0,1.0,2/5,28.19%,PTPRK;KLF9
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.29169208000817065,0.5980494805349171,1.0,1.0,1.0,2/16,9.38%,SLIT3;NR3C1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.29299850299844216,-0.596796944425483,1.0,1.0,1.0,22/83,32.17%,RIMS1;TUBGCP2;DARS1;TRAF2;ELOB;KNTC1;WASF1;NUP133;SEH1L;PPID;REPS2;HFE;NDUFAF1;SLC2A1;SPG7;FANCA;AFG3L2;DLG4;DMTN;NAPG;PARD3;KIFAP3
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.3570201307091899,-0.5967695142337961,0.9324324324324325,1.0,1.0,4/11,20.20%,MCMDC2;RFC4;MCM3;MCM7
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.2719888533830393,-0.5964263453962982,1.0,1.0,1.0,24/258,16.83%,RPS27A;DNAJB9;RNF126;KCTD2;RBX1;HERPUD1;FBXL2;ANKZF1;RNF175;SEC61B;UBA52;TRIM25;PSMA3;UBC;PSMA5;HSPA5;SPSB1;UBXN2B;PSMD8;UBB;PSMB4;FBXL13;FBXL7;SPSB3
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.26469655411153203,0.5961862712202537,1.0,1.0,1.0,2/18,6.14%,PHF8;MCPH1
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.2949729607498529,0.5961566001533676,1.0,1.0,1.0,3/10,20.36%,PAPOLA;CDC73;LEO1
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.26350611661249235,0.5956120187357262,0.9375,1.0,1.0,2/17,8.42%,ST8SIA4;GANC
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.34169350035812557,-0.5951248748014977,0.948051948051948,1.0,1.0,1/18,3.18%,MYRIP
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.38638418044719747,-0.5946803851102874,0.927536231884058,1.0,1.0,2/7,27.07%,FOXP1;CAMK4
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.34629064935230347,0.5946182291137401,0.9117647058823529,1.0,1.0,1/5,5.16%,RNF20
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.3461360639986114,-0.594617704436138,0.9594594594594594,1.0,1.0,1/15,4.42%,DUSP1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.28737193448031306,-0.5941917414742869,1.0,1.0,1.0,6/61,17.45%,EIF4A3;TENT4B;PAPOLG;SRSF5;SRSF2;CSTF2T
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.2577023336132314,0.5932025139039405,1.0,1.0,1.0,2/28,5.13%,RAB7A;RAB39A
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),-0.33642415068736276,-0.5925080719852138,0.948051948051948,1.0,1.0,2/16,13.71%,MDFIC;APOD
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.28031047876540677,-0.5924784171133614,1.0,1.0,1.0,10/88,14.47%,RPL11;IFIT2;DDX11;NMD3;B2M;CARD16;IFIT1;LRPAP1;TFIP11;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.34003659365700156,-0.591987625692701,0.9466666666666667,1.0,1.0,1/15,6.34%,CR1
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.3737915476236724,-0.5917877348980997,0.9393939393939394,1.0,1.0,3/8,38.42%,MBTPS1;SREBF1;MBTPS2
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),-0.3643988357812453,-0.5916550213293381,0.9420289855072463,1.0,1.0,2/11,8.66%,IL15;IL18
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.34585905433269637,-0.5915227000888191,0.9342105263157895,1.0,1.0,5/19,21.70%,ANK2;ARF6;PRRT1;PTPRK;JAM3
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.33396212629074695,-0.5910137007834152,0.948051948051948,1.0,1.0,3/15,19.53%,HSPA1B;CHMP5;PDCD6IP
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.33951992611811393,-0.59065996637021,0.9473684210526315,1.0,1.0,2/16,14.28%,CSKMT;SUV39H2
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),-0.37926545134800105,-0.5904513163879567,0.9253731343283582,1.0,1.0,2/6,22.20%,BMI1;PCGF5
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.32813818089466074,-0.5902556358272436,0.9746835443037974,1.0,1.0,6/18,25.45%,FCHO2;NLGN3;SYT1;AMPH;PIP5K1C;NLGN2
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.3336830448742125,-0.5901791161175036,0.9875,1.0,1.0,4/22,16.81%,CSKMT;ANTKMT;SUV39H2;KMT5C
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.34762294143560013,-0.5891223955425596,0.9473684210526315,1.0,1.0,2/11,15.46%,TFIP11;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.4019203573678506,-0.5890051620567834,0.9402985074626866,1.0,1.0,1/5,9.99%,CTBP1
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.28274110002032776,-0.5880935216109546,0.9893617021276596,1.0,1.0,12/75,18.67%,DTL;GPC3;EEF1A2;APC2;NSF;SNF8;CDKN1B;AZIN1;EEF1A1;FMN2;DDB1;HECW2
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),-0.3917765644700464,-0.5879014185116165,0.8852459016393442,1.0,1.0,3/5,30.61%,AMPD2;PFAS;HPRT1
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.2805079183282162,0.5875595040916567,0.9333333333333333,1.0,1.0,1/11,4.91%,AGO1
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.38945801751901404,-0.5875571997666438,0.974025974025974,1.0,1.0,1/7,5.00%,CFL1
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.3449253615677327,0.587348624151112,0.868421052631579,1.0,1.0,1/5,10.07%,NR1H3
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.35583302609287243,0.5871380097773159,0.8787878787878788,1.0,1.0,3/7,16.86%,CXCL12;COL16A1;FERMT2
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.3192769201445843,-0.5862546564903037,0.9759036144578314,1.0,1.0,2/23,6.12%,PKP2;ANK3
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.3840189873203468,-0.5859848428994539,0.9746835443037974,1.0,1.0,1/11,3.27%,RBPJ
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.28560926032525685,-0.5859695999436699,1.0,1.0,1.0,3/44,13.71%,ACVR1B;MAX;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.28648694329417734,0.5859469873118761,0.95,1.0,1.0,16/16,71.39%,CCT3;TREM2;CEP120;CEP295;CEP135;CCT4;TNF;CCT2;CCT5;TCP1;CCT7;CHP1;CORO2B;CCT6A;CCT8;DKC1
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.3759129135749596,-0.5859341191189839,0.9344262295081968,1.0,1.0,1/6,26.16%,DENND3
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.4114936074840465,0.5857414554395225,0.896551724137931,1.0,1.0,2/5,17.39%,PLEKHM1;ARL8B
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.2599803170507411,0.5853069006667139,0.9393939393939394,1.0,1.0,1/14,6.37%,SIRT1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),-0.39605255473743906,-0.5853059974875956,0.9358974358974359,1.0,1.0,1/6,18.00%,ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.39605255473743906,-0.5853059974875956,0.9358974358974359,1.0,1.0,1/6,18.00%,ATP2B4
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.29268301196142577,0.5852474387723351,1.0,1.0,1.0,3/8,19.26%,ABCB7;SLC40A1;ABCC5
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.29531924631204626,-0.5851426541826743,0.9883720930232558,1.0,1.0,7/37,20.44%,DOCK1;CARMIL1;DOCK5;PTPRD;IL1RAPL1;SS18L1;C1QBP
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",0.34440509691536825,0.5839053197293816,0.8823529411764706,1.0,1.0,1/8,3.11%,CD274
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.3738984654822701,-0.5836117313598996,0.8939393939393939,1.0,1.0,2/6,17.27%,CALM3;CALM1
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.3738984654822701,-0.5836117313598996,0.8939393939393939,1.0,1.0,2/6,17.27%,CALM3;CALM1
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.3610301772208516,-0.5828950612768867,0.9459459459459459,1.0,1.0,2/9,22.10%,TMEM14A;SLC25A5
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.3346636489392605,-0.5819065452425106,0.9733333333333334,1.0,1.0,1/11,5.53%,SVIL
prerank,GO_Biological_Process_2021__regulation of fat cell proliferation (GO:0070344),-0.39873924494545476,-0.581818787684444,0.921875,1.0,1.0,2/5,19.21%,PID1;PER2
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.3333333333333335,0.5813004800443091,0.9523809523809523,1.0,1.0,5/5,66.68%,RAB11B;PTPRN;SELENOT;RAB11FIP2;PTPRN2
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.27436598653235905,-0.5809831960085458,1.0,1.0,1.0,22/109,25.18%,SULF2;DKK2;GPC3;PRDM15;GPC5;PSMA3;PSMA5;DAAM2;PTK7;PSMD8;TLR2;PSMB4;GSKIP;PSMD7;GPRC5B;PSMD5;SOX4;PSMC2;PLEKHA4;CSNK1G2;PSMB9;PSMB2
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.3706042781065215,-0.5807046918973175,0.96,1.0,1.0,1/6,8.66%,IL18
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.3368754973697737,0.5806045246661888,0.868421052631579,1.0,1.0,1/6,4.79%,CAB39
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.35564715325453,-0.5804052659437628,0.927536231884058,1.0,1.0,2/10,16.96%,ATAD5;DNA2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.394944885569395,-0.5801260501489762,0.9041095890410958,1.0,1.0,1/6,8.57%,TIMM13
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.3003636287970553,-0.5800684195259566,0.9753086419753086,1.0,1.0,8/28,24.26%,SOD1;RPS7;RPS3;BMF;UBB;SEPTIN4;RACK1;SIAH1
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.35119809785628836,-0.5793966090585209,0.9333333333333333,1.0,1.0,1/5,18.30%,VRK1
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.3293463138346557,-0.5791417020469452,0.9583333333333334,1.0,1.0,5/15,27.63%,LARS1;SEH1L;GPR137B;LAMTOR5;RRAGA
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.3476123551524597,-0.5789231380025314,1.0,1.0,1.0,3/9,22.01%,PPP1R13L;PLEC;REL
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.3449782646444825,-0.5788763616863237,0.961038961038961,1.0,1.0,3/12,21.60%,SIRT3;NSMAF;RACK1
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.32320796797923634,-0.5787125123134955,0.9876543209876543,1.0,1.0,2/23,6.32%,CARMIL1;ABLIM3
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.31012057342550386,0.578684553651843,0.9285714285714286,1.0,1.0,1/11,1.77%,ITGA5
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.29148745855293595,-0.5785265987919834,0.9888888888888889,1.0,1.0,4/41,14.30%,DTL;RAB11A;RGCC;RDX
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),0.3208072960648539,0.5781934385746841,0.9411764705882353,1.0,1.0,7/7,67.94%,GSPT1;UPF1;OGFOD1;ETF1;GLE1;SHFL;MTRF1
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.35613940153426576,-0.5773730555240076,0.9629629629629629,1.0,1.0,1/12,10.25%,ATF3
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.2826570559422622,0.5770349128102275,1.0,1.0,1.0,6/16,20.63%,ADAM10;TSPAN33;P2RX7;AFDN;TPR;NUP98
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.3128020684319078,0.5767357404321558,1.0,1.0,1.0,1/6,8.48%,SLC35G1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.3000901681832209,-0.5766190632580519,0.974025974025974,1.0,1.0,2/26,17.47%,PRKCQ;KLF4
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.3328677752669431,-0.5763626958107233,0.9358974358974359,1.0,1.0,5/14,31.81%,RACK1;RIPOR2;ROCK1;KANK1;RUFY3
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.2606952694861232,-0.5756810124481201,1.0,1.0,1.0,21/300,12.52%,RPS27A;TRIM5;H2BC11;ARIH2;HIF1A;UVSSA;DTX3;RBX1;VPS11;DDRGK1;BRCA1;FBXL2;PINK1;KLHL13;UBA52;PIAS4;UBC;ENC1;SPSB1;TRAF7;UHRF1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.32366518205073413,-0.5755726059736845,0.961038961038961,1.0,1.0,3/15,33.13%,PNPLA8;NAAA;SELENOI
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.2635253380440542,-0.5745337156255726,1.0,1.0,1.0,28/288,19.66%,TOM1L1;RNF144B;ARIH2;DTL;RNF126;KCTD2;RBX1;HERPUD1;VPS37C;PINK1;TRIM25;PSMA3;PSMA5;SPSB1;RNF149;UBXN2B;UHRF1;RNF13;PSMD8;PSMB4;FBXL7;SPSB3;PPP1R11;DDB1;HECW2;DTX3L;UCHL1;PSMD7
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.3580528756192036,-0.57420792710953,0.9714285714285714,1.0,1.0,3/10,38.42%,MBTPS1;SREBF1;MBTPS2
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.26985648386660416,-0.5733944080755465,1.0,1.0,1.0,14/83,22.68%,FANCI;BRCA1;PINK1;HSPA1B;CAMLG;RPS3;UBB;PER2;SEPTIN4;PRICKLE1;RIPK2;UBXN1;SOX4;U2AF2
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.33024514834479557,-0.573249791942681,0.948051948051948,1.0,1.0,1/11,7.60%,MAPT
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.33527524484971283,0.5729993919145491,0.92,1.0,1.0,5/5,66.49%,MPST;MTHFR;MTRR;MMUT;BLMH
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.19838219116137049,0.572935476763585,1.0,1.0,1.0,15/73,21.01%,KHDRBS3;METTL16;RBM23;PRDX6;SAP18;SMU1;THRAP3;CELF1;SON;RBMX;FMR1;CWC22;NUP98;SFSWAP;TRA2A
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.3370532198442641,0.5727797406865154,0.9375,1.0,1.0,2/7,10.40%,NR1H3;WNK3
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.28952166287757974,-0.5721870225965456,0.9767441860465116,1.0,1.0,3/29,13.13%,ANK3;NSF;GOLGA4
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),0.31961356782378925,0.5716187468117104,0.95,1.0,1.0,2/5,18.71%,SERPINB9;IRAK4
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.32528289140347927,0.5712464167803696,0.9666666666666667,1.0,1.0,7/7,67.49%,LIG4;MR1;ZFP36L1;ZFP36L2;RABL3;ADAM17;PTPRC
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.266613947387157,0.5701128885142637,0.9629629629629629,1.0,1.0,4/18,18.88%,PEX16;TMEM135;PEX2;ABCD3
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.29976495181014157,-0.5700582925652533,0.9880952380952381,1.0,1.0,1/25,5.20%,XRCC3
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.3070788921112695,-0.5696929996454333,0.9625,1.0,1.0,2/26,9.99%,BRCA1;CTBP1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.2693661423987659,-0.5696534340761749,1.0,1.0,1.0,13/72,21.10%,RHOB;ARHGAP4;ALOX15B;ADAM15;PTPRT;FRMD5;TP53INP1;THY1;CLIC4;CITED2;MCTP1;SRGAP3;PTPRK
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.3312253520588433,-0.569596400938475,0.9176470588235294,1.0,1.0,4/14,23.79%,DAPK2;C1QBP;THBS4;RIPOR2
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.297587376742149,-0.566554270186349,0.9767441860465116,1.0,1.0,1/30,2.59%,HMGB2
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.35048394751271106,-0.5650224807810166,0.9726027397260274,1.0,1.0,3/14,17.75%,CD44;KLF4;THY1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.2867135131334945,-0.5649484088201675,1.0,1.0,1.0,6/38,18.00%,CLIP3;PRKCE;EPHA3;GPSM2;ARF6;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.36326494392010955,0.5649470547143719,0.9333333333333333,1.0,1.0,1/5,18.73%,FMR1
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.3245379069529776,-0.5648204285609565,0.9375,1.0,1.0,6/18,28.14%,UHRF1;ATXN7L3;DTX3L;UBR2;CTR9;UBE2B
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),-0.37013556989473523,-0.5647036997384904,0.9166666666666666,1.0,1.0,4/7,23.71%,NRXN1;NEURL1;RELN;CAMK2B
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.37313135308798234,-0.5644611673149408,0.958904109589041,1.0,1.0,3/7,32.24%,MYBL1;UBR2;SMYD5
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),-0.339760235064679,-0.5642284936081327,0.9466666666666667,1.0,1.0,5/11,28.22%,MCMDC2;MCM6;MCM7;WRN;RECQL5
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.2919084333313659,-0.563830195779146,0.9880952380952381,1.0,1.0,10/42,22.78%,SLC7A5;SFXN3;SLC13A4;SLC16A7;SLC35A1;LRRC8B;SLC13A3;SLC25A19;SLC25A5;SLC1A2
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.3388425174047897,0.562855282784534,0.8857142857142857,1.0,1.0,2/6,13.53%,ABCB7;SLC30A10
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),0.3687883131800221,0.5628047301145918,0.9210526315789473,1.0,1.0,1/5,7.28%,LAPTM5
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.27171269965568334,-0.5627490431636006,1.0,1.0,1.0,6/80,9.25%,RPL11;CNEP1R1;GBP2;HEATR3;NOP53;APPL1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.31669622498099814,0.5626273541255633,1.0,1.0,1.0,8/8,68.35%,ATP6V1G1;ATP6AP1;ATP6V0D1;ATP6V1A;CPEB4;PICK1;ATP6V0A2;NDUFS2
prerank,GO_Biological_Process_2021__regulation of T-helper 17 type immune response (GO:2000316),0.3414817554925913,0.5621176705755013,0.9354838709677419,1.0,1.0,1/5,2.63%,SMAD7
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.28634175183714844,0.5612334834811255,1.0,1.0,1.0,10/10,71.39%,CCT3;TERF1;CCT4;CCT2;CCT5;TCP1;CCT7;CCT6A;CCT8;DKC1
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),-0.34987732436138447,-0.5611385550765842,0.9154929577464789,1.0,1.0,3/7,29.03%,SYT4;KIF5A;PPFIA2
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),0.31572061262002,0.5610110594410274,0.926829268292683,1.0,1.0,1/5,8.87%,IVD
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.28416303955308275,-0.5609548194910717,1.0,1.0,1.0,9/55,22.05%,GCNT1;B4GAT1;GALNT8;OGA;GALNTL6;SDF2L1;TET1;GALNT6;GALNT18
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.31772031982091176,-0.5609280138427325,0.9866666666666667,1.0,1.0,5/19,21.58%,TGFB2;ZFPM2;ROBO2;CITED2;SOX4
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.3209539748048832,0.5592257516581224,0.8928571428571429,1.0,1.0,3/6,28.77%,SLC30A10;ROCK2;NFKB1
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.27383898323152756,-0.5591320923505734,0.9883720930232558,1.0,1.0,3/53,8.93%,TGFB2;APBB3;TTN
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.2866889092675242,-0.5585606173007555,1.0,1.0,1.0,13/46,26.77%,EPB41L3;TTN;CIT;EPB41L4B;FRMD5;OBSCN;FAM171A1;FRMD3;MYH10;CDC42BPA;SORBS1;ACTN2;ROCK1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.34882045743488754,-0.5583159454159431,0.9577464788732394,1.0,1.0,1/10,7.45%,FCGR2B
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.3703905728926212,-0.5567092481068792,1.0,1.0,1.0,2/6,32.52%,NDST3;NDST1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.29483835952071175,0.5565089967238572,0.8333333333333334,1.0,1.0,3/14,12.53%,SYK;NMI;LILRA2
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),-0.2981223161960738,-0.5560733625283962,0.9880952380952381,1.0,1.0,4/26,18.66%,FHL1;ANK2;CAV3;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),0.32817044881195345,0.555623853594118,0.9375,1.0,1.0,1/6,10.74%,CYP19A1
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),-0.34007097497874916,-0.5555164631767696,0.958904109589041,1.0,1.0,2/10,13.12%,EMB;PALLD
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),-0.361703666401927,-0.5549432522866896,0.9846153846153847,1.0,1.0,2/7,17.87%,ALDH1A1;AMDHD2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.3315745067000044,-0.554738533147656,0.9634146341463414,1.0,1.0,4/13,23.79%,DAPK2;C1QBP;THBS4;RIPOR2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.3315745067000044,-0.554738533147656,0.9634146341463414,1.0,1.0,4/13,23.79%,DAPK2;C1QBP;THBS4;RIPOR2
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.3350461503040991,-0.5547121491615625,0.9868421052631579,1.0,1.0,4/13,18.67%,PLN;PRKCE;CAV3;HECW2
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.3052715113100862,-0.5538919842426813,0.9625,1.0,1.0,8/20,26.55%,BRCA1;GSTM3;TRIM25;SRA1;CITED2;TRIM24;WBP2;CRHBP
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.33341776426882797,0.5532816279776412,0.9565217391304348,1.0,1.0,5/5,66.67%,HDHD5;CPNE1;FAR1;CPNE3;AGK
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.30661373426809696,0.5524113299375284,0.9411764705882353,1.0,1.0,10/10,69.36%,RPS6KB1;PRKAA1;ATF4;MEAK7;ULK1;RPTOR;KCNB1;MTOR;EIF4G1;PRKAA2
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.29043155138924065,0.5520223920204774,0.9333333333333333,1.0,1.0,8/8,70.98%,TRAPPC8;WIPI1;STX17;PACS2;WIPI2;ATG13;WDR45B;MFN2
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),0.3003460542087397,0.5513863763235027,1.0,1.0,1.0,1/8,6.72%,HLCS
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.3171076757508364,-0.55137908771604,0.9722222222222222,1.0,1.0,7/16,26.58%,MAPT;SH3GL2;STMN2;WASF1;NTRK3;MAGI2;TMEM108
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.32340515774370737,-0.5509582730562343,0.9466666666666667,1.0,1.0,8/12,35.29%,SNF8;TMEM50A;CHMP5;VPS28;VPS36;CHMP4B;CHMP6;STAM
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.35185034917667063,-0.5500281471759756,1.0,1.0,1.0,3/8,29.47%,PCSK5;SEC11A;SPCS2
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.3114112384001071,-0.5497816049086486,1.0,1.0,1.0,2/22,10.27%,GCNT1;GALNT8
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),-0.3537789466668374,-0.549555361745918,0.9420289855072463,1.0,1.0,3/8,20.50%,ABCA1;KLF4;KLF2
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.27326995587156544,-0.549530719812396,0.9767441860465116,1.0,1.0,8/38,25.13%,PPA1;DARS1;LARS1;NARS1;GARS1;HARS2;TARS3;WARS1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),-0.33886277946910076,-0.5488935810811576,0.9859154929577465,1.0,1.0,2/9,12.74%,NR1H2;ABCA1
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.31345488529474963,-0.5488585784208865,0.9875,1.0,1.0,4/23,14.02%,RAB7B;GRAMD4;NR1D1;CD14
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.3333490799360984,-0.5487700188898131,0.9305555555555556,1.0,1.0,1/9,14.47%,KDM1A
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.33606349742463915,0.5484467078528072,0.9285714285714286,1.0,1.0,6/6,66.41%,HNMT;AMD1;SMS;OAZ2;SRM;ODC1
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.29406522825903725,-0.54794608209726,0.9550561797752809,1.0,1.0,3/27,11.44%,HSPA1B;HSPA2;HSPA5
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.26626962744702476,0.5469205092927424,1.0,1.0,1.0,3/13,16.85%,SRC;ITGB5;ARRB1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.26626962744702476,0.5469205092927424,1.0,1.0,1.0,3/13,16.85%,SRC;ITGB5;ARRB1
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.22052235652100413,0.5468225217367757,1.0,1.0,1.0,18/18,77.98%,OSBPL6;NPC1;OSBPL7;OSBPL3;OSBP;ACAA1;OSBPL2;CYP7B1;GBA2;CYP46A1;ACOT8;SCP2;CYP27A1;OSBPL9;OSBPL1A;HSD17B4;CH25H;SLC27A5
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.33917783525652945,0.546450121641964,0.9,0.9998338865731582,1.0,3/6,23.24%,CTTNBP2NL;WWP2;PPIF
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.2895783962388685,-0.5458061945124769,0.9634146341463414,1.0,1.0,4/30,16.96%,RPA2;RPA3;TERF2IP;DNA2
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.23893005667007808,0.5457114543533583,1.0,0.9993691742780275,1.0,3/19,15.38%,RAB7A;WDR91;PTPN23
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.3013195286082606,0.5448528802189403,0.9459459459459459,0.9988867655978773,1.0,2/6,12.55%,PKDCC;SOX5
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.28044467634746406,0.5440397562100269,1.0,0.998478725775739,1.0,1/10,6.37%,SIRT1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.31037930474179076,-0.5438344338911044,0.9552238805970149,1.0,1.0,3/11,32.14%,GNL3;DKC1;CCT8
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),-0.3706340410637229,-0.5434585954958155,0.9444444444444444,1.0,1.0,2/5,31.36%,CEP250;BICD1
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.34617727849506774,-0.5427974656608043,0.9722222222222222,1.0,1.0,1/7,16.20%,ADCY10
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.26351103702187717,-0.5427486008696215,1.0,1.0,1.0,1/43,2.56%,VEGFA
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.2669121962586468,-0.5422953609778601,1.0,1.0,1.0,7/71,15.09%,DTL;UVSSA;TMEM161A;ERCC2;COPS9;KDM1A;BMF
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.3333516234209518,-0.5415277614143583,0.9733333333333334,1.0,1.0,3/12,19.53%,SDCBP;SNF8;PDCD6IP
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.3073200783450507,0.5406166287093215,0.9130434782608695,0.9990368212837426,1.0,3/9,17.48%,CAMKK2;VDAC1;PRKN
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.3254934825133737,-0.5398658791464613,0.9861111111111112,1.0,1.0,3/13,19.38%,CARMIL1;ARF6;AIF1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.30034168035639264,0.5396332968369062,0.875,0.9987211793689629,1.0,2/13,7.54%,TP53;TMEM109
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.26831020951863294,-0.5393764627109338,1.0,1.0,1.0,7/47,18.52%,CARMIL1;BAIAP2L1;PRKCE;HCLS1;PYCARD;ARF6;CRACD
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.2715507218794742,-0.5392768501684623,1.0,1.0,1.0,11/34,34.05%,SNF8;KLF4;LILRB2;KLF2;VPS35;APP;HSP90AB1;CNDP1;GSAP;ODC1;CHMP6
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.3339065015719265,-0.5378630327961265,0.9342105263157895,1.0,1.0,2/7,27.14%,PLEKHA4;CSNK1D
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),-0.34574022456905174,-0.5370089805913462,0.987012987012987,1.0,1.0,1/7,11.61%,SLC12A8
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),-0.34574022456905174,-0.5370089805913462,0.987012987012987,1.0,1.0,1/7,11.61%,SLC12A8
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),-0.3715545991380622,-0.5366875540210095,0.9444444444444444,1.0,1.0,4/6,23.71%,NRXN1;NEURL1;RELN;CAMK2B
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.2937848336429657,0.5361438965620419,0.96,0.9995903756077579,1.0,7/7,70.64%,CEP120;AKNA;NUMBL;NUMB;PCM1;DOCK7;HOOK3
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.3388377321451935,-0.535177974783281,0.935064935064935,1.0,1.0,2/8,22.93%,DDB1;VAPA
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.3365524492106935,-0.5340777642172602,0.9692307692307692,1.0,1.0,1/6,19.53%,PDCD6IP
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.3365524492106935,-0.5340777642172602,0.9692307692307692,1.0,1.0,1/6,19.53%,PDCD6IP
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.31904159381844466,0.5337364875576562,0.9629629629629629,0.999916965977944,1.0,2/5,13.66%,LHFPL2;CFAP69
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.2863175675675676,0.5332165744558466,0.9696969696969697,0.9993172053768702,1.0,9/9,71.39%,CCT3;CCT4;CCT2;CCT5;TCP1;CCT7;CCT6A;CCT8;DKC1
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),-0.2456245441727579,-0.5317027314157196,0.9893617021276596,1.0,1.0,5/79,9.22%,TAF6L;CHD3;SMARCD3;KDM6B;HCFC1
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.2838394180270868,0.5285947022118405,0.972972972972973,1.0,1.0,1/6,7.89%,SRGAP2C
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.294195056706805,-0.527709487193133,0.987012987012987,1.0,1.0,2/19,17.09%,TENT4B;SLX4
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.2392025234417468,0.5254138496853806,1.0,1.0,1.0,3/17,13.46%,BCKDHB;IVD;SLC25A44
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.2392025234417468,0.5254138496853806,1.0,1.0,1.0,3/17,13.46%,BCKDHB;IVD;SLC25A44
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.27801350289513455,0.5253252494704072,0.96,0.9996689666537601,1.0,1/10,13.33%,FGF2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.2884607987087036,-0.5249824947168967,0.9647058823529412,1.0,1.0,5/16,28.58%,CAV3;ATP2B4;SCN3B;SNTA1;FXYD7
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.27888549226679993,0.5247473503790062,1.0,0.9991173666090799,1.0,4/11,19.26%,ABCC4;LRRC8D;SLC19A1;ABCC5
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.34177642688280985,0.5247366290050495,0.925,0.998347630579335,1.0,5/5,65.84%,SLC39A12;SLC39A8;SLC39A10;SLC39A14;SLC39A6
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.3267335642930402,-0.5245069428447365,0.9696969696969697,1.0,1.0,2/6,23.99%,ING5;MEAF6
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.3596165613988904,-0.5242056499870879,0.9848484848484849,1.0,1.0,2/6,17.92%,AZIN1;ARG2
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.3093700599456096,-0.523910921197757,0.9863013698630136,1.0,1.0,2/16,12.74%,NR1H2;ABCA1
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.3426878243030924,-0.523022593823801,0.967741935483871,1.0,1.0,2/5,19.88%,SLC25A36;SLC25A19
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.3116411386072247,0.522532968403542,0.975609756097561,0.9976225345475022,1.0,3/6,19.79%,CYB5R3;DDAH2;GCH1
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.3116411386072247,0.522532968403542,0.975609756097561,0.9976225345475022,1.0,3/6,19.79%,CYB5R3;DDAH2;GCH1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.26739622389993223,-0.5222796257616331,0.98989898989899,1.0,1.0,4/52,12.62%,MDFIC;POLR2G;PPIE;IFIT1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),0.33834586275420897,0.5221438046344961,0.9210526315789473,0.9969649629255223,1.0,1/5,5.09%,LAPTM4B
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.28869468019926103,0.5206406601726258,0.9655172413793104,0.9966358711086879,1.0,3/12,18.96%,TASOR;TPR;SETDB1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.28473849488470465,-0.5199988575090733,0.987012987012987,1.0,1.0,1/25,6.46%,RBM3
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),-0.2970881081946821,-0.5199487887979627,0.9838709677419355,1.0,1.0,2/11,23.28%,ACAT1;MVD
prerank,GO_Biological_Process_2021__detection of virus (GO:0009597),-0.361965217039969,-0.5197629182783027,0.9821428571428571,1.0,1.0,3/5,33.15%,SERINC5;ZCCHC3;IFIH1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.3291576490965938,-0.5190741162755986,1.0,1.0,1.0,2/15,15.09%,TIMM13;BMF
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),-0.3352892416043846,-0.5181813445839777,1.0,1.0,1.0,2/7,21.17%,CDH2;NRG1
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.27717004667100575,0.5178109212416554,1.0,0.9969071848041857,1.0,4/11,17.48%,SYT17;SYT6;SYT13;PRKN
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.31133025927257457,-0.5173332421938027,1.0,1.0,1.0,4/11,23.23%,DYNC2I1;DYNC2LI1;DYNC2H1;IFT122
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.31335487080805635,-0.5166681282544866,0.961038961038961,1.0,1.0,3/15,18.00%,DDX11;TIMELESS;ATP2B4
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.25240914079289145,-0.515912834293882,1.0,1.0,1.0,11/67,25.70%,POLR1C;CGGBP1;BMI1;TAF1D;DNMT1;ERCC6;WBP2;TDG;JARID2;MACROH2A2;GLMN
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.36353949134302016,-0.5153684086934494,1.0,1.0,1.0,3/6,26.94%,MYBL1;TDRD1;MOV10L1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.3247067543732249,-0.5149781090023461,0.9692307692307692,1.0,1.0,1/7,11.84%,RAB3A
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.2601023308839478,-0.5131732786398149,1.0,1.0,1.0,4/38,13.29%,RPS14;ATP5IF1;RASGRP4;HCLS1
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.3211985957768373,0.51303503402107,0.9714285714285714,0.9977684402816476,1.0,2/7,10.56%,CST7;LDLR
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.27547074804052823,-0.512532922205309,0.9885057471264368,1.0,1.0,4/25,20.69%,RPS3;THY1;CD300A;TESPA1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.2529029742991671,0.5121439234675526,0.9655172413793104,0.997276130852987,1.0,2/12,16.95%,JAG1;TCF7L2
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.26935998237195047,-0.5101032202645631,0.9879518072289156,1.0,1.0,4/36,14.87%,CR1;PDE4B;RPS3;TRAF2
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),-0.2939516589855552,-0.5098871828919624,0.9759036144578314,1.0,1.0,3/11,26.96%,SLC12A8;SLC9A7;SLC12A7
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.31490517043422084,0.5095515496725195,0.9142857142857143,0.9973740291807809,1.0,2/5,16.24%,AK3;DHODH
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.2550460265180307,0.5086533726790836,0.9393939393939394,0.9968737132808851,1.0,8/8,74.51%,ANKS1A;C3;SCARF1;FARP2;ADGRB3;CX3CL1;C1QA;APP
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),-0.2782221151062532,-0.5065400785366378,1.0,1.0,1.0,5/24,24.08%,BRINP1;IMPACT;VWC2;GPRC5B;TCF4
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),-0.31552812274084807,-0.5045758245268622,1.0,1.0,1.0,2/9,17.03%,PRKCE;IRS2
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.32245045803081995,-0.5034123213479696,0.975,1.0,1.0,2/8,24.14%,AKAP6;AKAP9
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.2893156014395014,0.5021144795243844,0.875,0.9981036013668961,1.0,1/8,6.90%,STK26
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.33018301505336367,-0.5019484114231362,0.9846153846153847,1.0,1.0,3/7,27.93%,BCS1L;TTC19;UQCRFS1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.33018301505336367,-0.5019484114231362,0.9846153846153847,1.0,1.0,3/7,27.93%,BCS1L;TTC19;UQCRFS1
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),-0.3182858364023329,-0.5009909780933364,0.9857142857142858,1.0,1.0,2/7,21.17%,CDH2;NRG1
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.33821157447772615,-0.4993171618131503,1.0,1.0,1.0,2/6,32.96%,VCPIP1;RB1
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.3028056894342298,-0.4978845066241224,0.9726027397260274,1.0,1.0,2/10,22.36%,LIPE;STS
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),0.27242777496198695,0.4978159939544008,1.0,0.9985987436217025,1.0,11/11,72.78%,GLUD1;IDH3A;IDH2;IREB2;ACO2;IDH3G;IDH1;ACLY;IDH3B;SIRT4;ACO1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.26827916667940477,-0.49738724729799066,0.9746835443037974,1.0,1.0,8/23,34.77%,TCF7;FCER1G;SOX4;PTPN22;GPR89B;PTPRC;RHOH;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.2815640570897728,0.4966889376921175,0.9615384615384616,0.9982252102129027,1.0,8/8,71.86%,CDC73;LEO1;NUDT21;CPEB3;DHX36;NCBP1;HSF1;NCBP2
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.27570877096393714,0.4966536932831256,0.9545454545454546,0.9974637874743726,1.0,1/9,8.15%,SLC44A2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.33660624677824597,-0.49549984468461716,1.0,1.0,1.0,4/5,33.99%,TNFAIP3;PTPN22;FLOT2;FLOT1
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.28468785214993064,-0.49510833121298287,1.0,1.0,1.0,2/10,29.61%,PIPOX;CRYM
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.28468785214993064,-0.49510833121298287,1.0,1.0,1.0,2/10,29.61%,PIPOX;CRYM
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.28028659414540696,-0.4949900787530115,1.0,1.0,1.0,6/18,31.23%,SHANK3;RDX;ACTG1;ROCK1;PTGER4;RAC1
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.2796171808306055,0.4944223922204544,0.9629629629629629,0.9973444458972186,1.0,1/7,13.53%,SLC30A10
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.2611279163675466,-0.493859250253332,1.0,1.0,1.0,2/30,8.24%,POLR3F;DHX58
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.3157658094282166,-0.4936048075434972,0.9838709677419355,1.0,1.0,6/9,32.53%,HLA-F;KLRD1;HFE;IL4I1;LILRB1;PTPRC
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.2954350964757925,0.4919819848212636,0.9722222222222222,0.9972884273194498,1.0,1/6,9.84%,SKI
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.2816930293524429,-0.49144841035357917,0.9882352941176471,1.0,1.0,3/15,19.53%,SDCBP;SNF8;PDCD6IP
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.23059147998675833,0.49013559645479954,1.0,0.9970702544461162,1.0,2/17,7.54%,TP53;TMEM109
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),-0.33402706818190575,-0.49012999436190435,0.9558823529411765,1.0,1.0,1/5,25.99%,ATP8A2
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.31737066759601895,-0.4891780774618774,0.967741935483871,1.0,1.0,2/6,27.33%,CCDC88C;RILPL1
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),-0.3047149735746196,-0.4889190052892862,1.0,1.0,1.0,2/11,19.53%,CHMP5;PDCD6IP
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.30125848276216305,-0.48868173938607934,1.0,1.0,1.0,3/9,25.50%,PYCARD;AIF1;APP
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.25456957035251515,0.4884312545031085,0.9285714285714286,0.997005523123666,1.0,1/11,5.46%,LEPR
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.2703365830453379,-0.48800800111705356,0.9761904761904762,1.0,1.0,3/22,14.87%,PDE4B;RPS3;TRAF2
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),-0.3247123195285604,-0.4870769944576141,1.0,1.0,1.0,2/5,22.54%,TTBK2;MAP2
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.29564783801948435,-0.48649649489655594,0.9871794871794872,1.0,1.0,2/13,19.53%,CHMP5;PDCD6IP
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.23039054258060837,-0.4854810651838945,1.0,1.0,1.0,8/85,18.48%,VAV3;CFL1;CXCR4;CDKN1B;TRAF2;STAT2;MAPK10;RIT1
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.32762169565147925,-0.4847714202821915,1.0,1.0,1.0,1/5,22.54%,MAP2
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.27567145047278246,-0.48365040690798294,0.9861111111111112,1.0,1.0,3/20,15.51%,TOMM40;TOMM20;TIMM21
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.26123138100497956,0.48328102103968,0.9629629629629629,0.9976608590441164,1.0,3/14,14.46%,CXCL12;ADAM10;DOCK8
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.2737257469478027,-0.48325685447840944,0.9880952380952381,1.0,1.0,3/14,29.20%,SEC24C;SEC13;RAB1A
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.3303073991687798,-0.4828761726629932,0.972972972972973,1.0,1.0,3/7,22.85%,PLEKHA7;KIFC3;THBS4
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.26815672340199875,-0.4817005511321943,1.0,1.0,1.0,10/26,29.04%,BNIP3;GHITM;MICOS13;SLC25A5;RCC1L;HSPA9;APOO;SPG7;IMMT;MFN2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.2836035123269165,0.48012006445365996,0.9444444444444444,0.9977036909049605,1.0,5/5,71.65%,MTMR2;MTMR1;MTMR3;MTMR9;MTMR4
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),-0.3084741534000476,-0.4792051275086363,0.9857142857142858,1.0,1.0,3/6,32.29%,GPS2;PLAA;PARP10
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),-0.29834050594363204,-0.4791941294454045,1.0,1.0,1.0,2/11,20.15%,FAAH;FAH
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),-0.29893118612162384,-0.4771960830260666,0.9875,1.0,1.0,3/8,26.61%,VCPIP1;OTUD7B;TNFAIP3
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.2566091435880876,0.4770936685964649,0.9714285714285714,0.9978902330405246,1.0,3/7,23.27%,PHKG2;GSK3B;UGP2
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.2773689382297279,-0.4770135364035117,0.9868421052631579,1.0,1.0,2/12,25.34%,METTL4;PARG
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),0.2929450479299124,0.47636834817538626,0.9302325581395349,0.9973491818469409,1.0,1/6,9.84%,SKI
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.2915911860724747,0.47512288066423614,0.96875,0.996970452535111,1.0,4/6,27.60%,OPN3;CCND1;AKT1;EGFR
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.29921287333587054,0.4728797423356263,1.0,0.9969419529623172,1.0,1/5,10.47%,SRC
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.24277749619868239,0.4725383141911626,0.9583333333333334,0.9962326303347461,1.0,11/11,75.74%,CAMK2G;RAB11B;CYB5R4;PTPRN;SELENOT;ANXA1;RAB11FIP2;PARK7;SNX19;PTPRN2;RIMS2
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.2880541537616185,-0.472294097720569,1.0,1.0,1.0,3/14,32.06%,EMD;NEMP1;SUN2
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.2683640908525836,-0.472132254157278,1.0,1.0,1.0,2/21,11.21%,TENT4B;PAPOLG
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.2683640908525836,-0.472132254157278,1.0,1.0,1.0,2/21,11.21%,TENT4B;PAPOLG
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),-0.28713027550962744,-0.4717729295737149,0.9850746268656716,1.0,1.0,4/10,30.28%,MYRF;HTRA2;CASP1;AFG3L2
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.2582264799687362,-0.47006712802913553,1.0,1.0,1.0,2/21,20.56%,ACOT13;ACSM3
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),-0.2815402057893355,-0.4699052585047301,0.9863013698630136,1.0,1.0,3/11,21.77%,SPG11;KIF5A;KIF5C
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),-0.31572583706934765,-0.4684533855840369,0.9850746268656716,1.0,1.0,3/5,39.37%,IL4I1;HLA-DRB1;HSPD1
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.28906300430428256,-0.4668398049136202,1.0,1.0,1.0,5/8,36.17%,MPP1;JAM3;RAC1;RHOH;SLAMF8
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.2892603850050658,0.46300730523928624,1.0,0.997493818648247,1.0,5/5,71.09%,PRKN;SNCA;HDAC6;MT3;OXA1L
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.24978277881209554,-0.4629320123767796,1.0,1.0,1.0,5/36,20.99%,USP36;CHMP5;PDCD6IP;NUP133;SEH1L
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.252872274960821,-0.46040952574835686,1.0,1.0,1.0,1/21,9.79%,MTERF1
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.26073761343936486,-0.45919955239458105,1.0,1.0,1.0,7/15,31.57%,SRA1;RIPOR2;PLCB1;BTG1;LRRC8A;RANBP3L;FLOT2
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),-0.3146470761352158,-0.4569208257045094,0.9857142857142858,1.0,1.0,1/5,21.75%,LIG3
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.28607181677699595,-0.45586285335977167,1.0,1.0,1.0,2/8,26.20%,APOD;NDRG4
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),0.2879939209726443,0.4555210414376253,0.9210526315789473,0.998109045101674,1.0,5/5,71.21%,ADCY6;GNB1;TGFBR3;GNG2;PTGER4
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),-0.2478774583015611,-0.4552929717014997,1.0,1.0,1.0,9/20,36.18%,PINK1;TXN;PDE8A;HTRA2;HSPB1;GPR37;VNN1;SOD2;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.2722969480746049,-0.454659635892124,0.9861111111111112,1.0,1.0,2/10,30.98%,MAP1A;HSP90AB1
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.2533093857981987,-0.4544893548837071,1.0,1.0,1.0,6/21,30.72%,RPGRIP1L;DCTN1;IFT122;CSNK1D;BBS4;CEP250
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.2777978362348992,-0.4542239565546341,0.9866666666666667,1.0,1.0,1/13,13.46%,SNF8
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.2450861080858714,0.45411685850917966,1.0,0.9976239096984876,1.0,2/10,18.96%,TASOR;SETDB1
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.26108249598919187,0.4507329939000351,1.0,0.9974431851988731,1.0,6/6,73.90%,BCL2;ACTB;AHCYL1;SNCA;PIM1;CHRM3
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.2798885511651471,0.44465195772066446,0.9655172413793104,0.9975751084190717,1.0,5/5,72.02%,GBF1;SEC16A;LRRK2;MIA3;BCAP31
prerank,GO_Biological_Process_2021__melanosome assembly (GO:1903232),0.28014184397163133,0.44403237507023596,1.0,0.9969487783901997,1.0,5/5,72.00%,HPS4;RAB32;RAB38;HPS1;TRAPPC6A
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.21831173294924827,-0.4421258407879837,1.0,1.0,1.0,10/56,25.45%,MYRIP;NR1D1;SNAP25;IRS2;CACNA1C;PER2;SOX4;SLC2A1;RAPGEF3;NLGN2
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.2912026841923778,-0.44211141272967264,0.9661016949152542,1.0,1.0,2/7,24.30%,HMGCL;BCAT1
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),-0.2779255771881787,-0.440326939271378,1.0,1.0,1.0,1/7,25.34%,PARG
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.2705868303368346,-0.4377431512160473,1.0,1.0,1.0,3/8,29.24%,SCN3B;RYR2;ATP2A2
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),-0.22183382490630316,-0.4349385371940457,1.0,1.0,1.0,7/27,30.21%,LNPK;ANXA2;FYCO1;CALCOCO2;HTRA2;SURF4;KATNBL1
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.23933621196040528,-0.4302412642502792,1.0,1.0,1.0,4/20,24.52%,RGCC;RDX;AIF1;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.2782243297323209,-0.4302266392563057,1.0,1.0,1.0,1/6,25.77%,EPHA4
prerank,GO_Biological_Process_2021__negative regulation of myosin-light-chain-phosphatase activity (GO:0035509),-0.2907192283438165,-0.42728676487964035,1.0,1.0,1.0,1/5,26.77%,ROCK1
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.23777825741918301,0.42651640994407186,1.0,0.9980700603110173,1.0,3/11,22.76%,ARRB2;GSK3B;MEF2C
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),-0.2860522700611469,-0.42597285293901904,1.0,1.0,1.0,1/6,17.19%,AMPD2
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.2606641639069023,-0.42448255797658285,0.9852941176470589,1.0,1.0,2/7,26.17%,MFSD2A;ABCA3
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.28632719756038316,-0.4219903998674945,1.0,1.0,1.0,3/5,33.99%,RIPOR2;CFLAR;FLOT1
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.2521952043228639,0.4138315744785831,1.0,0.9983525975529395,1.0,5/5,74.79%,CLCN3;ATP6AP1;SLC9A1;PDK4;SLC9A7
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.2794168254269121,-0.4121268920660866,1.0,1.0,1.0,1/5,21.23%,NFS1
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.2597103021195777,-0.4043577937428583,0.9841269841269841,1.0,1.0,1/6,24.90%,PPARA
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.24137949054431695,-0.40349785118739045,0.9859154929577465,1.0,1.0,8/11,39.32%,ENO1;CHRM2;ATP1A2;KCNB2;MYBPC3;ANXA6;SRI;PLCE1
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.23771576499623345,-0.39592213200993004,1.0,1.0,1.0,3/10,33.00%,SPAST;CLASP2;CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.24650046770027997,-0.3957416989661331,1.0,1.0,1.0,4/9,36.78%,RIPOR2;RAPGEF3;FLOT1;CAMK1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.24148651771857393,-0.3943175383343102,0.9848484848484849,1.0,1.0,6/11,38.55%,ZWILCH;CHAMP1;IK;RB1;KNL1;MIS12
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.22115631549618553,-0.38028118995564403,1.0,1.0,1.0,6/15,34.75%,SLC27A5;CH25H;HSD17B4;OSBPL1A;OSBPL9;CYP27A1
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.23658365220499428,-0.37997601607927534,0.9852941176470589,1.0,1.0,2/7,33.00%,SPAST;CHMP4B
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.19419583387511982,-0.3714861431877189,1.0,1.0,1.0,7/36,25.23%,PER2;ELOVL4;ACSM3;GATM;ALDH1A2;SLC27A5;CH25H
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.2539373233516156,-0.3672585339915271,1.0,1.0,1.0,2/5,33.03%,SLC25A5;SLC25A4
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),-0.24486769482328452,-0.36348908472126146,1.0,1.0,1.0,1/6,23.66%,ERCC6
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.21512583854907552,-0.358110478951006,1.0,1.0,1.0,2/11,26.20%,AIF1;NDRG4
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.23969828599723608,-0.3557716606809596,1.0,0.9998426255394743,1.0,1/6,20.66%,NUP133
